data_1ezo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ezo _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.729 0.299 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.31 43.71 97.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.82 139.74 40.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.5 mt -138.21 154.77 49.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.61 102.82 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.43 118.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.406 ' CE2' HD12 ' A' ' 43' ' ' LEU . 93.8 m95 -94.98 112.05 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -145.24 145.56 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.068 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -163.75 112.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.66 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -176.92 -48.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -153.17 -175.15 5.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 -34.89 3.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 8.5 p90 -62.36 -34.65 77.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 21.4 t-20 -68.07 -36.89 80.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.57 -39.03 30.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.28 -31.32 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.35 94.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.44 -34.33 73.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.67 -31.0 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.13 -46.72 9.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -29.7 59.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.776 0.322 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -37.74 37.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -67.26 -56.5 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.588 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -53.58 -27.7 27.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 110.245 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -46.4 -32.49 3.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.809 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' CG2' ' A' ' 31' ' ' THR . 24.7 t0 -62.97 -57.41 10.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.61 37.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.653 0.596 . . . . 0.0 112.248 176.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.87 43.37 0.02 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 117.909 -2.091 . . . . 0.0 115.537 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.585 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 3.2 mp -140.38 95.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 118.039 0.919 . . . . 0.0 111.857 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.17 131.8 54.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.07 148.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.76 137.13 50.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.55 111.51 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.75 163.05 31.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -98.72 144.4 28.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 136.04 23.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.516 2.144 . . . . 0.0 112.326 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.46 -47.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -116.24 0.15 12.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.374 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 10' ' ' TRP . 7.2 tp -56.6 -25.41 52.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.746 0.308 . . . . 0.0 111.147 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -55.73 -31.96 62.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.24 -29.6 13.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -73.95 -24.55 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.15 -58.48 8.65 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 26.5 Cg_endo -61.96 -18.96 64.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.436 2.091 . . . . 0.0 112.455 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -89.75 -35.97 15.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.829 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.8 t -88.58 -17.83 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.39 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.27 -39.76 64.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.827 0.346 . . . . 0.0 111.271 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.35 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -169.66 -74.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.808 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.08 -74.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.18 -71.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.27 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.27 -177.74 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 167.09 106.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.8 tt -146.94 117.31 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.19 142.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.05 117.13 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.386 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -143.12 173.23 11.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.26 -168.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.186 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 261' ' ' VAL . 0.4 OUTLIER -76.1 -56.4 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.04 -28.98 57.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.982 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -41.77 84.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -111.88 -55.23 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.62 -29.07 74.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.81 29.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.548 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.63 -45.93 8.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.17 71.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.06 67.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -108.33 25.79 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.07 -75.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.77 83.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.25 143.7 40.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.49 83.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 96.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.07 158.32 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.6 p -101.2 157.96 32.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.8 89.64 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.605 2.203 . . . . 0.0 112.397 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.12 -55.2 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -25.29 64.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.25 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.493 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -75.13 -59.18 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.03 61.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.39 -39.86 52.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.02 37.3 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -170.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -98.05 146.53 31.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.97 -32.4 8.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.541 2.161 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -31.73 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -31.3 62.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.54 -41.78 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -30.93 70.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.53 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 64' ' ' HIS . 22.8 m -122.06 60.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 93.04 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -101.93 113.66 27.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.4 -68.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.54 39.11 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.492 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.6 171.5 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.39 92.03 3.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.97 46.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.51 124.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.96 100.99 36.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.997 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.87 127.72 7.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.199 . . . . 0.0 112.135 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mm -138.8 39.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 111.252 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 262' ' ' LEU . . . 176.02 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.779 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.97 105.72 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.918 0.39 . . . . 0.0 111.056 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 132.86 49.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.97 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.48 174.32 14.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.92 160.73 14.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 m -164.07 -179.79 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.99 133.67 54.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.71 143.57 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 245' ' ' THR . 46.7 p90 -139.1 179.36 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -139.41 177.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.77 34.93 4.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -131.11 -65.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.04 39.92 3.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.15 88.36 13.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.77 140.23 47.56 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.31 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -70.26 165.89 39.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.72 122.45 10.54 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.528 2.152 . . . . 0.0 112.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.64 -52.15 1.51 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.41 2.073 . . . . 0.0 112.361 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.43 -76.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.6 p -116.42 -173.64 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.036 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.429 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.6 m95 -70.6 -31.23 68.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.95 -24.17 8.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.313 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.05 -15.91 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.687 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.561 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 5.6 tp -52.75 -35.79 28.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 16.8 Cg_exo -68.2 -27.45 35.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.293 1.995 . . . . 0.0 112.2 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.05 -28.24 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 -31.86 52.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.08 -51.95 22.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -30.64 68.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.48 -43.28 23.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.0 -49.93 70.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -26.12 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.9 -23.12 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.383 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -110.63 -60.71 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.49 40.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.566 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.65 -178.03 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -139.29 175.36 9.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -135.12 44.96 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.221 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.14 115.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 14.6 mmt -159.14 106.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 156' ' ' PHE . 1.6 t80 -168.97 177.03 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -67.83 178.96 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -46.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.62 40.06 1.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.76 149.07 36.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 155.88 23.85 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.666 2.244 . . . . 0.0 112.321 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 60.26 20.36 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.497 ' CZ ' ' CE2' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -121.08 -56.35 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.927 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -72.35 -32.03 66.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.172 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.509 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 66.1 t90 -64.36 -55.16 32.62 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -62.29 -28.66 79.12 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.264 1.976 . . . . 0.0 112.275 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 tp -68.7 -56.96 6.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.23 -4.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.216 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 -50.45 11.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.874 0.369 . . . . 0.0 111.047 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -101.44 37.64 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -108.02 -31.21 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.3 -41.68 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.01 164.77 27.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -176.18 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.23 -35.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -85.23 57.28 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -130.83 160.03 35.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.24 -31.48 72.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.068 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.79 -55.36 25.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.26 -33.32 72.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -74.26 -46.28 42.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.15 -30.48 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.02 -60.32 3.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.451 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -31.57 65.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.818 0.342 . . . . 0.0 110.776 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 40.3 p -72.9 -28.72 62.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.7 -50.44 12.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.94 -28.84 68.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.663 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.42 -46.59 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 198' ' ' LEU . 10.5 p30 -62.55 -27.19 69.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 111.228 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.427 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 0.2 OUTLIER -57.48 -30.69 65.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.144 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 mt -79.8 -55.2 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -21.02 64.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.404 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.82 15.54 16.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.327 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -120.15 -75.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -120.12 -4.93 10.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.49 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 24.1 ptm 45.53 30.56 0.78 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.366 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.5 -43.84 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 67.52 73.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -113.07 28.25 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.18 119.65 39.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -166.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -79.1 -40.81 30.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.284 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -79.94 -24.63 40.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.58 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.0 mt -81.82 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.71 -30.28 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.491 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.36 -30.48 33.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.15 67.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.601 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.39 -56.92 10.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.612 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 20.4 p90 -76.39 -34.6 58.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.451 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 1.8 m-20 -73.66 -8.31 55.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.305 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -23.65 58.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.001 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 221' ' ' GLU . . . -159.33 -85.42 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.385 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 220' ' ' GLY . 0.5 OUTLIER 171.78 101.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.482 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.4 t -116.27 -177.36 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.88 39.56 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.98 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -162.47 99.68 1.04 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 17.3 m -144.51 105.15 4.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 4.0 mt -113.51 135.0 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.7 147.57 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -155.07 -157.05 8.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.326 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.6 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.889 0.376 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.19 -173.7 13.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.04 136.48 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.417 HG21 ' CE1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -130.58 156.18 45.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.1 p -77.42 150.63 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.93 146.72 81.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 95.6 Cg_endo -79.77 152.07 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.681 2.254 . . . . 0.0 112.435 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 45.6 p -63.82 177.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CD1' ' OD1' ' A' ' 164' ' ' ASP . 4.5 t80 -159.88 111.89 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.739 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.2 mttm 59.38 21.24 9.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.51 -47.64 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.59 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.93 151.19 29.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 -175.63 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.314 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -172.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -118.5 81.25 17.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.69 -168.3 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.631 2.221 . . . . 0.0 112.344 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.418 ' CZ ' ' HE3' ' A' ' 330' ' ' MET . 41.2 p90 -171.95 161.13 5.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 146.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -111.53 74.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.524 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.449 ' CG2' ' CD2' ' A' ' 64' ' ' HIS . 13.3 m -95.83 135.13 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.403 ' CD2' ' CB ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -86.87 124.25 32.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 t -92.95 112.86 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.758 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.12 49.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 169.1 -173.26 43.55 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 26.3 mm -88.53 159.74 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.046 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.12 108.02 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 67.78 10.28 7.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.827 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 45.41 30.3 0.7 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.559 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER -64.2 -61.04 7.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.032 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 270' ' ' SER . 63.4 Cg_endo -73.63 97.85 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.504 2.136 . . . . 0.0 112.468 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 59.1 86.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.041 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.99 -30.94 61.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -76.43 -57.23 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.96 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.62 -31.4 71.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.22 -56.75 18.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.22 -43.94 80.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.79 -42.27 99.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.07 -31.3 72.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.997 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.24 -25.76 36.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -93.8 -32.24 14.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.15 27.53 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.219 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 27' ' ' PHE . 1.4 m-85 -177.31 48.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 110.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.1 mt -178.25 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.44 65.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.1 t -150.99 171.85 16.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.739 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.37 -48.2 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -77.55 -35.02 53.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -55.34 -75.76 0.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.791 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 -21.92 29.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.316 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -29.12 5.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.359 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.91 -53.76 7.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.612 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.3 p -72.41 -46.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.8 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -58.29 -21.22 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.326 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -55.25 2.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.97 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -126.62 87.66 55.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.09 163.71 38.28 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.539 2.159 . . . . 0.0 112.23 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 299' ' ' LEU . 1.3 pt? -175.72 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -160.32 -167.1 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.448 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -136.51 160.06 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.95 -179.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -107.89 40.0 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.26 126.97 31.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.82 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.11 93.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.4 p -68.78 -52.42 30.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -27.35 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.37 -28.13 51.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.87 -45.68 89.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -93.23 -31.95 14.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.6 mp -59.88 -28.19 67.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.51 29.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.327 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -58.73 -30.75 67.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.91 140.59 33.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.95 -17.94 11.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.589 2.193 . . . . 0.0 112.825 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -51.18 -54.56 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.283 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.46 -29.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.357 . . . . 0.0 111.094 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.77 71.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.14 34.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 62.4 p -71.67 -43.39 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 ptm -59.43 -28.81 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -57.38 12.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -78.35 -31.13 48.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.1 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.298 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -50.27 65.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.147 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -47.62 11.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 159.91 136.72 2.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 89.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.64 118.49 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.418 ' HE3' ' CZ ' ' A' ' 258' ' ' PHE . 0.1 OUTLIER -61.02 120.31 53.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.42 -168.23 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.397 2.065 . . . . 0.0 112.289 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -98.45 -65.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 333' ' ' ILE . 4.5 tp 34.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.955 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.1 -25.24 31.82 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.471 2.114 . . . . 0.0 112.392 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -25.85 59.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -28.56 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 m -56.94 -47.6 80.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -33.88 63.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.041 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.4 -27.0 68.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -32.48 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.94 -31.46 45.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.82 -40.71 39.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 28.4 t -59.4 -30.1 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.97 -60.64 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 50.3 m -58.8 -27.78 65.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.49 -52.28 11.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.406 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.19 -54.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.691 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.43 -58.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.56 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -57.22 -50.66 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.78 59.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.31 -10.69 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.434 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 51.6 p -67.69 -30.22 69.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 112.54 -25.34 12.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -112.83 39.85 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.61 145.67 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 t -124.15 148.95 46.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.01 -28.2 43.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.37 -30.4 60.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 -54.75 5.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.06 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.138 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -56.6 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -60.74 -52.27 65.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -58.65 -34.88 71.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.91 72.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -31.58 69.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 27.0 m -80.7 -38.18 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 -43.43 59.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.47 -35.42 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.4 m -80.34 -54.37 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.52 86.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -167.96 138.29 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -147.86 159.57 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.53 103.44 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.04 119.53 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -103.29 126.37 50.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -172.11 158.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.426 ' HB2' ' CG ' ' A' ' 39' ' ' HIS . 9.9 t30 -176.53 -169.88 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.92 -31.63 3.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.31 -51.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -178.28 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.16 24.26 28.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.699 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.97 -58.08 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -60.16 -40.9 91.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -51.27 60.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.578 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -31.17 54.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.13 -38.0 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -52.71 64.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.68 -43.77 97.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.185 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.93 -36.34 92.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -59.45 -44.47 92.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -79.2 -30.06 43.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.966 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' ' CE1' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -60.66 -56.55 19.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.548 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -56.32 -27.89 57.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.536 0.684 . . . . 0.0 110.4 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -33.4 14.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.499 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.485 ' O ' ' CB ' ' A' ' 31' ' ' THR . 5.0 t70 -59.73 -57.4 13.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.485 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.65 36.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.872 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.61 44.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 117.958 -2.068 . . . . 0.0 115.47 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.548 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 2.3 mp -139.69 95.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 117.998 0.899 . . . . 0.0 111.608 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -126.4 114.8 18.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.419 HG11 ' CZ ' ' A' ' 283' ' ' TYR . 3.5 m -110.94 134.62 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 146.2 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.27 123.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.072 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -155.46 163.16 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.426 ' CG ' ' HB2' ' A' ' 12' ' ' ASN . 14.2 t-80 -152.8 79.42 5.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.79 -168.36 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.454 2.103 . . . . 0.0 112.268 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.69 -28.45 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -81.93 0.12 41.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -47.75 -28.77 2.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.779 0.323 . . . . 0.0 111.278 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -68.57 -37.0 79.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.26 -15.17 19.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -71.58 -24.54 61.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 9.6 m-85 -51.22 -60.77 5.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.257 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' PHE . 53.4 Cg_endo -69.61 -15.36 37.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.501 2.134 . . . . 0.0 112.658 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.52 -55.32 3.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.62 -26.22 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.14 69.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.183 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.3 -18.98 59.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -144.35 115.28 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.14 70.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.341 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -96.6 28.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.22 -93.47 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.33 128.35 17.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.541 2.161 . . . . 0.0 112.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.61 103.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.049 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 tt -133.04 145.66 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.647 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.17 142.76 20.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.396 . . . . 0.0 111.399 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CD2' HD13 ' A' ' 108' ' ' ILE . 64.5 m-85 -100.36 118.94 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 263' ' ' SER . 2.2 m95 -138.73 173.7 11.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.18 -177.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 111.336 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -76.92 -50.1 14.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.28 -25.96 67.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -29.51 53.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -115.72 -36.32 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.89 -26.1 39.73 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.715 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.9 -25.61 2.5 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.862 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -34.08 16.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 111.119 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.14 -55.66 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.18 -20.39 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -95.27 -26.77 15.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.51 -90.79 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.558 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.07 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -123.15 150.46 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.21 121.35 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 139.13 55.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -115.76 147.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -104.73 145.73 31.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.85 162.12 23.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.646 2.231 . . . . 0.0 112.434 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.42 -47.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.78 -20.43 29.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.7 19.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.379 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.04 -59.16 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.39 . . . . 0.0 110.639 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.51 -24.82 62.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.12 -26.24 62.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 tttm 66.62 72.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.34 163.02 13.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.14 139.16 97.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.78 -44.41 49.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.496 2.131 . . . . 0.0 112.321 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.08 -29.55 65.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.6 m -56.96 -30.22 63.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -92.58 -41.05 10.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -30.43 69.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.48 -30.99 63.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 54.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -138.34 96.36 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.11 120.22 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.6 -74.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.59 36.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -145.62 -178.5 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -137.96 92.7 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.25 40.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.92 65.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.22 113.27 29.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.74 133.2 10.19 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.443 2.095 . . . . 0.0 112.436 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.415 HD13 ' CD2' ' A' ' 61' ' ' PHE . 2.4 pp -145.77 39.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.03 154.43 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.69 106.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.14 135.37 54.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.79 176.58 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.61 164.64 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 m -165.05 -178.75 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.65 132.37 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -104.27 138.92 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.128 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE1' ' HA3' ' A' ' 243' ' ' GLY . 8.2 p90 -146.96 167.38 24.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.55 159.34 19.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.63 36.41 2.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -155.36 30.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.16 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.806 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tt -123.42 84.5 52.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.33 160.46 3.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.239 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.07 111.63 6.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.73 154.82 26.97 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.57 10.29 3.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.777 2.318 . . . . 0.0 112.893 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt 63.42 49.53 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.928 0.394 . . . . 0.0 111.196 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.6 t -160.14 142.63 13.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.948 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.423 ' CD2' HD13 ' A' ' 132' ' ' ILE . 2.8 m95 -57.98 -28.89 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.002 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.58 -23.8 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.632 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.31 -21.42 60.57 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 21.4 mt -73.33 -53.43 4.7 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 82.5 Cg_exo -46.79 -49.94 11.5 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.276 1.984 . . . . 0.0 112.536 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.98 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.7 mt -59.11 -32.17 69.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -57.08 -34.36 68.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -31.17 57.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.3 -41.61 33.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.39 -55.84 28.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -61.31 -24.42 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -23.23 24.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.476 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -110.61 -72.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.72 39.72 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.441 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.71 178.95 9.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.6 138.65 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.22 53.34 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.841 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -176.68 115.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.409 ' HG2' ' HA ' ' A' ' 225' ' ' THR . 1.1 ppp? -87.7 -173.63 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.428 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 41.4 p90 -86.5 107.67 18.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 t30 177.54 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.74 -32.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.68 43.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.075 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.8 144.23 26.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.817 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.67 90.8 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.535 2.157 . . . . 0.0 112.281 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.45 -31.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -117.64 -31.44 5.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.959 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -33.87 76.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.892 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.484 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -63.5 -56.14 29.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 52.7 Cg_endo -68.72 -11.12 31.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 0.0 112.44 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.77 -57.01 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.02 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 5.31 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.503 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -94.38 -69.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.905 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.87 -86.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.37 29.19 7.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.977 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.41 -75.33 0.65 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.05 107.51 0.98 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.539 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 111.95 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 -179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.98 -19.42 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.26 56.49 3.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.1 129.3 50.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.67 -23.92 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.312 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.63 70.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.647 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.65 -40.43 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -67.73 -30.91 70.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.89 -56.87 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.27 -26.02 74.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.609 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.78 -48.37 81.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.8 p -72.01 -31.03 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -70.21 -43.0 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -49.98 67.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.3 m -58.73 -43.22 87.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.28 -30.87 69.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -48.23 82.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.97 -33.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -29.93 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.14 -26.16 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -102.98 -69.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -60.24 -45.41 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.4 ttt 60.46 26.92 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.0 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.05 -45.27 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.02 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -166.75 76.64 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.6 p -55.23 148.11 15.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.11 -167.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.098 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -79.37 -41.81 26.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -78.8 -25.03 44.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.398 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.07 -54.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.078 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.51 -30.39 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.447 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.03 -23.38 52.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.103 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.69 -52.75 59.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.428 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.08 -55.48 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -55.38 -28.21 52.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -49.03 -30.86 6.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -23.99 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 62.82 22.59 64.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.06 73.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.977 0.417 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.8 p -109.77 -177.08 3.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.63 39.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.991 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.428 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 169.34 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.409 ' HA ' ' HG2' ' A' ' 148' ' ' MET . 0.8 OUTLIER -136.49 105.09 5.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.4 tt -92.98 114.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.088 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -142.29 164.19 30.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.81 -159.87 10.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.41 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.542 2.161 . . . . 0.0 112.335 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.849 0.357 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' A' ' 117' ' ' TYR . . . -95.79 83.5 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.46 114.71 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.4 p -141.08 162.72 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.39 150.56 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.92 158.67 23.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.43 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.88 2.387 . . . . 0.0 112.263 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.09 177.61 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 129' ' ' TRP . 4.2 t80 -164.74 115.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.6 tttt 61.23 19.0 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.75 47.77 9.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -141.07 90.76 9.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.21 130.29 10.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.604 2.203 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.9 t -53.09 160.31 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.4 90.77 35.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.52 -159.93 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.054 2.502 . . . . 0.0 112.086 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.75 138.81 47.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.17 155.17 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -132.86 136.08 8.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.612 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.77 144.59 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.3 mp -85.44 117.84 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' TRP . 92.4 p -87.65 114.73 24.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.58 128.84 56.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.9 -179.28 35.55 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.573 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 1.8 mt -111.68 159.36 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -127.22 134.88 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 58.68 30.64 20.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.72 34.97 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.424 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 1.4 m -55.76 -61.12 6.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 270' ' ' SER . 36.4 Cg_endo -65.36 -23.78 58.28 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.497 2.131 . . . . 0.0 112.542 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -117.09 38.06 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.004 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.67 -57.31 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.55 -30.03 68.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.2 -56.47 6.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.224 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.15 -40.43 89.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.65 -46.77 84.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -73.36 -29.61 62.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -53.99 51.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.36 -14.44 52.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.08 27.59 3.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.157 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.474 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -125.76 -57.05 1.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.771 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.474 ' HA ' ' HA3' ' A' ' 289' ' ' GLY . 4.9 mp -110.94 -78.17 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 18.5 tp 62.5 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.96 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.11 137.65 11.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.302 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.4 t70 70.84 -54.36 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 111.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.79 -58.05 8.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 284' ' ' LEU . . . -120.75 -38.93 0.63 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.829 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 1.0 OUTLIER -55.14 -58.85 5.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.893 0.378 . . . . 0.0 111.184 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 5.6 mm-40 -55.25 -35.87 65.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.116 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.82 -24.86 66.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.5 t -71.68 -30.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.48 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -105.59 -49.63 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.09 -42.64 81.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.69 -51.31 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.42 138.19 32.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.09 122.44 8.76 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.413 2.075 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.1 mp -151.62 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 178.1 -165.8 35.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.441 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -119.34 -176.62 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.61 156.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.45 40.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -175.77 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -102.8 -71.28 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 64.0 p -70.73 -47.06 61.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -58.77 -29.56 66.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -28.58 66.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.75 -61.73 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.71 -47.55 85.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.01 -23.3 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.63 26.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -90.18 46.6 1.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -118.25 147.37 41.49 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.95 -48.65 18.71 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.592 2.195 . . . . 0.0 112.457 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -59.09 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.28 -25.3 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.8 -39.94 72.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.218 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.12 -34.0 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -75.5 -29.12 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.5 ttt -57.15 -31.29 65.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.022 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.02 -44.39 80.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.22 -30.81 49.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.03 67.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -30.71 66.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -141.43 31.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.63 -170.94 19.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.409 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.83 168.75 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.971 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mm -70.4 138.28 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 5.3 ttt -51.86 106.8 0.7 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -168.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.444 2.096 . . . . 0.0 112.339 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -177.18 79.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.0 tt -124.97 123.24 25.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.97 -30.12 57.45 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.409 2.073 . . . . 0.0 112.224 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -58.91 -30.12 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.1 tpt -56.89 -28.27 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.054 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -59.24 -32.96 70.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.37 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -65.19 -28.02 69.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.59 -28.83 49.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.39 -46.89 86.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.3 -27.93 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.421 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 39.4 t -67.67 -42.1 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.405 ' O ' HG21 ' A' ' 348' ' ' ILE . 9.0 ptt180 -75.11 -47.19 29.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.404 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 55.2 p -49.87 -27.47 5.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.4 -59.13 3.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.44 -50.8 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.822 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 344' ' ' ARG . 7.4 tp -53.33 -40.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.738 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 345' ' ' THR . 5.4 t-20 -80.61 -41.67 23.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.18 87.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.04 -10.78 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.0 t -67.76 -57.02 7.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -132.43 -71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.569 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -176.67 50.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.03 132.52 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.2 p -93.29 153.96 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.02 -28.55 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.7 -37.75 79.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.2 -50.38 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.613 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.0 -25.19 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 17.8 mt -82.34 -56.47 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -70.43 -41.82 72.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.361 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.12 -46.96 78.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.22 -57.09 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.422 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -30.54 65.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 93.5 m -77.65 -54.91 5.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.106 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -59.13 -47.05 86.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.9 tt -56.36 -37.88 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.238 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -78.21 -64.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.01 86.37 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -153.63 137.36 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.984 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -133.92 131.5 39.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG1' ' CZ3' ' A' ' 10' ' ' TRP . 38.3 t -104.21 104.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mt -93.06 114.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CH2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -101.9 115.74 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.9 mt -140.84 145.74 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.51 44.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.05 79.17 1.38 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.359 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 8.28 26.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.607 0.242 . . . . 0.0 111.328 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 58.95 30.04 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.11 59.51 0.67 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.575 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -61.42 -54.46 43.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.771 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -30.41 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.25 -51.96 54.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.614 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.64 -26.35 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.727 0.299 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.47 -46.3 20.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.02 -41.89 84.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -59.45 -44.32 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 -25.51 57.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -43.76 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -74.39 -43.34 56.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.418 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 2.6 m-85 -63.9 -56.32 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.494 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 19.3 pt-20 -52.78 -28.05 20.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.487 0.66 . . . . 0.0 110.683 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -25.55 49.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.473 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.657 ' O ' ' OG1' ' A' ' 31' ' ' THR . 4.4 t70 -51.53 -56.81 11.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.657 ' OG1' ' O ' ' A' ' 30' ' ' ASP . 6.2 m 156.91 36.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.742 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.61 46.12 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.764 -2.16 . . . . 0.0 115.885 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.494 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 4.5 mm -131.37 95.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 118.535 1.167 . . . . 0.0 111.596 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -103.75 121.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.66 128.95 76.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.27 146.31 23.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.05 111.47 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 2.2 tt0 -142.8 163.14 33.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -104.9 150.3 38.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.13 -156.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.78 -75.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -59.27 -30.04 68.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.53 -24.01 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.93 -45.86 67.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.64 -28.26 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -24.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 3.6 t80 -45.76 -55.43 12.66 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.66 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.6 Cg_endo -61.24 -21.39 71.57 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.271 1.981 . . . . 0.0 112.503 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -89.77 -55.23 3.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 t -65.78 -30.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.8 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.86 -34.44 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -25.82 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.4 -51.1 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 75.46 -54.42 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 111.047 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.78 -94.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 149.33 61.63 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.578 2.186 . . . . 0.0 112.218 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 177.35 80.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.2 mt -103.1 106.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.1 mt -112.65 137.45 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.289 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -86.68 128.56 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.422 ' HA ' ' CE3' ' A' ' 62' ' ' TRP . 0.7 OUTLIER -157.62 173.25 17.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.848 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.62 -177.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -77.2 -52.0 9.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.19 -29.64 61.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -27.65 54.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -108.14 -30.31 8.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.2 57.22 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.88 -49.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.606 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.27 -50.15 75.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 67' ' ' PHE . . . -74.51 -31.37 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.41 -19.43 60.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 t -70.24 -26.7 63.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.57 50.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.607 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.36 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.891 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -177.22 133.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.71 160.49 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -85.7 134.8 33.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.09 158.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.061 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.9 p -88.94 146.31 36.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.92 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.606 2.204 . . . . 0.0 112.388 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -176.46 138.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -60.22 -48.02 83.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.64 -25.66 62.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 82' ' ' ASP . 6.2 m-85 -79.24 -59.24 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -24.85 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.791 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.28 -31.57 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -94.24 -58.48 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.16 158.33 11.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.417 ' CD1' ' HG3' ' A' ' 305' ' ' LYS . 4.7 m-85 -105.21 157.6 33.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 -26.27 24.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.54 -35.72 72.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -30.13 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -75.74 -53.45 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.07 -31.35 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.79 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.0 39.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -110.83 121.43 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.54 132.13 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 59.27 28.64 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.55 20.61 73.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.831 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 166.84 24.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.74 91.98 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mt -101.37 40.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.87 164.76 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.243 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.68 119.03 7.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.59 152.45 22.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.548 2.166 . . . . 0.0 112.336 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 tt -171.99 39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.07 104.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.8 110.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.64 147.19 27.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.93 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.06 159.51 15.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -164.93 145.57 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 pp -93.47 150.02 20.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.05 137.24 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -127.37 164.46 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.0 173.13 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -137.69 81.4 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -174.2 -54.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.51 62.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.85 92.28 2.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.69 154.1 7.16 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.526 2.151 . . . . 0.0 112.298 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.2 111.27 5.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.99 149.77 37.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.452 2.102 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -167.03 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.478 2.119 . . . . 0.0 112.229 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -95.71 -28.25 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 t -75.78 140.23 42.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -35.73 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.2 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -23.97 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.837 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.21 -16.32 35.65 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.3 mm -61.3 -47.71 93.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 74.0 Cg_exo -47.92 -35.17 24.18 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.381 2.054 . . . . 0.0 112.482 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mp -60.63 -30.68 70.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -50.85 36.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.3 74.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.46 -45.61 79.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.85 -43.94 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -27.15 67.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -27.7 49.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -109.44 -55.97 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 40.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -148.93 177.49 9.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.63 175.44 12.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 223' ' ' ALA . . . -129.04 45.34 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.08 115.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -154.62 106.53 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.056 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -158.0 176.81 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.688 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -50.63 156.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.07 -49.03 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.687 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -97.11 39.78 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -154.91 166.01 16.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.694 2.263 . . . . 0.0 112.258 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -173.27 -40.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.75 -41.73 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.5 p -68.55 -33.58 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 23.4 t90 -68.06 -55.79 12.47 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 38.2 Cg_endo -66.0 -14.08 42.8 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.301 2.001 . . . . 0.0 112.571 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -55.62 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.676 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.413 HG21 ' CZ ' ' A' ' 194' ' ' PHE . 3.1 pt -88.93 9.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.535 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.29 -15.98 14.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.422 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.27 65.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.256 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.92 -30.11 19.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.12 86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -154.48 89.99 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.536 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.15 52.62 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 339' ' ' PHE . 18.0 t -111.66 -30.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.401 ' OD2' ' CD2' ' A' ' 339' ' ' PHE . 22.1 p30 -94.17 50.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.34 162.79 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.99 -33.95 76.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.21 -28.3 49.53 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.14 -53.63 50.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -50.08 66.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.33 68.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -60.76 -56.47 24.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.508 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -24.76 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.689 0.28 . . . . 0.0 111.065 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 63.0 m -56.48 -59.02 5.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.148 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 11.2 p90 -81.88 -23.04 36.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.267 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.92 -61.21 2.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.74 -42.89 90.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.41 -30.3 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.89 -30.03 69.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 31.3 mt -77.2 -55.25 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -25.4 68.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.059 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -95.71 22.01 7.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -66.31 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -108.79 -29.25 8.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.8 mtp 62.87 31.39 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -176.71 114.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.95 88.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.98 -30.49 8.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 p -81.6 147.94 29.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.94 -161.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.284 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 211' ' ' SER . 47.0 p90 -78.73 -47.37 16.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.004 0.431 . . . . 0.0 110.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.3 m -81.09 -26.12 36.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.242 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.9 mt -82.44 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.23 66.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.565 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.44 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 41.3 tt0 -72.45 -36.69 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.42 59.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.457 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -75.15 -56.97 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.49 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CG ' ' CE1' ' A' ' 149' ' ' PHE . 1.1 p90 -75.14 -39.53 60.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -47.87 -35.94 11.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.119 0.485 . . . . 0.0 110.605 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -23.56 12.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.498 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.31 52.59 26.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.368 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.21 38.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.128 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.4 p -154.52 -177.97 6.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -86.4 39.54 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.357 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.18 112.82 0.45 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 26.4 m -144.66 105.12 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.449 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 23.6 mt -88.3 144.88 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -120.16 164.3 16.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -130.74 178.61 17.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.826 2.35 . . . . 0.0 112.238 -179.791 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.62 151.28 17.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.0 136.39 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 161.14 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.06 150.62 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.41 158.76 27.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.38 -173.98 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.904 2.402 . . . . 0.0 112.077 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.7 p -116.8 150.15 38.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 250' ' ' PHE . 44.1 p90 -159.04 112.03 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.89 11.48 7.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.379 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.74 41.39 6.01 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.96 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -156.55 90.65 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.694 0.283 . . . . 0.0 111.024 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.74 85.07 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.852 2.368 . . . . 0.0 112.164 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.6 p 57.08 176.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.02 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 13.2 tttm -92.1 142.09 25.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.2 Cg_exo -79.58 153.78 23.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.632 2.222 . . . . 0.0 111.967 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 330' ' ' MET . 11.8 t80 -153.62 107.34 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.94 99.91 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -102.36 63.28 0.47 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.555 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.92 144.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.31 . . . . 0.0 110.888 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.72 128.91 56.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.949 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.2 m -93.27 131.44 38.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.22 149.87 21.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.95 111.13 3.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.4 tp -135.16 104.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -96.86 116.38 29.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -93.01 -23.49 18.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.251 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.39 -30.6 52.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -82.1 155.66 69.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 61.46 2.57 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.393 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -165.17 31.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -75.07 -33.41 61.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -40.03 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.87 70.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.39 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.06 -39.11 83.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.48 -59.27 5.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.3 tt -59.4 -31.3 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.05 -31.71 73.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -115.77 27.39 9.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -107.15 -64.54 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.08 -55.65 2.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.804 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.98 64.34 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.4 t -146.23 151.58 37.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.3 -31.43 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.65 -37.66 49.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -87.62 -56.55 2.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.913 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -43.74 65.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.739 0.304 . . . . 0.0 111.208 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.78 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.55 -30.15 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.206 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -58.87 -28.31 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -113.68 -43.07 3.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.993 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -60.12 -69.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -124.16 72.38 55.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.46 107.16 2.33 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.629 2.219 . . . . 0.0 112.326 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -55.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.87 120.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.28 127.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.9 p -178.34 112.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -108.87 39.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 6.9 mt -133.89 156.93 47.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -93.41 -55.24 3.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.8 t -66.04 -48.06 72.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -59.47 -27.2 65.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.49 -28.73 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -49.51 77.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.952 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.85 -42.04 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.1 -20.85 64.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.0 -25.95 9.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.391 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -27.56 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 158.59 15.74 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.26 -57.96 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.714 2.276 . . . . 0.0 112.665 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -58.92 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.409 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.0 mp -52.22 -25.27 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.625 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.7 68.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.22 -28.9 42.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.5 m -58.37 -43.6 88.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -29.85 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.6 -54.7 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.31 -30.21 66.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.22 -29.1 60.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -58.74 -30.69 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -145.53 41.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.65 164.06 41.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -135.03 158.24 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.7 tp -77.47 116.94 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.444 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 0.2 OUTLIER -55.22 -61.29 6.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 330' ' ' MET . 18.8 Cg_endo -59.1 -164.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 0.0 112.416 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.0 69.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -161.59 60.75 1.22 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.61 -45.56 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.589 2.193 . . . . 0.0 112.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.91 -34.92 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.14 -23.76 49.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 340' ' ' TRP . 17.6 p -59.8 -24.92 64.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.75 -29.6 45.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.82 0.343 . . . . 0.0 111.302 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 183' ' ' VAL . 23.2 t80 -73.75 -23.7 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.403 ' CE3' ' O ' ' A' ' 337' ' ' SER . 0.0 OUTLIER -42.38 -29.37 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.833 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.2 -37.41 87.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.12 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.468 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.69 -29.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.35 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.59 -60.85 2.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 37.2 m -50.0 -29.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.84 -54.44 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.382 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.9 t -79.17 -58.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.029 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 344' ' ' ARG . 2.5 tp -47.34 -31.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.719 0.295 . . . . 0.0 111.515 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.31 -55.8 30.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -54.41 -26.8 32.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.343 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.11 -10.74 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.569 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.9 m -104.39 -31.27 9.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.95 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 108.53 -24.48 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -97.52 39.93 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 165.03 23.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.84 95.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.8 t -48.04 -27.82 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.17 -54.46 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -80.25 -25.94 39.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -77.79 -42.9 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.37 -54.82 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.458 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -55.87 20.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.524 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.81 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -59.92 -47.03 87.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -58.84 -56.2 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.04 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 9.4 t -58.38 -29.5 66.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -57.26 -29.84 64.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.4 mt -64.32 -36.82 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -65.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 40.7 mttp . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.826 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.28 27.41 73.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -82.24 134.66 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 mt -137.72 116.11 11.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.96 107.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.67 114.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CD1' HG13 ' A' ' 60' ' ' ILE . 67.2 m95 -96.75 112.1 23.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.9 tt -143.65 158.65 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -175.12 99.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.32 102.82 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.54 44.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.82 -166.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.24 12.72 8.05 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.725 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CE2' ' CG1' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -81.13 -59.53 2.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.09 -28.86 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.81 -48.9 69.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.523 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.48 -31.28 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 110.835 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.04 71.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -55.91 27.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.31 -31.02 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.088 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.09 -28.07 56.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -60.91 -30.81 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -74.82 -33.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -66.56 -56.31 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.776 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.564 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 11.7 pt-20 -58.32 -28.46 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 0.0 110.557 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.07 -25.78 47.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.214 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 31' ' ' THR . 17.6 t0 -54.01 -56.54 16.94 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.466 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.69 37.44 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.594 177.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.91 43.52 0.02 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 117.857 -2.116 . . . . 0.0 115.84 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.564 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 4.1 mm -136.94 152.67 28.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 118.064 0.932 . . . . 0.0 111.287 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -142.22 129.2 20.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.85 105.81 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 113.84 27.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.809 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 17' ' ' TYR . 10.8 p -100.35 140.89 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.55 160.28 40.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.29 147.38 36.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.94 125.7 11.22 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.365 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -173.73 -68.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -92.05 0.05 57.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.391 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.412 HD13 ' CD2' ' A' ' 10' ' ' TRP . 0.5 OUTLIER -56.48 -28.44 59.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.107 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.79 -43.47 76.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -98.39 -26.27 14.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -77.0 -24.57 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.141 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.492 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 68.8 t80 -52.87 -56.08 26.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.308 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.2 Cg_endo -63.71 -17.59 60.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.28 1.987 . . . . 0.0 112.448 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -89.67 -46.48 8.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.45 9.88 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.56 -47.5 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.24 79.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.6 p -85.17 -38.45 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.52 43.9 2.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -62.06 -31.0 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.57 -79.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.577 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 130.22 23.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.585 2.19 . . . . 0.0 112.323 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -175.93 71.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 mt -123.2 111.44 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 10' ' ' TRP . 2.0 mp -129.61 138.51 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.386 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.81 128.79 43.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -166.35 102.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 111.988 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 54.33 166.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.881 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.428 ' CD2' HG11 ' A' ' 97' ' ' VAL . 24.1 t-80 -77.22 -60.12 2.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.998 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -44.9 76.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.093 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HB3' ' CE2' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -56.79 -23.0 40.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CZ ' ' N ' ' A' ' 265' ' ' GLY . 0.5 OUTLIER -99.68 -56.66 2.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -18.39 50.76 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.748 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.37 -38.78 4.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.654 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -97.96 -54.84 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.12 -30.79 66.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -70.5 -21.57 62.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 p -107.38 -26.31 11.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.918 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.25 -87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.635 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 pp 177.41 46.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 67' ' ' PHE . 9.0 mp -80.05 137.66 36.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.59 121.74 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -58.89 159.89 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.8 pt -115.04 170.54 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 p -137.15 90.97 15.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.72 -176.14 3.09 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.585 2.19 . . . . 0.0 112.434 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.22 -176.17 3.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.85 83.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.27 32.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.418 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -80.2 -59.26 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.427 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -72.53 -24.73 61.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.816 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -76.33 -18.57 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.411 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -76.96 -67.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.89 151.01 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -97.63 156.35 36.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.82 -24.77 24.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.656 2.237 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.87 -62.51 1.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.031 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -65.05 -25.93 68.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 98' ' ' ARG . 3.1 m0 -57.91 -49.75 75.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.38 -26.83 0.91 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.65 -43.6 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.428 HG11 ' CD2' ' A' ' 64' ' ' HIS . 5.3 m -158.78 71.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.887 0.375 . . . . 0.0 111.511 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HG2' ' CE3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -145.21 109.14 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.804 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.53 174.74 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.16 62.56 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.31 27.94 5.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -145.36 101.2 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -114.17 99.45 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.961 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -139.71 40.0 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.075 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.97 128.76 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.27 111.02 15.31 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.771 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.6 139.23 14.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.44 2.093 . . . . 0.0 112.134 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 tt -166.51 39.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . -176.18 109.31 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.29 124.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.15 132.99 46.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.917 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.18 176.52 12.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.66 137.12 40.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 m -164.71 -176.06 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.2 152.53 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.768 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 147.72 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -120.0 126.56 51.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.0 155.4 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -75.73 -30.86 59.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.97 62.95 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 tp -175.85 39.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.88 151.43 20.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.15 160.39 49.76 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.256 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.13 164.17 25.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.777 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.02 136.38 40.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.454 2.102 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.4 -171.52 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.533 2.156 . . . . 0.0 112.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -109.58 -36.41 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -160.04 172.11 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.453 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -59.09 -24.71 63.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.3 53.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.61 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -89.37 -32.66 17.2 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 17.9 tt -56.43 -32.78 14.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 15.1 Cg_exo -69.49 -42.39 3.72 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.278 1.985 . . . . 0.0 112.198 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.03 64.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.248 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.89 -30.78 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -47.74 84.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -58.53 -31.73 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -54.18 48.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.6 mt -70.85 -40.56 72.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.948 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -27.6 65.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.09 -25.28 63.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -109.12 -75.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.53 39.84 0.16 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.403 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.57 -174.89 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 m -150.19 162.05 41.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -111.77 33.49 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER 178.93 125.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.623 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.8 mtt -170.09 106.18 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.64 177.35 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.76 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -45.55 167.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.425 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 -45.55 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -95.52 39.54 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.98 170.73 5.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.76 166.17 21.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.59 2.194 . . . . 0.0 112.445 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.02 28.6 17.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -120.88 -59.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.2 m -73.11 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.499 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -64.03 -55.42 32.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.5 Cg_endo -64.2 -27.17 64.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.288 1.992 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.94 -56.48 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.569 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tt -76.01 -9.9 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.289 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.85 -23.54 44.91 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.72 0.295 . . . . 0.0 111.306 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.83 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -122.26 39.97 3.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.34 -41.94 3.32 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.504 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.7 -48.46 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.36 175.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 339' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.41 -34.58 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -104.99 30.69 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -103.66 175.24 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.64 74.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.069 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.51 66.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.34 -41.93 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.91 -31.89 70.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 -46.19 15.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.04 63.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.58 -49.1 78.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.3 m -60.79 -34.55 74.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.3 -46.89 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mt -58.91 -47.35 85.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.979 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.23 -48.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.84 -35.42 78.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.15 -41.21 92.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -76.55 -30.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -31.65 72.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.06 18.34 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.1 -76.6 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.789 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -115.23 -13.42 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 ttt 70.02 -66.04 0.29 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -102.67 128.46 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.11 87.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.61 -29.47 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 t -78.14 108.83 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 211' ' ' SER . 2.8 p30 -94.12 -148.21 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 211' ' ' SER . 38.4 p90 -78.68 -51.72 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD2' ' A' ' 210' ' ' TYR . 88.6 p -62.34 -25.25 67.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.036 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.1 mm -82.01 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.53 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.676 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -66.44 -28.97 69.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.37 -25.06 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.336 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.79 12.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 225' ' ' THR . 51.2 t80 -76.29 -36.74 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.76 -5.67 44.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.647 0.26 . . . . 0.0 110.935 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 221' ' ' GLU . . . -172.01 -78.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.321 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 0.9 OUTLIER 163.48 100.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 110.49 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.7 p -109.32 -177.41 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.88 38.96 0.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.789 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.439 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -146.66 111.64 5.37 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.934 0.397 . . . . 0.0 111.143 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -144.56 104.71 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 37.0 mt -115.26 142.67 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -144.04 111.64 6.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.44 62.03 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.56 2.173 . . . . 0.0 112.372 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.776 0.322 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -124.26 165.88 17.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.71 136.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.48 149.67 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.35 150.57 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.05 158.77 24.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.2 166.04 23.09 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.875 2.383 . . . . 0.0 112.168 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 177.55 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -159.31 111.9 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.2 mttm 59.95 20.51 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.71 44.91 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.621 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -156.37 90.83 2.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.649 0.261 . . . . 0.0 110.864 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.21 159.39 22.64 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.587 2.191 . . . . 0.0 112.296 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.8 p -67.19 -175.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -107.29 94.31 11.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.67 151.14 21.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.461 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.417 ' CE2' ' HD2' ' A' ' 331' ' ' PRO . 3.8 t80 -108.13 82.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.91 151.81 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.84 171.75 29.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.81 144.95 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.674 0.274 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 7.1 mp -78.3 105.25 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.8 m -79.79 116.55 20.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.288 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -101.57 155.3 18.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.597 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.449 ' N ' ' CZ ' ' A' ' 67' ' ' PHE . . . -146.17 172.13 26.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.939 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.401 ' CD1' ' CD ' ' A' ' 273' ' ' LYS . 11.3 tt -113.68 159.74 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.669 0.271 . . . . 0.0 110.777 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -116.47 108.01 15.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 78.94 -53.71 0.45 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.415 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 66.73 6.71 4.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.504 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.463 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 3.3 t -67.45 -60.53 5.6 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.306 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 270' ' ' SER . 12.0 Cg_endo -55.88 -163.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.551 2.167 . . . . 0.0 112.442 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 55.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.052 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.401 ' CD ' ' CD1' ' A' ' 266' ' ' ILE . 0.7 OUTLIER -73.25 -29.66 62.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.817 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.24 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -74.17 -48.78 26.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.08 73.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.03 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -78.86 -40.18 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.56 -36.59 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.38 -38.79 85.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.65 -27.66 67.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.61 -22.19 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.17 5.66 29.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.31 -48.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 110.991 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 mt -89.31 53.42 2.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.774 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.6 p -154.71 174.9 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -21.03 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.56 -54.67 7.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.11 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.59 -45.75 4.21 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.773 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -30.21 49.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.61 -38.09 70.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.5 67.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.416 ' CG1' ' CB ' ' A' ' 297' ' ' LYS . 85.9 t -58.12 -30.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.179 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.36 -13.23 60.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -114.31 -25.24 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -119.47 -81.65 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.693 0.282 . . . . 0.0 111.514 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.416 ' CB ' ' CG1' ' A' ' 293' ' ' VAL . 0.2 OUTLIER -49.53 164.93 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.354 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.39 147.16 69.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.548 2.166 . . . . 0.0 112.275 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.13 -25.84 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.108 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -79.8 114.34 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -169.89 137.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 111.076 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.5 m -155.82 108.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -146.08 39.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.1 mt -153.66 165.45 35.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -38.59 3.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.014 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 p -79.5 -47.82 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -60.65 -21.9 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -51.02 -28.21 9.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.19 -47.85 59.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.21 -54.15 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.51 -17.75 60.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.295 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.71 -23.35 11.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.614 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.34 46.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.774 0.321 . . . . 0.0 111.301 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 317' ' ' ILE . 0.4 OUTLIER -124.14 173.73 4.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.783 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -90.09 -51.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.839 2.359 . . . . 0.0 113.725 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -81.3 -59.44 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 314' ' ' ASP . 16.7 tt -56.27 -31.58 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.08 58.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.151 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.47 75.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 44.9 p -76.76 -30.94 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -32.15 70.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.06 -52.7 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -69.58 -30.45 68.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.25 71.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.32 -29.24 69.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -118.43 59.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 178.39 -154.19 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.92 166.23 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.5 101.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 53.66 87.62 0.14 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.417 ' HD2' ' CE2' ' A' ' 258' ' ' PHE . 47.8 Cg_endo -68.77 161.47 45.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.492 2.128 . . . . 0.0 112.228 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -157.39 91.24 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.47 HG22 HD13 ' A' ' 333' ' ' ILE . 12.0 pt -152.59 132.15 7.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 -23.56 22.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.468 2.112 . . . . 0.0 112.411 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -55.94 -43.81 77.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.6 mtp -69.17 -35.36 76.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.2 p -62.57 -35.55 79.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.7 -33.87 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 168' ' ' ALA . 2.5 m-85 -73.49 -27.28 61.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -42.74 81.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.99 -35.43 42.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.51 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.59 -30.13 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -58.89 -60.81 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 0.9 OUTLIER -67.45 -27.5 67.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.85 -59.72 4.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.651 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.36 -59.1 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 21.9 mt -48.19 -58.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 345' ' ' THR . 15.2 t-20 -55.47 -36.21 66.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 111.179 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -56.02 -30.11 61.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.21 -10.15 55.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.553 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.6 p -67.58 -25.14 65.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 111.95 -27.82 9.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.18 39.34 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 124.9 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.805 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.2 t -115.56 177.92 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.966 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.31 -35.15 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -45.98 88.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.96 -43.4 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.51 82.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.1 -48.82 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -62.81 -44.06 97.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.35 -26.52 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -51.81 -56.86 11.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -56.55 -30.51 63.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 13.6 m -67.66 -43.2 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -29.82 62.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.995 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 mt -75.06 -44.93 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 23.3 m -79.65 -67.94 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.775 0.321 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.04 85.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -149.27 158.7 44.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.58 155.35 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.947 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.91 102.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mt -94.88 114.98 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -94.91 124.46 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pt -134.66 149.06 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.186 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.73 94.27 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.44 27.94 53.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.31 -29.98 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.706 0.288 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 tttt 62.75 118.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 48.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.56 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -78.78 -34.72 45.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.36 -42.0 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.37 -33.75 30.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.57 -31.56 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.12 77.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.271 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -76.96 -32.2 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.429 HG13 ' CE2' ' A' ' 27' ' ' PHE . 27.9 t -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.104 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.42 -38.04 89.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -74.11 -26.74 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -44.15 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.434 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 67.2 m-85 -62.24 -56.67 16.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -59.37 -27.42 65.95 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 110.131 179.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -27.3 1.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -69.28 -56.87 6.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.56 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.031 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.25 49.05 0.01 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 118.115 -1.993 . . . . 0.0 115.513 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.474 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -139.56 95.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 118.103 0.951 . . . . 0.0 111.628 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -99.95 106.38 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.11 146.34 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.01 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.63 118.26 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -143.9 162.8 35.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -87.16 154.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.51 130.01 20.1 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.595 2.197 . . . . 0.0 112.277 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.34 -60.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -79.41 -7.58 58.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.33 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.62 -24.93 36.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -34.39 62.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.067 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.3 -29.94 12.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -69.27 -31.18 69.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -56.36 -60.76 8.13 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.4 Cg_endo -63.77 -16.83 57.09 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.423 2.082 . . . . 0.0 112.513 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.86 -44.5 18.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.792 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.1 m -90.21 -24.36 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.2 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.89 70.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.78 71.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.059 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.84 128.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.64 72.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.24 -30.99 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.28 -168.81 12.36 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -171.61 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.314 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 175.09 103.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.2 mt -143.6 136.25 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.25 141.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -108.79 144.67 36.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 263' ' ' SER . 1.3 m95 -165.62 173.6 10.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.57 -174.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.344 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -77.69 -45.01 26.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.3 -28.81 44.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.59 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -24.17 21.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.217 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CE1' ' O ' ' A' ' 263' ' ' SER . 4.3 m-85 -101.11 -28.5 12.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.965 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.74 -23.13 49.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.655 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.4 -50.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.3 -57.51 3.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.6 67.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -28.42 64.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 p -70.26 -26.74 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.34 77.68 1.07 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.8 tp -167.48 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -141.5 127.82 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 138.48 57.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.04 157.96 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mm -111.3 141.49 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 148.56 40.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.78 168.2 19.61 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.725 2.284 . . . . 0.0 112.372 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.95 153.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -31.65 70.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 -23.28 64.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.403 ' CE2' HD21 ' A' ' 89' ' ' LEU . 1.4 t80 -79.3 -59.16 2.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 8.3 pt20 -62.55 -24.73 67.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.66 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -68.19 -32.8 73.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -104.96 -63.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.403 HD21 ' CE2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.07 113.53 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -62.25 143.89 95.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.51 -24.94 30.4 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.468 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -57.03 -34.72 68.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.076 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -86.76 -28.23 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.982 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 86' ' ' GLN . 4.4 m0 -59.74 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.69 -29.25 70.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.63 -29.6 68.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.203 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.77 61.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.38 81.44 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -79.26 98.07 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.77 31.51 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.47 50.65 7.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -131.32 129.74 41.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.65 40.02 1.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.78 39.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 178.22 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 6.7 p90 -118.73 129.14 25.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 168.14 19.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.606 2.204 . . . . 0.0 112.283 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -175.01 39.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.21 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 174.18 108.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.982 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.09 134.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.05 164.35 28.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.62 10.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.11 157.54 43.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -175.95 5.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mt -92.62 146.15 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.467 HD11 ' HB ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -73.77 155.94 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.05 0.452 . . . . 0.0 111.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -135.78 114.71 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -133.77 -177.49 4.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.35 76.27 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -156.05 -50.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.06 39.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.27 91.13 47.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.37 159.42 53.42 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.444 2.096 . . . . 0.0 112.27 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -102.2 95.77 6.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 159.48 52.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.59 49.42 3.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.678 2.252 . . . . 0.0 112.702 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 55.47 32.9 19.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.07 140.44 52.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -32.35 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.643 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.71 17.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.485 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.36 -17.09 58.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 mt -73.47 -53.0 4.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.1 Cg_exo -52.15 -36.74 67.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.312 2.008 . . . . 0.0 112.428 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -32.87 56.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.5 mt -77.02 -31.91 56.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -76.6 -31.07 57.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -71.75 -32.16 67.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.46 -40.69 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD1' ' CB ' ' A' ' 146' ' ' ALA . 6.7 mt -73.15 -53.24 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -57.77 -24.63 58.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.37 -26.13 60.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -109.76 -70.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.62 39.85 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -174.89 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.725 0.297 . . . . 0.0 110.787 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.4 m -157.13 171.24 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 147' ' ' LEU . . . -142.94 49.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 4.4 tt 170.62 120.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.03 106.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CD2' ' CD1' ' A' ' 226' ' ' ILE . 0.6 OUTLIER -172.24 167.04 5.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 148.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -178.64 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.811 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -133.95 39.93 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 154' ' ' PRO . 6.8 pt-20 -87.65 173.41 6.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.452 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 88.7 Cg_endo -85.89 118.75 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.435 2.09 . . . . 0.0 112.617 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 61.52 80.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.41 ' C ' ' HD2' ' A' ' 159' ' ' PRO . 4.1 p90 -121.13 -48.25 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.4 t -72.8 -35.27 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.349 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.444 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -49.27 -55.81 19.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.326 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.0 Cg_endo -78.7 -18.31 11.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.627 2.218 . . . . 0.0 112.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.39 -56.7 4.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.174 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 167' ' ' TYR . 1.8 pt -80.6 1.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 158' ' ' TRP . . . -88.13 -54.54 4.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 253' ' ' GLN . . . 62.67 -81.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -56.8 2.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 100.67 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.579 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.95 87.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.421 ' CE1' HD13 ' A' ' 161' ' ' ILE . 33.7 t80 -171.49 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 184' ' ' ASP . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.56 42.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.808 0.337 . . . . 0.0 111.184 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 182' ' ' GLY . 3.2 p30 -110.93 -7.86 14.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.723 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.58 -173.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.63 63.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.79 -49.34 79.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.36 -45.18 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -60.2 -58.59 7.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.52 87.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.12 -53.34 18.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.598 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.05 -42.68 94.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.9 m -59.46 -30.44 68.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -76.15 -47.87 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -50.02 63.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.0 p -56.49 -28.07 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.255 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.44 -54.6 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -59.05 6.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.026 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.96 -25.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.37 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -60.51 -59.97 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.18 20.99 18.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . 0.447 ' CE ' ' CD2' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -120.28 -68.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.464 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 27.4 m80 -81.16 -0.52 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.715 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -20.27 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.626 0.25 . . . . 0.0 111.288 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -142.52 37.93 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -162.28 84.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.72 57.71 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.5 t -57.4 108.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -78.43 -156.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.721 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -78.38 -44.45 24.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.157 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.1 p -73.93 -25.1 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.173 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.05 -53.94 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.107 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.27 64.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -72.86 -42.62 63.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.16 -24.92 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.23 -56.66 11.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.681 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 8.6 p90 -67.56 -30.93 70.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.749 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -79.9 -11.9 59.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -74.45 -24.04 59.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.687 0.279 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.65 -92.77 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.178 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.54 91.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.607 0.241 . . . . 0.0 110.561 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.35 -177.89 3.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 38.59 0.66 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.52 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -154.11 101.87 2.43 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.044 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.467 ' HB ' HD11 ' A' ' 116' ' ' ILE . 0.7 OUTLIER -144.6 104.93 4.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.191 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.434 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 3.9 mp -106.26 119.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.229 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -139.18 162.89 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.14 -150.91 17.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 112.318 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.834 0.349 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -156.92 175.97 34.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.36 136.43 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 146.52 52.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.82 150.7 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 4.0 mt -59.95 149.18 74.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 4.8 Cg_exo -79.52 -174.61 2.35 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.185 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.84 177.69 6.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 24.4 t80 -158.27 111.74 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.49 12.64 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.26 5.53 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.736 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 163' ' ' ALA . 3.4 pt20 -156.35 90.49 2.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.784 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.72 150.28 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.889 2.392 . . . . 0.0 112.618 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 69.5 m -55.24 150.5 10.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -109.41 89.5 7.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.76 125.3 6.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.578 2.185 . . . . 0.0 112.391 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -79.98 172.04 14.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.5 p -94.88 138.13 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.72 129.97 10.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.22 144.78 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.169 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -92.57 115.67 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.461 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' TRP . 8.9 m -94.59 133.73 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 106' ' ' TYR . . . -101.67 126.07 48.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.603 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.91 159.04 13.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.743 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 10.5 tt -140.2 136.38 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -51.37 125.56 14.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.86 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.249 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.74 46.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.7 m -96.13 112.81 60.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.39 -26.98 12.74 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.448 2.099 . . . . 0.0 112.437 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -120.22 65.53 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -75.04 -53.98 7.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.28 -32.17 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.419 ' CD2' ' CE1' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -73.0 -49.17 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.73 -42.96 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -59.86 -42.68 94.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.97 -30.51 58.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.419 ' CE1' ' CD2' ' A' ' 275' ' ' LEU . 1.8 m-85 -64.16 -59.2 4.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 pp -58.86 -27.0 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.33 -29.26 61.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.54 27.47 9.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 27' ' ' PHE . 14.6 m-85 -148.2 -74.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.83 -31.38 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.48 72.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.76 164.42 38.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -27.86 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -77.54 -27.68 51.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.125 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -105.62 -54.46 0.73 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.711 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.39 -30.71 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.152 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -72.28 -40.71 67.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.65 81.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.08 -33.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -80.15 -55.06 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -59.72 -57.8 11.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.47 -34.4 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -139.24 89.42 12.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 115.73 4.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.55 2.166 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 -43.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.88 123.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -86.07 90.13 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.15 79.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -139.08 78.17 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.418 ' CD2' ' N ' ' A' ' 304' ' ' LEU . 0.1 OUTLIER 40.59 -91.87 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.971 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -78.37 -41.26 33.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.784 0.326 . . . . 0.0 111.203 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -53.28 -25.16 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.234 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.411 ' CE2' HD23 ' A' ' 311' ' ' LEU . 87.8 t80 -56.1 -44.67 79.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.35 -31.81 58.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -66.86 -48.22 69.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.19 -35.9 71.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 307' ' ' TYR . 3.4 mp -56.03 -23.06 30.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.1 71.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -176.8 74.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.16 139.16 19.85 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.34 -62.38 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.445 2.096 . . . . 0.0 112.352 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -60.78 -48.52 81.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 42.2 mm -59.52 -29.91 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.48 71.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -78.46 -56.26 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.1 t -58.38 -27.27 64.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 mtt -56.23 -29.14 60.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.47 -57.41 12.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -78.36 -31.85 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.92 71.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -59.68 -32.24 70.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -109.37 38.88 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.2 179.59 24.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.578 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.76 -177.2 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.978 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 329' ' ' ILE . 0.0 OUTLIER -135.32 107.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 3.4 mmt 60.66 155.77 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.975 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.31 -161.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.231 . . . . 0.0 112.256 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -170.39 -42.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 3.3 tt -123.77 122.97 26.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.51 -21.23 34.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.088 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.35 -30.68 62.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -30.99 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 60.5 p -65.21 -41.74 94.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.93 74.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.72 -27.52 66.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.43 -32.21 62.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.88 -31.42 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.71 -53.25 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.41 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 21.9 t -58.05 -30.04 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.42 ' HD2' ' CE3' ' A' ' 340' ' ' TRP . 16.9 mtp180 -59.71 -54.4 46.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 69.0 p -49.78 -27.66 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.28 7.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.47 -59.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.932 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 2.4 tt -49.62 -39.63 14.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.917 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.64 -28.6 36.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -59.61 -31.47 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.977 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.92 -10.2 59.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.517 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.0 p -67.57 -26.04 66.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.122 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 109.56 -24.34 20.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.568 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 39.55 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.44 114.14 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.765 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.18 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.28 -28.89 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.213 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 -37.48 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.22 -55.78 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -50.33 -36.49 32.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -42.52 18.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -65.53 -55.67 16.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.8 -27.17 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -53.36 -54.91 29.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -58.86 -30.44 67.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.4 m -59.47 -57.66 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -58.37 -41.24 84.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.146 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 33.1 mm -71.96 -32.04 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.4 p -108.52 35.45 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.89 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.854 0.359 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.8 72.19 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.66 141.58 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 279' ' ' PHE . 2.7 mp -141.82 138.87 32.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.721 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 57' ' ' PRO . 44.9 t -115.22 113.53 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.094 0.474 . . . . 0.0 111.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 4.9 mt -99.15 133.89 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -94.71 111.95 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 tt -139.59 148.74 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.096 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -171.43 75.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.07 -112.34 1.4 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 178.38 58.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.849 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -125.38 -97.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.81 80.76 0.28 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.596 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -61.94 -30.95 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -59.15 -28.38 66.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.77 -51.59 55.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.637 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.73 -37.2 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.32 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -64.25 -56.09 17.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.37 -43.97 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.57 -27.69 64.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.616 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -32.87 70.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.59 -45.06 89.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.9 -56.03 18.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.533 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 8.7 mt-10 -53.91 -28.4 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.437 0.637 . . . . 0.0 110.59 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -78.09 -25.78 47.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.486 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 31' ' ' THR . 4.4 t70 -52.65 -56.46 15.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.469 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.48 36.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.456 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.26 44.39 0.02 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.883 -2.103 . . . . 0.0 115.75 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.533 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 3.4 mm -133.94 149.28 30.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 118.21 1.005 . . . . 0.0 111.377 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.56 137.4 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.55 129.78 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.85 134.63 54.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.91 120.17 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.11 163.02 33.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -80.11 152.91 74.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.86 179.07 5.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.551 2.167 . . . . 0.0 112.449 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 76.67 -0.28 3.04 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.65 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 -48.83 2.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.2 -12.73 57.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.412 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -26.37 8.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.279 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.63 -51.12 9.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -71.81 -24.55 61.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.431 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.85 -60.46 5.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.316 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 36.1 Cg_endo -65.08 -15.35 49.96 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.432 2.088 . . . . 0.0 112.568 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.67 -40.95 12.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.961 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.28 -29.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.64 -30.97 71.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.77 66.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.1 m -100.26 -45.48 5.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.69 73.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -99.68 -28.86 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 0.0 111.085 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . -171.29 -64.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 5.8 Cg_endo -48.96 115.3 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.823 2.349 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -175.32 39.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.803 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -145.25 129.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.516 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.8 mt -141.5 142.72 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.736 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 51.0 m-85 -123.14 112.38 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.268 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -162.95 174.03 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.753 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.88 -173.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -76.86 -33.41 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.01 -29.28 63.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -56.98 14.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.074 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.415 ' CD2' HD21 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -66.34 -48.83 68.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.47 -17.87 54.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.719 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.77 -56.07 1.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -95.45 -54.45 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 76' ' ' LEU . . . -55.67 -27.81 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.363 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -68.25 -22.33 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.9 p -95.82 25.63 4.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.27 77.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.578 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.36 39.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.879 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.415 HD21 ' CD2' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -158.3 136.55 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.922 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 130.46 52.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 138.76 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.2 pt -83.66 162.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -89.2 147.74 39.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.66 110.96 2.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.613 2.209 . . . . 0.0 112.44 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -176.77 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -21.83 47.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.412 ' CB ' ' CZ2' ' A' ' 94' ' ' TRP . . . -54.8 -23.16 16.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.551 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -59.22 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.382 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.2 -24.64 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -73.94 -20.58 60.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.35 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 53.15 48.57 21.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.89 0.376 . . . . 0.0 111.255 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mt -102.12 155.49 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -96.32 145.0 28.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.16 -26.66 43.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.509 2.14 . . . . 0.0 112.345 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -56.62 -30.57 63.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -90.7 -29.76 17.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CZ2' ' CB ' ' A' ' 84' ' ' ALA . 34.1 m0 -70.1 -47.57 61.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -59.51 -30.71 68.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.6 83.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.15 43.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -99.37 89.44 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 120.15 35.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 p30 44.43 38.66 2.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.13 31.12 78.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.642 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -145.62 160.05 42.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 93.23 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 pt -114.43 39.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.25 125.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.73 116.23 57.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.81 133.82 10.46 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.466 2.11 . . . . 0.0 112.419 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 pt -156.07 39.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.045 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.409 ' N ' HG21 ' A' ' 302' ' ' VAL . . . 169.58 102.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.86 116.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.326 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -116.98 132.58 56.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.67 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.48 176.56 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.188 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.83 171.37 7.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.33 -177.41 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mt -109.6 149.88 29.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 pt -110.48 140.53 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.186 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.77 130.87 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.29 162.09 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.5 37.7 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -90.19 -35.13 15.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 pp -157.73 39.98 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mt -137.55 131.07 17.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 157.78 41.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.257 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -65.08 110.77 4.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.6 140.29 86.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.477 2.118 . . . . 0.0 112.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.56 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.228 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.42 -39.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 t -70.94 152.23 43.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.5 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -60.14 -23.56 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 33.4 mt-10 -45.26 -23.47 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -48.78 -31.0 6.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -73.53 -62.58 1.14 Allowed Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.324 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.415 ' HD3' HG13 ' A' ' 132' ' ' ILE . 82.9 Cg_exo -45.67 -34.42 11.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.232 1.955 . . . . 0.0 112.407 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.53 61.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.79 -28.77 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -43.42 75.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -68.73 -28.03 66.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.83 -50.84 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.92 -55.83 29.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -58.72 -24.66 61.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.16 -25.51 59.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -111.21 -67.47 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.4 39.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -142.07 -177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -150.37 157.54 43.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.013 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.406 ' CB ' ' CB ' ' A' ' 223' ' ' ALA . . . -107.6 42.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.409 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER 176.84 115.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.77 106.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' A' ' 226' ' ' ILE . 2.3 t80 -156.36 176.74 12.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -64.72 -169.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.5 mt -148.81 -46.01 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.35 44.2 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -108.25 166.78 10.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 150.97 22.38 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.949 2.433 . . . . 0.0 112.173 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.31 55.24 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 160' ' ' LEU . 77.8 t80 -120.93 -49.57 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -73.42 -42.84 61.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.49 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 9.8 t90 -55.72 -53.88 57.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.429 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.53 -24.17 42.47 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.17 1.913 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 156' ' ' PHE . 5.0 mp -81.57 -56.77 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.27 -21.81 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.254 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.35 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.32 -25.16 65.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.286 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.55 -41.35 18.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.097 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.98 -82.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.596 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.09 -38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.551 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.48 ' CD2' ' CD1' ' A' ' 158' ' ' TRP . 38.8 t80 70.16 -65.69 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.062 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.08 -31.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -123.52 72.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -128.92 -176.67 3.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.07 78.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.61 -52.06 32.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.8 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 111.136 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -61.05 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 194' ' ' PHE . . . -77.77 -43.77 29.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -54.27 -26.21 35.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.761 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.68 -58.17 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.769 0.319 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.7 t -64.2 -28.87 70.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.024 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 190' ' ' ALA . 2.6 m-85 -56.99 -63.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.13 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.41 -46.63 87.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.19 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 36.4 t -59.3 -46.96 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.02 -36.44 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.46 -58.89 6.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.063 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 28.8 pt -49.84 -27.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -77.59 -31.7 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.991 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.7 18.32 22.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.399 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -41.75 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -114.56 -51.67 2.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 169.54 -75.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -156.39 153.03 28.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.746 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.13 77.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -164.95 31.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 17.3 p -61.98 139.98 58.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 212' ' ' ILE . 4.7 m-20 -108.76 -150.73 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.1 -53.0 7.43 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.105 0.479 . . . . 0.0 110.083 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.1 m -56.88 -24.42 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.397 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 209' ' ' ASP . 2.7 mp -81.94 -58.85 3.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.015 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.32 -30.42 70.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -22.6 38.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.443 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.75 -55.58 9.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.489 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.66 -54.94 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.931 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -47.38 -28.47 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -41.35 23.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -106.78 -23.58 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.773 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 55.01 46.74 76.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.41 43.02 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 111.23 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.77 -177.63 3.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.406 ' CB ' ' CB ' ' A' ' 146' ' ' ALA . . . -82.82 38.67 0.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.894 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.409 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -173.8 99.22 0.11 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.04 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.51 105.31 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.807 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.424 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 23.7 mm -82.77 138.53 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.45 112.22 24.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -111.84 159.83 13.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.344 0.303 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 4.6 p90 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.796 0.331 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -151.7 150.76 22.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.71 127.72 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.8 p -141.12 162.74 34.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.182 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.8 m -86.6 150.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.045 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.76 151.68 61.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.71 -158.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.914 2.41 . . . . 0.0 112.343 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -77.94 177.82 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.36 111.54 3.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? 60.1 17.71 7.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 120.66 -24.95 7.42 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.684 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.61 140.04 18.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.31 169.04 21.97 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.449 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.5 m -58.31 -175.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.005 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -144.15 73.72 16.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.49 174.13 12.25 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.223 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -111.81 135.22 52.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.97 154.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.66 77.99 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.612 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 m -88.81 132.09 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.756 0.313 . . . . 0.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.29 127.48 32.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.003 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -91.32 110.52 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.764 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 61' ' ' PHE . . . -126.79 117.71 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -177.61 -169.99 39.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.618 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -100.82 159.22 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.5 p30 -88.79 158.2 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -97.46 29.08 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -100.64 -30.7 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 t -118.2 146.66 39.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 74.86 2.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.488 2.125 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -117.48 35.42 4.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -66.03 -48.97 69.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.57 -36.09 70.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mt -76.35 -29.68 57.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.82 83.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -74.23 -29.38 61.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.09 -35.19 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.38 -25.61 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -14.06 62.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -88.95 27.93 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.348 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.92 35.46 1.69 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 110.725 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.24 28.3 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.795 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 tp -147.0 28.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.969 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 290' ' ' LEU . 3.0 t -136.84 155.62 49.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -57.63 -20.99 36.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.305 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.17 -38.13 61.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.418 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -119.64 -50.51 0.29 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.032 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . 25.1 tp -54.59 -55.14 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.809 0.338 . . . . 0.0 111.392 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.1 -32.93 44.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.734 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.17 -58.59 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 28.8 t -82.03 -60.62 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -21.65 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.879 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.76 -20.04 12.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.377 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.68 90.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 64.65 165.9 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.6 144.63 79.37 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.504 2.136 . . . . 0.0 112.375 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.5 pp -174.74 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -119.21 160.79 14.11 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -132.95 105.04 6.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.876 0.37 . . . . 0.0 111.391 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.409 HG21 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.99 44.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.198 0.523 . . . . 0.0 110.645 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.77 88.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.668 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 77.17 115.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -55.28 -23.98 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.9 m -53.94 -52.41 60.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.36 -30.4 37.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.14 -27.74 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -56.98 -37.18 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.62 -44.61 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.53 -18.6 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.09 -25.87 9.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 111.502 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -58.4 -27.57 64.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 146.57 95.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.8 -51.42 9.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.39 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -55.44 -56.26 22.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mm -52.92 -55.34 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.303 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.49 75.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.7 -56.56 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 32.9 p -62.97 -29.96 71.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.53 -52.25 66.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.63 23.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.13 -30.49 66.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.14 67.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -40.2 96.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.72 -58.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.04 177.46 54.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.425 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -154.22 151.44 29.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.17 138.17 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.42 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -127.47 137.67 31.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 -168.37 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.578 2.185 . . . . 0.0 112.387 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -136.44 76.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -86.2 148.6 47.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.08 -27.9 38.62 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.675 2.25 . . . . 0.0 112.323 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.96 -41.59 87.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -66.65 -31.72 72.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -44.28 97.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.56 72.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.05 -37.51 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.12 97.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -59.36 -52.09 67.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.91 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 28.9 t -69.5 -29.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.131 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -59.42 -60.66 3.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 9.2 t -71.64 -41.18 69.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.37 -56.34 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.586 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.37 -55.76 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.813 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 348' ' ' ILE . 34.8 mm -57.08 -58.75 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.728 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 345' ' ' THR . 1.0 OUTLIER -59.49 -27.91 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.671 0.272 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 355' ' ' GLN . . . -61.92 -57.07 13.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -60.82 -10.57 5.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.004 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.5 m -110.04 26.63 10.45 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.614 0.245 . . . . 0.0 111.385 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 154.3 -71.53 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.005 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -87.76 51.63 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.464 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -79.37 99.29 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 1.5 t -166.22 97.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.86 -27.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.324 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -57.49 -45.72 84.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -80.01 -43.91 21.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.82 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.77 70.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 -53.06 6.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -58.83 -55.69 31.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.11 92.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -58.48 -32.41 68.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.0 m -72.66 -31.26 64.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -40.77 68.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 31.8 mm -71.22 -35.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 18.8 m 61.3 51.02 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.44 28.64 21.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -114.92 130.27 56.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.833 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -129.1 148.56 51.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.48 102.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.87 114.87 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 95.5 m95 -105.83 111.96 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.25 157.27 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -170.31 40.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.91 25.7 3.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.92 31.81 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 110.785 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -165.91 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.11 63.86 0.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.543 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -62.9 -29.59 70.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 111.058 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -59.34 -47.18 86.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.68 -28.3 65.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -64.76 -32.81 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.17 72.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -31.41 65.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.45 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.55 -35.18 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -59.73 -28.44 67.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -68.02 -33.45 74.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.416 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 9.3 m-85 -78.08 -50.6 11.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -51.54 -27.93 12.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.464 0.65 . . . . 0.0 110.425 179.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.45 -26.4 66.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.301 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 31' ' ' THR . 7.4 m-20 -64.32 -57.19 10.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.98 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.611 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 48.49 0.01 OUTLIER Glycine 0 C--N 1.338 0.682 0 C-N-CA 117.873 -2.108 . . . . 0.0 115.566 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 5.4 mm -139.27 95.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 118.071 0.935 . . . . 0.0 111.676 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.27 113.76 26.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.85 139.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.29 119.63 39.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.9 112.97 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -151.84 163.08 39.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -104.73 142.05 23.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.15 155.62 37.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.551 2.167 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -178.84 -51.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -111.57 -23.31 10.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD11 ' CZ3' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -79.77 -1.12 37.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.545 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -54.4 -30.36 51.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.041 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -90.4 -30.9 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -24.53 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -52.8 -59.31 9.15 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.303 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.2 Cg_endo -63.1 -17.25 59.24 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.482 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -89.69 -43.84 10.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 t -82.76 -30.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.51 61.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -71.06 -31.89 68.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.33 55.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.41 -34.08 72.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.36 -93.92 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.569 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.85 -173.42 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.581 2.187 . . . . 0.0 112.4 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.8 t0 178.97 60.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.773 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mm -99.01 121.07 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tt -146.68 141.62 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.5 136.87 52.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.408 ' CD1' ' HG3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -161.17 173.31 15.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -76.9 -53.26 8.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.39 -28.44 65.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.408 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 13.0 mmt180 -57.54 -29.17 64.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 263' ' ' SER . 48.3 m-85 -107.52 -37.4 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.86 -23.47 51.05 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.653 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.28 4.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.651 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.65 -59.38 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.074 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.3 -29.76 64.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.26 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.53 -27.05 66.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 t -70.19 -26.73 64.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.088 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.31 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.84 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.36 127.9 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.16 126.56 30.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.09 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.05 132.73 43.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tt -102.87 147.56 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.4 p -98.03 145.87 30.52 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.84 146.71 18.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.94 -55.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -30.48 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.79 -23.39 42.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -79.25 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.5 -26.54 67.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.43 -41.9 45.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.812 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.65 40.05 13.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -177.32 6.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.91 112.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 78.1 Cg_exo -50.51 -25.21 13.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.514 2.143 . . . . 0.0 112.482 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -21.07 41.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.5 p -69.39 -53.95 16.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.442 ' CE3' ' N ' ' A' ' 95' ' ' ASP . 46.9 p-90 -92.92 -45.31 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 6.7 t70 -53.29 -26.72 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.288 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.56 -28.88 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.235 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.57 63.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.34 104.66 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -94.44 93.1 7.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.61 -70.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.06 30.89 0.19 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -127.57 96.61 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -92.48 102.69 15.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.88 39.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.025 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -172.42 93.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 t80 -98.95 141.73 23.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 106' ' ' TYR . 92.3 Cg_endo -79.85 138.76 13.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.608 2.205 . . . . 0.0 112.205 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 mm -143.6 39.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.245 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 173.26 99.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.976 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.34 111.21 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -104.27 133.16 49.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.36 170.05 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.003 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.17 152.31 50.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.955 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 t -164.92 -176.06 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.53 138.18 44.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.17 140.22 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.088 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -152.76 165.66 34.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -80.32 168.8 18.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.89 36.9 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.68 -64.01 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.38 48.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.63 103.68 10.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.24 160.36 49.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.431 2.088 . . . . 0.0 112.313 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.19 110.85 4.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.09 124.66 11.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.439 2.093 . . . . 0.0 112.278 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.4 2.066 . . . . 0.0 112.238 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -101.04 -30.59 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 m -126.62 169.11 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -72.58 -31.28 65.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -23.71 17.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.549 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.19 -16.33 40.69 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 42.0 mt -65.55 -47.41 67.93 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 89.2 Cg_exo -46.38 -30.02 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.366 2.044 . . . . 0.0 112.629 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.89 60.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.11 -45.81 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.171 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.12 -28.69 41.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.208 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -55.79 -42.69 75.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.071 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -81.79 -33.31 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.79 -55.9 16.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 -25.01 9.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.54 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -112.2 -50.42 2.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.76 41.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.653 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -155.24 179.2 9.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -128.47 165.62 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.24 3.99 40.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.67 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 170.8 151.19 0.05 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.859 0.362 . . . . 0.0 110.995 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.4 tpt -117.77 144.75 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.09 145.86 40.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.0 170.79 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.5 mt -131.19 -46.5 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -98.5 39.72 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.732 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 93.87 8.68 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.55 112.78 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.153 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.07 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -111.94 -30.63 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.5 t -70.43 -27.09 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -70.22 -56.01 7.43 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.272 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 42.1 Cg_endo -67.13 -16.19 48.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.37 2.047 . . . . 0.0 112.446 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.18 -56.72 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 29.0 pt -65.09 -16.76 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -84.61 -70.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.992 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.58 -80.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.2 -41.93 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.003 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.29 -35.49 65.68 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.66 116.97 9.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.566 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.14 78.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.31 -31.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -116.55 36.57 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 177.63 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.23 -30.93 58.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.43 -52.65 49.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.71 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -56.89 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.82 -30.66 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.05 -45.47 95.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 -46.89 39.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.968 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.9 p -59.89 -29.04 68.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.4 -53.07 62.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.83 -50.39 73.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.7 t -59.74 -37.8 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -27.68 56.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.45 -49.62 12.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 pp -57.16 -40.16 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.301 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -28.08 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -26.23 62.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -118.46 -67.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . 0.426 ' CD2' ' CB ' ' A' ' 207' ' ' ASP . 30.9 m170 -65.15 -28.78 69.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 mtm 69.28 -67.41 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.41 -48.42 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.23 -58.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . 0.426 ' CB ' ' CD2' ' A' ' 203' ' ' HIS . 6.4 t0 78.1 -55.18 0.5 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.82 147.86 31.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -144.0 -162.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.358 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 211' ' ' SER . 39.4 p90 -78.83 -46.02 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 110.392 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.7 p -81.08 -25.64 36.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.045 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.45 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.58 -30.36 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.625 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.41 -22.74 62.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.72 7.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.68 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -41.99 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -75.98 -58.7 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -62.73 -32.94 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -23.47 16.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.632 0.253 . . . . 0.0 111.33 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.54 52.15 8.78 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.066 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.26 39.41 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.34 . . . . 0.0 111.121 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.8 p -149.58 -177.69 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.55 39.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.66 128.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.925 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 1.3 t -144.54 106.35 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 156' ' ' PHE . 14.6 mt -78.99 141.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -86.81 112.48 21.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.08 -157.17 33.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 112.348 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.08 171.85 21.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.29 136.36 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 111.112 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.4 t -125.24 159.41 31.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.62 150.55 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.91 156.82 33.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.82 -168.33 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 t -123.99 177.48 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 253' ' ' GLN . 54.7 p90 -167.18 117.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt 64.17 16.24 9.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.62 33.04 28.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.667 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.409 ' O ' ' CE1' ' A' ' 250' ' ' PHE . 16.6 pt20 -156.19 90.63 2.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 111.003 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.52 161.08 47.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.788 2.326 . . . . 0.0 112.154 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 81.1 p -57.43 163.8 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -105.15 99.53 20.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 130.06 8.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.468 2.112 . . . . 0.0 112.249 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -111.87 139.75 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.11 150.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.72 160.39 28.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.621 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 m -129.85 144.96 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.861 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 126.29 35.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.978 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.42 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 28.3 m -91.71 125.88 36.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.62 140.12 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.58 168.12 34.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.404 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.1 tt -101.67 158.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.016 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -73.64 173.16 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -94.23 -27.4 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -30.95 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 p -76.75 122.36 86.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.18 -1.46 11.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.498 2.132 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -96.37 38.27 1.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -75.04 -31.05 61.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -60.33 -42.89 96.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.5 tp -75.59 -28.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.024 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 279' ' ' PHE . . . -76.8 -32.35 57.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.306 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -79.13 -30.76 43.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.54 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.18 -48.72 19.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.7 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -70.25 -24.22 63.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.239 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.5 tp -78.89 -29.9 44.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -105.56 -14.47 15.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.759 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 283' ' ' TYR . 14.7 m120 -111.06 27.42 9.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.685 0.278 . . . . 0.0 111.621 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 282' ' ' ASN . 6.7 m-85 -168.69 -52.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.185 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.7 tp -46.41 -66.51 0.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.72 63.25 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.0 m -154.78 166.33 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.75 -20.31 55.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.46 -29.57 52.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.181 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -111.46 -52.92 0.54 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.761 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.3 tp -50.64 -27.3 6.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.91 -26.03 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.264 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.79 -57.94 3.53 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.381 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 294' ' ' ASN . 1.8 m -62.42 -28.78 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.634 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 297' ' ' LYS . 2.1 t-20 -22.2 -48.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -50.78 -27.77 7.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -135.62 -13.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.962 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 298' ' ' PRO . 0.0 OUTLIER -45.52 -49.81 33.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 297' ' ' LYS . 59.5 Cg_endo -73.73 104.52 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.301 2.0 . . . . 0.0 112.556 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 3.9 pp -177.94 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.655 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 177.82 72.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.36 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.31 93.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 111.201 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.9 t -154.89 109.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.76 40.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 3.2 mp -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -59.34 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 m -79.15 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.29 -35.75 35.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -25.27 28.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.234 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.47 -61.34 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.052 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.25 -31.16 14.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -55.71 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.38 -54.25 6.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt 54.1 30.06 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.06 110.42 18.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.68 -13.09 31.78 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.602 2.202 . . . . 0.0 112.615 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.95 4.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.719 0.295 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 317' ' ' ILE . 0.0 OUTLIER -58.51 -32.73 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.25 58.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.58 -26.47 61.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 12.1 t -55.6 -29.44 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.034 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.9 mmm -59.4 -30.44 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.33 -52.59 13.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.6 -31.04 67.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.66 69.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -59.88 -31.13 69.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 36.35 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -172.57 171.42 44.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.07 147.18 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 27.6 pt -59.33 130.35 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -178.47 136.62 0.34 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -178.19 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.454 2.103 . . . . 0.0 112.272 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -127.31 36.5 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 3.4 mp 64.13 127.76 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.46 -27.68 32.82 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.089 . . . . 0.0 112.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -58.28 -31.26 67.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.41 -28.47 68.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.9 m -58.65 -59.26 5.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.62 -27.46 66.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 368' ' ' ILE . 0.5 OUTLIER -56.37 -24.32 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -27.32 62.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -52.29 13.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.179 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.23 59.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.32 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.29 -29.93 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.448 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -52.55 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 11.5 m -69.35 -27.66 65.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.5 -60.56 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.416 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.52 -57.02 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.087 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -52.15 -58.79 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 345' ' ' THR . 0.1 OUTLIER -62.34 -31.06 71.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.75 0.31 . . . . 0.0 111.193 -179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.02 65.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.999 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.17 -9.87 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.1 t -67.28 -22.82 65.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 110.46 -29.34 9.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.441 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 39.2 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -163.96 122.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.77 171.06 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.21 -31.71 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.21 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.53 -33.85 71.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.14 -53.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -57.13 -30.08 64.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.1 mt -82.32 -56.63 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.07 -44.72 91.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.376 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 -35.36 80.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -79.78 -55.42 5.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -34.91 24.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 12.8 t -80.48 -29.5 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.55 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.008 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 339' ' ' PHE . 33.7 mm -64.35 -47.24 90.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.8 m -66.72 -58.68 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.39 45.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 168.98 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -149.95 139.43 21.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -113.08 102.83 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 61' ' ' PHE . 3.4 mp -97.51 129.95 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CZ3' HD22 ' A' ' 43' ' ' LEU . 8.9 t90 -94.9 113.28 24.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.79 141.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -165.3 78.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.98 35.93 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.564 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.7 89.09 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.747 0.308 . . . . 0.0 110.991 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -152.92 81.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.51 78.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -80.94 -56.59 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -76.12 -32.26 59.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.71 98.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.567 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.73 -31.53 59.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.68 -42.11 74.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.94 -33.31 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 t -70.32 -35.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.44 -34.63 81.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.597 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -69.51 -28.38 66.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.983 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.3 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.778 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.437 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 6.9 m-85 -64.27 -56.39 14.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -58.36 -28.16 64.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.141 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 -26.98 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.644 ' O ' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -64.94 -57.3 9.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.644 ' OG1' ' O ' ' A' ' 30' ' ' ASP . 5.9 m 156.45 36.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.731 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.48 52.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.705 0 C-N-CA 117.96 -2.067 . . . . 0.0 115.452 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 2.5 mm -138.36 95.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 118.168 0.984 . . . . 0.0 111.459 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.29 108.92 20.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.028 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.26 138.07 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 t -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.15 120.96 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -96.34 153.96 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.013 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.15 167.37 12.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.98 92.56 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.609 2.206 . . . . 0.0 112.35 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -177.43 -40.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.021 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -109.65 -29.09 8.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD22 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -57.42 -23.81 51.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.211 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.21 -28.74 55.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.09 -26.79 18.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.045 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -69.49 -29.38 67.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.94 -60.77 7.83 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.143 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.0 Cg_endo -66.28 -15.83 49.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.553 2.169 . . . . 0.0 112.512 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.35 -55.22 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.789 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.92 -24.8 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.16 -31.28 65.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.42 92.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.42 152.09 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.45 85.43 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.535 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.05 -35.94 16.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.38 -157.59 7.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.536 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.42 -175.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.585 2.19 . . . . 0.0 112.25 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 173.68 49.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -99.03 127.43 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.58 138.76 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 9' ' ' ILE . 7.6 m-85 -116.12 148.97 39.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -165.78 173.7 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.41 -173.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.448 ' CE1' ' CG2' ' A' ' 261' ' ' VAL . 2.1 t-160 -76.82 -53.18 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.21 66.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.421 ' CE2' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -110.01 -23.17 11.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.45 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.725 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.72 -24.81 68.95 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.717 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -64.45 -53.1 53.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.962 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.58 32.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.297 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -27.05 66.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -75.83 -26.85 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 -81.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.84 87.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.421 HD22 ' CE2' ' A' ' 67' ' ' PHE . 1.1 tp -117.52 141.51 48.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.91 119.86 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.22 159.34 12.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mt -126.24 148.94 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 m -120.41 92.66 47.71 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.48 114.41 3.26 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.954 2.436 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.27 -35.3 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -30.64 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' OD1' ' A' ' 87' ' ' ASP . . . -53.46 -22.94 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.617 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -80.16 -57.77 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 111.217 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -24.61 58.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 18.1 p-10 -62.4 -17.72 59.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.339 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 66.71 71.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.353 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.36 155.92 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 134.38 44.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.78 -25.92 36.62 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.469 2.113 . . . . 0.0 112.296 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -55.69 -30.29 60.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 m -75.72 -31.34 59.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.13 -48.02 39.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.39 -27.89 62.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 -30.02 57.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.208 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 64' ' ' HIS . 29.5 m -134.66 68.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.251 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -149.26 140.71 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.3 174.04 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.47 68.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.08 37.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.48 159.14 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.822 0.344 . . . . 0.0 110.837 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mp -141.94 85.96 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -136.87 40.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.9 131.43 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.04 118.6 10.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.812 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.7 124.77 5.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.453 2.102 . . . . 0.0 112.463 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mm -141.2 39.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.07 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 177.52 125.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.32 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.45 136.49 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 176.44 8.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 mt -81.26 149.0 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 m -164.71 170.9 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 tp -103.09 136.63 42.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.6 mm -111.64 125.85 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 51.1 p90 -128.18 152.4 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -105.04 176.98 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 30.83 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.41 -57.86 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -140.28 82.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.36 106.07 35.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 160.34 50.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.45 2.1 . . . . 0.0 112.346 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.9 149.43 98.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.28 119.11 6.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.555 2.17 . . . . 0.0 112.214 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.04 -71.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.353 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -177.15 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.68 -176.31 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.488 ' CE2' ' CE2' ' A' ' 250' ' ' PHE . 1.0 OUTLIER -65.5 -26.74 68.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -51.46 -24.07 4.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.383 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -15.81 33.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.592 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.563 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 3.5 tt -52.44 -35.66 25.61 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.2 Cg_exo -67.93 -31.41 31.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.207 1.938 . . . . 0.0 112.104 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.51 63.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mp -77.68 -38.12 48.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.78 -36.51 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -28.14 67.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.74 -31.58 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.48 -55.94 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -30.36 67.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.08 76.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.038 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -139.39 -60.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.775 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.03 41.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -126.63 121.94 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.9 t -140.69 170.67 15.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -147.15 13.38 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 0.2 OUTLIER 170.67 115.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 111.717 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.35 148.8 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.129 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.99 132.96 21.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.019 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -61.1 -176.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.7 -47.43 1.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.482 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.91 39.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.82 157.85 33.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.74 149.93 21.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.563 2.175 . . . . 0.0 112.315 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 61.57 67.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -120.31 -39.3 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.3 p -63.6 -36.51 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.484 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 3.1 t-105 -67.95 -55.7 12.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.442 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -64.21 -11.72 29.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.276 1.984 . . . . 0.0 113.142 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.48 -56.79 2.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.643 0.259 . . . . 0.0 111.59 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 42.8 mt -65.81 -20.16 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 158' ' ' TRP . . . -89.37 12.2 16.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.2 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 110.976 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.5 -51.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.059 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.75 -86.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -56.14 142.86 38.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -169.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.05 -38.37 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.3 61.05 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -122.96 168.71 11.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.37 -33.02 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.98 -32.38 36.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.46 74.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -60.45 -46.07 91.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.18 -35.2 31.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.03 -28.31 73.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.53 -50.43 8.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 p -57.58 -28.93 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 2.1 m-85 -55.0 -60.63 3.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.51 -30.78 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.968 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.04 -54.03 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.3 -32.35 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.07 -55.98 27.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 6.2 mt -61.71 -33.71 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -33.29 71.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.968 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -106.51 19.34 20.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.28 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 -54.99 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.813 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.37 -46.15 3.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.833 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.8 ttm 58.34 44.31 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -176.79 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 65.76 77.09 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -143.96 30.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.2 t -81.8 148.08 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -124.01 -165.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 211' ' ' SER . 30.3 p90 -78.92 -44.26 23.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.083 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.448 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 14.2 t -73.18 -24.67 60.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.353 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.9 -50.48 16.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.082 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.34 69.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.467 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 210' ' ' TYR . 4.4 tt0 -75.15 -25.69 58.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -51.55 -25.58 7.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.533 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -57.01 -57.47 12.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.763 0.315 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 220' ' ' GLY . 20.2 t80 -69.57 -40.27 76.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -59.43 -49.6 77.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -94.25 -1.49 53.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.642 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 217' ' ' PHE . . . -147.81 87.35 0.16 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.725 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.25 59.75 2.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.657 . . . . 0.0 110.461 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 224' ' ' MET . 0.3 OUTLIER -107.58 -175.07 2.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.125 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.8 44.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.45 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -116.87 45.88 1.76 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.829 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.446 ' CG2' ' CE1' ' A' ' 217' ' ' PHE . 1.8 t -143.56 114.63 7.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.58 122.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -86.85 110.76 20.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.984 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 174.62 58.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -134.45 120.93 2.55 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.52 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.59 132.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 25.2 m -141.09 156.75 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.77 150.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.22 154.63 89.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.78 -164.13 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.844 2.363 . . . . 0.0 112.135 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.8 p -97.29 177.95 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.488 ' CE2' ' CE2' ' A' ' 129' ' ' TRP . 79.8 m-85 -144.88 110.93 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.425 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 39.65 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.872 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 154.42 -59.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.803 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -150.87 166.06 15.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.96 173.83 11.45 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.682 2.255 . . . . 0.0 112.284 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.66 179.46 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 125.85 66.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 -168.25 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.451 2.101 . . . . 0.0 112.333 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.19 119.62 13.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.34 123.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.04 134.53 9.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 64' ' ' HIS . 14.4 m -97.39 144.87 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -81.97 121.99 27.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.3 113.43 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.82 43.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.023 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 176.94 -157.94 23.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.568 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.8 pt -137.95 155.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.802 0.334 . . . . 0.0 111.122 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -147.09 128.06 14.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.12 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -178.68 36.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.87 55.03 9.38 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.27 -45.56 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -151.88 80.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -30.24 71.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -69.56 -42.47 74.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' ' 279' ' ' PHE . 6.2 tp -77.69 -31.24 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.61 -46.26 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -50.65 72.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.47 -40.66 92.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.411 ' CD2' ' HG ' ' A' ' 275' ' ' LEU . 1.1 m-85 -67.8 -53.87 23.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.43 -29.15 63.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -92.18 -25.04 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.86 27.33 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.018 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.82 -62.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.871 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -139.07 57.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.3 mt -161.85 29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.1 t -154.76 177.35 11.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.87 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.4 -49.15 67.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -77.39 -28.08 52.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.49 -66.5 2.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.429 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -20.78 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.83 -31.4 27.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.29 6.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 297' ' ' LYS . 11.2 m -64.31 -29.58 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -48.02 -28.6 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.39 -70.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -73.05 -50.01 25.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.789 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER 64.13 140.96 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.038 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.88 -2.23 10.78 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.689 2.26 . . . . 0.0 112.601 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 299' ' ' LEU . 2.8 mm? 61.78 46.51 6.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.96 83.87 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -166.98 133.59 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 9.0 p -178.63 99.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.969 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.76 54.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 146.17 40.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -60.23 -37.37 80.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.1 m -79.54 -27.04 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.962 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -40.93 69.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.76 -32.28 65.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.96 -37.64 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.649 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -74.34 -30.32 61.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.49 -29.79 1.23 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.388 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.48 -29.49 50.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.215 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 30.93 4.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.97 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.4 172.83 8.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -88.04 -76.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.78 2.32 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -81.32 -58.83 2.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.0 mt -50.76 -28.14 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.409 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.15 75.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.56 -45.65 18.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -37.91 88.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -27.5 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.158 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -55.26 -46.86 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.27 -31.73 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.71 66.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.86 -32.19 67.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -111.15 36.36 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -135.04 -175.4 13.83 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -120.42 -176.63 3.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.98 116.01 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.436 ' CE ' ' CE1' ' A' ' 64' ' ' HIS . 7.2 ptp 43.84 52.94 9.67 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.516 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.7 97.66 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.553 2.169 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -134.5 -70.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.4 mt 63.72 139.11 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.73 -26.48 17.56 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.542 2.161 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.87 -27.23 63.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.4 tpt -57.57 -27.95 63.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.96 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.45 77.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.153 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -59.97 -25.64 65.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -38.7 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.049 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -44.27 22.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.73 96.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.0 -30.37 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.1 t -49.61 -27.58 4.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.364 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.42 -52.22 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.137 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.54 -55.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.987 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 344' ' ' ARG . 9.0 tp -53.48 -38.74 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -28.35 35.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.05 68.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.261 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.23 -14.28 44.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.5 p -67.69 -56.32 9.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.768 0.318 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -134.1 -70.8 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -173.44 39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -88.46 99.07 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.1 t -103.31 -167.05 1.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.38 -27.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.376 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -46.79 -56.12 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.506 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -80.34 -41.17 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.613 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.469 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -54.95 -53.09 60.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.258 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.67 -56.87 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.477 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -41.38 84.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.471 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -76.51 -47.71 21.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.716 0.293 . . . . 0.0 111.131 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -66.79 -47.4 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.31 -37.62 56.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.285 . . . . 0.0 111.296 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.1 t -80.68 -29.5 36.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -73.81 -41.85 61.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.34 -47.24 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.087 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.3 t -159.9 -52.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.7 tttm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.861 0.362 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.89 -72.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 172.77 13.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -111.04 160.01 17.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 t -118.62 102.91 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.03 114.95 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CD1' ' CD2' ' A' ' 43' ' ' LEU . 47.1 t90 -94.94 111.9 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 tt -164.88 158.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.64 -171.28 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 51.53 0.78 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.394 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.11 -26.74 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.603 0.24 . . . . 0.0 111.135 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -43.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.279 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 42.19 2.91 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.851 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 40.7 p90 -81.12 -46.64 14.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 40.4 m-20 -76.62 -37.46 56.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -39.03 89.73 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.46 -28.95 52.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.288 . . . . 0.0 110.986 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.46 -49.2 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.133 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.02 -50.54 73.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 ' CZ ' ' A' ' 27' ' ' PHE . 11.9 p -58.55 -30.89 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.72 -34.03 64.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -77.14 -28.28 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -29.7 70.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.426 ' CZ ' HG22 ' A' ' 23' ' ' VAL . 37.6 m-85 -74.39 -56.77 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -60.84 -27.42 68.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.269 0.557 . . . . 0.0 110.417 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.22 -29.21 1.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.863 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.502 ' O ' ' CG2' ' A' ' 31' ' ' THR . 4.8 m-20 -66.33 -57.37 7.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.77 37.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.722 0.639 . . . . 0.0 112.037 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 47.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.67 0 C-N-CA 118.131 -1.985 . . . . 0.0 115.358 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -140.36 95.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 118.077 0.938 . . . . 0.0 111.63 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.37 129.77 52.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.77 130.47 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.1 p -105.71 121.59 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.34 118.2 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -109.76 159.92 16.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.53 166.43 23.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 122.02 9.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.25 -75.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 0.09 27.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.51 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -55.06 -30.54 59.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 111.06 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -33.5 76.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.93 -29.21 15.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.93 -25.46 63.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.424 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.48 -60.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.6 Cg_endo -63.85 -15.42 48.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.642 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -38.4 22.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.25 -18.31 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.267 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -37.12 65.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.31 -37.71 32.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -164.31 -71.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.94 -74.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.537 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -165.02 -57.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.95 -63.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.2 159.15 27.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.602 2.201 . . . . 0.0 112.276 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.52 67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 34.4 mt -107.0 113.68 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.58 142.68 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.406 ' CE1' ' HB1' ' A' ' 264' ' ' ALA . 12.1 m-85 -108.64 123.58 49.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.44 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -163.18 174.01 12.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.721 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.52 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.7 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -77.24 -51.22 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -48.06 -28.14 2.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.624 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HG2' ' CE3' ' A' ' 62' ' ' TRP . 4.8 tpp180 -64.75 -36.54 84.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 263' ' ' SER . 34.0 m-85 -110.46 -59.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.32 -23.62 19.15 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.17 -50.41 2.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.41 -40.35 73.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.995 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.7 -26.64 57.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.31 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -54.84 -28.59 50.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -70.62 -26.76 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.91 64.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mt -149.81 40.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.53 146.05 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 131.49 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -58.02 160.94 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 mt -114.77 158.79 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.6 97.83 51.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.848 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.67 161.35 24.76 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 2.0 m-20 -97.79 -177.94 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -97.52 -51.4 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.13 -25.32 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.343 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 82' ' ' ASP . 34.2 m-85 -79.29 -59.04 2.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.22 -24.78 68.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.99 -38.17 90.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.96 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.63 39.57 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.78 153.35 41.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.76 134.26 69.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.419 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.2 Cg_exo -54.25 -22.89 27.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.414 2.076 . . . . 0.0 112.376 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -57.45 -40.71 79.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.433 ' CG2' ' CD1' ' A' ' 94' ' ' TRP . 12.5 t -58.98 -29.7 67.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.433 ' CD1' ' CG2' ' A' ' 93' ' ' THR . 11.4 m0 -77.98 -56.67 4.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.91 -25.2 60.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.059 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.0 76.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.149 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.76 70.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.199 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 109.65 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -101.12 104.53 15.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 68.57 -67.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.006 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.01 33.01 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -136.23 140.37 43.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 tp -108.59 89.47 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.9 pt -102.4 41.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.041 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.49 155.71 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -134.63 100.69 12.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.174 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.436 ' CB ' ' CG2' ' A' ' 261' ' ' VAL . 5.6 Cg_endo -85.41 142.32 8.28 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.074 2.516 . . . . 0.0 111.504 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 15.9 mt -155.88 39.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 108' ' ' ILE . . . 160.6 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.267 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 11.0 p -118.09 104.08 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.061 0.458 . . . . 0.0 110.841 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -158.49 132.23 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.775 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 113' ' ' LEU . . . -165.1 105.52 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 112' ' ' ALA . 4.2 mt 158.2 106.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.305 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 m -164.98 123.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.876 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 tp -101.2 116.04 31.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.126 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.6 mt -74.71 133.16 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.553 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.417 ' CE2' HG22 ' A' ' 245' ' ' THR . 50.5 p90 -152.87 124.14 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.674 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -150.81 -179.56 7.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt 59.53 24.07 12.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.075 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.43 27.83 4.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 39.73 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.841 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.01 114.65 1.97 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.43 160.43 49.53 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.42 2.08 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -64.95 154.04 87.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.09 108.98 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.62 2.214 . . . . 0.0 112.41 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.51 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.51 2.14 . . . . 0.0 112.344 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -101.34 14.77 30.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.3 m -160.22 141.15 12.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.422 ' CG ' HD13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.69 -29.15 64.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.01 -23.71 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.89 -21.63 60.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.684 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 4.3 mt -73.38 -54.34 4.18 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.6 Cg_exo -52.92 -30.92 50.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.227 1.951 . . . . 0.0 112.332 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.07 -37.12 71.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.15 -30.08 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.02 -34.9 72.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -59.27 -37.94 78.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.76 -42.02 20.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -50.98 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -25.95 64.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.32 35.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.359 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -109.23 -53.51 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.941 0.401 . . . . 0.0 110.749 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.94 40.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.525 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 172.22 18.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 m -122.68 177.53 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 223' ' ' ALA . . . -118.56 30.79 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.037 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp 170.4 138.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.755 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.409 ' CB ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -164.69 139.19 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.016 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -171.93 176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.56 155.31 12.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.49 -48.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -98.82 39.77 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.714 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.11 148.38 54.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.786 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 155' ' ' TYR . 98.8 Cg_endo -79.87 161.98 23.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.624 2.216 . . . . 0.0 112.503 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' A' ' 154' ' ' PRO . 14.0 m-85 77.85 -2.13 2.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -121.04 -69.82 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.357 . . . . 0.0 110.836 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -29.59 60.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -64.31 -55.98 26.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 46.2 Cg_endo -68.82 -22.3 36.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.519 2.146 . . . . 0.0 112.673 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -53.76 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 0.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.329 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.53 -68.15 0.81 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.404 ' HB1' ' CZ ' ' A' ' 250' ' ' PHE . . . 63.64 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.73 -29.45 69.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 69.67 1.38 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.499 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 94.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -173.41 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.187 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.1 p 43.55 38.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.952 0.406 . . . . 0.0 111.601 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -98.65 37.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -126.31 143.43 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.72 -28.43 67.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -58.87 -45.17 95.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.95 -35.29 59.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.089 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -63.41 -49.42 73.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.09 80.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.45 80.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.22 -41.7 96.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 t -77.46 -37.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.005 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -53.35 56.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.036 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.45 -53.07 62.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.01 -28.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.456 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.18 -56.89 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.298 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.41 -37.35 75.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.34 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.67 -31.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 111.266 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -78.8 -26.12 44.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.204 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.39 23.1 14.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -76.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.936 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.03 -4.09 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.438 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.8 ptp 44.65 47.4 8.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.985 0.421 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -56.82 109.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.018 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.97 67.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -164.91 94.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 t -98.48 129.59 45.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.773 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.8 -162.14 0.79 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 214' ' ' GLU . 2.3 t80 -79.13 -46.78 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 214' ' ' GLU . 1.7 t -63.86 -24.68 67.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.1 mt -82.71 -57.28 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.539 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.97 68.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.012 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 210' ' ' TYR . 0.0 OUTLIER -51.25 -31.47 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 111.337 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.23 57.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.83 -52.92 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.833 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 226' ' ' ILE . 53.2 t80 -76.43 -58.67 3.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.793 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 214' ' ' GLU . 14.5 t-20 -47.48 -31.84 4.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.557 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -105.35 -23.7 12.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 52.87 43.42 60.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.25 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -110.48 39.26 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.585 0.231 . . . . 0.0 111.516 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 17.6 p -131.59 -177.91 4.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -88.43 38.48 0.87 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.376 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.5 ttt 176.45 128.44 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.933 0.397 . . . . 0.0 111.513 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.71 105.04 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.484 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.404 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 2.4 tt -76.97 142.21 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.91 129.75 34.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -109.68 -144.48 10.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.396 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.456 2.104 . . . . 0.0 112.315 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.89 0.376 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.37 132.81 11.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.561 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.76 106.37 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -123.47 158.95 30.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.46 149.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 156.17 37.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.79 -158.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.925 2.417 . . . . 0.0 112.209 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.3 p -127.13 177.28 6.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CZ ' ' HB1' ' A' ' 163' ' ' ALA . 49.9 p90 -167.26 118.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.77 12.21 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.85 16.03 60.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -152.91 92.75 3.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.643 0.258 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.22 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.484 2.123 . . . . 0.0 112.217 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.4 m -49.7 175.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 111.208 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 2.5 mtpm? -86.28 134.59 38.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.3 Cg_exo -79.55 111.79 2.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.65 2.234 . . . . 0.0 112.213 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -132.33 103.35 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 30.2 m -101.51 153.06 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -130.4 117.62 2.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 9.3 p -86.37 145.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.307 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 107.78 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.076 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 4.1 m -91.79 117.49 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.82 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.406 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -135.93 108.74 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -151.15 -143.41 3.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.567 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -137.24 146.48 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 111.144 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -127.63 118.82 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.44 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 179.93 36.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 55.42 54.09 9.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 270' ' ' SER . 50.1 Cg_endo -69.07 -46.77 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.66 2.24 . . . . 0.0 112.299 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.8 65.06 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.81 -45.59 93.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.18 -33.39 72.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.957 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.82 -55.78 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.47 -52.58 63.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -29.43 68.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.85 -56.6 19.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.36 -29.7 62.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -33.53 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.084 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.31 -31.88 8.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.219 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -97.25 27.45 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 -43.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.98 42.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.1 38.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.0 p -136.03 153.75 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -38.14 65.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -57.26 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.1 -57.46 15.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.939 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 293' ' ' VAL . 2.8 tt -45.98 -40.71 10.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.332 . . . . 0.0 111.511 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 -57.91 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.411 . . . . 0.0 110.812 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -49.06 -24.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.223 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 294' ' ' ASN . 34.4 m -80.86 -29.51 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.349 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.441 ' N ' HG22 ' A' ' 293' ' ' VAL . 6.3 m120 -100.72 -85.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.389 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -120.39 14.61 12.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.7 t0 59.95 27.97 17.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.75 160.26 2.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.17 155.46 6.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -164.46 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.66 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.413 ' N ' ' CD2' ' A' ' 299' ' ' LEU . . . 170.19 140.57 3.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.474 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 172.88 156.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.6 m -160.28 40.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -129.34 40.11 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.068 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 116.38 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -41.62 90.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 p -68.5 -31.52 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -74.71 -27.28 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.27 -36.45 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.0 -56.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.58 -22.42 21.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.317 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -47.31 -29.17 2.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.541 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -29.6 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.96 109.83 2.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.927 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 -11.63 18.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.103 . . . . 0.0 112.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -66.04 -59.33 3.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.4 mp -80.13 -34.67 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.41 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.264 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.78 -49.0 76.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 p -67.9 -26.51 66.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -26.9 28.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.239 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -66.57 -57.43 7.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.987 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -76.47 -34.19 58.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.85 59.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.11 -30.87 66.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 -30.19 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.062 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -90.07 -148.01 18.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.64 -178.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.55 114.96 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.51 147.09 0.77 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 -167.68 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.502 2.135 . . . . 0.0 112.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 30.29 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.95 90.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -51.94 -36.88 65.89 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.575 2.183 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.57 -36.74 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 19.8 mmt -61.81 -22.08 65.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 t -52.06 -27.31 13.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.0 -33.45 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.149 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -29.12 66.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 45.2 t90 -47.98 -28.83 2.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.92 -42.95 90.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.93 -30.45 39.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.5 t -53.9 -29.72 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.642 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 348' ' ' ILE . 0.2 OUTLIER -52.55 -46.73 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.186 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 14.8 t -50.0 -30.57 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.079 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.18 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.754 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 34.8 m -79.83 -49.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 344' ' ' ARG . 1.5 tt -49.99 -42.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.698 0.285 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.3 m120 -60.86 -33.23 72.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.17 65.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.39 -10.57 59.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.534 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 54.2 m -67.62 -29.05 68.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.035 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.01 -12.33 65.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -129.66 39.59 3.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -123.73 127.1 47.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.786 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 18.2 p -110.07 141.26 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.79 -27.91 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -37.75 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -80.24 -52.76 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -53.88 -33.21 55.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.107 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -49.38 10.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -64.63 -55.48 19.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 364' ' ' ALA . 1.3 p-10 -59.64 -29.68 68.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.689 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.411 ' N ' ' OD1' ' A' ' 363' ' ' ASP . . . -64.79 -55.49 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -30.74 60.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.0 p -80.06 -30.08 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.935 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -47.11 41.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.31 -35.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.3 p -99.0 30.7 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.717 0.294 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.32 51.97 3.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -134.48 130.44 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.85 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.4 mp -125.75 157.29 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 16.7 t -134.18 104.15 5.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.307 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 3.7 mp -99.88 124.18 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.346 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.418 ' CE3' HG22 ' A' ' 60' ' ' ILE . 9.8 t90 -107.07 117.72 34.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.514 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 155.96 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.232 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -143.82 110.73 5.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.65 57.37 0.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -140.36 -50.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 tttt 59.4 31.53 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.66 36.52 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.525 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -60.13 -35.62 75.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.52 -51.15 38.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.13 54.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.97 -56.47 21.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.826 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.85 69.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -31.85 70.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.951 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -75.35 -38.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -25.32 75.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.54 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -57.26 -41.89 80.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -74.61 -47.67 30.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 1.5 m-85 -62.32 -56.24 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.489 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -51.85 -28.25 15.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.434 0.635 . . . . 0.0 110.683 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -25.69 49.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.61 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.65 ' O ' ' OG1' ' A' ' 31' ' ' THR . 14.5 t0 -51.58 -56.73 11.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.65 ' OG1' ' O ' ' A' ' 30' ' ' ASP . 6.9 m 156.97 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.761 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.76 45.91 0.01 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 117.58 -2.248 . . . . 0.0 115.898 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 4.0 mm -131.45 95.79 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 118.425 1.113 . . . . 0.0 111.541 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -111.07 128.49 55.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.85 138.7 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.28 115.2 27.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 p -86.3 116.27 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.808 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -104.27 143.32 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 111.277 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -112.42 158.47 37.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.564 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.67 -83.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.358 2.039 . . . . 0.0 112.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 49.98 -92.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -120.34 -2.99 9.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.26 -25.79 15.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.687 0.28 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -55.15 -38.84 68.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.36 -23.3 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.067 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -29.53 60.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.164 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 64.5 t80 -55.74 -56.58 28.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.273 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.3 Cg_endo -64.01 -15.27 48.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.556 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.65 -55.3 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.08 -28.87 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.04 -28.07 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -26.23 62.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.336 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.6 m -148.4 124.08 10.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.9 -54.25 2.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.343 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.98 -55.04 0.5 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.38 -107.01 0.35 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.575 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 87.3 Cg_exo -48.3 150.17 5.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.631 2.22 . . . . 0.0 112.259 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -153.89 38.53 0.46 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 13.1 mt -152.73 118.47 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 110.533 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.418 HG22 ' CE3' ' A' ' 10' ' ' TRP . 12.7 mt -151.15 142.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 111.694 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.463 ' CE2' ' CB ' ' A' ' 264' ' ' ALA . 2.1 m-85 -128.38 120.47 27.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.89 92.48 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.741 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 42.59 -165.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.054 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -76.94 -29.53 55.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -47.78 -35.16 9.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.527 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -36.86 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 105' ' ' ALA . 13.5 t80 -77.56 -64.03 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.2 -10.21 61.97 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.054 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.39 -61.11 1.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -96.57 -48.23 5.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.691 0.282 . . . . 0.0 111.088 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.01 -29.69 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.251 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -64.11 -31.62 72.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -26.8 25.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.77 70.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.59 39.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.79 118.48 7.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.41 156.09 28.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -93.4 156.85 16.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.12 163.86 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -110.49 86.13 5.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.8 -168.35 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.531 2.154 . . . . 0.0 112.362 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 86' ' ' GLN . 21.8 m-20 64.01 131.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -120.26 -100.89 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.71 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.4 -59.18 2.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 86' ' ' GLN . 50.9 p90 -80.91 -53.13 6.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.446 ' N ' ' CD2' ' A' ' 85' ' ' PHE . 2.5 mt-30 -52.76 -23.07 6.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.997 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 1.8 p-10 -45.5 -30.86 1.55 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -65.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.821 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp 42.69 -168.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.607 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.24 112.83 13.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.83 -26.12 29.66 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.384 2.056 . . . . 0.0 112.354 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.29 -31.9 70.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -75.35 -31.02 60.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -70.17 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.81 -26.43 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.213 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.01 67.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.102 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.46 68.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.48 155.57 42.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.31 168.6 13.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -71.71 65.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.3 28.47 13.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 163.98 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 mt -145.33 75.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' A' ' 67' ' ' PHE . 2.3 pt -108.22 39.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -170.89 132.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.14 102.19 2.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.22 167.34 21.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.743 2.295 . . . . 0.0 111.925 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.99 39.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -176.85 157.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.27 106.16 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -126.94 159.65 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.25 159.43 20.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -79.72 161.43 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.15 -176.03 3.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.09 108.68 19.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 242' ' ' TYR . 9.1 tt -87.99 149.31 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.42 163.53 30.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -102.53 -178.04 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.7 81.25 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -163.06 -63.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -123.71 40.03 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 tt -144.65 115.82 5.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.12 158.0 59.02 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.425 2.083 . . . . 0.0 112.197 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -65.02 111.25 5.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.51 154.76 24.29 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.51 2.14 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.54 -167.52 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.526 2.151 . . . . 0.0 112.238 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 p -76.99 140.52 40.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.01 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.493 ' CD2' ' CE2' ' A' ' 250' ' ' PHE . 3.1 m95 -71.71 -37.34 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.58 -23.82 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.643 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.04 -16.26 41.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.523 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 37.0 mt -65.61 -48.77 64.2 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 84.9 Cg_exo -46.4 -35.78 16.66 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.419 2.079 . . . . 0.0 112.465 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.07 93.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.51 -31.66 53.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -71.83 -31.84 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.32 -45.27 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.44 -48.83 30.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -59.22 -25.64 64.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.021 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.76 33.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.387 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -109.03 -63.39 1.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.82 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.9 39.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.327 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -153.88 166.29 33.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -119.15 162.81 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 147' ' ' LEU . . . -93.0 -2.15 56.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.597 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 146' ' ' ALA . 1.9 pt? 172.61 126.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.716 0.293 . . . . 0.0 110.477 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.23 120.74 8.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.587 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.38 123.85 48.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.077 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 156' ' ' PHE . 1.4 p-10 -85.04 154.25 22.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.8 mt -128.37 -46.27 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.37 39.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 3.2 mt-10 -120.18 137.03 25.5 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 4.4 Cg_exo -79.63 179.24 6.49 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.726 2.284 . . . . 0.0 112.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' A' ' 258' ' ' PHE . 3.6 m-85 59.8 20.11 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CZ ' ' OD1' ' A' ' 150' ' ' ASN . 19.3 m-85 -120.84 -33.0 3.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.166 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -77.23 -24.28 51.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -69.42 -55.31 9.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 158' ' ' TRP . 21.6 Cg_exo -65.35 -32.84 49.79 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.48 2.12 . . . . 0.0 112.23 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 250' ' ' PHE . 0.5 OUTLIER -70.1 -52.64 22.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.237 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.0 mt -77.06 -5.1 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.821 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 164' ' ' ASP . . . -83.91 -63.96 1.25 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.34 -87.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ALA . 2.0 t0 -115.89 -39.57 3.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.67 -91.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.13 -47.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 60.76 42.23 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.27 -24.68 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -144.23 65.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.64 -174.89 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.2 -30.0 51.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.13 93.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.181 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -67.04 -33.64 75.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.48 -46.32 80.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.77 -28.34 67.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.99 -31.82 61.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 p -75.25 -30.78 60.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.66 -41.98 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.54 -37.84 82.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.05 -30.26 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.78 -41.33 68.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.23 -50.15 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 17.1 tt -59.47 -30.85 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -62.23 -26.78 68.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -97.53 -23.73 15.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.071 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -88.88 -66.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -35.2 73.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 mtt -101.54 72.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -179.15 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.46 -45.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.07 95.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.9 t -63.36 137.56 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.78 -166.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 211' ' ' SER . 48.8 p90 -79.0 -40.36 31.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.172 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.412 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -79.53 -24.67 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.356 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.56 -57.29 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.42 68.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.3 -42.62 20.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -31.37 65.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.422 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.43 -52.23 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -68.65 -28.36 66.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.626 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -69.29 -50.85 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -107.05 -23.76 12.2 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 99.97 67.7 0.85 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.749 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.08 38.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -152.16 179.99 8.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -85.82 38.85 0.77 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.39 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.63 159.19 0.24 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.024 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.52 105.14 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.827 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.4 mt -80.82 136.15 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -115.24 163.77 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -163.62 163.02 35.46 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.343 0.257 0 C-N-CA 122.576 2.184 . . . . 0.0 112.347 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 116' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.809 0.337 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -145.1 144.22 12.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 23.6 m -93.4 136.47 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 61.6 m -141.01 150.13 42.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.3 150.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 0.0 OUTLIER -126.25 97.45 34.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.54 51.89 4.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.924 2.416 . . . . 0.0 112.691 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.12 114.41 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.493 ' CE2' ' CD2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -155.09 111.69 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.763 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.7 mptt 58.11 19.97 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.261 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 116.06 -34.79 4.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.889 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -132.37 152.13 79.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.295 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.04 132.4 12.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.73 2.287 . . . . 0.0 112.485 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 67.5 m -54.42 178.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.39 83.43 46.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.59 162.89 24.44 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.962 2.441 . . . . 0.0 112.151 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 5.1 m-85 -88.36 144.32 26.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.83 154.51 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.08 110.51 1.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.442 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.4 m -108.33 144.65 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.76 90.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.597 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.2 m -79.59 120.84 24.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.463 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . . . -83.54 123.89 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.112 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -102.75 106.13 2.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 14.7 tt -95.73 141.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 0.0 111.074 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -83.59 138.39 33.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -78.94 -30.84 44.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.6 52.53 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.8 p -115.86 149.24 42.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 125.64 12.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.599 2.199 . . . . 0.0 112.318 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.88 88.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -75.08 -33.89 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.52 -30.89 67.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.64 -32.96 60.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.78 69.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -65.23 -58.99 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.92 -32.09 70.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -51.35 69.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -31.28 64.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -71.79 -30.26 65.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.56 27.48 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -132.89 -69.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.33 -52.14 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.11 67.88 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.5 t -146.4 168.0 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.775 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.66 -45.66 66.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.47 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -71.87 -57.4 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.54 -57.19 20.66 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.803 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -36.72 68.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 111.123 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -78.66 -27.7 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.07 -57.8 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.189 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.03 -29.9 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.371 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -64.72 -60.42 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -82.01 -47.44 12.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.398 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.52 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.259 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -159.93 89.77 1.86 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.011 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -173.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.188 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.6 pp -178.84 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 164.34 121.89 0.58 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 179.25 157.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 p -178.28 56.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -97.33 40.34 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.26 167.74 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -113.33 -36.66 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.2 m -79.37 -52.46 8.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -67.48 -24.64 65.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -53.59 -29.9 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -69.17 -31.14 69.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -92.92 -38.16 11.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.97 -28.17 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.74 56.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -57.24 -29.51 63.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.85 143.27 97.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.69 -37.27 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -59.02 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.54 -29.93 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.39 -36.29 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.29 -33.79 43.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.2 m -76.85 -40.86 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -58.17 -25.82 61.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.64 -57.62 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -78.47 -30.58 47.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.21 90.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.27 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -29.05 64.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -97.44 -30.72 12.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.0 -165.02 30.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.57 165.78 30.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.21 130.77 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.407 ' HE1' ' CE1' ' A' ' 258' ' ' PHE . 0.5 OUTLIER -96.82 101.76 10.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.82 -10.91 30.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.478 2.119 . . . . 0.0 112.541 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 65.87 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.878 0.371 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -79.48 127.6 77.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.67 -34.59 54.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.344 2.029 . . . . 0.0 112.429 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -57.79 -30.4 65.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.7 p -54.73 -30.87 57.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.76 -30.95 45.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -77.93 -26.49 48.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.21 -43.68 78.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.98 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -28.94 43.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.39 -51.29 58.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.333 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.61 -29.89 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.349 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -60.9 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 4.5 p -60.54 -29.94 69.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.6 -50.52 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.54 -53.36 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.789 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 69.3 mt -51.68 -39.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.901 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 350' ' ' ALA . 35.8 p30 -51.45 -25.8 7.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 111.41 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . 0.44 ' N ' ' OD1' ' A' ' 349' ' ' ASN . . . -62.14 -33.61 74.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.36 -11.57 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.484 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.5 p -67.67 -30.23 69.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.64 -14.24 64.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.73 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -130.38 39.86 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.17 132.87 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 68.5 p -115.7 142.22 47.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 31.0 m -58.62 -27.94 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.243 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.37 -38.24 65.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -51.08 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.76 -29.9 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.18 -56.39 3.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -63.62 -53.18 55.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -55.93 -47.88 76.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.47 -53.21 55.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -56.97 -30.53 64.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 8.7 p -80.68 -40.24 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.3 mtp-105 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.5 mt -75.72 -47.21 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.247 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 92.8 m -103.65 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.956 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 17.7 tptm . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.877 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -103.02 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -130.3 131.71 45.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 64.97 -75.3 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.31 43.71 97.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.82 139.74 40.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.5 mt -138.21 154.77 49.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.61 102.82 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.8 mp -96.43 118.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.406 ' CE2' HD12 ' A' ' 43' ' ' LEU . 93.8 m95 -94.98 112.05 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -145.24 145.56 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.068 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -163.75 112.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.66 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -176.92 -48.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -153.17 -175.15 5.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 -34.89 3.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.489 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 8.5 p90 -62.36 -34.65 77.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 21.4 t-20 -68.07 -36.89 80.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.57 -39.03 30.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.28 -31.32 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.35 94.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.44 -34.33 73.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.67 -31.0 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.13 -46.72 9.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -29.7 59.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.776 0.322 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -37.74 37.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -67.26 -56.5 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.588 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -53.58 -27.7 27.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 110.245 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -46.4 -32.49 3.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.809 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' CG2' ' A' ' 31' ' ' THR . 24.7 t0 -62.97 -57.41 10.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.61 37.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.653 0.596 . . . . 0.0 112.248 176.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.87 43.37 0.02 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 117.909 -2.091 . . . . 0.0 115.537 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.585 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 3.2 mp -140.38 95.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 118.039 0.919 . . . . 0.0 111.857 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.17 131.8 54.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.07 148.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.76 137.13 50.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.55 111.51 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.75 163.05 31.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -98.72 144.4 28.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 136.04 23.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.516 2.144 . . . . 0.0 112.326 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.46 -47.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -116.24 0.15 12.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.374 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 10' ' ' TRP . 7.2 tp -56.6 -25.41 52.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.746 0.308 . . . . 0.0 111.147 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -55.73 -31.96 62.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.24 -29.6 13.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -73.95 -24.55 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.15 -58.48 8.65 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 26.5 Cg_endo -61.96 -18.96 64.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.436 2.091 . . . . 0.0 112.455 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -89.75 -35.97 15.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.829 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.8 t -88.58 -17.83 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.39 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.27 -39.76 64.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.827 0.346 . . . . 0.0 111.271 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.35 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -169.66 -74.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.808 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.08 -74.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.18 -71.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.27 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.27 -177.74 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 167.09 106.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.8 tt -146.94 117.31 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.19 142.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -96.05 117.13 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.386 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -143.12 173.23 11.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.26 -168.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.186 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 261' ' ' VAL . 0.4 OUTLIER -76.1 -56.4 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.04 -28.98 57.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.982 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -41.77 84.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -111.88 -55.23 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.62 -29.07 74.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.81 29.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.548 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.63 -45.93 8.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.17 71.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.06 67.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -108.33 25.79 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.07 -75.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -176.77 83.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.952 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.25 143.7 40.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.49 83.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 96.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.07 158.32 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 43.6 p -101.2 157.96 32.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.8 89.64 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.605 2.203 . . . . 0.0 112.397 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.12 -55.2 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -25.29 64.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.25 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.493 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -75.13 -59.18 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.03 61.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.39 -39.86 52.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.02 37.3 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -170.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -98.05 146.53 31.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.97 -32.4 8.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.541 2.161 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -31.73 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -31.3 62.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.54 -41.78 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -30.93 70.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.53 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 64' ' ' HIS . 22.8 m -122.06 60.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 93.04 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -101.93 113.66 27.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.4 -68.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.54 39.11 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.492 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.6 171.5 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.39 92.03 3.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -112.97 46.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.51 124.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.96 100.99 36.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.997 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.87 127.72 7.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.199 . . . . 0.0 112.135 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.3 mm -138.8 39.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 111.252 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 262' ' ' LEU . . . 176.02 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.779 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.97 105.72 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.918 0.39 . . . . 0.0 111.056 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 132.86 49.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.97 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.48 174.32 14.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.92 160.73 14.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 m -164.07 -179.79 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.99 133.67 54.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.71 143.57 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.417 ' CE1' HG21 ' A' ' 245' ' ' THR . 46.7 p90 -139.1 179.36 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -139.41 177.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.77 34.93 4.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -131.11 -65.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.04 39.92 3.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.15 88.36 13.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.77 140.23 47.56 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.31 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -70.26 165.89 39.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.72 122.45 10.54 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.528 2.152 . . . . 0.0 112.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.64 -52.15 1.51 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.41 2.073 . . . . 0.0 112.361 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.43 -76.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.6 p -116.42 -173.64 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.036 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.429 ' CD1' ' HG2' ' A' ' 248' ' ' PRO . 7.6 m95 -70.6 -31.23 68.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -52.95 -24.17 8.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.313 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.05 -15.91 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.687 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.561 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 5.6 tp -52.75 -35.79 28.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 16.8 Cg_exo -68.2 -27.45 35.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.293 1.995 . . . . 0.0 112.2 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.05 -28.24 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 -31.86 52.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.08 -51.95 22.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -30.64 68.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.48 -43.28 23.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.0 -49.93 70.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -26.12 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.9 -23.12 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.383 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -110.63 -60.71 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.49 40.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.566 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.65 -178.03 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -139.29 175.36 9.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -135.12 44.96 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.221 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.14 115.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 14.6 mmt -159.14 106.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 156' ' ' PHE . 1.6 t80 -168.97 177.03 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -67.83 178.96 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -46.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.62 40.06 1.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.76 149.07 36.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 155.88 23.85 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.666 2.244 . . . . 0.0 112.321 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 60.26 20.36 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.497 ' CZ ' ' CE2' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -121.08 -56.35 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.927 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.1 t -72.35 -32.03 66.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.172 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.509 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 66.1 t90 -64.36 -55.16 32.62 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -62.29 -28.66 79.12 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.264 1.976 . . . . 0.0 112.275 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 tp -68.7 -56.96 6.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.23 -4.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.216 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.11 -50.45 11.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.874 0.369 . . . . 0.0 111.047 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -101.44 37.64 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -108.02 -31.21 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.3 -41.68 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 171.01 164.77 27.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.506 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -176.18 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.17 -50.87 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -152.75 165.38 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 135.3 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.422 ' CE2' ' HA2' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -101.99 115.16 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.32 102.21 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.805 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.1 m120 60.04 31.14 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 171' ' ' TYR . . . 82.94 51.37 4.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -143.5 125.36 15.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -103.24 150.2 23.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.16 171.53 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.49 -66.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.32 32.98 4.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -128.36 98.85 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 150.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.3 42.63 1.4 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.23 -35.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -85.23 57.28 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -130.83 160.03 35.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.24 -31.48 72.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.068 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.79 -55.36 25.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.26 -33.32 72.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 111.103 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -74.26 -46.28 42.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.15 -30.48 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.02 -60.32 3.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.451 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -31.57 65.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.818 0.342 . . . . 0.0 110.776 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 40.3 p -72.9 -28.72 62.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.7 -50.44 12.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.4 mt -66.94 -28.84 68.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.663 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.42 -46.59 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 198' ' ' LEU . 10.5 p30 -62.55 -27.19 69.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 111.228 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.427 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 0.2 OUTLIER -57.48 -30.69 65.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.144 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 mt -79.8 -55.2 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -21.02 64.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.404 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.82 15.54 16.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.327 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -120.15 -75.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -120.12 -4.93 10.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.49 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 24.1 ptm 45.53 30.56 0.78 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.366 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.5 -43.84 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 67.52 73.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -113.07 28.25 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.18 119.65 39.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -166.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -79.1 -40.81 30.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.284 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -79.94 -24.63 40.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.58 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.0 mt -81.82 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.71 -30.28 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.491 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.36 -30.48 33.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.15 67.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.601 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.39 -56.92 10.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.612 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 20.4 p90 -76.39 -34.6 58.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.451 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 1.8 m-20 -73.66 -8.31 55.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.305 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -23.65 58.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.001 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 221' ' ' GLU . . . -159.33 -85.42 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.385 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 220' ' ' GLY . 0.5 OUTLIER 171.78 101.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.482 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.4 t -116.27 -177.36 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.88 39.56 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.98 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -162.47 99.68 1.04 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 17.3 m -144.51 105.15 4.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 4.0 mt -113.51 135.0 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.7 147.57 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -155.07 -157.05 8.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.34 76.83 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.326 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.25 -52.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.54 79.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.096 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -31.5 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.4 p -126.73 147.84 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -154.47 40.07 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 21.8 mt 69.11 -67.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -160.27 170.42 21.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.89 168.19 27.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.28 114.69 4.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.01 31.22 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.879 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.4 t 68.79 -67.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -147.58 126.89 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -149.17 136.01 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.19 -173.7 13.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.04 136.48 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.417 HG21 ' CE1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -130.58 156.18 45.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.1 p -77.42 150.63 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.93 146.72 81.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 95.6 Cg_endo -79.77 152.07 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.681 2.254 . . . . 0.0 112.435 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 45.6 p -63.82 177.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CD1' ' OD1' ' A' ' 164' ' ' ASP . 4.5 t80 -159.88 111.89 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.739 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.2 mttm 59.38 21.24 9.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.51 -47.64 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.59 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.93 151.19 29.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.21 -175.63 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.314 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -172.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -118.5 81.25 17.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.69 -168.3 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.631 2.221 . . . . 0.0 112.344 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.418 ' CZ ' ' HE3' ' A' ' 330' ' ' MET . 41.2 p90 -171.95 161.13 5.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.8 146.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -111.53 74.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.524 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.449 ' CG2' ' CD2' ' A' ' 64' ' ' HIS . 13.3 m -95.83 135.13 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.403 ' CD2' ' CB ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -86.87 124.25 32.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 t -92.95 112.86 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.758 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.12 49.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 169.1 -173.26 43.55 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 26.3 mm -88.53 159.74 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.046 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.12 108.02 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.994 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 67.78 10.28 7.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.827 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 45.41 30.3 0.7 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.559 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER -64.2 -61.04 7.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.032 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 270' ' ' SER . 63.4 Cg_endo -73.63 97.85 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.504 2.136 . . . . 0.0 112.468 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 59.1 86.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.041 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.99 -30.94 61.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -76.43 -57.23 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.96 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.62 -31.4 71.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.22 -56.75 18.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.22 -43.94 80.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.79 -42.27 99.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.07 -31.3 72.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.997 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.24 -25.76 36.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -93.8 -32.24 14.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.15 27.53 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.219 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 27' ' ' PHE . 1.4 m-85 -177.31 48.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 110.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.1 mt -178.25 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.44 65.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.1 t -150.99 171.85 16.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.739 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.37 -48.2 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -77.55 -35.02 53.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -55.34 -75.76 0.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.791 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 -21.92 29.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.316 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -29.12 5.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.359 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.91 -53.76 7.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.612 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.3 p -72.41 -46.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.8 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -58.29 -21.22 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.326 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -55.25 2.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.97 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -126.62 87.66 55.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.09 163.71 38.28 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.539 2.159 . . . . 0.0 112.23 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' A' ' 299' ' ' LEU . 1.3 pt? -175.72 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -160.32 -167.1 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.448 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -136.51 160.06 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.5 m -79.95 -179.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -107.89 40.0 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.26 126.97 31.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.82 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.11 93.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.4 p -68.78 -52.42 30.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -27.35 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.37 -28.13 51.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.87 -45.68 89.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -93.23 -31.95 14.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.6 mp -59.88 -28.19 67.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.51 29.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.327 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -58.73 -30.75 67.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.91 140.59 33.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -78.95 -17.94 11.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.589 2.193 . . . . 0.0 112.825 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -51.18 -54.56 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.283 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.46 -29.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.357 . . . . 0.0 111.094 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.77 71.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.13 -39.14 34.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 62.4 p -71.67 -43.39 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 ptm -59.43 -28.81 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -57.38 12.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -78.35 -31.13 48.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.1 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.298 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -50.27 65.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.147 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -47.62 11.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 159.91 136.72 2.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -173.31 89.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.64 118.49 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.418 ' HE3' ' CZ ' ' A' ' 258' ' ' PHE . 0.1 OUTLIER -61.02 120.31 53.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.42 -168.23 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.397 2.065 . . . . 0.0 112.289 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -98.45 -65.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 333' ' ' ILE . 4.5 tp 34.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.955 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.1 -25.24 31.82 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.471 2.114 . . . . 0.0 112.392 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -25.85 59.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -28.56 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 m -56.94 -47.6 80.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -33.88 63.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.041 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -61.4 -27.0 68.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -32.48 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.94 -31.46 45.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.82 -40.71 39.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 28.4 t -59.4 -30.1 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.97 -60.64 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 50.3 m -58.8 -27.78 65.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.49 -52.28 11.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.406 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.19 -54.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.691 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -49.43 -58.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.56 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -57.22 -50.66 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.78 59.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.31 -10.69 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.434 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 51.6 p -67.69 -30.22 69.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 112.54 -25.34 12.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -112.83 39.85 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.61 145.67 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 t -124.15 148.95 46.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.01 -28.2 43.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.37 -30.4 60.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 -54.75 5.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.74 -30.06 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.138 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -56.6 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -60.74 -52.27 65.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -58.65 -34.88 71.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.98 -33.91 72.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.163 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -31.58 69.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 27.0 m -80.7 -38.18 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 -43.43 59.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.47 -35.42 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.4 m -80.34 -54.37 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.8 0.333 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.3 p -80.47 84.67 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.57 164.89 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.64 172.28 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.52 86.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -167.96 138.29 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -147.86 159.57 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.53 103.44 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.04 119.53 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -103.29 126.37 50.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -172.11 158.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' HB2' ' CG ' ' A' ' 39' ' ' HIS . 9.9 t30 -176.53 -169.88 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.92 -31.63 3.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.31 -51.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -178.28 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.16 24.26 28.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.699 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.97 -58.08 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -60.16 -40.9 91.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -51.27 60.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.578 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -31.17 54.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.13 -38.0 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -52.71 64.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.68 -43.77 97.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.185 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.93 -36.34 92.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -59.45 -44.47 92.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -79.2 -30.06 43.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.966 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' ' CE1' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -60.66 -56.55 19.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.548 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -56.32 -27.89 57.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.536 0.684 . . . . 0.0 110.4 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -33.4 14.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.499 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.485 ' O ' ' CB ' ' A' ' 31' ' ' THR . 5.0 t70 -59.73 -57.4 13.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.485 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.65 36.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.872 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.61 44.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 117.958 -2.068 . . . . 0.0 115.47 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.548 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 2.3 mp -139.69 95.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 117.998 0.899 . . . . 0.0 111.608 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -126.4 114.8 18.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 HG11 ' CZ ' ' A' ' 283' ' ' TYR . 3.5 m -110.94 134.62 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 146.2 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.27 123.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.072 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -155.46 163.16 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.426 ' CG ' ' HB2' ' A' ' 12' ' ' ASN . 14.2 t-80 -152.8 79.42 5.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.79 -168.36 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.454 2.103 . . . . 0.0 112.268 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.69 -28.45 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -81.93 0.12 41.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -47.75 -28.77 2.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.779 0.323 . . . . 0.0 111.278 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -68.57 -37.0 79.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.26 -15.17 19.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -71.58 -24.54 61.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.223 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 9.6 m-85 -51.22 -60.77 5.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.257 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 47' ' ' PHE . 53.4 Cg_endo -69.61 -15.36 37.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.501 2.134 . . . . 0.0 112.658 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.52 -55.32 3.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.62 -26.22 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.14 69.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.183 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.3 -18.98 59.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -144.35 115.28 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.14 70.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.341 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -96.6 28.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.22 -93.47 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.33 128.35 17.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.541 2.161 . . . . 0.0 112.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.61 103.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.049 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.3 tt -133.04 145.66 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.647 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.17 142.76 20.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.396 . . . . 0.0 111.399 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.415 ' CD2' HD13 ' A' ' 108' ' ' ILE . 64.5 m-85 -100.36 118.94 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 263' ' ' SER . 2.2 m95 -138.73 173.7 11.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.18 -177.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 111.336 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -76.92 -50.1 14.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.28 -25.96 67.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -29.51 53.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -115.72 -36.32 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.89 -26.1 39.73 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.715 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.9 -25.61 2.5 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.862 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -34.08 16.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 111.119 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.14 -55.66 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.18 -20.39 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -95.27 -26.77 15.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.51 -90.79 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.558 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.07 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -123.15 150.46 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.21 121.35 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 139.13 55.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -115.76 147.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -104.73 145.73 31.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.85 162.12 23.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.646 2.231 . . . . 0.0 112.434 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.42 -47.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.78 -20.43 29.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.7 19.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.379 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.04 -59.16 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.39 . . . . 0.0 110.639 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.51 -24.82 62.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.12 -26.24 62.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 tttm 66.62 72.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.34 163.02 13.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.14 139.16 97.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.78 -44.41 49.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.496 2.131 . . . . 0.0 112.321 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.08 -29.55 65.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 35.6 m -56.96 -30.22 63.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -92.58 -41.05 10.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -30.43 69.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.48 -30.99 63.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.72 54.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -138.34 96.36 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.11 120.22 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.6 -74.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.59 36.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -145.62 -178.5 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -137.96 92.7 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.25 40.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.92 65.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.22 113.27 29.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.74 133.2 10.19 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.443 2.095 . . . . 0.0 112.436 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.415 HD13 ' CD2' ' A' ' 61' ' ' PHE . 2.4 pp -145.77 39.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -177.03 154.43 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.69 106.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.14 135.37 54.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.79 176.58 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.61 164.64 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 m -165.05 -178.75 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.65 132.37 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -104.27 138.92 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.128 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.412 ' CE1' ' HA3' ' A' ' 243' ' ' GLY . 8.2 p90 -146.96 167.38 24.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.55 159.34 19.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.63 36.41 2.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -155.36 30.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.16 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.806 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tt -123.42 84.5 52.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.33 160.46 3.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.239 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.07 111.63 6.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.73 154.82 26.97 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.57 10.29 3.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.777 2.318 . . . . 0.0 112.893 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt 63.42 49.53 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.928 0.394 . . . . 0.0 111.196 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 12.6 t -160.14 142.63 13.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.948 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.423 ' CD2' HD13 ' A' ' 132' ' ' ILE . 2.8 m95 -57.98 -28.89 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.002 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -53.58 -23.8 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.632 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.31 -21.42 60.57 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 21.4 mt -73.33 -53.43 4.7 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 82.5 Cg_exo -46.79 -49.94 11.5 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.276 1.984 . . . . 0.0 112.536 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.98 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.7 mt -59.11 -32.17 69.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -57.08 -34.36 68.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -31.17 57.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -78.3 -41.61 33.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.39 -55.84 28.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.822 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -61.31 -24.42 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -23.23 24.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.476 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -110.61 -72.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.72 39.72 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.441 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.71 178.95 9.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.6 138.65 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.22 53.34 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.841 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -176.68 115.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.409 ' HG2' ' HA ' ' A' ' 225' ' ' THR . 1.1 ppp? -87.7 -173.63 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.428 ' O ' ' CD2' ' A' ' 149' ' ' PHE . 41.4 p90 -86.5 107.67 18.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 t30 177.54 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.511 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.74 -32.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.68 43.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.075 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.8 144.23 26.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.817 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.67 90.8 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.535 2.157 . . . . 0.0 112.281 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.45 -31.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -117.64 -31.44 5.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.959 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -33.87 76.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.892 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.484 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.2 OUTLIER -63.5 -56.14 29.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 52.7 Cg_endo -68.72 -11.12 31.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 0.0 112.44 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.77 -57.01 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.02 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.56 5.31 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.503 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -94.38 -69.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.905 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.87 -86.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.37 29.19 7.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.977 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.41 -75.33 0.65 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.05 107.51 0.98 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.539 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 111.95 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.87 -67.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -139.72 165.65 26.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -131.74 119.53 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -79.41 128.59 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.43 113.73 19.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.64 30.07 18.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.77 74.15 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.18 129.59 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -59.34 162.57 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -143.06 160.37 40.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -142.77 -45.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -62.36 -52.22 64.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.92 106.42 2.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.57 151.38 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -125.68 52.36 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.38 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.98 -19.42 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.26 56.49 3.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.1 129.3 50.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.67 -23.92 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.312 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.63 70.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.647 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.65 -40.43 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -67.73 -30.91 70.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.89 -56.87 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.27 -26.02 74.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.609 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.78 -48.37 81.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.8 p -72.01 -31.03 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -70.21 -43.0 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.34 -49.98 67.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.3 m -58.73 -43.22 87.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -69.28 -30.87 69.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -48.23 82.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.9 pt -74.97 -33.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -29.93 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.14 -26.16 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -102.98 -69.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -60.24 -45.41 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.4 ttt 60.46 26.92 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.0 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.05 -45.27 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.02 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -166.75 76.64 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.6 p -55.23 148.11 15.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -111.11 -167.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.098 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -79.37 -41.81 26.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -78.8 -25.03 44.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.398 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.07 -54.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.078 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.51 -30.39 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.447 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.03 -23.38 52.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.103 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.69 -52.75 59.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.428 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.08 -55.48 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -55.38 -28.21 52.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -49.03 -30.86 6.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -23.99 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 62.82 22.59 64.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.06 73.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.977 0.417 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.8 p -109.77 -177.08 3.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.63 39.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.991 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.428 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 169.34 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.409 ' HA ' ' HG2' ' A' ' 148' ' ' MET . 0.8 OUTLIER -136.49 105.09 5.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 2.4 tt -92.98 114.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.088 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -142.29 164.19 30.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.81 -159.87 10.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.41 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.3 62.32 2.69 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.542 2.161 . . . . 0.0 112.335 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -170.6 34.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.48 -35.05 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.029 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -76.99 69.59 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 t -166.88 -52.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -58.23 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 129.83 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -119.34 112.17 19.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.07 31.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 17.6 m 59.56 -177.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -130.22 144.72 51.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.775 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 p -160.78 -44.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.087 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -156.56 146.87 21.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -147.1 123.39 10.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.412 ' HA3' ' CE1' ' A' ' 117' ' ' TYR . . . -95.79 83.5 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.46 114.71 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.4 p -141.08 162.72 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.39 150.56 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.92 158.67 23.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.43 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.88 2.387 . . . . 0.0 112.263 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.09 177.61 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 129' ' ' TRP . 4.2 t80 -164.74 115.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.6 tttt 61.23 19.0 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.75 47.77 9.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -141.07 90.76 9.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.21 130.29 10.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.604 2.203 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.9 t -53.09 160.31 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.4 90.77 35.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.52 -159.93 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.054 2.502 . . . . 0.0 112.086 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.75 138.81 47.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.17 155.17 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -132.86 136.08 8.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.612 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.77 144.59 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.3 mp -85.44 117.84 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' TRP . 92.4 p -87.65 114.73 24.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.58 128.84 56.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.9 -179.28 35.55 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.573 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 1.8 mt -111.68 159.36 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -127.22 134.88 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 58.68 30.64 20.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -97.72 34.97 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.424 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 1.4 m -55.76 -61.12 6.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 270' ' ' SER . 36.4 Cg_endo -65.36 -23.78 58.28 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.497 2.131 . . . . 0.0 112.542 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -117.09 38.06 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.004 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.67 -57.31 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.55 -30.03 68.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -70.2 -56.47 6.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.224 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.15 -40.43 89.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.65 -46.77 84.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -73.36 -29.61 62.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -53.99 51.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.36 -14.44 52.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.08 27.59 3.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.157 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.474 ' CE1' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -125.76 -57.05 1.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.771 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.474 ' HA ' ' HA3' ' A' ' 289' ' ' GLY . 4.9 mp -110.94 -78.17 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 290' ' ' LEU . 18.5 tp 62.5 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.96 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.11 137.65 11.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.302 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.4 t70 70.84 -54.36 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 111.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.79 -58.05 8.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 284' ' ' LEU . . . -120.75 -38.93 0.63 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.829 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 1.0 OUTLIER -55.14 -58.85 5.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.893 0.378 . . . . 0.0 111.184 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 5.6 mm-40 -55.25 -35.87 65.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.116 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.82 -24.86 66.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 23.5 t -71.68 -30.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.48 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -105.59 -49.63 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.09 -42.64 81.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.69 -51.31 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.42 138.19 32.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.09 122.44 8.76 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.413 2.075 . . . . 0.0 112.305 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 4.1 mp -151.62 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 178.1 -165.8 35.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.441 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -119.34 -176.62 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.61 156.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.45 40.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.58 -175.77 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -102.8 -71.28 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 64.0 p -70.73 -47.06 61.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -58.77 -29.56 66.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -28.58 66.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.75 -61.73 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.71 -47.55 85.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -61.01 -23.3 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.63 26.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -90.18 46.6 1.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -118.25 147.37 41.49 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.95 -48.65 18.71 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.592 2.195 . . . . 0.0 112.457 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -59.09 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.7 tp -62.28 -25.3 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.8 -39.94 72.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.218 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.12 -34.0 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -75.5 -29.12 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.5 ttt -57.15 -31.29 65.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.022 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -67.02 -44.39 80.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.22 -30.81 49.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.03 67.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -30.71 66.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -141.43 31.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.63 -170.94 19.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.409 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.83 168.75 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.971 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mm -70.4 138.28 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 5.3 ttt -51.86 106.8 0.7 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -168.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.444 2.096 . . . . 0.0 112.339 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -177.18 79.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.0 tt -124.97 123.24 25.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.97 -30.12 57.45 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.409 2.073 . . . . 0.0 112.224 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -58.91 -30.12 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.1 tpt -56.89 -28.27 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.054 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -59.24 -32.96 70.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.37 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -65.19 -28.02 69.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.59 -28.83 49.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.39 -46.89 86.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.975 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.3 -27.93 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.421 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 39.4 t -67.67 -42.1 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.405 ' O ' HG21 ' A' ' 348' ' ' ILE . 9.0 ptt180 -75.11 -47.19 29.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.404 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 55.2 p -49.87 -27.47 5.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.4 -59.13 3.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.44 -50.8 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.822 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.405 HG21 ' O ' ' A' ' 344' ' ' ARG . 7.4 tp -53.33 -40.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.738 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 345' ' ' THR . 5.4 t-20 -80.61 -41.67 23.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.18 87.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.04 -10.78 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.0 t -67.76 -57.02 7.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -132.43 -71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.569 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -176.67 50.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.03 132.52 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.2 p -93.29 153.96 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.02 -28.55 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.7 -37.75 79.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.2 -50.38 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.613 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.0 -25.19 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 17.8 mt -82.34 -56.47 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -70.43 -41.82 72.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.361 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.12 -46.96 78.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.22 -57.09 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.422 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -30.54 65.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 93.5 m -77.65 -54.91 5.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.106 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -59.13 -47.05 86.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.9 tt -56.36 -37.88 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.238 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.3 p -78.21 -64.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.814 0.34 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.51 97.47 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -124.71 165.08 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.16 107.44 18.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.01 86.37 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 pttm -153.63 137.36 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.984 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -133.92 131.5 39.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' CG1' ' CZ3' ' A' ' 10' ' ' TRP . 38.3 t -104.21 104.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mt -93.06 114.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CH2' ' HB3' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -101.9 115.74 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.9 mt -140.84 145.74 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.51 44.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.05 79.17 1.38 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.359 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.8 8.28 26.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.607 0.242 . . . . 0.0 111.328 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 58.95 30.04 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.11 59.51 0.67 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.575 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -61.42 -54.46 43.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.771 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -30.41 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.25 -51.96 54.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.614 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.64 -26.35 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.727 0.299 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.47 -46.3 20.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.02 -41.89 84.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.2 t -59.45 -44.32 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.975 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 -25.51 57.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -43.76 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -74.39 -43.34 56.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 2.6 m-85 -63.9 -56.32 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.494 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 19.3 pt-20 -52.78 -28.05 20.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.487 0.66 . . . . 0.0 110.683 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -25.55 49.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.473 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.657 ' O ' ' OG1' ' A' ' 31' ' ' THR . 4.4 t70 -51.53 -56.81 11.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.657 ' OG1' ' O ' ' A' ' 30' ' ' ASP . 6.2 m 156.91 36.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.742 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.61 46.12 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.764 -2.16 . . . . 0.0 115.885 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.494 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 4.5 mm -131.37 95.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 118.535 1.167 . . . . 0.0 111.596 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -103.75 121.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.66 128.95 76.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.27 146.31 23.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.05 111.47 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 2.2 tt0 -142.8 163.14 33.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -104.9 150.3 38.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.13 -156.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.78 -75.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -59.27 -30.04 68.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.53 -24.01 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.93 -45.86 67.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.64 -28.26 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -24.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 3.6 t80 -45.76 -55.43 12.66 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.66 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.6 Cg_endo -61.24 -21.39 71.57 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.271 1.981 . . . . 0.0 112.503 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -89.77 -55.23 3.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.8 t -65.78 -30.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.8 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.86 -34.44 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -25.82 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.4 -51.1 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 75.46 -54.42 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 111.047 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.78 -94.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 149.33 61.63 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.578 2.186 . . . . 0.0 112.218 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 177.35 80.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.2 mt -103.1 106.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.1 mt -112.65 137.45 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.289 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -86.68 128.56 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.422 ' HA ' ' CE3' ' A' ' 62' ' ' TRP . 0.7 OUTLIER -157.62 173.25 17.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.848 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.62 -177.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -77.2 -52.0 9.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.19 -29.64 61.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -27.65 54.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.142 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -108.14 -30.31 8.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.2 57.22 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.88 -49.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.606 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.27 -50.15 75.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 67' ' ' PHE . . . -74.51 -31.37 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.41 -19.43 60.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 t -70.24 -26.7 63.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.57 50.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.607 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.36 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.891 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -177.22 133.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.71 160.49 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -85.7 134.8 33.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.09 158.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.061 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.9 p -88.94 146.31 36.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.92 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.606 2.204 . . . . 0.0 112.388 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -176.46 138.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -60.22 -48.02 83.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.64 -25.66 62.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 82' ' ' ASP . 6.2 m-85 -79.24 -59.24 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -24.85 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.791 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.28 -31.57 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -94.24 -58.48 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.16 158.33 11.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' CD1' ' HG3' ' A' ' 305' ' ' LYS . 4.7 m-85 -105.21 157.6 33.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 -26.27 24.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.54 -35.72 72.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -30.13 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -75.74 -53.45 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.07 -31.35 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.79 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.9 m -117.0 39.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -110.83 121.43 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.54 132.13 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 59.27 28.64 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.55 20.61 73.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.831 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 166.84 24.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -118.74 91.98 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.1 mt -101.37 40.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.87 164.76 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.243 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.68 119.03 7.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -79.59 152.45 22.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.548 2.166 . . . . 0.0 112.336 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.4 tt -171.99 39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -178.07 104.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.8 110.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.64 147.19 27.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.93 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.06 159.51 15.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -164.93 145.57 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 pp -93.47 150.02 20.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.05 137.24 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -127.37 164.46 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.0 173.13 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -137.69 81.4 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -174.2 -54.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.51 62.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.845 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.85 92.28 2.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.69 154.1 7.16 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.526 2.151 . . . . 0.0 112.298 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.2 111.27 5.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.99 149.77 37.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.452 2.102 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.3 -167.03 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.478 2.119 . . . . 0.0 112.229 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -95.71 -28.25 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 t -75.78 140.23 42.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -35.73 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.2 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -23.97 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.837 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.21 -16.32 35.65 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.3 mm -61.3 -47.71 93.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 74.0 Cg_exo -47.92 -35.17 24.18 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.381 2.054 . . . . 0.0 112.482 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mp -60.63 -30.68 70.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -50.85 36.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.3 74.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.46 -45.61 79.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 10.1 mt -71.85 -43.94 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -27.15 67.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -27.7 49.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -109.44 -55.97 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 40.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -148.93 177.49 9.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.63 175.44 12.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.43 ' HA ' ' CB ' ' A' ' 223' ' ' ALA . . . -129.04 45.34 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.08 115.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -154.62 106.53 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.056 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -158.0 176.81 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.688 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -50.63 156.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.07 -49.03 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.687 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -97.11 39.78 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -154.91 166.01 16.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.694 2.263 . . . . 0.0 112.258 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -173.27 -40.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.75 -41.73 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.5 p -68.55 -33.58 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 23.4 t90 -68.06 -55.79 12.47 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 38.2 Cg_endo -66.0 -14.08 42.8 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.301 2.001 . . . . 0.0 112.571 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.86 -55.62 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.676 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.413 HG21 ' CZ ' ' A' ' 194' ' ' PHE . 3.1 pt -88.93 9.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.535 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -109.29 -15.98 14.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.422 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.27 65.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.256 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.92 -30.11 19.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.12 86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -154.48 89.99 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.536 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.15 52.62 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.75 96.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.72 126.58 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -108.21 108.6 19.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 175' ' ' LYS . 2.4 t80 -97.35 110.68 23.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 102.23 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 58.93 31.24 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.95 74.3 1.16 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.52 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 1.3 mtpt -158.26 166.72 31.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -175.54 113.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.6 t0 60.17 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.863 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.476 HD12 HG22 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -155.31 -45.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -120.57 -55.78 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.15 141.95 39.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.017 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.52 139.54 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.027 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -139.24 50.69 0.78 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.66 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 339' ' ' PHE . 18.0 t -111.66 -30.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.401 ' OD2' ' CD2' ' A' ' 339' ' ' PHE . 22.1 p30 -94.17 50.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.34 162.79 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.99 -33.95 76.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.21 -28.3 49.53 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.14 -53.63 50.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -50.08 66.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.33 68.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -60.76 -56.47 24.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.508 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.95 -24.76 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.689 0.28 . . . . 0.0 111.065 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 63.0 m -56.48 -59.02 5.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.148 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 11.2 p90 -81.88 -23.04 36.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.267 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.7 tp -52.92 -61.21 2.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 111.165 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.74 -42.89 90.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.41 -30.3 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.89 -30.03 69.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 31.3 mt -77.2 -55.25 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -25.4 68.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.059 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -95.71 22.01 7.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -66.31 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -108.79 -29.25 8.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.8 mtp 62.87 31.39 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -176.71 114.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.95 88.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.98 -30.49 8.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.7 p -81.6 147.94 29.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.94 -161.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.284 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 211' ' ' SER . 47.0 p90 -78.73 -47.37 16.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.004 0.431 . . . . 0.0 110.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.3 m -81.09 -26.12 36.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.242 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.9 mt -82.44 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.23 66.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.565 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.44 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 41.3 tt0 -72.45 -36.69 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.42 59.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.457 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -75.15 -56.97 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.49 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CG ' ' CE1' ' A' ' 149' ' ' PHE . 1.1 p90 -75.14 -39.53 60.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -47.87 -35.94 11.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.119 0.485 . . . . 0.0 110.605 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -23.56 12.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.498 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.31 52.59 26.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.368 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.21 38.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.128 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.4 p -154.52 -177.97 6.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -86.4 39.54 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.357 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.18 112.82 0.45 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 26.4 m -144.66 105.12 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.449 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 23.6 mt -88.3 144.88 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -120.16 164.3 16.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -130.74 178.61 17.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.01 66.05 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.826 2.35 . . . . 0.0 112.238 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.3 t-105 -112.97 -19.75 11.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.254 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 65.1 26.95 12.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.16 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 26.8 m95 55.13 -176.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.57 154.64 43.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.6 m120 61.2 168.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.0 pt -119.24 -41.45 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.0 100.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.823 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.1 t -123.03 138.61 54.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.59 -168.87 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 60.62 176.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 11.3 p -60.0 158.25 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -104.18 166.42 10.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.22 170.78 8.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.62 151.28 17.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.0 136.39 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.134 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 161.14 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.06 150.62 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.41 158.76 27.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.38 -173.98 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.904 2.402 . . . . 0.0 112.077 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.7 p -116.8 150.15 38.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 250' ' ' PHE . 44.1 p90 -159.04 112.03 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.89 11.48 7.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.379 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.74 41.39 6.01 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.96 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -156.55 90.65 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.694 0.283 . . . . 0.0 111.024 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.74 85.07 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.852 2.368 . . . . 0.0 112.164 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 18.6 p 57.08 176.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.02 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 13.2 tttm -92.1 142.09 25.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.2 Cg_exo -79.58 153.78 23.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.632 2.222 . . . . 0.0 111.967 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 330' ' ' MET . 11.8 t80 -153.62 107.34 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.94 99.91 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -102.36 63.28 0.47 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.555 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.8 p -87.92 144.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.31 . . . . 0.0 110.888 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.72 128.91 56.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.949 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.2 m -93.27 131.44 38.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.22 149.87 21.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -79.95 111.13 3.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.4 tp -135.16 104.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -96.86 116.38 29.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -93.01 -23.49 18.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.251 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.39 -30.6 52.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -82.1 155.66 69.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 61.46 2.57 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.393 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -165.17 31.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -75.07 -33.41 61.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -40.03 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.87 70.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.39 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.06 -39.11 83.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.48 -59.27 5.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.3 tt -59.4 -31.3 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.05 -31.71 73.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -115.77 27.39 9.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -107.15 -64.54 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.08 -55.65 2.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.804 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.98 64.34 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.4 t -146.23 151.58 37.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.3 -31.43 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.65 -37.66 49.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -87.62 -56.55 2.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.913 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -43.74 65.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.739 0.304 . . . . 0.0 111.208 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.78 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.55 -30.15 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.206 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -58.87 -28.31 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -113.68 -43.07 3.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.993 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -60.12 -69.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -124.16 72.38 55.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.988 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.46 107.16 2.33 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.629 2.219 . . . . 0.0 112.326 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.1 -55.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.985 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.87 120.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.28 127.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.9 p -178.34 112.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -108.87 39.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 6.9 mt -133.89 156.93 47.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.417 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -93.41 -55.24 3.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.8 t -66.04 -48.06 72.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -59.47 -27.2 65.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.49 -28.73 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -49.51 77.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.952 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.85 -42.04 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.1 -20.85 64.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.0 -25.95 9.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.391 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -27.56 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 158.59 15.74 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.26 -57.96 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.714 2.276 . . . . 0.0 112.665 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -58.92 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.409 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.0 mp -52.22 -25.27 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.625 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.59 -51.7 68.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.22 -28.9 42.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.5 m -58.37 -43.6 88.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -29.85 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.6 -54.7 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.31 -30.21 66.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.22 -29.1 60.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -58.74 -30.69 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -145.53 41.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.65 164.06 41.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -135.03 158.24 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 4.7 tp -77.47 116.94 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.444 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 0.2 OUTLIER -55.22 -61.29 6.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 330' ' ' MET . 18.8 Cg_endo -59.1 -164.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 0.0 112.416 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 70.0 69.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -161.59 60.75 1.22 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.61 -45.56 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.589 2.193 . . . . 0.0 112.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.91 -34.92 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.14 -23.76 49.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 340' ' ' TRP . 17.6 p -59.8 -24.92 64.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.75 -29.6 45.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.82 0.343 . . . . 0.0 111.302 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 183' ' ' VAL . 23.2 t80 -73.75 -23.7 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.403 ' CE3' ' O ' ' A' ' 337' ' ' SER . 0.0 OUTLIER -42.38 -29.37 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.833 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.2 -37.41 87.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.91 -26.12 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.468 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.69 -29.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.35 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.59 -60.85 2.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 37.2 m -50.0 -29.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.84 -54.44 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.382 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.9 t -79.17 -58.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.029 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 344' ' ' ARG . 2.5 tp -47.34 -31.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.719 0.295 . . . . 0.0 111.515 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.31 -55.8 30.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -54.41 -26.8 32.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.343 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.11 -10.74 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.569 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.9 m -104.39 -31.27 9.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.95 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 108.53 -24.48 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -97.52 39.93 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 165.03 23.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -162.84 95.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.8 t -48.04 -27.82 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.17 -54.46 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -80.25 -25.94 39.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -77.79 -42.9 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.37 -54.82 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.458 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -55.87 20.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.524 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.81 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -59.92 -47.03 87.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -58.84 -56.2 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.04 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 9.4 t -58.38 -29.5 66.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -57.26 -29.84 64.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.4 mt -64.32 -36.82 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -65.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 40.7 mttp . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.826 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.869 0.366 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 t -137.78 162.59 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.13 170.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.96 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.28 27.41 73.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -82.24 134.66 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.4 mt -137.72 116.11 11.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.96 107.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 pp -98.67 114.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.42 ' CD1' HG13 ' A' ' 60' ' ' ILE . 67.2 m95 -96.75 112.1 23.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.9 tt -143.65 158.65 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -175.12 99.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.32 102.82 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.419 ' HA ' ' CZ2' ' A' ' 232' ' ' TRP . 0.3 OUTLIER 69.54 44.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 110.72 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.82 -166.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.24 12.72 8.05 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.725 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' CE2' ' CG1' ' A' ' 37' ' ' VAL . 0.3 OUTLIER -81.13 -59.53 2.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.09 -28.86 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.81 -48.9 69.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.523 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.48 -31.28 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 110.835 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.04 71.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -55.91 27.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.31 -31.02 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.088 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.09 -28.07 56.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -60.91 -30.81 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -74.82 -33.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -66.56 -56.31 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.776 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.564 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 11.7 pt-20 -58.32 -28.46 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 0.0 110.557 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.07 -25.78 47.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.214 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.466 ' O ' ' CB ' ' A' ' 31' ' ' THR . 17.6 t0 -54.01 -56.54 16.94 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.466 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.69 37.44 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.594 177.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.91 43.52 0.02 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 117.857 -2.116 . . . . 0.0 115.84 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.564 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 4.1 mm -136.94 152.67 28.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 118.064 0.932 . . . . 0.0 111.287 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -142.22 129.2 20.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.85 105.81 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 113.84 27.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.809 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 17' ' ' TYR . 10.8 p -100.35 140.89 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.55 160.28 40.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.29 147.38 36.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.94 125.7 11.22 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.365 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -173.73 -68.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -92.05 0.05 57.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.391 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.412 HD13 ' CD2' ' A' ' 10' ' ' TRP . 0.5 OUTLIER -56.48 -28.44 59.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.107 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.79 -43.47 76.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -98.39 -26.27 14.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -77.0 -24.57 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.141 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.492 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 68.8 t80 -52.87 -56.08 26.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.308 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.2 Cg_endo -63.71 -17.59 60.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.28 1.987 . . . . 0.0 112.448 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -89.67 -46.48 8.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 t -90.45 9.88 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.56 -47.5 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.24 79.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.6 p -85.17 -38.45 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.52 43.9 2.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -62.06 -31.0 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.57 -79.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.577 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 130.22 23.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.585 2.19 . . . . 0.0 112.323 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -175.93 71.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 mt -123.2 111.44 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 10' ' ' TRP . 2.0 mp -129.61 138.51 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.386 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.81 128.79 43.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -166.35 102.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 111.988 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 54.33 166.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.881 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.428 ' CD2' HG11 ' A' ' 97' ' ' VAL . 24.1 t-80 -77.22 -60.12 2.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.998 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -44.9 76.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.093 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HB3' ' CE2' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -56.79 -23.0 40.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CZ ' ' N ' ' A' ' 265' ' ' GLY . 0.5 OUTLIER -99.68 -56.66 2.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -18.39 50.76 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.748 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.37 -38.78 4.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.654 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -97.96 -54.84 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.12 -30.79 66.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -70.5 -21.57 62.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 p -107.38 -26.31 11.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.918 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.25 -87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.635 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 pp 177.41 46.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.955 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.426 HD23 ' CZ ' ' A' ' 67' ' ' PHE . 9.0 mp -80.05 137.66 36.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.59 121.74 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -58.89 159.89 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.8 pt -115.04 170.54 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 p -137.15 90.97 15.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.72 -176.14 3.09 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.585 2.19 . . . . 0.0 112.434 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.22 -176.17 3.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.85 83.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.27 32.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.418 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -80.2 -59.26 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.427 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -72.53 -24.73 61.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.816 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -76.33 -18.57 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.411 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -76.96 -67.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.89 151.01 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -97.63 156.35 36.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.82 -24.77 24.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.656 2.237 . . . . 0.0 112.489 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.87 -62.51 1.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.031 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -65.05 -25.93 68.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 98' ' ' ARG . 3.1 m0 -57.91 -49.75 75.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.38 -26.83 0.91 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.65 -43.6 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.43 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 HG11 ' CD2' ' A' ' 64' ' ' HIS . 5.3 m -158.78 71.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.887 0.375 . . . . 0.0 111.511 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HG2' ' CE3' ' A' ' 94' ' ' TRP . 0.0 OUTLIER -145.21 109.14 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.804 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.53 174.74 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.16 62.56 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.31 27.94 5.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -145.36 101.2 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 tp -114.17 99.45 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.961 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -139.71 40.0 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.075 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.97 128.76 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.27 111.02 15.31 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.771 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.6 139.23 14.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.44 2.093 . . . . 0.0 112.134 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 tt -166.51 39.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.411 ' CB ' ' HB2' ' A' ' 262' ' ' LEU . . . -176.18 109.31 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.29 124.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.15 132.99 46.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.917 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.18 176.52 12.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.66 137.12 40.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 m -164.71 -176.06 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.2 152.53 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.768 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.9 mm -100.8 147.72 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -120.0 126.56 51.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.0 155.4 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -75.73 -30.86 59.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.97 62.95 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 20.9 tp -175.85 39.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.908 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.88 151.43 20.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.15 160.39 49.76 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.256 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.13 164.17 25.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.777 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.02 136.38 40.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.454 2.102 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.4 -171.52 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.533 2.156 . . . . 0.0 112.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -109.58 -36.41 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -160.04 172.11 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.453 ' O ' ' HD3' ' A' ' 133' ' ' PRO . 0.2 OUTLIER -59.09 -24.71 63.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.78 -25.3 53.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.61 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -89.37 -32.66 17.2 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.578 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 17.9 tt -56.43 -32.78 14.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 15.1 Cg_exo -69.49 -42.39 3.72 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.278 1.985 . . . . 0.0 112.198 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.03 64.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.248 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.3 tp -58.89 -30.78 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -47.74 84.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -58.53 -31.73 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -54.18 48.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.6 mt -70.85 -40.56 72.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.948 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -27.6 65.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.09 -25.28 63.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -109.12 -75.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.53 39.84 0.16 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.403 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.57 -174.89 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 m -150.19 162.05 41.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -111.77 33.49 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 0.3 OUTLIER 178.93 125.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.623 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.8 mtt -170.09 106.18 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.64 177.35 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.76 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -45.55 167.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.425 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 -45.55 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.674 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -95.52 39.54 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.98 170.73 5.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.76 166.17 21.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.59 2.194 . . . . 0.0 112.445 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.02 28.6 17.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -120.88 -59.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.2 m -73.11 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.499 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -64.03 -55.42 32.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.5 Cg_endo -64.2 -27.17 64.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.288 1.992 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.94 -56.48 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.569 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 2.2 tt -76.01 -9.9 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.289 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.85 -23.54 44.91 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.72 0.295 . . . . 0.0 111.306 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.83 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -122.26 39.97 3.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.34 -41.94 3.32 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.504 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.7 -48.46 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.496 ' CD2' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER 62.36 175.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 339' ' ' PHE . . . -72.5 -29.17 63.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.254 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 167' ' ' TYR . 13.7 p90 -113.78 117.46 31.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -96.04 138.03 34.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.36 110.69 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.729 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -137.2 178.61 6.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -67.57 72.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.777 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.7 25.5 4.24 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.538 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.01 154.59 22.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -148.94 127.5 12.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -71.65 122.86 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.4 tp -162.23 -44.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.097 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -132.1 37.86 3.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.87 141.35 38.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -140.67 148.28 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.251 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.79 39.92 1.41 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.41 -34.58 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -104.99 30.69 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -103.66 175.24 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.64 74.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.069 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.51 66.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.34 -41.93 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.91 -31.89 70.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 -46.19 15.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.04 63.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.9 tp -60.58 -49.1 78.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.3 m -60.79 -34.55 74.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.3 -46.89 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mt -58.91 -47.35 85.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.979 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.23 -48.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.84 -35.42 78.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.15 -41.21 92.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 21.6 mt -76.55 -30.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -31.65 72.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.06 18.34 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.1 -76.6 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.789 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -115.23 -13.42 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 ttt 70.02 -66.04 0.29 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -102.67 128.46 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -59.11 87.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.61 -29.47 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 t -78.14 108.83 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 211' ' ' SER . 2.8 p30 -94.12 -148.21 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 211' ' ' SER . 38.4 p90 -78.68 -51.72 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD2' ' A' ' 210' ' ' TYR . 88.6 p -62.34 -25.25 67.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.036 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.1 mm -82.01 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.53 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.676 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -66.44 -28.97 69.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.37 -25.06 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.336 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.45 -56.79 12.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 225' ' ' THR . 51.2 t80 -76.29 -36.74 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.76 -5.67 44.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.647 0.26 . . . . 0.0 110.935 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 221' ' ' GLU . . . -172.01 -78.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.321 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 0.9 OUTLIER 163.48 100.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 110.49 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.7 p -109.32 -177.41 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.88 38.96 0.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.789 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.439 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -146.66 111.64 5.37 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.934 0.397 . . . . 0.0 111.143 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -144.56 104.71 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 37.0 mt -115.26 142.67 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -144.04 111.64 6.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.44 62.03 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.42 -44.73 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.56 2.173 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 -148.97 -47.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -132.7 -53.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.419 ' CZ2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.64 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.1 p 58.64 166.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.38 106.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.7 mt -145.92 145.04 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -160.17 -56.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.8 p 55.87 102.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.055 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 92.8 p -116.31 -55.02 2.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -164.49 -60.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 p -72.51 125.78 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -99.7 -179.29 4.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -132.75 170.8 14.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -124.26 165.88 17.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.71 136.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.48 149.67 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.931 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.35 150.57 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mp -60.05 158.77 24.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.2 166.04 23.09 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.875 2.383 . . . . 0.0 112.168 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.61 177.55 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -159.31 111.9 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.2 mttm 59.95 20.51 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.71 44.91 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.621 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -156.37 90.83 2.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.649 0.261 . . . . 0.0 110.864 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.21 159.39 22.64 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.587 2.191 . . . . 0.0 112.296 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.8 p -67.19 -175.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -107.29 94.31 11.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.67 151.14 21.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.461 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.417 ' CE2' ' HD2' ' A' ' 331' ' ' PRO . 3.8 t80 -108.13 82.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.91 151.81 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.84 171.75 29.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.81 144.95 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.674 0.274 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 109' ' ' ALA . 7.1 mp -78.3 105.25 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.8 m -79.79 116.55 20.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.288 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -101.57 155.3 18.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.597 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.449 ' N ' ' CZ ' ' A' ' 67' ' ' PHE . . . -146.17 172.13 26.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.939 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.401 ' CD1' ' CD ' ' A' ' 273' ' ' LYS . 11.3 tt -113.68 159.74 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.669 0.271 . . . . 0.0 110.777 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -116.47 108.01 15.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 78.94 -53.71 0.45 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.415 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 66.73 6.71 4.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.504 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.463 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 3.3 t -67.45 -60.53 5.6 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.306 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 270' ' ' SER . 12.0 Cg_endo -55.88 -163.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.551 2.167 . . . . 0.0 112.442 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 55.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.052 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.401 ' CD ' ' CD1' ' A' ' 266' ' ' ILE . 0.7 OUTLIER -73.25 -29.66 62.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.817 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.24 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -74.17 -48.78 26.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.69 -32.08 73.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.03 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -78.86 -40.18 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.56 -36.59 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.38 -38.79 85.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.65 -27.66 67.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.61 -22.19 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.17 5.66 29.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.31 -48.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 110.991 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 mt -89.31 53.42 2.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.774 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.6 p -154.71 174.9 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -21.03 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.56 -54.67 7.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.11 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.59 -45.75 4.21 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.773 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.27 -30.21 49.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.61 -38.09 70.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.5 67.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.416 ' CG1' ' CB ' ' A' ' 297' ' ' LYS . 85.9 t -58.12 -30.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.179 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.36 -13.23 60.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -114.31 -25.24 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -119.47 -81.65 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.693 0.282 . . . . 0.0 111.514 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.416 ' CB ' ' CG1' ' A' ' 293' ' ' VAL . 0.2 OUTLIER -49.53 164.93 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.354 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.39 147.16 69.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.548 2.166 . . . . 0.0 112.275 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.13 -25.84 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.108 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -79.8 114.34 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -169.89 137.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 111.076 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.5 m -155.82 108.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -146.08 39.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.1 mt -153.66 165.45 35.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -38.59 3.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.014 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 p -79.5 -47.82 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -60.65 -21.9 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -51.02 -28.21 9.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.273 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.19 -47.85 59.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.21 -54.15 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.51 -17.75 60.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.295 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -53.71 -23.35 11.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.614 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.34 46.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.774 0.321 . . . . 0.0 111.301 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 317' ' ' ILE . 0.4 OUTLIER -124.14 173.73 4.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.783 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -90.09 -51.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.839 2.359 . . . . 0.0 113.725 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -81.3 -59.44 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 314' ' ' ASP . 16.7 tt -56.27 -31.58 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -76.52 -33.08 58.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.151 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.47 75.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 44.9 p -76.76 -30.94 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -32.15 70.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.06 -52.7 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -69.58 -30.45 68.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.25 71.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.32 -29.24 69.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -118.43 59.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 178.39 -154.19 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.92 166.23 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.5 101.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 53.66 87.62 0.14 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.417 ' HD2' ' CE2' ' A' ' 258' ' ' PHE . 47.8 Cg_endo -68.77 161.47 45.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.492 2.128 . . . . 0.0 112.228 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -157.39 91.24 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.47 HG22 HD13 ' A' ' 333' ' ' ILE . 12.0 pt -152.59 132.15 7.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 -23.56 22.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.468 2.112 . . . . 0.0 112.411 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -55.94 -43.81 77.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.405 ' HG2' ' CE2' ' A' ' 169' ' ' PHE . 1.6 mtp -69.17 -35.36 76.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.2 p -62.57 -35.55 79.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.7 -33.87 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 168' ' ' ALA . 2.5 m-85 -73.49 -27.28 61.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -42.74 81.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.99 -35.43 42.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.51 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.3 t -59.59 -30.13 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -58.89 -60.81 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 0.9 OUTLIER -67.45 -27.5 67.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.85 -59.72 4.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.651 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.36 -59.1 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 21.9 mt -48.19 -58.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 345' ' ' THR . 15.2 t-20 -55.47 -36.21 66.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 111.179 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -56.02 -30.11 61.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.097 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.21 -10.15 55.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.553 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.6 p -67.58 -25.14 65.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 111.95 -27.82 9.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.18 39.34 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 124.9 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.805 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.2 t -115.56 177.92 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.966 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 22.0 t -72.31 -35.15 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -45.98 88.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.96 -43.4 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.99 -38.51 82.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.1 -48.82 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -62.81 -44.06 97.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.35 -26.52 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -51.81 -56.86 11.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.388 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -56.55 -30.51 63.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 13.6 m -67.66 -43.2 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -29.82 62.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.995 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 16.8 mt -75.06 -44.93 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.99 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 23.3 m -79.65 -67.94 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.83 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.09 40.03 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -119.71 153.08 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -133.86 -68.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.04 85.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -149.27 158.7 44.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.58 155.35 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.947 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 28.3 t -123.91 102.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mt -94.88 114.98 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -94.91 124.46 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pt -134.66 149.06 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.186 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.73 94.27 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.44 27.94 53.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.31 -29.98 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.706 0.288 . . . . 0.0 110.899 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.0 tttt 62.75 118.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 48.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.56 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -78.78 -34.72 45.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.36 -42.0 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.37 -33.75 30.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.57 -31.56 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.95 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.12 77.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.271 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -76.96 -32.2 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.429 HG13 ' CE2' ' A' ' 27' ' ' PHE . 27.9 t -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.104 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.42 -38.04 89.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -74.11 -26.74 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -44.15 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.434 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 67.2 m-85 -62.24 -56.67 16.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.474 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -59.37 -27.42 65.95 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 110.131 179.226 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -27.3 1.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -69.28 -56.87 6.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.56 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.031 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.25 49.05 0.01 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 118.115 -1.993 . . . . 0.0 115.513 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.474 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 0.9 OUTLIER -139.56 95.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 118.103 0.951 . . . . 0.0 111.628 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -99.95 106.38 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.11 146.34 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.01 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 m -116.63 118.26 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -143.9 162.8 35.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -87.16 154.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.51 130.01 20.1 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.595 2.197 . . . . 0.0 112.277 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.34 -60.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -79.41 -7.58 58.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.33 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.62 -24.93 36.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.78 -34.39 62.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.067 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.3 -29.94 12.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -69.27 -31.18 69.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.435 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -56.36 -60.76 8.13 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.4 Cg_endo -63.77 -16.83 57.09 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.423 2.082 . . . . 0.0 112.513 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.86 -44.5 18.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.792 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.1 m -90.21 -24.36 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.2 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.89 70.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.24 -30.78 71.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.059 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.84 128.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.64 72.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.24 -30.99 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.28 -168.81 12.36 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.23 -171.61 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.314 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 175.09 103.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.2 mt -143.6 136.25 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.25 141.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -108.79 144.67 36.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 263' ' ' SER . 1.3 m95 -165.62 173.6 10.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.57 -174.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.344 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -77.69 -45.01 26.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.3 -28.81 44.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.59 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.75 -24.17 21.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.217 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CE1' ' O ' ' A' ' 263' ' ' SER . 4.3 m-85 -101.11 -28.5 12.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.965 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.74 -23.13 49.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.655 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.4 -50.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.3 -57.51 3.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.71 -30.6 67.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -28.42 64.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 p -70.26 -26.74 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.34 77.68 1.07 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.8 tp -167.48 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -141.5 127.82 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 138.48 57.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.04 157.96 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mm -111.3 141.49 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 148.56 40.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.78 168.2 19.61 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.725 2.284 . . . . 0.0 112.372 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.95 153.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -31.65 70.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 -23.28 64.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.403 ' CE2' HD21 ' A' ' 89' ' ' LEU . 1.4 t80 -79.3 -59.16 2.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.41 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 8.3 pt20 -62.55 -24.73 67.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.66 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -68.19 -32.8 73.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -104.96 -63.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.403 HD21 ' CE2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.07 113.53 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -62.25 143.89 95.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.889 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.51 -24.94 30.4 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.468 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -57.03 -34.72 68.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.076 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -86.76 -28.23 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.982 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CZ2' ' HB3' ' A' ' 86' ' ' GLN . 4.4 m0 -59.74 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.69 -29.25 70.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.63 -29.6 68.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.203 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.77 61.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.38 81.44 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -79.26 98.07 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.77 31.51 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.47 50.65 7.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -131.32 129.74 41.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.65 40.02 1.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -97.78 39.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 178.22 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.419 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 6.7 p90 -118.73 129.14 25.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 168.14 19.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.606 2.204 . . . . 0.0 112.283 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -175.01 39.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.21 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 174.18 108.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.982 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.4 p -90.09 134.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.05 164.35 28.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.62 10.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.11 157.54 43.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -175.95 5.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mt -92.62 146.15 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.467 HD11 ' HB ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -73.77 155.94 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.05 0.452 . . . . 0.0 111.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -135.78 114.71 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -133.77 -177.49 4.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.35 76.27 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -156.05 -50.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.06 39.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.27 91.13 47.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.37 159.42 53.42 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.444 2.096 . . . . 0.0 112.27 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -102.2 95.77 6.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 159.48 52.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.59 49.42 3.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.678 2.252 . . . . 0.0 112.702 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 55.47 32.9 19.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.07 140.44 52.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -32.35 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.643 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.71 17.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.485 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.36 -17.09 58.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 mt -73.47 -53.0 4.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.1 Cg_exo -52.15 -36.74 67.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.312 2.008 . . . . 0.0 112.428 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -32.87 56.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.5 mt -77.02 -31.91 56.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -76.6 -31.07 57.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -71.75 -32.16 67.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.46 -40.69 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD1' ' CB ' ' A' ' 146' ' ' ALA . 6.7 mt -73.15 -53.24 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -57.77 -24.63 58.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.37 -26.13 60.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -109.76 -70.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.62 39.85 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -174.89 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.725 0.297 . . . . 0.0 110.787 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.4 m -157.13 171.24 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 147' ' ' LEU . . . -142.94 49.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 4.4 tt 170.62 120.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.03 106.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.434 ' CD2' ' CD1' ' A' ' 226' ' ' ILE . 0.6 OUTLIER -172.24 167.04 5.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 148.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 ' CD2' ' CD2' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -178.64 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.811 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -133.95 39.93 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 154' ' ' PRO . 6.8 pt-20 -87.65 173.41 6.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.452 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 88.7 Cg_endo -85.89 118.75 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.435 2.09 . . . . 0.0 112.617 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 61.52 80.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.41 ' C ' ' HD2' ' A' ' 159' ' ' PRO . 4.1 p90 -121.13 -48.25 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.4 t -72.8 -35.27 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.349 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.444 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -49.27 -55.81 19.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.326 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.0 Cg_endo -78.7 -18.31 11.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.627 2.218 . . . . 0.0 112.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.39 -56.7 4.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.174 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 167' ' ' TYR . 1.8 pt -80.6 1.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 158' ' ' TRP . . . -88.13 -54.54 4.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 253' ' ' GLN . . . 62.67 -81.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -56.8 2.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 100.67 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.579 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.95 87.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.421 ' CE1' HD13 ' A' ' 161' ' ' ILE . 33.7 t80 -171.49 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -131.88 -46.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' CE1' HG21 ' A' ' 333' ' ' ILE . 30.1 p90 -152.27 160.01 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.22 138.0 36.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -117.48 110.71 18.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -137.18 178.43 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.729 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -70.34 66.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.15 -26.62 1.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -89.01 159.27 17.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.348 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -172.39 74.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 43.16 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.448 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.9 pp -142.9 -45.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.268 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -133.61 -44.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.39 95.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 5.8 m -148.94 106.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 184' ' ' ASP . . . 159.2 109.73 0.27 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.046 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.2 m -74.56 42.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.808 0.337 . . . . 0.0 111.184 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 182' ' ' GLY . 3.2 p30 -110.93 -7.86 14.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.723 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.58 -173.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.63 63.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.79 -49.34 79.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.36 -45.18 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -60.2 -58.59 7.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.52 87.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.12 -53.34 18.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.598 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.05 -42.68 94.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.9 m -59.46 -30.44 68.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -76.15 -47.87 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -50.02 63.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.0 p -56.49 -28.07 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.255 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.44 -54.6 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.0 -59.05 6.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.026 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.96 -25.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.37 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -60.51 -59.97 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.18 20.99 18.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . 0.447 ' CE ' ' CD2' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -120.28 -68.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.464 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 27.4 m80 -81.16 -0.52 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.715 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -20.27 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.626 0.25 . . . . 0.0 111.288 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -142.52 37.93 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -162.28 84.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.72 57.71 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.5 t -57.4 108.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -78.43 -156.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.721 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -78.38 -44.45 24.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.157 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.1 p -73.93 -25.1 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.173 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.3 mt -82.05 -53.94 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.107 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.27 64.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -72.86 -42.62 63.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.423 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.16 -24.92 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.23 -56.66 11.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.681 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 8.6 p90 -67.56 -30.93 70.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.749 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -79.9 -11.9 59.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -74.45 -24.04 59.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.687 0.279 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.65 -92.77 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.178 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 165.54 91.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.607 0.241 . . . . 0.0 110.561 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.35 -177.89 3.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 38.59 0.66 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.52 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.425 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -154.11 101.87 2.43 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.044 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.467 ' HB ' HD11 ' A' ' 116' ' ' ILE . 0.7 OUTLIER -144.6 104.93 4.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.191 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.434 ' CD1' ' CD2' ' A' ' 149' ' ' PHE . 3.9 mp -106.26 119.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.229 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -139.18 162.89 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.14 -150.91 17.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.63 169.54 17.18 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 112.318 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t90 61.71 37.02 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -141.61 -47.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.39 69.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 4.7 t 60.26 -166.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.15 131.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.93 -66.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.32 154.52 24.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m -89.29 86.26 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.817 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 70.6 m -84.27 147.08 27.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 85.35 3.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.2 t -128.52 -69.32 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.049 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.4 p30 178.32 40.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -144.79 115.84 7.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -156.92 175.97 34.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.36 136.43 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 146.52 52.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.82 150.7 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 4.0 mt -59.95 149.18 74.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 4.8 Cg_exo -79.52 -174.61 2.35 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.185 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.84 177.69 6.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 194' ' ' PHE . 24.4 t80 -158.27 111.74 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.49 12.64 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.26 5.53 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.736 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 163' ' ' ALA . 3.4 pt20 -156.35 90.49 2.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.784 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -86.72 150.28 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.889 2.392 . . . . 0.0 112.618 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 69.5 m -55.24 150.5 10.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -109.41 89.5 7.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.76 125.3 6.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.578 2.185 . . . . 0.0 112.391 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -79.98 172.04 14.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 10.5 p -94.88 138.13 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.72 129.97 10.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 30.8 m -122.22 144.78 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.169 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -92.57 115.67 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.461 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' TRP . 8.9 m -94.59 133.73 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 106' ' ' TYR . . . -101.67 126.07 48.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.603 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -114.91 159.04 13.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.743 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 10.5 tt -140.2 136.38 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -51.37 125.56 14.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.86 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.249 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.74 46.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.7 m -96.13 112.81 60.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.39 -26.98 12.74 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.448 2.099 . . . . 0.0 112.437 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -120.22 65.53 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -75.04 -53.98 7.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.28 -32.17 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.419 ' CD2' ' CE1' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -73.0 -49.17 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.73 -42.96 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -59.86 -42.68 94.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.97 -30.51 58.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.419 ' CE1' ' CD2' ' A' ' 275' ' ' LEU . 1.8 m-85 -64.16 -59.2 4.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 pp -58.86 -27.0 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.33 -29.26 61.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.54 27.47 9.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 27' ' ' PHE . 14.6 m-85 -148.2 -74.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.83 -31.38 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.48 72.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.76 164.42 38.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -27.86 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -77.54 -27.68 51.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.125 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -105.62 -54.46 0.73 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.711 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.39 -30.71 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.152 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -72.28 -40.71 67.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.65 81.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.08 -33.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -80.15 -55.06 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -59.72 -57.8 11.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.47 -34.4 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -139.24 89.42 12.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 115.73 4.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.55 2.166 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 -43.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.88 123.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -86.07 90.13 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.15 79.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.414 ' O ' ' HG ' ' A' ' 304' ' ' LEU . . . -139.08 78.17 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.418 ' CD2' ' N ' ' A' ' 304' ' ' LEU . 0.1 OUTLIER 40.59 -91.87 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.971 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -78.37 -41.26 33.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.784 0.326 . . . . 0.0 111.203 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -53.28 -25.16 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.234 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.411 ' CE2' HD23 ' A' ' 311' ' ' LEU . 87.8 t80 -56.1 -44.67 79.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.35 -31.81 58.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -66.86 -48.22 69.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.19 -35.9 71.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 307' ' ' TYR . 3.4 mp -56.03 -23.06 30.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.1 71.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -176.8 74.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.16 139.16 19.85 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.34 -62.38 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.445 2.096 . . . . 0.0 112.352 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -60.78 -48.52 81.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 42.2 mm -59.52 -29.91 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.48 71.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -78.46 -56.26 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.1 t -58.38 -27.27 64.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 mtt -56.23 -29.14 60.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.47 -57.41 12.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -78.36 -31.85 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.92 71.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -59.68 -32.24 70.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -109.37 38.88 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.2 179.59 24.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.578 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.76 -177.2 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.978 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 329' ' ' ILE . 0.0 OUTLIER -135.32 107.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 3.4 mmt 60.66 155.77 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.975 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.31 -161.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.231 . . . . 0.0 112.256 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -170.39 -42.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.421 HG21 ' CE1' ' A' ' 169' ' ' PHE . 3.3 tt -123.77 122.97 26.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.51 -21.23 34.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.088 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.35 -30.68 62.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -30.99 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 60.5 p -65.21 -41.74 94.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.93 74.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -67.72 -27.52 66.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.42 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.43 -32.21 62.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.88 -31.42 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -76.71 -53.25 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.41 HG23 ' CZ ' ' A' ' 167' ' ' TYR . 21.9 t -58.05 -30.04 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.42 ' HD2' ' CE3' ' A' ' 340' ' ' TRP . 16.9 mtp180 -59.71 -54.4 46.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 69.0 p -49.78 -27.66 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.28 7.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.47 -59.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.932 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 2.4 tt -49.62 -39.63 14.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.917 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.64 -28.6 36.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -59.61 -31.47 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.977 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.92 -10.2 59.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.517 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.0 p -67.57 -26.04 66.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.122 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 109.56 -24.34 20.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.568 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 39.55 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.44 114.14 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.765 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.18 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.28 -28.89 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.213 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 -37.48 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.22 -55.78 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -50.33 -36.49 32.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.35 -42.52 18.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -65.53 -55.67 16.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.8 -27.17 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -53.36 -54.91 29.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -58.86 -30.44 67.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.4 m -59.47 -57.66 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -58.37 -41.24 84.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.146 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 33.1 mm -71.96 -32.04 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.4 p -108.52 35.45 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.89 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -151.43 169.09 22.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.17 150.05 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -108.97 154.42 22.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.8 72.19 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.66 141.58 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 279' ' ' PHE . 2.7 mp -141.82 138.87 32.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.721 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 57' ' ' PRO . 44.9 t -115.22 113.53 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.094 0.474 . . . . 0.0 111.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 4.9 mt -99.15 133.89 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.1 m0 -94.71 111.95 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 tt -139.59 148.74 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.096 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -171.43 75.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.07 -112.34 1.4 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 178.38 58.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.849 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -125.38 -97.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.006 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.81 80.76 0.28 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.596 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -61.94 -30.95 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -59.15 -28.38 66.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -56.77 -51.59 55.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.637 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.73 -37.2 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.32 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -64.25 -56.09 17.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.37 -43.97 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.57 -27.69 64.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.616 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -32.87 70.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.59 -45.06 89.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -63.9 -56.03 18.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.533 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 8.7 mt-10 -53.91 -28.4 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.437 0.637 . . . . 0.0 110.59 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -78.09 -25.78 47.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.486 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 31' ' ' THR . 4.4 t70 -52.65 -56.46 15.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.469 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.48 36.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.456 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.26 44.39 0.02 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.883 -2.103 . . . . 0.0 115.75 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.533 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 3.4 mm -133.94 149.28 30.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 118.21 1.005 . . . . 0.0 111.377 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.56 137.4 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.55 129.78 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.85 134.63 54.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.2 m -127.91 120.17 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.151 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.11 163.02 33.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -80.11 152.91 74.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.86 179.07 5.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.551 2.167 . . . . 0.0 112.449 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 76.67 -0.28 3.04 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.65 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 -48.83 2.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.2 -12.73 57.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.412 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -26.37 8.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.279 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.63 -51.12 9.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -71.81 -24.55 61.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.431 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.85 -60.46 5.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.316 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 36.1 Cg_endo -65.08 -15.35 49.96 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.432 2.088 . . . . 0.0 112.568 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.67 -40.95 12.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.961 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.28 -29.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.64 -30.97 71.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.77 66.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.1 m -100.26 -45.48 5.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.69 73.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -99.68 -28.86 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 0.0 111.085 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . -171.29 -64.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.63 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.444 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 5.8 Cg_endo -48.96 115.3 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.823 2.349 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -175.32 39.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.803 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -145.25 129.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.516 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.8 mt -141.5 142.72 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.736 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 264' ' ' ALA . 51.0 m-85 -123.14 112.38 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.268 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -162.95 174.03 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.753 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.88 -173.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -76.86 -33.41 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.01 -29.28 63.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -56.98 14.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.074 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.415 ' CD2' HD21 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -66.34 -48.83 68.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.47 -17.87 54.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.719 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.77 -56.07 1.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -95.45 -54.45 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 76' ' ' LEU . . . -55.67 -27.81 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.363 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -68.25 -22.33 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.9 p -95.82 25.63 4.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.27 77.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.578 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.36 39.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.879 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.415 HD21 ' CD2' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -158.3 136.55 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.922 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.41 130.46 52.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.4 138.76 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.2 pt -83.66 162.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -89.2 147.74 39.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.66 110.96 2.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.613 2.209 . . . . 0.0 112.44 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -176.77 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -21.83 47.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.412 ' CB ' ' CZ2' ' A' ' 94' ' ' TRP . . . -54.8 -23.16 16.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.551 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -59.22 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.382 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.2 -24.64 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -73.94 -20.58 60.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.35 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 53.15 48.57 21.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.89 0.376 . . . . 0.0 111.255 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 mt -102.12 155.49 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -96.32 145.0 28.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.16 -26.66 43.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.509 2.14 . . . . 0.0 112.345 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -56.62 -30.57 63.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -90.7 -29.76 17.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CZ2' ' CB ' ' A' ' 84' ' ' ALA . 34.1 m0 -70.1 -47.57 61.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -59.51 -30.71 68.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.6 83.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.9 t -95.15 43.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -99.37 89.44 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 120.15 35.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 p30 44.43 38.66 2.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.13 31.12 78.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.642 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -145.62 160.05 42.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 93.23 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.5 pt -114.43 39.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -176.25 125.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.73 116.23 57.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.81 133.82 10.46 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.466 2.11 . . . . 0.0 112.419 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.3 pt -156.07 39.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.045 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.409 ' N ' HG21 ' A' ' 302' ' ' VAL . . . 169.58 102.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.86 116.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.326 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -116.98 132.58 56.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.67 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.48 176.56 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.188 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.83 171.37 7.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.33 -177.41 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mt -109.6 149.88 29.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 pt -110.48 140.53 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.186 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.77 130.87 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.29 162.09 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.5 37.7 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -90.19 -35.13 15.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.5 pp -157.73 39.98 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mt -137.55 131.07 17.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 157.78 41.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.257 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -65.08 110.77 4.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.6 140.29 86.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.477 2.118 . . . . 0.0 112.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.56 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.228 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.42 -39.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.0 t -70.94 152.23 43.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.5 ' O ' HG13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -60.14 -23.56 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 33.4 mt-10 -45.26 -23.47 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -48.78 -31.0 6.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -73.53 -62.58 1.14 Allowed Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.324 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.415 ' HD3' HG13 ' A' ' 132' ' ' ILE . 82.9 Cg_exo -45.67 -34.42 11.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.232 1.955 . . . . 0.0 112.407 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.53 61.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.1 mp -77.79 -28.77 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -43.42 75.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -68.73 -28.03 66.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -81.83 -50.84 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 19.5 mt -57.92 -55.83 29.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -58.72 -24.66 61.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.16 -25.51 59.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -111.21 -67.47 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.4 39.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -142.07 -177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.3 t -150.37 157.54 43.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.013 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.406 ' CB ' ' CB ' ' A' ' 223' ' ' ALA . . . -107.6 42.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.409 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER 176.84 115.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.77 106.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' A' ' 226' ' ' ILE . 2.3 t80 -156.36 176.74 12.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -64.72 -169.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.5 mt -148.81 -46.01 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.35 44.2 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -108.25 166.78 10.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 150.97 22.38 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.949 2.433 . . . . 0.0 112.173 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.31 55.24 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.41 ' CE2' HD21 ' A' ' 160' ' ' LEU . 77.8 t80 -120.93 -49.57 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.6 m -73.42 -42.84 61.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.49 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 9.8 t90 -55.72 -53.88 57.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.429 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.53 -24.17 42.47 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.17 1.913 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 156' ' ' PHE . 5.0 mp -81.57 -56.77 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.27 -21.81 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.254 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.35 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.201 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.32 -25.16 65.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.286 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.55 -41.35 18.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.097 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.98 -82.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.596 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.09 -38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.551 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.48 ' CD2' ' CD1' ' A' ' 158' ' ' TRP . 38.8 t80 70.16 -65.69 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.26 -82.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.062 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -155.94 -174.82 5.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -130.29 115.94 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -79.39 142.46 35.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -136.96 128.32 28.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.29 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.83 52.07 0.25 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.486 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 159.74 3.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -97.74 130.25 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.9 -175.99 2.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.6 mm -137.04 -48.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -31.53 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.65 108.31 4.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 22.0 t -121.62 150.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.155 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.26 50.02 0.9 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.4 t -94.08 -31.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 111.08 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -123.52 72.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -128.92 -176.67 3.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.07 78.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.61 -52.06 32.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.92 -30.8 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 111.136 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -61.05 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 194' ' ' PHE . . . -77.77 -43.77 29.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -54.27 -26.21 35.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.761 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 6.4 tp -81.68 -58.17 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.769 0.319 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.7 t -64.2 -28.87 70.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.024 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 190' ' ' ALA . 2.6 m-85 -56.99 -63.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.13 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.41 -46.63 87.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.19 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 36.4 t -59.3 -46.96 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.02 -36.44 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.46 -58.89 6.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.063 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 28.8 pt -49.84 -27.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -77.59 -31.7 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.991 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.7 18.32 22.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.399 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -41.75 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -114.56 -51.67 2.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 169.54 -75.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -156.39 153.03 28.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.746 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.13 77.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -164.95 31.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 17.3 p -61.98 139.98 58.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.416 ' HB2' HD11 ' A' ' 212' ' ' ILE . 4.7 m-20 -108.76 -150.73 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.1 -53.0 7.43 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.105 0.479 . . . . 0.0 110.083 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.1 m -56.88 -24.42 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.397 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 209' ' ' ASP . 2.7 mp -81.94 -58.85 3.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.015 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.32 -30.42 70.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -22.6 38.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.443 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -47.75 -55.58 9.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.489 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.66 -54.94 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.931 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -47.38 -28.47 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -41.35 23.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -106.78 -23.58 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.773 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 55.01 46.74 76.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.41 43.02 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 111.23 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.77 -177.63 3.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.406 ' CB ' ' CB ' ' A' ' 146' ' ' ALA . . . -82.82 38.67 0.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.894 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.409 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -173.8 99.22 0.11 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.04 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.51 105.31 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.807 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.424 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 23.7 mm -82.77 138.53 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.45 112.22 24.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -111.84 159.83 13.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.47 -27.16 30.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -137.31 37.32 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.962 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -118.66 38.56 3.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -131.25 100.78 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.73 -41.22 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.7 m120 60.59 174.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -161.74 -44.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -95.12 -47.99 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 m 59.66 104.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.2 m -98.12 168.87 9.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -98.66 31.95 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.7 t -102.65 158.45 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -84.79 132.93 34.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -101.23 170.44 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -151.7 150.76 22.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.71 127.72 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.922 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.8 p -141.12 162.74 34.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.182 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.8 m -86.6 150.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.045 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 mp -59.76 151.68 61.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.71 -158.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.914 2.41 . . . . 0.0 112.343 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -77.94 177.82 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.36 111.54 3.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? 60.1 17.71 7.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 120.66 -24.95 7.42 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.684 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.61 140.04 18.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.31 169.04 21.97 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.449 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.5 m -58.31 -175.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.005 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -144.15 73.72 16.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.49 174.13 12.25 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.223 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -111.81 135.22 52.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.97 154.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.66 77.99 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.612 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 m -88.81 132.09 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.756 0.313 . . . . 0.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.9 tp -79.29 127.48 32.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.003 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -91.32 110.52 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.764 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 61' ' ' PHE . . . -126.79 117.71 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -177.61 -169.99 39.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.618 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 3.9 mp -100.82 159.22 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.5 p30 -88.79 158.2 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -97.46 29.08 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -100.64 -30.7 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 t -118.2 146.66 39.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 74.86 2.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.488 2.125 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -117.48 35.42 4.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -66.03 -48.97 69.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.57 -36.09 70.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mt -76.35 -29.68 57.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -58.37 -40.82 83.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -74.23 -29.38 61.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.09 -35.19 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.38 -25.61 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -14.06 62.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -88.95 27.93 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.348 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.92 35.46 1.69 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 110.725 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.24 28.3 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.795 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.9 tp -147.0 28.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.969 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 290' ' ' LEU . 3.0 t -136.84 155.62 49.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -57.63 -20.99 36.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.305 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -75.17 -38.13 61.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.418 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -119.64 -50.51 0.29 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.032 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . 25.1 tp -54.59 -55.14 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.809 0.338 . . . . 0.0 111.392 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.1 -32.93 44.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.734 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.17 -58.59 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 28.8 t -82.03 -60.62 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -21.65 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.879 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.76 -20.04 12.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.377 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.68 90.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 64.65 165.9 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.6 144.63 79.37 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.504 2.136 . . . . 0.0 112.375 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.5 pp -174.74 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -119.21 160.79 14.11 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -132.95 105.04 6.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.876 0.37 . . . . 0.0 111.391 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.409 HG21 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.99 44.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.198 0.523 . . . . 0.0 110.645 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.77 88.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.668 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 77.17 115.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -55.28 -23.98 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.9 m -53.94 -52.41 60.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.36 -30.4 37.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -59.14 -27.74 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -56.98 -37.18 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.62 -44.61 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.53 -18.6 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.09 -25.87 9.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 111.502 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -58.4 -27.57 64.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 146.57 95.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.8 -51.42 9.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.39 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -55.44 -56.26 22.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mm -52.92 -55.34 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.303 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.49 75.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.7 -56.56 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 32.9 p -62.97 -29.96 71.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.53 -52.25 66.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.63 23.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.13 -30.49 66.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.14 67.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -40.2 96.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.72 -58.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.04 177.46 54.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.425 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -154.22 151.44 29.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.17 138.17 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.42 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -127.47 137.67 31.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 -168.37 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.578 2.185 . . . . 0.0 112.387 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -136.44 76.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 25.2 pt -86.2 148.6 47.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.08 -27.9 38.62 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.675 2.25 . . . . 0.0 112.323 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -58.96 -41.59 87.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -66.65 -31.72 72.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -44.28 97.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.56 72.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.05 -37.51 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.12 97.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -59.36 -52.09 67.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.91 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 28.9 t -69.5 -29.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.131 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -59.42 -60.66 3.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 9.2 t -71.64 -41.18 69.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -46.37 -56.34 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.586 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.37 -55.76 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.813 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 348' ' ' ILE . 34.8 mm -57.08 -58.75 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.728 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 345' ' ' THR . 1.0 OUTLIER -59.49 -27.91 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.671 0.272 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 355' ' ' GLN . . . -61.92 -57.07 13.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -60.82 -10.57 5.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.004 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.5 m -110.04 26.63 10.45 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.614 0.245 . . . . 0.0 111.385 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 154.3 -71.53 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.005 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -87.76 51.63 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.464 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.421 ' HB3' ' HA ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -79.37 99.29 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 1.5 t -166.22 97.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.86 -27.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.324 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -57.49 -45.72 84.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -80.01 -43.91 21.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.82 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.35 -37.77 70.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.144 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 -53.06 6.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -58.83 -55.69 31.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.28 -44.11 92.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -58.48 -32.41 68.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.0 m -72.66 -31.26 64.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -40.77 68.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 31.8 mm -71.22 -35.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 18.8 m 61.3 51.02 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 pttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.846 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.9 p -87.13 153.39 21.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.47 157.8 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -175.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.44 28.64 21.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -114.92 130.27 56.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.833 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -129.1 148.56 51.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.48 102.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -94.87 114.87 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CZ3' HD11 ' A' ' 43' ' ' LEU . 95.5 m95 -105.83 111.96 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.7 mt -118.25 157.27 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -170.31 40.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.91 25.7 3.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.92 31.81 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 110.785 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -165.91 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.11 63.86 0.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.543 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -62.9 -29.59 70.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 111.058 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -59.34 -47.18 86.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.68 -28.3 65.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 tp -64.76 -32.81 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.17 72.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -31.41 65.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.45 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.55 -35.18 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -59.73 -28.44 67.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -68.02 -33.45 74.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.416 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 9.3 m-85 -78.08 -50.6 11.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -51.54 -27.93 12.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.464 0.65 . . . . 0.0 110.425 179.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.45 -26.4 66.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.301 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' CB ' ' A' ' 31' ' ' THR . 7.4 m-20 -64.32 -57.19 10.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.98 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.611 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 48.49 0.01 OUTLIER Glycine 0 C--N 1.338 0.682 0 C-N-CA 117.873 -2.108 . . . . 0.0 115.566 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 5.4 mm -139.27 95.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 118.071 0.935 . . . . 0.0 111.676 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.27 113.76 26.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.2 m -98.85 139.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.29 119.63 39.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.9 112.97 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -151.84 163.08 39.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -104.73 142.05 23.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.15 155.62 37.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.551 2.167 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -178.84 -51.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -111.57 -23.31 10.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD11 ' CZ3' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -79.77 -1.12 37.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.545 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -54.4 -30.36 51.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.041 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -90.4 -30.9 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -24.53 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -52.8 -59.31 9.15 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.303 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.2 Cg_endo -63.1 -17.25 59.24 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.482 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -89.69 -43.84 10.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.8 t -82.76 -30.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.51 61.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -71.06 -31.89 68.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.33 55.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -59.41 -34.08 72.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.36 -93.92 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.569 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.85 -173.42 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.581 2.187 . . . . 0.0 112.4 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.8 t0 178.97 60.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.773 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mm -99.01 121.07 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tt -146.68 141.62 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.5 136.87 52.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.408 ' CD1' ' HG3' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -161.17 173.31 15.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -76.9 -53.26 8.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.39 -28.44 65.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 13.0 mmt180 -57.54 -29.17 64.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 263' ' ' SER . 48.3 m-85 -107.52 -37.4 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.86 -23.47 51.05 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.653 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.28 4.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.651 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.65 -59.38 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.074 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.3 -29.76 64.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.26 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.53 -27.05 66.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 t -70.19 -26.73 64.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.088 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.31 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.84 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.36 127.9 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.16 126.56 30.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.09 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.05 132.73 43.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tt -102.87 147.56 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.4 p -98.03 145.87 30.52 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.84 146.71 18.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.94 -55.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -30.48 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.79 -23.39 42.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -79.25 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.5 -26.54 67.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.43 -41.9 45.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.812 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.65 40.05 13.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -177.32 6.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.91 112.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 78.1 Cg_exo -50.51 -25.21 13.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.514 2.143 . . . . 0.0 112.482 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -21.07 41.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 57.5 p -69.39 -53.95 16.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.442 ' CE3' ' N ' ' A' ' 95' ' ' ASP . 46.9 p-90 -92.92 -45.31 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 6.7 t70 -53.29 -26.72 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.288 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -80.56 -28.88 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.235 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.57 63.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.34 104.66 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -94.44 93.1 7.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.61 -70.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.06 30.89 0.19 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -127.57 96.61 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -92.48 102.69 15.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.88 39.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.025 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -172.42 93.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 t80 -98.95 141.73 23.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HD2' ' CD2' ' A' ' 106' ' ' TYR . 92.3 Cg_endo -79.85 138.76 13.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.608 2.205 . . . . 0.0 112.205 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.0 mm -143.6 39.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.245 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 173.26 99.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.976 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.2 p -89.34 111.21 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -104.27 133.16 49.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.36 170.05 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.003 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.17 152.31 50.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.955 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 t -164.92 -176.06 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.53 138.18 44.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.0 pt -130.17 140.22 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.088 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -152.76 165.66 34.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -80.32 168.8 18.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.89 36.9 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.68 -64.01 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.38 48.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.63 103.68 10.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.24 160.36 49.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.431 2.088 . . . . 0.0 112.313 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.19 110.85 4.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.09 124.66 11.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.439 2.093 . . . . 0.0 112.278 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.4 2.066 . . . . 0.0 112.238 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -101.04 -30.59 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.5 m -126.62 169.11 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.448 ' CD1' ' CD1' ' A' ' 132' ' ' ILE . 0.0 OUTLIER -72.58 -31.28 65.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -23.71 17.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.549 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.19 -16.33 40.69 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.471 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 42.0 mt -65.55 -47.41 67.93 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 89.2 Cg_exo -46.38 -30.02 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.366 2.044 . . . . 0.0 112.629 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.89 60.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.11 -45.81 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.171 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.12 -28.69 41.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.208 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -55.79 -42.69 75.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.071 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -81.79 -33.31 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.79 -55.9 16.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.51 -25.01 9.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.54 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -112.2 -50.42 2.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.76 41.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.653 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -155.24 179.2 9.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -128.47 165.62 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -86.24 3.99 40.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.67 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 170.8 151.19 0.05 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.859 0.362 . . . . 0.0 110.995 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 6.4 tpt -117.77 144.75 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.09 145.86 40.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.0 170.79 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 12.5 mt -131.19 -46.5 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -98.5 39.72 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.732 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 93.87 8.68 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.55 112.78 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.153 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.07 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.415 ' CE2' HD12 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -111.94 -30.63 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.5 t -70.43 -27.09 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.468 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -70.22 -56.01 7.43 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.272 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 42.1 Cg_endo -67.13 -16.19 48.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.37 2.047 . . . . 0.0 112.446 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -78.18 -56.72 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.626 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 29.0 pt -65.09 -16.76 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -84.61 -70.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.992 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.58 -80.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.2 -41.93 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.003 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.29 -35.49 65.68 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.66 116.97 9.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.566 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.14 78.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.62 -69.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CZ ' HG11 ' A' ' 181' ' ' VAL . 6.7 m-85 -139.93 158.92 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.12 125.42 44.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.418 ' CE1' ' HG2' ' A' ' 330' ' ' MET . 9.3 p90 -107.85 116.39 31.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -137.05 130.14 30.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 64.18 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.85 66.27 0.15 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -163.97 149.3 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.35 . . . . 0.0 110.912 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.407 ' CE2' HG13 ' A' ' 333' ' ' ILE . 96.2 m-85 -125.5 72.68 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -177.7 109.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.0 tt -138.2 28.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.141 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.73 31.05 19.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.15 143.46 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.409 HG11 ' CZ ' ' A' ' 169' ' ' PHE . 18.9 m -148.35 129.76 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -95.43 39.92 2.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.416 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.31 -31.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -116.55 36.57 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 177.63 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.23 -30.93 58.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.43 -52.65 49.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.71 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -56.89 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.82 -30.66 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.05 -45.47 95.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 -46.89 39.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.968 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.9 p -59.89 -29.04 68.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.4 -53.07 62.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.83 -50.39 73.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.7 t -59.74 -37.8 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -27.68 56.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.45 -49.62 12.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 pp -57.16 -40.16 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.301 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -28.08 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -26.23 62.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -118.46 -67.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . 0.426 ' CD2' ' CB ' ' A' ' 207' ' ' ASP . 30.9 m170 -65.15 -28.78 69.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 mtm 69.28 -67.41 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.41 -48.42 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.23 -58.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . 0.426 ' CB ' ' CD2' ' A' ' 203' ' ' HIS . 6.4 t0 78.1 -55.18 0.5 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.82 147.86 31.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -144.0 -162.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.358 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 211' ' ' SER . 39.4 p90 -78.83 -46.02 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 110.392 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.7 p -81.08 -25.64 36.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.045 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.45 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.58 -30.36 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.625 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -70.41 -22.74 62.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.72 7.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.68 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.75 -41.99 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -75.98 -58.7 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -62.73 -32.94 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -23.47 16.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.632 0.253 . . . . 0.0 111.33 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.54 52.15 8.78 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.066 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.26 39.41 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.34 . . . . 0.0 111.121 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.8 p -149.58 -177.69 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.856 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.55 39.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 173.66 128.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.925 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 1.3 t -144.54 106.35 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 156' ' ' PHE . 14.6 mt -78.99 141.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -86.81 112.48 21.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.08 -157.17 33.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.32 -46.43 32.94 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 112.348 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -158.12 45.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.822 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.86 39.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -172.72 175.55 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 17.4 p -123.0 -72.7 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.818 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 60.34 90.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 24.0 mt -123.84 -66.38 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.7 150.32 39.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.1 t -161.69 106.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.7 m -143.06 96.5 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.15 -69.37 0.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.974 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.8 m -92.32 134.83 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -176.37 -167.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.07 130.67 45.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.08 171.85 21.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.29 136.36 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 111.112 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.4 t -125.24 159.41 31.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.62 150.55 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.91 156.82 33.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.82 -168.33 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 t -123.99 177.48 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 253' ' ' GLN . 54.7 p90 -167.18 117.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt 64.17 16.24 9.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.62 33.04 28.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.667 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.409 ' O ' ' CE1' ' A' ' 250' ' ' PHE . 16.6 pt20 -156.19 90.63 2.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 111.003 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.52 161.08 47.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.788 2.326 . . . . 0.0 112.154 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 81.1 p -57.43 163.8 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -105.15 99.53 20.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 130.06 8.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.468 2.112 . . . . 0.0 112.249 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -111.87 139.75 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.11 150.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.72 160.39 28.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.621 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 m -129.85 144.96 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.861 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.0 126.29 35.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.978 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.42 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 28.3 m -91.71 125.88 36.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.62 140.12 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.58 168.12 34.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.404 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.1 tt -101.67 158.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.016 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -73.64 173.16 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -94.23 -27.4 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -30.95 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 p -76.75 122.36 86.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.18 -1.46 11.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.498 2.132 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -96.37 38.27 1.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -75.04 -31.05 61.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -60.33 -42.89 96.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.5 tp -75.59 -28.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.024 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 279' ' ' PHE . . . -76.8 -32.35 57.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.306 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -79.13 -30.76 43.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.54 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.18 -48.72 19.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.7 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -70.25 -24.22 63.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.239 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.5 tp -78.89 -29.9 44.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -105.56 -14.47 15.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.759 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 283' ' ' TYR . 14.7 m120 -111.06 27.42 9.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.685 0.278 . . . . 0.0 111.621 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 282' ' ' ASN . 6.7 m-85 -168.69 -52.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.185 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.7 tp -46.41 -66.51 0.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 2.6 mt -95.72 63.25 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.896 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.0 m -154.78 166.33 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.75 -20.31 55.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.46 -29.57 52.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.181 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -111.46 -52.92 0.54 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.761 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.3 tp -50.64 -27.3 6.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.91 -26.03 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.264 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.79 -57.94 3.53 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.381 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 294' ' ' ASN . 1.8 m -62.42 -28.78 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.634 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 297' ' ' LYS . 2.1 t-20 -22.2 -48.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -50.78 -27.77 7.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.4 OUTLIER -135.62 -13.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.962 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 298' ' ' PRO . 0.0 OUTLIER -45.52 -49.81 33.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 297' ' ' LYS . 59.5 Cg_endo -73.73 104.52 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.301 2.0 . . . . 0.0 112.556 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 3.9 pp -177.94 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.655 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 177.82 72.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.36 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.31 93.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 111.201 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 34.9 t -154.89 109.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.76 40.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 3.2 mp -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -59.34 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 m -79.15 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -80.29 -35.75 35.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.97 -25.27 28.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.234 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.47 -61.34 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.052 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.25 -31.16 14.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.92 -55.71 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -77.38 -54.25 6.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt 54.1 30.06 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.06 110.42 18.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.68 -13.09 31.78 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.602 2.202 . . . . 0.0 112.615 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.95 4.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.719 0.295 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 317' ' ' ILE . 0.0 OUTLIER -58.51 -32.73 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.25 58.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.58 -26.47 61.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 12.1 t -55.6 -29.44 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.034 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.9 mmm -59.4 -30.44 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.33 -52.59 13.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.6 -31.04 67.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.66 69.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -59.88 -31.13 69.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 36.35 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -172.57 171.42 44.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.07 147.18 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 27.6 pt -59.33 130.35 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.418 ' HG2' ' CE1' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -178.47 136.62 0.34 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -178.19 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.454 2.103 . . . . 0.0 112.272 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -127.31 36.5 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.407 HG13 ' CE2' ' A' ' 176' ' ' TYR . 3.4 mp 64.13 127.76 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.46 -27.68 32.82 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.089 . . . . 0.0 112.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -58.28 -31.26 67.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.41 -28.47 68.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.9 m -58.65 -59.26 5.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.62 -27.46 66.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CZ ' ' CD1' ' A' ' 368' ' ' ILE . 0.5 OUTLIER -56.37 -24.32 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.31 -27.32 62.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -52.29 13.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.179 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.23 59.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.32 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 27.4 m -56.29 -29.93 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.448 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -52.55 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 11.5 m -69.35 -27.66 65.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.5 -60.56 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.416 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.52 -57.02 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.087 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.1 mt -52.15 -58.79 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 345' ' ' THR . 0.1 OUTLIER -62.34 -31.06 71.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.75 0.31 . . . . 0.0 111.193 -179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.02 65.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.999 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.17 -9.87 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.1 t -67.28 -22.82 65.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 110.46 -29.34 9.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.441 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 39.2 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -163.96 122.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.77 171.06 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.21 -31.71 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.21 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.53 -33.85 71.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.14 -53.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -57.13 -30.08 64.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.1 mt -82.32 -56.63 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -64.07 -44.72 91.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.376 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 -35.36 80.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -79.78 -55.42 5.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -34.91 24.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 12.8 t -80.48 -29.5 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.55 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.008 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 339' ' ' PHE . 33.7 mm -64.35 -47.24 90.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.8 m -66.72 -58.68 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -160.54 117.66 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.79 141.02 29.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.47 166.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.39 45.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 168.98 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.4 mt -149.95 139.43 21.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.8 t -113.08 102.83 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 61' ' ' PHE . 3.4 mp -97.51 129.95 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CZ3' HD22 ' A' ' 43' ' ' LEU . 8.9 t90 -94.9 113.28 24.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -147.79 141.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -165.3 78.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.98 35.93 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.564 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.7 89.09 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.747 0.308 . . . . 0.0 110.991 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -152.92 81.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.51 78.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -80.94 -56.59 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -76.12 -32.26 59.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.11 -41.71 98.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.567 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.73 -31.53 59.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.68 -42.11 74.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.94 -33.31 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 t -70.32 -35.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.44 -34.63 81.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.597 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -69.51 -28.38 66.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.983 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.3 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.778 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.437 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 6.9 m-85 -64.27 -56.39 14.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -58.36 -28.16 64.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.141 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 -26.98 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.644 ' O ' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -64.94 -57.3 9.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.644 ' OG1' ' O ' ' A' ' 30' ' ' ASP . 5.9 m 156.45 36.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.731 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.48 52.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.705 0 C-N-CA 117.96 -2.067 . . . . 0.0 115.452 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 2.5 mm -138.36 95.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 118.168 0.984 . . . . 0.0 111.459 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.29 108.92 20.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.028 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.26 138.07 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 t -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 0.0 111.173 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.15 120.96 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -96.34 153.96 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.013 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.15 167.37 12.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.98 92.56 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.609 2.206 . . . . 0.0 112.35 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -177.43 -40.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.021 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -109.65 -29.09 8.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD22 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -57.42 -23.81 51.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.211 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.21 -28.74 55.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.09 -26.79 18.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.045 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -69.49 -29.38 67.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.417 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.94 -60.77 7.83 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.143 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.0 Cg_endo -66.28 -15.83 49.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.553 2.169 . . . . 0.0 112.512 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.35 -55.22 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.789 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.3 p -73.92 -24.8 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.16 -31.28 65.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.1 -43.42 92.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.068 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -170.42 152.09 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.45 85.43 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.535 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.05 -35.94 16.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.38 -157.59 7.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.536 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.42 -175.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.585 2.19 . . . . 0.0 112.25 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 173.68 49.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -99.03 127.43 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.6 pt -151.58 138.76 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 9' ' ' ILE . 7.6 m-85 -116.12 148.97 39.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -165.78 173.7 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.41 -173.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.448 ' CE1' ' CG2' ' A' ' 261' ' ' VAL . 2.1 t-160 -76.82 -53.18 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.21 66.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.421 ' CE2' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -110.01 -23.17 11.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.45 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.725 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.72 -24.81 68.95 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.717 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -64.45 -53.1 53.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.962 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.58 32.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.297 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -27.05 66.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -75.83 -26.85 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 -81.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.84 87.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.421 HD22 ' CE2' ' A' ' 67' ' ' PHE . 1.1 tp -117.52 141.51 48.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.91 119.86 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -61.22 159.34 12.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mt -126.24 148.94 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 m -120.41 92.66 47.71 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.48 114.41 3.26 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.954 2.436 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.27 -35.3 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -30.64 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' O ' ' OD1' ' A' ' 87' ' ' ASP . . . -53.46 -22.94 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.617 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -80.16 -57.77 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 111.217 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -24.61 58.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 18.1 p-10 -62.4 -17.72 59.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.339 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 66.71 71.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.353 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.36 155.92 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.95 134.38 44.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.78 -25.92 36.62 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.469 2.113 . . . . 0.0 112.296 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -55.69 -30.29 60.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.1 m -75.72 -31.34 59.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.13 -48.02 39.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.39 -27.89 62.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 -30.02 57.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.208 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 64' ' ' HIS . 29.5 m -134.66 68.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.251 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -149.26 140.71 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.3 174.04 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.47 68.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.08 37.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.48 159.14 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.822 0.344 . . . . 0.0 110.837 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mp -141.94 85.96 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.414 ' CD1' ' N ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -136.87 40.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.9 131.43 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.04 118.6 10.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.812 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.7 124.77 5.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.453 2.102 . . . . 0.0 112.463 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 21.8 mm -141.2 39.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.07 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 177.52 125.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 m -106.32 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.45 136.49 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 176.44 8.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 mt -81.26 149.0 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.0 m -164.71 170.9 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 tp -103.09 136.63 42.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.6 mm -111.64 125.85 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CZ ' ' HA3' ' A' ' 243' ' ' GLY . 51.1 p90 -128.18 152.4 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -105.04 176.98 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 30.83 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.41 -57.86 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.5 tt -140.28 82.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.36 106.07 35.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 160.34 50.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.45 2.1 . . . . 0.0 112.346 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.9 149.43 98.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.28 119.11 6.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.555 2.17 . . . . 0.0 112.214 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.04 -71.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.353 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -177.15 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.68 -176.31 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.488 ' CE2' ' CE2' ' A' ' 250' ' ' PHE . 1.0 OUTLIER -65.5 -26.74 68.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -51.46 -24.07 4.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.383 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -15.81 33.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.592 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.563 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 3.5 tt -52.44 -35.66 25.61 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.2 Cg_exo -67.93 -31.41 31.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.207 1.938 . . . . 0.0 112.104 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.51 63.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.3 mp -77.68 -38.12 48.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.78 -36.51 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -28.14 67.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.74 -31.58 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.48 -55.94 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -30.36 67.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.08 76.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.038 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -139.39 -60.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.775 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.03 41.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -126.63 121.94 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 9.9 t -140.69 170.67 15.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -147.15 13.38 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 0.2 OUTLIER 170.67 115.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 111.717 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.35 148.8 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.129 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.99 132.96 21.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.019 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -61.1 -176.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.787 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.7 -47.43 1.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.482 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.91 39.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.82 157.85 33.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.74 149.93 21.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.563 2.175 . . . . 0.0 112.315 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 61.57 67.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -120.31 -39.3 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.3 p -63.6 -36.51 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.484 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 3.1 t-105 -67.95 -55.7 12.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.442 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -64.21 -11.72 29.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.276 1.984 . . . . 0.0 113.142 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.48 -56.79 2.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.643 0.259 . . . . 0.0 111.59 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 42.8 mt -65.81 -20.16 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.821 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 158' ' ' TRP . . . -89.37 12.2 16.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.2 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 110.976 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.5 -51.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.059 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.75 -86.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -56.14 142.86 38.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -169.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.99 -45.66 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 333' ' ' ILE . 23.8 m-85 -153.26 160.35 42.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -129.11 135.05 48.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 110.78 12.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -137.02 178.23 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -70.93 69.67 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.96 -30.92 0.81 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -91.72 139.13 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.415 ' CZ ' HG23 ' A' ' 178' ' ' ILE . 3.0 p90 -140.07 36.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.09 93.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.415 HG23 ' CZ ' ' A' ' 176' ' ' TYR . 2.4 pp -157.47 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -139.01 31.82 2.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.04 121.57 39.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.68 151.4 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.193 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.89 40.0 2.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.05 -38.37 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.3 61.05 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -122.96 168.71 11.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.37 -33.02 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.98 -32.38 36.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.46 74.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -60.45 -46.07 91.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.18 -35.2 31.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.03 -28.31 73.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.53 -50.43 8.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 p -57.58 -28.93 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 2.1 m-85 -55.0 -60.63 3.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.51 -30.78 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.968 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.04 -54.03 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.3 -32.35 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.07 -55.98 27.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 6.2 mt -61.71 -33.71 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -33.29 71.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.968 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -106.51 19.34 20.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.28 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 -54.99 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.813 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.37 -46.15 3.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.833 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.8 ttm 58.34 44.31 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -176.79 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 65.76 77.09 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -143.96 30.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.2 t -81.8 148.08 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -124.01 -165.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 211' ' ' SER . 30.3 p90 -78.92 -44.26 23.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.083 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.448 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 14.2 t -73.18 -24.67 60.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.353 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.9 -50.48 16.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.082 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.74 -30.34 69.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.467 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 210' ' ' TYR . 4.4 tt0 -75.15 -25.69 58.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -51.55 -25.58 7.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.533 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -57.01 -57.47 12.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.763 0.315 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 220' ' ' GLY . 20.2 t80 -69.57 -40.27 76.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -59.43 -49.6 77.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -94.25 -1.49 53.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.642 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 217' ' ' PHE . . . -147.81 87.35 0.16 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.725 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.25 59.75 2.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.657 . . . . 0.0 110.461 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 224' ' ' MET . 0.3 OUTLIER -107.58 -175.07 2.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.125 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.8 44.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.45 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -116.87 45.88 1.76 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.829 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.446 ' CG2' ' CE1' ' A' ' 217' ' ' PHE . 1.8 t -143.56 114.63 7.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.7 mp -91.58 122.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -86.85 110.76 20.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.984 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 174.62 58.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.72 -42.53 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -44.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.33 -46.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -170.01 -47.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.6 m 61.41 -179.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -176.54 -47.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 30.4 mt 59.44 41.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.83 113.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 -46.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.44 163.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.44 155.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.47 111.34 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.3 77.55 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -149.11 168.16 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.416 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -134.45 120.93 2.55 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.52 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.1 t -91.59 132.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 111.068 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 25.2 m -141.09 156.75 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.77 150.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.22 154.63 89.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.78 -164.13 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.844 2.363 . . . . 0.0 112.135 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.8 p -97.29 177.95 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.488 ' CE2' ' CE2' ' A' ' 129' ' ' TRP . 79.8 m-85 -144.88 110.93 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.425 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 250' ' ' PHE . 0.0 OUTLIER 39.65 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.872 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 154.42 -59.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.803 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -150.87 166.06 15.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.96 173.83 11.45 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.682 2.255 . . . . 0.0 112.284 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.66 179.46 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 125.85 66.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 -168.25 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.451 2.101 . . . . 0.0 112.333 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.19 119.62 13.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 27.0 m -110.34 123.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.04 134.53 9.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 64' ' ' HIS . 14.4 m -97.39 144.87 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tp -81.97 121.99 27.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.3 113.43 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.75 145.82 43.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.023 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 176.94 -157.94 23.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.568 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.8 pt -137.95 155.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.802 0.334 . . . . 0.0 111.122 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -147.09 128.06 14.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.12 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -178.68 36.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.87 55.03 9.38 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.27 -45.56 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -151.88 80.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -30.24 71.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -69.56 -42.47 74.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.411 ' HG ' ' CD2' ' A' ' 279' ' ' PHE . 6.2 tp -77.69 -31.24 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -73.61 -46.26 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -50.65 72.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.47 -40.66 92.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.411 ' CD2' ' HG ' ' A' ' 275' ' ' LEU . 1.1 m-85 -67.8 -53.87 23.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.43 -29.15 63.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -92.18 -25.04 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.86 27.33 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.018 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.82 -62.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.871 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -139.07 57.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.3 mt -161.85 29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.1 t -154.76 177.35 11.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.87 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.4 -49.15 67.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -77.39 -28.08 52.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -66.49 -66.5 2.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.429 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.05 -20.78 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.83 -31.4 27.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.29 6.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 297' ' ' LYS . 11.2 m -64.31 -29.58 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -48.02 -28.6 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.39 -70.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -73.05 -50.01 25.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.789 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER 64.13 140.96 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.038 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.88 -2.23 10.78 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.689 2.26 . . . . 0.0 112.601 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 299' ' ' LEU . 2.8 mm? 61.78 46.51 6.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.96 83.87 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -166.98 133.59 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 9.0 p -178.63 99.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.969 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.76 54.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 146.17 40.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -60.23 -37.37 80.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.1 m -79.54 -27.04 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.962 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.71 -40.93 69.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.76 -32.28 65.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.96 -37.64 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.649 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -74.34 -30.32 61.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.49 -29.79 1.23 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.388 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.48 -29.49 50.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.215 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 30.93 4.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.97 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.4 172.83 8.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -88.04 -76.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.78 2.32 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -81.32 -58.83 2.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.0 mt -50.76 -28.14 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.409 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.15 75.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.56 -45.65 18.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -37.91 88.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -27.5 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.158 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -55.26 -46.86 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.27 -31.73 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.71 66.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.86 -32.19 67.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -111.15 36.36 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -135.04 -175.4 13.83 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -120.42 -176.63 3.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.98 116.01 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.436 ' CE ' ' CE1' ' A' ' 64' ' ' HIS . 7.2 ptp 43.84 52.94 9.67 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.516 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.7 97.66 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.553 2.169 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -134.5 -70.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 169' ' ' PHE . 8.4 mt 63.72 139.11 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.73 -26.48 17.56 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.542 2.161 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.87 -27.23 63.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.4 tpt -57.57 -27.95 63.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.96 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.45 77.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.153 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -59.97 -25.64 65.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.03 -38.7 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.049 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.96 -44.27 22.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.73 96.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.0 -30.37 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.407 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.1 t -49.61 -27.58 4.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.364 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.42 -52.22 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.137 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.54 -55.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.987 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 344' ' ' ARG . 9.0 tp -53.48 -38.74 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -28.35 35.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.07 -39.05 68.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.261 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.23 -14.28 44.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.5 p -67.69 -56.32 9.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.768 0.318 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -134.1 -70.8 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -173.44 39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -88.46 99.07 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 11.1 t -103.31 -167.05 1.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.38 -27.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.376 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -46.79 -56.12 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.506 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -80.34 -41.17 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.613 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.469 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -54.95 -53.09 60.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.258 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -64.67 -56.87 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.477 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -41.38 84.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.471 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -76.51 -47.71 21.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.716 0.293 . . . . 0.0 111.131 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -66.79 -47.4 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.31 -37.62 56.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.285 . . . . 0.0 111.296 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.1 t -80.68 -29.5 36.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.917 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -73.81 -41.85 61.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.34 -47.24 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.087 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 1.3 t -159.9 -52.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.7 tttm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 tptt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.5 p -105.54 110.91 23.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.7 118.82 29.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -158.88 88.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.89 -72.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 172.77 13.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -111.04 160.01 17.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.8 t -118.62 102.91 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.7 pt -105.03 114.95 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.189 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CD1' ' CD2' ' A' ' 43' ' ' LEU . 47.1 t90 -94.94 111.9 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 tt -164.88 158.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.64 -171.28 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 51.53 0.78 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.394 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.11 -26.74 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.603 0.24 . . . . 0.0 111.135 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -43.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.279 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 42.19 2.91 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.851 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 40.7 p90 -81.12 -46.64 14.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 40.4 m-20 -76.62 -37.46 56.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -39.03 89.73 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.46 -28.95 52.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.288 . . . . 0.0 110.986 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.46 -49.2 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.133 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.02 -50.54 73.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.426 HG22 ' CZ ' ' A' ' 27' ' ' PHE . 11.9 p -58.55 -30.89 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.72 -34.03 64.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -77.14 -28.28 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -29.7 70.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.426 ' CZ ' HG22 ' A' ' 23' ' ' VAL . 37.6 m-85 -74.39 -56.77 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -60.84 -27.42 68.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.269 0.557 . . . . 0.0 110.417 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.22 -29.21 1.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.863 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.502 ' O ' ' CG2' ' A' ' 31' ' ' THR . 4.8 m-20 -66.33 -57.37 7.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.77 37.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.722 0.639 . . . . 0.0 112.037 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 47.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.67 0 C-N-CA 118.131 -1.985 . . . . 0.0 115.358 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -140.36 95.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 118.077 0.938 . . . . 0.0 111.63 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.37 129.77 52.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.77 130.47 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.1 p -105.71 121.59 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.34 118.2 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.08 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -109.76 159.92 16.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.53 166.43 23.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 122.02 9.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.25 -75.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 0.09 27.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.51 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -55.06 -30.54 59.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 111.06 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -33.5 76.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.93 -29.21 15.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -69.93 -25.46 63.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.424 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.48 -60.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.6 Cg_endo -63.85 -15.42 48.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.642 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -38.4 22.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.0 p -92.25 -18.31 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.267 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -37.12 65.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.31 -37.71 32.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -164.31 -71.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.94 -74.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.537 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -165.02 -57.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.95 -63.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.2 159.15 27.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.602 2.201 . . . . 0.0 112.276 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.52 67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 34.4 mt -107.0 113.68 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.58 142.68 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.406 ' CE1' ' HB1' ' A' ' 264' ' ' ALA . 12.1 m-85 -108.64 123.58 49.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.44 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -163.18 174.01 12.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.721 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.52 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.7 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -77.24 -51.22 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -48.06 -28.14 2.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.624 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.44 ' HG2' ' CE3' ' A' ' 62' ' ' TRP . 4.8 tpp180 -64.75 -36.54 84.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 263' ' ' SER . 34.0 m-85 -110.46 -59.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.32 -23.62 19.15 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.17 -50.41 2.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.41 -40.35 73.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.995 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.7 -26.64 57.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.31 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -54.84 -28.59 50.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -70.62 -26.76 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.91 64.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mt -149.81 40.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.53 146.05 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 131.49 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -58.02 160.94 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.9 mt -114.77 158.79 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.6 97.83 51.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.848 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.67 161.35 24.76 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.411 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 2.0 m-20 -97.79 -177.94 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -97.52 -51.4 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.13 -25.32 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.343 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 82' ' ' ASP . 34.2 m-85 -79.29 -59.04 2.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.22 -24.78 68.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.99 -38.17 90.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.96 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.63 39.57 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.78 153.35 41.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -76.76 134.26 69.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.419 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 51.2 Cg_exo -54.25 -22.89 27.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.414 2.076 . . . . 0.0 112.376 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -57.45 -40.71 79.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.433 ' CG2' ' CD1' ' A' ' 94' ' ' TRP . 12.5 t -58.98 -29.7 67.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.433 ' CD1' ' CG2' ' A' ' 93' ' ' THR . 11.4 m0 -77.98 -56.67 4.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.91 -25.2 60.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.059 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.0 76.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.149 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.7 m -150.76 70.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.199 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 109.65 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -101.12 104.53 15.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 68.57 -67.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.006 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.01 33.01 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -136.23 140.37 43.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 tp -108.59 89.47 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 34.9 pt -102.4 41.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.041 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.49 155.71 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -134.63 100.69 12.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.174 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.436 ' CB ' ' CG2' ' A' ' 261' ' ' VAL . 5.6 Cg_endo -85.41 142.32 8.28 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.074 2.516 . . . . 0.0 111.504 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 109' ' ' ALA . 15.9 mt -155.88 39.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 108' ' ' ILE . . . 160.6 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.267 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 261' ' ' VAL . 11.0 p -118.09 104.08 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.061 0.458 . . . . 0.0 110.841 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -158.49 132.23 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.775 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 113' ' ' LEU . . . -165.1 105.52 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.437 ' CB ' ' O ' ' A' ' 112' ' ' ALA . 4.2 mt 158.2 106.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.305 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 m -164.98 123.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.876 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 tp -101.2 116.04 31.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.126 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.6 mt -74.71 133.16 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.553 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.417 ' CE2' HG22 ' A' ' 245' ' ' THR . 50.5 p90 -152.87 124.14 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.674 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -150.81 -179.56 7.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt 59.53 24.07 12.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.075 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.43 27.83 4.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 39.73 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.841 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.01 114.65 1.97 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.43 160.43 49.53 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.42 2.08 . . . . 0.0 112.224 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -64.95 154.04 87.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.09 108.98 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.62 2.214 . . . . 0.0 112.41 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.51 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.51 2.14 . . . . 0.0 112.344 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -101.34 14.77 30.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.3 m -160.22 141.15 12.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.422 ' CG ' HD13 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.69 -29.15 64.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.01 -23.71 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.89 -21.63 60.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.684 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 4.3 mt -73.38 -54.34 4.18 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.6 Cg_exo -52.92 -30.92 50.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.227 1.951 . . . . 0.0 112.332 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.07 -37.12 71.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.15 -30.08 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.02 -34.9 72.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -59.27 -37.94 78.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.76 -42.02 20.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.66 -50.98 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -25.95 64.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.84 -22.32 35.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.359 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -109.23 -53.51 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.941 0.401 . . . . 0.0 110.749 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.94 40.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.525 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 172.22 18.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 m -122.68 177.53 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.938 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 223' ' ' ALA . . . -118.56 30.79 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.037 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp 170.4 138.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.755 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.409 ' CB ' ' CB ' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -164.69 139.19 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.016 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -171.93 176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.56 155.31 12.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.49 -48.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -98.82 39.77 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.714 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.11 148.38 54.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.786 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' HG2' ' CE2' ' A' ' 155' ' ' TYR . 98.8 Cg_endo -79.87 161.98 23.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.624 2.216 . . . . 0.0 112.503 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' A' ' 154' ' ' PRO . 14.0 m-85 77.85 -2.13 2.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -121.04 -69.82 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.357 . . . . 0.0 110.836 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -29.59 60.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -64.31 -55.98 26.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 46.2 Cg_endo -68.82 -22.3 36.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.519 2.146 . . . . 0.0 112.673 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.65 -53.76 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.3 pp -83.61 0.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.329 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -92.53 -68.15 0.81 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.404 ' HB1' ' CZ ' ' A' ' 250' ' ' PHE . . . 63.64 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.73 -29.45 69.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 69.67 1.38 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.499 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 94.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -173.41 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.63 8.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.187 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CD1' ' HG3' ' A' ' 336' ' ' MET . 0.2 OUTLIER -153.71 117.14 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.97 134.81 45.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -106.97 120.23 41.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -127.68 127.93 44.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.41 32.87 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.32 30.3 77.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -126.94 125.72 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -82.64 157.92 23.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.83 116.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.424 ' N ' ' CD1' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -138.79 19.53 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.354 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.86 30.26 11.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.86 92.98 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.4 m -148.33 124.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 173.65 48.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.1 p 43.55 38.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.952 0.406 . . . . 0.0 111.601 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -98.65 37.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -126.31 143.43 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.72 -28.43 67.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -58.87 -45.17 95.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.95 -35.29 59.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.089 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -63.41 -49.42 73.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.09 80.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.45 80.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.22 -41.7 96.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.925 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.6 t -77.46 -37.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.005 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -53.35 56.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.036 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.45 -53.07 62.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.2 m -64.01 -28.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.456 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.18 -56.89 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.298 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.41 -37.35 75.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.34 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.67 -31.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 111.266 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -78.8 -26.12 44.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.204 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.39 23.1 14.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -76.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.936 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.03 -4.09 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.438 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.8 ptp 44.65 47.4 8.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.985 0.421 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -56.82 109.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.018 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.97 67.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -164.91 94.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 t -98.48 129.59 45.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.773 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.8 -162.14 0.79 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.417 ' O ' ' HB3' ' A' ' 214' ' ' GLU . 2.3 t80 -79.13 -46.78 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 214' ' ' GLU . 1.7 t -63.86 -24.68 67.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.1 mt -82.71 -57.28 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.539 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.97 68.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.012 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 210' ' ' TYR . 0.0 OUTLIER -51.25 -31.47 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 111.337 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.23 57.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.83 -52.92 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.833 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 226' ' ' ILE . 53.2 t80 -76.43 -58.67 3.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.793 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 214' ' ' GLU . 14.5 t-20 -47.48 -31.84 4.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.557 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -105.35 -23.7 12.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 52.87 43.42 60.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.25 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -110.48 39.26 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.585 0.231 . . . . 0.0 111.516 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 17.6 p -131.59 -177.91 4.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -88.43 38.48 0.87 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.376 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.5 ttt 176.45 128.44 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.933 0.397 . . . . 0.0 111.513 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.71 105.04 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.484 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.404 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 2.4 tt -76.97 142.21 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.91 129.75 34.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -109.68 -144.48 10.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.396 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.1 -179.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.456 2.104 . . . . 0.0 112.315 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -98.37 34.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.37 -30.71 17.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 59.96 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.7 t -89.9 -63.66 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.31 65.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 27.5 mt 61.43 155.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.49 -48.38 79.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 p 56.8 174.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 23.3 t 62.12 150.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -72.85 -46.07 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.1 p -163.01 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -167.65 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.75 115.96 10.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.37 132.81 11.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.561 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.76 106.37 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 117' ' ' TYR . 0.8 OUTLIER -123.47 158.95 30.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.46 149.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 156.17 37.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.79 -158.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.925 2.417 . . . . 0.0 112.209 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.3 p -127.13 177.28 6.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CZ ' ' HB1' ' A' ' 163' ' ' ALA . 49.9 p90 -167.26 118.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.77 12.21 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.85 16.03 60.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -152.91 92.75 3.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.643 0.258 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.22 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.484 2.123 . . . . 0.0 112.217 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.4 m -49.7 175.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 111.208 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 2.5 mtpm? -86.28 134.59 38.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.3 Cg_exo -79.55 111.79 2.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.65 2.234 . . . . 0.0 112.213 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -132.33 103.35 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 30.2 m -101.51 153.06 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -130.4 117.62 2.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 110' ' ' VAL . 9.3 p -86.37 145.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.307 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.77 107.78 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.076 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 4.1 m -91.79 117.49 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.82 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.406 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -135.93 108.74 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -151.15 -143.41 3.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.567 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.42 ' N ' ' CD1' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -137.24 146.48 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 111.144 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -127.63 118.82 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.44 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 179.93 36.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 55.42 54.09 9.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 270' ' ' SER . 50.1 Cg_endo -69.07 -46.77 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.66 2.24 . . . . 0.0 112.299 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.8 65.06 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.81 -45.59 93.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.18 -33.39 72.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.957 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.82 -55.78 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.47 -52.58 63.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -29.43 68.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.85 -56.6 19.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.36 -29.7 62.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -33.53 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.084 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.31 -31.88 8.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.219 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -97.25 27.45 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 -43.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.98 42.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.1 38.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.0 p -136.03 153.75 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -38.14 65.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -57.26 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.1 -57.46 15.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.939 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 293' ' ' VAL . 2.8 tt -45.98 -40.71 10.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.332 . . . . 0.0 111.511 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 -57.91 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.411 . . . . 0.0 110.812 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -49.06 -24.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.223 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.441 HG22 ' N ' ' A' ' 294' ' ' ASN . 34.4 m -80.86 -29.51 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.349 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.441 ' N ' HG22 ' A' ' 293' ' ' VAL . 6.3 m120 -100.72 -85.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.389 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -120.39 14.61 12.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.7 t0 59.95 27.97 17.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.75 160.26 2.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.17 155.46 6.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.512 ' N ' ' CD1' ' A' ' 299' ' ' LEU . 0.0 OUTLIER -164.46 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.66 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.413 ' N ' ' CD2' ' A' ' 299' ' ' LEU . . . 170.19 140.57 3.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.474 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 172.88 156.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.6 m -160.28 40.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -129.34 40.11 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.068 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 116.38 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -41.62 90.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 p -68.5 -31.52 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -74.71 -27.28 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.27 -36.45 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.0 -56.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 2.0 tt -55.58 -22.42 21.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.317 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -47.31 -29.17 2.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.541 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -29.6 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.96 109.83 2.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.927 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.89 -11.63 18.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.103 . . . . 0.0 112.736 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -66.04 -59.33 3.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.4 mp -80.13 -34.67 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.41 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.264 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -56.78 -49.0 76.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.4 p -67.9 -26.51 66.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -26.9 28.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.239 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -66.57 -57.43 7.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.987 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -76.47 -34.19 58.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.967 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.85 59.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.11 -30.87 66.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 -30.19 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.062 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -90.07 -148.01 18.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.64 -178.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 12.0 tt -104.55 114.96 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.51 147.09 0.77 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 -167.68 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.502 2.135 . . . . 0.0 112.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 30.29 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.95 90.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -51.94 -36.88 65.89 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.575 2.183 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.57 -36.74 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.4 ' HG3' ' CD1' ' A' ' 169' ' ' PHE . 19.8 mmt -61.81 -22.08 65.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 t -52.06 -27.31 13.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.0 -33.45 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.149 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -29.12 66.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 45.2 t90 -47.98 -28.83 2.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.92 -42.95 90.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -79.93 -30.45 39.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.5 t -53.9 -29.72 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.642 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 348' ' ' ILE . 0.2 OUTLIER -52.55 -46.73 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.186 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 349' ' ' ASN . 14.8 t -50.0 -30.57 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.079 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.18 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.754 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 34.8 m -79.83 -49.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 344' ' ' ARG . 1.5 tt -49.99 -42.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.698 0.285 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.3 m120 -60.86 -33.23 72.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.17 65.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.39 -10.57 59.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.534 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 54.2 m -67.62 -29.05 68.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.035 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.01 -12.33 65.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -129.66 39.59 3.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -123.73 127.1 47.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.786 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 18.2 p -110.07 141.26 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.2 t -57.79 -27.91 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -37.75 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -80.24 -52.76 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' A' ' 364' ' ' ALA . . . -53.88 -33.21 55.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.107 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -49.38 10.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -64.63 -55.48 19.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 364' ' ' ALA . 1.3 p-10 -59.64 -29.68 68.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.689 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.411 ' N ' ' OD1' ' A' ' 363' ' ' ASP . . . -64.79 -55.49 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -30.74 60.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.0 p -80.06 -30.08 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.935 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -47.11 41.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.31 -35.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.3 p -99.0 30.7 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.821 0.343 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.11 93.1 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.16 119.29 38.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 63.78 -79.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.32 51.97 3.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -134.48 130.44 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.85 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.4 mp -125.75 157.29 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 16.7 t -134.18 104.15 5.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.307 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ILE . 3.7 mp -99.88 124.18 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.346 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.418 ' CE3' HG22 ' A' ' 60' ' ' ILE . 9.8 t90 -107.07 117.72 34.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.514 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 155.96 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.232 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -143.82 110.73 5.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.65 57.37 0.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -140.36 -50.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 tttt 59.4 31.53 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.66 36.52 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.525 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -60.13 -35.62 75.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.52 -51.15 38.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.13 54.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.97 -56.47 21.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.826 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.85 69.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -31.85 70.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.951 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -75.35 -38.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -25.32 75.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.54 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -57.26 -41.89 80.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -74.61 -47.67 30.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' ' CG2' ' A' ' 33' ' ' ILE . 1.5 m-85 -62.32 -56.24 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.489 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -51.85 -28.25 15.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.434 0.635 . . . . 0.0 110.683 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -25.69 49.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.61 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.65 ' O ' ' OG1' ' A' ' 31' ' ' THR . 14.5 t0 -51.58 -56.73 11.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.65 ' OG1' ' O ' ' A' ' 30' ' ' ASP . 6.9 m 156.97 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.761 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.76 45.91 0.01 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 117.58 -2.248 . . . . 0.0 115.898 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' HB ' ' N ' ' A' ' 28' ' ' GLU . 4.0 mm -131.45 95.79 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 118.425 1.113 . . . . 0.0 111.541 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -111.07 128.49 55.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.85 138.7 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.9 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.28 115.2 27.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 p -86.3 116.27 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.808 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -104.27 143.32 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 111.277 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -112.42 158.47 37.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.564 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.67 -83.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.358 2.039 . . . . 0.0 112.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 49.98 -92.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -120.34 -2.99 9.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mp -53.26 -25.79 15.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.687 0.28 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -55.15 -38.84 68.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.36 -23.3 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.067 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -29.53 60.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.164 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 64.5 t80 -55.74 -56.58 28.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.273 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.3 Cg_endo -64.01 -15.27 48.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.556 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.65 -55.3 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.1 m -73.08 -28.87 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.04 -28.07 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -26.23 62.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.336 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.6 m -148.4 124.08 10.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.9 -54.25 2.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.343 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.98 -55.04 0.5 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.38 -107.01 0.35 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.575 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.466 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 87.3 Cg_exo -48.3 150.17 5.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.631 2.22 . . . . 0.0 112.259 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -153.89 38.53 0.46 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' ILE . 13.1 mt -152.73 118.47 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 110.533 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.418 HG22 ' CE3' ' A' ' 10' ' ' TRP . 12.7 mt -151.15 142.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 111.694 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.463 ' CE2' ' CB ' ' A' ' 264' ' ' ALA . 2.1 m-85 -128.38 120.47 27.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.89 92.48 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.741 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 42.59 -165.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.054 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -76.94 -29.53 55.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -47.78 -35.16 9.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.527 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -36.86 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CZ ' ' HB1' ' A' ' 105' ' ' ALA . 13.5 t80 -77.56 -64.03 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.2 -10.21 61.97 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.054 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.39 -61.11 1.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -96.57 -48.23 5.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.691 0.282 . . . . 0.0 111.088 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.01 -29.69 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.251 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -64.11 -31.62 72.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -26.8 25.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.77 70.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.59 39.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.2 tt -148.79 118.48 7.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.41 156.09 28.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.038 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -93.4 156.85 16.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.9 pt -147.12 163.86 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -110.49 86.13 5.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.8 -168.35 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.531 2.154 . . . . 0.0 112.362 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.438 ' HA ' ' CB ' ' A' ' 86' ' ' GLN . 21.8 m-20 64.01 131.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -120.26 -100.89 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.71 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.4 -59.18 2.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 86' ' ' GLN . 50.9 p90 -80.91 -53.13 6.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.446 ' N ' ' CD2' ' A' ' 85' ' ' PHE . 2.5 mt-30 -52.76 -23.07 6.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.997 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.536 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 1.8 p-10 -45.5 -30.86 1.55 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.39 -65.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.821 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 pp 42.69 -168.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.607 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.24 112.83 13.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.83 -26.12 29.66 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.384 2.056 . . . . 0.0 112.354 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.29 -31.9 70.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -75.35 -31.02 60.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.4 m0 -70.17 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.81 -26.43 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.213 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.01 67.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.102 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -152.46 68.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.48 155.57 42.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.31 168.6 13.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -71.71 65.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.3 28.47 13.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 163.98 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 mt -145.33 75.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' A' ' 67' ' ' PHE . 2.3 pt -108.22 39.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -170.89 132.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.14 102.19 2.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.22 167.34 21.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.743 2.295 . . . . 0.0 111.925 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.99 39.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -176.85 157.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.27 106.16 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -126.94 159.65 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.25 159.43 20.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -79.72 161.43 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.15 -176.03 3.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.09 108.68 19.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 242' ' ' TYR . 9.1 tt -87.99 149.31 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.42 163.53 30.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -102.53 -178.04 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.7 81.25 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -163.06 -63.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -123.71 40.03 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.0 tt -144.65 115.82 5.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.12 158.0 59.02 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.425 2.083 . . . . 0.0 112.197 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -65.02 111.25 5.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.51 154.76 24.29 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.51 2.14 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.54 -167.52 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.526 2.151 . . . . 0.0 112.238 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 p -76.99 140.52 40.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.01 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.493 ' CD2' ' CE2' ' A' ' 250' ' ' PHE . 3.1 m95 -71.71 -37.34 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.58 -23.82 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.643 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.04 -16.26 41.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.523 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 37.0 mt -65.61 -48.77 64.2 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 84.9 Cg_exo -46.4 -35.78 16.66 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.419 2.079 . . . . 0.0 112.465 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.07 93.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.51 -31.66 53.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -71.83 -31.84 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.32 -45.27 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.44 -48.83 30.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -59.22 -25.64 64.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.021 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.76 33.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.387 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -109.03 -63.39 1.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.82 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.9 39.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.327 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -153.88 166.29 33.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 m -119.15 162.81 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 147' ' ' LEU . . . -93.0 -2.15 56.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.597 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 146' ' ' ALA . 1.9 pt? 172.61 126.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.716 0.293 . . . . 0.0 110.477 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.23 120.74 8.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.587 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.38 123.85 48.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.077 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 156' ' ' PHE . 1.4 p-10 -85.04 154.25 22.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.8 mt -128.37 -46.27 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.37 39.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 3.2 mt-10 -120.18 137.03 25.5 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 4.4 Cg_exo -79.63 179.24 6.49 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.726 2.284 . . . . 0.0 112.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' A' ' 258' ' ' PHE . 3.6 m-85 59.8 20.11 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CZ ' ' OD1' ' A' ' 150' ' ' ASN . 19.3 m-85 -120.84 -33.0 3.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.166 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -77.23 -24.28 51.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.482 ' CB ' ' HD3' ' A' ' 159' ' ' PRO . 0.0 OUTLIER -69.42 -55.31 9.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.482 ' HD3' ' CB ' ' A' ' 158' ' ' TRP . 21.6 Cg_exo -65.35 -32.84 49.79 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.48 2.12 . . . . 0.0 112.23 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 250' ' ' PHE . 0.5 OUTLIER -70.1 -52.64 22.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.237 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 47.0 mt -77.06 -5.1 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.821 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 164' ' ' ASP . . . -83.91 -63.96 1.25 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.34 -87.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ALA . 2.0 t0 -115.89 -39.57 3.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.67 -91.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.13 -47.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 60.76 42.23 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.87 -63.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 17.5 p90 -155.32 172.93 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.14 125.85 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 328' ' ' GLU . 45.9 p90 -133.53 123.64 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -137.06 102.13 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 t30 56.2 29.08 14.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -157.28 -85.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.56 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -173.25 174.49 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 15.2 p90 -59.75 134.06 56.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 164.69 23.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 4.3 tt -119.93 -41.85 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.36 -37.43 32.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.944 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -94.94 97.62 10.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.0 151.42 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -112.0 39.87 2.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.387 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.27 -24.68 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -144.23 65.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.64 -174.89 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.2 -30.0 51.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.13 93.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.181 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -67.04 -33.64 75.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.48 -46.32 80.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.77 -28.34 67.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.99 -31.82 61.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 p -75.25 -30.78 60.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.66 -41.98 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.54 -37.84 82.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 31.4 m -76.05 -30.26 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.78 -41.33 68.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.23 -50.15 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 17.1 tt -59.47 -30.85 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -62.23 -26.78 68.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -97.53 -23.73 15.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.071 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -88.88 -66.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -35.2 73.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 mtt -101.54 72.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -179.15 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.46 -45.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.07 95.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.9 t -63.36 137.56 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -86.78 -166.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.017 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 211' ' ' SER . 48.8 p90 -79.0 -40.36 31.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.172 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.412 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 0.3 OUTLIER -79.53 -24.67 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.356 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 12.7 mt -81.56 -57.29 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.42 68.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.3 -42.62 20.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -31.37 65.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.422 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.43 -52.23 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -68.65 -28.36 66.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.626 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -69.29 -50.85 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -107.05 -23.76 12.2 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 99.97 67.7 0.85 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.749 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.08 38.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.9 p -152.16 179.99 8.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -85.82 38.85 0.77 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.39 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.63 159.19 0.24 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.024 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.52 105.14 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.827 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.4 mt -80.82 136.15 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.418 ' HB3' ' CH2' ' A' ' 232' ' ' TRP . 60.7 m-20 -115.24 163.77 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -163.62 163.02 35.46 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.84 -28.28 25.04 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.576 2.184 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -75.65 -34.85 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.88 62.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.418 ' CH2' ' HB3' ' A' ' 227' ' ' ASN . 0.0 OUTLIER -154.0 104.6 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.8 p -167.58 -56.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.36 -60.88 3.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.6 mt 64.16 136.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -126.87 160.81 29.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.7 p -68.38 169.48 10.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 54.0 p -145.13 162.74 36.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.61 -40.94 3.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.1 148.75 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -80.26 140.15 36.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -137.84 166.6 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -145.1 144.22 12.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 23.6 m -93.4 136.47 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 61.6 m -141.01 150.13 42.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.3 150.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 0.0 OUTLIER -126.25 97.45 34.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.54 51.89 4.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.924 2.416 . . . . 0.0 112.691 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.12 114.41 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.493 ' CE2' ' CD2' ' A' ' 129' ' ' TRP . 0.9 OUTLIER -155.09 111.69 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.763 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.7 mptt 58.11 19.97 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.261 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 116.06 -34.79 4.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.889 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -132.37 152.13 79.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.295 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.04 132.4 12.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.73 2.287 . . . . 0.0 112.485 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 67.5 m -54.42 178.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.39 83.43 46.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.59 162.89 24.44 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.962 2.441 . . . . 0.0 112.151 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 5.1 m-85 -88.36 144.32 26.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.83 154.51 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.08 110.51 1.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.442 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 18.4 m -108.33 144.65 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.8 mt -69.76 90.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.597 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.2 m -79.59 120.84 24.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.463 ' CB ' ' CE2' ' A' ' 61' ' ' PHE . . . -83.54 123.89 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.112 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -102.75 106.13 2.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 14.7 tt -95.73 141.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 0.0 111.074 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -83.59 138.39 33.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -78.94 -30.84 44.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.6 52.53 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.8 p -115.86 149.24 42.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 125.64 12.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.599 2.199 . . . . 0.0 112.318 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.88 88.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -75.08 -33.89 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.52 -30.89 67.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.64 -32.96 60.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.78 69.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -65.23 -58.99 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.92 -32.09 70.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -51.35 69.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -31.28 64.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -71.79 -30.26 65.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.56 27.48 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -132.89 -69.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.98 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.33 -52.14 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.11 67.88 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.5 t -146.4 168.0 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.775 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.66 -45.66 66.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.47 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -71.87 -57.4 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -56.54 -57.19 20.66 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.803 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -36.72 68.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 111.123 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -78.66 -27.7 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.07 -57.8 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.189 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.03 -29.9 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.371 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -64.72 -60.42 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -82.01 -47.44 12.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.398 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.52 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.259 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -159.93 89.77 1.86 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.011 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -173.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.188 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.6 pp -178.84 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 164.34 121.89 0.58 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 179.25 157.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 p -178.28 56.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -97.33 40.34 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.26 167.74 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -113.33 -36.66 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.2 m -79.37 -52.46 8.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -67.48 -24.64 65.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -53.59 -29.9 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -69.17 -31.14 69.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -92.92 -38.16 11.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.97 -28.17 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.74 56.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -57.24 -29.51 63.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.85 143.27 97.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.69 -37.27 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -59.02 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 8.9 tp -67.54 -29.93 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -67.39 -36.29 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.29 -33.79 43.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.2 m -76.85 -40.86 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -58.17 -25.82 61.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.64 -57.62 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -78.47 -30.58 47.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.3 -42.21 90.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.27 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -29.05 64.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 6.0 mttp -97.44 -30.72 12.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.921 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.0 -165.02 30.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -160.57 165.78 30.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 110.915 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.21 130.77 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.407 ' HE1' ' CE1' ' A' ' 258' ' ' PHE . 0.5 OUTLIER -96.82 101.76 10.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.82 -10.91 30.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.478 2.119 . . . . 0.0 112.541 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 65.87 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.878 0.371 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.3 tt -79.48 127.6 77.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.67 -34.59 54.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.344 2.029 . . . . 0.0 112.429 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -57.79 -30.4 65.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.7 p -54.73 -30.87 57.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.76 -30.95 45.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -77.93 -26.49 48.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.21 -43.68 78.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.98 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -28.94 43.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.39 -51.29 58.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.333 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 12.8 p -54.61 -29.89 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.349 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -60.9 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 4.5 p -60.54 -29.94 69.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.6 -50.52 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 37.4 t -79.54 -53.36 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.789 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 69.3 mt -51.68 -39.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.901 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 350' ' ' ALA . 35.8 p30 -51.45 -25.8 7.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 111.41 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . 0.44 ' N ' ' OD1' ' A' ' 349' ' ' ASN . . . -62.14 -33.61 74.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.36 -11.57 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.484 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.5 p -67.67 -30.23 69.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.64 -14.24 64.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.73 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -130.38 39.86 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.17 132.87 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 68.5 p -115.7 142.22 47.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 31.0 m -58.62 -27.94 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.243 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.37 -38.24 65.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -51.08 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.76 -29.9 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -82.18 -56.39 3.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -63.62 -53.18 55.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -55.93 -47.88 76.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.47 -53.21 55.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -56.97 -30.53 64.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 8.7 p -80.68 -40.24 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.3 mtp-105 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.5 mt -75.72 -47.21 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.247 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 92.8 m -103.65 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.956 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 17.7 tptm . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.877 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.729 0.299 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.31 43.71 97.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.82 139.74 40.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 57' ' ' PRO . 85.5 mt -138.21 154.77 49.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' HG2' ' A' ' 57' ' ' PRO . 5.4 m -125.61 102.82 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HA ' HG23 ' A' ' 59' ' ' ILE . 3.8 mp -96.43 118.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.436 ' CE2' HD13 ' A' ' 43' ' ' LEU . 93.8 m95 -94.98 112.05 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -145.24 145.56 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.068 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -163.75 112.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.66 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -176.92 -48.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -153.17 -175.15 5.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 124.97 -34.89 3.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.489 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 8.5 p90 -62.36 -34.65 77.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 21.4 t-20 -68.07 -36.89 80.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.57 -39.03 30.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.5 mm? -68.28 -31.32 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.942 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.35 94.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.44 -34.33 73.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.67 -31.0 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.13 -46.72 9.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -29.7 59.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.776 0.322 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -37.74 37.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.26 -56.5 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.588 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.685 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -53.58 -27.7 27.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 110.245 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -46.4 -32.49 3.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.809 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 31' ' ' THR . 24.7 t0 -62.97 -57.41 10.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.61 37.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.653 0.596 . . . . 0.0 112.248 176.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.87 43.37 0.02 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 117.909 -2.091 . . . . 0.0 115.537 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 27' ' ' PHE . 3.2 mp -140.38 95.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 118.039 0.919 . . . . 0.0 111.857 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.17 131.8 54.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.07 148.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.76 137.13 50.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.55 111.51 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.75 163.05 31.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -98.72 144.4 28.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 136.04 23.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.516 2.144 . . . . 0.0 112.326 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.46 -47.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -116.24 0.15 12.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.374 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' CE2' ' A' ' 10' ' ' TRP . 7.2 tp -56.6 -25.41 52.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.746 0.308 . . . . 0.0 111.147 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -55.73 -31.96 62.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.24 -29.6 13.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 50' ' ' VAL . 18.2 tttt -73.95 -24.55 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.15 -58.48 8.65 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 26.5 Cg_endo -61.96 -18.96 64.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.436 2.091 . . . . 0.0 112.455 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -89.75 -35.97 15.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.829 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 46' ' ' LYS . 27.8 t -88.58 -17.83 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.39 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.27 -39.76 64.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.827 0.346 . . . . 0.0 111.271 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.695 ' O ' HG23 ' A' ' 53' ' ' THR . . . -80.55 -40.35 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.66 -74.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.808 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.08 -74.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.18 -71.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.27 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.644 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.3 Cg_endo -64.27 -177.74 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.26 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 167.09 106.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 9' ' ' ILE . 6.8 tt -146.94 117.31 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 43' ' ' LEU . 3.2 mp -121.19 142.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.656 ' HD1' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -96.05 117.13 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.386 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -143.12 173.23 11.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -57.26 -168.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.433 ' CE1' ' CG1' ' A' ' 97' ' ' VAL . 2.6 t-160 -76.1 -56.4 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.04 -28.98 57.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.982 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -58.24 -41.77 84.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -111.88 -55.23 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.62 -29.07 74.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.81 29.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.548 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.63 -45.93 8.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.788 ' HB3' HD12 ' A' ' 76' ' ' LEU . . . -61.5 -31.17 71.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.06 67.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -108.33 25.79 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.07 -75.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -176.77 83.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.952 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -110.25 143.7 40.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.659 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -62.49 83.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 96.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 80' ' ' THR . 40.2 mt -72.07 158.32 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 79' ' ' ILE . 43.6 p -101.2 157.96 32.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 98.1 Cg_endo -79.8 89.64 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.605 2.203 . . . . 0.0 112.397 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.12 -55.2 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -25.29 64.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.25 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.493 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -75.13 -59.18 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.03 61.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.39 -39.86 52.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.02 37.3 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -170.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -98.05 146.53 31.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.97 -32.4 8.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.541 2.161 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -31.73 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -31.3 62.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.54 -41.78 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -30.93 70.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.53 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 22.8 m -122.06 60.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 93.04 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -101.93 113.66 27.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.4 -68.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.54 39.11 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.492 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.6 171.5 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.39 92.03 3.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 ' HB3' ' A' ' 76' ' ' LEU . 1.7 pp -112.97 46.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.51 124.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.741 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -123.96 100.99 36.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.997 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.84 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.0 Cg_endo -79.87 127.72 7.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.199 . . . . 0.0 112.135 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 285' ' ' LEU . 9.3 mm -138.8 39.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 111.252 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.939 ' CB ' HD23 ' A' ' 262' ' ' LEU . . . 176.02 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.779 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.97 105.72 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.918 0.39 . . . . 0.0 111.056 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 132.86 49.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.97 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -152.48 174.32 14.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -99.92 160.73 14.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.65 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 4.2 m -164.07 -179.79 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -111.99 133.67 54.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.71 143.57 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' A' ' 245' ' ' THR . 46.7 p90 -139.1 179.36 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -139.41 177.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.77 34.93 4.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -131.11 -65.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.3 pp -130.04 39.92 3.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.15 88.36 13.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.77 140.23 47.56 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.31 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -70.26 165.89 39.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.72 122.45 10.54 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.528 2.152 . . . . 0.0 112.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.64 -52.15 1.51 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.41 2.073 . . . . 0.0 112.361 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.43 -76.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 249' ' ' THR . 17.6 p -116.42 -173.64 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.036 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.547 ' CE3' HG21 ' A' ' 132' ' ' ILE . 7.6 m95 -70.6 -31.23 68.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 2.4 tt0 -52.95 -24.17 8.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.05 -15.91 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.687 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.733 HG22 ' HD3' ' A' ' 133' ' ' PRO . 5.6 tp -52.75 -35.79 28.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.733 ' HD3' HG22 ' A' ' 132' ' ' ILE . 16.8 Cg_exo -68.2 -27.45 35.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.293 1.995 . . . . 0.0 112.2 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.05 -28.24 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -77.8 -31.86 52.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.08 -51.95 22.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -30.64 68.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.9 mt-10 -79.48 -43.28 23.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 135' ' ' LEU . 3.7 mm? -64.0 -49.93 70.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -26.12 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.9 -23.12 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.383 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -110.63 -60.71 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.49 40.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.566 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.525 ' CB ' HD12 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -150.65 -178.03 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -139.29 175.36 9.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.791 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -135.12 44.96 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.221 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.14 115.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 14.6 mmt -159.14 106.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 156' ' ' PHE . 1.6 t80 -168.97 177.03 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HA ' ' HB1' ' A' ' 213' ' ' ALA . 1.2 m120 -67.83 178.96 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -46.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.62 40.06 1.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.76 149.07 36.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 155.88 23.85 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.666 2.244 . . . . 0.0 112.321 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 60.26 20.36 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 226' ' ' ILE . 0.4 OUTLIER -121.08 -56.35 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.927 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.455 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.1 t -72.35 -32.03 66.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.172 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.546 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 66.1 t90 -64.36 -55.16 32.62 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -62.29 -28.66 79.12 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.264 1.976 . . . . 0.0 112.275 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.522 HD22 HD11 ' A' ' 195' ' ' LEU . 2.0 tp -68.7 -56.96 6.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.801 HD13 HD22 ' A' ' 192' ' ' LEU . 4.9 mt -78.23 -4.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.216 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -79.11 -50.45 11.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.874 0.369 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 254' ' ' PRO . . . -101.44 37.64 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -108.02 -31.21 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.3 -41.68 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . 171.01 164.77 27.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.506 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -176.18 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.23 -35.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -85.23 57.28 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -130.83 160.03 35.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.24 -31.48 72.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.068 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.79 -55.36 25.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . -60.26 -33.32 72.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 193' ' ' THR . 11.2 ttmt -74.26 -46.28 42.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.15 -30.48 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.642 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.02 -60.32 3.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.451 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.801 HD22 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -56.99 -31.57 65.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.818 0.342 . . . . 0.0 110.776 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 189' ' ' LYS . 40.3 p -72.9 -28.72 62.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.7 -50.44 12.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.654 HD12 HD11 ' A' ' 161' ' ' ILE . 8.4 mt -66.94 -28.84 68.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.663 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 192' ' ' LEU . 14.9 p -77.42 -46.59 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 196' ' ' VAL . 10.5 p30 -62.55 -27.19 69.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 111.228 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.427 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 0.2 OUTLIER -57.48 -30.69 65.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.144 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 mt -79.8 -55.2 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -21.02 64.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.404 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.82 15.54 16.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.327 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -120.15 -75.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -120.12 -4.93 10.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.49 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 24.1 ptm 45.53 30.56 0.78 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.366 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.9 OUTLIER -136.5 -43.84 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 205' ' ' ASN . . . 67.52 73.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -113.07 28.25 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.7 OUTLIER -106.18 119.65 39.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.899 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -166.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.401 ' HA ' ' ND2' ' A' ' 150' ' ' ASN . 52.2 p90 -79.1 -40.81 30.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.284 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -79.94 -24.63 40.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.58 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.0 mt -81.82 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -55.71 -30.28 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.36 -30.48 33.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.15 67.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.601 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.39 -56.92 10.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.612 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 20.4 p90 -76.39 -34.6 58.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.451 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 1.8 m-20 -73.66 -8.31 55.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.305 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -23.65 58.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.001 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 221' ' ' GLU . . . -159.33 -85.42 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.385 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 220' ' ' GLY . 0.5 OUTLIER 171.78 101.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.482 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.4 t -116.27 -177.36 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.791 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 39.56 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -162.47 99.68 1.04 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 17.3 m -144.51 105.15 4.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.636 HD13 ' HZ ' ' A' ' 156' ' ' PHE . 4.0 mt -113.51 135.0 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.7 147.57 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -155.07 -157.05 8.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.326 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.6 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.889 0.376 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.19 -173.7 13.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 319' ' ' ALA . 11.4 p -132.04 136.48 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.416 HG23 ' CE1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -130.58 156.18 45.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.1 p -77.42 150.63 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.93 146.72 81.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 95.6 Cg_endo -79.77 152.07 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.681 2.254 . . . . 0.0 112.435 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.79 HG22 ' HD3' ' A' ' 254' ' ' PRO . 45.6 p -63.82 177.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CD1' ' OD1' ' A' ' 164' ' ' ASP . 4.5 t80 -159.88 111.89 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.739 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.2 mttm 59.38 21.24 9.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.51 -47.64 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.59 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.93 151.19 29.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 249' ' ' THR . 59.5 Cg_endo -72.21 -175.63 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.314 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -172.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -118.5 81.25 17.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.69 -168.3 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.631 2.221 . . . . 0.0 112.344 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -171.95 161.13 5.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 328' ' ' GLU . 27.6 m -75.8 146.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -111.53 74.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.524 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 13.3 m -95.83 135.13 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.939 HD23 ' CB ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -86.87 124.25 32.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 t -92.95 112.86 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.758 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.12 49.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 169.1 -173.26 43.55 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 276' ' ' ALA . 26.3 mm -88.53 159.74 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.487 ' N ' HG22 ' A' ' 266' ' ' ILE . 6.4 m120 -98.12 108.02 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.994 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . . . 67.78 10.28 7.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.827 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . . . 45.41 30.3 0.7 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.559 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER -64.2 -61.04 7.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.032 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 270' ' ' SER . 63.4 Cg_endo -73.63 97.85 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.504 2.136 . . . . 0.0 112.468 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 23.9 m-20 59.1 86.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.99 -30.94 61.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -76.43 -57.23 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.96 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.62 -31.4 71.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 266' ' ' ILE . . . -59.22 -56.75 18.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.22 -43.94 80.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.79 -42.27 99.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.07 -31.3 72.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.997 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -81.24 -25.76 36.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -93.8 -32.24 14.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.15 27.53 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.219 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 27' ' ' PHE . 1.4 m-85 -177.31 48.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 110.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 280' ' ' LEU . 1.1 mt -178.25 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 108' ' ' ILE . 4.1 mm? -107.44 65.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.832 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.1 t -150.99 171.85 16.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.739 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.37 -48.2 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -77.55 -35.02 53.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.832 ' H ' HG23 ' A' ' 286' ' ' THR . . . -55.34 -75.76 0.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.791 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 -21.92 29.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.316 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -29.12 5.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.359 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.91 -53.76 7.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.612 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 294' ' ' ASN . 12.3 p -72.41 -46.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.8 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.494 ' N ' HG13 ' A' ' 293' ' ' VAL . 46.6 p-10 -58.29 -21.22 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.326 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -55.25 2.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.97 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -126.62 87.66 55.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.485 ' C ' HD23 ' A' ' 299' ' ' LEU . 57.6 Cg_endo -71.09 163.71 38.28 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.539 2.159 . . . . 0.0 112.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 299' ' ' LEU . 1.3 pt? -175.72 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -160.32 -167.1 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.448 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.723 ' HB3' ' CG2' ' A' ' 317' ' ' ILE . . . -136.51 160.06 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.557 ' CG2' HD23 ' A' ' 304' ' ' LEU . 27.5 m -79.95 -179.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -107.89 40.0 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.557 HD23 ' CG2' ' A' ' 302' ' ' VAL . 3.8 mm? -78.26 126.97 31.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.82 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.11 93.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.4 p -68.78 -52.42 30.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -27.35 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.37 -28.13 51.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.87 -45.68 89.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -93.23 -31.95 14.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.726 ' O ' HD11 ' A' ' 317' ' ' ILE . 4.6 mp -59.88 -28.19 67.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.51 29.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.327 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -58.73 -30.75 67.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.91 140.59 33.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 95.8 Cg_endo -78.95 -17.94 11.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.589 2.193 . . . . 0.0 112.825 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.407 ' CG ' HD13 ' A' ' 317' ' ' ILE . 3.3 ptt180 -51.18 -54.56 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.283 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -80.46 -29.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.357 . . . . 0.0 111.094 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -60.79 -31.77 71.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.65 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -79.13 -39.14 34.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.703 HG22 ' HB3' ' A' ' 112' ' ' ALA . 62.4 p -71.67 -43.39 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 ptm -59.43 -28.81 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -57.38 12.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -78.35 -31.13 48.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.1 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.298 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -50.27 65.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.147 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -47.62 11.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 159.91 136.72 2.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -173.31 89.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 329' ' ' ILE . 1.0 OUTLIER -133.64 118.49 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.02 120.31 53.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.42 -168.23 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.397 2.065 . . . . 0.0 112.289 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -98.45 -65.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 333' ' ' ILE . 4.5 tp 34.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.955 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.1 -25.24 31.82 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.471 2.114 . . . . 0.0 112.392 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -25.85 59.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -28.56 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 m -56.94 -47.6 80.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -33.88 63.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.041 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -61.4 -27.0 68.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -32.48 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.94 -31.46 45.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.82 -40.71 39.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.4 t -59.4 -30.1 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.5 ' HB3' HD12 ' A' ' 348' ' ' ILE . 10.5 mmt180 -74.97 -60.64 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 50.3 m -58.8 -27.78 65.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.49 -52.28 11.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.406 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.7 t -79.19 -54.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.691 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 344' ' ' ARG . 62.1 mt -49.43 -58.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.56 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -57.22 -50.66 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.78 59.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.31 -10.69 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.434 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 51.6 p -67.69 -30.22 69.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 112.54 -25.34 12.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -112.83 39.85 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -149.61 145.67 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 t -124.15 148.95 46.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.01 -28.2 43.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.37 -30.4 60.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 -54.75 5.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -62.74 -30.06 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -56.6 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -60.74 -52.27 65.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -58.65 -34.88 71.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -69.98 -33.91 72.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.163 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -31.58 69.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 27.0 m -80.7 -38.18 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 -43.43 59.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 364' ' ' ALA . 1.0 OUTLIER -59.47 -35.42 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.4 m -80.34 -54.37 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.52 86.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' C ' HD12 ' A' ' 7' ' ' LEU . 14.3 tttt -167.96 138.29 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 6' ' ' LYS . 4.9 mp -147.86 159.57 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.53 103.44 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 mp -100.04 119.53 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -103.29 126.37 50.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.4 HG12 ' N ' ' A' ' 12' ' ' ASN . 18.7 tt -172.11 158.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 39' ' ' HIS . 9.9 t30 -176.53 -169.88 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.92 -31.63 3.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.31 -51.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -178.28 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.16 24.26 28.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.699 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.97 -58.08 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -60.16 -40.9 91.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -51.27 60.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.578 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -31.17 54.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.13 -38.0 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -52.71 64.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 24' ' ' GLY . 28.1 m -61.68 -43.77 97.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.185 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.93 -36.34 92.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -59.45 -44.47 92.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -79.2 -30.06 43.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.966 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.877 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -60.66 -56.55 19.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -56.32 -27.89 57.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.536 0.684 . . . . 0.0 110.4 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -33.4 14.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.499 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' ' HB ' ' A' ' 31' ' ' THR . 5.0 t70 -59.73 -57.4 13.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.65 36.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.872 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.61 44.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 117.958 -2.068 . . . . 0.0 115.47 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 27' ' ' PHE . 2.3 mp -139.69 95.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 117.998 0.899 . . . . 0.0 111.608 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -126.4 114.8 18.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 9' ' ' ILE . 3.5 m -110.94 134.62 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 146.2 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.27 123.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.072 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -155.46 163.16 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 12' ' ' ASN . 14.2 t-80 -152.8 79.42 5.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' HD23 ' A' ' 43' ' ' LEU . 60.9 Cg_endo -72.79 -168.36 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.454 2.103 . . . . 0.0 112.268 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.69 -28.45 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -81.93 0.12 41.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 40' ' ' PRO . 2.9 pp -47.75 -28.77 2.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.779 0.323 . . . . 0.0 111.278 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -68.57 -37.0 79.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.26 -15.17 19.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.738 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.5 mttm -71.58 -24.54 61.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.6 m-85 -51.22 -60.77 5.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.257 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.4 Cg_endo -69.61 -15.36 37.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.501 2.134 . . . . 0.0 112.658 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.52 -55.32 3.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.2 p -63.62 -26.22 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.14 69.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.183 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.3 -18.98 59.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -144.35 115.28 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.14 70.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.341 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -96.6 28.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.22 -93.47 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.33 128.35 17.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.541 2.161 . . . . 0.0 112.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.61 103.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.049 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 9' ' ' ILE . 2.3 tt -133.04 145.66 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.17 142.76 20.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.396 . . . . 0.0 111.399 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 64.5 m-85 -100.36 118.94 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 263' ' ' SER . 2.2 m95 -138.73 173.7 11.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.18 -177.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 111.336 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -76.92 -50.1 14.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.28 -25.96 67.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -29.51 53.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 17.7 m-85 -115.72 -36.32 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.89 -26.1 39.73 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.715 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.9 -25.61 2.5 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.862 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -34.08 16.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 111.119 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 76' ' ' LEU . . . -69.14 -55.66 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.172 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.18 -20.39 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -95.27 -26.77 15.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.51 -90.79 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.558 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.646 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER 179.07 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 71' ' ' ALA . 4.1 mm? -123.15 150.46 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.21 121.35 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 139.13 55.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -115.76 147.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -104.73 145.73 31.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.85 162.12 23.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.646 2.231 . . . . 0.0 112.434 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.42 -47.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.78 -20.43 29.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.7 19.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.379 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.04 -59.16 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.39 . . . . 0.0 110.639 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.51 -24.82 62.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.695 ' OD1' HD21 ' A' ' 304' ' ' LEU . 9.8 t70 -72.12 -26.24 62.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 tttm 66.62 72.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.34 163.02 13.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 305' ' ' LYS . 0.3 OUTLIER -64.14 139.16 97.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.78 -44.41 49.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.496 2.131 . . . . 0.0 112.321 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.08 -29.55 65.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 107' ' ' PRO . 35.6 m -56.96 -30.22 63.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.949 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -92.58 -41.05 10.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -30.43 69.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.48 -30.99 63.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 97' ' ' VAL . 21.6 t -87.72 54.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -138.34 96.36 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.11 120.22 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.6 -74.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.59 36.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 103' ' ' LEU . 21.3 mttp -145.62 -178.5 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 102' ' ' LYS . 5.9 mp -137.96 92.7 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.5 mp -132.25 40.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.92 65.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.22 113.27 29.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 93' ' ' THR . 98.2 Cg_endo -79.74 133.2 10.19 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.443 2.095 . . . . 0.0 112.436 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.4 pp -145.77 39.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.838 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -177.03 154.43 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 110' ' ' VAL . 5.2 m -126.69 106.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.14 135.37 54.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.79 176.58 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.61 164.64 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 m -165.05 -178.75 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.65 132.37 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -104.27 138.92 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.128 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 243' ' ' GLY . 8.2 p90 -146.96 167.38 24.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.595 ' CB ' HD21 ' A' ' 121' ' ' LEU . 3.2 m120 -86.55 159.34 19.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.63 36.41 2.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.561 ' C ' HD23 ' A' ' 121' ' ' LEU . 8.0 p-10 -155.36 30.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.595 HD21 ' CB ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -178.16 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.806 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tt -123.42 84.5 52.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.33 160.46 3.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.239 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.07 111.63 6.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.73 154.82 26.97 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.74 ' HG2' HG22 ' A' ' 128' ' ' THR . 83.5 Cg_endo -82.57 10.29 3.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.777 2.318 . . . . 0.0 112.893 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt 63.42 49.53 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.928 0.394 . . . . 0.0 111.196 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 126' ' ' PRO . 12.6 t -160.14 142.63 13.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.948 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.936 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.8 m95 -57.98 -28.89 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.002 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 1.4 tp10 -53.58 -23.8 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.632 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 126' ' ' PRO . 0.6 OUTLIER -73.31 -21.42 60.57 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.936 HD12 ' CE3' ' A' ' 129' ' ' TRP . 21.4 mt -73.33 -53.43 4.7 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 82.5 Cg_exo -46.79 -49.94 11.5 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.276 1.984 . . . . 0.0 112.536 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.98 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 6.7 mt -59.11 -32.17 69.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -57.08 -34.36 68.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -31.17 57.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.7 mm-40 -78.3 -41.61 33.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.62 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 4.2 mm? -60.39 -55.84 28.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -61.31 -24.42 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.45 -23.23 24.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.476 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -110.61 -72.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.72 39.72 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.441 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.71 178.95 9.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.6 138.65 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 223' ' ' ALA . . . -92.22 53.34 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -176.68 115.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 225' ' ' THR . 1.1 ppp? -87.7 -173.63 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 41.4 p90 -86.5 107.67 18.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.58 ' CG ' HG21 ' A' ' 226' ' ' ILE . 0.9 OUTLIER 177.54 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.511 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -177.74 -32.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.68 43.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.075 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.8 144.23 26.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.817 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.67 90.8 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.535 2.157 . . . . 0.0 112.281 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.45 -31.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -117.64 -31.44 5.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.959 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -33.87 76.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.892 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.754 ' CE2' HG13 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -63.5 -56.14 29.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 52.7 Cg_endo -68.72 -11.12 31.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 0.0 112.44 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.77 -57.01 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.02 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -90.56 5.31 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.503 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -94.38 -69.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.905 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.87 -86.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.452 ' OD1' ' NE2' ' A' ' 253' ' ' GLN . 5.0 p-10 -122.37 29.19 7.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.977 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.41 -75.33 0.65 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.05 107.51 0.98 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.539 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 111.95 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 -179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.98 -19.42 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.855 ' HA ' HD22 ' A' ' 361' ' ' LEU . 2.8 m-20 -83.26 56.49 3.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.1 129.3 50.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.67 -23.92 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.312 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.63 70.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.647 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.65 -40.43 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.805 ' HG3' HD11 ' A' ' 361' ' ' LEU . 9.0 mmpt? -67.73 -30.91 70.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.89 -56.87 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.27 -26.02 74.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.609 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.78 -48.37 81.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.8 p -72.01 -31.03 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -70.21 -43.0 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.524 ' HB2' HG21 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -65.34 -49.98 67.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 197' ' ' ASP . 28.3 m -58.73 -43.22 87.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 196' ' ' VAL . 1.7 m-20 -69.28 -30.87 69.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -48.23 82.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 151' ' ' LEU . 11.9 pt -74.97 -33.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -29.93 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.14 -26.16 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -102.98 -69.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -60.24 -45.41 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.4 ttt 60.46 26.92 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.0 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.05 -45.27 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.02 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -166.75 76.64 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.6 p -55.23 148.11 15.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.6 t0 -111.11 -167.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.098 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -79.37 -41.81 26.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -78.8 -25.03 44.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.398 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 1.6 mp -82.07 -54.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.078 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 149' ' ' PHE . . . -60.51 -30.39 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.447 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.03 -23.38 52.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.103 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.69 -52.75 59.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.428 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.08 -55.48 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -55.38 -28.21 52.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -49.03 -30.86 6.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -23.99 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 62.82 22.59 64.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.06 73.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.977 0.417 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.8 p -109.77 -177.08 3.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.997 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -79.63 39.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.991 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.439 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 169.34 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 148' ' ' MET . 0.8 OUTLIER -136.49 105.09 5.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.58 HG21 ' CG ' ' A' ' 150' ' ' ASN . 2.4 tt -92.98 114.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.088 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -142.29 164.19 30.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.81 -159.87 10.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.41 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.542 2.161 . . . . 0.0 112.335 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.849 0.357 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 117' ' ' TYR . . . -95.79 83.5 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 244' ' ' VAL . 15.0 p -98.46 114.71 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.4 p -141.08 162.72 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.437 HG11 ' CD ' ' A' ' 322' ' ' GLU . 11.6 p -77.39 150.56 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.92 158.67 23.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.43 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.88 2.387 . . . . 0.0 112.263 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.09 177.61 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 129' ' ' TRP . 4.2 t80 -164.74 115.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.6 tttt 61.23 19.0 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.75 47.77 9.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.452 ' NE2' ' OD1' ' A' ' 164' ' ' ASP . 4.4 mm-40 -141.07 90.76 9.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.21 130.29 10.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.604 2.203 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.9 t -53.09 160.31 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.4 90.77 35.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.52 -159.93 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.054 2.502 . . . . 0.0 112.086 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.75 138.81 47.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 260' ' ' GLY . 22.2 t -100.17 155.17 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -132.86 136.08 8.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.612 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.77 144.59 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.838 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.3 mp -85.44 117.84 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' TRP . 92.4 p -87.65 114.73 24.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.569 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -115.58 128.84 56.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.9 -179.28 35.55 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.573 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.666 ' CG2' ' HB2' ' A' ' 269' ' ' ALA . 1.8 mt -111.68 159.36 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 266' ' ' ILE . 5.7 p-10 -127.22 134.88 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 58.68 30.64 20.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 266' ' ' ILE . . . -97.72 34.97 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.435 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 1.4 m -55.76 -61.12 6.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 270' ' ' SER . 36.4 Cg_endo -65.36 -23.78 58.28 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.497 2.131 . . . . 0.0 112.542 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -117.09 38.06 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.004 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.67 -57.31 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.55 -30.03 68.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -70.2 -56.47 6.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.224 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.15 -40.43 89.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.65 -46.77 84.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -73.36 -29.61 62.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -53.99 51.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.36 -14.44 52.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.08 27.59 3.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.157 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -125.76 -57.05 1.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.771 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 283' ' ' TYR . 4.9 mp -110.94 -78.17 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.657 ' O ' HD13 ' A' ' 290' ' ' LEU . 18.5 tp 62.5 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.96 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.443 HG21 HD11 ' A' ' 304' ' ' LEU . 0.8 OUTLIER -158.11 137.65 11.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.302 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.4 t70 70.84 -54.36 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 111.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.79 -58.05 8.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 284' ' ' LEU . . . -120.75 -38.93 0.63 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.829 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 285' ' ' LEU . 1.0 OUTLIER -55.14 -58.85 5.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.893 0.378 . . . . 0.0 111.184 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.615 ' OE1' HD11 ' A' ' 311' ' ' LEU . 5.6 mm-40 -55.25 -35.87 65.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.116 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.82 -24.86 66.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 289' ' ' GLY . 23.5 t -71.68 -30.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.48 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -105.59 -49.63 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.09 -42.64 81.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.69 -51.31 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.42 138.19 32.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 299' ' ' LEU . 58.0 Cg_endo -71.09 122.44 8.76 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.413 2.075 . . . . 0.0 112.305 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 298' ' ' PRO . 4.1 mp -151.62 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 178.1 -165.8 35.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.441 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.652 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -119.34 -176.62 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.678 HG11 HD12 ' A' ' 304' ' ' LEU . 22.0 t -93.61 156.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.44 ' N ' HG12 ' A' ' 302' ' ' VAL . . . -100.45 40.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.695 HD21 ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -89.58 -175.77 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 14.3 mttt -102.8 -71.28 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 64.0 p -70.73 -47.06 61.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -58.77 -29.56 66.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -28.58 66.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 5.8 mt-10 -56.75 -61.73 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.71 -47.55 85.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.615 HD11 ' OE1' ' A' ' 291' ' ' GLU . 4.2 mm? -61.01 -23.3 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 309' ' ' GLU . . . -56.45 -21.63 26.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -90.18 46.6 1.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.894 ' HB3' HG22 ' A' ' 317' ' ' ILE . 1.1 t0 -118.25 147.37 41.49 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.95 -48.65 18.71 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.592 2.195 . . . . 0.0 112.457 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -59.09 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.894 HG22 ' HB3' ' A' ' 314' ' ' ASP . 8.7 tp -62.28 -25.3 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -55.8 -39.94 72.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.218 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.12 -34.0 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -75.5 -29.12 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.5 ttt -57.15 -31.29 65.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.022 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.437 ' CD ' HG11 ' A' ' 246' ' ' VAL . 1.5 tt0 -67.02 -44.39 80.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.22 -30.81 49.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.03 67.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -30.71 66.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -141.43 31.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.63 -170.94 19.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.409 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.83 168.75 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.971 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mm -70.4 138.28 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 5.3 ttt -51.86 106.8 0.7 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -168.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.444 2.096 . . . . 0.0 112.339 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -177.18 79.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 333' ' ' ILE . 8.0 tt -124.97 123.24 25.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.97 -30.12 57.45 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.409 2.073 . . . . 0.0 112.224 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -58.91 -30.12 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.1 tpt -56.89 -28.27 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.054 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -59.24 -32.96 70.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.37 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.764 ' O ' HG23 ' A' ' 343' ' ' VAL . 37.8 m-85 -65.19 -28.02 69.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.59 -28.83 49.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 345' ' ' THR . 0.2 OUTLIER -62.39 -46.89 86.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.975 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.3 -27.93 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 339' ' ' PHE . 39.4 t -67.67 -42.1 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 ptt180 -75.11 -47.19 29.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 341' ' ' TYR . 55.2 p -49.87 -27.47 5.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.4 -59.13 3.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.44 -50.8 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.822 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 344' ' ' ARG . 7.4 tp -53.33 -40.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.738 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 345' ' ' THR . 5.4 t-20 -80.61 -41.67 23.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.18 87.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.04 -10.78 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.0 t -67.76 -57.02 7.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -132.43 -71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.569 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -176.67 50.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.3 OUTLIER -80.03 132.52 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.2 p -93.29 153.96 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.02 -28.55 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.7 -37.75 79.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.2 -50.38 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.613 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -58.0 -25.19 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.855 HD22 ' HA ' ' A' ' 184' ' ' ASP . 17.8 mt -82.34 -56.47 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -70.43 -41.82 72.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.361 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.12 -46.96 78.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -58.22 -57.09 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.643 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -57.6 -30.54 65.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 93.5 m -77.65 -54.91 5.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.106 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -59.13 -47.05 86.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 364' ' ' ALA . 2.9 tt -56.36 -37.88 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.238 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 365' ' ' GLN . 77.3 p -78.21 -64.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.01 86.37 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.752 ' C ' HD22 ' A' ' 7' ' ' LEU . 2.9 pttm -153.63 137.36 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.752 HD22 ' C ' ' A' ' 6' ' ' LYS . 3.9 mm? -133.92 131.5 39.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.804 HG23 ' HB2' ' A' ' 57' ' ' PRO . 38.3 t -104.21 104.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mt -93.06 114.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.585 ' NE1' HD22 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.9 115.74 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' ASP . 29.9 mt -140.84 145.74 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.51 44.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.05 79.17 1.38 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.359 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.759 ' HB2' HG21 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -87.8 8.28 26.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.607 0.242 . . . . 0.0 111.328 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 58.95 30.04 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.11 59.51 0.67 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.575 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -61.42 -54.46 43.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.771 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -30.41 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.25 -51.96 54.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.614 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.64 -26.35 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.727 0.299 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.47 -46.3 20.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.02 -41.89 84.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' GLY . 35.2 t -59.45 -44.32 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 -25.51 57.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -43.76 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -74.39 -43.34 56.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.625 ' HB3' HG21 ' A' ' 33' ' ' ILE . 2.6 m-85 -63.9 -56.32 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.517 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 19.3 pt-20 -52.78 -28.05 20.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.487 0.66 . . . . 0.0 110.683 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -25.55 49.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.473 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.645 ' O ' ' OG1' ' A' ' 31' ' ' THR . 4.4 t70 -51.53 -56.81 11.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 31' ' ' THR . 6.2 m 156.91 36.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.742 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.748 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.61 46.12 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.764 -2.16 . . . . 0.0 115.885 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.5 mm -131.37 95.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 118.535 1.167 . . . . 0.0 111.596 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -103.75 121.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.66 128.95 76.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.27 146.31 23.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.3 p -139.05 111.47 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 2.2 tt0 -142.8 163.14 33.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -104.9 150.3 38.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.13 -156.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.78 -75.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -59.27 -30.04 68.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.585 HD22 ' NE1' ' A' ' 10' ' ' TRP . 28.9 tp -67.53 -24.01 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.93 -45.86 67.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.64 -28.26 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -24.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' HZ ' HD22 ' A' ' 75' ' ' LEU . 3.6 t80 -45.76 -55.43 12.66 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.66 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.6 Cg_endo -61.24 -21.39 71.57 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.271 1.981 . . . . 0.0 112.503 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -89.77 -55.23 3.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 55' ' ' ASP . 33.8 t -65.78 -30.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.8 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.86 -34.44 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -25.82 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.4 -51.1 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.3 t70 75.46 -54.42 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 111.047 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.78 -94.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.804 ' HB2' HG23 ' A' ' 8' ' ' VAL . 56.7 Cg_endo -70.56 149.33 61.63 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.578 2.186 . . . . 0.0 112.218 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 177.35 80.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 265' ' ' GLY . 28.2 mt -103.1 106.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB3' ' A' ' 10' ' ' TRP . 27.1 mt -112.65 137.45 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.289 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -86.68 128.56 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -157.62 173.25 17.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.848 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -54.62 -177.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.691 ' HB3' HG13 ' A' ' 261' ' ' VAL . 13.8 p80 -77.2 -52.0 9.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.19 -29.64 61.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -56.14 -27.65 54.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.142 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -108.14 -30.31 8.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.2 57.22 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.88 -49.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.606 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.27 -50.15 75.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -74.51 -31.37 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HG3' HD13 ' A' ' 104' ' ' ILE . 1.2 tm0? -73.41 -19.43 60.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 t -70.24 -26.7 63.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.57 50.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.607 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -179.36 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.891 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.641 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 1.4 tp -177.22 133.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB3' ' H ' ' A' ' 268' ' ' ALA . . . -110.71 160.49 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -85.7 134.8 33.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 80' ' ' THR . 4.6 mt -89.09 158.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.061 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 79' ' ' ILE . 74.9 p -88.94 146.31 36.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.92 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.606 2.204 . . . . 0.0 112.388 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -176.46 138.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -60.22 -48.02 83.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.64 -25.66 62.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 82' ' ' ASP . 6.2 m-85 -79.24 -59.24 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -24.85 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.791 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.28 -31.57 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -94.24 -58.48 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.16 158.33 11.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 305' ' ' LYS . 4.7 m-85 -105.21 157.6 33.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 -26.27 24.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.54 -35.72 72.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -30.13 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -75.74 -53.45 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.07 -31.35 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.79 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.777 HG11 ' HD3' ' A' ' 107' ' ' PRO . 10.9 m -117.0 39.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -110.83 121.43 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.54 132.13 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.401 ' CB ' ' HD3' ' A' ' 102' ' ' LYS . 16.1 m-20 59.27 28.64 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.993 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.55 20.61 73.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.831 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HG3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -145.73 166.84 24.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.68 HD23 HG23 ' A' ' 97' ' ' VAL . 5.4 mp -118.74 91.98 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' HD23 ' A' ' 76' ' ' LEU . 5.1 mt -101.37 40.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.87 164.76 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.243 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.68 119.03 7.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.777 ' HD3' HG11 ' A' ' 97' ' ' VAL . 94.6 Cg_endo -79.59 152.45 22.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.548 2.166 . . . . 0.0 112.336 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 284' ' ' LEU . 7.4 tt -171.99 39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.304 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.07 104.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 320' ' ' THR . 21.6 t -91.8 110.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.017 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.64 147.19 27.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.93 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.06 159.51 15.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -164.93 145.57 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 115' ' ' LEU . 4.1 pp -93.47 150.02 20.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 227' ' ' ASN . 4.5 mt -115.05 137.24 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -127.37 164.46 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.0 173.13 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -137.69 81.4 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HB3' HD23 ' A' ' 121' ' ' LEU . 28.2 t0 -174.2 -54.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -134.51 62.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.845 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD11 ' CB ' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -156.85 92.28 2.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.69 154.1 7.16 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.526 2.151 . . . . 0.0 112.298 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.2 111.27 5.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.99 149.77 37.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.452 2.102 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.403 ' CG ' ' HB3' ' A' ' 131' ' ' GLU . 59.6 Cg_endo -72.3 -167.03 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.478 2.119 . . . . 0.0 112.229 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -95.71 -28.25 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 131' ' ' GLU . 15.4 t -75.78 140.23 42.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -73.07 -35.73 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.2 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -23.97 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.837 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' HB2' HG23 ' A' ' 128' ' ' THR . 0.8 OUTLIER -87.21 -16.32 35.65 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.3 mm -61.3 -47.71 93.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 74.0 Cg_exo -47.92 -35.17 24.18 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.381 2.054 . . . . 0.0 112.482 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mp -60.63 -30.68 70.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -50.85 36.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.3 74.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.46 -45.61 79.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 145' ' ' SER . 10.1 mt -71.85 -43.94 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -27.15 67.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -27.7 49.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -109.44 -55.97 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 40.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -148.93 177.49 9.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.501 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -152.63 175.44 12.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -129.04 45.34 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.08 115.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.437 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -154.62 106.53 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.056 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -158.0 176.81 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.688 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -50.63 156.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD11 HD13 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -129.07 -49.03 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.687 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -97.11 39.78 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -154.91 166.01 16.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.694 2.263 . . . . 0.0 112.258 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -173.27 -40.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 160' ' ' LEU . 12.6 t80 -120.75 -41.73 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.416 ' HB ' HD11 ' A' ' 195' ' ' LEU . 2.5 p -68.55 -33.58 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.501 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 23.4 t90 -68.06 -55.79 12.47 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 38.2 Cg_endo -66.0 -14.08 42.8 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.301 2.001 . . . . 0.0 112.571 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -77.86 -55.62 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.676 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.429 HG22 ' CZ ' ' A' ' 194' ' ' PHE . 3.1 pt -88.93 9.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.535 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . . . -109.29 -15.98 14.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.422 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.27 65.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.256 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.92 -30.11 19.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.12 86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -154.48 89.99 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.536 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.15 52.62 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 339' ' ' PHE . 18.0 t -111.66 -30.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.401 ' OD2' ' CD2' ' A' ' 339' ' ' PHE . 22.1 p30 -94.17 50.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.34 162.79 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.99 -33.95 76.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.21 -28.3 49.53 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.14 -53.63 50.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -53.75 -50.08 66.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.33 68.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -60.76 -56.47 24.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.508 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.475 HD23 HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -63.95 -24.76 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.689 0.28 . . . . 0.0 111.065 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 63.0 m -56.48 -59.02 5.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.148 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 11.2 p90 -81.88 -23.04 36.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.267 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.416 HD11 ' HB ' ' A' ' 157' ' ' THR . 5.7 tp -52.92 -61.21 2.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.475 HG23 HD23 ' A' ' 192' ' ' LEU . 30.5 t -59.74 -42.89 90.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.41 -30.3 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.89 -30.03 69.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 151' ' ' LEU . 31.3 mt -77.2 -55.25 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -25.4 68.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.059 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -95.71 22.01 7.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -66.31 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -108.79 -29.25 8.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.8 mtp 62.87 31.39 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -176.71 114.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.95 88.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.98 -30.49 8.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 213' ' ' ALA . 2.7 p -81.6 147.94 29.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -140.94 -161.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.284 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 211' ' ' SER . 47.0 p90 -78.73 -47.37 16.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.004 0.431 . . . . 0.0 110.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.3 m -81.09 -26.12 36.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.242 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 209' ' ' ASP . 22.9 mt -82.44 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 209' ' ' ASP . . . -58.13 -30.23 66.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.565 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 41.3 tt0 -72.45 -36.69 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.42 59.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.457 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -75.15 -56.97 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.49 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CG ' ' CE1' ' A' ' 149' ' ' PHE . 1.1 p90 -75.14 -39.53 60.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -47.87 -35.94 11.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.119 0.485 . . . . 0.0 110.605 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -23.56 12.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.498 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.31 52.59 26.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.368 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.21 38.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.128 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.4 p -154.52 -177.97 6.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -86.4 39.54 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.357 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.18 112.82 0.45 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 116' ' ' ILE . 26.4 m -144.66 105.12 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 23.6 mt -88.3 144.88 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.658 ' HB2' HD11 ' A' ' 116' ' ' ILE . 2.0 t30 -120.16 164.3 16.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -130.74 178.61 17.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.826 2.35 . . . . 0.0 112.238 -179.791 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.62 151.28 17.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 315' ' ' PRO . 15.8 m -105.0 136.39 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.134 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 161.14 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.424 HG11 ' OE2' ' A' ' 322' ' ' GLU . 10.7 p -78.06 150.62 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.881 HD13 ' CB ' ' A' ' 255' ' ' SER . 1.3 mt -60.41 158.76 27.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.38 -173.98 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.904 2.402 . . . . 0.0 112.077 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 254' ' ' PRO . 43.7 p -116.8 150.15 38.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 250' ' ' PHE . 44.1 p90 -159.04 112.03 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.89 11.48 7.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.379 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.74 41.39 6.01 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.96 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -156.55 90.65 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.694 0.283 . . . . 0.0 111.024 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' A' ' 249' ' ' THR . 6.6 Cg_exo -73.74 85.07 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.852 2.368 . . . . 0.0 112.164 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.881 ' CB ' HD13 ' A' ' 247' ' ' LEU . 18.6 p 57.08 176.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 13.2 tttm -92.1 142.09 25.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.2 Cg_exo -79.58 153.78 23.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.632 2.222 . . . . 0.0 111.967 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 330' ' ' MET . 11.8 t80 -153.62 107.34 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.94 99.91 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -102.36 63.28 0.47 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.555 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 64' ' ' HIS . 10.8 p -87.92 144.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.31 . . . . 0.0 110.888 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -111.72 128.91 56.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.949 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.2 m -93.27 131.44 38.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.22 149.87 21.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -79.95 111.13 3.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 266' ' ' ILE . 8.4 tp -135.16 104.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -96.86 116.38 29.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.575 ' H ' ' HB3' ' A' ' 77' ' ' ALA . . . -93.01 -23.49 18.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.39 -30.6 52.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -82.1 155.66 69.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 61.46 2.57 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.393 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -165.17 31.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -75.07 -33.41 61.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -40.03 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.87 70.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.39 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.06 -39.11 83.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.48 -59.27 5.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 280' ' ' LEU . 2.3 tt -59.4 -31.3 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.05 -31.71 73.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -115.77 27.39 9.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -107.15 -64.54 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -100.08 -55.65 2.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.804 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.8 mm? -74.98 64.34 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.4 t -146.23 151.58 37.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.3 -31.43 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.65 -37.66 49.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -87.62 -56.55 2.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.913 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -43.74 65.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.739 0.304 . . . . 0.0 111.208 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 296' ' ' ASP . . . -76.8 -34.78 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.814 HG13 ' HG3' ' A' ' 297' ' ' LYS . 21.8 t -69.55 -30.15 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.206 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -58.87 -28.31 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -113.68 -43.07 3.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.993 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.445 ' OD2' ' HB1' ' A' ' 292' ' ' ALA . 91.5 m-20 -60.12 -69.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.923 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.814 ' HG3' HG13 ' A' ' 293' ' ' VAL . 3.7 pttt -124.16 72.38 55.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.988 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.46 107.16 2.33 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.629 2.219 . . . . 0.0 112.326 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 300' ' ' GLY . 0.9 OUTLIER -135.1 -55.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.985 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.609 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 159.87 120.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.28 127.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 302' ' ' VAL . 10.9 p -178.34 112.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -108.87 39.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.645 HD13 ' CD2' ' A' ' 307' ' ' TYR . 6.9 mt -133.89 156.93 47.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.421 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -93.41 -55.24 3.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.8 t -66.04 -48.06 72.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 304' ' ' LEU . 4.4 m-85 -59.47 -27.2 65.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.49 -28.73 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -49.51 77.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.952 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.85 -42.04 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 307' ' ' TYR . 4.5 mm? -62.1 -20.85 64.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 317' ' ' ILE . . . -52.0 -25.95 9.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.391 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -27.56 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.707 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 3.7 m-20 -58.81 158.59 15.74 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 244' ' ' VAL . 35.5 Cg_exo -61.26 -57.96 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.714 2.276 . . . . 0.0 112.665 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -58.92 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.409 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 312' ' ' ALA . 3.0 mp -52.22 -25.27 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.625 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -58.59 -51.7 68.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.22 -28.9 42.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.887 HG21 HG11 ' A' ' 110' ' ' VAL . 24.5 m -58.37 -43.6 88.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -29.85 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.424 ' OE2' HG11 ' A' ' 246' ' ' VAL . 4.5 tt0 -77.6 -54.7 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.31 -30.21 66.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.22 -29.1 60.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -58.74 -30.69 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -145.53 41.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.65 164.06 41.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -135.03 158.24 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 329' ' ' ILE . 4.7 tp -77.47 116.94 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.455 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 0.2 OUTLIER -55.22 -61.29 6.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 330' ' ' MET . 18.8 Cg_endo -59.1 -164.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 0.0 112.416 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 333' ' ' ILE . 2.9 m120 70.0 69.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 332' ' ' ASN . 0.8 OUTLIER -161.59 60.75 1.22 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.61 -45.56 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.589 2.193 . . . . 0.0 112.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.91 -34.92 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.14 -23.76 49.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 340' ' ' TRP . 17.6 p -59.8 -24.92 64.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.75 -29.6 45.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.82 0.343 . . . . 0.0 111.302 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.438 ' CE1' ' HB ' ' A' ' 183' ' ' VAL . 23.2 t80 -73.75 -23.7 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.403 ' CE3' ' O ' ' A' ' 337' ' ' SER . 0.0 OUTLIER -42.38 -29.37 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.833 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.2 -37.41 87.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -74.91 -26.12 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.468 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.69 -29.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.35 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.59 -60.85 2.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 37.2 m -50.0 -29.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.84 -54.44 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.382 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.9 t -79.17 -58.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.029 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.5 tp -47.34 -31.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.719 0.295 . . . . 0.0 111.515 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.31 -55.8 30.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -54.41 -26.8 32.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.343 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.11 -10.74 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.569 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.9 m -104.39 -31.27 9.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.95 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 108.53 -24.48 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -97.52 39.93 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 356' ' ' THR . 0.8 OUTLIER -79.69 165.03 23.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.9 OUTLIER -162.84 95.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.663 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.8 t -48.04 -27.82 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.17 -54.46 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -80.25 -25.94 39.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.79 -42.9 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 189' ' ' LYS . 1.5 tt -82.37 -54.82 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.458 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -55.87 20.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.524 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.81 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -59.92 -47.03 87.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.505 ' O ' HD12 ' A' ' 368' ' ' ILE . 3.2 tt0 -58.84 -56.2 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 9.4 t -58.38 -29.5 66.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -57.26 -29.84 64.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 365' ' ' GLN . 7.4 mt -64.32 -36.82 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -65.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 40.7 mttp . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.826 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.28 27.41 73.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -82.24 134.66 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 276' ' ' ALA . 6.4 mt -137.72 116.11 11.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 57' ' ' PRO . 10.7 p -96.96 107.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.694 HD13 HD22 ' A' ' 20' ' ' LEU . 1.6 pp -98.67 114.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.656 ' HB2' HG23 ' A' ' 60' ' ' ILE . 67.2 m95 -96.75 112.1 23.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' HB ' ' CE2' ' A' ' 61' ' ' PHE . 16.9 tt -143.65 158.65 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -175.12 99.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.32 102.82 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.54 44.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.82 -166.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.24 12.72 8.05 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.725 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.617 ' CE2' HG13 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -81.13 -59.53 2.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.09 -28.86 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.81 -48.9 69.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.523 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mp -77.48 -31.28 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.04 71.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -55.91 27.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.31 -31.02 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.088 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.09 -28.07 56.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -60.91 -30.81 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -74.82 -33.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.572 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.7 m-85 -66.56 -56.31 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.776 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 11.7 pt-20 -58.32 -28.46 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 0.0 110.557 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.07 -25.78 47.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.214 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 31' ' ' THR . 17.6 t0 -54.01 -56.54 16.94 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.69 37.44 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.594 177.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.857 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.91 43.52 0.02 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 117.857 -2.116 . . . . 0.0 115.84 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.1 mm -136.94 152.67 28.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 118.064 0.932 . . . . 0.0 111.287 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -142.22 129.2 20.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.85 105.81 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 113.84 27.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.809 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.617 HG13 ' CE2' ' A' ' 17' ' ' TYR . 10.8 p -100.35 140.89 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.55 160.28 40.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.29 147.38 36.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.94 125.7 11.22 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.365 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -173.73 -68.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -92.05 0.05 57.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.391 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.639 HD12 ' CE3' ' A' ' 10' ' ' TRP . 0.5 OUTLIER -56.48 -28.44 59.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.107 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.79 -43.47 76.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -98.39 -26.27 14.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -77.0 -24.57 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.141 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.567 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 68.8 t80 -52.87 -56.08 26.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.308 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.2 Cg_endo -63.71 -17.59 60.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.28 1.987 . . . . 0.0 112.448 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -89.67 -46.48 8.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.8 t -90.45 9.88 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -79.56 -47.5 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.24 79.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.6 p -85.17 -38.45 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.52 43.9 2.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -62.06 -31.0 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.57 -79.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.577 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 8' ' ' VAL . 38.0 Cg_endo -66.21 130.22 23.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.585 2.19 . . . . 0.0 112.323 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -175.93 71.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.54 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.7 mt -123.2 111.44 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 10' ' ' TRP . 2.0 mp -129.61 138.51 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.386 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -129.81 128.79 43.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -166.35 102.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 111.988 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . 54.33 166.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.881 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 97' ' ' VAL . 24.1 t-80 -77.22 -60.12 2.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.998 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -44.9 76.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.093 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -56.79 -23.0 40.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -99.68 -56.66 2.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -18.39 50.76 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.748 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.37 -38.78 4.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.654 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -97.96 -54.84 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.792 ' HB1' HD22 ' A' ' 76' ' ' LEU . . . -58.12 -30.79 66.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -70.5 -21.57 62.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 p -107.38 -26.31 11.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.918 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.25 -87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.635 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.5 pp 177.41 46.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 ' HB1' ' A' ' 71' ' ' ALA . 9.0 mp -80.05 137.66 36.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.59 121.74 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -58.89 159.89 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.8 pt -115.04 170.54 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 p -137.15 90.97 15.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.72 -176.14 3.09 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.585 2.19 . . . . 0.0 112.434 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.22 -176.17 3.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.85 83.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.27 32.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.418 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -80.2 -59.26 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.427 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -72.53 -24.73 61.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.816 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -76.33 -18.57 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.411 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -76.96 -67.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.89 151.01 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -97.63 156.35 36.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 52.6 Cg_exo -52.82 -24.77 24.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.656 2.237 . . . . 0.0 112.489 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.87 -62.51 1.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.031 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -65.05 -25.93 68.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 98' ' ' ARG . 3.1 m0 -57.91 -49.75 75.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.38 -26.83 0.91 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 97' ' ' VAL . . . -54.65 -43.6 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.641 HG21 ' HD3' ' A' ' 107' ' ' PRO . 5.3 m -158.78 71.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.887 0.375 . . . . 0.0 111.511 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.759 ' CZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -145.21 109.14 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.804 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.53 174.74 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.16 62.56 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.31 27.94 5.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -145.36 101.2 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.759 HD11 ' CZ ' ' A' ' 98' ' ' ARG . 9.5 tp -114.17 99.45 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -139.71 40.0 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.075 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.97 128.76 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.27 111.02 15.31 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.771 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.641 ' HD3' HG21 ' A' ' 97' ' ' VAL . 98.6 Cg_endo -79.6 139.23 14.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.44 2.093 . . . . 0.0 112.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 tt -166.51 39.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.18 109.31 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 302' ' ' VAL . 12.5 p -89.29 124.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.15 132.99 46.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.917 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.18 176.52 12.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.66 137.12 40.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 m -164.71 -176.06 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 ' OG1' ' A' ' 245' ' ' THR . 0.2 OUTLIER -96.2 152.53 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.768 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 243' ' ' GLY . 22.9 mm -100.8 147.72 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -120.0 126.56 51.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.0 155.4 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -75.73 -30.86 59.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.97 62.95 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 122' ' ' LEU . 20.9 tp -175.85 39.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.908 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -156.88 151.43 20.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 223' ' ' ALA . 55.6 Cg_endo -70.15 160.39 49.76 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.256 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.13 164.17 25.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.777 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.02 136.38 40.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.454 2.102 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.4 -171.52 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.533 2.156 . . . . 0.0 112.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -109.58 -36.41 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -160.04 172.11 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.472 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -59.09 -24.71 63.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -76.78 -25.3 53.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.61 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -89.37 -32.66 17.2 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.647 HG22 ' HD3' ' A' ' 133' ' ' PRO . 17.9 tt -56.43 -32.78 14.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.647 ' HD3' HG22 ' A' ' 132' ' ' ILE . 15.1 Cg_exo -69.49 -42.39 3.72 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.278 1.985 . . . . 0.0 112.198 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.03 64.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.248 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 123' ' ' PRO . 5.3 tp -58.89 -30.78 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -47.74 84.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -58.53 -31.73 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -54.18 48.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 146' ' ' ALA . 5.6 mt -70.85 -40.56 72.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.948 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -27.6 65.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.09 -25.28 63.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -109.12 -75.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.53 39.84 0.16 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.403 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.57 -174.89 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' HD13 ' A' ' 139' ' ' LEU . 37.7 m -150.19 162.05 41.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.723 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -111.77 33.49 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER 178.93 125.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.623 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.638 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 1.8 mtt -170.09 106.18 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.64 177.35 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.76 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.449 ' N ' ' HB1' ' A' ' 213' ' ' ALA . 13.0 m-80 -45.55 167.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.425 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 HG12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -134.15 -45.55 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.674 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.455 ' OE1' ' HB1' ' A' ' 206' ' ' ALA . 78.9 mt-30 -95.52 39.54 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.98 170.73 5.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.76 166.17 21.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.59 2.194 . . . . 0.0 112.445 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.02 28.6 17.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -120.88 -59.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 1.026 HG23 HD13 ' A' ' 195' ' ' LEU . 62.2 m -73.11 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.512 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -64.03 -55.42 32.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.5 Cg_endo -64.2 -27.17 64.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.288 1.992 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.728 HD13 ' CD2' ' A' ' 195' ' ' LEU . 1.1 tt -71.94 -56.48 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.569 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' THR . 2.2 tt -76.01 -9.9 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.289 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -78.85 -23.54 44.91 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.72 0.295 . . . . 0.0 111.306 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.83 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -122.26 39.97 3.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.34 -41.94 3.32 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.504 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.7 -48.46 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.36 175.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.41 -34.58 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -104.99 30.69 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -103.66 175.24 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.64 74.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.069 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.51 66.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -71.34 -41.93 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.91 -31.89 70.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 -46.19 15.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.04 63.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 361' ' ' LEU . 3.9 tp -60.58 -49.1 78.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.3 m -60.79 -34.55 74.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.3 -46.89 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 1.026 HD13 HG23 ' A' ' 157' ' ' THR . 3.3 mt -58.91 -47.35 85.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.4 t -64.23 -48.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.84 -35.42 78.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.15 -41.21 92.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.649 HG12 HD23 ' A' ' 151' ' ' LEU . 21.6 mt -76.55 -30.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -31.65 72.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.06 18.34 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.1 -76.6 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.789 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -115.23 -13.42 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 ttt 70.02 -66.04 0.29 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -102.67 128.46 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.455 ' HB1' ' OE1' ' A' ' 152' ' ' GLN . . . -59.11 87.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.61 -29.47 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 t -78.14 108.83 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 211' ' ' SER . 2.8 p30 -94.12 -148.21 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 211' ' ' SER . 38.4 p90 -78.68 -51.72 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD2' ' A' ' 210' ' ' TYR . 88.6 p -62.34 -25.25 67.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.036 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.1 mm -82.01 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.449 ' HB1' ' N ' ' A' ' 150' ' ' ASN . . . -60.29 -30.53 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -66.44 -28.97 69.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.37 -25.06 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.336 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -52.45 -56.79 12.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 225' ' ' THR . 51.2 t80 -76.29 -36.74 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.76 -5.67 44.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.647 0.26 . . . . 0.0 110.935 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 221' ' ' GLU . . . -172.01 -78.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.321 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 0.9 OUTLIER 163.48 100.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 110.49 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 145' ' ' SER . 4.7 p -109.32 -177.41 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 38.96 0.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -146.66 111.64 5.37 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.934 0.397 . . . . 0.0 111.143 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -144.56 104.71 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 37.0 mt -115.26 142.67 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -144.04 111.64 6.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.44 62.03 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.56 2.173 . . . . 0.0 112.372 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.776 0.322 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -124.26 165.88 17.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.71 136.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.473 ' OG1' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -123.48 149.67 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.931 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.441 HG13 ' ND2' ' A' ' 323' ' ' ASN . 21.5 t -91.35 150.57 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 247' ' ' LEU . 4.2 mp -60.05 158.77 24.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.818 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.2 166.04 23.09 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.875 2.383 . . . . 0.0 112.168 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -95.61 177.55 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.446 ' H ' HG22 ' A' ' 249' ' ' THR . 46.2 t80 -159.31 111.9 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.2 mttm 59.95 20.51 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.71 44.91 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.621 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -156.37 90.83 2.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.649 0.261 . . . . 0.0 110.864 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.21 159.39 22.64 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.587 2.191 . . . . 0.0 112.296 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.8 p -67.19 -175.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.484 ' CG ' ' HB1' ' A' ' 162' ' ' ALA . 20.0 mmtp -107.29 94.31 11.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.67 151.14 21.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.461 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 331' ' ' PRO . 3.8 t80 -108.13 82.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.91 151.81 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.84 171.75 29.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.81 144.95 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.674 0.274 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.1 mp -78.3 105.25 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.8 m -79.79 116.55 20.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.288 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -101.57 155.3 18.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.597 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.449 ' N ' ' CZ ' ' A' ' 67' ' ' PHE . . . -146.17 172.13 26.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.939 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.724 HD11 ' CD ' ' A' ' 273' ' ' LYS . 11.3 tt -113.68 159.74 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.669 0.271 . . . . 0.0 110.777 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 2.1 t-20 -116.47 108.01 15.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 267' ' ' ASN . . . 78.94 -53.71 0.45 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.415 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 66.73 6.71 4.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.504 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 3.3 t -67.45 -60.53 5.6 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.306 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 270' ' ' SER . 12.0 Cg_endo -55.88 -163.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.551 2.167 . . . . 0.0 112.442 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.26 55.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.052 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.724 ' CD ' HD11 ' A' ' 266' ' ' ILE . 0.7 OUTLIER -73.25 -29.66 62.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.817 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.24 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -74.17 -48.78 26.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -66.69 -32.08 73.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -78.86 -40.18 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.56 -36.59 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.38 -38.79 85.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.65 -27.66 67.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.61 -22.19 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.17 5.66 29.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.31 -48.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 110.991 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.766 HD21 ' NZ ' ' A' ' 297' ' ' LYS . 1.3 mt -89.31 53.42 2.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.774 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.6 p -154.71 174.9 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -21.03 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.56 -54.67 7.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.11 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.59 -45.75 4.21 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.773 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.2 OUTLIER -54.27 -30.21 49.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.142 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.61 -38.09 70.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.5 67.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.942 HG13 ' CB ' ' A' ' 297' ' ' LYS . 85.9 t -58.12 -30.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.179 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.36 -13.23 60.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -114.31 -25.24 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -119.47 -81.65 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.693 0.282 . . . . 0.0 111.514 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.942 ' CB ' HG13 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -49.53 164.93 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.354 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.39 147.16 69.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.548 2.166 . . . . 0.0 112.275 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 299' ' ' LEU . 3.4 mm? -79.13 -25.84 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.108 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -79.8 114.34 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 317' ' ' ILE . . . -169.89 137.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 110' ' ' VAL . 28.5 m -155.82 108.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -146.08 39.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.1 mt -153.66 165.45 35.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -38.59 3.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.014 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 p -79.5 -47.82 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -60.65 -21.9 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.527 ' OE2' HD21 ' A' ' 311' ' ' LEU . 35.1 mm-40 -51.02 -28.21 9.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.273 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.19 -47.85 59.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.21 -54.15 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 317' ' ' ILE . 4.5 pp -62.51 -17.75 60.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.295 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -53.71 -23.35 11.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.614 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.34 46.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.774 0.321 . . . . 0.0 111.301 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.615 ' HB3' HG22 ' A' ' 317' ' ' ILE . 0.4 OUTLIER -124.14 173.73 4.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.783 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -90.09 -51.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.839 2.359 . . . . 0.0 113.725 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -81.3 -59.44 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.635 ' CD1' HD13 ' A' ' 311' ' ' LEU . 16.7 tt -56.27 -31.58 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 314' ' ' ASP . . . -76.52 -33.08 58.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.47 75.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 44.9 p -76.76 -30.94 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -32.15 70.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.06 -52.7 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.441 ' ND2' HG13 ' A' ' 246' ' ' VAL . 16.0 m-20 -69.58 -30.45 68.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.25 71.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.32 -29.24 69.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -118.43 59.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 178.39 -154.19 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.92 166.23 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.5 101.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 53.66 87.62 0.14 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 258' ' ' PHE . 47.8 Cg_endo -68.77 161.47 45.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.492 2.128 . . . . 0.0 112.228 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -157.39 91.24 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 12.0 pt -152.59 132.15 7.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 -23.56 22.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.468 2.112 . . . . 0.0 112.411 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -55.94 -43.81 77.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.6 mtp -69.17 -35.36 76.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.2 p -62.57 -35.55 79.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.7 -33.87 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.763 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -73.49 -27.28 61.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -42.74 81.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.99 -35.43 42.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.51 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.3 t -59.59 -30.13 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.878 ' HG3' HD12 ' A' ' 348' ' ' ILE . 4.2 tpt180 -58.89 -60.81 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 0.9 OUTLIER -67.45 -27.5 67.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.85 -59.72 4.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.651 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 350' ' ' ALA . 20.1 t -79.36 -59.1 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.878 HD12 ' HG3' ' A' ' 344' ' ' ARG . 21.9 mt -48.19 -58.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 345' ' ' THR . 15.2 t-20 -55.47 -36.21 66.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 111.179 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -56.02 -30.11 61.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.21 -10.15 55.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.553 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.6 p -67.58 -25.14 65.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 111.95 -27.82 9.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.18 39.34 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 124.9 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.805 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 359' ' ' GLU . 8.2 t -115.56 177.92 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.966 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 192' ' ' LEU . 22.0 t -72.31 -35.15 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -45.98 88.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.445 ' H ' HG23 ' A' ' 356' ' ' THR . 23.1 mt-10 -79.96 -43.4 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -59.99 -38.51 82.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -82.1 -48.82 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -62.81 -44.06 97.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.35 -26.52 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -51.81 -56.86 11.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.388 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.6 pt20 -56.55 -30.51 63.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 13.6 m -67.66 -43.2 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.407 ' HG3' HG13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -73.89 -29.82 62.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.995 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 365' ' ' GLN . 16.8 mt -75.06 -44.93 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.99 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 23.3 m -79.65 -67.94 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.775 0.321 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.04 85.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -149.27 158.7 44.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.481 HD22 HD11 ' A' ' 59' ' ' ILE . 9.2 mt -136.58 155.35 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.947 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.772 HG23 ' HG2' ' A' ' 57' ' ' PRO . 28.3 t -123.91 102.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mt -94.88 114.98 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -94.91 124.46 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pt -134.66 149.06 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.186 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.73 94.27 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.44 27.94 53.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.64 ' O ' HD22 ' A' ' 299' ' ' LEU . 1.3 m-20 -75.31 -29.98 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.706 0.288 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 299' ' ' LEU . 18.0 tttt 62.75 118.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 48.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.56 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -78.78 -34.72 45.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.36 -42.0 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.695 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.37 -33.75 30.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 37' ' ' VAL . 1.2 tt -74.57 -31.56 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.12 77.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.271 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -76.96 -32.2 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 27' ' ' PHE . 27.9 t -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.104 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.42 -38.04 89.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -74.11 -26.74 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -44.15 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 23' ' ' VAL . 67.2 m-85 -62.24 -56.67 16.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -59.37 -27.42 65.95 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 110.131 179.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -27.3 1.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -69.28 -56.87 6.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.56 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.031 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.25 49.05 0.01 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 118.115 -1.993 . . . . 0.0 115.513 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -139.56 95.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 118.103 0.951 . . . . 0.0 111.628 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -99.95 106.38 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.11 146.34 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.01 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 20' ' ' LEU . 5.8 m -116.63 118.26 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -143.9 162.8 35.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -87.16 154.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.51 130.01 20.1 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.595 2.197 . . . . 0.0 112.277 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.34 -60.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -79.41 -7.58 58.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.33 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 43' ' ' LEU . 4.6 pp -55.62 -24.93 36.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.78 -34.39 62.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.067 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.3 -29.94 12.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.0 tttt -69.27 -31.18 69.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -56.36 -60.76 8.13 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.4 Cg_endo -63.77 -16.83 57.09 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.423 2.082 . . . . 0.0 112.513 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.86 -44.5 18.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.792 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 46' ' ' LYS . 31.1 m -90.21 -24.36 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.2 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.89 70.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 53' ' ' THR . . . -63.24 -30.78 71.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.059 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.84 128.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.64 72.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.24 -30.99 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.28 -168.81 12.36 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HG2' HG23 ' A' ' 8' ' ' VAL . 55.8 Cg_endo -70.23 -171.61 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.314 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 175.09 103.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.481 HD11 HD22 ' A' ' 7' ' ' LEU . 32.2 mt -143.6 136.25 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.25 141.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 12.7 m-85 -108.79 144.67 36.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.606 ' N ' HD23 ' A' ' 262' ' ' LEU . 1.3 m95 -165.62 173.6 10.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.57 -174.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.344 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' HB2' HG23 ' A' ' 261' ' ' VAL . 57.1 t-80 -77.69 -45.01 26.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.3 -28.81 44.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.59 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -54.75 -24.17 21.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.217 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 4.3 m-85 -101.11 -28.5 12.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.965 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.74 -23.13 49.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.655 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.4 -50.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.3 -57.51 3.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -58.71 -30.6 67.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -28.42 64.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 p -70.26 -26.74 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.34 77.68 1.07 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.797 ' O ' HD22 ' A' ' 76' ' ' LEU . 7.8 tp -167.48 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.797 HD22 ' O ' ' A' ' 75' ' ' LEU . 1.3 mm? -141.5 127.82 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.884 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -59.79 138.48 57.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' HG23 ' A' ' 104' ' ' ILE . 17.7 tt0 -89.04 157.96 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mm -111.3 141.49 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 148.56 40.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.78 168.2 19.61 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.725 2.284 . . . . 0.0 112.372 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.95 153.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -31.65 70.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 -23.28 64.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CE2' HD22 ' A' ' 89' ' ' LEU . 1.4 t80 -79.3 -59.16 2.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 8.3 pt20 -62.55 -24.73 67.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.66 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -68.19 -32.8 73.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 304' ' ' LEU . 8.9 mtmm -104.96 -63.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.07 113.53 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.825 ' O ' HG22 ' A' ' 93' ' ' THR . 15.3 m-85 -62.25 143.89 95.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.51 -24.94 30.4 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.468 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -57.03 -34.72 68.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.076 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 90' ' ' TYR . 8.8 t -86.76 -28.23 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.982 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' A' ' 86' ' ' GLN . 4.4 m0 -59.74 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.69 -29.25 70.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 330' ' ' MET . . . -59.63 -29.6 68.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.203 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.926 HG11 ' HD3' ' A' ' 107' ' ' PRO . 27.0 m -129.77 61.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.38 81.44 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -79.26 98.07 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.77 31.51 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.47 50.65 7.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -131.32 129.74 41.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.65 40.02 1.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.0 pp -97.78 39.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 178.22 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 6.7 p90 -118.73 129.14 25.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.926 ' HD3' HG11 ' A' ' 97' ' ' VAL . 98.0 Cg_endo -79.8 168.14 19.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.606 2.204 . . . . 0.0 112.283 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -175.01 39.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.21 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.916 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 174.18 108.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.982 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 259' ' ' VAL . 10.4 p -90.09 134.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.05 164.35 28.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.62 10.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.604 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -146.11 157.54 43.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -175.95 5.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mt -92.62 146.15 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -73.77 155.94 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.05 0.452 . . . . 0.0 111.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -135.78 114.71 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -133.77 -177.49 4.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.35 76.27 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -156.05 -50.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 221' ' ' GLU . 0.6 OUTLIER -148.06 39.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.27 91.13 47.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.37 159.42 53.42 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.444 2.096 . . . . 0.0 112.27 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -102.2 95.77 6.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 159.48 52.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.59 49.42 3.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.678 2.252 . . . . 0.0 112.702 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 55.47 32.9 19.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.07 140.44 52.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -32.35 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.643 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.71 17.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.485 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.36 -17.09 58.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 mt -73.47 -53.0 4.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.1 Cg_exo -52.15 -36.74 67.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.312 2.008 . . . . 0.0 112.428 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -32.87 56.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 139' ' ' LEU . 60.5 mt -77.02 -31.91 56.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -76.6 -31.07 57.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -71.75 -32.16 67.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.46 -40.69 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.799 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 6.7 mt -73.15 -53.24 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -57.77 -24.63 58.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.37 -26.13 60.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -109.76 -70.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.62 39.85 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -174.89 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.725 0.297 . . . . 0.0 110.787 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.474 ' C ' HD13 ' A' ' 139' ' ' LEU . 1.4 m -157.13 171.24 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.799 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -142.94 49.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 4.4 tt 170.62 120.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.03 106.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -172.24 167.04 5.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 148.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -178.64 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.811 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -133.95 39.93 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 154' ' ' PRO . 6.8 pt-20 -87.65 173.41 6.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.452 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 88.7 Cg_endo -85.89 118.75 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.435 2.09 . . . . 0.0 112.617 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 61.52 80.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.614 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.1 p90 -121.13 -48.25 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.4 t -72.8 -35.27 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.349 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -49.27 -55.81 19.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.326 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.0 Cg_endo -78.7 -18.31 11.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.627 2.218 . . . . 0.0 112.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 156' ' ' PHE . 2.3 mm? -80.39 -56.7 4.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.174 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 167' ' ' TYR . 1.8 pt -80.6 1.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -88.13 -54.54 4.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 253' ' ' GLN . . . 62.67 -81.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -56.8 2.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 100.67 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.579 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.95 87.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.82 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 33.7 t80 -171.49 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 167' ' ' TYR . 17.2 m -74.56 42.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.808 0.337 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -110.93 -7.86 14.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.723 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.58 -173.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.63 63.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.79 -49.34 79.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.36 -45.18 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HG3' HD21 ' A' ' 361' ' ' LEU . 20.4 mtpt -60.2 -58.59 7.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.52 87.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.12 -53.34 18.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.598 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 196' ' ' VAL . 3.3 tt -60.05 -42.68 94.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.9 m -59.46 -30.44 68.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -76.15 -47.87 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -67.05 -50.02 63.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.767 HG11 HG21 ' A' ' 357' ' ' VAL . 12.0 p -56.49 -28.07 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.255 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.44 -54.6 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -59.0 -59.05 6.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.026 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -51.96 -25.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.37 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 196' ' ' VAL . 1.2 tptp -60.51 -59.97 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.517 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.18 20.99 18.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . 0.447 ' CE ' ' CD2' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -120.28 -68.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' ' 151' ' ' LEU . 27.4 m80 -81.16 -0.52 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.715 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -20.27 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.626 0.25 . . . . 0.0 111.288 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.52 37.93 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -162.28 84.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.72 57.71 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.541 ' O ' HG23 ' A' ' 208' ' ' THR . 11.5 t -57.4 108.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 212' ' ' ILE . 3.3 t0 -78.43 -156.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.721 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -78.38 -44.45 24.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.157 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.1 p -73.93 -25.1 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.173 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 209' ' ' ASP . 13.3 mt -82.05 -53.94 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.107 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.27 64.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.403 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 12.0 tm-20 -72.86 -42.62 63.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.423 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.16 -24.92 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.23 -56.66 11.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.681 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.94 ' CG ' HG23 ' A' ' 225' ' ' THR . 8.6 p90 -67.56 -30.93 70.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.749 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -79.9 -11.9 59.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -74.45 -24.04 59.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.687 0.279 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.65 -92.77 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.178 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.4 OUTLIER 165.54 91.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.607 0.241 . . . . 0.0 110.561 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.35 -177.89 3.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 38.59 0.66 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.52 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -154.11 101.87 2.43 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.044 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.94 HG23 ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -144.6 104.93 4.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.191 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.906 HD13 ' CD2' ' A' ' 149' ' ' PHE . 3.9 mp -106.26 119.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.229 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -139.18 162.89 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.14 -150.91 17.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 112.318 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.834 0.349 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -156.92 175.97 34.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.36 136.43 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 146.52 52.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.82 150.7 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.95 149.18 74.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.52 -174.61 2.35 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.185 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -127.84 177.69 6.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.499 ' H ' HG22 ' A' ' 249' ' ' THR . 24.4 t80 -158.27 111.74 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.49 12.64 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.26 5.53 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.736 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.603 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 3.4 pt20 -156.35 90.49 2.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.784 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.453 ' HB3' HG23 ' A' ' 249' ' ' THR . 91.9 Cg_endo -86.72 150.28 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.889 2.392 . . . . 0.0 112.618 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 69.5 m -55.24 150.5 10.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -109.41 89.5 7.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.76 125.3 6.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.578 2.185 . . . . 0.0 112.391 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -79.98 172.04 14.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 110' ' ' VAL . 10.5 p -94.88 138.13 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.72 129.97 10.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 64' ' ' HIS . 30.8 m -122.22 144.78 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -92.57 115.67 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.461 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' TRP . 8.9 m -94.59 133.73 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.475 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -101.67 126.07 48.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.603 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 76' ' ' LEU . . . -114.91 159.04 13.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.743 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.884 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.5 tt -140.2 136.38 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -51.37 125.56 14.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.46 -29.86 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.249 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.74 46.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.7 m -96.13 112.81 60.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.39 -26.98 12.74 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.448 2.099 . . . . 0.0 112.437 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -120.22 65.53 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.402 ' NZ ' ' HB1' ' A' ' 77' ' ' ALA . 7.2 tttp -75.04 -53.98 7.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.28 -32.17 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -73.0 -49.17 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.73 -42.96 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -59.86 -42.68 94.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.97 -30.51 58.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.513 ' CE1' HD23 ' A' ' 275' ' ' LEU . 1.8 m-85 -64.16 -59.2 4.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 281' ' ' GLU . 4.5 pp -58.86 -27.0 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.647 ' N ' HD12 ' A' ' 280' ' ' LEU . 1.1 mm-40 -74.33 -29.26 61.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.54 27.47 9.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 27' ' ' PHE . 14.6 m-85 -148.2 -74.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.83 -31.38 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.48 72.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.76 164.42 38.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -27.86 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -77.54 -27.68 51.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.125 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -105.62 -54.46 0.73 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.711 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.39 -30.71 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.152 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -72.28 -40.71 67.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.65 81.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.08 -33.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -80.15 -55.06 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -59.72 -57.8 11.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.47 -34.4 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 299' ' ' LEU . 2.6 tptt -139.24 89.42 12.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 115.73 4.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.55 2.166 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -126.34 -43.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.88 123.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -86.07 90.13 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.15 79.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 306' ' ' SER . . . -139.08 78.17 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 304' ' ' LEU . 0.1 OUTLIER 40.59 -91.87 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.971 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -78.37 -41.26 33.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.784 0.326 . . . . 0.0 111.203 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.83 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 1.8 m -53.28 -25.16 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.234 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 311' ' ' LEU . 87.8 t80 -56.1 -44.67 79.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.35 -31.81 58.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -66.86 -48.22 69.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB2' ' HB1' ' A' ' 301' ' ' ALA . 71.4 mm-40 -71.19 -35.9 71.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 307' ' ' TYR . 3.4 mp -56.03 -23.06 30.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.1 71.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -176.8 74.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.16 139.16 19.85 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.34 -62.38 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.445 2.096 . . . . 0.0 112.352 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -60.78 -48.52 81.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.528 HG22 ' CE ' ' A' ' 321' ' ' MET . 42.2 mm -59.52 -29.91 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.48 71.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -78.46 -56.26 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.1 t -58.38 -27.27 64.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.528 ' CE ' HG22 ' A' ' 317' ' ' ILE . 7.8 mtt -56.23 -29.14 60.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.47 -57.41 12.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -78.36 -31.85 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.92 71.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -59.68 -32.24 70.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -109.37 38.88 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.2 179.59 24.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.578 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.76 -177.2 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.978 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -135.32 107.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 329' ' ' ILE . 3.4 mmt 60.66 155.77 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.975 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.31 -161.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.231 . . . . 0.0 112.256 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -170.39 -42.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 333' ' ' ILE . 3.3 tt -123.77 122.97 26.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.51 -21.23 34.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.088 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.35 -30.68 62.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -30.99 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 60.5 p -65.21 -41.74 94.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.93 74.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 343' ' ' VAL . 0.4 OUTLIER -67.72 -27.52 66.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.43 -32.21 62.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.88 -31.42 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 367' ' ' ARG . . . -76.71 -53.25 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.82 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 21.9 t -58.05 -30.04 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 348' ' ' ILE . 16.9 mtp180 -59.71 -54.4 46.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 69.0 p -49.78 -27.66 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -75.66 -54.28 7.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.47 -59.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.932 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.4 tt -49.62 -39.63 14.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.917 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.64 -28.6 36.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -59.61 -31.47 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.92 -10.2 59.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.517 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.0 p -67.57 -26.04 66.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.122 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 109.56 -24.34 20.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.568 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 39.55 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.44 114.14 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.765 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.2 OUTLIER -105.18 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 196' ' ' VAL . 21.6 t -72.28 -28.89 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.213 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 -37.48 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.22 -55.78 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.814 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -50.33 -36.49 32.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -82.35 -42.52 18.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -65.53 -55.67 16.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.8 -27.17 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.814 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.36 -54.91 29.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 369' ' ' THR . 1.4 tt0 -58.86 -30.44 67.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.4 m -59.47 -57.66 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 342' ' ' ALA . 24.1 ptt180 -58.37 -41.24 84.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.146 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 33.1 mm -71.96 -32.04 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 365' ' ' GLN . 17.4 p -108.52 35.45 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.89 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.854 0.359 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.8 72.19 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.66 141.58 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.713 HD22 ' CE1' ' A' ' 279' ' ' PHE . 2.7 mp -141.82 138.87 32.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.721 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 59' ' ' ILE . 44.9 t -115.22 113.53 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.094 0.474 . . . . 0.0 111.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt -99.15 133.89 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.1 m0 -94.71 111.95 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 tt -139.59 148.74 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.096 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -171.43 75.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.07 -112.34 1.4 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 178.38 58.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.849 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 296' ' ' ASP . 3.6 pttt -125.38 -97.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.006 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.81 80.76 0.28 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.596 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -61.94 -30.95 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -59.15 -28.38 66.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 293' ' ' VAL . . . -56.77 -51.59 55.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.637 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.73 -37.2 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.32 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -64.25 -56.09 17.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.521 HG12 ' ND2' ' A' ' 282' ' ' ASN . 21.3 t -69.37 -43.97 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.57 -27.69 64.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.616 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -32.87 70.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.59 -45.06 89.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.4 m-85 -63.9 -56.03 18.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 35' ' ' VAL . 8.7 mt-10 -53.91 -28.4 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.437 0.637 . . . . 0.0 110.59 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -78.09 -25.78 47.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.486 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' HB ' ' A' ' 31' ' ' THR . 4.4 t70 -52.65 -56.46 15.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.48 36.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.456 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.26 44.39 0.02 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.883 -2.103 . . . . 0.0 115.75 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 32' ' ' GLY . 3.4 mm -133.94 149.28 30.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 118.21 1.005 . . . . 0.0 111.377 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.56 137.4 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.861 HG22 ' OE2' ' A' ' 28' ' ' GLU . 30.0 m -130.55 129.78 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.85 134.63 54.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 9' ' ' ILE . 31.2 m -127.91 120.17 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.11 163.02 33.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -80.11 152.91 74.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.86 179.07 5.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.551 2.167 . . . . 0.0 112.449 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 76.67 -0.28 3.04 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.65 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 -48.83 2.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.2 -12.73 57.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.412 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -26.37 8.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.279 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.63 -51.12 9.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -71.81 -24.55 61.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -49.85 -60.46 5.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.316 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 36.1 Cg_endo -65.08 -15.35 49.96 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.432 2.088 . . . . 0.0 112.568 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.67 -40.95 12.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.961 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.28 -29.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.64 -30.97 71.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.77 66.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.1 m -100.26 -45.48 5.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.69 73.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -99.68 -28.86 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 0.0 111.085 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.29 -64.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.63 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' HG21 ' A' ' 8' ' ' VAL . 5.8 Cg_endo -48.96 115.3 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.823 2.349 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -175.32 39.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.803 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -145.25 129.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.516 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 10' ' ' TRP . 63.8 mt -141.5 142.72 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE2' ' HB1' ' A' ' 264' ' ' ALA . 51.0 m-85 -123.14 112.38 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.268 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -162.95 174.03 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.753 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.88 -173.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -76.86 -33.41 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.01 -29.28 63.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -56.98 14.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.074 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -66.34 -48.83 68.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.47 -17.87 54.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.719 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.77 -56.07 1.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -95.45 -54.45 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.032 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -55.67 -27.81 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.363 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -68.25 -22.33 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.9 p -95.82 25.63 4.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 75' ' ' LEU . . . 91.27 77.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.578 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -168.36 39.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.879 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.032 HD23 ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -158.3 136.55 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.922 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' N ' ' HB2' ' A' ' 268' ' ' ALA . . . -104.41 130.46 52.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' HG22 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -68.4 138.76 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.438 HD11 ' HG ' ' A' ' 103' ' ' LEU . 18.2 pt -83.66 162.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -89.2 147.74 39.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.66 110.96 2.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.613 2.209 . . . . 0.0 112.44 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -176.77 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -21.83 47.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.779 ' HB1' ' CH2' ' A' ' 94' ' ' TRP . . . -54.8 -23.16 16.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.551 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -59.22 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.382 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.2 -24.64 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.714 ' OD2' HD12 ' A' ' 89' ' ' LEU . 13.7 p-10 -73.94 -20.58 60.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.35 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 53.15 48.57 21.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.89 0.376 . . . . 0.0 111.255 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.714 HD12 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -102.12 155.49 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -96.32 145.0 28.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.16 -26.66 43.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.509 2.14 . . . . 0.0 112.345 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -56.62 -30.57 63.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -90.7 -29.76 17.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.779 ' CH2' ' HB1' ' A' ' 84' ' ' ALA . 34.1 m0 -70.1 -47.57 61.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -59.51 -30.71 68.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.6 83.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 97' ' ' VAL . 18.9 t -95.15 43.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -99.37 89.44 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 120.15 35.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 p30 44.43 38.66 2.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.13 31.12 78.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.642 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -145.62 160.05 42.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -105.8 93.23 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.601 ' HB ' HD13 ' A' ' 76' ' ' LEU . 4.5 pt -114.43 39.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' O ' HG11 ' A' ' 97' ' ' VAL . . . -176.25 125.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.73 116.23 57.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.81 133.82 10.46 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.466 2.11 . . . . 0.0 112.419 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 7.3 pt -156.07 39.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.045 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 169.58 102.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.95 HG22 HG21 ' A' ' 320' ' ' THR . 14.6 p -101.86 116.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.326 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -116.98 132.58 56.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.67 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.48 176.56 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.188 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.83 171.37 7.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 319' ' ' ALA . 0.2 OUTLIER -164.33 -177.41 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.904 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HG ' ' A' ' 247' ' ' LEU . 3.3 mt -109.6 149.88 29.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 pt -110.48 140.53 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.186 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.77 130.87 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.29 162.09 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.5 37.7 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -90.19 -35.13 15.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 121' ' ' LEU . 3.5 pp -157.73 39.98 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.533 ' CD2' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -137.55 131.07 17.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 157.78 41.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.257 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -65.08 110.77 4.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.6 140.29 86.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.477 2.118 . . . . 0.0 112.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.56 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.228 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.42 -39.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 130' ' ' GLU . 14.0 t -70.94 152.23 43.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.691 ' CE3' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -60.14 -23.56 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 128' ' ' THR . 33.4 mt-10 -45.26 -23.47 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HD13 ' A' ' 135' ' ' LEU . 4.8 pt-20 -48.78 -31.0 6.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.691 HD11 ' CE3' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -73.53 -62.58 1.14 Allowed Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.324 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 132' ' ' ILE . 82.9 Cg_exo -45.67 -34.42 11.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.232 1.955 . . . . 0.0 112.407 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.53 61.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 131' ' ' GLU . 9.1 mp -77.79 -28.77 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -43.42 75.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -68.73 -28.03 66.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.4 tt0 -81.83 -50.84 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 146' ' ' ALA . 19.5 mt -57.92 -55.83 29.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -58.72 -24.66 61.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -57.16 -25.51 59.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -111.21 -67.47 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.4 39.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -142.07 -177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD13 ' A' ' 139' ' ' LEU . 48.3 t -150.37 157.54 43.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.013 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.797 ' CB ' ' HB3' ' A' ' 223' ' ' ALA . . . -107.6 42.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER 176.84 115.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.77 106.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 226' ' ' ILE . 2.3 t80 -156.36 176.74 12.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -169.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.82 HD12 HG23 ' A' ' 208' ' ' THR . 11.5 mt -148.81 -46.01 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.35 44.2 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -108.25 166.78 10.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 150.97 22.38 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.949 2.433 . . . . 0.0 112.173 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.31 55.24 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.449 ' O ' HD13 ' A' ' 160' ' ' LEU . 77.8 t80 -120.93 -49.57 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 161' ' ' ILE . 63.6 m -73.42 -42.84 61.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.52 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 9.8 t90 -55.72 -53.88 57.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.429 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.53 -24.17 42.47 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.17 1.913 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 195' ' ' LEU . 5.0 mp -81.57 -56.77 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 157' ' ' THR . 3.3 tt -67.27 -21.81 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -64.54 -30.35 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.201 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 250' ' ' PHE . . . -67.32 -25.16 65.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.286 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.55 -41.35 18.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.097 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.98 -82.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.596 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.09 -38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.551 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.595 ' OH ' HG11 ' A' ' 343' ' ' VAL . 38.8 t80 70.16 -65.69 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.062 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.444 HG21 ' CE1' ' A' ' 339' ' ' PHE . 27.4 t -94.08 -31.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 111.08 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.583 ' OD1' ' HB3' ' A' ' 364' ' ' ALA . 26.6 m-20 -123.52 72.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -128.92 -176.67 3.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.07 78.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.61 -52.06 32.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.522 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -62.92 -30.8 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -61.05 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 194' ' ' PHE . . . -77.77 -43.77 29.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -54.27 -26.21 35.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.761 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.754 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.4 tp -81.68 -58.17 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.769 0.319 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.7 t -64.2 -28.87 70.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.024 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.597 ' CE1' ' HB1' ' A' ' 190' ' ' ALA . 2.6 m-85 -56.99 -63.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.13 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 160' ' ' LEU . 4.3 mm? -62.41 -46.63 87.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.19 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 192' ' ' LEU . 36.4 t -59.3 -46.96 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.02 -36.44 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.46 -58.89 6.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.063 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 28.8 pt -49.84 -27.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -77.59 -31.7 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.991 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.7 18.32 22.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.399 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -41.75 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -114.56 -51.67 2.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 169.54 -75.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -156.39 153.03 28.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.746 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -65.13 77.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -164.95 31.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.82 HG23 HD12 ' A' ' 151' ' ' LEU . 17.3 p -61.98 139.98 58.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.528 ' H ' HD13 ' A' ' 212' ' ' ILE . 4.7 m-20 -108.76 -150.73 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.1 -53.0 7.43 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.105 0.479 . . . . 0.0 110.083 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 1.1 m -56.88 -24.42 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 212' ' ' ILE . 2.7 mp -81.94 -58.85 3.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.015 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.32 -30.42 70.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -22.6 38.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.443 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -47.75 -55.58 9.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.489 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.66 -54.94 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.931 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -47.38 -28.47 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -41.35 23.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -106.78 -23.58 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.773 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 55.01 46.74 76.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.41 43.02 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 111.23 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.77 -177.63 3.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.797 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . . . -82.82 38.67 0.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.894 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.577 ' HE2' ' HA ' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.8 99.22 0.11 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.04 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.51 105.31 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.807 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 23.7 mm -82.77 138.53 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 227' ' ' ASN . 1.3 p-10 -97.45 112.22 24.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -111.84 159.83 13.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.344 0.303 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 4.6 p90 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.796 0.331 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -151.7 150.76 22.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 315' ' ' PRO . 10.3 p -122.71 127.72 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.8 p -141.12 162.74 34.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.182 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 322' ' ' GLU . 15.8 m -86.6 150.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.045 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 247' ' ' LEU . 1.2 mp -59.76 151.68 61.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.71 -158.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.914 2.41 . . . . 0.0 112.343 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -77.94 177.82 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CB ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -152.36 111.54 3.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? 60.1 17.71 7.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 120.66 -24.95 7.42 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.684 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.61 140.04 18.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.31 169.04 21.97 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.449 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.5 m -58.31 -175.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.005 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -144.15 73.72 16.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.49 174.13 12.25 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.223 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -111.81 135.22 52.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' ILE . 21.5 t -77.97 154.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -107.66 77.99 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.612 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 m -88.81 132.09 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.756 0.313 . . . . 0.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 4.9 tp -79.29 127.48 32.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.003 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -91.32 110.52 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.764 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' CE2' ' A' ' 61' ' ' PHE . . . -126.79 117.71 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -177.61 -169.99 39.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.618 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 276' ' ' ALA . 3.9 mp -100.82 159.22 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 266' ' ' ILE . 53.5 p30 -88.79 158.2 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.624 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -97.46 29.08 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -100.64 -30.7 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 t -118.2 146.66 39.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 74.86 2.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.488 2.125 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 2.4 t30 -117.48 35.42 4.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -66.03 -48.97 69.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.57 -36.09 70.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mt -76.35 -29.68 57.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -58.37 -40.82 83.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -74.23 -29.38 61.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.09 -35.19 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.713 ' CE1' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 280' ' ' LEU . 3.7 mm? -60.38 -25.61 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -14.06 62.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.521 ' ND2' HG12 ' A' ' 23' ' ' VAL . 27.7 t30 -88.95 27.93 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.348 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.92 35.46 1.69 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 110.725 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.75 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -101.24 28.3 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.795 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 290' ' ' LEU . 5.9 tp -147.0 28.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.0 t -136.84 155.62 49.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -57.63 -20.99 36.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.305 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 292' ' ' ALA . 3.8 mt-10 -75.17 -38.13 61.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.418 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 286' ' ' THR . . . -119.64 -50.51 0.29 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.032 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 284' ' ' LEU . 25.1 tp -54.59 -55.14 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.809 0.338 . . . . 0.0 111.392 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.1 -32.93 44.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.734 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -77.17 -58.59 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 19' ' ' GLY . 28.8 t -82.03 -60.62 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.412 ' OD1' HD23 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -56.27 -21.65 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.879 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.765 ' O ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -111.76 -20.04 12.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.377 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 37.6 t70 54.68 90.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 64.65 165.9 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.6 144.63 79.37 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.504 2.136 . . . . 0.0 112.375 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 295' ' ' LYS . 2.5 pp -174.74 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 299' ' ' LEU . . . -119.21 160.79 14.11 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 317' ' ' ILE . . . -132.95 105.04 6.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.876 0.37 . . . . 0.0 111.391 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.549 HG21 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.99 44.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.198 0.523 . . . . 0.0 110.645 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.77 88.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.668 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER 77.17 115.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -55.28 -23.98 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.9 m -53.94 -52.41 60.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.36 -30.4 37.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.624 ' HG3' ' HB1' ' A' ' 301' ' ' ALA . 8.3 tt0 -59.14 -27.74 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -56.98 -37.18 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.62 -44.61 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 23.8 mt -62.53 -18.6 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.09 -25.87 9.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 111.502 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -58.4 -27.57 64.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 146.57 95.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.803 ' HA ' HG11 ' A' ' 244' ' ' VAL . 49.1 Cg_exo -55.8 -51.42 9.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.39 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 320' ' ' THR . 7.9 mtm180 -55.44 -56.26 22.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 301' ' ' ALA . 3.9 mm -52.92 -55.34 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.49 75.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 114' ' ' SER . . . -69.7 -56.56 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.95 HG21 HG22 ' A' ' 110' ' ' VAL . 32.9 p -62.97 -29.96 71.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.53 -52.25 66.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.638 ' HB3' HG21 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -77.8 -45.63 23.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.13 -30.49 66.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.14 67.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -40.2 96.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.72 -58.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.04 177.46 54.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.425 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.424 ' HG2' HD13 ' A' ' 329' ' ' ILE . 1.1 tt0 -154.22 151.44 29.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 0.0 110.892 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.782 HG22 ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -49.17 138.17 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.42 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -127.47 137.67 31.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 -168.37 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.578 2.185 . . . . 0.0 112.387 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -136.44 76.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.587 HD12 ' HB2' ' A' ' 335' ' ' GLN . 25.2 pt -86.2 148.6 47.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.08 -27.9 38.62 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.675 2.25 . . . . 0.0 112.323 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.587 ' HB2' HD12 ' A' ' 333' ' ' ILE . 10.4 mt-30 -58.96 -41.59 87.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -66.65 -31.72 72.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -44.28 97.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.56 72.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 343' ' ' VAL . 40.3 m-85 -71.05 -37.51 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.12 97.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -59.36 -52.09 67.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 346' ' ' ALA . . . -59.79 -46.91 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.9 t -69.5 -29.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -59.42 -60.66 3.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 9.2 t -71.64 -41.18 69.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -46.37 -56.34 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.586 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.37 -55.76 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.813 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.8 mm -57.08 -58.75 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.728 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 345' ' ' THR . 1.0 OUTLIER -59.49 -27.91 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.671 0.272 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -61.92 -57.07 13.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -60.82 -10.57 5.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.004 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.5 m -110.04 26.63 10.45 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.614 0.245 . . . . 0.0 111.385 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 154.3 -71.53 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.005 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -87.76 51.63 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.464 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.519 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -79.37 99.29 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 1.5 t -166.22 97.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.86 -27.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.324 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -57.49 -45.72 84.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -80.01 -43.91 21.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.82 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -56.35 -37.77 70.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 -53.06 6.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -58.83 -55.69 31.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -59.28 -44.11 92.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -58.48 -32.41 68.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.0 m -72.66 -31.26 64.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -40.77 68.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.409 HD12 ' HE1' ' A' ' 339' ' ' PHE . 31.8 mm -71.22 -35.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 18.8 m 61.3 51.02 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.44 28.64 21.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 12.8 mttm -114.92 130.27 56.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.833 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 6' ' ' LYS . 4.3 mm? -129.1 148.56 51.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.8 m -126.48 102.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 20' ' ' LEU . 3.9 mt -94.87 114.87 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.561 ' CH2' HD13 ' A' ' 43' ' ' LEU . 95.5 m95 -105.83 111.96 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 12' ' ' ASN . 4.7 mt -118.25 157.27 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' ILE . 1.7 t30 -170.31 40.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.91 25.7 3.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.92 31.81 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 110.785 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -165.91 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.11 63.86 0.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.543 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -62.9 -29.59 70.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 111.058 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -59.34 -47.18 86.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.68 -28.3 65.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 9' ' ' ILE . 56.6 tp -64.76 -32.81 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.17 72.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -31.41 65.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.45 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.55 -35.18 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -59.73 -28.44 67.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -68.02 -33.45 74.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' HG21 ' A' ' 33' ' ' ILE . 9.3 m-85 -78.08 -50.6 11.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.542 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -51.54 -27.93 12.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.464 0.65 . . . . 0.0 110.425 179.127 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.45 -26.4 66.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.301 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 31' ' ' THR . 7.4 m-20 -64.32 -57.19 10.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.98 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.611 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.841 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.89 48.49 0.01 OUTLIER Glycine 0 C--N 1.338 0.682 0 C-N-CA 117.873 -2.108 . . . . 0.0 115.566 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.4 mm -139.27 95.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 118.071 0.935 . . . . 0.0 111.676 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.27 113.76 26.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 7' ' ' LEU . 30.2 m -98.85 139.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.29 119.63 39.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.9 112.97 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -151.84 163.08 39.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -104.73 142.05 23.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.15 155.62 37.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.551 2.167 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -178.84 -51.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -111.57 -23.31 10.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' CH2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -79.77 -1.12 37.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.545 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -54.4 -30.36 51.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.041 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -90.4 -30.9 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -72.46 -24.53 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -52.8 -59.31 9.15 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.303 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.2 Cg_endo -63.1 -17.25 59.24 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.482 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -89.69 -43.84 10.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG23 ' HG2' ' A' ' 46' ' ' LYS . 29.8 t -82.76 -30.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.51 61.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -71.06 -31.89 68.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.33 55.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB2' HG12 ' A' ' 50' ' ' VAL . 13.5 t0 -59.41 -34.08 72.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.36 -93.92 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.569 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.519 ' HB2' HG22 ' A' ' 8' ' ' VAL . 60.8 Cg_endo -72.85 -173.42 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.581 2.187 . . . . 0.0 112.4 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.8 t0 178.97 60.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.773 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mm -99.01 121.07 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 3.2 tt -146.68 141.62 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.5 136.87 52.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.583 ' CZ3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.17 173.31 15.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -76.9 -53.26 8.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.39 -28.44 65.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 13.0 mmt180 -57.54 -29.17 64.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HZ ' HG23 ' A' ' 60' ' ' ILE . 48.3 m-85 -107.52 -37.4 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.86 -23.47 51.05 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.653 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.28 4.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.651 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.65 -59.38 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.074 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -57.3 -29.76 64.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.26 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -67.53 -27.05 66.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 t -70.19 -26.73 64.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.088 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.31 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.84 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.682 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -165.36 127.9 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' N ' HD13 ' A' ' 76' ' ' LEU . . . -69.16 126.56 30.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.09 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -73.05 132.73 43.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tt -102.87 147.56 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.4 p -98.03 145.87 30.52 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.84 146.71 18.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.94 -55.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -30.48 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.79 -23.39 42.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -79.25 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.5 -26.54 67.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 89' ' ' LEU . 1.2 m-20 -76.43 -41.9 45.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.812 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.65 40.05 13.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -82.3 -177.32 6.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -66.91 112.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 78.1 Cg_exo -50.51 -25.21 13.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.514 2.143 . . . . 0.0 112.482 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -21.07 41.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 90' ' ' TYR . 57.5 p -69.39 -53.95 16.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.442 ' CE3' ' N ' ' A' ' 95' ' ' ASP . 46.9 p-90 -92.92 -45.31 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 6.7 t70 -53.29 -26.72 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.288 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB1' HD11 ' A' ' 329' ' ' ILE . . . -80.56 -28.88 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.235 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.802 HG21 ' O ' ' A' ' 105' ' ' ALA . 11.3 p -114.57 63.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.34 104.66 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -94.44 93.1 7.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.61 -70.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.06 30.89 0.19 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -127.57 96.61 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -92.48 102.69 15.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.761 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -133.88 39.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.025 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.802 ' O ' HG21 ' A' ' 97' ' ' VAL . . . -172.42 93.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 t80 -98.95 141.73 23.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.71 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.3 Cg_endo -79.85 138.76 13.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.608 2.205 . . . . 0.0 112.205 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 107' ' ' PRO . 18.0 mm -143.6 39.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.245 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 173.26 99.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.976 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 317' ' ' ILE . 9.2 p -89.34 111.21 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -104.27 133.16 49.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.36 170.05 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.003 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.17 152.31 50.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.955 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 t -164.92 -176.06 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -107.53 138.18 44.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 244' ' ' VAL . 3.0 pt -130.17 140.22 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.088 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -152.76 165.66 34.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -80.32 168.8 18.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.89 36.9 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.68 -64.01 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -97.38 48.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.63 103.68 10.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.24 160.36 49.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.431 2.088 . . . . 0.0 112.313 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.19 110.85 4.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.09 124.66 11.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.439 2.093 . . . . 0.0 112.278 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.4 2.066 . . . . 0.0 112.238 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -101.04 -30.59 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 129' ' ' TRP . 1.5 m -126.62 169.11 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.519 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -72.58 -31.28 65.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -23.71 17.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.549 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.19 -16.33 40.69 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 147' ' ' LEU . 42.0 mt -65.55 -47.41 67.93 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 89.2 Cg_exo -46.38 -30.02 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.366 2.044 . . . . 0.0 112.629 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.89 60.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.11 -45.81 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.171 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 3.5 p30 -54.12 -28.69 41.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.208 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 15.8 tttt -55.79 -42.69 75.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -81.79 -33.31 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.79 -55.9 16.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -52.51 -25.01 9.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.54 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -112.2 -50.42 2.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.76 41.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.653 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -155.24 179.2 9.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -128.47 165.62 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -86.24 3.99 40.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.67 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER 170.8 151.19 0.05 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.859 0.362 . . . . 0.0 110.995 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 216' ' ' ALA . 6.4 tpt -117.77 144.75 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.09 145.86 40.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.0 170.79 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 12.5 mt -131.19 -46.5 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -98.5 39.72 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.732 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 93.87 8.68 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.55 112.78 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.153 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.07 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.464 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -111.94 -30.63 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.5 t -70.43 -27.09 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -70.22 -56.01 7.43 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.272 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 42.1 Cg_endo -67.13 -16.19 48.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.37 2.047 . . . . 0.0 112.446 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 255' ' ' SER . 1.7 tm? -78.18 -56.72 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.626 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.58 ' CG2' HD13 ' A' ' 195' ' ' LEU . 29.0 pt -65.09 -16.76 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 166' ' ' GLY . . . -84.61 -70.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.992 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.58 -80.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.2 -41.93 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.003 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.29 -35.49 65.68 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 162' ' ' ALA . . . -59.66 116.97 9.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.566 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.14 78.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.31 -31.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -116.55 36.57 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 177.63 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.23 -30.93 58.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.43 -52.65 49.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.71 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.705 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -60.4 -56.89 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.82 -30.66 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.05 -45.47 95.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 -46.89 39.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.968 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 189' ' ' LYS . 58.9 p -59.89 -29.04 68.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.4 -53.07 62.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.58 HD13 ' CG2' ' A' ' 161' ' ' ILE . 3.4 tp -59.83 -50.39 73.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.7 t -59.74 -37.8 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -27.68 56.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.45 -49.62 12.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 200' ' ' LYS . 2.3 pp -57.16 -40.16 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.495 ' N ' HD12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -72.08 -28.08 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -26.23 62.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -118.46 -67.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -65.15 -28.78 69.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 mtm 69.28 -67.41 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.41 -48.42 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.23 -58.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.4 t0 78.1 -55.18 0.5 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.107 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -79.82 147.86 31.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.873 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 t0 -144.0 -162.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.358 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 211' ' ' SER . 39.4 p90 -78.83 -46.02 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 110.392 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.7 p -81.08 -25.64 36.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.045 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.45 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 1.107 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.58 -30.36 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.625 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.6 tm-20 -70.41 -22.74 62.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.72 7.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.68 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -81.75 -41.99 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -75.98 -58.7 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -62.73 -32.94 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -23.47 16.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.632 0.253 . . . . 0.0 111.33 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.54 52.15 8.78 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.066 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.26 39.41 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.34 . . . . 0.0 111.121 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.4 HG23 ' HB1' ' A' ' 216' ' ' ALA . 20.8 p -149.58 -177.69 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.856 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -83.55 39.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.465 ' HG2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 173.66 128.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.925 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 116' ' ' ILE . 1.3 t -144.54 106.35 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.464 HD13 ' CD2' ' A' ' 156' ' ' PHE . 14.6 mt -78.99 141.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -86.81 112.48 21.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.08 -157.17 33.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 112.348 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.08 171.85 21.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 116' ' ' ILE . 19.5 t -113.29 136.36 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 111.112 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 115' ' ' LEU . 9.4 t -125.24 159.41 31.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.62 150.55 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.91 156.82 33.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.82 -168.33 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 t -123.99 177.48 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 253' ' ' GLN . 54.7 p90 -167.18 117.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt 64.17 16.24 9.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.62 33.04 28.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.667 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.409 ' O ' ' CE1' ' A' ' 250' ' ' PHE . 16.6 pt20 -156.19 90.63 2.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 111.003 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.52 161.08 47.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.788 2.326 . . . . 0.0 112.154 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.609 ' HB3' HD22 ' A' ' 160' ' ' LEU . 81.1 p -57.43 163.8 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -105.15 99.53 20.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 130.06 8.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.468 2.112 . . . . 0.0 112.249 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -111.87 139.75 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.11 150.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.72 160.39 28.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.621 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 m -129.85 144.96 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.861 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -88.0 126.29 35.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.978 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 28.3 m -91.71 125.88 36.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.62 140.12 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.58 168.12 34.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.404 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.1 tt -101.67 158.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.016 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -73.64 173.16 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -94.23 -27.4 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -30.95 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 p -76.75 122.36 86.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.18 -1.46 11.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.498 2.132 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -96.37 38.27 1.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -75.04 -31.05 61.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -60.33 -42.89 96.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.5 tp -75.59 -28.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.024 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 279' ' ' PHE . . . -76.8 -32.35 57.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.306 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -79.13 -30.76 43.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.54 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 279' ' ' PHE . 12.9 pt-20 -76.18 -48.72 19.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.7 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -70.25 -24.22 63.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.239 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 284' ' ' LEU . 6.5 tp -78.89 -29.9 44.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -105.56 -14.47 15.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.759 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 283' ' ' TYR . 14.7 m120 -111.06 27.42 9.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.685 0.278 . . . . 0.0 111.621 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 282' ' ' ASN . 6.7 m-85 -168.69 -52.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.185 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.41 HD13 HD12 ' A' ' 280' ' ' LEU . 2.7 tp -46.41 -66.51 0.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 290' ' ' LEU . 2.6 mt -95.72 63.25 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.0 m -154.78 166.33 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.75 -20.31 55.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.46 -29.57 52.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.181 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -111.46 -52.92 0.54 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.761 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 285' ' ' LEU . 1.3 tp -50.64 -27.3 6.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.91 -26.03 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.264 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.79 -57.94 3.53 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.381 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 297' ' ' LYS . 1.8 m -62.42 -28.78 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.634 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 297' ' ' LYS . 2.1 t-20 -22.2 -48.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -50.78 -27.77 7.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.785 ' O ' HD23 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -135.62 -13.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.962 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 298' ' ' PRO . 0.0 OUTLIER -45.52 -49.81 33.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 297' ' ' LYS . 59.5 Cg_endo -73.73 104.52 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.301 2.0 . . . . 0.0 112.556 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 296' ' ' ASP . 3.9 pp -177.94 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.655 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.633 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 177.82 72.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -179.31 93.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 308' ' ' GLU . 34.9 t -154.89 109.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.76 40.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 307' ' ' TYR . 3.2 mp -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -59.34 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 m -79.15 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.6 ' HB3' HD22 ' A' ' 304' ' ' LEU . 0.5 OUTLIER -80.29 -35.75 35.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -54.97 -25.27 28.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.234 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.47 -61.34 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.052 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.25 -31.16 14.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.422 ' CD2' HD23 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -71.92 -55.71 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 308' ' ' GLU . . . -77.38 -54.25 6.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt 54.1 30.06 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.06 110.42 18.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.68 -13.09 31.78 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.602 2.202 . . . . 0.0 112.615 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.95 4.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.719 0.295 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -58.51 -32.73 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.25 58.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.58 -26.47 61.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 317' ' ' ILE . 12.1 t -55.6 -29.44 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.9 mmm -59.4 -30.44 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.33 -52.59 13.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.6 -31.04 67.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.66 69.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -59.88 -31.13 69.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 36.35 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -172.57 171.42 44.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.07 147.18 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.452 HD11 ' HB1' ' A' ' 96' ' ' ALA . 27.6 pt -59.33 130.35 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -178.47 136.62 0.34 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -178.19 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.454 2.103 . . . . 0.0 112.272 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.687 ' C ' HD12 ' A' ' 333' ' ' ILE . 16.3 t-20 -127.31 36.5 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 332' ' ' ASN . 3.4 mp 64.13 127.76 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.46 -27.68 32.82 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.089 . . . . 0.0 112.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 333' ' ' ILE . 21.9 tt0 -58.28 -31.26 67.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.41 -28.47 68.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.9 m -58.65 -59.26 5.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.62 -27.46 66.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.5 OUTLIER -56.37 -24.32 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 343' ' ' VAL . 0.8 OUTLIER -57.31 -27.32 62.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -52.29 13.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.179 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.23 59.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.32 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 339' ' ' PHE . 27.4 m -56.29 -29.93 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.448 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.766 ' HG2' HD12 ' A' ' 348' ' ' ILE . 1.8 ttt85 -52.55 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 11.5 m -69.35 -27.66 65.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -60.5 -60.56 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.416 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.52 -57.02 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.087 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.766 HD12 ' HG2' ' A' ' 344' ' ' ARG . 27.1 mt -52.15 -58.79 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 345' ' ' THR . 0.1 OUTLIER -62.34 -31.06 71.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.75 0.31 . . . . 0.0 111.193 -179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -57.67 -30.02 65.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.17 -9.87 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.1 t -67.28 -22.82 65.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 110.46 -29.34 9.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.441 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 39.2 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -163.96 122.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.8 OUTLIER -104.77 171.06 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 361' ' ' LEU . 25.4 t -72.21 -31.71 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.21 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.53 -33.85 71.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.14 -53.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.572 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -57.13 -30.08 64.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 357' ' ' VAL . 21.1 mt -82.32 -56.63 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 366' ' ' THR . 10.7 mttm -64.07 -44.72 91.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 -35.36 80.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -79.78 -55.42 5.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -34.91 24.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 362' ' ' LYS . 12.8 t -80.48 -29.5 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.55 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.008 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 339' ' ' PHE . 33.7 mm -64.35 -47.24 90.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.8 m -66.72 -58.68 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.39 45.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 168.98 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 279' ' ' PHE . 67.4 mt -149.95 139.43 21.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 36' ' ' THR . 29.8 t -113.08 102.83 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 mp -97.51 129.95 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.774 ' CZ3' HD22 ' A' ' 43' ' ' LEU . 8.9 t90 -94.9 113.28 24.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -147.79 141.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -165.3 78.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.98 35.93 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.564 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.7 89.09 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.747 0.308 . . . . 0.0 110.991 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 mttp -152.92 81.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.51 78.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -80.94 -56.59 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -76.12 -32.26 59.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.83 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -64.11 -41.71 98.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.567 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.73 -31.53 59.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.68 -42.11 74.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.94 -33.31 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 19' ' ' GLY . 22.8 t -70.32 -35.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.44 -34.63 81.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.597 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -69.51 -28.38 66.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.983 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.3 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.778 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 6.9 m-85 -64.27 -56.39 14.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -58.36 -28.16 64.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.141 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 -26.98 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.644 ' O ' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -64.94 -57.3 9.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.828 HG22 ' O ' ' A' ' 31' ' ' THR . 5.9 m 156.45 36.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.731 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.48 52.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.705 0 C-N-CA 117.96 -2.067 . . . . 0.0 115.452 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 2.5 mm -138.36 95.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 118.168 0.984 . . . . 0.0 111.459 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.29 108.92 20.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.028 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.26 138.07 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.408 ' CG2' HG22 ' A' ' 8' ' ' VAL . 1.7 t -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 0.0 111.173 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.15 120.96 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -96.34 153.96 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.013 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.15 167.37 12.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.98 92.56 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.609 2.206 . . . . 0.0 112.35 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -177.43 -40.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.021 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -109.65 -29.09 8.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -57.42 -23.81 51.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.211 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.21 -28.74 55.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.09 -26.79 18.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.045 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 50' ' ' VAL . 36.8 mttm -69.49 -29.38 67.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.431 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.94 -60.77 7.83 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.143 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.0 Cg_endo -66.28 -15.83 49.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.553 2.169 . . . . 0.0 112.512 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.35 -55.22 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.789 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.3 p -73.92 -24.8 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.16 -31.28 65.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -65.1 -43.42 92.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.068 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.42 152.09 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.45 85.43 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.535 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.05 -35.94 16.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.38 -157.59 7.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.536 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.42 -175.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.585 2.19 . . . . 0.0 112.25 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 173.68 49.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -99.03 127.43 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 10' ' ' TRP . 32.6 pt -151.58 138.76 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' CD1' ' HB1' ' A' ' 264' ' ' ALA . 7.6 m-85 -116.12 148.97 39.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.445 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -165.78 173.7 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.41 -173.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.525 ' NE2' HG12 ' A' ' 97' ' ' VAL . 2.1 t-160 -76.82 -53.18 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.21 66.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -110.01 -23.17 11.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.45 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.725 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.72 -24.81 68.95 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.717 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -64.45 -53.1 53.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.962 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -59.49 -55.58 32.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -27.05 66.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -75.83 -26.85 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 -81.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.84 87.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.705 HD23 ' HB ' ' A' ' 104' ' ' ILE . 1.1 tp -117.52 141.51 48.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.91 119.86 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' A' ' 104' ' ' ILE . 9.8 pt-20 -61.22 159.34 12.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mt -126.24 148.94 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 m -120.41 92.66 47.71 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.48 114.41 3.26 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.954 2.436 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.27 -35.3 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -30.64 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB1' ' HZ2' ' A' ' 94' ' ' TRP . . . -53.46 -22.94 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.617 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -80.16 -57.77 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 111.217 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -24.61 58.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 18.1 p-10 -62.4 -17.72 59.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.339 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 66.71 71.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.353 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -105.36 155.92 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.443 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -83.95 134.38 44.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.78 -25.92 36.62 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.469 2.113 . . . . 0.0 112.296 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -55.69 -30.29 60.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 97' ' ' VAL . 5.1 m -75.72 -31.34 59.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.513 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 66.2 m95 -73.13 -48.02 39.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.39 -27.89 62.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 -30.02 57.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.208 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HD3' ' A' ' 107' ' ' PRO . 29.5 m -134.66 68.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.251 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -149.26 140.71 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.3 174.04 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.47 68.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.08 37.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -145.48 159.14 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.822 0.344 . . . . 0.0 110.837 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.1 mp -141.94 85.96 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -136.87 40.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.9 131.43 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.04 118.6 10.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.812 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.762 ' O ' HD13 ' A' ' 108' ' ' ILE . 94.1 Cg_endo -79.7 124.77 5.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.453 2.102 . . . . 0.0 112.463 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 107' ' ' PRO . 21.8 mm -141.2 39.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.07 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.773 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.52 125.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 HG12 ' A' ' 302' ' ' VAL . 3.9 m -106.32 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.45 136.49 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 176.44 8.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 mt -81.26 149.0 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.615 ' HB3' HG13 ' A' ' 244' ' ' VAL . 2.0 m -164.71 170.9 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 223' ' ' ALA . 12.1 tp -103.09 136.63 42.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 225' ' ' THR . 31.6 mm -111.64 125.85 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 51.1 p90 -128.18 152.4 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -105.04 176.98 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 30.83 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.41 -57.86 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 222' ' ' THR . 1.5 tt -140.28 82.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 ' N ' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -122.36 106.07 35.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 160.34 50.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.45 2.1 . . . . 0.0 112.346 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.9 149.43 98.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.28 119.11 6.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.555 2.17 . . . . 0.0 112.214 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.04 -71.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.353 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -177.15 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.68 -176.31 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.806 ' CZ3' HD13 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -65.5 -26.74 68.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 64.3 mm-40 -51.46 -24.07 4.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.383 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -15.81 33.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.592 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.806 HD13 ' CZ3' ' A' ' 129' ' ' TRP . 3.5 tt -52.44 -35.66 25.61 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.742 ' HD3' HG22 ' A' ' 132' ' ' ILE . 17.2 Cg_exo -67.93 -31.41 31.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.207 1.938 . . . . 0.0 112.104 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.51 63.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 146' ' ' ALA . 4.3 mp -77.68 -38.12 48.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.78 -36.51 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -28.14 67.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.74 -31.58 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.838 HD13 ' CB ' ' A' ' 145' ' ' SER . 11.9 tp -60.48 -55.94 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -30.36 67.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.08 76.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.038 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -139.39 -60.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.775 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.03 41.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -126.63 121.94 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.838 ' CB ' HD13 ' A' ' 139' ' ' LEU . 9.9 t -140.69 170.67 15.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.504 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.652 ' HB3' HD22 ' A' ' 135' ' ' LEU . . . -147.15 13.38 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.762 ' HB3' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER 170.67 115.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 111.717 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.412 ' N ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -121.35 148.8 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.129 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.99 132.96 21.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.019 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB1' ' A' ' 213' ' ' ALA . 2.3 m-80 -61.1 -176.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.787 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.789 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.1 OUTLIER -124.7 -47.43 1.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.482 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.91 39.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.82 157.85 33.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.74 149.93 21.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.563 2.175 . . . . 0.0 112.315 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 61.57 67.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.596 ' CE2' HG23 ' A' ' 157' ' ' THR . 20.3 p90 -120.31 -39.3 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.691 ' HB ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -63.6 -36.51 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.578 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 3.1 t-105 -67.95 -55.7 12.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.442 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -64.21 -11.72 29.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.276 1.984 . . . . 0.0 113.142 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.48 -56.79 2.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.643 0.259 . . . . 0.0 111.59 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 157' ' ' THR . 42.8 mt -65.81 -20.16 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.821 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -89.37 12.2 16.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -64.2 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.5 -51.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.059 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.75 -86.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -56.14 142.86 38.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -169.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.05 -38.37 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.3 61.05 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -122.96 168.71 11.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.37 -33.02 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.98 -32.38 36.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.46 74.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -60.45 -46.07 91.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.18 -35.2 31.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.03 -28.31 73.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.663 HD13 HG12 ' A' ' 357' ' ' VAL . 1.6 tt -82.53 -50.43 8.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 p -57.58 -28.93 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 2.1 m-85 -55.0 -60.63 3.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.51 -30.78 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.968 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.3 t -69.04 -54.03 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.3 -32.35 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.07 -55.98 27.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.708 HG12 HD21 ' A' ' 151' ' ' LEU . 6.2 mt -61.71 -33.71 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -33.29 71.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.968 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -106.51 19.34 20.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.28 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 -54.99 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.813 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.37 -46.15 3.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.833 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.8 ttm 58.34 44.31 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -176.79 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 65.76 77.09 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -143.96 30.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.789 HG21 ' HB2' ' A' ' 151' ' ' LEU . 3.2 t -81.8 148.08 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -124.01 -165.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 211' ' ' SER . 30.3 p90 -78.92 -44.26 23.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.083 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.448 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 14.2 t -73.18 -24.67 60.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.353 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -81.9 -50.48 16.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.082 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.46 ' N ' HG22 ' A' ' 212' ' ' ILE . . . -67.74 -30.34 69.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.467 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 210' ' ' TYR . 4.4 tt0 -75.15 -25.69 58.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -51.55 -25.58 7.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.533 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.726 ' HB1' ' SD ' ' A' ' 224' ' ' MET . . . -57.01 -57.47 12.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.763 0.315 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.696 ' CE1' HG21 ' A' ' 225' ' ' THR . 20.2 t80 -69.57 -40.27 76.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -59.43 -49.6 77.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -94.25 -1.49 53.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.642 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 217' ' ' PHE . . . -147.81 87.35 0.16 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.725 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.25 59.75 2.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.657 . . . . 0.0 110.461 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 145' ' ' SER . 0.3 OUTLIER -107.58 -175.07 2.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.125 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.632 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . . . -77.8 44.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.726 ' SD ' ' HB1' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -116.87 45.88 1.76 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.829 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.696 HG21 ' CE1' ' A' ' 217' ' ' PHE . 1.8 t -143.56 114.63 7.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.7 mp -91.58 122.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -86.85 110.76 20.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.984 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 174.62 58.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -134.45 120.93 2.55 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.52 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 114' ' ' SER . 22.1 t -91.59 132.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 25.2 m -141.09 156.75 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.77 150.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.416 HD13 ' HD3' ' A' ' 248' ' ' PRO . 4.2 mm? -66.22 154.63 89.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.416 ' HD3' HD13 ' A' ' 247' ' ' LEU . 4.1 Cg_exo -79.78 -164.13 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.844 2.363 . . . . 0.0 112.135 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.854 HG22 ' HD3' ' A' ' 254' ' ' PRO . 21.8 p -97.29 177.95 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.509 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 79.8 m-85 -144.88 110.93 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.425 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 194' ' ' PHE . 0.0 OUTLIER 39.65 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.872 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 154.42 -59.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.803 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -150.87 166.06 15.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.854 ' HD3' HG22 ' A' ' 249' ' ' THR . 57.1 Cg_endo -70.96 173.83 11.45 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.682 2.255 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.66 179.46 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 125.85 66.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 -168.25 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.451 2.101 . . . . 0.0 112.333 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.19 119.62 13.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 328' ' ' GLU . 27.0 m -110.34 123.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.04 134.53 9.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 64' ' ' HIS . 14.4 m -97.39 144.87 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.773 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 6.3 tp -81.97 121.99 27.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.3 113.43 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 61' ' ' PHE . . . -116.75 145.82 43.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.023 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 176.94 -157.94 23.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.568 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.472 HD13 ' HB1' ' A' ' 276' ' ' ALA . 32.8 pt -137.95 155.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.802 0.334 . . . . 0.0 111.122 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.555 ' HB3' HD12 ' A' ' 76' ' ' LEU . 11.2 p30 -147.09 128.06 14.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.12 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -178.68 36.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.87 55.03 9.38 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.27 -45.56 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -151.88 80.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -30.24 71.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -69.56 -42.47 74.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 279' ' ' PHE . 6.2 tp -77.69 -31.24 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -73.61 -46.26 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -50.65 72.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.47 -40.66 92.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.414 ' CD2' ' HG ' ' A' ' 275' ' ' LEU . 1.1 m-85 -67.8 -53.87 23.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 280' ' ' LEU . 23.3 mt -57.43 -29.15 63.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -92.18 -25.04 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.86 27.33 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.018 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.738 ' C ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -112.82 -62.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.871 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 283' ' ' TYR . 3.8 mm? -139.07 57.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.3 mt -161.85 29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.759 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.1 t -154.76 177.35 11.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.87 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.4 -49.15 67.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -77.39 -28.08 52.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.759 ' H ' HG23 ' A' ' 286' ' ' THR . . . -66.49 -66.5 2.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.429 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.75 HD21 ' OH ' ' A' ' 307' ' ' TYR . 0.8 OUTLIER -59.05 -20.78 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.83 -31.4 27.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.29 6.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.407 ' CG2' ' HG ' ' A' ' 290' ' ' LEU . 11.2 m -64.31 -29.58 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -48.02 -28.6 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.39 -70.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -73.05 -50.01 25.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.789 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER 64.13 140.96 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.038 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.88 -2.23 10.78 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.689 2.26 . . . . 0.0 112.601 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 299' ' ' LEU . 2.8 mm? 61.78 46.51 6.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.96 83.87 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.514 ' CA ' HG22 ' A' ' 110' ' ' VAL . . . -166.98 133.59 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.222 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 110' ' ' VAL . 9.0 p -178.63 99.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.969 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.76 54.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 146.17 40.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -60.23 -37.37 80.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.1 m -79.54 -27.04 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.962 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.75 ' OH ' HD21 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -71.71 -40.93 69.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.76 -32.28 65.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.96 -37.64 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.649 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -74.34 -30.32 61.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.909 HD12 HG21 ' A' ' 302' ' ' VAL . 0.8 OUTLIER -45.49 -29.79 1.23 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.388 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.48 -29.49 50.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.215 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 30.93 4.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.97 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.4 172.83 8.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -88.04 -76.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.78 2.32 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -81.32 -58.83 2.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.406 HG22 HD21 ' A' ' 311' ' ' LEU . 2.0 mt -50.76 -28.14 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.409 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.15 75.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.56 -45.65 18.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -37.91 88.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -27.5 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.158 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -55.26 -46.86 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.27 -31.73 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.71 66.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.86 -32.19 67.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -111.15 36.36 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -135.04 -175.4 13.83 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 259' ' ' VAL . 6.0 mm-40 -120.42 -176.63 3.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.9 OUTLIER -118.98 116.01 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.436 ' CE ' ' CE1' ' A' ' 64' ' ' HIS . 7.2 ptp 43.84 52.94 9.67 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.516 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.7 97.66 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.553 2.169 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -134.5 -70.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.4 mt 63.72 139.11 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.73 -26.48 17.56 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.542 2.161 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.87 -27.23 63.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.4 tpt -57.57 -27.95 63.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.96 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.45 77.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.153 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.787 ' O ' HG12 ' A' ' 343' ' ' VAL . 4.3 t80 -59.97 -25.64 65.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.03 -38.7 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.049 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.549 ' O ' HG22 ' A' ' 345' ' ' THR . 0.1 OUTLIER -78.96 -44.27 22.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.73 96.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 339' ' ' PHE . 11.5 p -69.0 -30.37 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 341' ' ' TYR . 10.1 t -49.61 -27.58 4.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.364 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -75.42 -52.22 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.54 -55.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.987 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 344' ' ' ARG . 9.0 tp -53.48 -38.74 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.88 -28.35 35.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 111.146 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -55.07 -39.05 68.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.261 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.23 -14.28 44.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.5 p -67.69 -56.32 9.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.768 0.318 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -134.1 -70.8 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -173.44 39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -88.46 99.07 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 358' ' ' ASP . 11.1 t -103.31 -167.05 1.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.663 HG12 HD13 ' A' ' 192' ' ' LEU . 16.7 m -56.38 -27.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.709 ' H ' HG23 ' A' ' 356' ' ' THR . 3.3 t70 -46.79 -56.12 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -80.34 -41.17 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.613 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 357' ' ' VAL . . . -54.95 -53.09 60.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.258 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 357' ' ' VAL . 4.0 mm? -64.67 -56.87 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.477 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -41.38 84.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.471 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 366' ' ' THR . 8.7 t0 -76.51 -47.71 21.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.716 0.293 . . . . 0.0 111.131 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -66.79 -47.4 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.613 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.2 pp0? -52.31 -37.62 56.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.285 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 363' ' ' ASP . 14.1 t -80.68 -29.5 36.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -73.81 -41.85 61.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.4 mt -59.34 -47.24 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.087 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 370' ' ' LYS . 1.3 t -159.9 -52.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 369' ' ' THR . 5.7 tttm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.861 0.362 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.89 -72.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 172.77 13.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -111.04 160.01 17.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 57' ' ' PRO . 31.8 t -118.62 102.91 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 37' ' ' VAL . 7.7 pt -105.03 114.95 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.189 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.915 ' CB ' HG22 ' A' ' 60' ' ' ILE . 47.1 t90 -94.94 111.9 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 tt -164.88 158.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.64 -171.28 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 51.53 0.78 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.394 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.11 -26.74 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.603 0.24 . . . . 0.0 111.135 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -43.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.279 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 42.19 2.91 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.851 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 40.7 p90 -81.12 -46.64 14.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 40.4 m-20 -76.62 -37.46 56.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -39.03 89.73 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.46 -28.95 52.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.288 . . . . 0.0 110.986 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.46 -49.2 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.133 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.02 -50.54 73.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 27' ' ' PHE . 11.9 p -58.55 -30.89 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.72 -34.03 64.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -77.14 -28.28 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -29.7 70.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 37.6 m-85 -74.39 -56.77 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.606 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -60.84 -27.42 68.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.269 0.557 . . . . 0.0 110.417 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.22 -29.21 1.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.863 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.737 ' O ' HG23 ' A' ' 31' ' ' THR . 4.8 m-20 -66.33 -57.37 7.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.77 37.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.722 0.639 . . . . 0.0 112.037 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 47.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.67 0 C-N-CA 118.131 -1.985 . . . . 0.0 115.358 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -140.36 95.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 118.077 0.938 . . . . 0.0 111.63 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.37 129.77 52.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.77 130.47 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.1 p -105.71 121.59 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 9' ' ' ILE . 19.8 t -94.34 118.2 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.08 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -109.76 159.92 16.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.53 166.43 23.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 122.02 9.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.25 -75.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 0.09 27.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.51 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -55.06 -30.54 59.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 111.06 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -33.5 76.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.93 -29.21 15.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 tptm -69.93 -25.46 63.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.48 -60.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.6 Cg_endo -63.85 -15.42 48.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.642 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -38.4 22.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.633 HG23 ' HA3' ' A' ' 54' ' ' GLY . 10.0 p -92.25 -18.31 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.267 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -37.12 65.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.31 -37.71 32.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -164.31 -71.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.633 ' HA3' HG23 ' A' ' 50' ' ' VAL . . . 65.94 -74.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.537 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -165.02 -57.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.95 -63.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.667 ' HB2' HG23 ' A' ' 8' ' ' VAL . 19.0 Cg_endo -60.2 159.15 27.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.602 2.201 . . . . 0.0 112.276 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.52 67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 266' ' ' ILE . 34.4 mt -107.0 113.68 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.915 HG22 ' CB ' ' A' ' 10' ' ' TRP . 42.9 pt -132.58 142.68 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.493 ' CE1' ' HB1' ' A' ' 264' ' ' ALA . 12.1 m-85 -108.64 123.58 49.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.45 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -163.18 174.01 12.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.721 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.52 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.7 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -77.24 -51.22 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -48.06 -28.14 2.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.624 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HG2' ' CE3' ' A' ' 62' ' ' TRP . 4.8 tpp180 -64.75 -36.54 84.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 263' ' ' SER . 34.0 m-85 -110.46 -59.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.32 -23.62 19.15 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.17 -50.41 2.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.41 -40.35 73.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.995 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.734 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -56.7 -26.64 57.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.31 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -54.84 -28.59 50.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -70.62 -26.76 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.91 64.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mt -149.81 40.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -133.53 146.05 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 131.49 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -58.02 160.94 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 80' ' ' THR . 32.9 mt -114.77 158.79 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -117.6 97.83 51.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.848 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.67 161.35 24.76 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 2.0 m-20 -97.79 -177.94 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -97.52 -51.4 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.13 -25.32 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.343 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 82' ' ' ASP . 34.2 m-85 -79.29 -59.04 2.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.22 -24.78 68.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.99 -38.17 90.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.96 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.63 39.57 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.562 HD22 HG21 ' A' ' 93' ' ' THR . 0.7 OUTLIER -123.78 153.35 41.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 93' ' ' THR . 3.1 m-85 -76.76 134.26 69.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.25 -22.89 27.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.414 2.076 . . . . 0.0 112.376 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -57.45 -40.71 79.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 90' ' ' TYR . 12.5 t -58.98 -29.7 67.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.819 ' CD1' HG23 ' A' ' 93' ' ' THR . 11.4 m0 -77.98 -56.67 4.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.91 -25.2 60.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.059 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.0 76.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.149 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.467 HG11 ' HG3' ' A' ' 107' ' ' PRO . 11.7 m -150.76 70.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.199 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 109.65 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -101.12 104.53 15.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 68.57 -67.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.006 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.01 33.01 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -136.23 140.37 43.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 tp -108.59 89.47 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.614 ' O ' HD22 ' A' ' 76' ' ' LEU . 34.9 pt -102.4 41.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.041 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.49 155.71 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.553 ' CD1' HD11 ' A' ' 108' ' ' ILE . 2.2 t80 -134.63 100.69 12.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.174 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.633 ' CB ' HG21 ' A' ' 261' ' ' VAL . 5.6 Cg_endo -85.41 142.32 8.28 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.074 2.516 . . . . 0.0 111.504 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 15.9 mt -155.88 39.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 160.6 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.267 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 110' ' ' VAL . 11.0 p -118.09 104.08 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.061 0.458 . . . . 0.0 110.841 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.783 ' HA ' HG21 ' A' ' 320' ' ' THR . 46.4 mp0 -158.49 132.23 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.775 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 113' ' ' LEU . . . -165.1 105.52 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.487 HD12 ' CG ' ' A' ' 323' ' ' ASN . 4.2 mt 158.2 106.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.305 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 m -164.98 123.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.876 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 224' ' ' MET . 4.8 tp -101.2 116.04 31.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.126 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.6 mt -74.71 133.16 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.553 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.851 ' HB3' HD22 ' A' ' 122' ' ' LEU . 50.5 p90 -152.87 124.14 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.674 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -150.81 -179.56 7.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt 59.53 24.07 12.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.075 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.43 27.83 4.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 39.73 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.841 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.851 HD22 ' HB3' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -157.01 114.65 1.97 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.422 ' HG3' HD12 ' A' ' 135' ' ' LEU . 56.5 Cg_endo -70.43 160.43 49.53 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.42 2.08 . . . . 0.0 112.224 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -64.95 154.04 87.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.09 108.98 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.62 2.214 . . . . 0.0 112.41 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.51 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.51 2.14 . . . . 0.0 112.344 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -101.34 14.77 30.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 130' ' ' GLU . 4.3 m -160.22 141.15 12.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.447 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.69 -29.15 64.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' HG22 ' A' ' 128' ' ' THR . 3.6 mt-10 -54.01 -23.71 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.89 -21.63 60.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 4.3 mt -73.38 -54.34 4.18 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.6 Cg_exo -52.92 -30.92 50.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.227 1.951 . . . . 0.0 112.332 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.07 -37.12 71.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.422 HD12 ' HG3' ' A' ' 123' ' ' PRO . 1.4 mt -65.15 -30.08 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -59.02 -34.9 72.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -59.27 -37.94 78.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.8 mp0 -81.76 -42.02 20.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.669 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -62.66 -50.98 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -25.95 64.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -56.84 -22.32 35.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.359 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -109.23 -53.51 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.941 0.401 . . . . 0.0 110.749 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.94 40.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.525 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 172.22 18.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 139' ' ' LEU . 5.6 m -122.68 177.53 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 136' ' ' ASP . . . -118.56 30.79 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.037 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 132' ' ' ILE . 1.3 pp 170.4 138.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.755 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.621 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -164.69 139.19 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.016 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -171.93 176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.56 155.31 12.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.661 ' CD1' HG21 ' A' ' 208' ' ' THR . 0.5 OUTLIER -128.49 -48.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -98.82 39.77 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.714 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.11 148.38 54.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.786 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HG2' ' CE2' ' A' ' 155' ' ' TYR . 98.8 Cg_endo -79.87 161.98 23.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.624 2.216 . . . . 0.0 112.503 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 154' ' ' PRO . 14.0 m-85 77.85 -2.13 2.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -121.04 -69.82 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.357 . . . . 0.0 110.836 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -29.59 60.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -64.31 -55.98 26.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 46.2 Cg_endo -68.82 -22.3 36.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.519 2.146 . . . . 0.0 112.673 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.65 -53.76 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.547 HD13 HD22 ' A' ' 192' ' ' LEU . 1.3 pp -83.61 0.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.329 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -92.53 -68.15 0.81 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 250' ' ' PHE . . . 63.64 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.73 -29.45 69.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 69.67 1.38 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.499 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 94.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -173.41 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.187 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.443 ' O ' HG12 ' A' ' 183' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 183' ' ' VAL . 14.1 p 43.55 38.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.952 0.406 . . . . 0.0 111.601 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -98.65 37.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -126.31 143.43 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.72 -28.43 67.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -58.87 -45.17 95.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.756 ' O ' HD23 ' A' ' 192' ' ' LEU . . . -75.95 -35.29 59.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -63.41 -49.42 73.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 193' ' ' THR . . . -67.27 -44.09 80.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.45 80.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 188' ' ' ALA . 1.9 mm? -64.22 -41.7 96.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HG21 ' A' ' 357' ' ' VAL . 7.6 t -77.46 -37.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.005 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -53.35 56.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.036 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -57.45 -53.07 62.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 192' ' ' LEU . 27.2 m -64.01 -28.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.18 -56.89 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.298 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 195' ' ' LEU . 3.5 pp -58.41 -37.35 75.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 195' ' ' LEU . 2.3 pp -74.67 -31.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 111.266 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -78.8 -26.12 44.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.204 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.39 23.1 14.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -76.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.936 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.03 -4.09 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.438 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.8 ptp 44.65 47.4 8.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.985 0.421 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -56.82 109.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.018 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.97 67.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -164.91 94.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.661 HG21 ' CD1' ' A' ' 151' ' ' LEU . 2.6 t -98.48 129.59 45.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.524 ' H ' HD12 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -113.8 -162.14 0.79 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 214' ' ' GLU . 2.3 t80 -79.13 -46.78 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 214' ' ' GLU . 1.7 t -63.86 -24.68 67.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 209' ' ' ASP . 23.1 mt -82.71 -57.28 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.539 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.97 68.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.012 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 210' ' ' TYR . 0.0 OUTLIER -51.25 -31.47 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 111.337 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.23 57.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.83 -52.92 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.833 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 226' ' ' ILE . 53.2 t80 -76.43 -58.67 3.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.793 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 214' ' ' GLU . 14.5 t-20 -47.48 -31.84 4.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.557 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -105.35 -23.7 12.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 52.87 43.42 60.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.25 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -110.48 39.26 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.585 0.231 . . . . 0.0 111.516 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.621 HG21 ' SD ' ' A' ' 148' ' ' MET . 17.6 p -131.59 -177.91 4.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.708 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -88.43 38.48 0.87 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.376 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.663 ' HG2' HD11 ' A' ' 115' ' ' LEU . 2.5 ttt 176.45 128.44 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.933 0.397 . . . . 0.0 111.513 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.71 105.04 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.484 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.404 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 2.4 tt -76.97 142.21 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.91 129.75 34.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -109.68 -144.48 10.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.396 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.456 2.104 . . . . 0.0 112.315 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.89 0.376 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.37 132.81 11.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.561 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.76 106.37 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.47 158.95 30.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.46 149.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 156.17 37.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.79 -158.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.925 2.417 . . . . 0.0 112.209 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.3 p -127.13 177.28 6.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 163' ' ' ALA . 49.9 p90 -167.26 118.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.77 12.21 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.85 16.03 60.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 46.0 mm-40 -152.91 92.75 3.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.643 0.258 . . . . 0.0 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 35.8 Cg_endo -65.22 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.484 2.123 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.4 m -49.7 175.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 111.208 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 2.5 mtpm? -86.28 134.59 38.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.3 Cg_exo -79.55 111.79 2.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.65 2.234 . . . . 0.0 112.213 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -132.33 103.35 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.641 HG23 HG13 ' A' ' 329' ' ' ILE . 30.2 m -101.51 153.06 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.4 ' C ' HG23 ' A' ' 110' ' ' VAL . . . -130.4 117.62 2.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.244 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.633 HG21 ' CB ' ' A' ' 107' ' ' PRO . 9.3 p -86.37 145.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.307 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.804 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.77 107.78 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.076 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 4.1 m -91.79 117.49 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.82 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -135.93 108.74 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -151.15 -143.41 3.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.567 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.668 HD13 ' H ' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -137.24 146.48 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 111.144 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -127.63 118.82 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.44 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 179.93 36.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 55.42 54.09 9.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 270' ' ' SER . 50.1 Cg_endo -69.07 -46.77 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.66 2.24 . . . . 0.0 112.299 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.8 65.06 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.81 -45.59 93.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.18 -33.39 72.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.957 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.82 -55.78 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.47 -52.58 63.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -29.43 68.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.85 -56.6 19.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.36 -29.7 62.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -33.53 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.084 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.31 -31.88 8.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.219 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -97.25 27.45 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 -43.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.98 42.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.1 38.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.0 p -136.03 153.75 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -38.14 65.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -57.26 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -63.1 -57.46 15.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.939 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 293' ' ' VAL . 2.8 tt -45.98 -40.71 10.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.332 . . . . 0.0 111.511 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 -57.91 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.411 . . . . 0.0 110.812 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 296' ' ' ASP . . . -49.06 -24.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.223 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 289' ' ' GLY . 34.4 m -80.86 -29.51 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.349 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -100.72 -85.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.389 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -120.39 14.61 12.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 292' ' ' ALA . 2.7 t0 59.95 27.97 17.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.75 160.26 2.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.17 155.46 6.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.909 HD22 ' N ' ' A' ' 300' ' ' GLY . 0.0 OUTLIER -164.46 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.66 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.909 ' N ' HD22 ' A' ' 299' ' ' LEU . . . 170.19 140.57 3.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.474 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 302' ' ' VAL . . . 172.88 156.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 301' ' ' ALA . 4.6 m -160.28 40.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -129.34 40.11 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.068 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 116.38 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -41.62 90.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 p -68.5 -31.52 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -74.71 -27.28 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.27 -36.45 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.0 -56.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.666 HD11 ' CB ' ' A' ' 317' ' ' ILE . 2.0 tt -55.58 -22.42 21.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.317 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -47.31 -29.17 2.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.541 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -29.6 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.96 109.83 2.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.927 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 319' ' ' ALA . 71.9 Cg_endo -76.89 -11.63 18.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.103 . . . . 0.0 112.736 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -66.04 -59.33 3.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.666 ' CB ' HD11 ' A' ' 311' ' ' LEU . 2.4 mp -80.13 -34.67 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.41 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.264 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 315' ' ' PRO . . . -56.78 -49.0 76.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.783 HG21 ' HA ' ' A' ' 111' ' ' GLU . 63.4 p -67.9 -26.51 66.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -26.9 28.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.239 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -66.57 -57.43 7.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.987 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.487 ' CG ' HD12 ' A' ' 113' ' ' LEU . 5.9 p-10 -76.47 -34.19 58.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.85 59.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.11 -30.87 66.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 -30.19 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.062 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -90.07 -148.01 18.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.64 -178.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.641 HG13 HG23 ' A' ' 259' ' ' VAL . 12.0 tt -104.55 114.96 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.51 147.09 0.77 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 -167.68 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.502 2.135 . . . . 0.0 112.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 30.29 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.95 90.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -51.94 -36.88 65.89 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.575 2.183 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.57 -36.74 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 19.8 mmt -61.81 -22.08 65.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 t -52.06 -27.31 13.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.0 -33.45 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.149 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -29.12 66.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 45.2 t90 -47.98 -28.83 2.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.92 -42.95 90.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.903 ' O ' HG22 ' A' ' 345' ' ' THR . . . -79.93 -30.45 39.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.471 HG11 ' HE1' ' A' ' 158' ' ' TRP . 43.5 t -53.9 -29.72 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.642 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -52.55 -46.73 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.186 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 342' ' ' ALA . 14.8 t -50.0 -30.57 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.079 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.18 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.754 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 348' ' ' ILE . 34.8 m -79.83 -49.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 347' ' ' VAL . 1.5 tt -49.99 -42.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.698 0.285 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 345' ' ' THR . 13.0 m-20 -60.86 -33.23 72.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.17 65.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.39 -10.57 59.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.534 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 54.2 m -67.62 -29.05 68.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.035 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.01 -12.33 65.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -129.66 39.59 3.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.404 ' CG ' ' HB3' ' A' ' 349' ' ' ASN . 7.6 tp60 -123.73 127.1 47.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 18.2 p -110.07 141.26 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.824 HG21 ' HB ' ' A' ' 193' ' ' THR . 21.2 t -57.79 -27.91 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -37.75 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -80.24 -52.76 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -53.88 -33.21 55.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.107 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 361' ' ' LEU . 0.8 OUTLIER -82.24 -49.38 10.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -64.63 -55.48 19.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 364' ' ' ALA . 1.3 p-10 -59.64 -29.68 68.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.689 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.79 -55.49 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -30.74 60.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.0 p -80.06 -30.08 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.935 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -47.11 41.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.31 -35.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.3 p -99.0 30.7 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.717 0.294 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.32 51.97 3.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.674 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.5 ptmt -134.48 130.44 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 6' ' ' LYS . 9.4 mp -125.75 157.29 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 16.7 t -134.18 104.15 5.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.307 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.649 HG23 ' HE1' ' A' ' 61' ' ' PHE . 3.7 mp -99.88 124.18 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.346 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' ILE . 9.8 t90 -107.07 117.72 34.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.514 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -131.21 155.96 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.232 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -143.82 110.73 5.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.65 57.37 0.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -140.36 -50.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 tttt 59.4 31.53 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.66 36.52 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.525 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -60.13 -35.62 75.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.52 -51.15 38.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.13 54.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.97 -56.47 21.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.826 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.85 69.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -31.85 70.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.951 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -75.35 -38.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -25.32 75.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.54 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -57.26 -41.89 80.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -74.61 -47.67 30.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.609 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.5 m-85 -62.32 -56.24 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -51.85 -28.25 15.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.434 0.635 . . . . 0.0 110.683 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -25.69 49.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.61 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.643 ' O ' ' OG1' ' A' ' 31' ' ' THR . 14.5 t0 -51.58 -56.73 11.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 31' ' ' THR . 6.9 m 156.97 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.761 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.76 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.76 45.91 0.01 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 117.58 -2.248 . . . . 0.0 115.898 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.0 mm -131.45 95.79 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 118.425 1.113 . . . . 0.0 111.541 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -111.07 128.49 55.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.483 HG11 ' CE2' ' A' ' 283' ' ' TYR . 27.2 m -126.85 138.7 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.9 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.28 115.2 27.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 37' ' ' VAL . 14.7 p -86.3 116.27 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.808 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG3' ' CG1' ' A' ' 8' ' ' VAL . 6.0 mm-40 -104.27 143.32 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 111.277 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.59 ' O ' HD22 ' A' ' 43' ' ' LEU . 5.1 p80 -112.42 158.47 37.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.67 -83.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.358 2.039 . . . . 0.0 112.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 49.98 -92.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -120.34 -2.99 9.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 39' ' ' HIS . 7.2 mp -53.26 -25.79 15.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.687 0.28 . . . . 0.0 111.319 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -55.15 -38.84 68.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.36 -23.3 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.067 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -75.3 -29.53 60.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.164 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 64.5 t80 -55.74 -56.58 28.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.273 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.3 Cg_endo -64.01 -15.27 48.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.556 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.65 -55.3 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 46' ' ' LYS . 14.1 m -73.08 -28.87 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.04 -28.07 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -26.23 62.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.336 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.6 m -148.4 124.08 10.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.9 -54.25 2.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.343 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.98 -55.04 0.5 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.38 -107.01 0.35 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.575 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 87.3 Cg_exo -48.3 150.17 5.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.631 2.22 . . . . 0.0 112.259 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -153.89 38.53 0.46 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG22 ' HE1' ' A' ' 61' ' ' PHE . 13.1 mt -152.73 118.47 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 110.533 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 ' HB3' ' A' ' 10' ' ' TRP . 12.7 mt -151.15 142.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 111.694 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.779 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 2.1 m-85 -128.38 120.47 27.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.89 92.48 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.741 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . . . 42.59 -165.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.054 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -76.94 -29.53 55.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 p30 -47.78 -35.16 9.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.527 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -36.86 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.79 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 13.5 t80 -77.56 -64.03 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.2 -10.21 61.97 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.054 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.39 -61.11 1.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -96.57 -48.23 5.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.691 0.282 . . . . 0.0 111.088 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -57.01 -29.69 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.251 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -64.11 -31.62 72.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -26.8 25.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.77 70.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.59 39.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 265' ' ' GLY . 1.2 tt -148.79 118.48 7.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.41 156.09 28.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -93.4 156.85 16.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 HG22 ' CE ' ' A' ' 277' ' ' LYS . 2.9 pt -147.12 163.86 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -110.49 86.13 5.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.593 ' HD2' HD13 ' A' ' 103' ' ' LEU . 98.9 Cg_endo -79.8 -168.35 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.531 2.154 . . . . 0.0 112.362 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 86' ' ' GLN . 21.8 m-20 64.01 131.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -120.26 -100.89 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.71 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.4 -59.18 2.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 86' ' ' GLN . 50.9 p90 -80.91 -53.13 6.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 89' ' ' LEU . 2.5 mt-30 -52.76 -23.07 6.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.997 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 1.8 p-10 -45.5 -30.86 1.55 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -123.39 -65.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.821 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.581 ' C ' HD12 ' A' ' 89' ' ' LEU . 3.6 pp 42.69 -168.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.607 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.411 ' N ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -69.24 112.83 13.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.83 -26.12 29.66 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.384 2.056 . . . . 0.0 112.354 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.29 -31.9 70.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -75.35 -31.02 60.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 89' ' ' LEU . 2.4 m0 -70.17 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.81 -26.43 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.213 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.01 67.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.102 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 24.1 t -152.46 68.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.48 155.57 42.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.31 168.6 13.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -71.71 65.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.3 28.47 13.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 163.98 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.593 HD13 ' HD2' ' A' ' 81' ' ' PRO . 1.4 mt -145.33 75.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' A' ' 67' ' ' PHE . 2.3 pt -108.22 39.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -170.89 132.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 285' ' ' LEU . 29.5 t80 -155.14 102.19 2.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 5.3 Cg_exo -79.22 167.34 21.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.743 2.295 . . . . 0.0 111.925 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.99 39.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 262' ' ' LEU . . . -176.85 157.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 317' ' ' ILE . 30.9 m -132.27 106.16 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -126.94 159.65 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.25 159.43 20.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.642 HD22 ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -79.72 161.43 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.496 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -165.15 -176.03 3.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 224' ' ' MET . 8.5 mp -103.09 108.68 19.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.864 HD11 ' CD1' ' A' ' 242' ' ' TYR . 9.1 tt -87.99 149.31 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.42 163.53 30.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -102.53 -178.04 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.7 81.25 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -163.06 -63.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 121' ' ' LEU . 1.6 pt? -123.71 40.03 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.4 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 tt -144.65 115.82 5.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' HD23 ' A' ' 122' ' ' LEU . 40.6 Cg_endo -67.12 158.0 59.02 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.425 2.083 . . . . 0.0 112.197 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -65.02 111.25 5.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.51 154.76 24.29 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.51 2.14 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.54 -167.52 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.526 2.151 . . . . 0.0 112.238 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 p -76.99 140.52 40.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.01 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.837 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.1 m95 -71.71 -37.34 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.58 -23.82 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.643 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.04 -16.26 41.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.837 HD12 ' CE3' ' A' ' 129' ' ' TRP . 37.0 mt -65.61 -48.77 64.2 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 84.9 Cg_exo -46.4 -35.78 16.66 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.419 2.079 . . . . 0.0 112.465 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.07 93.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.51 -31.66 53.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.691 ' OD1' HG22 ' A' ' 132' ' ' ILE . 1.1 m-20 -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -71.83 -31.84 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.32 -45.27 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.44 -48.83 30.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -59.22 -25.64 64.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.021 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.76 33.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.387 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -109.03 -63.39 1.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.82 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.9 39.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.327 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -153.88 166.29 33.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 222' ' ' THR . 4.0 m -119.15 162.81 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.806 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -93.0 -2.15 56.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.597 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 147' ' ' LEU . 1.9 pt? 172.61 126.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.716 0.293 . . . . 0.0 110.477 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.23 120.74 8.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.587 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.38 123.85 48.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.077 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.55 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 14.5 p30 -85.04 154.25 22.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 151' ' ' LEU . 9.8 mt -128.37 -46.27 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.37 39.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 3.2 mt-10 -120.18 137.03 25.5 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 4.4 Cg_exo -79.63 179.24 6.49 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.726 2.284 . . . . 0.0 112.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 258' ' ' PHE . 3.6 m-85 59.8 20.11 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.55 ' CZ ' ' ND2' ' A' ' 150' ' ' ASN . 19.3 m-85 -120.84 -33.0 3.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.166 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -77.23 -24.28 51.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -69.42 -55.31 9.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 158' ' ' TRP . 21.6 Cg_exo -65.35 -32.84 49.79 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.48 2.12 . . . . 0.0 112.23 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.529 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.5 OUTLIER -70.1 -52.64 22.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.237 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.521 HD11 HD13 ' A' ' 195' ' ' LEU . 47.0 mt -77.06 -5.1 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.821 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -83.91 -63.96 1.25 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.34 -87.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ALA . 2.0 t0 -115.89 -39.57 3.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.67 -91.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.13 -47.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.516 ' OH ' HD21 ' A' ' 361' ' ' LEU . 0.3 OUTLIER 60.76 42.23 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.27 -24.68 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -144.23 65.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.64 -174.89 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.2 -30.0 51.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.13 93.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.181 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -67.04 -33.64 75.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.48 -46.32 80.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.77 -28.34 67.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -74.99 -31.82 61.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.89 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 p -75.25 -30.78 60.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CE1' ' HE3' ' A' ' 251' ' ' LYS . 5.8 m-85 -72.66 -41.98 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 161' ' ' ILE . 1.2 tt -60.54 -37.84 82.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 199' ' ' ILE . 31.4 m -76.05 -30.26 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.78 -41.33 68.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.23 -50.15 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 195' ' ' LEU . 17.1 tt -59.47 -30.85 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -62.23 -26.78 68.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -97.53 -23.73 15.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.071 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -88.88 -66.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.41 -35.2 73.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 mtt -101.54 72.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -179.15 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.46 -45.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.07 95.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.9 t -63.36 137.56 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' HD12 ' A' ' 212' ' ' ILE . 2.8 t0 -86.78 -166.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.017 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 211' ' ' SER . 48.8 p90 -79.0 -40.36 31.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.172 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 0.3 OUTLIER -79.53 -24.67 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.356 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 209' ' ' ASP . 12.7 mt -81.56 -57.29 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.42 68.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.3 -42.62 20.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -57.18 -31.37 65.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.422 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.43 -52.23 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -68.65 -28.36 66.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.626 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -69.29 -50.85 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -107.05 -23.76 12.2 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 99.97 67.7 0.85 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.749 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.08 38.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 145' ' ' SER . 14.9 p -152.16 179.99 8.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -85.82 38.85 0.77 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.39 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.454 ' HG2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.63 159.19 0.24 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.024 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -144.52 105.14 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.827 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.4 mt -80.82 136.15 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -115.24 163.77 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -163.62 163.02 35.46 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.343 0.257 0 C-N-CA 122.576 2.184 . . . . 0.0 112.347 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.864 ' CD1' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.809 0.337 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -145.1 144.22 12.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' A' ' 116' ' ' ILE . 23.6 m -93.4 136.47 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 61.6 m -141.01 150.13 42.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 323' ' ' ASN . 9.9 p -100.3 150.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.784 ' H ' HD22 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -126.25 97.45 34.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.54 51.89 4.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.924 2.416 . . . . 0.0 112.691 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.12 114.41 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -155.09 111.69 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.763 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HE3' ' CE1' ' A' ' 194' ' ' PHE . 13.7 mptt 58.11 19.97 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.261 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 116.06 -34.79 4.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.889 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -132.37 152.13 79.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.295 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HG3' ' CD ' ' A' ' 326' ' ' LYS . 71.8 Cg_endo -77.04 132.4 12.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.73 2.287 . . . . 0.0 112.485 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 159' ' ' PRO . 67.5 m -54.42 178.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.39 83.43 46.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.59 162.89 24.44 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.962 2.441 . . . . 0.0 112.151 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.501 ' CD2' ' CD2' ' A' ' 155' ' ' TYR . 5.1 m-85 -88.36 144.32 26.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 329' ' ' ILE . 35.8 m -99.83 154.51 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.08 110.51 1.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.442 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 109' ' ' ALA . 18.4 m -108.33 144.65 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 109' ' ' ALA . 9.8 mt -69.76 90.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.2 m -79.59 120.84 24.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.779 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -83.54 123.89 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.112 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.543 ' HA2' HD11 ' A' ' 76' ' ' LEU . . . -102.75 106.13 2.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 76' ' ' LEU . 14.7 tt -95.73 141.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 0.0 111.074 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -83.59 138.39 33.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.94 -30.84 44.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.6 52.53 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.8 p -115.86 149.24 42.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 125.64 12.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.599 2.199 . . . . 0.0 112.318 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.88 88.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -75.08 -33.89 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.52 -30.89 67.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.64 -32.96 60.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.78 69.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.518 ' CE ' HG22 ' A' ' 79' ' ' ILE . 32.2 mttt -65.23 -58.99 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.92 -32.09 70.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -51.35 69.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -31.28 64.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -71.79 -30.26 65.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.56 27.48 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -132.89 -69.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.33 -52.14 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 106' ' ' TYR . 16.8 mt -83.11 67.88 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.767 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.5 t -146.4 168.0 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.775 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.66 -45.66 66.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.47 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -71.87 -57.4 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.767 ' H ' HG23 ' A' ' 286' ' ' THR . . . -56.54 -57.19 20.66 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.803 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.2 OUTLIER -56.1 -36.72 68.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 111.123 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -78.66 -27.7 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.07 -57.8 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.189 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.03 -29.9 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.371 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -64.72 -60.42 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -82.01 -47.44 12.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.398 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.52 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.259 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -159.93 89.77 1.86 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.011 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -173.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.188 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 300' ' ' GLY . 1.6 pp -178.84 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 164.34 121.89 0.58 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 110' ' ' VAL . . . 179.25 157.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 110' ' ' VAL . 11.8 p -178.28 56.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -97.33 40.34 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.26 167.74 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -113.33 -36.66 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.2 m -79.37 -52.46 8.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 311' ' ' LEU . 6.2 m-85 -67.48 -24.64 65.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -53.59 -29.9 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -69.17 -31.14 69.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -92.92 -38.16 11.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 307' ' ' TYR . 7.3 mp -58.97 -28.17 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.74 56.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -57.24 -29.51 63.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 0.8 OUTLIER -66.85 143.27 97.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.69 -37.27 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -59.02 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.637 ' CD1' HG21 ' A' ' 110' ' ' VAL . 8.9 tp -67.54 -29.93 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -67.39 -36.29 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.29 -33.79 43.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.2 m -76.85 -40.86 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.464 ' HA ' ' HB3' ' A' ' 324' ' ' ALA . 3.3 ptt? -58.17 -25.82 61.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.64 -57.62 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.677 ' HB2' HG21 ' A' ' 246' ' ' VAL . 2.2 t30 -78.47 -30.58 47.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 321' ' ' MET . . . -59.3 -42.21 90.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.27 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -29.05 64.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.402 ' CD ' ' HG3' ' A' ' 254' ' ' PRO . 6.0 mttp -97.44 -30.72 12.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.0 -165.02 30.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.57 165.78 30.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 329' ' ' ILE . 3.9 mp -83.21 130.77 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.82 101.76 10.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.82 -10.91 30.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.478 2.119 . . . . 0.0 112.541 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 65.87 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.878 0.371 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 336' ' ' MET . 8.3 tt -79.48 127.6 77.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.67 -34.59 54.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.344 2.029 . . . . 0.0 112.429 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -57.79 -30.4 65.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.416 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.7 p -54.73 -30.87 57.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.76 -30.95 45.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -77.93 -26.49 48.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.21 -43.68 78.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.98 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -28.94 43.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.39 -51.29 58.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.333 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 p -54.61 -29.89 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.349 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.493 ' HB3' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -75.17 -60.9 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 4.5 p -60.54 -29.94 69.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.6 -50.52 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 343' ' ' VAL . 37.4 t -79.54 -53.36 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.789 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 344' ' ' ARG . 69.3 mt -51.68 -39.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.901 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 350' ' ' ALA . 35.8 p30 -51.45 -25.8 7.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 111.41 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . 0.44 ' N ' ' OD1' ' A' ' 349' ' ' ASN . . . -62.14 -33.61 74.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.36 -11.57 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.484 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.5 p -67.67 -30.23 69.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.64 -14.24 64.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.73 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -130.38 39.86 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.17 132.87 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 68.5 p -115.7 142.22 47.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 31.0 m -58.62 -27.94 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.243 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.37 -38.24 65.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -51.08 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.76 -29.9 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.516 HD21 ' OH ' ' A' ' 167' ' ' TYR . 9.9 mt -82.18 -56.39 3.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.004 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -63.62 -53.18 55.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -55.93 -47.88 76.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.47 -53.21 55.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -56.97 -30.53 64.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 8.7 p -80.68 -40.24 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.3 mtp-105 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.5 mt -75.72 -47.21 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.247 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 92.8 m -103.65 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.956 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 17.7 tptm . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.877 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -103.02 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -130.3 131.71 45.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 64.97 -75.3 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.31 43.71 97.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.82 139.74 40.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 57' ' ' PRO . 85.5 mt -138.21 154.77 49.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' HG2' ' A' ' 57' ' ' PRO . 5.4 m -125.61 102.82 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HA ' HG23 ' A' ' 59' ' ' ILE . 3.8 mp -96.43 118.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.436 ' CE2' HD13 ' A' ' 43' ' ' LEU . 93.8 m95 -94.98 112.05 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -145.24 145.56 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.068 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -163.75 112.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.66 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -176.92 -48.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -153.17 -175.15 5.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 124.97 -34.89 3.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.489 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 8.5 p90 -62.36 -34.65 77.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 21.4 t-20 -68.07 -36.89 80.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.57 -39.03 30.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.5 mm? -68.28 -31.32 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.942 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.35 94.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.44 -34.33 73.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.67 -31.0 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.13 -46.72 9.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -29.7 59.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.776 0.322 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -37.74 37.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.26 -56.5 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.588 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.685 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -53.58 -27.7 27.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 110.245 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -46.4 -32.49 3.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.809 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 31' ' ' THR . 24.7 t0 -62.97 -57.41 10.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.61 37.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.653 0.596 . . . . 0.0 112.248 176.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.87 43.37 0.02 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 117.909 -2.091 . . . . 0.0 115.537 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 27' ' ' PHE . 3.2 mp -140.38 95.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 118.039 0.919 . . . . 0.0 111.857 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.17 131.8 54.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.07 148.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.76 137.13 50.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.55 111.51 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.75 163.05 31.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 -98.72 144.4 28.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 136.04 23.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.516 2.144 . . . . 0.0 112.326 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.46 -47.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -116.24 0.15 12.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.374 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' CE2' ' A' ' 10' ' ' TRP . 7.2 tp -56.6 -25.41 52.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.746 0.308 . . . . 0.0 111.147 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -55.73 -31.96 62.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.24 -29.6 13.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 50' ' ' VAL . 18.2 tttt -73.95 -24.55 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.15 -58.48 8.65 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 26.5 Cg_endo -61.96 -18.96 64.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.436 2.091 . . . . 0.0 112.455 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -89.75 -35.97 15.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.829 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 46' ' ' LYS . 27.8 t -88.58 -17.83 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.39 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.27 -39.76 64.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.827 0.346 . . . . 0.0 111.271 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.695 ' O ' HG23 ' A' ' 53' ' ' THR . . . -80.55 -40.35 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.66 -74.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.808 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.08 -74.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.18 -71.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.27 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.644 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.3 Cg_endo -64.27 -177.74 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.26 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 167.09 106.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 9' ' ' ILE . 6.8 tt -146.94 117.31 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 43' ' ' LEU . 3.2 mp -121.19 142.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.656 ' HD1' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -96.05 117.13 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.386 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -143.12 173.23 11.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -57.26 -168.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.433 ' CE1' ' CG1' ' A' ' 97' ' ' VAL . 2.6 t-160 -76.1 -56.4 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.04 -28.98 57.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.982 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -58.24 -41.77 84.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -111.88 -55.23 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.62 -29.07 74.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.81 29.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.548 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.63 -45.93 8.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.788 ' HB3' HD12 ' A' ' 76' ' ' LEU . . . -61.5 -31.17 71.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.06 67.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -108.33 25.79 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.07 -75.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -176.77 83.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.952 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -110.25 143.7 40.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.659 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -62.49 83.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 96.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 80' ' ' THR . 40.2 mt -72.07 158.32 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 79' ' ' ILE . 43.6 p -101.2 157.96 32.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 98.1 Cg_endo -79.8 89.64 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.605 2.203 . . . . 0.0 112.397 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.12 -55.2 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -25.29 64.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.25 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.493 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -75.13 -59.18 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.03 61.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.39 -39.86 52.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.02 37.3 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -170.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -98.05 146.53 31.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.97 -32.4 8.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.541 2.161 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -31.73 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -31.3 62.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.54 -41.78 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -30.93 70.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.53 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.433 ' CG1' ' CE1' ' A' ' 64' ' ' HIS . 22.8 m -122.06 60.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 93.04 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -101.93 113.66 27.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.4 -68.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.54 39.11 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.492 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.6 171.5 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.39 92.03 3.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 ' HB3' ' A' ' 76' ' ' LEU . 1.7 pp -112.97 46.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.51 124.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.741 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -123.96 100.99 36.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.997 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.84 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.0 Cg_endo -79.87 127.72 7.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.199 . . . . 0.0 112.135 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 285' ' ' LEU . 9.3 mm -138.8 39.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 111.252 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.939 ' CB ' HD23 ' A' ' 262' ' ' LEU . . . 176.02 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.779 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.97 105.72 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.918 0.39 . . . . 0.0 111.056 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 132.86 49.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.97 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -152.48 174.32 14.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -99.92 160.73 14.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.65 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 4.2 m -164.07 -179.79 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -111.99 133.67 54.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.71 143.57 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' A' ' 245' ' ' THR . 46.7 p90 -139.1 179.36 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -139.41 177.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.77 34.93 4.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -131.11 -65.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.3 pp -130.04 39.92 3.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.15 88.36 13.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.77 140.23 47.56 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.31 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -70.26 165.89 39.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.72 122.45 10.54 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.528 2.152 . . . . 0.0 112.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.64 -52.15 1.51 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.41 2.073 . . . . 0.0 112.361 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.43 -76.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 249' ' ' THR . 17.6 p -116.42 -173.64 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.036 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.547 ' CE3' HG21 ' A' ' 132' ' ' ILE . 7.6 m95 -70.6 -31.23 68.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 2.4 tt0 -52.95 -24.17 8.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.05 -15.91 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.687 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.733 HG22 ' HD3' ' A' ' 133' ' ' PRO . 5.6 tp -52.75 -35.79 28.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.733 ' HD3' HG22 ' A' ' 132' ' ' ILE . 16.8 Cg_exo -68.2 -27.45 35.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.293 1.995 . . . . 0.0 112.2 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.05 -28.24 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -77.8 -31.86 52.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.08 -51.95 22.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -30.64 68.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.9 mt-10 -79.48 -43.28 23.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 135' ' ' LEU . 3.7 mm? -64.0 -49.93 70.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -26.12 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.9 -23.12 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.383 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -110.63 -60.71 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.49 40.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.566 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.525 ' CB ' HD12 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -150.65 -178.03 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -139.29 175.36 9.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.791 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -135.12 44.96 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.221 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.14 115.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 14.6 mmt -159.14 106.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 156' ' ' PHE . 1.6 t80 -168.97 177.03 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HA ' ' HB1' ' A' ' 213' ' ' ALA . 1.2 m120 -67.83 178.96 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.04 -46.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.62 40.06 1.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.76 149.07 36.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 155.88 23.85 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.666 2.244 . . . . 0.0 112.321 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 60.26 20.36 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 226' ' ' ILE . 0.4 OUTLIER -121.08 -56.35 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.927 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.455 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.1 t -72.35 -32.03 66.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.172 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.546 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 66.1 t90 -64.36 -55.16 32.62 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -62.29 -28.66 79.12 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.264 1.976 . . . . 0.0 112.275 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.522 HD22 HD11 ' A' ' 195' ' ' LEU . 2.0 tp -68.7 -56.96 6.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.801 HD13 HD22 ' A' ' 192' ' ' LEU . 4.9 mt -78.23 -4.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.216 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -79.11 -50.45 11.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.874 0.369 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 254' ' ' PRO . . . -101.44 37.64 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -108.02 -31.21 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.3 -41.68 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . 171.01 164.77 27.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.506 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -176.18 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.17 -50.87 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -152.75 165.38 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 135.3 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.427 ' CE2' ' HA2' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -101.99 115.16 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.32 102.21 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.805 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.1 m120 60.04 31.14 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 171' ' ' TYR . . . 82.94 51.37 4.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -143.5 125.36 15.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -103.24 150.2 23.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.16 171.53 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.49 -66.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.32 32.98 4.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -128.36 98.85 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 150.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.3 42.63 1.4 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.23 -35.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -85.23 57.28 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -130.83 160.03 35.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.24 -31.48 72.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.068 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.79 -55.36 25.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . -60.26 -33.32 72.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 193' ' ' THR . 11.2 ttmt -74.26 -46.28 42.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.15 -30.48 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.642 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.02 -60.32 3.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.451 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.801 HD22 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -56.99 -31.57 65.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.818 0.342 . . . . 0.0 110.776 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 189' ' ' LYS . 40.3 p -72.9 -28.72 62.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.7 -50.44 12.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.654 HD12 HD11 ' A' ' 161' ' ' ILE . 8.4 mt -66.94 -28.84 68.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.663 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 192' ' ' LEU . 14.9 p -77.42 -46.59 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 196' ' ' VAL . 10.5 p30 -62.55 -27.19 69.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 111.228 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.427 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 0.2 OUTLIER -57.48 -30.69 65.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.144 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 mt -79.8 -55.2 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -21.02 64.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.404 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.82 15.54 16.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.327 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -120.15 -75.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -120.12 -4.93 10.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.49 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 24.1 ptm 45.53 30.56 0.78 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.366 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.9 OUTLIER -136.5 -43.84 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 205' ' ' ASN . . . 67.52 73.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -113.07 28.25 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.7 OUTLIER -106.18 119.65 39.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.899 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -166.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.401 ' HA ' ' ND2' ' A' ' 150' ' ' ASN . 52.2 p90 -79.1 -40.81 30.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.284 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -79.94 -24.63 40.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.58 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.0 mt -81.82 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -55.71 -30.28 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.36 -30.48 33.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.15 67.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.601 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.39 -56.92 10.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.612 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 20.4 p90 -76.39 -34.6 58.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.451 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 1.8 m-20 -73.66 -8.31 55.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.305 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -23.65 58.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.001 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 221' ' ' GLU . . . -159.33 -85.42 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.385 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 220' ' ' GLY . 0.5 OUTLIER 171.78 101.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.482 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.4 t -116.27 -177.36 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.791 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 39.56 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -162.47 99.68 1.04 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 17.3 m -144.51 105.15 4.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.636 HD13 ' HZ ' ' A' ' 156' ' ' PHE . 4.0 mt -113.51 135.0 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.7 147.57 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -155.07 -157.05 8.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.34 76.83 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.326 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.25 -52.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.54 79.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.096 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -31.5 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.4 p -126.73 147.84 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -154.47 40.07 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 21.8 mt 69.11 -67.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 237' ' ' THR . 5.3 m-20 -160.27 170.42 21.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 236' ' ' ASP . 0.8 OUTLIER -157.89 168.19 27.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.28 114.69 4.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.01 31.22 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.879 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.4 t 68.79 -67.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -147.58 126.89 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -149.17 136.01 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.19 -173.7 13.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 319' ' ' ALA . 11.4 p -132.04 136.48 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.416 HG23 ' CE1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -130.58 156.18 45.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.1 p -77.42 150.63 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.93 146.72 81.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 95.6 Cg_endo -79.77 152.07 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.681 2.254 . . . . 0.0 112.435 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.79 HG22 ' HD3' ' A' ' 254' ' ' PRO . 45.6 p -63.82 177.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CD1' ' OD1' ' A' ' 164' ' ' ASP . 4.5 t80 -159.88 111.89 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.739 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.2 mttm 59.38 21.24 9.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.51 -47.64 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.59 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.93 151.19 29.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 249' ' ' THR . 59.5 Cg_endo -72.21 -175.63 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.314 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -172.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -118.5 81.25 17.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.69 -168.3 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.631 2.221 . . . . 0.0 112.344 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -171.95 161.13 5.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 328' ' ' GLU . 27.6 m -75.8 146.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -111.53 74.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.524 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 109' ' ' ALA . 13.3 m -95.83 135.13 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.939 HD23 ' CB ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -86.87 124.25 32.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 t -92.95 112.86 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.758 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.12 49.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 169.1 -173.26 43.55 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 276' ' ' ALA . 26.3 mm -88.53 159.74 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.487 ' N ' HG22 ' A' ' 266' ' ' ILE . 6.4 m120 -98.12 108.02 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.994 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . . . 67.78 10.28 7.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.827 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . . . 45.41 30.3 0.7 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.559 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER -64.2 -61.04 7.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.032 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 270' ' ' SER . 63.4 Cg_endo -73.63 97.85 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.504 2.136 . . . . 0.0 112.468 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 23.9 m-20 59.1 86.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.99 -30.94 61.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -76.43 -57.23 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.96 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.62 -31.4 71.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 266' ' ' ILE . . . -59.22 -56.75 18.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.22 -43.94 80.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.79 -42.27 99.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.07 -31.3 72.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.997 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -81.24 -25.76 36.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -93.8 -32.24 14.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.15 27.53 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.219 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 27' ' ' PHE . 1.4 m-85 -177.31 48.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 110.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 280' ' ' LEU . 1.1 mt -178.25 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 108' ' ' ILE . 4.1 mm? -107.44 65.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.832 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.1 t -150.99 171.85 16.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.739 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.37 -48.2 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -77.55 -35.02 53.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.832 ' H ' HG23 ' A' ' 286' ' ' THR . . . -55.34 -75.76 0.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.791 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 -21.92 29.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.316 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -29.12 5.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.359 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.91 -53.76 7.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.612 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 294' ' ' ASN . 12.3 p -72.41 -46.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.8 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.494 ' N ' HG13 ' A' ' 293' ' ' VAL . 46.6 p-10 -58.29 -21.22 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.326 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -55.25 2.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.97 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -126.62 87.66 55.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.485 ' C ' HD23 ' A' ' 299' ' ' LEU . 57.6 Cg_endo -71.09 163.71 38.28 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.539 2.159 . . . . 0.0 112.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.633 ' N ' HD23 ' A' ' 299' ' ' LEU . 1.3 pt? -175.72 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -160.32 -167.1 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.448 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.723 ' HB3' ' CG2' ' A' ' 317' ' ' ILE . . . -136.51 160.06 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.557 ' CG2' HD23 ' A' ' 304' ' ' LEU . 27.5 m -79.95 -179.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -107.89 40.0 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.557 HD23 ' CG2' ' A' ' 302' ' ' VAL . 3.8 mm? -78.26 126.97 31.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.82 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.11 93.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.4 p -68.78 -52.42 30.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -27.35 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.37 -28.13 51.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.87 -45.68 89.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -93.23 -31.95 14.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.726 ' O ' HD11 ' A' ' 317' ' ' ILE . 4.6 mp -59.88 -28.19 67.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.51 29.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.327 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -58.73 -30.75 67.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.91 140.59 33.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 95.8 Cg_endo -78.95 -17.94 11.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.589 2.193 . . . . 0.0 112.825 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.407 ' CG ' HD13 ' A' ' 317' ' ' ILE . 3.3 ptt180 -51.18 -54.56 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.283 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -80.46 -29.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.357 . . . . 0.0 111.094 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -60.79 -31.77 71.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.65 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -79.13 -39.14 34.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.703 HG22 ' HB3' ' A' ' 112' ' ' ALA . 62.4 p -71.67 -43.39 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 ptm -59.43 -28.81 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -57.38 12.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -78.35 -31.13 48.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.1 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.298 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -50.27 65.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.147 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -47.62 11.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 159.91 136.72 2.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -173.31 89.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 329' ' ' ILE . 1.0 OUTLIER -133.64 118.49 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.02 120.31 53.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.42 -168.23 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.397 2.065 . . . . 0.0 112.289 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -98.45 -65.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 333' ' ' ILE . 4.5 tp 34.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.955 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.1 -25.24 31.82 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.471 2.114 . . . . 0.0 112.392 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -25.85 59.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -28.56 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 m -56.94 -47.6 80.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -33.88 63.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.041 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -61.4 -27.0 68.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -32.48 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.94 -31.46 45.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.82 -40.71 39.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.4 t -59.4 -30.1 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.5 ' HB3' HD12 ' A' ' 348' ' ' ILE . 10.5 mmt180 -74.97 -60.64 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 50.3 m -58.8 -27.78 65.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.49 -52.28 11.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.406 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.7 t -79.19 -54.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.691 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 344' ' ' ARG . 62.1 mt -49.43 -58.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.56 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -57.22 -50.66 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.78 59.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.31 -10.69 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.434 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 51.6 p -67.69 -30.22 69.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 112.54 -25.34 12.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -112.83 39.85 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -149.61 145.67 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 t -124.15 148.95 46.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.01 -28.2 43.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.37 -30.4 60.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 -54.75 5.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -62.74 -30.06 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -56.6 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -60.74 -52.27 65.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -58.65 -34.88 71.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -69.98 -33.91 72.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.163 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -31.58 69.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 27.0 m -80.7 -38.18 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 -43.43 59.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 364' ' ' ALA . 1.0 OUTLIER -59.47 -35.42 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.4 m -80.34 -54.37 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.8 0.333 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.3 p -80.47 84.67 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.57 164.89 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.64 172.28 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.52 86.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' C ' HD12 ' A' ' 7' ' ' LEU . 14.3 tttt -167.96 138.29 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 6' ' ' LYS . 4.9 mp -147.86 159.57 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.53 103.44 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 mp -100.04 119.53 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -103.29 126.37 50.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.4 HG12 ' N ' ' A' ' 12' ' ' ASN . 18.7 tt -172.11 158.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 39' ' ' HIS . 9.9 t30 -176.53 -169.88 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.92 -31.63 3.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.31 -51.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -178.28 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.16 24.26 28.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.699 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.97 -58.08 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -60.16 -40.9 91.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -51.27 60.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.578 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -31.17 54.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.13 -38.0 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -52.71 64.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 24' ' ' GLY . 28.1 m -61.68 -43.77 97.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.185 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.93 -36.34 92.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -59.45 -44.47 92.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -79.2 -30.06 43.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.966 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.877 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -60.66 -56.55 19.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -56.32 -27.89 57.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.536 0.684 . . . . 0.0 110.4 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -33.4 14.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.499 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' ' HB ' ' A' ' 31' ' ' THR . 5.0 t70 -59.73 -57.4 13.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.65 36.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.872 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.61 44.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 117.958 -2.068 . . . . 0.0 115.47 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 27' ' ' PHE . 2.3 mp -139.69 95.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 117.998 0.899 . . . . 0.0 111.608 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -126.4 114.8 18.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 9' ' ' ILE . 3.5 m -110.94 134.62 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 146.2 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.27 123.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.072 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -155.46 163.16 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 12' ' ' ASN . 14.2 t-80 -152.8 79.42 5.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' HD23 ' A' ' 43' ' ' LEU . 60.9 Cg_endo -72.79 -168.36 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.454 2.103 . . . . 0.0 112.268 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.69 -28.45 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -81.93 0.12 41.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 40' ' ' PRO . 2.9 pp -47.75 -28.77 2.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.779 0.323 . . . . 0.0 111.278 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -68.57 -37.0 79.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.26 -15.17 19.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.738 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.5 mttm -71.58 -24.54 61.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.6 m-85 -51.22 -60.77 5.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.257 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.4 Cg_endo -69.61 -15.36 37.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.501 2.134 . . . . 0.0 112.658 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.52 -55.32 3.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.2 p -63.62 -26.22 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.14 69.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.183 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.3 -18.98 59.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -144.35 115.28 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.14 70.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.341 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -96.6 28.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.22 -93.47 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.33 128.35 17.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.541 2.161 . . . . 0.0 112.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.61 103.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.049 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 9' ' ' ILE . 2.3 tt -133.04 145.66 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.17 142.76 20.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.396 . . . . 0.0 111.399 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 64.5 m-85 -100.36 118.94 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 263' ' ' SER . 2.2 m95 -138.73 173.7 11.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.18 -177.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 111.336 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -76.92 -50.1 14.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.28 -25.96 67.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -29.51 53.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 17.7 m-85 -115.72 -36.32 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.89 -26.1 39.73 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.715 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.9 -25.61 2.5 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.862 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -34.08 16.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 111.119 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 76' ' ' LEU . . . -69.14 -55.66 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.172 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.18 -20.39 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -95.27 -26.77 15.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.51 -90.79 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.558 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER 179.07 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 71' ' ' ALA . 4.1 mm? -123.15 150.46 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.21 121.35 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 139.13 55.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -115.76 147.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -104.73 145.73 31.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.85 162.12 23.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.646 2.231 . . . . 0.0 112.434 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.42 -47.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.78 -20.43 29.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.7 19.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.379 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.04 -59.16 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.39 . . . . 0.0 110.639 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.51 -24.82 62.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.695 ' OD1' HD21 ' A' ' 304' ' ' LEU . 9.8 t70 -72.12 -26.24 62.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 tttm 66.62 72.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.34 163.02 13.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 305' ' ' LYS . 0.3 OUTLIER -64.14 139.16 97.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.78 -44.41 49.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.496 2.131 . . . . 0.0 112.321 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.08 -29.55 65.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 107' ' ' PRO . 35.6 m -56.96 -30.22 63.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.949 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -92.58 -41.05 10.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -30.43 69.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.48 -30.99 63.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 97' ' ' VAL . 21.6 t -87.72 54.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -138.34 96.36 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.11 120.22 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.6 -74.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.59 36.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 103' ' ' LEU . 21.3 mttp -145.62 -178.5 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 102' ' ' LYS . 5.9 mp -137.96 92.7 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.5 mp -132.25 40.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.92 65.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.22 113.27 29.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 93' ' ' THR . 98.2 Cg_endo -79.74 133.2 10.19 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.443 2.095 . . . . 0.0 112.436 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.4 pp -145.77 39.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.838 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -177.03 154.43 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 110' ' ' VAL . 5.2 m -126.69 106.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.14 135.37 54.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.79 176.58 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.61 164.64 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 m -165.05 -178.75 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.65 132.37 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -104.27 138.92 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.128 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 243' ' ' GLY . 8.2 p90 -146.96 167.38 24.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.595 ' CB ' HD21 ' A' ' 121' ' ' LEU . 3.2 m120 -86.55 159.34 19.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.63 36.41 2.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.561 ' C ' HD23 ' A' ' 121' ' ' LEU . 8.0 p-10 -155.36 30.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.595 HD21 ' CB ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -178.16 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.806 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tt -123.42 84.5 52.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.33 160.46 3.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.239 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.07 111.63 6.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.73 154.82 26.97 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.74 ' HG2' HG22 ' A' ' 128' ' ' THR . 83.5 Cg_endo -82.57 10.29 3.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.777 2.318 . . . . 0.0 112.893 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt 63.42 49.53 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.928 0.394 . . . . 0.0 111.196 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 126' ' ' PRO . 12.6 t -160.14 142.63 13.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.948 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.936 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.8 m95 -57.98 -28.89 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.002 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 1.4 tp10 -53.58 -23.8 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.632 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 126' ' ' PRO . 0.6 OUTLIER -73.31 -21.42 60.57 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.936 HD12 ' CE3' ' A' ' 129' ' ' TRP . 21.4 mt -73.33 -53.43 4.7 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 82.5 Cg_exo -46.79 -49.94 11.5 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.276 1.984 . . . . 0.0 112.536 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.98 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 6.7 mt -59.11 -32.17 69.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -57.08 -34.36 68.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -31.17 57.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.7 mm-40 -78.3 -41.61 33.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.62 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 4.2 mm? -60.39 -55.84 28.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -61.31 -24.42 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.45 -23.23 24.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.476 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -110.61 -72.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.72 39.72 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.441 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.71 178.95 9.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.6 138.65 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 223' ' ' ALA . . . -92.22 53.34 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -176.68 115.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 225' ' ' THR . 1.1 ppp? -87.7 -173.63 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 41.4 p90 -86.5 107.67 18.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.58 ' CG ' HG21 ' A' ' 226' ' ' ILE . 0.9 OUTLIER 177.54 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.511 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -177.74 -32.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.68 43.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.075 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.8 144.23 26.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.817 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.67 90.8 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.535 2.157 . . . . 0.0 112.281 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.45 -31.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -117.64 -31.44 5.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.959 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -33.87 76.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.892 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.754 ' CE2' HG13 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -63.5 -56.14 29.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 52.7 Cg_endo -68.72 -11.12 31.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 0.0 112.44 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.77 -57.01 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.02 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -90.56 5.31 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.503 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -94.38 -69.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.905 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.87 -86.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.452 ' OD1' ' NE2' ' A' ' 253' ' ' GLN . 5.0 p-10 -122.37 29.19 7.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.977 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.41 -75.33 0.65 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.05 107.51 0.98 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.539 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 111.95 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.87 -67.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -139.72 165.65 26.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -131.74 119.53 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -79.41 128.59 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.43 113.73 19.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.64 30.07 18.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.77 74.15 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.18 129.59 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -59.34 162.57 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -143.06 160.37 40.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.646 HD13 ' O ' ' A' ' 178' ' ' ILE . 0.0 OUTLIER -142.77 -45.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.489 ' N ' HG23 ' A' ' 178' ' ' ILE . 61.1 mttt -62.36 -52.22 64.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.92 106.42 2.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.57 151.38 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -125.68 52.36 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.38 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.98 -19.42 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.855 ' HA ' HD22 ' A' ' 361' ' ' LEU . 2.8 m-20 -83.26 56.49 3.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.1 129.3 50.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.67 -23.92 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.312 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.63 70.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.647 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.65 -40.43 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.805 ' HG3' HD11 ' A' ' 361' ' ' LEU . 9.0 mmpt? -67.73 -30.91 70.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.89 -56.87 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.27 -26.02 74.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.609 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.78 -48.37 81.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.8 p -72.01 -31.03 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -70.21 -43.0 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.524 ' HB2' HG21 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -65.34 -49.98 67.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 197' ' ' ASP . 28.3 m -58.73 -43.22 87.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 196' ' ' VAL . 1.7 m-20 -69.28 -30.87 69.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -48.23 82.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 151' ' ' LEU . 11.9 pt -74.97 -33.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -29.93 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.14 -26.16 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -102.98 -69.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -60.24 -45.41 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.4 ttt 60.46 26.92 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.0 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.05 -45.27 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.02 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -166.75 76.64 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.6 p -55.23 148.11 15.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.6 t0 -111.11 -167.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.098 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -79.37 -41.81 26.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -78.8 -25.03 44.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.398 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 1.6 mp -82.07 -54.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.078 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 149' ' ' PHE . . . -60.51 -30.39 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.447 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.03 -23.38 52.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.103 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.69 -52.75 59.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.428 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.08 -55.48 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -55.38 -28.21 52.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -49.03 -30.86 6.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -23.99 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 62.82 22.59 64.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.06 73.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.977 0.417 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.8 p -109.77 -177.08 3.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.997 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -79.63 39.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.991 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.439 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 169.34 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 148' ' ' MET . 0.8 OUTLIER -136.49 105.09 5.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.58 HG21 ' CG ' ' A' ' 150' ' ' ASN . 2.4 tt -92.98 114.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.088 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -142.29 164.19 30.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.81 -159.87 10.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.41 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.3 62.32 2.69 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.542 2.161 . . . . 0.0 112.335 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -170.6 34.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.48 -35.05 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.029 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -76.99 69.59 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 t -166.88 -52.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -58.23 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 129.83 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -119.34 112.17 19.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.07 31.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 17.6 m 59.56 -177.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -130.22 144.72 51.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.775 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 241' ' ' ASN . 12.2 p -160.78 -44.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.087 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.486 ' N ' HG13 ' A' ' 240' ' ' VAL . 4.4 m120 -156.56 146.87 21.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -147.1 123.39 10.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 117' ' ' TYR . . . -95.79 83.5 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 244' ' ' VAL . 15.0 p -98.46 114.71 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.4 p -141.08 162.72 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.437 HG11 ' CD ' ' A' ' 322' ' ' GLU . 11.6 p -77.39 150.56 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.92 158.67 23.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.43 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.88 2.387 . . . . 0.0 112.263 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.09 177.61 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 129' ' ' TRP . 4.2 t80 -164.74 115.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.6 tttt 61.23 19.0 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.75 47.77 9.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.452 ' NE2' ' OD1' ' A' ' 164' ' ' ASP . 4.4 mm-40 -141.07 90.76 9.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 0.0 110.959 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.21 130.29 10.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.604 2.203 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.9 t -53.09 160.31 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.4 90.77 35.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.52 -159.93 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.054 2.502 . . . . 0.0 112.086 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.75 138.81 47.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 260' ' ' GLY . 22.2 t -100.17 155.17 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -132.86 136.08 8.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.612 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.77 144.59 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.838 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.3 mp -85.44 117.84 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' TRP . 92.4 p -87.65 114.73 24.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.569 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -115.58 128.84 56.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.9 -179.28 35.55 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.573 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.666 ' CG2' ' HB2' ' A' ' 269' ' ' ALA . 1.8 mt -111.68 159.36 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 266' ' ' ILE . 5.7 p-10 -127.22 134.88 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 58.68 30.64 20.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 266' ' ' ILE . . . -97.72 34.97 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.435 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 1.4 m -55.76 -61.12 6.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 270' ' ' SER . 36.4 Cg_endo -65.36 -23.78 58.28 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.497 2.131 . . . . 0.0 112.542 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -117.09 38.06 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.004 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.67 -57.31 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.55 -30.03 68.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -70.2 -56.47 6.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.224 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.15 -40.43 89.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.65 -46.77 84.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -73.36 -29.61 62.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -53.99 51.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.36 -14.44 52.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.08 27.59 3.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.157 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -125.76 -57.05 1.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.771 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 283' ' ' TYR . 4.9 mp -110.94 -78.17 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.657 ' O ' HD13 ' A' ' 290' ' ' LEU . 18.5 tp 62.5 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.96 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.443 HG21 HD11 ' A' ' 304' ' ' LEU . 0.8 OUTLIER -158.11 137.65 11.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.302 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.4 t70 70.84 -54.36 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 111.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.79 -58.05 8.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 284' ' ' LEU . . . -120.75 -38.93 0.63 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.829 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 285' ' ' LEU . 1.0 OUTLIER -55.14 -58.85 5.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.893 0.378 . . . . 0.0 111.184 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.615 ' OE1' HD11 ' A' ' 311' ' ' LEU . 5.6 mm-40 -55.25 -35.87 65.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.116 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.82 -24.86 66.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 289' ' ' GLY . 23.5 t -71.68 -30.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.48 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -105.59 -49.63 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.09 -42.64 81.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.69 -51.31 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.42 138.19 32.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 299' ' ' LEU . 58.0 Cg_endo -71.09 122.44 8.76 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.413 2.075 . . . . 0.0 112.305 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 298' ' ' PRO . 4.1 mp -151.62 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 178.1 -165.8 35.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.441 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.652 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -119.34 -176.62 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.678 HG11 HD12 ' A' ' 304' ' ' LEU . 22.0 t -93.61 156.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.44 ' N ' HG12 ' A' ' 302' ' ' VAL . . . -100.45 40.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.695 HD21 ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -89.58 -175.77 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 14.3 mttt -102.8 -71.28 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 64.0 p -70.73 -47.06 61.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -58.77 -29.56 66.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -28.58 66.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 5.8 mt-10 -56.75 -61.73 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.71 -47.55 85.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.615 HD11 ' OE1' ' A' ' 291' ' ' GLU . 4.2 mm? -61.01 -23.3 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 309' ' ' GLU . . . -56.45 -21.63 26.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -90.18 46.6 1.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.894 ' HB3' HG22 ' A' ' 317' ' ' ILE . 1.1 t0 -118.25 147.37 41.49 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.95 -48.65 18.71 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.592 2.195 . . . . 0.0 112.457 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -59.09 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.894 HG22 ' HB3' ' A' ' 314' ' ' ASP . 8.7 tp -62.28 -25.3 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -55.8 -39.94 72.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.218 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.12 -34.0 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -75.5 -29.12 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.5 ttt -57.15 -31.29 65.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.022 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.437 ' CD ' HG11 ' A' ' 246' ' ' VAL . 1.5 tt0 -67.02 -44.39 80.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.22 -30.81 49.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.03 67.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -30.71 66.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -141.43 31.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.63 -170.94 19.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.409 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.83 168.75 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.971 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mm -70.4 138.28 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 5.3 ttt -51.86 106.8 0.7 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -168.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.444 2.096 . . . . 0.0 112.339 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -177.18 79.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 333' ' ' ILE . 8.0 tt -124.97 123.24 25.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.97 -30.12 57.45 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.409 2.073 . . . . 0.0 112.224 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -58.91 -30.12 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.1 tpt -56.89 -28.27 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.054 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -59.24 -32.96 70.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.37 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.764 ' O ' HG23 ' A' ' 343' ' ' VAL . 37.8 m-85 -65.19 -28.02 69.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.59 -28.83 49.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 345' ' ' THR . 0.2 OUTLIER -62.39 -46.89 86.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.975 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.3 -27.93 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 339' ' ' PHE . 39.4 t -67.67 -42.1 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 ptt180 -75.11 -47.19 29.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 341' ' ' TYR . 55.2 p -49.87 -27.47 5.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.4 -59.13 3.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.44 -50.8 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.822 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 344' ' ' ARG . 7.4 tp -53.33 -40.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.738 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 345' ' ' THR . 5.4 t-20 -80.61 -41.67 23.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.18 87.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.04 -10.78 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.0 t -67.76 -57.02 7.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -132.43 -71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.569 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -176.67 50.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.3 OUTLIER -80.03 132.52 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.2 p -93.29 153.96 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.02 -28.55 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.7 -37.75 79.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.2 -50.38 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.613 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -58.0 -25.19 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.855 HD22 ' HA ' ' A' ' 184' ' ' ASP . 17.8 mt -82.34 -56.47 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -70.43 -41.82 72.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.361 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.12 -46.96 78.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -58.22 -57.09 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.643 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -57.6 -30.54 65.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 93.5 m -77.65 -54.91 5.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.106 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -59.13 -47.05 86.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 364' ' ' ALA . 2.9 tt -56.36 -37.88 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.238 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 365' ' ' GLN . 77.3 p -78.21 -64.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.814 0.34 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.51 97.47 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -124.71 165.08 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.16 107.44 18.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.01 86.37 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.752 ' C ' HD22 ' A' ' 7' ' ' LEU . 2.9 pttm -153.63 137.36 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.752 HD22 ' C ' ' A' ' 6' ' ' LYS . 3.9 mm? -133.92 131.5 39.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.804 HG23 ' HB2' ' A' ' 57' ' ' PRO . 38.3 t -104.21 104.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mt -93.06 114.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.585 ' NE1' HD22 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.9 115.74 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' ASP . 29.9 mt -140.84 145.74 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.51 44.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.05 79.17 1.38 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.359 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.759 ' HB2' HG21 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -87.8 8.28 26.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.607 0.242 . . . . 0.0 111.328 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 58.95 30.04 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.11 59.51 0.67 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.575 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -61.42 -54.46 43.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.771 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -30.41 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.25 -51.96 54.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.614 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.64 -26.35 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.727 0.299 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.47 -46.3 20.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.02 -41.89 84.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' GLY . 35.2 t -59.45 -44.32 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 -25.51 57.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -43.76 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -74.39 -43.34 56.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.625 ' HB3' HG21 ' A' ' 33' ' ' ILE . 2.6 m-85 -63.9 -56.32 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.517 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 19.3 pt-20 -52.78 -28.05 20.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.487 0.66 . . . . 0.0 110.683 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -25.55 49.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.473 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.645 ' O ' ' OG1' ' A' ' 31' ' ' THR . 4.4 t70 -51.53 -56.81 11.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.84 HG22 ' O ' ' A' ' 31' ' ' THR . 6.2 m 156.91 36.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.742 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.748 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.61 46.12 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.764 -2.16 . . . . 0.0 115.885 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.5 mm -131.37 95.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 118.535 1.167 . . . . 0.0 111.596 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -103.75 121.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.66 128.95 76.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.27 146.31 23.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.577 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.3 p -139.05 111.47 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 2.2 tt0 -142.8 163.14 33.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -104.9 150.3 38.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.13 -156.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.78 -75.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -59.27 -30.04 68.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.585 HD22 ' NE1' ' A' ' 10' ' ' TRP . 28.9 tp -67.53 -24.01 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.93 -45.86 67.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.64 -28.26 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -24.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' HZ ' HD22 ' A' ' 75' ' ' LEU . 3.6 t80 -45.76 -55.43 12.66 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.66 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.6 Cg_endo -61.24 -21.39 71.57 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.271 1.981 . . . . 0.0 112.503 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -89.77 -55.23 3.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 55' ' ' ASP . 33.8 t -65.78 -30.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.8 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.86 -34.44 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -25.82 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.4 -51.1 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.3 t70 75.46 -54.42 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 111.047 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.78 -94.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.804 ' HB2' HG23 ' A' ' 8' ' ' VAL . 56.7 Cg_endo -70.56 149.33 61.63 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.578 2.186 . . . . 0.0 112.218 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 177.35 80.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 265' ' ' GLY . 28.2 mt -103.1 106.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB3' ' A' ' 10' ' ' TRP . 27.1 mt -112.65 137.45 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.289 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -86.68 128.56 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -157.62 173.25 17.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.848 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -54.62 -177.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.691 ' HB3' HG13 ' A' ' 261' ' ' VAL . 13.8 p80 -77.2 -52.0 9.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.19 -29.64 61.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -56.14 -27.65 54.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.142 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -108.14 -30.31 8.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.2 57.22 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.88 -49.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.606 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.27 -50.15 75.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -74.51 -31.37 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HG3' HD13 ' A' ' 104' ' ' ILE . 1.2 tm0? -73.41 -19.43 60.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 t -70.24 -26.7 63.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.57 50.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.607 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -179.36 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.891 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.641 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 1.4 tp -177.22 133.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB3' ' H ' ' A' ' 268' ' ' ALA . . . -110.71 160.49 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -85.7 134.8 33.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 80' ' ' THR . 4.6 mt -89.09 158.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.061 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 79' ' ' ILE . 74.9 p -88.94 146.31 36.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.92 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.606 2.204 . . . . 0.0 112.388 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -176.46 138.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -60.22 -48.02 83.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.64 -25.66 62.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 82' ' ' ASP . 6.2 m-85 -79.24 -59.24 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -24.85 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.791 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.28 -31.57 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -94.24 -58.48 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.16 158.33 11.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 305' ' ' LYS . 4.7 m-85 -105.21 157.6 33.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 -26.27 24.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.54 -35.72 72.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -30.13 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -75.74 -53.45 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.07 -31.35 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.79 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.777 HG11 ' HD3' ' A' ' 107' ' ' PRO . 10.9 m -117.0 39.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -110.83 121.43 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.54 132.13 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.401 ' CB ' ' HD3' ' A' ' 102' ' ' LYS . 16.1 m-20 59.27 28.64 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.993 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.55 20.61 73.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.831 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HG3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -145.73 166.84 24.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.68 HD23 HG23 ' A' ' 97' ' ' VAL . 5.4 mp -118.74 91.98 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' HD23 ' A' ' 76' ' ' LEU . 5.1 mt -101.37 40.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.87 164.76 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.243 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.68 119.03 7.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.777 ' HD3' HG11 ' A' ' 97' ' ' VAL . 94.6 Cg_endo -79.59 152.45 22.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.548 2.166 . . . . 0.0 112.336 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 284' ' ' LEU . 7.4 tt -171.99 39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.304 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.07 104.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 320' ' ' THR . 21.6 t -91.8 110.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.017 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.64 147.19 27.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.93 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.06 159.51 15.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -164.93 145.57 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 115' ' ' LEU . 4.1 pp -93.47 150.02 20.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 227' ' ' ASN . 4.5 mt -115.05 137.24 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -127.37 164.46 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.0 173.13 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -137.69 81.4 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HB3' HD23 ' A' ' 121' ' ' LEU . 28.2 t0 -174.2 -54.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -134.51 62.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.845 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD11 ' CB ' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -156.85 92.28 2.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.69 154.1 7.16 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.526 2.151 . . . . 0.0 112.298 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.2 111.27 5.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.99 149.77 37.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.452 2.102 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.403 ' CG ' ' HB3' ' A' ' 131' ' ' GLU . 59.6 Cg_endo -72.3 -167.03 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.478 2.119 . . . . 0.0 112.229 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -95.71 -28.25 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 131' ' ' GLU . 15.4 t -75.78 140.23 42.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -73.07 -35.73 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.2 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -23.97 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.837 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' HB2' HG23 ' A' ' 128' ' ' THR . 0.8 OUTLIER -87.21 -16.32 35.65 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.3 mm -61.3 -47.71 93.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 74.0 Cg_exo -47.92 -35.17 24.18 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.381 2.054 . . . . 0.0 112.482 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mp -60.63 -30.68 70.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -50.85 36.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.3 74.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.46 -45.61 79.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 145' ' ' SER . 10.1 mt -71.85 -43.94 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -27.15 67.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -27.7 49.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -109.44 -55.97 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 40.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -148.93 177.49 9.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.501 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -152.63 175.44 12.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -129.04 45.34 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.08 115.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.437 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -154.62 106.53 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.056 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -158.0 176.81 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.688 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -50.63 156.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD11 HD13 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -129.07 -49.03 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.687 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -97.11 39.78 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -154.91 166.01 16.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.694 2.263 . . . . 0.0 112.258 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -173.27 -40.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 160' ' ' LEU . 12.6 t80 -120.75 -41.73 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.416 ' HB ' HD11 ' A' ' 195' ' ' LEU . 2.5 p -68.55 -33.58 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.501 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 23.4 t90 -68.06 -55.79 12.47 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 38.2 Cg_endo -66.0 -14.08 42.8 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.301 2.001 . . . . 0.0 112.571 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -77.86 -55.62 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.676 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.429 HG22 ' CZ ' ' A' ' 194' ' ' PHE . 3.1 pt -88.93 9.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.535 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . . . -109.29 -15.98 14.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.422 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.27 65.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.256 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.92 -30.11 19.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.12 86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -154.48 89.99 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.536 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.15 52.62 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.75 96.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.72 126.58 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -108.21 108.6 19.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 175' ' ' LYS . 2.4 t80 -97.35 110.68 23.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 102.23 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 58.93 31.24 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.95 74.3 1.16 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.52 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 1.3 mtpt -158.26 166.72 31.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -175.54 113.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.637 ' OD1' HG11 ' A' ' 343' ' ' VAL . 10.6 t0 60.17 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.648 HD13 ' O ' ' A' ' 178' ' ' ILE . 0.0 OUTLIER -155.31 -45.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 178' ' ' ILE . 8.3 tttt -120.57 -55.78 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.741 ' CA ' HD13 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -77.15 141.95 39.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.017 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.909 HG22 ' HB3' ' A' ' 336' ' ' MET . 34.4 m -138.52 139.54 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.027 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -139.24 50.69 0.78 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.66 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 339' ' ' PHE . 18.0 t -111.66 -30.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.401 ' OD2' ' CD2' ' A' ' 339' ' ' PHE . 22.1 p30 -94.17 50.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.34 162.79 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.99 -33.95 76.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.21 -28.3 49.53 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.14 -53.63 50.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -53.75 -50.08 66.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.33 68.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -60.76 -56.47 24.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.508 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.475 HD23 HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -63.95 -24.76 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.689 0.28 . . . . 0.0 111.065 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 63.0 m -56.48 -59.02 5.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.148 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 11.2 p90 -81.88 -23.04 36.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.267 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.416 HD11 ' HB ' ' A' ' 157' ' ' THR . 5.7 tp -52.92 -61.21 2.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.475 HG23 HD23 ' A' ' 192' ' ' LEU . 30.5 t -59.74 -42.89 90.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.41 -30.3 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.89 -30.03 69.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 151' ' ' LEU . 31.3 mt -77.2 -55.25 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -25.4 68.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.059 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -95.71 22.01 7.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -66.31 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -108.79 -29.25 8.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.8 mtp 62.87 31.39 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -176.71 114.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.95 88.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.98 -30.49 8.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 213' ' ' ALA . 2.7 p -81.6 147.94 29.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -140.94 -161.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.284 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 211' ' ' SER . 47.0 p90 -78.73 -47.37 16.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.004 0.431 . . . . 0.0 110.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.3 m -81.09 -26.12 36.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.242 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 209' ' ' ASP . 22.9 mt -82.44 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 209' ' ' ASP . . . -58.13 -30.23 66.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.565 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 41.3 tt0 -72.45 -36.69 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.42 59.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.457 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -75.15 -56.97 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.49 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CG ' ' CE1' ' A' ' 149' ' ' PHE . 1.1 p90 -75.14 -39.53 60.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -47.87 -35.94 11.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.119 0.485 . . . . 0.0 110.605 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -23.56 12.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.498 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.31 52.59 26.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.368 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.21 38.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.128 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.4 p -154.52 -177.97 6.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -86.4 39.54 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.357 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.18 112.82 0.45 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 116' ' ' ILE . 26.4 m -144.66 105.12 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 23.6 mt -88.3 144.88 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.658 ' HB2' HD11 ' A' ' 116' ' ' ILE . 2.0 t30 -120.16 164.3 16.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -130.74 178.61 17.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.01 66.05 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.826 2.35 . . . . 0.0 112.238 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.3 t-105 -112.97 -19.75 11.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.254 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 65.1 26.95 12.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.16 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 26.8 m95 55.13 -176.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.57 154.64 43.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.6 m120 61.2 168.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.0 pt -119.24 -41.45 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.0 100.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.823 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.1 t -123.03 138.61 54.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.59 -168.87 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 60.62 176.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 241' ' ' ASN . 11.3 p -60.0 158.25 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.482 ' N ' HG22 ' A' ' 240' ' ' VAL . 3.4 m-80 -104.18 166.42 10.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.22 170.78 8.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.62 151.28 17.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 315' ' ' PRO . 15.8 m -105.0 136.39 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.134 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 161.14 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.424 HG11 ' OE2' ' A' ' 322' ' ' GLU . 10.7 p -78.06 150.62 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.881 HD13 ' CB ' ' A' ' 255' ' ' SER . 1.3 mt -60.41 158.76 27.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.38 -173.98 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.904 2.402 . . . . 0.0 112.077 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 254' ' ' PRO . 43.7 p -116.8 150.15 38.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 250' ' ' PHE . 44.1 p90 -159.04 112.03 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.89 11.48 7.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.379 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.74 41.39 6.01 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.96 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -156.55 90.65 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.694 0.283 . . . . 0.0 111.024 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' A' ' 249' ' ' THR . 6.6 Cg_exo -73.74 85.07 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.852 2.368 . . . . 0.0 112.164 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.881 ' CB ' HD13 ' A' ' 247' ' ' LEU . 18.6 p 57.08 176.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 13.2 tttm -92.1 142.09 25.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.2 Cg_exo -79.58 153.78 23.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.632 2.222 . . . . 0.0 111.967 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 330' ' ' MET . 11.8 t80 -153.62 107.34 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.94 99.91 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -102.36 63.28 0.47 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.555 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 64' ' ' HIS . 10.8 p -87.92 144.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.31 . . . . 0.0 110.888 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -111.72 128.91 56.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.949 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.2 m -93.27 131.44 38.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.22 149.87 21.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -79.95 111.13 3.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 266' ' ' ILE . 8.4 tp -135.16 104.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -96.86 116.38 29.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.575 ' H ' ' HB3' ' A' ' 77' ' ' ALA . . . -93.01 -23.49 18.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.39 -30.6 52.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -82.1 155.66 69.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 61.46 2.57 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.393 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -165.17 31.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -75.07 -33.41 61.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -40.03 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.87 70.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.39 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.06 -39.11 83.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.48 -59.27 5.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.54 ' O ' HD23 ' A' ' 280' ' ' LEU . 2.3 tt -59.4 -31.3 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.05 -31.71 73.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -115.77 27.39 9.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -107.15 -64.54 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -100.08 -55.65 2.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.804 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.8 mm? -74.98 64.34 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.4 t -146.23 151.58 37.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.3 -31.43 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.65 -37.66 49.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -87.62 -56.55 2.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.913 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -43.74 65.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.739 0.304 . . . . 0.0 111.208 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 296' ' ' ASP . . . -76.8 -34.78 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.814 HG13 ' HG3' ' A' ' 297' ' ' LYS . 21.8 t -69.55 -30.15 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.206 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -58.87 -28.31 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -113.68 -43.07 3.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.993 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.445 ' OD2' ' HB1' ' A' ' 292' ' ' ALA . 91.5 m-20 -60.12 -69.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.923 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.814 ' HG3' HG13 ' A' ' 293' ' ' VAL . 3.7 pttt -124.16 72.38 55.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.988 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.46 107.16 2.33 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.629 2.219 . . . . 0.0 112.326 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 300' ' ' GLY . 0.9 OUTLIER -135.1 -55.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.985 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.609 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 159.87 120.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.28 127.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 302' ' ' VAL . 10.9 p -178.34 112.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -108.87 39.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.645 HD13 ' CD2' ' A' ' 307' ' ' TYR . 6.9 mt -133.89 156.93 47.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.421 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -93.41 -55.24 3.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.8 t -66.04 -48.06 72.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 304' ' ' LEU . 4.4 m-85 -59.47 -27.2 65.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.49 -28.73 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -49.51 77.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.952 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.85 -42.04 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 307' ' ' TYR . 4.5 mm? -62.1 -20.85 64.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 317' ' ' ILE . . . -52.0 -25.95 9.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.391 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -27.56 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.707 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 3.7 m-20 -58.81 158.59 15.74 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 244' ' ' VAL . 35.5 Cg_exo -61.26 -57.96 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.714 2.276 . . . . 0.0 112.665 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -58.92 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.409 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 312' ' ' ALA . 3.0 mp -52.22 -25.27 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.625 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -58.59 -51.7 68.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.22 -28.9 42.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.887 HG21 HG11 ' A' ' 110' ' ' VAL . 24.5 m -58.37 -43.6 88.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -29.85 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.424 ' OE2' HG11 ' A' ' 246' ' ' VAL . 4.5 tt0 -77.6 -54.7 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.31 -30.21 66.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.22 -29.1 60.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -58.74 -30.69 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -145.53 41.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.65 164.06 41.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -135.03 158.24 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 329' ' ' ILE . 4.7 tp -77.47 116.94 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.455 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 0.2 OUTLIER -55.22 -61.29 6.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 330' ' ' MET . 18.8 Cg_endo -59.1 -164.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 0.0 112.416 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 333' ' ' ILE . 2.9 m120 70.0 69.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.741 HD13 ' CA ' ' A' ' 180' ' ' ASP . 0.8 OUTLIER -161.59 60.75 1.22 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.61 -45.56 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.589 2.193 . . . . 0.0 112.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.91 -34.92 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.909 ' HB3' HG22 ' A' ' 181' ' ' VAL . 23.9 mmt -57.14 -23.76 49.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 340' ' ' TRP . 17.6 p -59.8 -24.92 64.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.75 -29.6 45.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.82 0.343 . . . . 0.0 111.302 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.793 ' HB3' HG21 ' A' ' 181' ' ' VAL . 23.2 t80 -73.75 -23.7 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.449 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -42.38 -29.37 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.833 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.2 -37.41 87.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -74.91 -26.12 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.468 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.637 HG11 ' OD1' ' A' ' 177' ' ' ASP . 48.8 t -55.69 -29.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.35 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.59 -60.85 2.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 37.2 m -50.0 -29.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.84 -54.44 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.382 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.9 t -79.17 -58.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.029 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.5 tp -47.34 -31.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.719 0.295 . . . . 0.0 111.515 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.31 -55.8 30.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -54.41 -26.8 32.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.343 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.11 -10.74 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.569 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.9 m -104.39 -31.27 9.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.95 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 108.53 -24.48 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -97.52 39.93 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 356' ' ' THR . 0.8 OUTLIER -79.69 165.03 23.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.9 OUTLIER -162.84 95.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.663 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.8 t -48.04 -27.82 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.17 -54.46 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -80.25 -25.94 39.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.79 -42.9 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 189' ' ' LYS . 1.5 tt -82.37 -54.82 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.458 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -55.87 20.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.524 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.81 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -59.92 -47.03 87.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.505 ' O ' HD12 ' A' ' 368' ' ' ILE . 3.2 tt0 -58.84 -56.2 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 9.4 t -58.38 -29.5 66.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -57.26 -29.84 64.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 365' ' ' GLN . 7.4 mt -64.32 -36.82 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -65.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 40.7 mttp . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.826 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.869 0.366 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 t -137.78 162.59 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.13 170.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.96 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.28 27.41 73.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -82.24 134.66 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 276' ' ' ALA . 6.4 mt -137.72 116.11 11.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 57' ' ' PRO . 10.7 p -96.96 107.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.694 HD13 HD22 ' A' ' 20' ' ' LEU . 1.6 pp -98.67 114.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.656 ' HB2' HG23 ' A' ' 60' ' ' ILE . 67.2 m95 -96.75 112.1 23.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' HB ' ' CE2' ' A' ' 61' ' ' PHE . 16.9 tt -143.65 158.65 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -175.12 99.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.32 102.82 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 232' ' ' TRP . 0.3 OUTLIER 69.54 44.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 110.72 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HE3' HG21 ' A' ' 237' ' ' THR . 0.1 OUTLIER 67.82 -166.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.24 12.72 8.05 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.725 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.617 ' CE2' HG13 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -81.13 -59.53 2.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.09 -28.86 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.81 -48.9 69.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.523 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mp -77.48 -31.28 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.04 71.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -55.91 27.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.31 -31.02 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.088 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.09 -28.07 56.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -60.91 -30.81 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -74.82 -33.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.572 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.7 m-85 -66.56 -56.31 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.776 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 11.7 pt-20 -58.32 -28.46 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 0.0 110.557 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.07 -25.78 47.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.214 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 31' ' ' THR . 17.6 t0 -54.01 -56.54 16.94 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.69 37.44 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.594 177.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.857 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.91 43.52 0.02 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 117.857 -2.116 . . . . 0.0 115.84 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.1 mm -136.94 152.67 28.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 118.064 0.932 . . . . 0.0 111.287 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -142.22 129.2 20.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.85 105.81 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 113.84 27.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.809 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.617 HG13 ' CE2' ' A' ' 17' ' ' TYR . 10.8 p -100.35 140.89 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.55 160.28 40.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.29 147.38 36.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.94 125.7 11.22 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.365 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -173.73 -68.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -92.05 0.05 57.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.391 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.639 HD12 ' CE3' ' A' ' 10' ' ' TRP . 0.5 OUTLIER -56.48 -28.44 59.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.107 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.79 -43.47 76.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -98.39 -26.27 14.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -77.0 -24.57 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.141 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.567 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 68.8 t80 -52.87 -56.08 26.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.308 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.2 Cg_endo -63.71 -17.59 60.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.28 1.987 . . . . 0.0 112.448 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -89.67 -46.48 8.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.8 t -90.45 9.88 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -79.56 -47.5 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.24 79.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.6 p -85.17 -38.45 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.52 43.9 2.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -62.06 -31.0 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.57 -79.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.577 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 8' ' ' VAL . 38.0 Cg_endo -66.21 130.22 23.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.585 2.19 . . . . 0.0 112.323 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -175.93 71.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.54 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.7 mt -123.2 111.44 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 10' ' ' TRP . 2.0 mp -129.61 138.51 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.386 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -129.81 128.79 43.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -166.35 102.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 111.988 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . 54.33 166.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.881 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 97' ' ' VAL . 24.1 t-80 -77.22 -60.12 2.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.998 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -44.9 76.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.093 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -56.79 -23.0 40.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -99.68 -56.66 2.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -18.39 50.76 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.748 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.37 -38.78 4.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.654 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -97.96 -54.84 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.792 ' HB1' HD22 ' A' ' 76' ' ' LEU . . . -58.12 -30.79 66.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -70.5 -21.57 62.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 p -107.38 -26.31 11.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.918 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.25 -87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.635 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.5 pp 177.41 46.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 ' HB1' ' A' ' 71' ' ' ALA . 9.0 mp -80.05 137.66 36.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.59 121.74 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -58.89 159.89 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.8 pt -115.04 170.54 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 p -137.15 90.97 15.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.72 -176.14 3.09 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.585 2.19 . . . . 0.0 112.434 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.22 -176.17 3.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.85 83.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.27 32.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.418 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -80.2 -59.26 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.427 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -72.53 -24.73 61.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.816 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -76.33 -18.57 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.411 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -76.96 -67.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.89 151.01 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -97.63 156.35 36.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 52.6 Cg_exo -52.82 -24.77 24.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.656 2.237 . . . . 0.0 112.489 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.87 -62.51 1.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.031 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -65.05 -25.93 68.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 98' ' ' ARG . 3.1 m0 -57.91 -49.75 75.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.38 -26.83 0.91 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 97' ' ' VAL . . . -54.65 -43.6 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.641 HG21 ' HD3' ' A' ' 107' ' ' PRO . 5.3 m -158.78 71.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.887 0.375 . . . . 0.0 111.511 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.759 ' CZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -145.21 109.14 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.804 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.53 174.74 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.16 62.56 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.31 27.94 5.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -145.36 101.2 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.759 HD11 ' CZ ' ' A' ' 98' ' ' ARG . 9.5 tp -114.17 99.45 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.686 HD13 ' H ' ' A' ' 104' ' ' ILE . 0.2 OUTLIER -139.71 40.0 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.075 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.97 128.76 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.27 111.02 15.31 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.771 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.641 ' HD3' HG21 ' A' ' 97' ' ' VAL . 98.6 Cg_endo -79.6 139.23 14.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.44 2.093 . . . . 0.0 112.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 tt -166.51 39.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.18 109.31 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 302' ' ' VAL . 12.5 p -89.29 124.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.15 132.99 46.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.917 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.18 176.52 12.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.66 137.12 40.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 m -164.71 -176.06 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 ' OG1' ' A' ' 245' ' ' THR . 0.2 OUTLIER -96.2 152.53 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.768 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 243' ' ' GLY . 22.9 mm -100.8 147.72 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -120.0 126.56 51.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.0 155.4 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -75.73 -30.86 59.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.97 62.95 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 122' ' ' LEU . 20.9 tp -175.85 39.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.908 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -156.88 151.43 20.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 223' ' ' ALA . 55.6 Cg_endo -70.15 160.39 49.76 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.256 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.13 164.17 25.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.777 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.02 136.38 40.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.454 2.102 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.4 -171.52 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.533 2.156 . . . . 0.0 112.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -109.58 -36.41 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -160.04 172.11 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.472 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -59.09 -24.71 63.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -76.78 -25.3 53.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.61 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -89.37 -32.66 17.2 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.647 HG22 ' HD3' ' A' ' 133' ' ' PRO . 17.9 tt -56.43 -32.78 14.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.647 ' HD3' HG22 ' A' ' 132' ' ' ILE . 15.1 Cg_exo -69.49 -42.39 3.72 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.278 1.985 . . . . 0.0 112.198 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.03 64.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.248 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 123' ' ' PRO . 5.3 tp -58.89 -30.78 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -47.74 84.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -58.53 -31.73 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -54.18 48.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 146' ' ' ALA . 5.6 mt -70.85 -40.56 72.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.948 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -27.6 65.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.09 -25.28 63.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -109.12 -75.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.53 39.84 0.16 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.403 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.57 -174.89 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' HD13 ' A' ' 139' ' ' LEU . 37.7 m -150.19 162.05 41.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.723 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -111.77 33.49 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER 178.93 125.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.623 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.638 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 1.8 mtt -170.09 106.18 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.64 177.35 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.76 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.449 ' N ' ' HB1' ' A' ' 213' ' ' ALA . 13.0 m-80 -45.55 167.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.425 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 HG12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -134.15 -45.55 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.674 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.455 ' OE1' ' HB1' ' A' ' 206' ' ' ALA . 78.9 mt-30 -95.52 39.54 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.98 170.73 5.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.76 166.17 21.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.59 2.194 . . . . 0.0 112.445 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.02 28.6 17.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -120.88 -59.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 1.026 HG23 HD13 ' A' ' 195' ' ' LEU . 62.2 m -73.11 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.512 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -64.03 -55.42 32.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.5 Cg_endo -64.2 -27.17 64.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.288 1.992 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.728 HD13 ' CD2' ' A' ' 195' ' ' LEU . 1.1 tt -71.94 -56.48 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.569 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' THR . 2.2 tt -76.01 -9.9 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.289 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -78.85 -23.54 44.91 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.72 0.295 . . . . 0.0 111.306 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.83 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -122.26 39.97 3.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.34 -41.94 3.32 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.504 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.7 -48.46 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.496 ' CD2' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER 62.36 175.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -72.5 -29.17 63.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.254 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 167' ' ' TYR . 13.7 p90 -113.78 117.46 31.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -96.04 138.03 34.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.36 110.69 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.729 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -137.2 178.61 6.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -67.57 72.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.777 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.7 25.5 4.24 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.538 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.01 154.59 22.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -148.94 127.5 12.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -71.65 122.86 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 179' ' ' LYS . 7.4 tp -162.23 -44.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.097 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.477 ' N ' HG23 ' A' ' 178' ' ' ILE . 3.9 pttm -132.1 37.86 3.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.87 141.35 38.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -140.67 148.28 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.251 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.79 39.92 1.41 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.41 -34.58 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -104.99 30.69 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -103.66 175.24 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.64 74.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.069 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.51 66.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -71.34 -41.93 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.91 -31.89 70.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 -46.19 15.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.04 63.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 361' ' ' LEU . 3.9 tp -60.58 -49.1 78.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.3 m -60.79 -34.55 74.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.3 -46.89 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 1.026 HD13 HG23 ' A' ' 157' ' ' THR . 3.3 mt -58.91 -47.35 85.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.4 t -64.23 -48.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.84 -35.42 78.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.15 -41.21 92.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.649 HG12 HD23 ' A' ' 151' ' ' LEU . 21.6 mt -76.55 -30.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -31.65 72.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.06 18.34 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.1 -76.6 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.789 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -115.23 -13.42 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 ttt 70.02 -66.04 0.29 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -102.67 128.46 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.455 ' HB1' ' OE1' ' A' ' 152' ' ' GLN . . . -59.11 87.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.61 -29.47 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 t -78.14 108.83 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 211' ' ' SER . 2.8 p30 -94.12 -148.21 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 211' ' ' SER . 38.4 p90 -78.68 -51.72 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD2' ' A' ' 210' ' ' TYR . 88.6 p -62.34 -25.25 67.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.036 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.1 mm -82.01 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.449 ' HB1' ' N ' ' A' ' 150' ' ' ASN . . . -60.29 -30.53 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -66.44 -28.97 69.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.37 -25.06 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.336 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -52.45 -56.79 12.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 225' ' ' THR . 51.2 t80 -76.29 -36.74 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.76 -5.67 44.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.647 0.26 . . . . 0.0 110.935 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 221' ' ' GLU . . . -172.01 -78.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.321 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 0.9 OUTLIER 163.48 100.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 110.49 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 145' ' ' SER . 4.7 p -109.32 -177.41 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 38.96 0.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -146.66 111.64 5.37 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.934 0.397 . . . . 0.0 111.143 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -144.56 104.71 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 37.0 mt -115.26 142.67 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -144.04 111.64 6.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.44 62.03 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.42 -44.73 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.56 2.173 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 -148.97 -47.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -132.7 -53.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.64 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.1 p 58.64 166.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.38 106.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.7 mt -145.92 145.04 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -160.17 -56.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.715 HG21 ' HE3' ' A' ' 15' ' ' LYS . 10.8 p 55.87 102.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.055 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 92.8 p -116.31 -55.02 2.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -164.49 -60.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 240' ' ' VAL . 12.2 p -72.51 125.78 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -99.7 -179.29 4.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -132.75 170.8 14.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -124.26 165.88 17.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.71 136.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.473 ' OG1' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -123.48 149.67 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.931 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.441 HG13 ' ND2' ' A' ' 323' ' ' ASN . 21.5 t -91.35 150.57 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.585 HD12 ' H ' ' A' ' 247' ' ' LEU . 4.2 mp -60.05 158.77 24.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.818 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.2 166.04 23.09 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.875 2.383 . . . . 0.0 112.168 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -95.61 177.55 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.446 ' H ' HG22 ' A' ' 249' ' ' THR . 46.2 t80 -159.31 111.9 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.2 mttm 59.95 20.51 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.71 44.91 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.621 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -156.37 90.83 2.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.649 0.261 . . . . 0.0 110.864 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.21 159.39 22.64 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.587 2.191 . . . . 0.0 112.296 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.8 p -67.19 -175.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.484 ' CG ' ' HB1' ' A' ' 162' ' ' ALA . 20.0 mmtp -107.29 94.31 11.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.67 151.14 21.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.461 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 331' ' ' PRO . 3.8 t80 -108.13 82.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.91 151.81 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.84 171.75 29.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.81 144.95 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.674 0.274 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.1 mp -78.3 105.25 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.8 m -79.79 116.55 20.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.288 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -101.57 155.3 18.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.597 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.449 ' N ' ' CZ ' ' A' ' 67' ' ' PHE . . . -146.17 172.13 26.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.939 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.724 HD11 ' CD ' ' A' ' 273' ' ' LYS . 11.3 tt -113.68 159.74 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.669 0.271 . . . . 0.0 110.777 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 2.1 t-20 -116.47 108.01 15.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 267' ' ' ASN . . . 78.94 -53.71 0.45 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.415 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 66.73 6.71 4.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.504 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 3.3 t -67.45 -60.53 5.6 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.306 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 270' ' ' SER . 12.0 Cg_endo -55.88 -163.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.551 2.167 . . . . 0.0 112.442 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -79.26 55.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.052 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.724 ' CD ' HD11 ' A' ' 266' ' ' ILE . 0.7 OUTLIER -73.25 -29.66 62.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.817 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.24 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -74.17 -48.78 26.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -66.69 -32.08 73.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -78.86 -40.18 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.56 -36.59 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.38 -38.79 85.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.65 -27.66 67.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.61 -22.19 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.17 5.66 29.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.31 -48.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 110.991 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.766 HD21 ' NZ ' ' A' ' 297' ' ' LYS . 1.3 mt -89.31 53.42 2.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.774 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.6 p -154.71 174.9 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -21.03 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.56 -54.67 7.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.11 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.59 -45.75 4.21 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.773 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.2 OUTLIER -54.27 -30.21 49.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.142 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.61 -38.09 70.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.5 67.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.942 HG13 ' CB ' ' A' ' 297' ' ' LYS . 85.9 t -58.12 -30.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.179 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.36 -13.23 60.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -114.31 -25.24 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -119.47 -81.65 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.693 0.282 . . . . 0.0 111.514 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.942 ' CB ' HG13 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -49.53 164.93 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.354 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.39 147.16 69.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.548 2.166 . . . . 0.0 112.275 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 299' ' ' LEU . 3.4 mm? -79.13 -25.84 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.108 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -79.8 114.34 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 317' ' ' ILE . . . -169.89 137.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 110' ' ' VAL . 28.5 m -155.82 108.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -146.08 39.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.1 mt -153.66 165.45 35.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -38.59 3.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.014 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 p -79.5 -47.82 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -60.65 -21.9 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.527 ' OE2' HD21 ' A' ' 311' ' ' LEU . 35.1 mm-40 -51.02 -28.21 9.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.273 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.19 -47.85 59.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.21 -54.15 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 317' ' ' ILE . 4.5 pp -62.51 -17.75 60.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.295 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -53.71 -23.35 11.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.614 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.34 46.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.774 0.321 . . . . 0.0 111.301 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.615 ' HB3' HG22 ' A' ' 317' ' ' ILE . 0.4 OUTLIER -124.14 173.73 4.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.783 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -90.09 -51.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.839 2.359 . . . . 0.0 113.725 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -81.3 -59.44 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.635 ' CD1' HD13 ' A' ' 311' ' ' LEU . 16.7 tt -56.27 -31.58 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 314' ' ' ASP . . . -76.52 -33.08 58.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.47 75.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 44.9 p -76.76 -30.94 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -32.15 70.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.06 -52.7 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.441 ' ND2' HG13 ' A' ' 246' ' ' VAL . 16.0 m-20 -69.58 -30.45 68.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.25 71.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.32 -29.24 69.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -118.43 59.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 178.39 -154.19 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.92 166.23 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.5 101.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 53.66 87.62 0.14 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 258' ' ' PHE . 47.8 Cg_endo -68.77 161.47 45.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.492 2.128 . . . . 0.0 112.228 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -157.39 91.24 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 12.0 pt -152.59 132.15 7.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 -23.56 22.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.468 2.112 . . . . 0.0 112.411 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -55.94 -43.81 77.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 169' ' ' PHE . 1.6 mtp -69.17 -35.36 76.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.2 p -62.57 -35.55 79.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.7 -33.87 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.763 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -73.49 -27.28 61.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -42.74 81.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.99 -35.43 42.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.51 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.3 t -59.59 -30.13 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.878 ' HG3' HD12 ' A' ' 348' ' ' ILE . 4.2 tpt180 -58.89 -60.81 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 0.9 OUTLIER -67.45 -27.5 67.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.85 -59.72 4.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.651 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 350' ' ' ALA . 20.1 t -79.36 -59.1 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.878 HD12 ' HG3' ' A' ' 344' ' ' ARG . 21.9 mt -48.19 -58.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 345' ' ' THR . 15.2 t-20 -55.47 -36.21 66.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 111.179 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -56.02 -30.11 61.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.21 -10.15 55.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.553 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.6 p -67.58 -25.14 65.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 111.95 -27.82 9.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.18 39.34 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 124.9 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.805 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 359' ' ' GLU . 8.2 t -115.56 177.92 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.966 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 192' ' ' LEU . 22.0 t -72.31 -35.15 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -45.98 88.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.445 ' H ' HG23 ' A' ' 356' ' ' THR . 23.1 mt-10 -79.96 -43.4 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -59.99 -38.51 82.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 361' ' ' LEU . 0.3 OUTLIER -82.1 -48.82 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -62.81 -44.06 97.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.35 -26.52 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -51.81 -56.86 11.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.388 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.6 pt20 -56.55 -30.51 63.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 13.6 m -67.66 -43.2 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.407 ' HG3' HG13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -73.89 -29.82 62.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.995 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 365' ' ' GLN . 16.8 mt -75.06 -44.93 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.99 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 23.3 m -79.65 -67.94 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.83 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.09 40.03 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -119.71 153.08 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -133.86 -68.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.04 85.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -149.27 158.7 44.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.481 HD22 HD11 ' A' ' 59' ' ' ILE . 9.2 mt -136.58 155.35 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.947 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.772 HG23 ' HG2' ' A' ' 57' ' ' PRO . 28.3 t -123.91 102.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mt -94.88 114.98 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -94.91 124.46 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pt -134.66 149.06 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.186 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.73 94.27 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.44 27.94 53.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.64 ' O ' HD22 ' A' ' 299' ' ' LEU . 1.3 m-20 -75.31 -29.98 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.706 0.288 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 299' ' ' LEU . 18.0 tttt 62.75 118.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 48.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.56 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -78.78 -34.72 45.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.36 -42.0 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.695 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.37 -33.75 30.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 37' ' ' VAL . 1.2 tt -74.57 -31.56 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.12 77.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.271 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -76.96 -32.2 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 27' ' ' PHE . 27.9 t -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.104 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.42 -38.04 89.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -74.11 -26.74 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -44.15 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 23' ' ' VAL . 67.2 m-85 -62.24 -56.67 16.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -59.37 -27.42 65.95 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 110.131 179.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -27.3 1.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -69.28 -56.87 6.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.56 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.031 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.25 49.05 0.01 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 118.115 -1.993 . . . . 0.0 115.513 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -139.56 95.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 118.103 0.951 . . . . 0.0 111.628 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -99.95 106.38 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.11 146.34 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.01 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 20' ' ' LEU . 5.8 m -116.63 118.26 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -143.9 162.8 35.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -87.16 154.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.51 130.01 20.1 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.595 2.197 . . . . 0.0 112.277 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.34 -60.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -79.41 -7.58 58.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.33 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 43' ' ' LEU . 4.6 pp -55.62 -24.93 36.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.78 -34.39 62.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.067 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.3 -29.94 12.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.0 tttt -69.27 -31.18 69.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -56.36 -60.76 8.13 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.4 Cg_endo -63.77 -16.83 57.09 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.423 2.082 . . . . 0.0 112.513 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.86 -44.5 18.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.792 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 46' ' ' LYS . 31.1 m -90.21 -24.36 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.2 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.89 70.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 53' ' ' THR . . . -63.24 -30.78 71.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.059 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.84 128.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.64 72.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.24 -30.99 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.28 -168.81 12.36 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HG2' HG23 ' A' ' 8' ' ' VAL . 55.8 Cg_endo -70.23 -171.61 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.314 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 175.09 103.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.481 HD11 HD22 ' A' ' 7' ' ' LEU . 32.2 mt -143.6 136.25 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.25 141.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 12.7 m-85 -108.79 144.67 36.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.606 ' N ' HD23 ' A' ' 262' ' ' LEU . 1.3 m95 -165.62 173.6 10.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.57 -174.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.344 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' HB2' HG23 ' A' ' 261' ' ' VAL . 57.1 t-80 -77.69 -45.01 26.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.3 -28.81 44.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.59 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -54.75 -24.17 21.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.217 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 4.3 m-85 -101.11 -28.5 12.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.965 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.74 -23.13 49.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.655 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.4 -50.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.3 -57.51 3.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -58.71 -30.6 67.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -28.42 64.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 p -70.26 -26.74 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.34 77.68 1.07 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.797 ' O ' HD22 ' A' ' 76' ' ' LEU . 7.8 tp -167.48 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.797 HD22 ' O ' ' A' ' 75' ' ' LEU . 1.3 mm? -141.5 127.82 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.884 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -59.79 138.48 57.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' HG23 ' A' ' 104' ' ' ILE . 17.7 tt0 -89.04 157.96 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mm -111.3 141.49 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 148.56 40.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.78 168.2 19.61 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.725 2.284 . . . . 0.0 112.372 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.95 153.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -31.65 70.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 -23.28 64.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CE2' HD22 ' A' ' 89' ' ' LEU . 1.4 t80 -79.3 -59.16 2.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 8.3 pt20 -62.55 -24.73 67.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.66 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -68.19 -32.8 73.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 304' ' ' LEU . 8.9 mtmm -104.96 -63.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.07 113.53 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.825 ' O ' HG22 ' A' ' 93' ' ' THR . 15.3 m-85 -62.25 143.89 95.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.51 -24.94 30.4 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.468 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -57.03 -34.72 68.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.076 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 90' ' ' TYR . 8.8 t -86.76 -28.23 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.982 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' A' ' 86' ' ' GLN . 4.4 m0 -59.74 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.69 -29.25 70.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 330' ' ' MET . . . -59.63 -29.6 68.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.203 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.926 HG11 ' HD3' ' A' ' 107' ' ' PRO . 27.0 m -129.77 61.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.38 81.44 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -79.26 98.07 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.77 31.51 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.47 50.65 7.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -131.32 129.74 41.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.65 40.02 1.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.0 pp -97.78 39.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 178.22 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 6.7 p90 -118.73 129.14 25.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.926 ' HD3' HG11 ' A' ' 97' ' ' VAL . 98.0 Cg_endo -79.8 168.14 19.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.606 2.204 . . . . 0.0 112.283 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -175.01 39.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.21 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.916 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 174.18 108.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.982 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 259' ' ' VAL . 10.4 p -90.09 134.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.05 164.35 28.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.62 10.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.604 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -146.11 157.54 43.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -175.95 5.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mt -92.62 146.15 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -73.77 155.94 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.05 0.452 . . . . 0.0 111.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -135.78 114.71 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -133.77 -177.49 4.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.35 76.27 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -156.05 -50.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 221' ' ' GLU . 0.6 OUTLIER -148.06 39.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.27 91.13 47.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.37 159.42 53.42 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.444 2.096 . . . . 0.0 112.27 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -102.2 95.77 6.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 159.48 52.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.59 49.42 3.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.678 2.252 . . . . 0.0 112.702 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 55.47 32.9 19.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.07 140.44 52.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -32.35 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.643 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.71 17.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.485 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.36 -17.09 58.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 mt -73.47 -53.0 4.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.1 Cg_exo -52.15 -36.74 67.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.312 2.008 . . . . 0.0 112.428 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -32.87 56.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 139' ' ' LEU . 60.5 mt -77.02 -31.91 56.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -76.6 -31.07 57.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -71.75 -32.16 67.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.46 -40.69 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.799 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 6.7 mt -73.15 -53.24 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -57.77 -24.63 58.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.37 -26.13 60.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -109.76 -70.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.62 39.85 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -174.89 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.725 0.297 . . . . 0.0 110.787 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.474 ' C ' HD13 ' A' ' 139' ' ' LEU . 1.4 m -157.13 171.24 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.799 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -142.94 49.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 4.4 tt 170.62 120.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.03 106.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -172.24 167.04 5.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 148.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -178.64 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.811 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -133.95 39.93 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 154' ' ' PRO . 6.8 pt-20 -87.65 173.41 6.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.452 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 88.7 Cg_endo -85.89 118.75 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.435 2.09 . . . . 0.0 112.617 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 61.52 80.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.614 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.1 p90 -121.13 -48.25 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.4 t -72.8 -35.27 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.349 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -49.27 -55.81 19.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.326 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.0 Cg_endo -78.7 -18.31 11.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.627 2.218 . . . . 0.0 112.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 156' ' ' PHE . 2.3 mm? -80.39 -56.7 4.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.174 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 167' ' ' TYR . 1.8 pt -80.6 1.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -88.13 -54.54 4.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 253' ' ' GLN . . . 62.67 -81.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -56.8 2.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 100.67 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.579 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.95 87.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.82 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 33.7 t80 -171.49 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -131.88 -46.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.27 160.01 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.22 138.0 36.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -117.48 110.71 18.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -137.18 178.43 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.729 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -70.34 66.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.15 -26.62 1.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -89.01 159.27 17.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.348 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -172.39 74.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 43.16 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.448 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.841 HD12 ' HB2' ' A' ' 179' ' ' LYS . 1.9 pp -142.9 -45.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.268 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.841 ' HB2' HD12 ' A' ' 178' ' ' ILE . 9.7 tptt -133.61 -44.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.39 95.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 179' ' ' LYS . 5.8 m -148.94 106.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 159.2 109.73 0.27 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.046 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 167' ' ' TYR . 17.2 m -74.56 42.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.808 0.337 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -110.93 -7.86 14.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.723 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.58 -173.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.63 63.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.79 -49.34 79.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.36 -45.18 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HG3' HD21 ' A' ' 361' ' ' LEU . 20.4 mtpt -60.2 -58.59 7.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.52 87.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.12 -53.34 18.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.598 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 196' ' ' VAL . 3.3 tt -60.05 -42.68 94.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.9 m -59.46 -30.44 68.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -76.15 -47.87 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -67.05 -50.02 63.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.767 HG11 HG21 ' A' ' 357' ' ' VAL . 12.0 p -56.49 -28.07 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.255 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.44 -54.6 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -59.0 -59.05 6.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.026 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -51.96 -25.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.37 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 196' ' ' VAL . 1.2 tptp -60.51 -59.97 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.517 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.18 20.99 18.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . 0.447 ' CE ' ' CD2' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -120.28 -68.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' ' 151' ' ' LEU . 27.4 m80 -81.16 -0.52 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.715 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -20.27 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.626 0.25 . . . . 0.0 111.288 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -142.52 37.93 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -162.28 84.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.72 57.71 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.541 ' O ' HG23 ' A' ' 208' ' ' THR . 11.5 t -57.4 108.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 212' ' ' ILE . 3.3 t0 -78.43 -156.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.721 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -78.38 -44.45 24.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.157 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.1 p -73.93 -25.1 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.173 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 209' ' ' ASP . 13.3 mt -82.05 -53.94 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.107 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.27 64.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.403 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 12.0 tm-20 -72.86 -42.62 63.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.423 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.16 -24.92 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.23 -56.66 11.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.681 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.94 ' CG ' HG23 ' A' ' 225' ' ' THR . 8.6 p90 -67.56 -30.93 70.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.749 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -79.9 -11.9 59.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -74.45 -24.04 59.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.687 0.279 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.65 -92.77 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.178 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.4 OUTLIER 165.54 91.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.607 0.241 . . . . 0.0 110.561 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.35 -177.89 3.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 38.59 0.66 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.52 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -154.11 101.87 2.43 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.044 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.94 HG23 ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -144.6 104.93 4.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.191 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.906 HD13 ' CD2' ' A' ' 149' ' ' PHE . 3.9 mp -106.26 119.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.229 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -139.18 162.89 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.14 -150.91 17.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.63 169.54 17.18 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 112.318 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t90 61.71 37.02 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -141.61 -47.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.39 69.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 4.7 t 60.26 -166.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.15 131.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.93 -66.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.32 154.52 24.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m -89.29 86.26 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.817 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 70.6 m -84.27 147.08 27.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 85.35 3.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.56 HG12 ' ND2' ' A' ' 241' ' ' ASN . 26.2 t -128.52 -69.32 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.049 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.56 ' ND2' HG12 ' A' ' 240' ' ' VAL . 16.4 p30 178.32 40.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -144.79 115.84 7.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -156.92 175.97 34.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.36 136.43 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 146.52 52.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.82 150.7 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.95 149.18 74.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.52 -174.61 2.35 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.185 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -127.84 177.69 6.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.499 ' H ' HG22 ' A' ' 249' ' ' THR . 24.4 t80 -158.27 111.74 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.49 12.64 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.26 5.53 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.736 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.603 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 3.4 pt20 -156.35 90.49 2.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.784 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.453 ' HB3' HG23 ' A' ' 249' ' ' THR . 91.9 Cg_endo -86.72 150.28 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.889 2.392 . . . . 0.0 112.618 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 69.5 m -55.24 150.5 10.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -109.41 89.5 7.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.76 125.3 6.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.578 2.185 . . . . 0.0 112.391 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -79.98 172.04 14.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 110' ' ' VAL . 10.5 p -94.88 138.13 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.72 129.97 10.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 64' ' ' HIS . 30.8 m -122.22 144.78 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -92.57 115.67 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.461 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' TRP . 8.9 m -94.59 133.73 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.475 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -101.67 126.07 48.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.603 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 76' ' ' LEU . . . -114.91 159.04 13.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.743 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.884 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.5 tt -140.2 136.38 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -51.37 125.56 14.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.46 -29.86 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.249 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.74 46.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.7 m -96.13 112.81 60.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.39 -26.98 12.74 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.448 2.099 . . . . 0.0 112.437 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -120.22 65.53 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.402 ' NZ ' ' HB1' ' A' ' 77' ' ' ALA . 7.2 tttp -75.04 -53.98 7.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.28 -32.17 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -73.0 -49.17 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.73 -42.96 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -59.86 -42.68 94.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.97 -30.51 58.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.513 ' CE1' HD23 ' A' ' 275' ' ' LEU . 1.8 m-85 -64.16 -59.2 4.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 281' ' ' GLU . 4.5 pp -58.86 -27.0 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.647 ' N ' HD12 ' A' ' 280' ' ' LEU . 1.1 mm-40 -74.33 -29.26 61.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.54 27.47 9.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 27' ' ' PHE . 14.6 m-85 -148.2 -74.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.83 -31.38 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.48 72.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.76 164.42 38.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -27.86 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -77.54 -27.68 51.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.125 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -105.62 -54.46 0.73 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.711 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.39 -30.71 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.152 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -72.28 -40.71 67.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.65 81.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.08 -33.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -80.15 -55.06 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -59.72 -57.8 11.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.47 -34.4 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 299' ' ' LEU . 2.6 tptt -139.24 89.42 12.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 115.73 4.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.55 2.166 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -126.34 -43.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.88 123.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -86.07 90.13 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.15 79.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 306' ' ' SER . . . -139.08 78.17 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 304' ' ' LEU . 0.1 OUTLIER 40.59 -91.87 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.971 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -78.37 -41.26 33.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.784 0.326 . . . . 0.0 111.203 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.83 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 1.8 m -53.28 -25.16 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.234 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 311' ' ' LEU . 87.8 t80 -56.1 -44.67 79.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.35 -31.81 58.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -66.86 -48.22 69.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB2' ' HB1' ' A' ' 301' ' ' ALA . 71.4 mm-40 -71.19 -35.9 71.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 307' ' ' TYR . 3.4 mp -56.03 -23.06 30.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.1 71.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -176.8 74.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.16 139.16 19.85 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.34 -62.38 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.445 2.096 . . . . 0.0 112.352 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -60.78 -48.52 81.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.528 HG22 ' CE ' ' A' ' 321' ' ' MET . 42.2 mm -59.52 -29.91 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.48 71.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -78.46 -56.26 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.1 t -58.38 -27.27 64.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.528 ' CE ' HG22 ' A' ' 317' ' ' ILE . 7.8 mtt -56.23 -29.14 60.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.47 -57.41 12.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -78.36 -31.85 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.92 71.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -59.68 -32.24 70.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -109.37 38.88 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.2 179.59 24.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.578 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.76 -177.2 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.978 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -135.32 107.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 329' ' ' ILE . 3.4 mmt 60.66 155.77 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.975 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.31 -161.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.231 . . . . 0.0 112.256 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -170.39 -42.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 333' ' ' ILE . 3.3 tt -123.77 122.97 26.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.51 -21.23 34.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.088 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.35 -30.68 62.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -30.99 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 60.5 p -65.21 -41.74 94.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.93 74.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 343' ' ' VAL . 0.4 OUTLIER -67.72 -27.52 66.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.43 -32.21 62.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.88 -31.42 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 367' ' ' ARG . . . -76.71 -53.25 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.82 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 21.9 t -58.05 -30.04 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 348' ' ' ILE . 16.9 mtp180 -59.71 -54.4 46.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 69.0 p -49.78 -27.66 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -75.66 -54.28 7.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.47 -59.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.932 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.4 tt -49.62 -39.63 14.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.917 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.64 -28.6 36.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.943 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -59.61 -31.47 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.92 -10.2 59.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.517 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.0 p -67.57 -26.04 66.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.122 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 109.56 -24.34 20.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.568 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 39.55 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.44 114.14 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.765 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.2 OUTLIER -105.18 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 196' ' ' VAL . 21.6 t -72.28 -28.89 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.213 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 -37.48 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.22 -55.78 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.814 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -50.33 -36.49 32.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -82.35 -42.52 18.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -65.53 -55.67 16.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.8 -27.17 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.814 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.36 -54.91 29.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 369' ' ' THR . 1.4 tt0 -58.86 -30.44 67.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.4 m -59.47 -57.66 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 342' ' ' ALA . 24.1 ptt180 -58.37 -41.24 84.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.146 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 33.1 mm -71.96 -32.04 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 365' ' ' GLN . 17.4 p -108.52 35.45 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.89 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -151.43 169.09 22.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.17 150.05 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -108.97 154.42 22.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.8 72.19 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.66 141.58 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.713 HD22 ' CE1' ' A' ' 279' ' ' PHE . 2.7 mp -141.82 138.87 32.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.721 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 59' ' ' ILE . 44.9 t -115.22 113.53 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.094 0.474 . . . . 0.0 111.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt -99.15 133.89 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.1 m0 -94.71 111.95 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 tt -139.59 148.74 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.096 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -171.43 75.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.07 -112.34 1.4 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 178.38 58.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.849 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 296' ' ' ASP . 3.6 pttt -125.38 -97.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.006 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.81 80.76 0.28 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.596 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -61.94 -30.95 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -59.15 -28.38 66.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 293' ' ' VAL . . . -56.77 -51.59 55.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.637 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.73 -37.2 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.32 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -64.25 -56.09 17.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.521 HG12 ' ND2' ' A' ' 282' ' ' ASN . 21.3 t -69.37 -43.97 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.57 -27.69 64.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.616 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -32.87 70.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.59 -45.06 89.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.4 m-85 -63.9 -56.03 18.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 35' ' ' VAL . 8.7 mt-10 -53.91 -28.4 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.437 0.637 . . . . 0.0 110.59 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -78.09 -25.78 47.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.486 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' HB ' ' A' ' 31' ' ' THR . 4.4 t70 -52.65 -56.46 15.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.48 36.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.456 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.26 44.39 0.02 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.883 -2.103 . . . . 0.0 115.75 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 32' ' ' GLY . 3.4 mm -133.94 149.28 30.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 118.21 1.005 . . . . 0.0 111.377 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.56 137.4 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.861 HG22 ' OE2' ' A' ' 28' ' ' GLU . 30.0 m -130.55 129.78 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.85 134.63 54.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 9' ' ' ILE . 31.2 m -127.91 120.17 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.11 163.02 33.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -80.11 152.91 74.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.86 179.07 5.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.551 2.167 . . . . 0.0 112.449 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 76.67 -0.28 3.04 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.65 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 -48.83 2.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.2 -12.73 57.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.412 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -26.37 8.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.279 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.63 -51.12 9.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -71.81 -24.55 61.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -49.85 -60.46 5.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.316 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 36.1 Cg_endo -65.08 -15.35 49.96 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.432 2.088 . . . . 0.0 112.568 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.67 -40.95 12.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.961 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.28 -29.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.64 -30.97 71.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.77 66.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.1 m -100.26 -45.48 5.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.69 73.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -99.68 -28.86 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 0.0 111.085 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.29 -64.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.63 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' HG21 ' A' ' 8' ' ' VAL . 5.8 Cg_endo -48.96 115.3 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.823 2.349 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -175.32 39.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.803 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -145.25 129.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.516 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 10' ' ' TRP . 63.8 mt -141.5 142.72 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE2' ' HB1' ' A' ' 264' ' ' ALA . 51.0 m-85 -123.14 112.38 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.268 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -162.95 174.03 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.753 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.88 -173.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -76.86 -33.41 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.01 -29.28 63.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -56.98 14.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.074 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -66.34 -48.83 68.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.47 -17.87 54.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.719 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.77 -56.07 1.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -95.45 -54.45 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.032 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -55.67 -27.81 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.363 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -68.25 -22.33 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.9 p -95.82 25.63 4.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 75' ' ' LEU . . . 91.27 77.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.578 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -168.36 39.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.879 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.032 HD23 ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -158.3 136.55 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.922 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' N ' ' HB2' ' A' ' 268' ' ' ALA . . . -104.41 130.46 52.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' HG22 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -68.4 138.76 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.438 HD11 ' HG ' ' A' ' 103' ' ' LEU . 18.2 pt -83.66 162.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -89.2 147.74 39.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.66 110.96 2.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.613 2.209 . . . . 0.0 112.44 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -176.77 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -21.83 47.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.779 ' HB1' ' CH2' ' A' ' 94' ' ' TRP . . . -54.8 -23.16 16.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.551 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -59.22 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.382 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.2 -24.64 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.714 ' OD2' HD12 ' A' ' 89' ' ' LEU . 13.7 p-10 -73.94 -20.58 60.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.35 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 53.15 48.57 21.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.89 0.376 . . . . 0.0 111.255 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.714 HD12 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -102.12 155.49 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -96.32 145.0 28.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.16 -26.66 43.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.509 2.14 . . . . 0.0 112.345 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -56.62 -30.57 63.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -90.7 -29.76 17.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.779 ' CH2' ' HB1' ' A' ' 84' ' ' ALA . 34.1 m0 -70.1 -47.57 61.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -59.51 -30.71 68.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.6 83.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 97' ' ' VAL . 18.9 t -95.15 43.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -99.37 89.44 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 120.15 35.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 p30 44.43 38.66 2.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.13 31.12 78.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.642 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -145.62 160.05 42.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -105.8 93.23 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.601 ' HB ' HD13 ' A' ' 76' ' ' LEU . 4.5 pt -114.43 39.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' O ' HG11 ' A' ' 97' ' ' VAL . . . -176.25 125.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.73 116.23 57.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.81 133.82 10.46 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.466 2.11 . . . . 0.0 112.419 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 7.3 pt -156.07 39.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.045 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 169.58 102.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.95 HG22 HG21 ' A' ' 320' ' ' THR . 14.6 p -101.86 116.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.326 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -116.98 132.58 56.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.67 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.48 176.56 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.188 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.83 171.37 7.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 319' ' ' ALA . 0.2 OUTLIER -164.33 -177.41 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.904 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HG ' ' A' ' 247' ' ' LEU . 3.3 mt -109.6 149.88 29.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 pt -110.48 140.53 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.186 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.77 130.87 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.29 162.09 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.5 37.7 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -90.19 -35.13 15.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 121' ' ' LEU . 3.5 pp -157.73 39.98 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.533 ' CD2' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -137.55 131.07 17.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 157.78 41.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.257 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -65.08 110.77 4.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.6 140.29 86.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.477 2.118 . . . . 0.0 112.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.56 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.228 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.42 -39.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 130' ' ' GLU . 14.0 t -70.94 152.23 43.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.691 ' CE3' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -60.14 -23.56 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 128' ' ' THR . 33.4 mt-10 -45.26 -23.47 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HD13 ' A' ' 135' ' ' LEU . 4.8 pt-20 -48.78 -31.0 6.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.691 HD11 ' CE3' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -73.53 -62.58 1.14 Allowed Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.324 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 132' ' ' ILE . 82.9 Cg_exo -45.67 -34.42 11.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.232 1.955 . . . . 0.0 112.407 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.53 61.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 131' ' ' GLU . 9.1 mp -77.79 -28.77 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -43.42 75.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -68.73 -28.03 66.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.4 tt0 -81.83 -50.84 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 146' ' ' ALA . 19.5 mt -57.92 -55.83 29.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -58.72 -24.66 61.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -57.16 -25.51 59.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -111.21 -67.47 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.4 39.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -142.07 -177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD13 ' A' ' 139' ' ' LEU . 48.3 t -150.37 157.54 43.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.013 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.797 ' CB ' ' HB3' ' A' ' 223' ' ' ALA . . . -107.6 42.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER 176.84 115.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.77 106.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 226' ' ' ILE . 2.3 t80 -156.36 176.74 12.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.72 -169.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.82 HD12 HG23 ' A' ' 208' ' ' THR . 11.5 mt -148.81 -46.01 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.35 44.2 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -108.25 166.78 10.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 150.97 22.38 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.949 2.433 . . . . 0.0 112.173 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.31 55.24 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.449 ' O ' HD13 ' A' ' 160' ' ' LEU . 77.8 t80 -120.93 -49.57 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 161' ' ' ILE . 63.6 m -73.42 -42.84 61.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.52 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 9.8 t90 -55.72 -53.88 57.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.429 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.53 -24.17 42.47 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.17 1.913 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 195' ' ' LEU . 5.0 mp -81.57 -56.77 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 157' ' ' THR . 3.3 tt -67.27 -21.81 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -64.54 -30.35 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.201 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 250' ' ' PHE . . . -67.32 -25.16 65.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.286 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.55 -41.35 18.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.097 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.98 -82.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.596 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.09 -38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.551 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.595 ' OH ' HG11 ' A' ' 343' ' ' VAL . 38.8 t80 70.16 -65.69 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.26 -82.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.062 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -155.94 -174.82 5.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -130.29 115.94 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -79.39 142.46 35.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -136.96 128.32 28.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.29 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.83 52.07 0.25 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.486 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 159.74 3.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -97.74 130.25 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.655 ' O ' HD13 ' A' ' 178' ' ' ILE . 1.4 m-20 -74.9 -175.99 2.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 177' ' ' ASP . 23.6 mm -137.04 -48.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -31.53 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.65 108.31 4.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.691 HG12 HG23 ' A' ' 183' ' ' VAL . 22.0 t -121.62 150.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.155 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.26 50.02 0.9 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.691 HG23 HG12 ' A' ' 181' ' ' VAL . 27.4 t -94.08 -31.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 111.08 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.583 ' OD1' ' HB3' ' A' ' 364' ' ' ALA . 26.6 m-20 -123.52 72.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -128.92 -176.67 3.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.07 78.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.61 -52.06 32.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.522 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -62.92 -30.8 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -61.05 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 194' ' ' PHE . . . -77.77 -43.77 29.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -54.27 -26.21 35.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.761 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.754 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.4 tp -81.68 -58.17 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.769 0.319 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.7 t -64.2 -28.87 70.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.024 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.597 ' CE1' ' HB1' ' A' ' 190' ' ' ALA . 2.6 m-85 -56.99 -63.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.13 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 160' ' ' LEU . 4.3 mm? -62.41 -46.63 87.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.19 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 192' ' ' LEU . 36.4 t -59.3 -46.96 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.02 -36.44 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.46 -58.89 6.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.063 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 28.8 pt -49.84 -27.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -77.59 -31.7 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.991 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.7 18.32 22.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.399 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -41.75 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -114.56 -51.67 2.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 169.54 -75.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -156.39 153.03 28.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.746 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -65.13 77.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -164.95 31.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.82 HG23 HD12 ' A' ' 151' ' ' LEU . 17.3 p -61.98 139.98 58.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.528 ' H ' HD13 ' A' ' 212' ' ' ILE . 4.7 m-20 -108.76 -150.73 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.1 -53.0 7.43 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.105 0.479 . . . . 0.0 110.083 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 1.1 m -56.88 -24.42 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 212' ' ' ILE . 2.7 mp -81.94 -58.85 3.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.015 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.32 -30.42 70.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -22.6 38.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.443 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -47.75 -55.58 9.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.489 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.66 -54.94 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.931 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -47.38 -28.47 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -41.35 23.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -106.78 -23.58 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.773 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 55.01 46.74 76.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.41 43.02 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 111.23 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.77 -177.63 3.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.797 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . . . -82.82 38.67 0.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.894 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.577 ' HE2' ' HA ' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.8 99.22 0.11 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.04 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.51 105.31 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.807 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 23.7 mm -82.77 138.53 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 227' ' ' ASN . 1.3 p-10 -97.45 112.22 24.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 231' ' ' ALA . . . -111.84 159.83 13.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.461 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.47 -27.16 30.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -137.31 37.32 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.962 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 228' ' ' GLY . . . -118.66 38.56 3.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -131.25 100.78 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.73 -41.22 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.7 m120 60.59 174.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 236' ' ' ASP . 1.0 OUTLIER -161.74 -44.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 235' ' ' ILE . 5.7 m-20 -95.12 -47.99 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 m 59.66 104.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.2 m -98.12 168.87 9.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -98.66 31.95 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 241' ' ' ASN . 27.7 t -102.65 158.45 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 240' ' ' VAL . 1.4 t-20 -84.79 132.93 34.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -101.23 170.44 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -151.7 150.76 22.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 315' ' ' PRO . 10.3 p -122.71 127.72 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.8 p -141.12 162.74 34.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.182 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 322' ' ' GLU . 15.8 m -86.6 150.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.045 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 247' ' ' LEU . 1.2 mp -59.76 151.68 61.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.71 -158.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.914 2.41 . . . . 0.0 112.343 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -77.94 177.82 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CB ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -152.36 111.54 3.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? 60.1 17.71 7.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 120.66 -24.95 7.42 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.684 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.61 140.04 18.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.31 169.04 21.97 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.449 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.5 m -58.31 -175.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.005 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -144.15 73.72 16.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.49 174.13 12.25 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.223 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -111.81 135.22 52.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' ILE . 21.5 t -77.97 154.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -107.66 77.99 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.612 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 m -88.81 132.09 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.756 0.313 . . . . 0.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 4.9 tp -79.29 127.48 32.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.003 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -91.32 110.52 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.764 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' CE2' ' A' ' 61' ' ' PHE . . . -126.79 117.71 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -177.61 -169.99 39.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.618 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 276' ' ' ALA . 3.9 mp -100.82 159.22 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 266' ' ' ILE . 53.5 p30 -88.79 158.2 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.624 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -97.46 29.08 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -100.64 -30.7 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 t -118.2 146.66 39.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 74.86 2.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.488 2.125 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 2.4 t30 -117.48 35.42 4.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -66.03 -48.97 69.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.57 -36.09 70.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mt -76.35 -29.68 57.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -58.37 -40.82 83.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -74.23 -29.38 61.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.09 -35.19 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.713 ' CE1' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 280' ' ' LEU . 3.7 mm? -60.38 -25.61 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -14.06 62.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.521 ' ND2' HG12 ' A' ' 23' ' ' VAL . 27.7 t30 -88.95 27.93 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.348 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.92 35.46 1.69 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 110.725 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.75 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -101.24 28.3 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.795 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 290' ' ' LEU . 5.9 tp -147.0 28.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.0 t -136.84 155.62 49.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -57.63 -20.99 36.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.305 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 292' ' ' ALA . 3.8 mt-10 -75.17 -38.13 61.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.418 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 286' ' ' THR . . . -119.64 -50.51 0.29 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.032 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 284' ' ' LEU . 25.1 tp -54.59 -55.14 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.809 0.338 . . . . 0.0 111.392 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.1 -32.93 44.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.734 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -77.17 -58.59 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 19' ' ' GLY . 28.8 t -82.03 -60.62 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.412 ' OD1' HD23 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -56.27 -21.65 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.879 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.765 ' O ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -111.76 -20.04 12.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.377 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 37.6 t70 54.68 90.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 64.65 165.9 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.6 144.63 79.37 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.504 2.136 . . . . 0.0 112.375 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 295' ' ' LYS . 2.5 pp -174.74 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 299' ' ' LEU . . . -119.21 160.79 14.11 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 317' ' ' ILE . . . -132.95 105.04 6.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.876 0.37 . . . . 0.0 111.391 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.549 HG21 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.99 44.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.198 0.523 . . . . 0.0 110.645 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.77 88.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.668 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER 77.17 115.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -55.28 -23.98 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.9 m -53.94 -52.41 60.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.36 -30.4 37.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.624 ' HG3' ' HB1' ' A' ' 301' ' ' ALA . 8.3 tt0 -59.14 -27.74 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -56.98 -37.18 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.62 -44.61 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 23.8 mt -62.53 -18.6 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.09 -25.87 9.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 111.502 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -58.4 -27.57 64.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 146.57 95.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.803 ' HA ' HG11 ' A' ' 244' ' ' VAL . 49.1 Cg_exo -55.8 -51.42 9.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.39 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 320' ' ' THR . 7.9 mtm180 -55.44 -56.26 22.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 301' ' ' ALA . 3.9 mm -52.92 -55.34 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.49 75.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 114' ' ' SER . . . -69.7 -56.56 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.95 HG21 HG22 ' A' ' 110' ' ' VAL . 32.9 p -62.97 -29.96 71.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.53 -52.25 66.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.638 ' HB3' HG21 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -77.8 -45.63 23.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.13 -30.49 66.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.14 67.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -40.2 96.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.72 -58.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.04 177.46 54.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.425 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.424 ' HG2' HD13 ' A' ' 329' ' ' ILE . 1.1 tt0 -154.22 151.44 29.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 0.0 110.892 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.782 HG22 ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -49.17 138.17 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.42 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -127.47 137.67 31.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 -168.37 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.578 2.185 . . . . 0.0 112.387 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -136.44 76.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.587 HD12 ' HB2' ' A' ' 335' ' ' GLN . 25.2 pt -86.2 148.6 47.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.08 -27.9 38.62 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.675 2.25 . . . . 0.0 112.323 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.587 ' HB2' HD12 ' A' ' 333' ' ' ILE . 10.4 mt-30 -58.96 -41.59 87.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -66.65 -31.72 72.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -44.28 97.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.56 72.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 343' ' ' VAL . 40.3 m-85 -71.05 -37.51 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.12 97.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -59.36 -52.09 67.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 346' ' ' ALA . . . -59.79 -46.91 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.9 t -69.5 -29.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -59.42 -60.66 3.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 9.2 t -71.64 -41.18 69.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -46.37 -56.34 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.586 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.37 -55.76 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.813 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.8 mm -57.08 -58.75 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.728 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 345' ' ' THR . 1.0 OUTLIER -59.49 -27.91 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.671 0.272 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -61.92 -57.07 13.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -60.82 -10.57 5.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.004 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.5 m -110.04 26.63 10.45 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.614 0.245 . . . . 0.0 111.385 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 154.3 -71.53 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.005 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -87.76 51.63 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.464 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.519 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -79.37 99.29 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 1.5 t -166.22 97.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.86 -27.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.324 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -57.49 -45.72 84.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -80.01 -43.91 21.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.82 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -56.35 -37.77 70.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 -53.06 6.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -58.83 -55.69 31.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -59.28 -44.11 92.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -58.48 -32.41 68.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.0 m -72.66 -31.26 64.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -40.77 68.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.409 HD12 ' HE1' ' A' ' 339' ' ' PHE . 31.8 mm -71.22 -35.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 18.8 m 61.3 51.02 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 pttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.846 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.9 p -87.13 153.39 21.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.47 157.8 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -175.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.44 28.64 21.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 12.8 mttm -114.92 130.27 56.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.833 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 6' ' ' LYS . 4.3 mm? -129.1 148.56 51.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.8 m -126.48 102.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 20' ' ' LEU . 3.9 mt -94.87 114.87 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.561 ' CH2' HD13 ' A' ' 43' ' ' LEU . 95.5 m95 -105.83 111.96 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 12' ' ' ASN . 4.7 mt -118.25 157.27 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' ILE . 1.7 t30 -170.31 40.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.91 25.7 3.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.92 31.81 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 110.785 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -165.91 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.11 63.86 0.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.543 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -62.9 -29.59 70.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 111.058 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -59.34 -47.18 86.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.68 -28.3 65.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 9' ' ' ILE . 56.6 tp -64.76 -32.81 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.17 72.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -31.41 65.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.45 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.55 -35.18 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -59.73 -28.44 67.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -68.02 -33.45 74.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' HG21 ' A' ' 33' ' ' ILE . 9.3 m-85 -78.08 -50.6 11.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.542 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -51.54 -27.93 12.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.464 0.65 . . . . 0.0 110.425 179.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.45 -26.4 66.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.301 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 31' ' ' THR . 7.4 m-20 -64.32 -57.19 10.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.98 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.611 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.841 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.89 48.49 0.01 OUTLIER Glycine 0 C--N 1.338 0.682 0 C-N-CA 117.873 -2.108 . . . . 0.0 115.566 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.4 mm -139.27 95.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 118.071 0.935 . . . . 0.0 111.676 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.27 113.76 26.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 7' ' ' LEU . 30.2 m -98.85 139.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.29 119.63 39.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.9 112.97 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -151.84 163.08 39.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -104.73 142.05 23.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.15 155.62 37.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.551 2.167 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -178.84 -51.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -111.57 -23.31 10.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' CH2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -79.77 -1.12 37.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.545 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -54.4 -30.36 51.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.041 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -90.4 -30.9 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -72.46 -24.53 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -52.8 -59.31 9.15 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.303 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.2 Cg_endo -63.1 -17.25 59.24 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.482 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -89.69 -43.84 10.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG23 ' HG2' ' A' ' 46' ' ' LYS . 29.8 t -82.76 -30.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.51 61.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -71.06 -31.89 68.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.33 55.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB2' HG12 ' A' ' 50' ' ' VAL . 13.5 t0 -59.41 -34.08 72.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.36 -93.92 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.569 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.519 ' HB2' HG22 ' A' ' 8' ' ' VAL . 60.8 Cg_endo -72.85 -173.42 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.581 2.187 . . . . 0.0 112.4 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.8 t0 178.97 60.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.773 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mm -99.01 121.07 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 3.2 tt -146.68 141.62 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.5 136.87 52.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.583 ' CZ3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.17 173.31 15.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -76.9 -53.26 8.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.39 -28.44 65.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 13.0 mmt180 -57.54 -29.17 64.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HZ ' HG23 ' A' ' 60' ' ' ILE . 48.3 m-85 -107.52 -37.4 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.86 -23.47 51.05 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.653 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.28 4.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.651 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.65 -59.38 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.074 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -57.3 -29.76 64.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.26 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -67.53 -27.05 66.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 t -70.19 -26.73 64.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.088 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.31 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.84 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.682 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -165.36 127.9 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' N ' HD13 ' A' ' 76' ' ' LEU . . . -69.16 126.56 30.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.09 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -73.05 132.73 43.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tt -102.87 147.56 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.4 p -98.03 145.87 30.52 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.84 146.71 18.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.94 -55.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -30.48 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.79 -23.39 42.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -79.25 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.5 -26.54 67.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 89' ' ' LEU . 1.2 m-20 -76.43 -41.9 45.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.812 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.65 40.05 13.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -82.3 -177.32 6.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -66.91 112.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 78.1 Cg_exo -50.51 -25.21 13.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.514 2.143 . . . . 0.0 112.482 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -21.07 41.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 90' ' ' TYR . 57.5 p -69.39 -53.95 16.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.442 ' CE3' ' N ' ' A' ' 95' ' ' ASP . 46.9 p-90 -92.92 -45.31 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 6.7 t70 -53.29 -26.72 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.288 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB1' HD11 ' A' ' 329' ' ' ILE . . . -80.56 -28.88 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.235 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.802 HG21 ' O ' ' A' ' 105' ' ' ALA . 11.3 p -114.57 63.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.34 104.66 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -94.44 93.1 7.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.61 -70.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.06 30.89 0.19 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -127.57 96.61 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -92.48 102.69 15.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.761 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -133.88 39.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.025 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.802 ' O ' HG21 ' A' ' 97' ' ' VAL . . . -172.42 93.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 t80 -98.95 141.73 23.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.71 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.3 Cg_endo -79.85 138.76 13.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.608 2.205 . . . . 0.0 112.205 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 107' ' ' PRO . 18.0 mm -143.6 39.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.245 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 173.26 99.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.976 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 317' ' ' ILE . 9.2 p -89.34 111.21 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -104.27 133.16 49.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.36 170.05 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.003 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.17 152.31 50.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.955 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 t -164.92 -176.06 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -107.53 138.18 44.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 244' ' ' VAL . 3.0 pt -130.17 140.22 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.088 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -152.76 165.66 34.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -80.32 168.8 18.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.89 36.9 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.68 -64.01 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -97.38 48.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.63 103.68 10.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.24 160.36 49.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.431 2.088 . . . . 0.0 112.313 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.19 110.85 4.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.09 124.66 11.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.439 2.093 . . . . 0.0 112.278 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.4 2.066 . . . . 0.0 112.238 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -101.04 -30.59 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 129' ' ' TRP . 1.5 m -126.62 169.11 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -72.58 -31.28 65.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -23.71 17.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.549 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.19 -16.33 40.69 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 147' ' ' LEU . 42.0 mt -65.55 -47.41 67.93 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 89.2 Cg_exo -46.38 -30.02 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.366 2.044 . . . . 0.0 112.629 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.89 60.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.11 -45.81 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.171 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 3.5 p30 -54.12 -28.69 41.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.208 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 15.8 tttt -55.79 -42.69 75.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -81.79 -33.31 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.79 -55.9 16.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -52.51 -25.01 9.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.54 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -112.2 -50.42 2.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.76 41.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.653 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -155.24 179.2 9.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -128.47 165.62 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -86.24 3.99 40.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.67 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER 170.8 151.19 0.05 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.859 0.362 . . . . 0.0 110.995 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 216' ' ' ALA . 6.4 tpt -117.77 144.75 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.09 145.86 40.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.0 170.79 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 12.5 mt -131.19 -46.5 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -98.5 39.72 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.732 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 93.87 8.68 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.55 112.78 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.153 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.07 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.464 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -111.94 -30.63 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.5 t -70.43 -27.09 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -70.22 -56.01 7.43 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.272 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 42.1 Cg_endo -67.13 -16.19 48.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.37 2.047 . . . . 0.0 112.446 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 255' ' ' SER . 1.7 tm? -78.18 -56.72 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.626 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.58 ' CG2' HD13 ' A' ' 195' ' ' LEU . 29.0 pt -65.09 -16.76 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 166' ' ' GLY . . . -84.61 -70.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.992 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.58 -80.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.2 -41.93 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.003 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.29 -35.49 65.68 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 162' ' ' ALA . . . -59.66 116.97 9.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.566 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.14 78.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.62 -69.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 181' ' ' VAL . 6.7 m-85 -139.93 158.92 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.12 125.42 44.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.439 ' CE1' ' HG2' ' A' ' 330' ' ' MET . 9.3 p90 -107.85 116.39 31.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -137.05 130.14 30.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 64.18 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.85 66.27 0.15 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -163.97 149.3 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.35 . . . . 0.0 110.912 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.43 ' CE2' HG13 ' A' ' 333' ' ' ILE . 96.2 m-85 -125.5 72.68 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -177.7 109.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 180' ' ' ASP . 4.0 tt -138.2 28.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.73 31.05 19.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.466 ' HB2' HG23 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -132.15 143.46 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' A' ' 169' ' ' PHE . 18.9 m -148.35 129.76 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -95.43 39.92 2.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.416 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.31 -31.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -116.55 36.57 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 177.63 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.23 -30.93 58.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.43 -52.65 49.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.71 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.705 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -60.4 -56.89 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.82 -30.66 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.05 -45.47 95.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 -46.89 39.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.968 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 189' ' ' LYS . 58.9 p -59.89 -29.04 68.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.4 -53.07 62.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.58 HD13 ' CG2' ' A' ' 161' ' ' ILE . 3.4 tp -59.83 -50.39 73.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.7 t -59.74 -37.8 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -27.68 56.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.45 -49.62 12.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 200' ' ' LYS . 2.3 pp -57.16 -40.16 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.495 ' N ' HD12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -72.08 -28.08 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -26.23 62.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -118.46 -67.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -65.15 -28.78 69.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 mtm 69.28 -67.41 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.41 -48.42 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.23 -58.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.4 t0 78.1 -55.18 0.5 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.107 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -79.82 147.86 31.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.873 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 t0 -144.0 -162.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.358 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 211' ' ' SER . 39.4 p90 -78.83 -46.02 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 110.392 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.7 p -81.08 -25.64 36.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.045 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.45 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 1.107 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.58 -30.36 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.625 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.6 tm-20 -70.41 -22.74 62.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.72 7.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.68 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -81.75 -41.99 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -75.98 -58.7 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -62.73 -32.94 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -23.47 16.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.632 0.253 . . . . 0.0 111.33 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.54 52.15 8.78 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.066 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.26 39.41 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.34 . . . . 0.0 111.121 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.4 HG23 ' HB1' ' A' ' 216' ' ' ALA . 20.8 p -149.58 -177.69 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.856 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -83.55 39.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.465 ' HG2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 173.66 128.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.925 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 116' ' ' ILE . 1.3 t -144.54 106.35 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.464 HD13 ' CD2' ' A' ' 156' ' ' PHE . 14.6 mt -78.99 141.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -86.81 112.48 21.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.08 -157.17 33.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.32 -46.43 32.94 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 112.348 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -158.12 45.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.822 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.86 39.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -172.72 175.55 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 17.4 p -123.0 -72.7 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.818 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 60.34 90.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 24.0 mt -123.84 -66.38 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.7 150.32 39.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 237' ' ' THR . 10.1 t -161.69 106.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.7 m -143.06 96.5 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.15 -69.37 0.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.974 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.8 m -92.32 134.83 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -176.37 -167.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.07 130.67 45.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.08 171.85 21.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 116' ' ' ILE . 19.5 t -113.29 136.36 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 111.112 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 115' ' ' LEU . 9.4 t -125.24 159.41 31.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.62 150.55 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.91 156.82 33.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.82 -168.33 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 t -123.99 177.48 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 253' ' ' GLN . 54.7 p90 -167.18 117.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt 64.17 16.24 9.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.62 33.04 28.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.667 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.409 ' O ' ' CE1' ' A' ' 250' ' ' PHE . 16.6 pt20 -156.19 90.63 2.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 111.003 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.52 161.08 47.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.788 2.326 . . . . 0.0 112.154 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.609 ' HB3' HD22 ' A' ' 160' ' ' LEU . 81.1 p -57.43 163.8 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -105.15 99.53 20.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 130.06 8.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.468 2.112 . . . . 0.0 112.249 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -111.87 139.75 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.11 150.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.72 160.39 28.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.621 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 m -129.85 144.96 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.861 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -88.0 126.29 35.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.978 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 28.3 m -91.71 125.88 36.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.62 140.12 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.58 168.12 34.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.404 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.1 tt -101.67 158.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.016 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -73.64 173.16 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -94.23 -27.4 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -30.95 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 p -76.75 122.36 86.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.18 -1.46 11.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.498 2.132 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -96.37 38.27 1.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -75.04 -31.05 61.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -60.33 -42.89 96.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.5 tp -75.59 -28.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.024 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 279' ' ' PHE . . . -76.8 -32.35 57.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.306 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -79.13 -30.76 43.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.54 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 279' ' ' PHE . 12.9 pt-20 -76.18 -48.72 19.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.7 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -70.25 -24.22 63.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.239 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 284' ' ' LEU . 6.5 tp -78.89 -29.9 44.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -105.56 -14.47 15.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.759 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 283' ' ' TYR . 14.7 m120 -111.06 27.42 9.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.685 0.278 . . . . 0.0 111.621 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 282' ' ' ASN . 6.7 m-85 -168.69 -52.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.185 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.41 HD13 HD12 ' A' ' 280' ' ' LEU . 2.7 tp -46.41 -66.51 0.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 290' ' ' LEU . 2.6 mt -95.72 63.25 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.0 m -154.78 166.33 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.75 -20.31 55.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.46 -29.57 52.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.181 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -111.46 -52.92 0.54 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.761 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 285' ' ' LEU . 1.3 tp -50.64 -27.3 6.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.91 -26.03 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.264 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.79 -57.94 3.53 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.381 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 297' ' ' LYS . 1.8 m -62.42 -28.78 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.634 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 297' ' ' LYS . 2.1 t-20 -22.2 -48.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -50.78 -27.77 7.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.785 ' O ' HD23 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -135.62 -13.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.962 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 298' ' ' PRO . 0.0 OUTLIER -45.52 -49.81 33.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 297' ' ' LYS . 59.5 Cg_endo -73.73 104.52 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.301 2.0 . . . . 0.0 112.556 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 296' ' ' ASP . 3.9 pp -177.94 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.655 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.633 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 177.82 72.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -179.31 93.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 308' ' ' GLU . 34.9 t -154.89 109.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.76 40.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 307' ' ' TYR . 3.2 mp -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -59.34 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 m -79.15 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.6 ' HB3' HD22 ' A' ' 304' ' ' LEU . 0.5 OUTLIER -80.29 -35.75 35.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -54.97 -25.27 28.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.234 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.47 -61.34 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.052 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.25 -31.16 14.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.422 ' CD2' HD23 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -71.92 -55.71 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 308' ' ' GLU . . . -77.38 -54.25 6.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt 54.1 30.06 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.06 110.42 18.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.68 -13.09 31.78 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.602 2.202 . . . . 0.0 112.615 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.95 4.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.719 0.295 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -58.51 -32.73 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.25 58.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.58 -26.47 61.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 317' ' ' ILE . 12.1 t -55.6 -29.44 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.9 mmm -59.4 -30.44 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.33 -52.59 13.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.6 -31.04 67.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.66 69.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -59.88 -31.13 69.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 36.35 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -172.57 171.42 44.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.07 147.18 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.452 HD11 ' HB1' ' A' ' 96' ' ' ALA . 27.6 pt -59.33 130.35 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.439 ' HG2' ' CE1' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -178.47 136.62 0.34 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -178.19 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.454 2.103 . . . . 0.0 112.272 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.687 ' C ' HD12 ' A' ' 333' ' ' ILE . 16.3 t-20 -127.31 36.5 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 332' ' ' ASN . 3.4 mp 64.13 127.76 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.46 -27.68 32.82 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.089 . . . . 0.0 112.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 333' ' ' ILE . 21.9 tt0 -58.28 -31.26 67.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.41 -28.47 68.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.9 m -58.65 -59.26 5.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.62 -27.46 66.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.5 OUTLIER -56.37 -24.32 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 343' ' ' VAL . 0.8 OUTLIER -57.31 -27.32 62.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -52.29 13.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.179 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.23 59.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.32 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 339' ' ' PHE . 27.4 m -56.29 -29.93 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.448 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.766 ' HG2' HD12 ' A' ' 348' ' ' ILE . 1.8 ttt85 -52.55 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 11.5 m -69.35 -27.66 65.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -60.5 -60.56 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.416 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.52 -57.02 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.087 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.766 HD12 ' HG2' ' A' ' 344' ' ' ARG . 27.1 mt -52.15 -58.79 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 345' ' ' THR . 0.1 OUTLIER -62.34 -31.06 71.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.75 0.31 . . . . 0.0 111.193 -179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -57.67 -30.02 65.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.17 -9.87 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.1 t -67.28 -22.82 65.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 110.46 -29.34 9.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.441 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 39.2 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -163.96 122.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.8 OUTLIER -104.77 171.06 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 361' ' ' LEU . 25.4 t -72.21 -31.71 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.21 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.53 -33.85 71.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.14 -53.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.572 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -57.13 -30.08 64.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 357' ' ' VAL . 21.1 mt -82.32 -56.63 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 366' ' ' THR . 10.7 mttm -64.07 -44.72 91.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 -35.36 80.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -79.78 -55.42 5.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -34.91 24.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 362' ' ' LYS . 12.8 t -80.48 -29.5 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.55 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.008 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 339' ' ' PHE . 33.7 mm -64.35 -47.24 90.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.8 m -66.72 -58.68 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -160.54 117.66 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.79 141.02 29.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.47 166.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.39 45.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 168.98 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 279' ' ' PHE . 67.4 mt -149.95 139.43 21.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 36' ' ' THR . 29.8 t -113.08 102.83 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 mp -97.51 129.95 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.774 ' CZ3' HD22 ' A' ' 43' ' ' LEU . 8.9 t90 -94.9 113.28 24.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -147.79 141.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -165.3 78.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.98 35.93 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.564 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.7 89.09 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.747 0.308 . . . . 0.0 110.991 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 mttp -152.92 81.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.51 78.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -80.94 -56.59 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -76.12 -32.26 59.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.83 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -64.11 -41.71 98.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.567 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.73 -31.53 59.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.68 -42.11 74.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.94 -33.31 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 19' ' ' GLY . 22.8 t -70.32 -35.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.44 -34.63 81.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.597 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -69.51 -28.38 66.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.983 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.3 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.778 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 6.9 m-85 -64.27 -56.39 14.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -58.36 -28.16 64.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.141 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 -26.98 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.644 ' O ' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -64.94 -57.3 9.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.828 HG22 ' O ' ' A' ' 31' ' ' THR . 5.9 m 156.45 36.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.731 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.48 52.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.705 0 C-N-CA 117.96 -2.067 . . . . 0.0 115.452 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 2.5 mm -138.36 95.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 118.168 0.984 . . . . 0.0 111.459 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.29 108.92 20.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.028 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.26 138.07 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.408 ' CG2' HG22 ' A' ' 8' ' ' VAL . 1.7 t -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 0.0 111.173 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.15 120.96 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -96.34 153.96 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.013 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.15 167.37 12.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.98 92.56 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.609 2.206 . . . . 0.0 112.35 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -177.43 -40.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.021 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -109.65 -29.09 8.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -57.42 -23.81 51.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.211 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.21 -28.74 55.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.09 -26.79 18.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.045 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 50' ' ' VAL . 36.8 mttm -69.49 -29.38 67.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.431 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.94 -60.77 7.83 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.143 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.0 Cg_endo -66.28 -15.83 49.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.553 2.169 . . . . 0.0 112.512 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.35 -55.22 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.789 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.3 p -73.92 -24.8 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.16 -31.28 65.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -65.1 -43.42 92.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.068 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.42 152.09 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.45 85.43 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.535 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.05 -35.94 16.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.38 -157.59 7.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.536 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.42 -175.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.585 2.19 . . . . 0.0 112.25 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 173.68 49.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -99.03 127.43 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 10' ' ' TRP . 32.6 pt -151.58 138.76 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' CD1' ' HB1' ' A' ' 264' ' ' ALA . 7.6 m-85 -116.12 148.97 39.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.445 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -165.78 173.7 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.41 -173.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.525 ' NE2' HG12 ' A' ' 97' ' ' VAL . 2.1 t-160 -76.82 -53.18 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.21 66.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -110.01 -23.17 11.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.45 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.725 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.72 -24.81 68.95 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.717 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -64.45 -53.1 53.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.962 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -59.49 -55.58 32.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -27.05 66.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -75.83 -26.85 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 -81.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.84 87.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.705 HD23 ' HB ' ' A' ' 104' ' ' ILE . 1.1 tp -117.52 141.51 48.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.91 119.86 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' A' ' 104' ' ' ILE . 9.8 pt-20 -61.22 159.34 12.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mt -126.24 148.94 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 m -120.41 92.66 47.71 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.48 114.41 3.26 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.954 2.436 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.27 -35.3 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -30.64 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB1' ' HZ2' ' A' ' 94' ' ' TRP . . . -53.46 -22.94 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.617 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -80.16 -57.77 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 111.217 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -24.61 58.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 18.1 p-10 -62.4 -17.72 59.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.339 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 66.71 71.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.353 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -105.36 155.92 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.443 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -83.95 134.38 44.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.78 -25.92 36.62 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.469 2.113 . . . . 0.0 112.296 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -55.69 -30.29 60.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 97' ' ' VAL . 5.1 m -75.72 -31.34 59.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.513 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 66.2 m95 -73.13 -48.02 39.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.39 -27.89 62.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 -30.02 57.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.208 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HD3' ' A' ' 107' ' ' PRO . 29.5 m -134.66 68.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.251 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -149.26 140.71 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.3 174.04 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.47 68.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.08 37.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -145.48 159.14 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.822 0.344 . . . . 0.0 110.837 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.1 mp -141.94 85.96 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -136.87 40.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.9 131.43 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.04 118.6 10.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.812 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.762 ' O ' HD13 ' A' ' 108' ' ' ILE . 94.1 Cg_endo -79.7 124.77 5.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.453 2.102 . . . . 0.0 112.463 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 107' ' ' PRO . 21.8 mm -141.2 39.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.07 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.773 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.52 125.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 HG12 ' A' ' 302' ' ' VAL . 3.9 m -106.32 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.45 136.49 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 176.44 8.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 mt -81.26 149.0 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.615 ' HB3' HG13 ' A' ' 244' ' ' VAL . 2.0 m -164.71 170.9 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 223' ' ' ALA . 12.1 tp -103.09 136.63 42.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 225' ' ' THR . 31.6 mm -111.64 125.85 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 51.1 p90 -128.18 152.4 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -105.04 176.98 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 30.83 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.41 -57.86 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 222' ' ' THR . 1.5 tt -140.28 82.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 ' N ' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -122.36 106.07 35.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 160.34 50.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.45 2.1 . . . . 0.0 112.346 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.9 149.43 98.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.28 119.11 6.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.555 2.17 . . . . 0.0 112.214 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.04 -71.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.353 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -177.15 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.68 -176.31 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.806 ' CZ3' HD13 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -65.5 -26.74 68.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 64.3 mm-40 -51.46 -24.07 4.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.383 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -15.81 33.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.592 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.806 HD13 ' CZ3' ' A' ' 129' ' ' TRP . 3.5 tt -52.44 -35.66 25.61 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.742 ' HD3' HG22 ' A' ' 132' ' ' ILE . 17.2 Cg_exo -67.93 -31.41 31.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.207 1.938 . . . . 0.0 112.104 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.51 63.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 146' ' ' ALA . 4.3 mp -77.68 -38.12 48.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.78 -36.51 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -28.14 67.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.74 -31.58 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.838 HD13 ' CB ' ' A' ' 145' ' ' SER . 11.9 tp -60.48 -55.94 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -30.36 67.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.08 76.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.038 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -139.39 -60.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.775 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.03 41.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -126.63 121.94 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.838 ' CB ' HD13 ' A' ' 139' ' ' LEU . 9.9 t -140.69 170.67 15.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.504 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.652 ' HB3' HD22 ' A' ' 135' ' ' LEU . . . -147.15 13.38 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.762 ' HB3' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER 170.67 115.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 111.717 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.412 ' N ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -121.35 148.8 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.129 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.99 132.96 21.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.019 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB1' ' A' ' 213' ' ' ALA . 2.3 m-80 -61.1 -176.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.787 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.789 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.1 OUTLIER -124.7 -47.43 1.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.482 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.91 39.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.82 157.85 33.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.74 149.93 21.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.563 2.175 . . . . 0.0 112.315 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 61.57 67.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.596 ' CE2' HG23 ' A' ' 157' ' ' THR . 20.3 p90 -120.31 -39.3 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.691 ' HB ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -63.6 -36.51 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.578 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 3.1 t-105 -67.95 -55.7 12.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.442 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -64.21 -11.72 29.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.276 1.984 . . . . 0.0 113.142 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.48 -56.79 2.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.643 0.259 . . . . 0.0 111.59 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 157' ' ' THR . 42.8 mt -65.81 -20.16 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.821 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -89.37 12.2 16.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -64.2 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.5 -51.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.059 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.75 -86.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -56.14 142.86 38.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -169.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.99 -45.66 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' HE1' HD12 ' A' ' 333' ' ' ILE . 23.8 m-85 -153.26 160.35 42.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -129.11 135.05 48.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 110.78 12.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -137.02 178.23 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -70.93 69.67 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.96 -30.92 0.81 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -91.72 139.13 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.741 ' CZ ' HG21 ' A' ' 178' ' ' ILE . 3.0 p90 -140.07 36.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.7 OUTLIER 61.09 93.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.741 HG21 ' CZ ' ' A' ' 176' ' ' TYR . 2.4 pp -157.47 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.721 ' N ' HD12 ' A' ' 178' ' ' ILE . 8.3 mtpp -139.01 31.82 2.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.04 121.57 39.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.68 151.4 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.193 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.89 40.0 2.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.05 -38.37 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.3 61.05 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -122.96 168.71 11.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.37 -33.02 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.98 -32.38 36.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.46 74.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -60.45 -46.07 91.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.18 -35.2 31.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.03 -28.31 73.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.663 HD13 HG12 ' A' ' 357' ' ' VAL . 1.6 tt -82.53 -50.43 8.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 p -57.58 -28.93 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 2.1 m-85 -55.0 -60.63 3.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.51 -30.78 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.968 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.3 t -69.04 -54.03 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.3 -32.35 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.07 -55.98 27.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.708 HG12 HD21 ' A' ' 151' ' ' LEU . 6.2 mt -61.71 -33.71 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -33.29 71.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.968 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -106.51 19.34 20.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.28 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 -54.99 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.813 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.37 -46.15 3.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.833 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.8 ttm 58.34 44.31 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -176.79 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 65.76 77.09 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -143.96 30.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.789 HG21 ' HB2' ' A' ' 151' ' ' LEU . 3.2 t -81.8 148.08 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -124.01 -165.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 211' ' ' SER . 30.3 p90 -78.92 -44.26 23.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.083 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.448 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 14.2 t -73.18 -24.67 60.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.353 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -81.9 -50.48 16.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.082 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.46 ' N ' HG22 ' A' ' 212' ' ' ILE . . . -67.74 -30.34 69.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.467 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 210' ' ' TYR . 4.4 tt0 -75.15 -25.69 58.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -51.55 -25.58 7.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.533 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.726 ' HB1' ' SD ' ' A' ' 224' ' ' MET . . . -57.01 -57.47 12.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.763 0.315 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.696 ' CE1' HG21 ' A' ' 225' ' ' THR . 20.2 t80 -69.57 -40.27 76.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -59.43 -49.6 77.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -94.25 -1.49 53.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.642 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 217' ' ' PHE . . . -147.81 87.35 0.16 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.725 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.25 59.75 2.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.657 . . . . 0.0 110.461 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 145' ' ' SER . 0.3 OUTLIER -107.58 -175.07 2.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.125 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.632 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . . . -77.8 44.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.726 ' SD ' ' HB1' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -116.87 45.88 1.76 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.829 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.696 HG21 ' CE1' ' A' ' 217' ' ' PHE . 1.8 t -143.56 114.63 7.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 226' ' ' ILE . 3.7 mp -91.58 122.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -86.85 110.76 20.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.984 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 174.62 58.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.72 -42.53 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -44.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.33 -46.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -170.01 -47.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.6 m 61.41 -179.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -176.54 -47.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 235' ' ' ILE . 30.4 mt 59.44 41.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.83 113.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 -46.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.44 163.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.44 155.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.47 111.34 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.3 77.55 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -149.11 168.16 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -134.45 120.93 2.55 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.52 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 114' ' ' SER . 22.1 t -91.59 132.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 25.2 m -141.09 156.75 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.77 150.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.416 HD13 ' HD3' ' A' ' 248' ' ' PRO . 4.2 mm? -66.22 154.63 89.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.416 ' HD3' HD13 ' A' ' 247' ' ' LEU . 4.1 Cg_exo -79.78 -164.13 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.844 2.363 . . . . 0.0 112.135 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.854 HG22 ' HD3' ' A' ' 254' ' ' PRO . 21.8 p -97.29 177.95 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.509 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 79.8 m-85 -144.88 110.93 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.425 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 194' ' ' PHE . 0.0 OUTLIER 39.65 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.872 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 154.42 -59.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.803 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -150.87 166.06 15.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.854 ' HD3' HG22 ' A' ' 249' ' ' THR . 57.1 Cg_endo -70.96 173.83 11.45 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.682 2.255 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.66 179.46 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 125.85 66.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 -168.25 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.451 2.101 . . . . 0.0 112.333 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.19 119.62 13.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 328' ' ' GLU . 27.0 m -110.34 123.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.04 134.53 9.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 64' ' ' HIS . 14.4 m -97.39 144.87 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.773 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 6.3 tp -81.97 121.99 27.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.3 113.43 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 61' ' ' PHE . . . -116.75 145.82 43.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.023 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 176.94 -157.94 23.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.568 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.472 HD13 ' HB1' ' A' ' 276' ' ' ALA . 32.8 pt -137.95 155.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.802 0.334 . . . . 0.0 111.122 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.555 ' HB3' HD12 ' A' ' 76' ' ' LEU . 11.2 p30 -147.09 128.06 14.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.12 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -178.68 36.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.87 55.03 9.38 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.27 -45.56 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -151.88 80.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -30.24 71.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -69.56 -42.47 74.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 279' ' ' PHE . 6.2 tp -77.69 -31.24 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -73.61 -46.26 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -50.65 72.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.47 -40.66 92.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.414 ' CD2' ' HG ' ' A' ' 275' ' ' LEU . 1.1 m-85 -67.8 -53.87 23.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 280' ' ' LEU . 23.3 mt -57.43 -29.15 63.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -92.18 -25.04 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.86 27.33 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.018 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.738 ' C ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -112.82 -62.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.871 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 283' ' ' TYR . 3.8 mm? -139.07 57.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.3 mt -161.85 29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.759 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.1 t -154.76 177.35 11.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.87 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.4 -49.15 67.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -77.39 -28.08 52.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.759 ' H ' HG23 ' A' ' 286' ' ' THR . . . -66.49 -66.5 2.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.429 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.75 HD21 ' OH ' ' A' ' 307' ' ' TYR . 0.8 OUTLIER -59.05 -20.78 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.83 -31.4 27.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.29 6.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.407 ' CG2' ' HG ' ' A' ' 290' ' ' LEU . 11.2 m -64.31 -29.58 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -48.02 -28.6 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.39 -70.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -73.05 -50.01 25.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.789 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER 64.13 140.96 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.038 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.88 -2.23 10.78 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.689 2.26 . . . . 0.0 112.601 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 299' ' ' LEU . 2.8 mm? 61.78 46.51 6.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.96 83.87 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.514 ' CA ' HG22 ' A' ' 110' ' ' VAL . . . -166.98 133.59 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.222 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 110' ' ' VAL . 9.0 p -178.63 99.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.969 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.76 54.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 146.17 40.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -60.23 -37.37 80.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.1 m -79.54 -27.04 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.962 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.75 ' OH ' HD21 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -71.71 -40.93 69.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.76 -32.28 65.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.96 -37.64 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.649 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -74.34 -30.32 61.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.909 HD12 HG21 ' A' ' 302' ' ' VAL . 0.8 OUTLIER -45.49 -29.79 1.23 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.388 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.48 -29.49 50.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.215 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 30.93 4.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.97 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.4 172.83 8.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -88.04 -76.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.78 2.32 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -81.32 -58.83 2.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.406 HG22 HD21 ' A' ' 311' ' ' LEU . 2.0 mt -50.76 -28.14 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.409 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.15 75.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.56 -45.65 18.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -37.91 88.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -27.5 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.158 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -55.26 -46.86 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.27 -31.73 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.71 66.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.86 -32.19 67.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -111.15 36.36 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -135.04 -175.4 13.83 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 259' ' ' VAL . 6.0 mm-40 -120.42 -176.63 3.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.9 OUTLIER -118.98 116.01 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.436 ' CE ' ' CE1' ' A' ' 64' ' ' HIS . 7.2 ptp 43.84 52.94 9.67 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.516 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.7 97.66 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.553 2.169 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -134.5 -70.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' A' ' 169' ' ' PHE . 8.4 mt 63.72 139.11 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.73 -26.48 17.56 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.542 2.161 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.87 -27.23 63.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.4 tpt -57.57 -27.95 63.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.96 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.45 77.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.153 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.787 ' O ' HG12 ' A' ' 343' ' ' VAL . 4.3 t80 -59.97 -25.64 65.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.03 -38.7 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.049 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.549 ' O ' HG22 ' A' ' 345' ' ' THR . 0.1 OUTLIER -78.96 -44.27 22.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.73 96.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 339' ' ' PHE . 11.5 p -69.0 -30.37 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 341' ' ' TYR . 10.1 t -49.61 -27.58 4.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.364 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -75.42 -52.22 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.54 -55.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.987 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 344' ' ' ARG . 9.0 tp -53.48 -38.74 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -80.88 -28.35 35.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 111.146 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -55.07 -39.05 68.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.261 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.23 -14.28 44.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.5 p -67.69 -56.32 9.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.768 0.318 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -134.1 -70.8 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -173.44 39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -88.46 99.07 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 358' ' ' ASP . 11.1 t -103.31 -167.05 1.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.663 HG12 HD13 ' A' ' 192' ' ' LEU . 16.7 m -56.38 -27.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.709 ' H ' HG23 ' A' ' 356' ' ' THR . 3.3 t70 -46.79 -56.12 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -80.34 -41.17 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.613 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 357' ' ' VAL . . . -54.95 -53.09 60.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.258 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 357' ' ' VAL . 4.0 mm? -64.67 -56.87 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.477 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -41.38 84.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.471 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 366' ' ' THR . 8.7 t0 -76.51 -47.71 21.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.716 0.293 . . . . 0.0 111.131 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -66.79 -47.4 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.613 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.2 pp0? -52.31 -37.62 56.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.285 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 363' ' ' ASP . 14.1 t -80.68 -29.5 36.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -73.81 -41.85 61.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.4 mt -59.34 -47.24 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.087 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 370' ' ' LYS . 1.3 t -159.9 -52.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 369' ' ' THR . 5.7 tttm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 tptt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.5 p -105.54 110.91 23.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.7 118.82 29.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -158.88 88.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.89 -72.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 172.77 13.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -111.04 160.01 17.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 57' ' ' PRO . 31.8 t -118.62 102.91 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 37' ' ' VAL . 7.7 pt -105.03 114.95 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.189 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.915 ' CB ' HG22 ' A' ' 60' ' ' ILE . 47.1 t90 -94.94 111.9 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 tt -164.88 158.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.64 -171.28 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 51.53 0.78 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.394 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.11 -26.74 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.603 0.24 . . . . 0.0 111.135 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -43.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.279 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 42.19 2.91 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.851 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 40.7 p90 -81.12 -46.64 14.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 40.4 m-20 -76.62 -37.46 56.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -39.03 89.73 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.46 -28.95 52.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.288 . . . . 0.0 110.986 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.46 -49.2 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.133 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.02 -50.54 73.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 27' ' ' PHE . 11.9 p -58.55 -30.89 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.72 -34.03 64.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -77.14 -28.28 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -29.7 70.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 37.6 m-85 -74.39 -56.77 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.606 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -60.84 -27.42 68.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.269 0.557 . . . . 0.0 110.417 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.22 -29.21 1.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.863 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.737 ' O ' HG23 ' A' ' 31' ' ' THR . 4.8 m-20 -66.33 -57.37 7.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.77 37.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.722 0.639 . . . . 0.0 112.037 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 47.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.67 0 C-N-CA 118.131 -1.985 . . . . 0.0 115.358 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -140.36 95.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 118.077 0.938 . . . . 0.0 111.63 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.37 129.77 52.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.77 130.47 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.1 p -105.71 121.59 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 9' ' ' ILE . 19.8 t -94.34 118.2 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.08 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -109.76 159.92 16.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.53 166.43 23.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 122.02 9.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.25 -75.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 0.09 27.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.51 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -55.06 -30.54 59.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 111.06 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -33.5 76.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.93 -29.21 15.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 tptm -69.93 -25.46 63.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.48 -60.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.6 Cg_endo -63.85 -15.42 48.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.642 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -38.4 22.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.633 HG23 ' HA3' ' A' ' 54' ' ' GLY . 10.0 p -92.25 -18.31 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.267 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -37.12 65.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.31 -37.71 32.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -164.31 -71.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.633 ' HA3' HG23 ' A' ' 50' ' ' VAL . . . 65.94 -74.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.537 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -165.02 -57.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.95 -63.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.667 ' HB2' HG23 ' A' ' 8' ' ' VAL . 19.0 Cg_endo -60.2 159.15 27.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.602 2.201 . . . . 0.0 112.276 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.52 67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 266' ' ' ILE . 34.4 mt -107.0 113.68 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.915 HG22 ' CB ' ' A' ' 10' ' ' TRP . 42.9 pt -132.58 142.68 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.493 ' CE1' ' HB1' ' A' ' 264' ' ' ALA . 12.1 m-85 -108.64 123.58 49.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.45 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -163.18 174.01 12.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.721 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.52 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.7 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -77.24 -51.22 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -48.06 -28.14 2.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.624 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HG2' ' CE3' ' A' ' 62' ' ' TRP . 4.8 tpp180 -64.75 -36.54 84.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 263' ' ' SER . 34.0 m-85 -110.46 -59.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.32 -23.62 19.15 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.17 -50.41 2.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.41 -40.35 73.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.995 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.734 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -56.7 -26.64 57.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.31 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -54.84 -28.59 50.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -70.62 -26.76 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.91 64.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mt -149.81 40.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -133.53 146.05 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 131.49 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -58.02 160.94 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 80' ' ' THR . 32.9 mt -114.77 158.79 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -117.6 97.83 51.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.848 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.67 161.35 24.76 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 2.0 m-20 -97.79 -177.94 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -97.52 -51.4 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.13 -25.32 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.343 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 82' ' ' ASP . 34.2 m-85 -79.29 -59.04 2.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.22 -24.78 68.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.99 -38.17 90.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.96 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.63 39.57 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD22 HG21 ' A' ' 93' ' ' THR . 0.7 OUTLIER -123.78 153.35 41.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 93' ' ' THR . 3.1 m-85 -76.76 134.26 69.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.25 -22.89 27.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.414 2.076 . . . . 0.0 112.376 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -57.45 -40.71 79.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 90' ' ' TYR . 12.5 t -58.98 -29.7 67.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.819 ' CD1' HG23 ' A' ' 93' ' ' THR . 11.4 m0 -77.98 -56.67 4.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.91 -25.2 60.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.059 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.0 76.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.149 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.467 HG11 ' HG3' ' A' ' 107' ' ' PRO . 11.7 m -150.76 70.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.199 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 109.65 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -101.12 104.53 15.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 68.57 -67.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.006 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.01 33.01 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -136.23 140.37 43.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 tp -108.59 89.47 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.614 ' O ' HD22 ' A' ' 76' ' ' LEU . 34.9 pt -102.4 41.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.041 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.49 155.71 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.553 ' CD1' HD11 ' A' ' 108' ' ' ILE . 2.2 t80 -134.63 100.69 12.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.174 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.633 ' CB ' HG21 ' A' ' 261' ' ' VAL . 5.6 Cg_endo -85.41 142.32 8.28 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.074 2.516 . . . . 0.0 111.504 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 15.9 mt -155.88 39.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 160.6 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.267 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 110' ' ' VAL . 11.0 p -118.09 104.08 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.061 0.458 . . . . 0.0 110.841 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.783 ' HA ' HG21 ' A' ' 320' ' ' THR . 46.4 mp0 -158.49 132.23 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.775 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 113' ' ' LEU . . . -165.1 105.52 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.487 HD12 ' CG ' ' A' ' 323' ' ' ASN . 4.2 mt 158.2 106.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.305 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 m -164.98 123.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.876 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 224' ' ' MET . 4.8 tp -101.2 116.04 31.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.126 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.6 mt -74.71 133.16 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.553 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.851 ' HB3' HD22 ' A' ' 122' ' ' LEU . 50.5 p90 -152.87 124.14 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.674 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -150.81 -179.56 7.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt 59.53 24.07 12.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.075 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.43 27.83 4.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 39.73 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.841 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.851 HD22 ' HB3' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -157.01 114.65 1.97 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.422 ' HG3' HD12 ' A' ' 135' ' ' LEU . 56.5 Cg_endo -70.43 160.43 49.53 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.42 2.08 . . . . 0.0 112.224 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -64.95 154.04 87.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.09 108.98 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.62 2.214 . . . . 0.0 112.41 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.51 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.51 2.14 . . . . 0.0 112.344 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -101.34 14.77 30.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 130' ' ' GLU . 4.3 m -160.22 141.15 12.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.447 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.69 -29.15 64.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' HG22 ' A' ' 128' ' ' THR . 3.6 mt-10 -54.01 -23.71 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.89 -21.63 60.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 4.3 mt -73.38 -54.34 4.18 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.6 Cg_exo -52.92 -30.92 50.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.227 1.951 . . . . 0.0 112.332 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.07 -37.12 71.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.422 HD12 ' HG3' ' A' ' 123' ' ' PRO . 1.4 mt -65.15 -30.08 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -59.02 -34.9 72.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -59.27 -37.94 78.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.8 mp0 -81.76 -42.02 20.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.669 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -62.66 -50.98 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -25.95 64.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -56.84 -22.32 35.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.359 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -109.23 -53.51 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.941 0.401 . . . . 0.0 110.749 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.94 40.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.525 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 172.22 18.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 139' ' ' LEU . 5.6 m -122.68 177.53 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 136' ' ' ASP . . . -118.56 30.79 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.037 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 132' ' ' ILE . 1.3 pp 170.4 138.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.755 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.621 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -164.69 139.19 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.016 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -171.93 176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.56 155.31 12.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.661 ' CD1' HG21 ' A' ' 208' ' ' THR . 0.5 OUTLIER -128.49 -48.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -98.82 39.77 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.714 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.11 148.38 54.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.786 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HG2' ' CE2' ' A' ' 155' ' ' TYR . 98.8 Cg_endo -79.87 161.98 23.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.624 2.216 . . . . 0.0 112.503 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 154' ' ' PRO . 14.0 m-85 77.85 -2.13 2.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -121.04 -69.82 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.357 . . . . 0.0 110.836 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -29.59 60.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -64.31 -55.98 26.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 46.2 Cg_endo -68.82 -22.3 36.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.519 2.146 . . . . 0.0 112.673 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.65 -53.76 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.547 HD13 HD22 ' A' ' 192' ' ' LEU . 1.3 pp -83.61 0.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.329 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -92.53 -68.15 0.81 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 250' ' ' PHE . . . 63.64 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.73 -29.45 69.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 69.67 1.38 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.499 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 94.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -173.41 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.63 8.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.187 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.404 ' CD1' ' HG3' ' A' ' 336' ' ' MET . 0.2 OUTLIER -153.71 117.14 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.516 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.0 OUTLIER -102.97 134.81 45.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -106.97 120.23 41.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -127.68 127.93 44.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.41 32.87 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.32 30.3 77.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -126.94 125.72 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -82.64 157.92 23.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.83 116.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.678 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -138.79 19.53 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.354 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.86 30.26 11.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.86 92.98 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.4 m -148.33 124.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.443 ' O ' HG12 ' A' ' 183' ' ' VAL . . . 173.65 48.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 183' ' ' VAL . 14.1 p 43.55 38.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.952 0.406 . . . . 0.0 111.601 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -98.65 37.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -126.31 143.43 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.72 -28.43 67.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -58.87 -45.17 95.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.756 ' O ' HD23 ' A' ' 192' ' ' LEU . . . -75.95 -35.29 59.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -63.41 -49.42 73.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 193' ' ' THR . . . -67.27 -44.09 80.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.45 80.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 188' ' ' ALA . 1.9 mm? -64.22 -41.7 96.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HG21 ' A' ' 357' ' ' VAL . 7.6 t -77.46 -37.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.005 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -53.35 56.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.036 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -57.45 -53.07 62.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 192' ' ' LEU . 27.2 m -64.01 -28.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.18 -56.89 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.298 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 195' ' ' LEU . 3.5 pp -58.41 -37.35 75.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 195' ' ' LEU . 2.3 pp -74.67 -31.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 111.266 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -78.8 -26.12 44.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.204 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.39 23.1 14.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -76.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.936 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.03 -4.09 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.438 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.8 ptp 44.65 47.4 8.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.985 0.421 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -56.82 109.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.018 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.97 67.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -164.91 94.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.661 HG21 ' CD1' ' A' ' 151' ' ' LEU . 2.6 t -98.48 129.59 45.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.524 ' H ' HD12 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -113.8 -162.14 0.79 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 214' ' ' GLU . 2.3 t80 -79.13 -46.78 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 214' ' ' GLU . 1.7 t -63.86 -24.68 67.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 209' ' ' ASP . 23.1 mt -82.71 -57.28 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.539 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.97 68.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.012 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 210' ' ' TYR . 0.0 OUTLIER -51.25 -31.47 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 111.337 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.23 57.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.83 -52.92 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.833 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 226' ' ' ILE . 53.2 t80 -76.43 -58.67 3.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.793 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 214' ' ' GLU . 14.5 t-20 -47.48 -31.84 4.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.557 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -105.35 -23.7 12.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 52.87 43.42 60.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.25 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -110.48 39.26 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.585 0.231 . . . . 0.0 111.516 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.621 HG21 ' SD ' ' A' ' 148' ' ' MET . 17.6 p -131.59 -177.91 4.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.708 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -88.43 38.48 0.87 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.376 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.663 ' HG2' HD11 ' A' ' 115' ' ' LEU . 2.5 ttt 176.45 128.44 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.933 0.397 . . . . 0.0 111.513 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.71 105.04 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.484 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.404 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 2.4 tt -76.97 142.21 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.91 129.75 34.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -109.68 -144.48 10.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.396 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.1 -179.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.456 2.104 . . . . 0.0 112.315 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -98.37 34.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.37 -30.71 17.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 59.96 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.7 t -89.9 -63.66 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.31 65.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 236' ' ' ASP . 27.5 mt 61.43 155.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 235' ' ' ILE . 5.7 m-20 -62.49 -48.38 79.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 p 56.8 174.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 23.3 t 62.12 150.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -72.85 -46.07 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 240' ' ' VAL . 9.1 p -163.01 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -167.65 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.75 115.96 10.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.37 132.81 11.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.561 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.76 106.37 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.47 158.95 30.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.46 149.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 156.17 37.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.79 -158.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.925 2.417 . . . . 0.0 112.209 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.3 p -127.13 177.28 6.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 163' ' ' ALA . 49.9 p90 -167.26 118.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.77 12.21 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.85 16.03 60.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 46.0 mm-40 -152.91 92.75 3.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.643 0.258 . . . . 0.0 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 35.8 Cg_endo -65.22 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.484 2.123 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.4 m -49.7 175.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 111.208 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 2.5 mtpm? -86.28 134.59 38.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.3 Cg_exo -79.55 111.79 2.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.65 2.234 . . . . 0.0 112.213 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -132.33 103.35 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.641 HG23 HG13 ' A' ' 329' ' ' ILE . 30.2 m -101.51 153.06 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.4 ' C ' HG23 ' A' ' 110' ' ' VAL . . . -130.4 117.62 2.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.244 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.633 HG21 ' CB ' ' A' ' 107' ' ' PRO . 9.3 p -86.37 145.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.307 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.804 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.77 107.78 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.076 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 4.1 m -91.79 117.49 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.82 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -135.93 108.74 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -151.15 -143.41 3.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.567 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.668 HD13 ' H ' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -137.24 146.48 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 111.144 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -127.63 118.82 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.44 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 179.93 36.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 55.42 54.09 9.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 270' ' ' SER . 50.1 Cg_endo -69.07 -46.77 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.66 2.24 . . . . 0.0 112.299 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.8 65.06 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.81 -45.59 93.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.18 -33.39 72.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.957 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.82 -55.78 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.47 -52.58 63.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -29.43 68.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.85 -56.6 19.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.36 -29.7 62.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -33.53 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.084 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.31 -31.88 8.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.219 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -97.25 27.45 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 -43.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.98 42.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.1 38.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.0 p -136.03 153.75 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -38.14 65.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -57.26 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -63.1 -57.46 15.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.939 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 293' ' ' VAL . 2.8 tt -45.98 -40.71 10.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.332 . . . . 0.0 111.511 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 -57.91 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.411 . . . . 0.0 110.812 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 296' ' ' ASP . . . -49.06 -24.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.223 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 289' ' ' GLY . 34.4 m -80.86 -29.51 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.349 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -100.72 -85.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.389 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -120.39 14.61 12.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 292' ' ' ALA . 2.7 t0 59.95 27.97 17.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.75 160.26 2.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.17 155.46 6.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.909 HD22 ' N ' ' A' ' 300' ' ' GLY . 0.0 OUTLIER -164.46 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.66 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.909 ' N ' HD22 ' A' ' 299' ' ' LEU . . . 170.19 140.57 3.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.474 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 302' ' ' VAL . . . 172.88 156.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 301' ' ' ALA . 4.6 m -160.28 40.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -129.34 40.11 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.068 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 116.38 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -41.62 90.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 p -68.5 -31.52 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -74.71 -27.28 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.27 -36.45 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.0 -56.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.666 HD11 ' CB ' ' A' ' 317' ' ' ILE . 2.0 tt -55.58 -22.42 21.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.317 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -47.31 -29.17 2.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.541 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -29.6 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.96 109.83 2.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.927 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 319' ' ' ALA . 71.9 Cg_endo -76.89 -11.63 18.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.103 . . . . 0.0 112.736 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -66.04 -59.33 3.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.666 ' CB ' HD11 ' A' ' 311' ' ' LEU . 2.4 mp -80.13 -34.67 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.41 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.264 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 315' ' ' PRO . . . -56.78 -49.0 76.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.783 HG21 ' HA ' ' A' ' 111' ' ' GLU . 63.4 p -67.9 -26.51 66.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -26.9 28.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.239 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -66.57 -57.43 7.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.987 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.487 ' CG ' HD12 ' A' ' 113' ' ' LEU . 5.9 p-10 -76.47 -34.19 58.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.85 59.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.11 -30.87 66.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 -30.19 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.062 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -90.07 -148.01 18.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.64 -178.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.641 HG13 HG23 ' A' ' 259' ' ' VAL . 12.0 tt -104.55 114.96 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.51 147.09 0.77 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 -167.68 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.502 2.135 . . . . 0.0 112.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 30.29 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.95 90.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -51.94 -36.88 65.89 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.575 2.183 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.57 -36.74 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.404 ' HG3' ' CD1' ' A' ' 169' ' ' PHE . 19.8 mmt -61.81 -22.08 65.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 t -52.06 -27.31 13.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.0 -33.45 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.149 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -29.12 66.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 45.2 t90 -47.98 -28.83 2.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.92 -42.95 90.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.903 ' O ' HG22 ' A' ' 345' ' ' THR . . . -79.93 -30.45 39.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.471 HG11 ' HE1' ' A' ' 158' ' ' TRP . 43.5 t -53.9 -29.72 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.642 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -52.55 -46.73 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.186 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 342' ' ' ALA . 14.8 t -50.0 -30.57 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.079 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.18 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.754 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 348' ' ' ILE . 34.8 m -79.83 -49.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 347' ' ' VAL . 1.5 tt -49.99 -42.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.698 0.285 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 345' ' ' THR . 13.0 m-20 -60.86 -33.23 72.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.17 65.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.39 -10.57 59.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.534 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 54.2 m -67.62 -29.05 68.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.035 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.01 -12.33 65.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -129.66 39.59 3.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.404 ' CG ' ' HB3' ' A' ' 349' ' ' ASN . 7.6 tp60 -123.73 127.1 47.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 18.2 p -110.07 141.26 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.824 HG21 ' HB ' ' A' ' 193' ' ' THR . 21.2 t -57.79 -27.91 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -37.75 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -80.24 -52.76 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -53.88 -33.21 55.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.107 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 361' ' ' LEU . 0.8 OUTLIER -82.24 -49.38 10.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -64.63 -55.48 19.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 364' ' ' ALA . 1.3 p-10 -59.64 -29.68 68.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.689 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.79 -55.49 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -30.74 60.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.0 p -80.06 -30.08 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.935 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -47.11 41.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.31 -35.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.3 p -99.0 30.7 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.821 0.343 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.11 93.1 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.16 119.29 38.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 63.78 -79.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.32 51.97 3.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.674 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.5 ptmt -134.48 130.44 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 6' ' ' LYS . 9.4 mp -125.75 157.29 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 16.7 t -134.18 104.15 5.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.307 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.649 HG23 ' HE1' ' A' ' 61' ' ' PHE . 3.7 mp -99.88 124.18 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.346 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' ILE . 9.8 t90 -107.07 117.72 34.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.514 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -131.21 155.96 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.232 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -143.82 110.73 5.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.65 57.37 0.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -140.36 -50.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 tttt 59.4 31.53 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.66 36.52 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.525 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -60.13 -35.62 75.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.52 -51.15 38.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.13 54.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.97 -56.47 21.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.826 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.85 69.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -31.85 70.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.951 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -75.35 -38.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -25.32 75.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.54 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -57.26 -41.89 80.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -74.61 -47.67 30.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.609 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.5 m-85 -62.32 -56.24 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -51.85 -28.25 15.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.434 0.635 . . . . 0.0 110.683 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -25.69 49.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.61 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.643 ' O ' ' OG1' ' A' ' 31' ' ' THR . 14.5 t0 -51.58 -56.73 11.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.833 HG22 ' O ' ' A' ' 31' ' ' THR . 6.9 m 156.97 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.761 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.76 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.76 45.91 0.01 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 117.58 -2.248 . . . . 0.0 115.898 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.0 mm -131.45 95.79 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 118.425 1.113 . . . . 0.0 111.541 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -111.07 128.49 55.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.483 HG11 ' CE2' ' A' ' 283' ' ' TYR . 27.2 m -126.85 138.7 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.9 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.28 115.2 27.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 37' ' ' VAL . 14.7 p -86.3 116.27 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.808 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG3' ' CG1' ' A' ' 8' ' ' VAL . 6.0 mm-40 -104.27 143.32 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 111.277 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.59 ' O ' HD22 ' A' ' 43' ' ' LEU . 5.1 p80 -112.42 158.47 37.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.67 -83.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.358 2.039 . . . . 0.0 112.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 49.98 -92.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -120.34 -2.99 9.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 39' ' ' HIS . 7.2 mp -53.26 -25.79 15.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.687 0.28 . . . . 0.0 111.319 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -55.15 -38.84 68.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.36 -23.3 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.067 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -75.3 -29.53 60.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.164 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 64.5 t80 -55.74 -56.58 28.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.273 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.3 Cg_endo -64.01 -15.27 48.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.556 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.65 -55.3 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 46' ' ' LYS . 14.1 m -73.08 -28.87 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.04 -28.07 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -26.23 62.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.336 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.6 m -148.4 124.08 10.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.9 -54.25 2.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.343 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.98 -55.04 0.5 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.38 -107.01 0.35 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.575 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 87.3 Cg_exo -48.3 150.17 5.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.631 2.22 . . . . 0.0 112.259 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -153.89 38.53 0.46 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG22 ' HE1' ' A' ' 61' ' ' PHE . 13.1 mt -152.73 118.47 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 110.533 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 ' HB3' ' A' ' 10' ' ' TRP . 12.7 mt -151.15 142.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 111.694 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.779 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 2.1 m-85 -128.38 120.47 27.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.89 92.48 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.741 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . . . 42.59 -165.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.054 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -76.94 -29.53 55.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 p30 -47.78 -35.16 9.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.527 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -36.86 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.79 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 13.5 t80 -77.56 -64.03 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.2 -10.21 61.97 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.054 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.39 -61.11 1.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -96.57 -48.23 5.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.691 0.282 . . . . 0.0 111.088 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -57.01 -29.69 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.251 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -64.11 -31.62 72.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -26.8 25.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.77 70.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.59 39.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 265' ' ' GLY . 1.2 tt -148.79 118.48 7.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.41 156.09 28.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -93.4 156.85 16.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 HG22 ' CE ' ' A' ' 277' ' ' LYS . 2.9 pt -147.12 163.86 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -110.49 86.13 5.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.593 ' HD2' HD13 ' A' ' 103' ' ' LEU . 98.9 Cg_endo -79.8 -168.35 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.531 2.154 . . . . 0.0 112.362 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 86' ' ' GLN . 21.8 m-20 64.01 131.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -120.26 -100.89 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.71 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.4 -59.18 2.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 86' ' ' GLN . 50.9 p90 -80.91 -53.13 6.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 89' ' ' LEU . 2.5 mt-30 -52.76 -23.07 6.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.997 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 1.8 p-10 -45.5 -30.86 1.55 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -123.39 -65.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.821 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.581 ' C ' HD12 ' A' ' 89' ' ' LEU . 3.6 pp 42.69 -168.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.607 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.411 ' N ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -69.24 112.83 13.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.83 -26.12 29.66 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.384 2.056 . . . . 0.0 112.354 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.29 -31.9 70.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -75.35 -31.02 60.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 89' ' ' LEU . 2.4 m0 -70.17 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.81 -26.43 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.213 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.01 67.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.102 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 24.1 t -152.46 68.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.48 155.57 42.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.31 168.6 13.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -71.71 65.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.3 28.47 13.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 163.98 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.593 HD13 ' HD2' ' A' ' 81' ' ' PRO . 1.4 mt -145.33 75.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' A' ' 67' ' ' PHE . 2.3 pt -108.22 39.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -170.89 132.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 285' ' ' LEU . 29.5 t80 -155.14 102.19 2.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 5.3 Cg_exo -79.22 167.34 21.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.743 2.295 . . . . 0.0 111.925 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.99 39.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 262' ' ' LEU . . . -176.85 157.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 317' ' ' ILE . 30.9 m -132.27 106.16 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -126.94 159.65 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.25 159.43 20.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.642 HD22 ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -79.72 161.43 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.496 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -165.15 -176.03 3.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 224' ' ' MET . 8.5 mp -103.09 108.68 19.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.864 HD11 ' CD1' ' A' ' 242' ' ' TYR . 9.1 tt -87.99 149.31 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.42 163.53 30.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -102.53 -178.04 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.7 81.25 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -163.06 -63.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 121' ' ' LEU . 1.6 pt? -123.71 40.03 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.4 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 tt -144.65 115.82 5.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' HD23 ' A' ' 122' ' ' LEU . 40.6 Cg_endo -67.12 158.0 59.02 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.425 2.083 . . . . 0.0 112.197 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -65.02 111.25 5.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.51 154.76 24.29 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.51 2.14 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.54 -167.52 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.526 2.151 . . . . 0.0 112.238 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 p -76.99 140.52 40.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.01 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.837 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.1 m95 -71.71 -37.34 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.58 -23.82 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.643 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.04 -16.26 41.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.837 HD12 ' CE3' ' A' ' 129' ' ' TRP . 37.0 mt -65.61 -48.77 64.2 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 84.9 Cg_exo -46.4 -35.78 16.66 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.419 2.079 . . . . 0.0 112.465 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.07 93.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.51 -31.66 53.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.691 ' OD1' HG22 ' A' ' 132' ' ' ILE . 1.1 m-20 -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -71.83 -31.84 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.32 -45.27 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.44 -48.83 30.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -59.22 -25.64 64.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.021 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.76 33.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.387 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -109.03 -63.39 1.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.82 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.9 39.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.327 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -153.88 166.29 33.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 222' ' ' THR . 4.0 m -119.15 162.81 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.806 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -93.0 -2.15 56.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.597 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 147' ' ' LEU . 1.9 pt? 172.61 126.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.716 0.293 . . . . 0.0 110.477 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.23 120.74 8.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.587 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.38 123.85 48.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.077 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.55 ' ND2' ' CZ ' ' A' ' 156' ' ' PHE . 14.5 p30 -85.04 154.25 22.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' A' ' 151' ' ' LEU . 9.8 mt -128.37 -46.27 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.37 39.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 3.2 mt-10 -120.18 137.03 25.5 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 4.4 Cg_exo -79.63 179.24 6.49 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.726 2.284 . . . . 0.0 112.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 258' ' ' PHE . 3.6 m-85 59.8 20.11 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.55 ' CZ ' ' ND2' ' A' ' 150' ' ' ASN . 19.3 m-85 -120.84 -33.0 3.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.166 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -77.23 -24.28 51.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -69.42 -55.31 9.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 158' ' ' TRP . 21.6 Cg_exo -65.35 -32.84 49.79 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.48 2.12 . . . . 0.0 112.23 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.529 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.5 OUTLIER -70.1 -52.64 22.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.237 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.521 HD11 HD13 ' A' ' 195' ' ' LEU . 47.0 mt -77.06 -5.1 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.821 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -83.91 -63.96 1.25 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.34 -87.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ALA . 2.0 t0 -115.89 -39.57 3.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.67 -91.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.13 -47.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.516 ' OH ' HD21 ' A' ' 361' ' ' LEU . 0.3 OUTLIER 60.76 42.23 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.87 -63.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 17.5 p90 -155.32 172.93 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.14 125.85 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 328' ' ' GLU . 45.9 p90 -133.53 123.64 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -137.06 102.13 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 t30 56.2 29.08 14.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -157.28 -85.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.56 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -173.25 174.49 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.424 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 15.2 p90 -59.75 134.06 56.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 164.69 23.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 179' ' ' LYS . 4.3 tt -119.93 -41.85 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.44 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -80.36 -37.43 32.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.944 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -94.94 97.62 10.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.0 151.42 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -112.0 39.87 2.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.387 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.27 -24.68 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -144.23 65.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.64 -174.89 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.2 -30.0 51.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.13 93.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.181 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -67.04 -33.64 75.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.48 -46.32 80.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.77 -28.34 67.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -74.99 -31.82 61.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.89 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 p -75.25 -30.78 60.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CE1' ' HE3' ' A' ' 251' ' ' LYS . 5.8 m-85 -72.66 -41.98 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 161' ' ' ILE . 1.2 tt -60.54 -37.84 82.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 199' ' ' ILE . 31.4 m -76.05 -30.26 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.78 -41.33 68.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.23 -50.15 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 195' ' ' LEU . 17.1 tt -59.47 -30.85 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -62.23 -26.78 68.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -97.53 -23.73 15.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.071 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -88.88 -66.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.41 -35.2 73.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 mtt -101.54 72.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -179.15 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.46 -45.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.07 95.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.9 t -63.36 137.56 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' HD12 ' A' ' 212' ' ' ILE . 2.8 t0 -86.78 -166.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.017 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 211' ' ' SER . 48.8 p90 -79.0 -40.36 31.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.172 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 0.3 OUTLIER -79.53 -24.67 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.356 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 209' ' ' ASP . 12.7 mt -81.56 -57.29 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.42 68.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.3 -42.62 20.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -57.18 -31.37 65.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.422 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.43 -52.23 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -68.65 -28.36 66.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.626 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -69.29 -50.85 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -107.05 -23.76 12.2 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 99.97 67.7 0.85 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.749 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.08 38.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 145' ' ' SER . 14.9 p -152.16 179.99 8.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -85.82 38.85 0.77 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.39 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.454 ' HG2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.63 159.19 0.24 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.024 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -144.52 105.14 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.827 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.4 mt -80.82 136.15 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.435 ' HB3' ' CH2' ' A' ' 232' ' ' TRP . 60.7 m-20 -115.24 163.77 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -163.62 163.02 35.46 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.84 -28.28 25.04 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.576 2.184 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -75.65 -34.85 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.88 62.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.435 ' CH2' ' HB3' ' A' ' 227' ' ' ASN . 0.0 OUTLIER -154.0 104.6 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.8 p -167.58 -56.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.36 -60.88 3.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.6 mt 64.16 136.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -126.87 160.81 29.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.7 p -68.38 169.48 10.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 54.0 p -145.13 162.74 36.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.65 ' HG3' HG23 ' A' ' 240' ' ' VAL . 0.6 OUTLIER -116.61 -40.94 3.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.65 HG23 ' HG3' ' A' ' 239' ' ' LYS . 21.6 t -98.1 148.75 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -80.26 140.15 36.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.864 ' CD1' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -137.84 166.6 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -145.1 144.22 12.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' A' ' 116' ' ' ILE . 23.6 m -93.4 136.47 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 61.6 m -141.01 150.13 42.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 323' ' ' ASN . 9.9 p -100.3 150.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.784 ' H ' HD22 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -126.25 97.45 34.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.54 51.89 4.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.924 2.416 . . . . 0.0 112.691 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.12 114.41 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -155.09 111.69 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.763 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HE3' ' CE1' ' A' ' 194' ' ' PHE . 13.7 mptt 58.11 19.97 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.261 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 116.06 -34.79 4.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.889 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -132.37 152.13 79.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.295 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HG3' ' CD ' ' A' ' 326' ' ' LYS . 71.8 Cg_endo -77.04 132.4 12.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.73 2.287 . . . . 0.0 112.485 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 159' ' ' PRO . 67.5 m -54.42 178.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.39 83.43 46.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.59 162.89 24.44 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.962 2.441 . . . . 0.0 112.151 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.501 ' CD2' ' CD2' ' A' ' 155' ' ' TYR . 5.1 m-85 -88.36 144.32 26.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 329' ' ' ILE . 35.8 m -99.83 154.51 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.08 110.51 1.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.442 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 109' ' ' ALA . 18.4 m -108.33 144.65 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 109' ' ' ALA . 9.8 mt -69.76 90.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.2 m -79.59 120.84 24.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.779 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -83.54 123.89 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.112 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.543 ' HA2' HD11 ' A' ' 76' ' ' LEU . . . -102.75 106.13 2.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 76' ' ' LEU . 14.7 tt -95.73 141.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 0.0 111.074 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -83.59 138.39 33.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.94 -30.84 44.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.6 52.53 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.8 p -115.86 149.24 42.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 125.64 12.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.599 2.199 . . . . 0.0 112.318 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.88 88.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -75.08 -33.89 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.52 -30.89 67.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.64 -32.96 60.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.78 69.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.518 ' CE ' HG22 ' A' ' 79' ' ' ILE . 32.2 mttt -65.23 -58.99 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.92 -32.09 70.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -51.35 69.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -31.28 64.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -71.79 -30.26 65.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.56 27.48 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -132.89 -69.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.33 -52.14 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 106' ' ' TYR . 16.8 mt -83.11 67.88 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.767 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.5 t -146.4 168.0 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.775 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.66 -45.66 66.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.47 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -71.87 -57.4 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.767 ' H ' HG23 ' A' ' 286' ' ' THR . . . -56.54 -57.19 20.66 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.803 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 290' ' ' LEU . 0.2 OUTLIER -56.1 -36.72 68.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 111.123 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -78.66 -27.7 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.07 -57.8 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.189 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.03 -29.9 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.371 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -64.72 -60.42 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -82.01 -47.44 12.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.398 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.52 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.259 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -159.93 89.77 1.86 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.011 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -173.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.188 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 300' ' ' GLY . 1.6 pp -178.84 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 164.34 121.89 0.58 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 110' ' ' VAL . . . 179.25 157.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 110' ' ' VAL . 11.8 p -178.28 56.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -97.33 40.34 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.26 167.74 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -113.33 -36.66 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.2 m -79.37 -52.46 8.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 311' ' ' LEU . 6.2 m-85 -67.48 -24.64 65.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -53.59 -29.9 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -69.17 -31.14 69.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -92.92 -38.16 11.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 307' ' ' TYR . 7.3 mp -58.97 -28.17 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.74 56.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -57.24 -29.51 63.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 0.8 OUTLIER -66.85 143.27 97.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.69 -37.27 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -59.02 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.637 ' CD1' HG21 ' A' ' 110' ' ' VAL . 8.9 tp -67.54 -29.93 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -67.39 -36.29 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.29 -33.79 43.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.2 m -76.85 -40.86 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.464 ' HA ' ' HB3' ' A' ' 324' ' ' ALA . 3.3 ptt? -58.17 -25.82 61.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.64 -57.62 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.677 ' HB2' HG21 ' A' ' 246' ' ' VAL . 2.2 t30 -78.47 -30.58 47.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 321' ' ' MET . . . -59.3 -42.21 90.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.27 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -29.05 64.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.402 ' CD ' ' HG3' ' A' ' 254' ' ' PRO . 6.0 mttp -97.44 -30.72 12.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.0 -165.02 30.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -160.57 165.78 30.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 110.915 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 329' ' ' ILE . 3.9 mp -83.21 130.77 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.82 101.76 10.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.82 -10.91 30.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.478 2.119 . . . . 0.0 112.541 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 65.87 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.878 0.371 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 336' ' ' MET . 8.3 tt -79.48 127.6 77.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.67 -34.59 54.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.344 2.029 . . . . 0.0 112.429 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -57.79 -30.4 65.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.416 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.7 p -54.73 -30.87 57.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.76 -30.95 45.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -77.93 -26.49 48.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.21 -43.68 78.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.98 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -28.94 43.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.39 -51.29 58.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.333 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 p -54.61 -29.89 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.349 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.493 ' HB3' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -75.17 -60.9 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 4.5 p -60.54 -29.94 69.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.6 -50.52 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 343' ' ' VAL . 37.4 t -79.54 -53.36 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.789 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 344' ' ' ARG . 69.3 mt -51.68 -39.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.901 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 350' ' ' ALA . 35.8 p30 -51.45 -25.8 7.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 111.41 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . 0.44 ' N ' ' OD1' ' A' ' 349' ' ' ASN . . . -62.14 -33.61 74.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.36 -11.57 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.484 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.5 p -67.67 -30.23 69.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.64 -14.24 64.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.73 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -130.38 39.86 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.17 132.87 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 68.5 p -115.7 142.22 47.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 31.0 m -58.62 -27.94 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.243 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.37 -38.24 65.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -51.08 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.76 -29.9 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.516 HD21 ' OH ' ' A' ' 167' ' ' TYR . 9.9 mt -82.18 -56.39 3.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.004 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -63.62 -53.18 55.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -55.93 -47.88 76.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.47 -53.21 55.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -56.97 -30.53 64.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 8.7 p -80.68 -40.24 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.3 mtp-105 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.5 mt -75.72 -47.21 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.247 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 92.8 m -103.65 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.956 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 17.7 tptm . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.877 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.729 0.299 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.31 43.71 97.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.82 139.74 40.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 57' ' ' PRO . 85.5 mt -138.21 154.77 49.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' HG2' ' A' ' 57' ' ' PRO . 5.4 m -125.61 102.82 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HA ' HG23 ' A' ' 59' ' ' ILE . 3.8 mp -96.43 118.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.436 ' CE2' HD13 ' A' ' 43' ' ' LEU . 93.8 m95 -94.98 112.05 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -145.24 145.56 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.068 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -163.75 112.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.66 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -176.92 -48.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -153.17 -175.15 5.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 124.97 -34.89 3.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.489 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 8.5 p90 -62.36 -34.65 77.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 21.4 t-20 -68.07 -36.89 80.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.57 -39.03 30.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.5 mm? -68.28 -31.32 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.942 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.35 94.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.44 -34.33 73.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.67 -31.0 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.13 -46.72 9.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -29.7 59.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.776 0.322 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -37.74 37.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.26 -56.5 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.588 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.685 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -53.58 -27.7 27.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 110.245 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -46.4 -32.49 3.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.809 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 31' ' ' THR . 24.7 t0 -62.97 -57.41 10.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.61 37.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.653 0.596 . . . . 0.0 112.248 176.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.87 43.37 0.02 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 117.909 -2.091 . . . . 0.0 115.537 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 27' ' ' PHE . 3.2 mp -140.38 95.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 118.039 0.919 . . . . 0.0 111.857 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.17 131.8 54.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.07 148.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.76 137.13 50.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.55 111.51 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.75 163.05 31.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -98.72 144.4 28.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 136.04 23.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.516 2.144 . . . . 0.0 112.326 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.46 -47.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -116.24 0.15 12.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.374 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' CE2' ' A' ' 10' ' ' TRP . 7.2 tp -56.6 -25.41 52.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.746 0.308 . . . . 0.0 111.147 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -55.73 -31.96 62.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.24 -29.6 13.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 50' ' ' VAL . 18.2 tttt -73.95 -24.55 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.15 -58.48 8.65 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 26.5 Cg_endo -61.96 -18.96 64.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.436 2.091 . . . . 0.0 112.455 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -89.75 -35.97 15.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.829 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 46' ' ' LYS . 27.8 t -88.58 -17.83 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.39 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.27 -39.76 64.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.827 0.346 . . . . 0.0 111.271 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.695 ' O ' HG23 ' A' ' 53' ' ' THR . . . -80.55 -40.35 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.66 -74.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.808 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.08 -74.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.18 -71.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.27 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.644 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.3 Cg_endo -64.27 -177.74 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.26 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 167.09 106.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 9' ' ' ILE . 6.8 tt -146.94 117.31 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 43' ' ' LEU . 3.2 mp -121.19 142.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.656 ' HD1' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -96.05 117.13 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.386 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -143.12 173.23 11.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -57.26 -168.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 261' ' ' VAL . 0.4 OUTLIER -76.1 -56.4 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.04 -28.98 57.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.982 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -58.24 -41.77 84.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -111.88 -55.23 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.62 -29.07 74.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.81 29.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.548 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.63 -45.93 8.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.788 ' HB3' HD12 ' A' ' 76' ' ' LEU . . . -61.5 -31.17 71.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.06 67.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -108.33 25.79 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.07 -75.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -176.77 83.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.952 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -110.25 143.7 40.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.659 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -62.49 83.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 96.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 80' ' ' THR . 40.2 mt -72.07 158.32 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 79' ' ' ILE . 43.6 p -101.2 157.96 32.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 98.1 Cg_endo -79.8 89.64 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.605 2.203 . . . . 0.0 112.397 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.12 -55.2 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -25.29 64.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.25 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.493 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -75.13 -59.18 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.03 61.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.39 -39.86 52.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.02 37.3 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -170.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -98.05 146.53 31.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.97 -32.4 8.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.541 2.161 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -31.73 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -31.3 62.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.54 -41.78 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -30.93 70.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.53 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 97' ' ' VAL . 22.8 m -122.06 60.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 93.04 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -101.93 113.66 27.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.4 -68.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.54 39.11 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.492 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.6 171.5 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.39 92.03 3.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 ' HB3' ' A' ' 76' ' ' LEU . 1.7 pp -112.97 46.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.51 124.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.741 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -123.96 100.99 36.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.997 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.84 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.0 Cg_endo -79.87 127.72 7.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.199 . . . . 0.0 112.135 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 285' ' ' LEU . 9.3 mm -138.8 39.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 111.252 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.939 ' CB ' HD23 ' A' ' 262' ' ' LEU . . . 176.02 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.779 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.97 105.72 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.918 0.39 . . . . 0.0 111.056 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 132.86 49.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.97 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -152.48 174.32 14.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -99.92 160.73 14.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.65 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 4.2 m -164.07 -179.79 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -111.99 133.67 54.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.71 143.57 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' A' ' 245' ' ' THR . 46.7 p90 -139.1 179.36 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -139.41 177.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.77 34.93 4.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -131.11 -65.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.3 pp -130.04 39.92 3.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.15 88.36 13.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.77 140.23 47.56 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.31 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -70.26 165.89 39.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.72 122.45 10.54 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.528 2.152 . . . . 0.0 112.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.64 -52.15 1.51 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.41 2.073 . . . . 0.0 112.361 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.43 -76.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 249' ' ' THR . 17.6 p -116.42 -173.64 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.036 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.547 ' CE3' HG21 ' A' ' 132' ' ' ILE . 7.6 m95 -70.6 -31.23 68.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 2.4 tt0 -52.95 -24.17 8.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.05 -15.91 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.687 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.733 HG22 ' HD3' ' A' ' 133' ' ' PRO . 5.6 tp -52.75 -35.79 28.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.733 ' HD3' HG22 ' A' ' 132' ' ' ILE . 16.8 Cg_exo -68.2 -27.45 35.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.293 1.995 . . . . 0.0 112.2 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.05 -28.24 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -77.8 -31.86 52.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.08 -51.95 22.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -30.64 68.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.9 mt-10 -79.48 -43.28 23.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 135' ' ' LEU . 3.7 mm? -64.0 -49.93 70.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -26.12 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.9 -23.12 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.383 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -110.63 -60.71 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.49 40.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.566 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.525 ' CB ' HD12 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -150.65 -178.03 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -139.29 175.36 9.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.791 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -135.12 44.96 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.221 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.14 115.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 14.6 mmt -159.14 106.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 156' ' ' PHE . 1.6 t80 -168.97 177.03 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HA ' ' HB1' ' A' ' 213' ' ' ALA . 1.2 m120 -67.83 178.96 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.413 HD12 ' NE2' ' A' ' 152' ' ' GLN . 0.1 OUTLIER -135.04 -46.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.413 ' NE2' HD12 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -97.62 40.06 1.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.76 149.07 36.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 155.88 23.85 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.666 2.244 . . . . 0.0 112.321 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 60.26 20.36 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 226' ' ' ILE . 0.4 OUTLIER -121.08 -56.35 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.927 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.455 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.1 t -72.35 -32.03 66.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.172 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.546 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 66.1 t90 -64.36 -55.16 32.62 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -62.29 -28.66 79.12 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.264 1.976 . . . . 0.0 112.275 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.522 HD22 HD11 ' A' ' 195' ' ' LEU . 2.0 tp -68.7 -56.96 6.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.801 HD13 HD22 ' A' ' 192' ' ' LEU . 4.9 mt -78.23 -4.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.216 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -79.11 -50.45 11.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.874 0.369 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 254' ' ' PRO . . . -101.44 37.64 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -108.02 -31.21 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.3 -41.68 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . 171.01 164.77 27.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.506 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -176.18 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.23 -35.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -85.23 57.28 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -130.83 160.03 35.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.24 -31.48 72.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.068 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.79 -55.36 25.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . -60.26 -33.32 72.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 193' ' ' THR . 11.2 ttmt -74.26 -46.28 42.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.15 -30.48 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.642 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.02 -60.32 3.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.451 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.801 HD22 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -56.99 -31.57 65.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.818 0.342 . . . . 0.0 110.776 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 189' ' ' LYS . 40.3 p -72.9 -28.72 62.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.7 -50.44 12.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.654 HD12 HD11 ' A' ' 161' ' ' ILE . 8.4 mt -66.94 -28.84 68.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.663 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 192' ' ' LEU . 14.9 p -77.42 -46.59 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 196' ' ' VAL . 10.5 p30 -62.55 -27.19 69.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 111.228 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.427 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 0.2 OUTLIER -57.48 -30.69 65.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.144 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 mt -79.8 -55.2 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -21.02 64.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.404 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.82 15.54 16.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.327 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -120.15 -75.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -120.12 -4.93 10.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.49 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 24.1 ptm 45.53 30.56 0.78 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.366 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.9 OUTLIER -136.5 -43.84 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 205' ' ' ASN . . . 67.52 73.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -113.07 28.25 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.7 OUTLIER -106.18 119.65 39.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.899 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -166.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.401 ' HA ' ' ND2' ' A' ' 150' ' ' ASN . 52.2 p90 -79.1 -40.81 30.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.284 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -79.94 -24.63 40.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.58 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.0 mt -81.82 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -55.71 -30.28 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.36 -30.48 33.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.15 67.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.601 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.39 -56.92 10.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.612 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 20.4 p90 -76.39 -34.6 58.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.451 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 1.8 m-20 -73.66 -8.31 55.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.305 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -23.65 58.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.001 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 221' ' ' GLU . . . -159.33 -85.42 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.385 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 220' ' ' GLY . 0.5 OUTLIER 171.78 101.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.482 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.4 t -116.27 -177.36 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.791 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 39.56 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -162.47 99.68 1.04 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 17.3 m -144.51 105.15 4.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.636 HD13 ' HZ ' ' A' ' 156' ' ' PHE . 4.0 mt -113.51 135.0 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.7 147.57 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -155.07 -157.05 8.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.326 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.6 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.889 0.376 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.19 -173.7 13.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 319' ' ' ALA . 11.4 p -132.04 136.48 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.416 HG23 ' CE1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -130.58 156.18 45.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.1 p -77.42 150.63 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.93 146.72 81.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 95.6 Cg_endo -79.77 152.07 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.681 2.254 . . . . 0.0 112.435 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.79 HG22 ' HD3' ' A' ' 254' ' ' PRO . 45.6 p -63.82 177.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CD1' ' OD1' ' A' ' 164' ' ' ASP . 4.5 t80 -159.88 111.89 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.739 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.2 mttm 59.38 21.24 9.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.51 -47.64 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.59 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.93 151.19 29.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 249' ' ' THR . 59.5 Cg_endo -72.21 -175.63 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.314 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -172.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -118.5 81.25 17.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.69 -168.3 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.631 2.221 . . . . 0.0 112.344 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -171.95 161.13 5.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 328' ' ' GLU . 27.6 m -75.8 146.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -111.53 74.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.524 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.449 ' CG2' ' CD2' ' A' ' 64' ' ' HIS . 13.3 m -95.83 135.13 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.939 HD23 ' CB ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -86.87 124.25 32.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 t -92.95 112.86 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.758 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.12 49.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 169.1 -173.26 43.55 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 276' ' ' ALA . 26.3 mm -88.53 159.74 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.487 ' N ' HG22 ' A' ' 266' ' ' ILE . 6.4 m120 -98.12 108.02 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.994 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . . . 67.78 10.28 7.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.827 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . . . 45.41 30.3 0.7 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.559 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER -64.2 -61.04 7.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.032 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 270' ' ' SER . 63.4 Cg_endo -73.63 97.85 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.504 2.136 . . . . 0.0 112.468 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 23.9 m-20 59.1 86.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.99 -30.94 61.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -76.43 -57.23 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.96 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.62 -31.4 71.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 266' ' ' ILE . . . -59.22 -56.75 18.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.22 -43.94 80.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.79 -42.27 99.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.07 -31.3 72.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.997 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -81.24 -25.76 36.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -93.8 -32.24 14.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.15 27.53 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.219 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 27' ' ' PHE . 1.4 m-85 -177.31 48.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 110.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 280' ' ' LEU . 1.1 mt -178.25 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 108' ' ' ILE . 4.1 mm? -107.44 65.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.832 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.1 t -150.99 171.85 16.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.739 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.37 -48.2 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -77.55 -35.02 53.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.832 ' H ' HG23 ' A' ' 286' ' ' THR . . . -55.34 -75.76 0.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.791 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 -21.92 29.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.316 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -29.12 5.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.359 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.91 -53.76 7.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.612 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 294' ' ' ASN . 12.3 p -72.41 -46.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.8 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.494 ' N ' HG13 ' A' ' 293' ' ' VAL . 46.6 p-10 -58.29 -21.22 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.326 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -55.25 2.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.97 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -126.62 87.66 55.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.485 ' C ' HD23 ' A' ' 299' ' ' LEU . 57.6 Cg_endo -71.09 163.71 38.28 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.539 2.159 . . . . 0.0 112.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.633 HD23 ' N ' ' A' ' 299' ' ' LEU . 1.3 pt? -175.72 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -160.32 -167.1 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.448 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.723 ' HB3' ' CG2' ' A' ' 317' ' ' ILE . . . -136.51 160.06 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.557 ' CG2' HD23 ' A' ' 304' ' ' LEU . 27.5 m -79.95 -179.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -107.89 40.0 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.557 HD23 ' CG2' ' A' ' 302' ' ' VAL . 3.8 mm? -78.26 126.97 31.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.82 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.11 93.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.4 p -68.78 -52.42 30.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -27.35 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.37 -28.13 51.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.87 -45.68 89.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -93.23 -31.95 14.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.726 ' O ' HD11 ' A' ' 317' ' ' ILE . 4.6 mp -59.88 -28.19 67.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.51 29.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.327 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -58.73 -30.75 67.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.91 140.59 33.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 95.8 Cg_endo -78.95 -17.94 11.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.589 2.193 . . . . 0.0 112.825 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.407 ' CG ' HD13 ' A' ' 317' ' ' ILE . 3.3 ptt180 -51.18 -54.56 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.283 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -80.46 -29.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.357 . . . . 0.0 111.094 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -60.79 -31.77 71.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.65 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -79.13 -39.14 34.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.703 HG22 ' HB3' ' A' ' 112' ' ' ALA . 62.4 p -71.67 -43.39 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 ptm -59.43 -28.81 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -57.38 12.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -78.35 -31.13 48.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.1 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.298 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -50.27 65.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.147 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -47.62 11.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 159.91 136.72 2.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -173.31 89.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 329' ' ' ILE . 1.0 OUTLIER -133.64 118.49 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.02 120.31 53.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.42 -168.23 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.397 2.065 . . . . 0.0 112.289 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -98.45 -65.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 333' ' ' ILE . 4.5 tp 34.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.955 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.1 -25.24 31.82 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.471 2.114 . . . . 0.0 112.392 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -25.85 59.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -28.56 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 m -56.94 -47.6 80.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -33.88 63.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.041 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -61.4 -27.0 68.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -32.48 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.94 -31.46 45.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.82 -40.71 39.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.4 t -59.4 -30.1 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.5 ' HB3' HD12 ' A' ' 348' ' ' ILE . 10.5 mmt180 -74.97 -60.64 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 50.3 m -58.8 -27.78 65.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.49 -52.28 11.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.406 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.7 t -79.19 -54.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.691 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 344' ' ' ARG . 62.1 mt -49.43 -58.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.56 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -57.22 -50.66 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.78 59.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.31 -10.69 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.434 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 51.6 p -67.69 -30.22 69.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 112.54 -25.34 12.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -112.83 39.85 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.61 145.67 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 t -124.15 148.95 46.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.01 -28.2 43.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.37 -30.4 60.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 -54.75 5.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -62.74 -30.06 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -56.6 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -60.74 -52.27 65.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -58.65 -34.88 71.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -69.98 -33.91 72.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.163 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -31.58 69.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 27.0 m -80.7 -38.18 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 -43.43 59.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 364' ' ' ALA . 1.0 OUTLIER -59.47 -35.42 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.4 m -80.34 -54.37 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.79 0.329 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.52 86.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' C ' HD12 ' A' ' 7' ' ' LEU . 14.3 tttt -167.96 138.29 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 6' ' ' LYS . 4.9 mp -147.86 159.57 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.53 103.44 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 mp -100.04 119.53 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -103.29 126.37 50.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.4 HG12 ' N ' ' A' ' 12' ' ' ASN . 18.7 tt -172.11 158.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 39' ' ' HIS . 9.9 t30 -176.53 -169.88 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.92 -31.63 3.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.31 -51.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -178.28 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.16 24.26 28.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.699 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.97 -58.08 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -60.16 -40.9 91.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -51.27 60.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.578 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -31.17 54.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.13 -38.0 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -52.71 64.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 24' ' ' GLY . 28.1 m -61.68 -43.77 97.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.185 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.93 -36.34 92.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -59.45 -44.47 92.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -79.2 -30.06 43.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.966 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.877 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -60.66 -56.55 19.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -56.32 -27.89 57.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.536 0.684 . . . . 0.0 110.4 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -33.4 14.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.499 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' ' HB ' ' A' ' 31' ' ' THR . 5.0 t70 -59.73 -57.4 13.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.65 36.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.872 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.61 44.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 117.958 -2.068 . . . . 0.0 115.47 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 27' ' ' PHE . 2.3 mp -139.69 95.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 117.998 0.899 . . . . 0.0 111.608 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -126.4 114.8 18.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 9' ' ' ILE . 3.5 m -110.94 134.62 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 146.2 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.27 123.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.072 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -155.46 163.16 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 12' ' ' ASN . 14.2 t-80 -152.8 79.42 5.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' HD23 ' A' ' 43' ' ' LEU . 60.9 Cg_endo -72.79 -168.36 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.454 2.103 . . . . 0.0 112.268 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.69 -28.45 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -81.93 0.12 41.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 40' ' ' PRO . 2.9 pp -47.75 -28.77 2.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.779 0.323 . . . . 0.0 111.278 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -68.57 -37.0 79.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.26 -15.17 19.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.738 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.5 mttm -71.58 -24.54 61.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.6 m-85 -51.22 -60.77 5.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.257 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.4 Cg_endo -69.61 -15.36 37.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.501 2.134 . . . . 0.0 112.658 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.52 -55.32 3.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.2 p -63.62 -26.22 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.14 69.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.183 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.3 -18.98 59.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -144.35 115.28 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.14 70.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.341 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -96.6 28.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.22 -93.47 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.33 128.35 17.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.541 2.161 . . . . 0.0 112.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.61 103.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.049 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 9' ' ' ILE . 2.3 tt -133.04 145.66 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.17 142.76 20.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.396 . . . . 0.0 111.399 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 64.5 m-85 -100.36 118.94 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 263' ' ' SER . 2.2 m95 -138.73 173.7 11.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.18 -177.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 111.336 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -76.92 -50.1 14.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.28 -25.96 67.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -29.51 53.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 17.7 m-85 -115.72 -36.32 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.89 -26.1 39.73 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.715 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.9 -25.61 2.5 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.862 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -34.08 16.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 111.119 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 76' ' ' LEU . . . -69.14 -55.66 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.172 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.18 -20.39 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -95.27 -26.77 15.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.51 -90.79 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.558 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.646 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER 179.07 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 71' ' ' ALA . 4.1 mm? -123.15 150.46 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.21 121.35 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 139.13 55.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -115.76 147.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -104.73 145.73 31.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.85 162.12 23.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.646 2.231 . . . . 0.0 112.434 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.42 -47.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.78 -20.43 29.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.7 19.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.379 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.04 -59.16 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.39 . . . . 0.0 110.639 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.51 -24.82 62.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.695 ' OD1' HD21 ' A' ' 304' ' ' LEU . 9.8 t70 -72.12 -26.24 62.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 tttm 66.62 72.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.34 163.02 13.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 305' ' ' LYS . 0.3 OUTLIER -64.14 139.16 97.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.78 -44.41 49.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.496 2.131 . . . . 0.0 112.321 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.08 -29.55 65.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 107' ' ' PRO . 35.6 m -56.96 -30.22 63.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.949 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -92.58 -41.05 10.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -30.43 69.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.48 -30.99 63.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 97' ' ' VAL . 21.6 t -87.72 54.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -138.34 96.36 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.11 120.22 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.6 -74.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.59 36.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 103' ' ' LEU . 21.3 mttp -145.62 -178.5 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 102' ' ' LYS . 5.9 mp -137.96 92.7 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.5 mp -132.25 40.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.92 65.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.22 113.27 29.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 93' ' ' THR . 98.2 Cg_endo -79.74 133.2 10.19 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.443 2.095 . . . . 0.0 112.436 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.4 pp -145.77 39.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.838 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -177.03 154.43 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 110' ' ' VAL . 5.2 m -126.69 106.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.14 135.37 54.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.79 176.58 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.61 164.64 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 m -165.05 -178.75 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.65 132.37 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -104.27 138.92 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.128 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 243' ' ' GLY . 8.2 p90 -146.96 167.38 24.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.595 ' CB ' HD21 ' A' ' 121' ' ' LEU . 3.2 m120 -86.55 159.34 19.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.63 36.41 2.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.561 ' C ' HD23 ' A' ' 121' ' ' LEU . 8.0 p-10 -155.36 30.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.595 HD21 ' CB ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -178.16 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.806 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tt -123.42 84.5 52.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.33 160.46 3.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.239 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.07 111.63 6.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.73 154.82 26.97 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.74 ' HG2' HG22 ' A' ' 128' ' ' THR . 83.5 Cg_endo -82.57 10.29 3.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.777 2.318 . . . . 0.0 112.893 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt 63.42 49.53 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.928 0.394 . . . . 0.0 111.196 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 126' ' ' PRO . 12.6 t -160.14 142.63 13.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.948 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.936 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.8 m95 -57.98 -28.89 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.002 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 1.4 tp10 -53.58 -23.8 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.632 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 126' ' ' PRO . 0.6 OUTLIER -73.31 -21.42 60.57 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.936 HD12 ' CE3' ' A' ' 129' ' ' TRP . 21.4 mt -73.33 -53.43 4.7 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 82.5 Cg_exo -46.79 -49.94 11.5 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.276 1.984 . . . . 0.0 112.536 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.98 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 6.7 mt -59.11 -32.17 69.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -57.08 -34.36 68.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -31.17 57.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.7 mm-40 -78.3 -41.61 33.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.62 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 4.2 mm? -60.39 -55.84 28.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -61.31 -24.42 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.45 -23.23 24.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.476 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -110.61 -72.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.72 39.72 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.441 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.71 178.95 9.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.6 138.65 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 223' ' ' ALA . . . -92.22 53.34 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -176.68 115.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 225' ' ' THR . 1.1 ppp? -87.7 -173.63 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 41.4 p90 -86.5 107.67 18.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.621 ' ND2' HG21 ' A' ' 226' ' ' ILE . 2.2 t30 177.54 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -177.74 -32.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.68 43.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.075 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.8 144.23 26.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.817 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.67 90.8 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.535 2.157 . . . . 0.0 112.281 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.45 -31.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -117.64 -31.44 5.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.959 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -33.87 76.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.892 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.754 ' CE2' HG13 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -63.5 -56.14 29.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 52.7 Cg_endo -68.72 -11.12 31.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 0.0 112.44 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.77 -57.01 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.02 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -90.56 5.31 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.503 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -94.38 -69.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.905 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.87 -86.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.37 29.19 7.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.977 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.41 -75.33 0.65 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.05 107.51 0.98 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.539 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 111.95 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 -179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.98 -19.42 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.855 ' HA ' HD22 ' A' ' 361' ' ' LEU . 2.8 m-20 -83.26 56.49 3.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.1 129.3 50.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.67 -23.92 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.312 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.63 70.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.647 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.65 -40.43 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.805 ' HG3' HD11 ' A' ' 361' ' ' LEU . 9.0 mmpt? -67.73 -30.91 70.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.89 -56.87 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.27 -26.02 74.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.609 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.78 -48.37 81.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.8 p -72.01 -31.03 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -70.21 -43.0 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.524 ' HB2' HG21 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -65.34 -49.98 67.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 197' ' ' ASP . 28.3 m -58.73 -43.22 87.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 196' ' ' VAL . 1.7 m-20 -69.28 -30.87 69.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -48.23 82.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 151' ' ' LEU . 11.9 pt -74.97 -33.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -29.93 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.14 -26.16 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -102.98 -69.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -60.24 -45.41 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.4 ttt 60.46 26.92 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.0 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.05 -45.27 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.02 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -166.75 76.64 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.6 p -55.23 148.11 15.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.6 t0 -111.11 -167.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.098 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -79.37 -41.81 26.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -78.8 -25.03 44.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.398 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 1.6 mp -82.07 -54.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.078 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 149' ' ' PHE . . . -60.51 -30.39 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.447 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.03 -23.38 52.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.103 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.69 -52.75 59.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.428 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.08 -55.48 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -55.38 -28.21 52.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -49.03 -30.86 6.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -23.99 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 62.82 22.59 64.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.06 73.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.977 0.417 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.8 p -109.77 -177.08 3.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.997 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -79.63 39.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.991 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.439 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 169.34 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 148' ' ' MET . 0.8 OUTLIER -136.49 105.09 5.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.621 HG21 ' ND2' ' A' ' 150' ' ' ASN . 2.4 tt -92.98 114.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.088 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -142.29 164.19 30.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.81 -159.87 10.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.41 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 122.542 2.161 . . . . 0.0 112.335 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.2 p90 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.849 0.357 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 117' ' ' TYR . . . -95.79 83.5 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 244' ' ' VAL . 15.0 p -98.46 114.71 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.4 p -141.08 162.72 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.437 HG11 ' CD ' ' A' ' 322' ' ' GLU . 11.6 p -77.39 150.56 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.92 158.67 23.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.43 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.88 2.387 . . . . 0.0 112.263 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.09 177.61 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 129' ' ' TRP . 4.2 t80 -164.74 115.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.6 tttt 61.23 19.0 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.75 47.77 9.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -141.07 90.76 9.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.21 130.29 10.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.604 2.203 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.9 t -53.09 160.31 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.4 90.77 35.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.52 -159.93 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.054 2.502 . . . . 0.0 112.086 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.75 138.81 47.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 260' ' ' GLY . 22.2 t -100.17 155.17 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -132.86 136.08 8.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.612 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.77 144.59 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.838 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.3 mp -85.44 117.84 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' TRP . 92.4 p -87.65 114.73 24.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.569 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -115.58 128.84 56.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.9 -179.28 35.55 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.573 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.666 ' CG2' ' HB2' ' A' ' 269' ' ' ALA . 1.8 mt -111.68 159.36 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 266' ' ' ILE . 5.7 p-10 -127.22 134.88 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 58.68 30.64 20.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 266' ' ' ILE . . . -97.72 34.97 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.435 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 1.4 m -55.76 -61.12 6.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 270' ' ' SER . 36.4 Cg_endo -65.36 -23.78 58.28 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.497 2.131 . . . . 0.0 112.542 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -117.09 38.06 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.004 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.67 -57.31 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.55 -30.03 68.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -70.2 -56.47 6.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.224 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.15 -40.43 89.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.65 -46.77 84.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -73.36 -29.61 62.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -53.99 51.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.36 -14.44 52.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.08 27.59 3.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.157 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -125.76 -57.05 1.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.771 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 283' ' ' TYR . 4.9 mp -110.94 -78.17 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.657 ' O ' HD13 ' A' ' 290' ' ' LEU . 18.5 tp 62.5 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.96 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.443 HG21 HD11 ' A' ' 304' ' ' LEU . 0.8 OUTLIER -158.11 137.65 11.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.302 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.4 t70 70.84 -54.36 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 111.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.79 -58.05 8.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 284' ' ' LEU . . . -120.75 -38.93 0.63 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.829 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 285' ' ' LEU . 1.0 OUTLIER -55.14 -58.85 5.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.893 0.378 . . . . 0.0 111.184 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.615 ' OE1' HD11 ' A' ' 311' ' ' LEU . 5.6 mm-40 -55.25 -35.87 65.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.116 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.82 -24.86 66.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 289' ' ' GLY . 23.5 t -71.68 -30.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.48 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -105.59 -49.63 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.09 -42.64 81.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.69 -51.31 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.42 138.19 32.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 299' ' ' LEU . 58.0 Cg_endo -71.09 122.44 8.76 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.413 2.075 . . . . 0.0 112.305 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 298' ' ' PRO . 4.1 mp -151.62 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 178.1 -165.8 35.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.441 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.652 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -119.34 -176.62 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.678 HG11 HD12 ' A' ' 304' ' ' LEU . 22.0 t -93.61 156.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.44 ' N ' HG12 ' A' ' 302' ' ' VAL . . . -100.45 40.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.695 HD21 ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -89.58 -175.77 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 14.3 mttt -102.8 -71.28 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 64.0 p -70.73 -47.06 61.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -58.77 -29.56 66.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -28.58 66.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 5.8 mt-10 -56.75 -61.73 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.71 -47.55 85.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.615 HD11 ' OE1' ' A' ' 291' ' ' GLU . 4.2 mm? -61.01 -23.3 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 309' ' ' GLU . . . -56.45 -21.63 26.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -90.18 46.6 1.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.894 ' HB3' HG22 ' A' ' 317' ' ' ILE . 1.1 t0 -118.25 147.37 41.49 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.95 -48.65 18.71 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.592 2.195 . . . . 0.0 112.457 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -59.09 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.894 HG22 ' HB3' ' A' ' 314' ' ' ASP . 8.7 tp -62.28 -25.3 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -55.8 -39.94 72.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.218 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.12 -34.0 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -75.5 -29.12 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.5 ttt -57.15 -31.29 65.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.022 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.437 ' CD ' HG11 ' A' ' 246' ' ' VAL . 1.5 tt0 -67.02 -44.39 80.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.22 -30.81 49.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.03 67.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -30.71 66.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -141.43 31.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.63 -170.94 19.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.409 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.83 168.75 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.971 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mm -70.4 138.28 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 5.3 ttt -51.86 106.8 0.7 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -168.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.444 2.096 . . . . 0.0 112.339 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -177.18 79.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 333' ' ' ILE . 8.0 tt -124.97 123.24 25.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.97 -30.12 57.45 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.409 2.073 . . . . 0.0 112.224 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -58.91 -30.12 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.1 tpt -56.89 -28.27 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.054 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -59.24 -32.96 70.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.37 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.764 ' O ' HG23 ' A' ' 343' ' ' VAL . 37.8 m-85 -65.19 -28.02 69.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.59 -28.83 49.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 345' ' ' THR . 0.2 OUTLIER -62.39 -46.89 86.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.975 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.3 -27.93 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 339' ' ' PHE . 39.4 t -67.67 -42.1 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 ptt180 -75.11 -47.19 29.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 341' ' ' TYR . 55.2 p -49.87 -27.47 5.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.4 -59.13 3.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.44 -50.8 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.822 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 344' ' ' ARG . 7.4 tp -53.33 -40.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.738 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 345' ' ' THR . 5.4 t-20 -80.61 -41.67 23.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.18 87.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.04 -10.78 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.0 t -67.76 -57.02 7.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -132.43 -71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.569 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -176.67 50.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.3 OUTLIER -80.03 132.52 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.2 p -93.29 153.96 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.02 -28.55 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.7 -37.75 79.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.2 -50.38 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.613 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -58.0 -25.19 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.855 HD22 ' HA ' ' A' ' 184' ' ' ASP . 17.8 mt -82.34 -56.47 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -70.43 -41.82 72.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.361 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.12 -46.96 78.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -58.22 -57.09 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.643 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -57.6 -30.54 65.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 93.5 m -77.65 -54.91 5.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.106 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -59.13 -47.05 86.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 364' ' ' ALA . 2.9 tt -56.36 -37.88 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.238 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 365' ' ' GLN . 77.3 p -78.21 -64.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.789 0.328 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.01 86.37 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.752 ' C ' HD22 ' A' ' 7' ' ' LEU . 2.9 pttm -153.63 137.36 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.752 HD22 ' C ' ' A' ' 6' ' ' LYS . 3.9 mm? -133.92 131.5 39.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.804 HG23 ' HB2' ' A' ' 57' ' ' PRO . 38.3 t -104.21 104.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mt -93.06 114.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.585 ' NE1' HD22 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.9 115.74 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' ASP . 29.9 mt -140.84 145.74 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.51 44.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.05 79.17 1.38 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.359 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.759 ' HB2' HG21 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -87.8 8.28 26.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.607 0.242 . . . . 0.0 111.328 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 58.95 30.04 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.11 59.51 0.67 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.575 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -61.42 -54.46 43.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.771 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -30.41 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.25 -51.96 54.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.614 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.64 -26.35 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.727 0.299 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.47 -46.3 20.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.02 -41.89 84.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' GLY . 35.2 t -59.45 -44.32 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 -25.51 57.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -43.76 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -74.39 -43.34 56.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.625 ' HB3' HG21 ' A' ' 33' ' ' ILE . 2.6 m-85 -63.9 -56.32 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.517 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 19.3 pt-20 -52.78 -28.05 20.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.487 0.66 . . . . 0.0 110.683 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -25.55 49.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.473 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.645 ' O ' ' OG1' ' A' ' 31' ' ' THR . 4.4 t70 -51.53 -56.81 11.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.84 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m 156.91 36.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.742 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.748 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.61 46.12 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.764 -2.16 . . . . 0.0 115.885 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.5 mm -131.37 95.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 118.535 1.167 . . . . 0.0 111.596 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -103.75 121.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.66 128.95 76.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.27 146.31 23.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.3 p -139.05 111.47 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 2.2 tt0 -142.8 163.14 33.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -104.9 150.3 38.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.13 -156.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.78 -75.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -59.27 -30.04 68.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.585 HD22 ' NE1' ' A' ' 10' ' ' TRP . 28.9 tp -67.53 -24.01 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.93 -45.86 67.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.64 -28.26 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -24.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' HZ ' HD22 ' A' ' 75' ' ' LEU . 3.6 t80 -45.76 -55.43 12.66 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.66 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.6 Cg_endo -61.24 -21.39 71.57 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.271 1.981 . . . . 0.0 112.503 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -89.77 -55.23 3.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 55' ' ' ASP . 33.8 t -65.78 -30.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.8 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.86 -34.44 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -25.82 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.4 -51.1 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.3 t70 75.46 -54.42 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 111.047 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.78 -94.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.804 ' HB2' HG23 ' A' ' 8' ' ' VAL . 56.7 Cg_endo -70.56 149.33 61.63 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.578 2.186 . . . . 0.0 112.218 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 177.35 80.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 265' ' ' GLY . 28.2 mt -103.1 106.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB3' ' A' ' 10' ' ' TRP . 27.1 mt -112.65 137.45 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.289 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -86.68 128.56 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -157.62 173.25 17.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.848 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -54.62 -177.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.691 ' HB3' HG13 ' A' ' 261' ' ' VAL . 13.8 p80 -77.2 -52.0 9.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.19 -29.64 61.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -56.14 -27.65 54.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.142 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -108.14 -30.31 8.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.2 57.22 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.88 -49.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.606 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.27 -50.15 75.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -74.51 -31.37 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HG3' HD13 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -73.41 -19.43 60.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 t -70.24 -26.7 63.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.57 50.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.607 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -179.36 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.891 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.641 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 1.4 tp -177.22 133.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB3' ' H ' ' A' ' 268' ' ' ALA . . . -110.71 160.49 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -85.7 134.8 33.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 80' ' ' THR . 4.6 mt -89.09 158.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.061 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 79' ' ' ILE . 74.9 p -88.94 146.31 36.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.92 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.606 2.204 . . . . 0.0 112.388 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -176.46 138.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -60.22 -48.02 83.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.64 -25.66 62.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 82' ' ' ASP . 6.2 m-85 -79.24 -59.24 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -24.85 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.791 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.28 -31.57 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -94.24 -58.48 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.16 158.33 11.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 305' ' ' LYS . 4.7 m-85 -105.21 157.6 33.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 -26.27 24.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.54 -35.72 72.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -30.13 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -75.74 -53.45 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.07 -31.35 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.79 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.777 HG11 ' HD3' ' A' ' 107' ' ' PRO . 10.9 m -117.0 39.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -110.83 121.43 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.54 132.13 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.401 ' CB ' ' HD3' ' A' ' 102' ' ' LYS . 16.1 m-20 59.27 28.64 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.993 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.55 20.61 73.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.831 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HG3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -145.73 166.84 24.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.68 HD23 HG23 ' A' ' 97' ' ' VAL . 5.4 mp -118.74 91.98 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' HD23 ' A' ' 76' ' ' LEU . 5.1 mt -101.37 40.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.87 164.76 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.243 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.68 119.03 7.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.777 ' HD3' HG11 ' A' ' 97' ' ' VAL . 94.6 Cg_endo -79.59 152.45 22.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.548 2.166 . . . . 0.0 112.336 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 284' ' ' LEU . 7.4 tt -171.99 39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.304 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.07 104.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 320' ' ' THR . 21.6 t -91.8 110.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.017 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.64 147.19 27.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.93 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.06 159.51 15.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -164.93 145.57 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 115' ' ' LEU . 4.1 pp -93.47 150.02 20.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 227' ' ' ASN . 4.5 mt -115.05 137.24 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -127.37 164.46 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.0 173.13 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -137.69 81.4 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HB3' HD23 ' A' ' 121' ' ' LEU . 28.2 t0 -174.2 -54.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -134.51 62.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.845 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD11 ' CB ' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -156.85 92.28 2.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.69 154.1 7.16 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.526 2.151 . . . . 0.0 112.298 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.2 111.27 5.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.99 149.77 37.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.452 2.102 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.403 ' CG ' ' HB3' ' A' ' 131' ' ' GLU . 59.6 Cg_endo -72.3 -167.03 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.478 2.119 . . . . 0.0 112.229 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -95.71 -28.25 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 131' ' ' GLU . 15.4 t -75.78 140.23 42.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -73.07 -35.73 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.2 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -23.97 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.837 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' HB2' HG23 ' A' ' 128' ' ' THR . 0.8 OUTLIER -87.21 -16.32 35.65 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.3 mm -61.3 -47.71 93.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 74.0 Cg_exo -47.92 -35.17 24.18 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.381 2.054 . . . . 0.0 112.482 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mp -60.63 -30.68 70.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -50.85 36.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.3 74.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.46 -45.61 79.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 145' ' ' SER . 10.1 mt -71.85 -43.94 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -27.15 67.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -27.7 49.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -109.44 -55.97 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 40.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -148.93 177.49 9.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.501 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -152.63 175.44 12.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -129.04 45.34 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.08 115.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.437 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -154.62 106.53 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.056 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -158.0 176.81 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.688 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -50.63 156.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD11 HD13 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -129.07 -49.03 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.687 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -97.11 39.78 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -154.91 166.01 16.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.694 2.263 . . . . 0.0 112.258 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -173.27 -40.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 160' ' ' LEU . 12.6 t80 -120.75 -41.73 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.416 ' HB ' HD11 ' A' ' 195' ' ' LEU . 2.5 p -68.55 -33.58 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.501 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 23.4 t90 -68.06 -55.79 12.47 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 38.2 Cg_endo -66.0 -14.08 42.8 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.301 2.001 . . . . 0.0 112.571 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -77.86 -55.62 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.676 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.429 HG22 ' CZ ' ' A' ' 194' ' ' PHE . 3.1 pt -88.93 9.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.535 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . . . -109.29 -15.98 14.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.422 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.27 65.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.256 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.92 -30.11 19.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.12 86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -154.48 89.99 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.536 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.15 52.62 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.66 -0.176 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 339' ' ' PHE . 18.0 t -111.66 -30.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.401 ' OD2' ' CD2' ' A' ' 339' ' ' PHE . 22.1 p30 -94.17 50.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.34 162.79 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.99 -33.95 76.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.21 -28.3 49.53 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.14 -53.63 50.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -53.75 -50.08 66.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.33 68.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -60.76 -56.47 24.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.508 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.475 HD23 HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -63.95 -24.76 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.689 0.28 . . . . 0.0 111.065 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 63.0 m -56.48 -59.02 5.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.148 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 11.2 p90 -81.88 -23.04 36.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.267 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.416 HD11 ' HB ' ' A' ' 157' ' ' THR . 5.7 tp -52.92 -61.21 2.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.475 HG23 HD23 ' A' ' 192' ' ' LEU . 30.5 t -59.74 -42.89 90.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.41 -30.3 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.89 -30.03 69.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 151' ' ' LEU . 31.3 mt -77.2 -55.25 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -25.4 68.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.059 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -95.71 22.01 7.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -66.31 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -108.79 -29.25 8.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.8 mtp 62.87 31.39 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -176.71 114.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.95 88.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.98 -30.49 8.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 213' ' ' ALA . 2.7 p -81.6 147.94 29.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -140.94 -161.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.284 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 211' ' ' SER . 47.0 p90 -78.73 -47.37 16.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.004 0.431 . . . . 0.0 110.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.3 m -81.09 -26.12 36.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.242 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 209' ' ' ASP . 22.9 mt -82.44 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 209' ' ' ASP . . . -58.13 -30.23 66.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.565 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 41.3 tt0 -72.45 -36.69 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.42 59.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.457 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -75.15 -56.97 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.49 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CG ' ' CE1' ' A' ' 149' ' ' PHE . 1.1 p90 -75.14 -39.53 60.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -47.87 -35.94 11.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.119 0.485 . . . . 0.0 110.605 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -23.56 12.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.498 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.31 52.59 26.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.368 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.21 38.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.128 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.4 p -154.52 -177.97 6.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -86.4 39.54 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.357 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.18 112.82 0.45 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 116' ' ' ILE . 26.4 m -144.66 105.12 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 23.6 mt -88.3 144.88 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.658 ' HB2' HD11 ' A' ' 116' ' ' ILE . 2.0 t30 -120.16 164.3 16.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -130.74 178.61 17.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.826 2.35 . . . . 0.0 112.238 -179.791 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.811 0.339 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.62 151.28 17.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 315' ' ' PRO . 15.8 m -105.0 136.39 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.134 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 161.14 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.424 HG11 ' OE2' ' A' ' 322' ' ' GLU . 10.7 p -78.06 150.62 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.881 HD13 ' CB ' ' A' ' 255' ' ' SER . 1.3 mt -60.41 158.76 27.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.38 -173.98 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.904 2.402 . . . . 0.0 112.077 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 254' ' ' PRO . 43.7 p -116.8 150.15 38.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 250' ' ' PHE . 44.1 p90 -159.04 112.03 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.89 11.48 7.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.379 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.74 41.39 6.01 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.96 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -156.55 90.65 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.694 0.283 . . . . 0.0 111.024 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' A' ' 249' ' ' THR . 6.6 Cg_exo -73.74 85.07 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.852 2.368 . . . . 0.0 112.164 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.881 ' CB ' HD13 ' A' ' 247' ' ' LEU . 18.6 p 57.08 176.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 13.2 tttm -92.1 142.09 25.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.2 Cg_exo -79.58 153.78 23.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.632 2.222 . . . . 0.0 111.967 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 330' ' ' MET . 11.8 t80 -153.62 107.34 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.94 99.91 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -102.36 63.28 0.47 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.555 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 64' ' ' HIS . 10.8 p -87.92 144.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.31 . . . . 0.0 110.888 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -111.72 128.91 56.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.949 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.2 m -93.27 131.44 38.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.22 149.87 21.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -79.95 111.13 3.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 266' ' ' ILE . 8.4 tp -135.16 104.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -96.86 116.38 29.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.575 ' H ' ' HB3' ' A' ' 77' ' ' ALA . . . -93.01 -23.49 18.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.39 -30.6 52.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -82.1 155.66 69.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 61.46 2.57 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.393 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -165.17 31.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -75.07 -33.41 61.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -40.03 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.87 70.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.39 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.06 -39.11 83.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.48 -59.27 5.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 280' ' ' LEU . 2.3 tt -59.4 -31.3 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.05 -31.71 73.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -115.77 27.39 9.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -107.15 -64.54 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -100.08 -55.65 2.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.804 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 285' ' ' LEU . 3.8 mm? -74.98 64.34 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.4 t -146.23 151.58 37.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.3 -31.43 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.65 -37.66 49.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -87.62 -56.55 2.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.913 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -43.74 65.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.739 0.304 . . . . 0.0 111.208 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 296' ' ' ASP . . . -76.8 -34.78 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.814 HG13 ' HG3' ' A' ' 297' ' ' LYS . 21.8 t -69.55 -30.15 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.206 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -58.87 -28.31 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -113.68 -43.07 3.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.993 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.445 ' OD2' ' HB1' ' A' ' 292' ' ' ALA . 91.5 m-20 -60.12 -69.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.923 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.814 ' HG3' HG13 ' A' ' 293' ' ' VAL . 3.7 pttt -124.16 72.38 55.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.988 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.46 107.16 2.33 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.629 2.219 . . . . 0.0 112.326 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 300' ' ' GLY . 0.9 OUTLIER -135.1 -55.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.985 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.609 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 159.87 120.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.28 127.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 302' ' ' VAL . 10.9 p -178.34 112.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -108.87 39.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.645 HD13 ' CD2' ' A' ' 307' ' ' TYR . 6.9 mt -133.89 156.93 47.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.421 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -93.41 -55.24 3.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.8 t -66.04 -48.06 72.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 304' ' ' LEU . 4.4 m-85 -59.47 -27.2 65.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.49 -28.73 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -49.51 77.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.952 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.85 -42.04 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 307' ' ' TYR . 4.5 mm? -62.1 -20.85 64.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 317' ' ' ILE . . . -52.0 -25.95 9.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.391 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -27.56 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.707 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 3.7 m-20 -58.81 158.59 15.74 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 244' ' ' VAL . 35.5 Cg_exo -61.26 -57.96 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.714 2.276 . . . . 0.0 112.665 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -58.92 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.409 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 312' ' ' ALA . 3.0 mp -52.22 -25.27 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.625 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -58.59 -51.7 68.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.22 -28.9 42.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.887 HG21 HG11 ' A' ' 110' ' ' VAL . 24.5 m -58.37 -43.6 88.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -29.85 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.424 ' OE2' HG11 ' A' ' 246' ' ' VAL . 4.5 tt0 -77.6 -54.7 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.31 -30.21 66.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.22 -29.1 60.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -58.74 -30.69 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -145.53 41.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.65 164.06 41.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -135.03 158.24 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 329' ' ' ILE . 4.7 tp -77.47 116.94 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.455 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 0.2 OUTLIER -55.22 -61.29 6.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 330' ' ' MET . 18.8 Cg_endo -59.1 -164.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 0.0 112.416 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 333' ' ' ILE . 2.9 m120 70.0 69.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.625 HG23 ' O ' ' A' ' 332' ' ' ASN . 0.8 OUTLIER -161.59 60.75 1.22 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.61 -45.56 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.589 2.193 . . . . 0.0 112.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.91 -34.92 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 23.9 mmt -57.14 -23.76 49.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 340' ' ' TRP . 17.6 p -59.8 -24.92 64.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.75 -29.6 45.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.82 0.343 . . . . 0.0 111.302 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.438 ' CE1' ' HB ' ' A' ' 183' ' ' VAL . 23.2 t80 -73.75 -23.7 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.403 ' CE3' ' O ' ' A' ' 337' ' ' SER . 0.0 OUTLIER -42.38 -29.37 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.833 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.2 -37.41 87.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -74.91 -26.12 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.468 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.69 -29.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.35 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.59 -60.85 2.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 37.2 m -50.0 -29.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.84 -54.44 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.382 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.9 t -79.17 -58.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.029 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.5 tp -47.34 -31.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.719 0.295 . . . . 0.0 111.515 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.31 -55.8 30.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -54.41 -26.8 32.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.343 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.11 -10.74 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.569 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.9 m -104.39 -31.27 9.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.95 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 108.53 -24.48 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -97.52 39.93 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 356' ' ' THR . 0.8 OUTLIER -79.69 165.03 23.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.9 OUTLIER -162.84 95.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.663 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.8 t -48.04 -27.82 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.17 -54.46 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -80.25 -25.94 39.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.79 -42.9 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 189' ' ' LYS . 1.5 tt -82.37 -54.82 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.458 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -55.87 20.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.524 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.81 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -59.92 -47.03 87.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.505 ' O ' HD12 ' A' ' 368' ' ' ILE . 3.2 tt0 -58.84 -56.2 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 9.4 t -58.38 -29.5 66.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -57.26 -29.84 64.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 365' ' ' GLN . 7.4 mt -64.32 -36.82 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -65.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 40.7 mttp . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.826 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.8 0.333 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.28 27.41 73.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -82.24 134.66 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 276' ' ' ALA . 6.4 mt -137.72 116.11 11.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 57' ' ' PRO . 10.7 p -96.96 107.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.694 HD13 HD22 ' A' ' 20' ' ' LEU . 1.6 pp -98.67 114.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.656 ' HB2' HG23 ' A' ' 60' ' ' ILE . 67.2 m95 -96.75 112.1 23.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' HB ' ' CE2' ' A' ' 61' ' ' PHE . 16.9 tt -143.65 158.65 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -175.12 99.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.32 102.82 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.54 44.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 110.72 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.82 -166.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.24 12.72 8.05 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.725 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.617 ' CE2' HG13 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -81.13 -59.53 2.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.09 -28.86 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.81 -48.9 69.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.523 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mp -77.48 -31.28 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.04 71.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -55.91 27.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.31 -31.02 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.088 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.09 -28.07 56.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -60.91 -30.81 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -74.82 -33.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.572 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.7 m-85 -66.56 -56.31 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.776 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 11.7 pt-20 -58.32 -28.46 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 0.0 110.557 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.07 -25.78 47.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.214 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 31' ' ' THR . 17.6 t0 -54.01 -56.54 16.94 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.69 37.44 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.594 177.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.857 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.91 43.52 0.02 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 117.857 -2.116 . . . . 0.0 115.84 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.1 mm -136.94 152.67 28.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 118.064 0.932 . . . . 0.0 111.287 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -142.22 129.2 20.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.85 105.81 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 113.84 27.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.809 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.617 HG13 ' CE2' ' A' ' 17' ' ' TYR . 10.8 p -100.35 140.89 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.55 160.28 40.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.29 147.38 36.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.94 125.7 11.22 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.365 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -173.73 -68.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -92.05 0.05 57.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.391 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.639 HD12 ' CE3' ' A' ' 10' ' ' TRP . 0.5 OUTLIER -56.48 -28.44 59.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.107 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.79 -43.47 76.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -98.39 -26.27 14.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -77.0 -24.57 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.141 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.567 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 68.8 t80 -52.87 -56.08 26.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.308 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.2 Cg_endo -63.71 -17.59 60.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.28 1.987 . . . . 0.0 112.448 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -89.67 -46.48 8.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.8 t -90.45 9.88 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -79.56 -47.5 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.24 79.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.6 p -85.17 -38.45 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.52 43.9 2.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -62.06 -31.0 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.57 -79.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.577 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 8' ' ' VAL . 38.0 Cg_endo -66.21 130.22 23.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.585 2.19 . . . . 0.0 112.323 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -175.93 71.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.54 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.7 mt -123.2 111.44 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 10' ' ' TRP . 2.0 mp -129.61 138.51 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.386 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -129.81 128.79 43.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -166.35 102.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 111.988 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . 54.33 166.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.881 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 97' ' ' VAL . 24.1 t-80 -77.22 -60.12 2.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.998 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -44.9 76.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.093 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -56.79 -23.0 40.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -99.68 -56.66 2.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -18.39 50.76 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.748 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.37 -38.78 4.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.654 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -97.96 -54.84 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.792 ' HB1' HD22 ' A' ' 76' ' ' LEU . . . -58.12 -30.79 66.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -70.5 -21.57 62.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 p -107.38 -26.31 11.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.918 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.25 -87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.635 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.5 pp 177.41 46.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 ' HB1' ' A' ' 71' ' ' ALA . 9.0 mp -80.05 137.66 36.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.59 121.74 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -58.89 159.89 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.8 pt -115.04 170.54 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 p -137.15 90.97 15.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.72 -176.14 3.09 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.585 2.19 . . . . 0.0 112.434 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.22 -176.17 3.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.85 83.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.27 32.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.418 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -80.2 -59.26 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.427 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -72.53 -24.73 61.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.816 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -76.33 -18.57 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.411 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -76.96 -67.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.89 151.01 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -97.63 156.35 36.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 52.6 Cg_exo -52.82 -24.77 24.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.656 2.237 . . . . 0.0 112.489 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.87 -62.51 1.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.031 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -65.05 -25.93 68.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 98' ' ' ARG . 3.1 m0 -57.91 -49.75 75.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.38 -26.83 0.91 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 97' ' ' VAL . . . -54.65 -43.6 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.641 HG21 ' HD3' ' A' ' 107' ' ' PRO . 5.3 m -158.78 71.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.887 0.375 . . . . 0.0 111.511 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.759 ' CZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -145.21 109.14 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.804 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.53 174.74 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.16 62.56 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.31 27.94 5.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -145.36 101.2 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.759 HD11 ' CZ ' ' A' ' 98' ' ' ARG . 9.5 tp -114.17 99.45 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -139.71 40.0 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.075 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.97 128.76 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.27 111.02 15.31 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.771 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.641 ' HD3' HG21 ' A' ' 97' ' ' VAL . 98.6 Cg_endo -79.6 139.23 14.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.44 2.093 . . . . 0.0 112.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 tt -166.51 39.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.18 109.31 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 302' ' ' VAL . 12.5 p -89.29 124.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.15 132.99 46.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.917 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.18 176.52 12.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.66 137.12 40.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 m -164.71 -176.06 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 ' OG1' ' A' ' 245' ' ' THR . 0.2 OUTLIER -96.2 152.53 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.768 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 243' ' ' GLY . 22.9 mm -100.8 147.72 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -120.0 126.56 51.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.0 155.4 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -75.73 -30.86 59.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.97 62.95 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 122' ' ' LEU . 20.9 tp -175.85 39.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.908 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -156.88 151.43 20.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 223' ' ' ALA . 55.6 Cg_endo -70.15 160.39 49.76 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.256 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.13 164.17 25.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.777 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.02 136.38 40.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.454 2.102 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.4 -171.52 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.533 2.156 . . . . 0.0 112.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -109.58 -36.41 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -160.04 172.11 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.472 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -59.09 -24.71 63.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -76.78 -25.3 53.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.61 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -89.37 -32.66 17.2 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.647 HG22 ' HD3' ' A' ' 133' ' ' PRO . 17.9 tt -56.43 -32.78 14.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.647 ' HD3' HG22 ' A' ' 132' ' ' ILE . 15.1 Cg_exo -69.49 -42.39 3.72 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.278 1.985 . . . . 0.0 112.198 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.03 64.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.248 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 123' ' ' PRO . 5.3 tp -58.89 -30.78 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -47.74 84.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -58.53 -31.73 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -54.18 48.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 146' ' ' ALA . 5.6 mt -70.85 -40.56 72.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.948 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -27.6 65.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.09 -25.28 63.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -109.12 -75.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.53 39.84 0.16 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.403 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.57 -174.89 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' HD13 ' A' ' 139' ' ' LEU . 37.7 m -150.19 162.05 41.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.723 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -111.77 33.49 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER 178.93 125.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.623 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.638 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 1.8 mtt -170.09 106.18 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.64 177.35 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.76 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.449 ' N ' ' HB1' ' A' ' 213' ' ' ALA . 13.0 m-80 -45.55 167.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.425 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 HG12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -134.15 -45.55 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.674 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.455 ' OE1' ' HB1' ' A' ' 206' ' ' ALA . 78.9 mt-30 -95.52 39.54 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.98 170.73 5.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.76 166.17 21.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.59 2.194 . . . . 0.0 112.445 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.02 28.6 17.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -120.88 -59.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 1.026 HG23 HD13 ' A' ' 195' ' ' LEU . 62.2 m -73.11 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.512 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -64.03 -55.42 32.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.5 Cg_endo -64.2 -27.17 64.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.288 1.992 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.728 HD13 ' CD2' ' A' ' 195' ' ' LEU . 1.1 tt -71.94 -56.48 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.569 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' THR . 2.2 tt -76.01 -9.9 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.289 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -78.85 -23.54 44.91 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.72 0.295 . . . . 0.0 111.306 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.83 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -122.26 39.97 3.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.34 -41.94 3.32 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.504 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.7 -48.46 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 62.36 175.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.41 -34.58 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -104.99 30.69 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -103.66 175.24 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.64 74.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.069 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.51 66.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -71.34 -41.93 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.91 -31.89 70.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 -46.19 15.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.04 63.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 361' ' ' LEU . 3.9 tp -60.58 -49.1 78.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.3 m -60.79 -34.55 74.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.3 -46.89 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 1.026 HD13 HG23 ' A' ' 157' ' ' THR . 3.3 mt -58.91 -47.35 85.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.4 t -64.23 -48.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.84 -35.42 78.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.15 -41.21 92.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.649 HG12 HD23 ' A' ' 151' ' ' LEU . 21.6 mt -76.55 -30.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -31.65 72.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.06 18.34 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.1 -76.6 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.789 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -115.23 -13.42 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 ttt 70.02 -66.04 0.29 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -102.67 128.46 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.455 ' HB1' ' OE1' ' A' ' 152' ' ' GLN . . . -59.11 87.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.61 -29.47 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 t -78.14 108.83 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 211' ' ' SER . 2.8 p30 -94.12 -148.21 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 211' ' ' SER . 38.4 p90 -78.68 -51.72 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD2' ' A' ' 210' ' ' TYR . 88.6 p -62.34 -25.25 67.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.036 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.1 mm -82.01 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.449 ' HB1' ' N ' ' A' ' 150' ' ' ASN . . . -60.29 -30.53 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -66.44 -28.97 69.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.37 -25.06 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.336 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -52.45 -56.79 12.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 225' ' ' THR . 51.2 t80 -76.29 -36.74 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.76 -5.67 44.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.647 0.26 . . . . 0.0 110.935 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 221' ' ' GLU . . . -172.01 -78.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.321 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 0.9 OUTLIER 163.48 100.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 110.49 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 145' ' ' SER . 4.7 p -109.32 -177.41 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 38.96 0.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -146.66 111.64 5.37 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.934 0.397 . . . . 0.0 111.143 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -144.56 104.71 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 37.0 mt -115.26 142.67 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -144.04 111.64 6.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.44 62.03 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.56 2.173 . . . . 0.0 112.372 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.776 0.322 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -124.26 165.88 17.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.71 136.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.473 ' OG1' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -123.48 149.67 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.931 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.441 HG13 ' ND2' ' A' ' 323' ' ' ASN . 21.5 t -91.35 150.57 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.585 ' H ' HD12 ' A' ' 247' ' ' LEU . 4.2 mp -60.05 158.77 24.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.818 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.2 166.04 23.09 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.875 2.383 . . . . 0.0 112.168 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -95.61 177.55 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.446 ' H ' HG22 ' A' ' 249' ' ' THR . 46.2 t80 -159.31 111.9 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.2 mttm 59.95 20.51 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.71 44.91 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.621 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -156.37 90.83 2.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.649 0.261 . . . . 0.0 110.864 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.21 159.39 22.64 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.587 2.191 . . . . 0.0 112.296 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.8 p -67.19 -175.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.484 ' CG ' ' HB1' ' A' ' 162' ' ' ALA . 20.0 mmtp -107.29 94.31 11.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.67 151.14 21.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.461 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 331' ' ' PRO . 3.8 t80 -108.13 82.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.91 151.81 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.84 171.75 29.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.81 144.95 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.674 0.274 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.1 mp -78.3 105.25 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.8 m -79.79 116.55 20.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.288 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -101.57 155.3 18.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.597 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.449 ' N ' ' CZ ' ' A' ' 67' ' ' PHE . . . -146.17 172.13 26.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.939 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.724 HD11 ' CD ' ' A' ' 273' ' ' LYS . 11.3 tt -113.68 159.74 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.669 0.271 . . . . 0.0 110.777 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 2.1 t-20 -116.47 108.01 15.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 267' ' ' ASN . . . 78.94 -53.71 0.45 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.415 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 66.73 6.71 4.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.504 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 3.3 t -67.45 -60.53 5.6 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.306 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 270' ' ' SER . 12.0 Cg_endo -55.88 -163.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.551 2.167 . . . . 0.0 112.442 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 55.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.052 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.724 ' CD ' HD11 ' A' ' 266' ' ' ILE . 0.7 OUTLIER -73.25 -29.66 62.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.817 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.24 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -74.17 -48.78 26.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -66.69 -32.08 73.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -78.86 -40.18 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.56 -36.59 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.38 -38.79 85.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.65 -27.66 67.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.61 -22.19 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.17 5.66 29.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.31 -48.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 110.991 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.766 HD21 ' NZ ' ' A' ' 297' ' ' LYS . 1.3 mt -89.31 53.42 2.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.774 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.6 p -154.71 174.9 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -21.03 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.56 -54.67 7.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.11 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.59 -45.75 4.21 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.773 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.577 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -54.27 -30.21 49.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.142 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.61 -38.09 70.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.5 67.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.942 HG13 ' CB ' ' A' ' 297' ' ' LYS . 85.9 t -58.12 -30.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.179 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.36 -13.23 60.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -114.31 -25.24 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -119.47 -81.65 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.693 0.282 . . . . 0.0 111.514 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.942 ' CB ' HG13 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -49.53 164.93 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.354 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.39 147.16 69.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.548 2.166 . . . . 0.0 112.275 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.479 ' N ' HD22 ' A' ' 299' ' ' LEU . 3.4 mm? -79.13 -25.84 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.108 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -79.8 114.34 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 317' ' ' ILE . . . -169.89 137.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 110' ' ' VAL . 28.5 m -155.82 108.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -146.08 39.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.1 mt -153.66 165.45 35.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -38.59 3.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.014 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 p -79.5 -47.82 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -60.65 -21.9 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.527 ' OE2' HD21 ' A' ' 311' ' ' LEU . 35.1 mm-40 -51.02 -28.21 9.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.273 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.19 -47.85 59.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.21 -54.15 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 317' ' ' ILE . 4.5 pp -62.51 -17.75 60.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.295 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -53.71 -23.35 11.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.614 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.34 46.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.774 0.321 . . . . 0.0 111.301 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.615 ' HB3' HG22 ' A' ' 317' ' ' ILE . 0.4 OUTLIER -124.14 173.73 4.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.783 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -90.09 -51.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.839 2.359 . . . . 0.0 113.725 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -81.3 -59.44 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.635 ' CD1' HD13 ' A' ' 311' ' ' LEU . 16.7 tt -56.27 -31.58 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 314' ' ' ASP . . . -76.52 -33.08 58.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.47 75.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 44.9 p -76.76 -30.94 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -32.15 70.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.06 -52.7 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.441 ' ND2' HG13 ' A' ' 246' ' ' VAL . 16.0 m-20 -69.58 -30.45 68.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.25 71.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.32 -29.24 69.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -118.43 59.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 178.39 -154.19 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.92 166.23 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.5 101.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 53.66 87.62 0.14 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 258' ' ' PHE . 47.8 Cg_endo -68.77 161.47 45.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.492 2.128 . . . . 0.0 112.228 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -157.39 91.24 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 12.0 pt -152.59 132.15 7.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 -23.56 22.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.468 2.112 . . . . 0.0 112.411 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -55.94 -43.81 77.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 1.6 mtp -69.17 -35.36 76.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.2 p -62.57 -35.55 79.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.7 -33.87 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.763 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -73.49 -27.28 61.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -42.74 81.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.99 -35.43 42.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.51 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.3 t -59.59 -30.13 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.878 ' HG3' HD12 ' A' ' 348' ' ' ILE . 4.2 tpt180 -58.89 -60.81 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 0.9 OUTLIER -67.45 -27.5 67.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.85 -59.72 4.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.651 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 350' ' ' ALA . 20.1 t -79.36 -59.1 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.878 HD12 ' HG3' ' A' ' 344' ' ' ARG . 21.9 mt -48.19 -58.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 345' ' ' THR . 15.2 t-20 -55.47 -36.21 66.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 111.179 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -56.02 -30.11 61.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.21 -10.15 55.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.553 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.6 p -67.58 -25.14 65.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 111.95 -27.82 9.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.18 39.34 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 124.9 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.805 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 359' ' ' GLU . 8.2 t -115.56 177.92 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.966 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 192' ' ' LEU . 22.0 t -72.31 -35.15 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -45.98 88.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.445 ' H ' HG23 ' A' ' 356' ' ' THR . 23.1 mt-10 -79.96 -43.4 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -59.99 -38.51 82.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.47 ' O ' HD13 ' A' ' 361' ' ' LEU . 0.3 OUTLIER -82.1 -48.82 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -62.81 -44.06 97.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.35 -26.52 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -51.81 -56.86 11.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.388 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.6 pt20 -56.55 -30.51 63.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 13.6 m -67.66 -43.2 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.407 ' HG3' HG13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -73.89 -29.82 62.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.995 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 365' ' ' GLN . 16.8 mt -75.06 -44.93 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.99 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 23.3 m -79.65 -67.94 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.775 0.321 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.04 85.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -149.27 158.7 44.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.481 HD22 HD11 ' A' ' 59' ' ' ILE . 9.2 mt -136.58 155.35 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.947 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.772 HG23 ' HG2' ' A' ' 57' ' ' PRO . 28.3 t -123.91 102.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mt -94.88 114.98 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -94.91 124.46 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pt -134.66 149.06 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.186 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.73 94.27 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.44 27.94 53.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.64 ' O ' HD22 ' A' ' 299' ' ' LEU . 1.3 m-20 -75.31 -29.98 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.706 0.288 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 299' ' ' LEU . 18.0 tttt 62.75 118.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 48.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.56 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -78.78 -34.72 45.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.36 -42.0 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.695 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.37 -33.75 30.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 37' ' ' VAL . 1.2 tt -74.57 -31.56 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.12 77.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.271 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -76.96 -32.2 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 27' ' ' PHE . 27.9 t -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.104 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.42 -38.04 89.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -74.11 -26.74 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -44.15 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 23' ' ' VAL . 67.2 m-85 -62.24 -56.67 16.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -59.37 -27.42 65.95 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 110.131 179.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -27.3 1.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -69.28 -56.87 6.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.56 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.031 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.25 49.05 0.01 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 118.115 -1.993 . . . . 0.0 115.513 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -139.56 95.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 118.103 0.951 . . . . 0.0 111.628 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -99.95 106.38 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.11 146.34 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.01 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 20' ' ' LEU . 5.8 m -116.63 118.26 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -143.9 162.8 35.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -87.16 154.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.51 130.01 20.1 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.595 2.197 . . . . 0.0 112.277 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.34 -60.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -79.41 -7.58 58.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.33 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' C ' HD12 ' A' ' 43' ' ' LEU . 4.6 pp -55.62 -24.93 36.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.78 -34.39 62.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.067 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.3 -29.94 12.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.0 tttt -69.27 -31.18 69.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -56.36 -60.76 8.13 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.4 Cg_endo -63.77 -16.83 57.09 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.423 2.082 . . . . 0.0 112.513 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.86 -44.5 18.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.792 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 46' ' ' LYS . 31.1 m -90.21 -24.36 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.2 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.89 70.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 53' ' ' THR . . . -63.24 -30.78 71.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.059 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.84 128.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.64 72.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.24 -30.99 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.28 -168.81 12.36 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HG2' HG23 ' A' ' 8' ' ' VAL . 55.8 Cg_endo -70.23 -171.61 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.314 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 175.09 103.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.481 HD11 HD22 ' A' ' 7' ' ' LEU . 32.2 mt -143.6 136.25 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.25 141.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 12.7 m-85 -108.79 144.67 36.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.606 ' N ' HD23 ' A' ' 262' ' ' LEU . 1.3 m95 -165.62 173.6 10.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.57 -174.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.344 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' HB2' HG23 ' A' ' 261' ' ' VAL . 57.1 t-80 -77.69 -45.01 26.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.3 -28.81 44.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.59 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -54.75 -24.17 21.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.217 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 4.3 m-85 -101.11 -28.5 12.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.965 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.74 -23.13 49.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.655 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.4 -50.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.3 -57.51 3.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -58.71 -30.6 67.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -28.42 64.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 p -70.26 -26.74 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.34 77.68 1.07 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.797 ' O ' HD22 ' A' ' 76' ' ' LEU . 7.8 tp -167.48 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.797 HD22 ' O ' ' A' ' 75' ' ' LEU . 1.3 mm? -141.5 127.82 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.884 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -59.79 138.48 57.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' HG23 ' A' ' 104' ' ' ILE . 17.7 tt0 -89.04 157.96 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mm -111.3 141.49 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 148.56 40.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.78 168.2 19.61 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.725 2.284 . . . . 0.0 112.372 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.95 153.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -31.65 70.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 -23.28 64.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CE2' HD22 ' A' ' 89' ' ' LEU . 1.4 t80 -79.3 -59.16 2.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 8.3 pt20 -62.55 -24.73 67.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.66 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -68.19 -32.8 73.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 304' ' ' LEU . 8.9 mtmm -104.96 -63.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.07 113.53 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.825 ' O ' HG22 ' A' ' 93' ' ' THR . 15.3 m-85 -62.25 143.89 95.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.51 -24.94 30.4 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.468 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -57.03 -34.72 68.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.076 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 90' ' ' TYR . 8.8 t -86.76 -28.23 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.982 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' A' ' 86' ' ' GLN . 4.4 m0 -59.74 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.69 -29.25 70.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 330' ' ' MET . . . -59.63 -29.6 68.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.203 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.926 HG11 ' HD3' ' A' ' 107' ' ' PRO . 27.0 m -129.77 61.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.38 81.44 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -79.26 98.07 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.77 31.51 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.47 50.65 7.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -131.32 129.74 41.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.65 40.02 1.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.0 pp -97.78 39.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 178.22 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 6.7 p90 -118.73 129.14 25.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.926 ' HD3' HG11 ' A' ' 97' ' ' VAL . 98.0 Cg_endo -79.8 168.14 19.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.606 2.204 . . . . 0.0 112.283 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -175.01 39.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.21 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.916 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 174.18 108.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.982 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 259' ' ' VAL . 10.4 p -90.09 134.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.05 164.35 28.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.62 10.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.604 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -146.11 157.54 43.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -175.95 5.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mt -92.62 146.15 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -73.77 155.94 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.05 0.452 . . . . 0.0 111.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -135.78 114.71 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -133.77 -177.49 4.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.35 76.27 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -156.05 -50.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 221' ' ' GLU . 0.6 OUTLIER -148.06 39.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.27 91.13 47.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.37 159.42 53.42 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.444 2.096 . . . . 0.0 112.27 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -102.2 95.77 6.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 159.48 52.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.59 49.42 3.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.678 2.252 . . . . 0.0 112.702 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 55.47 32.9 19.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.07 140.44 52.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -32.35 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.643 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.71 17.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.485 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.36 -17.09 58.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 mt -73.47 -53.0 4.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.1 Cg_exo -52.15 -36.74 67.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.312 2.008 . . . . 0.0 112.428 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -32.87 56.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 139' ' ' LEU . 60.5 mt -77.02 -31.91 56.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -76.6 -31.07 57.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -71.75 -32.16 67.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.46 -40.69 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.799 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 6.7 mt -73.15 -53.24 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -57.77 -24.63 58.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.37 -26.13 60.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -109.76 -70.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.62 39.85 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -174.89 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.725 0.297 . . . . 0.0 110.787 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.474 ' C ' HD13 ' A' ' 139' ' ' LEU . 1.4 m -157.13 171.24 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.799 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -142.94 49.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 4.4 tt 170.62 120.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.03 106.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -172.24 167.04 5.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 148.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -178.64 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.811 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -133.95 39.93 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 154' ' ' PRO . 6.8 pt-20 -87.65 173.41 6.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.452 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 88.7 Cg_endo -85.89 118.75 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.435 2.09 . . . . 0.0 112.617 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 61.52 80.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.614 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.1 p90 -121.13 -48.25 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.4 t -72.8 -35.27 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.349 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -49.27 -55.81 19.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.326 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.0 Cg_endo -78.7 -18.31 11.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.627 2.218 . . . . 0.0 112.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 156' ' ' PHE . 2.3 mm? -80.39 -56.7 4.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.174 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 167' ' ' TYR . 1.8 pt -80.6 1.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -88.13 -54.54 4.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 253' ' ' GLN . . . 62.67 -81.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -56.8 2.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 100.67 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.579 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.95 87.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.82 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 33.7 t80 -171.49 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 -179.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 167' ' ' TYR . 17.2 m -74.56 42.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.808 0.337 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -110.93 -7.86 14.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.723 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.58 -173.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.63 63.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.79 -49.34 79.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.36 -45.18 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HG3' HD21 ' A' ' 361' ' ' LEU . 20.4 mtpt -60.2 -58.59 7.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.52 87.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.12 -53.34 18.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.598 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 196' ' ' VAL . 3.3 tt -60.05 -42.68 94.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.9 m -59.46 -30.44 68.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -76.15 -47.87 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -67.05 -50.02 63.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.767 HG11 HG21 ' A' ' 357' ' ' VAL . 12.0 p -56.49 -28.07 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.255 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.44 -54.6 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -59.0 -59.05 6.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.026 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -51.96 -25.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.37 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 196' ' ' VAL . 1.2 tptp -60.51 -59.97 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.517 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.18 20.99 18.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . 0.447 ' CE ' ' CD2' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -120.28 -68.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' ' 151' ' ' LEU . 27.4 m80 -81.16 -0.52 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.715 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -20.27 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.626 0.25 . . . . 0.0 111.288 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -142.52 37.93 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -162.28 84.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.72 57.71 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 208' ' ' THR . 11.5 t -57.4 108.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 212' ' ' ILE . 3.3 t0 -78.43 -156.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.721 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -78.38 -44.45 24.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.157 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.1 p -73.93 -25.1 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.173 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 209' ' ' ASP . 13.3 mt -82.05 -53.94 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.107 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.27 64.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.403 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 12.0 tm-20 -72.86 -42.62 63.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.423 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.16 -24.92 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.23 -56.66 11.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.681 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.94 ' CG ' HG23 ' A' ' 225' ' ' THR . 8.6 p90 -67.56 -30.93 70.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.749 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -79.9 -11.9 59.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -74.45 -24.04 59.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.687 0.279 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.65 -92.77 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.178 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.4 OUTLIER 165.54 91.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.607 0.241 . . . . 0.0 110.561 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.35 -177.89 3.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 38.59 0.66 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.52 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -154.11 101.87 2.43 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.044 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.94 HG23 ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -144.6 104.93 4.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.191 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.906 HD13 ' CD2' ' A' ' 149' ' ' PHE . 3.9 mp -106.26 119.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.229 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -139.18 162.89 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.14 -150.91 17.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 112.318 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.834 0.349 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -156.92 175.97 34.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.36 136.43 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 146.52 52.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.82 150.7 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.95 149.18 74.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.52 -174.61 2.35 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.185 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -127.84 177.69 6.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.499 ' H ' HG22 ' A' ' 249' ' ' THR . 24.4 t80 -158.27 111.74 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.49 12.64 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.26 5.53 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.736 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.603 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 3.4 pt20 -156.35 90.49 2.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.784 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.453 ' HB3' HG23 ' A' ' 249' ' ' THR . 91.9 Cg_endo -86.72 150.28 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.889 2.392 . . . . 0.0 112.618 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 69.5 m -55.24 150.5 10.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -109.41 89.5 7.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.76 125.3 6.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.578 2.185 . . . . 0.0 112.391 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -79.98 172.04 14.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 110' ' ' VAL . 10.5 p -94.88 138.13 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.72 129.97 10.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 64' ' ' HIS . 30.8 m -122.22 144.78 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -92.57 115.67 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.461 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' TRP . 8.9 m -94.59 133.73 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.475 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -101.67 126.07 48.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.603 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 76' ' ' LEU . . . -114.91 159.04 13.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.743 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.884 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.5 tt -140.2 136.38 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -51.37 125.56 14.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.46 -29.86 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.249 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.74 46.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.7 m -96.13 112.81 60.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.39 -26.98 12.74 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.448 2.099 . . . . 0.0 112.437 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -120.22 65.53 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.402 ' NZ ' ' HB1' ' A' ' 77' ' ' ALA . 7.2 tttp -75.04 -53.98 7.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.28 -32.17 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -73.0 -49.17 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.73 -42.96 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -59.86 -42.68 94.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.97 -30.51 58.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.513 ' CE1' HD23 ' A' ' 275' ' ' LEU . 1.8 m-85 -64.16 -59.2 4.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 281' ' ' GLU . 4.5 pp -58.86 -27.0 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.647 ' N ' HD12 ' A' ' 280' ' ' LEU . 1.1 mm-40 -74.33 -29.26 61.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.54 27.47 9.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 27' ' ' PHE . 14.6 m-85 -148.2 -74.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.83 -31.38 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.48 72.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.76 164.42 38.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -27.86 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -77.54 -27.68 51.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.125 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -105.62 -54.46 0.73 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.711 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.39 -30.71 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.152 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -72.28 -40.71 67.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.65 81.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.08 -33.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -80.15 -55.06 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -59.72 -57.8 11.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.47 -34.4 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 299' ' ' LEU . 2.6 tptt -139.24 89.42 12.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 115.73 4.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.55 2.166 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -126.34 -43.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.88 123.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -86.07 90.13 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.15 79.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 306' ' ' SER . . . -139.08 78.17 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 304' ' ' LEU . 0.1 OUTLIER 40.59 -91.87 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.971 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -78.37 -41.26 33.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.784 0.326 . . . . 0.0 111.203 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.83 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 1.8 m -53.28 -25.16 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.234 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 311' ' ' LEU . 87.8 t80 -56.1 -44.67 79.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.35 -31.81 58.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -66.86 -48.22 69.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB2' ' HB1' ' A' ' 301' ' ' ALA . 71.4 mm-40 -71.19 -35.9 71.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 307' ' ' TYR . 3.4 mp -56.03 -23.06 30.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.1 71.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -176.8 74.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.16 139.16 19.85 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.34 -62.38 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.445 2.096 . . . . 0.0 112.352 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -60.78 -48.52 81.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.528 HG22 ' CE ' ' A' ' 321' ' ' MET . 42.2 mm -59.52 -29.91 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.48 71.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -78.46 -56.26 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.1 t -58.38 -27.27 64.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.528 ' CE ' HG22 ' A' ' 317' ' ' ILE . 7.8 mtt -56.23 -29.14 60.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.47 -57.41 12.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -78.36 -31.85 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.92 71.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -59.68 -32.24 70.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -109.37 38.88 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.2 179.59 24.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.578 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.76 -177.2 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.978 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -135.32 107.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 329' ' ' ILE . 3.4 mmt 60.66 155.77 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.975 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.31 -161.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.231 . . . . 0.0 112.256 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -170.39 -42.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 333' ' ' ILE . 3.3 tt -123.77 122.97 26.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.51 -21.23 34.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.088 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.35 -30.68 62.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -30.99 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 60.5 p -65.21 -41.74 94.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.93 74.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 343' ' ' VAL . 0.4 OUTLIER -67.72 -27.52 66.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.43 -32.21 62.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.88 -31.42 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 367' ' ' ARG . . . -76.71 -53.25 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.82 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 21.9 t -58.05 -30.04 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 348' ' ' ILE . 16.9 mtp180 -59.71 -54.4 46.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 69.0 p -49.78 -27.66 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -75.66 -54.28 7.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.47 -59.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.932 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.4 tt -49.62 -39.63 14.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.917 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.64 -28.6 36.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -59.61 -31.47 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.92 -10.2 59.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.517 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.0 p -67.57 -26.04 66.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.122 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 109.56 -24.34 20.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.568 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 39.55 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.44 114.14 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.765 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.2 OUTLIER -105.18 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 196' ' ' VAL . 21.6 t -72.28 -28.89 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.213 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 -37.48 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.22 -55.78 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.814 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -50.33 -36.49 32.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -82.35 -42.52 18.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -65.53 -55.67 16.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.8 -27.17 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.814 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.36 -54.91 29.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 369' ' ' THR . 1.4 tt0 -58.86 -30.44 67.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.4 m -59.47 -57.66 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 342' ' ' ALA . 24.1 ptt180 -58.37 -41.24 84.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.146 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 33.1 mm -71.96 -32.04 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 365' ' ' GLN . 17.4 p -108.52 35.45 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.89 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.854 0.359 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.8 72.19 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.66 141.58 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.713 HD22 ' CE1' ' A' ' 279' ' ' PHE . 2.7 mp -141.82 138.87 32.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.721 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 59' ' ' ILE . 44.9 t -115.22 113.53 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.094 0.474 . . . . 0.0 111.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt -99.15 133.89 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.1 m0 -94.71 111.95 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 tt -139.59 148.74 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.096 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -171.43 75.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.07 -112.34 1.4 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 178.38 58.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.849 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 296' ' ' ASP . 3.6 pttt -125.38 -97.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.006 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.81 80.76 0.28 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.596 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -61.94 -30.95 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -59.15 -28.38 66.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 293' ' ' VAL . . . -56.77 -51.59 55.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.637 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.73 -37.2 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.32 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -64.25 -56.09 17.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.521 HG12 ' ND2' ' A' ' 282' ' ' ASN . 21.3 t -69.37 -43.97 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.57 -27.69 64.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.616 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -32.87 70.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.59 -45.06 89.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.4 m-85 -63.9 -56.03 18.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 35' ' ' VAL . 8.7 mt-10 -53.91 -28.4 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.437 0.637 . . . . 0.0 110.59 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -78.09 -25.78 47.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.486 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' HB ' ' A' ' 31' ' ' THR . 4.4 t70 -52.65 -56.46 15.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.48 36.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.456 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.26 44.39 0.02 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.883 -2.103 . . . . 0.0 115.75 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 32' ' ' GLY . 3.4 mm -133.94 149.28 30.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 118.21 1.005 . . . . 0.0 111.377 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.56 137.4 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.861 HG22 ' OE2' ' A' ' 28' ' ' GLU . 30.0 m -130.55 129.78 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.85 134.63 54.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 9' ' ' ILE . 31.2 m -127.91 120.17 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.11 163.02 33.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -80.11 152.91 74.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.86 179.07 5.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.551 2.167 . . . . 0.0 112.449 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 76.67 -0.28 3.04 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.65 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 -48.83 2.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.2 -12.73 57.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.412 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -26.37 8.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.279 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.63 -51.12 9.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -71.81 -24.55 61.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -49.85 -60.46 5.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.316 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 36.1 Cg_endo -65.08 -15.35 49.96 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.432 2.088 . . . . 0.0 112.568 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.67 -40.95 12.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.961 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.28 -29.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.64 -30.97 71.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.77 66.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.1 m -100.26 -45.48 5.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.69 73.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -99.68 -28.86 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 0.0 111.085 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.29 -64.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.63 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' HG21 ' A' ' 8' ' ' VAL . 5.8 Cg_endo -48.96 115.3 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.823 2.349 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -175.32 39.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.803 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -145.25 129.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.516 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 10' ' ' TRP . 63.8 mt -141.5 142.72 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE2' ' HB1' ' A' ' 264' ' ' ALA . 51.0 m-85 -123.14 112.38 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.268 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -162.95 174.03 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.753 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.88 -173.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -76.86 -33.41 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.01 -29.28 63.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -56.98 14.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.074 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -66.34 -48.83 68.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.47 -17.87 54.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.719 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.77 -56.07 1.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -95.45 -54.45 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.032 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -55.67 -27.81 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.363 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -68.25 -22.33 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.9 p -95.82 25.63 4.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 75' ' ' LEU . . . 91.27 77.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.578 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -168.36 39.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.879 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.032 HD23 ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -158.3 136.55 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.922 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' N ' ' HB2' ' A' ' 268' ' ' ALA . . . -104.41 130.46 52.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' HG22 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -68.4 138.76 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.438 HD11 ' HG ' ' A' ' 103' ' ' LEU . 18.2 pt -83.66 162.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -89.2 147.74 39.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.66 110.96 2.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.613 2.209 . . . . 0.0 112.44 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -176.77 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -21.83 47.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.779 ' HB1' ' CH2' ' A' ' 94' ' ' TRP . . . -54.8 -23.16 16.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.551 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -59.22 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.382 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.2 -24.64 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.714 ' OD2' HD12 ' A' ' 89' ' ' LEU . 13.7 p-10 -73.94 -20.58 60.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.35 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 53.15 48.57 21.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.89 0.376 . . . . 0.0 111.255 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.714 HD12 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -102.12 155.49 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -96.32 145.0 28.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.16 -26.66 43.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.509 2.14 . . . . 0.0 112.345 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -56.62 -30.57 63.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -90.7 -29.76 17.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.779 ' CH2' ' HB1' ' A' ' 84' ' ' ALA . 34.1 m0 -70.1 -47.57 61.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -59.51 -30.71 68.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.6 83.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 97' ' ' VAL . 18.9 t -95.15 43.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -99.37 89.44 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 120.15 35.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 p30 44.43 38.66 2.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.13 31.12 78.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.642 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -145.62 160.05 42.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -105.8 93.23 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.601 ' HB ' HD13 ' A' ' 76' ' ' LEU . 4.5 pt -114.43 39.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.477 ' O ' HG11 ' A' ' 97' ' ' VAL . . . -176.25 125.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.73 116.23 57.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.81 133.82 10.46 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.466 2.11 . . . . 0.0 112.419 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 7.3 pt -156.07 39.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.045 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 169.58 102.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.95 HG22 HG21 ' A' ' 320' ' ' THR . 14.6 p -101.86 116.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.326 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -116.98 132.58 56.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.67 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.48 176.56 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.188 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.83 171.37 7.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 319' ' ' ALA . 0.2 OUTLIER -164.33 -177.41 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.904 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HG ' ' A' ' 247' ' ' LEU . 3.3 mt -109.6 149.88 29.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 pt -110.48 140.53 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.186 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.77 130.87 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.29 162.09 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.5 37.7 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -90.19 -35.13 15.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 121' ' ' LEU . 3.5 pp -157.73 39.98 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.533 ' CD2' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -137.55 131.07 17.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 157.78 41.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.257 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -65.08 110.77 4.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.6 140.29 86.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.477 2.118 . . . . 0.0 112.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.56 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.228 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.42 -39.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 130' ' ' GLU . 14.0 t -70.94 152.23 43.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.691 ' CE3' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -60.14 -23.56 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 128' ' ' THR . 33.4 mt-10 -45.26 -23.47 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HD13 ' A' ' 135' ' ' LEU . 4.8 pt-20 -48.78 -31.0 6.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.691 HD11 ' CE3' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -73.53 -62.58 1.14 Allowed Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.324 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 132' ' ' ILE . 82.9 Cg_exo -45.67 -34.42 11.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.232 1.955 . . . . 0.0 112.407 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.53 61.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 131' ' ' GLU . 9.1 mp -77.79 -28.77 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -43.42 75.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -68.73 -28.03 66.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.4 tt0 -81.83 -50.84 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 146' ' ' ALA . 19.5 mt -57.92 -55.83 29.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -58.72 -24.66 61.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -57.16 -25.51 59.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -111.21 -67.47 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.4 39.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -142.07 -177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD13 ' A' ' 139' ' ' LEU . 48.3 t -150.37 157.54 43.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.013 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.797 ' CB ' ' HB3' ' A' ' 223' ' ' ALA . . . -107.6 42.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER 176.84 115.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.77 106.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 226' ' ' ILE . 2.3 t80 -156.36 176.74 12.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -64.72 -169.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.82 HD12 HG23 ' A' ' 208' ' ' THR . 11.5 mt -148.81 -46.01 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.35 44.2 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -108.25 166.78 10.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 150.97 22.38 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.949 2.433 . . . . 0.0 112.173 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.31 55.24 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.449 ' O ' HD13 ' A' ' 160' ' ' LEU . 77.8 t80 -120.93 -49.57 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 161' ' ' ILE . 63.6 m -73.42 -42.84 61.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.52 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 9.8 t90 -55.72 -53.88 57.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.429 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.53 -24.17 42.47 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.17 1.913 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 195' ' ' LEU . 5.0 mp -81.57 -56.77 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 157' ' ' THR . 3.3 tt -67.27 -21.81 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -64.54 -30.35 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.201 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 250' ' ' PHE . . . -67.32 -25.16 65.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.286 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.55 -41.35 18.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.097 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.98 -82.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.596 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.09 -38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.551 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.595 ' OH ' HG11 ' A' ' 343' ' ' VAL . 38.8 t80 70.16 -65.69 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.062 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.444 HG21 ' CE1' ' A' ' 339' ' ' PHE . 27.4 t -94.08 -31.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 111.08 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.583 ' OD1' ' HB3' ' A' ' 364' ' ' ALA . 26.6 m-20 -123.52 72.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -128.92 -176.67 3.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.07 78.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.61 -52.06 32.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.522 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -62.92 -30.8 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -61.05 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 194' ' ' PHE . . . -77.77 -43.77 29.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -54.27 -26.21 35.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.761 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.754 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.4 tp -81.68 -58.17 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.769 0.319 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.7 t -64.2 -28.87 70.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.024 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.597 ' CE1' ' HB1' ' A' ' 190' ' ' ALA . 2.6 m-85 -56.99 -63.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.13 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 160' ' ' LEU . 4.3 mm? -62.41 -46.63 87.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.19 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 192' ' ' LEU . 36.4 t -59.3 -46.96 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.02 -36.44 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.46 -58.89 6.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.063 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 28.8 pt -49.84 -27.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -77.59 -31.7 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.991 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.7 18.32 22.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.399 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -41.75 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -114.56 -51.67 2.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 169.54 -75.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -156.39 153.03 28.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.746 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -65.13 77.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -164.95 31.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.82 HG23 HD12 ' A' ' 151' ' ' LEU . 17.3 p -61.98 139.98 58.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.528 ' H ' HD13 ' A' ' 212' ' ' ILE . 4.7 m-20 -108.76 -150.73 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.1 -53.0 7.43 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.105 0.479 . . . . 0.0 110.083 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 1.1 m -56.88 -24.42 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 212' ' ' ILE . 2.7 mp -81.94 -58.85 3.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.015 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.32 -30.42 70.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -22.6 38.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.443 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -47.75 -55.58 9.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.489 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.66 -54.94 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.931 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -47.38 -28.47 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -41.35 23.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -106.78 -23.58 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.773 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 55.01 46.74 76.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.41 43.02 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 111.23 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.77 -177.63 3.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.797 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . . . -82.82 38.67 0.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.894 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.577 ' HE2' ' HA ' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.8 99.22 0.11 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.04 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.51 105.31 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.807 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 23.7 mm -82.77 138.53 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.45 112.22 24.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -111.84 159.83 13.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.461 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.344 0.303 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 4.6 p90 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.796 0.331 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -151.7 150.76 22.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 315' ' ' PRO . 10.3 p -122.71 127.72 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.8 p -141.12 162.74 34.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.182 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 322' ' ' GLU . 15.8 m -86.6 150.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.045 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 247' ' ' LEU . 1.2 mp -59.76 151.68 61.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.71 -158.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.914 2.41 . . . . 0.0 112.343 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -77.94 177.82 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CB ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -152.36 111.54 3.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? 60.1 17.71 7.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 120.66 -24.95 7.42 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.684 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.61 140.04 18.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.31 169.04 21.97 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.449 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.5 m -58.31 -175.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.005 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -144.15 73.72 16.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.49 174.13 12.25 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.223 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -111.81 135.22 52.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' ILE . 21.5 t -77.97 154.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -107.66 77.99 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.612 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 m -88.81 132.09 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.756 0.313 . . . . 0.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 4.9 tp -79.29 127.48 32.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.003 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -91.32 110.52 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.764 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' CE2' ' A' ' 61' ' ' PHE . . . -126.79 117.71 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -177.61 -169.99 39.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.618 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 276' ' ' ALA . 3.9 mp -100.82 159.22 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 266' ' ' ILE . 53.5 p30 -88.79 158.2 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.624 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -97.46 29.08 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -100.64 -30.7 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 t -118.2 146.66 39.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 74.86 2.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.488 2.125 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 2.4 t30 -117.48 35.42 4.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -66.03 -48.97 69.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.57 -36.09 70.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mt -76.35 -29.68 57.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -58.37 -40.82 83.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -74.23 -29.38 61.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.09 -35.19 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.713 ' CE1' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 280' ' ' LEU . 3.7 mm? -60.38 -25.61 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -14.06 62.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.521 ' ND2' HG12 ' A' ' 23' ' ' VAL . 27.7 t30 -88.95 27.93 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.348 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.92 35.46 1.69 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 110.725 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.75 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -101.24 28.3 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.795 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 290' ' ' LEU . 5.9 tp -147.0 28.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.0 t -136.84 155.62 49.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -57.63 -20.99 36.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.305 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 292' ' ' ALA . 3.8 mt-10 -75.17 -38.13 61.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.418 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 286' ' ' THR . . . -119.64 -50.51 0.29 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.032 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 284' ' ' LEU . 25.1 tp -54.59 -55.14 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.809 0.338 . . . . 0.0 111.392 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.1 -32.93 44.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.734 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -77.17 -58.59 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 19' ' ' GLY . 28.8 t -82.03 -60.62 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.412 ' OD1' HD23 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -56.27 -21.65 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.879 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.765 ' O ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -111.76 -20.04 12.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.377 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 37.6 t70 54.68 90.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 64.65 165.9 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.6 144.63 79.37 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.504 2.136 . . . . 0.0 112.375 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 295' ' ' LYS . 2.5 pp -174.74 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 299' ' ' LEU . . . -119.21 160.79 14.11 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 317' ' ' ILE . . . -132.95 105.04 6.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.876 0.37 . . . . 0.0 111.391 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.549 HG21 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.99 44.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.198 0.523 . . . . 0.0 110.645 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.77 88.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.668 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER 77.17 115.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -55.28 -23.98 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.9 m -53.94 -52.41 60.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.36 -30.4 37.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.624 ' HG3' ' HB1' ' A' ' 301' ' ' ALA . 8.3 tt0 -59.14 -27.74 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -56.98 -37.18 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.62 -44.61 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 23.8 mt -62.53 -18.6 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.09 -25.87 9.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 111.502 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -58.4 -27.57 64.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 146.57 95.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.803 ' HA ' HG11 ' A' ' 244' ' ' VAL . 49.1 Cg_exo -55.8 -51.42 9.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.39 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 320' ' ' THR . 7.9 mtm180 -55.44 -56.26 22.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 301' ' ' ALA . 3.9 mm -52.92 -55.34 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.49 75.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 114' ' ' SER . . . -69.7 -56.56 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.95 HG21 HG22 ' A' ' 110' ' ' VAL . 32.9 p -62.97 -29.96 71.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.53 -52.25 66.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.638 ' HB3' HG21 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -77.8 -45.63 23.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.13 -30.49 66.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.14 67.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -40.2 96.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.72 -58.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.04 177.46 54.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.425 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.424 ' HG2' HD13 ' A' ' 329' ' ' ILE . 1.1 tt0 -154.22 151.44 29.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 0.0 110.892 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.782 HG22 ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -49.17 138.17 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.42 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -127.47 137.67 31.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 -168.37 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.578 2.185 . . . . 0.0 112.387 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -136.44 76.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.587 HD12 ' HB2' ' A' ' 335' ' ' GLN . 25.2 pt -86.2 148.6 47.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.08 -27.9 38.62 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.675 2.25 . . . . 0.0 112.323 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.587 ' HB2' HD12 ' A' ' 333' ' ' ILE . 10.4 mt-30 -58.96 -41.59 87.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -66.65 -31.72 72.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -44.28 97.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.56 72.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 343' ' ' VAL . 40.3 m-85 -71.05 -37.51 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.12 97.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -59.36 -52.09 67.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 346' ' ' ALA . . . -59.79 -46.91 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.9 t -69.5 -29.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -59.42 -60.66 3.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 9.2 t -71.64 -41.18 69.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -46.37 -56.34 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.586 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.37 -55.76 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.813 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.8 mm -57.08 -58.75 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.728 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 345' ' ' THR . 1.0 OUTLIER -59.49 -27.91 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.671 0.272 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -61.92 -57.07 13.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -60.82 -10.57 5.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.004 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.5 m -110.04 26.63 10.45 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.614 0.245 . . . . 0.0 111.385 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 154.3 -71.53 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.005 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -87.76 51.63 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.464 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.519 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -79.37 99.29 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 1.5 t -166.22 97.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.86 -27.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.324 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -57.49 -45.72 84.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -80.01 -43.91 21.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.82 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -56.35 -37.77 70.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 -53.06 6.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -58.83 -55.69 31.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -59.28 -44.11 92.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -58.48 -32.41 68.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.0 m -72.66 -31.26 64.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -40.77 68.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.409 HD12 ' HE1' ' A' ' 339' ' ' PHE . 31.8 mm -71.22 -35.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 18.8 m 61.3 51.02 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.44 28.64 21.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 12.8 mttm -114.92 130.27 56.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.833 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 6' ' ' LYS . 4.3 mm? -129.1 148.56 51.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.8 m -126.48 102.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 20' ' ' LEU . 3.9 mt -94.87 114.87 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.561 ' CH2' HD13 ' A' ' 43' ' ' LEU . 95.5 m95 -105.83 111.96 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 12' ' ' ASN . 4.7 mt -118.25 157.27 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' ILE . 1.7 t30 -170.31 40.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.91 25.7 3.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.92 31.81 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 110.785 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -165.91 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.11 63.86 0.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.543 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -62.9 -29.59 70.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 111.058 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -59.34 -47.18 86.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.68 -28.3 65.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 9' ' ' ILE . 56.6 tp -64.76 -32.81 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.17 72.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -31.41 65.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.45 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.55 -35.18 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -59.73 -28.44 67.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -68.02 -33.45 74.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' HG21 ' A' ' 33' ' ' ILE . 9.3 m-85 -78.08 -50.6 11.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.542 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -51.54 -27.93 12.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.464 0.65 . . . . 0.0 110.425 179.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.45 -26.4 66.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.301 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 31' ' ' THR . 7.4 m-20 -64.32 -57.19 10.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.98 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.611 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.841 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.89 48.49 0.01 OUTLIER Glycine 0 C--N 1.338 0.682 0 C-N-CA 117.873 -2.108 . . . . 0.0 115.566 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.4 mm -139.27 95.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 118.071 0.935 . . . . 0.0 111.676 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.27 113.76 26.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 7' ' ' LEU . 30.2 m -98.85 139.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.29 119.63 39.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.9 112.97 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -151.84 163.08 39.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -104.73 142.05 23.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.15 155.62 37.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.551 2.167 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -178.84 -51.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -111.57 -23.31 10.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' CH2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -79.77 -1.12 37.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.545 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -54.4 -30.36 51.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.041 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -90.4 -30.9 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -72.46 -24.53 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -52.8 -59.31 9.15 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.303 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.2 Cg_endo -63.1 -17.25 59.24 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.482 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -89.69 -43.84 10.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG23 ' HG2' ' A' ' 46' ' ' LYS . 29.8 t -82.76 -30.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.51 61.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -71.06 -31.89 68.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.33 55.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB2' HG12 ' A' ' 50' ' ' VAL . 13.5 t0 -59.41 -34.08 72.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.36 -93.92 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.569 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.519 ' HB2' HG22 ' A' ' 8' ' ' VAL . 60.8 Cg_endo -72.85 -173.42 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.581 2.187 . . . . 0.0 112.4 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.8 t0 178.97 60.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.773 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mm -99.01 121.07 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 3.2 tt -146.68 141.62 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.5 136.87 52.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.583 ' CZ3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.17 173.31 15.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -76.9 -53.26 8.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.39 -28.44 65.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 13.0 mmt180 -57.54 -29.17 64.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HZ ' HG23 ' A' ' 60' ' ' ILE . 48.3 m-85 -107.52 -37.4 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.86 -23.47 51.05 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.653 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.28 4.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.651 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.65 -59.38 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.074 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -57.3 -29.76 64.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.26 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.53 -27.05 66.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 t -70.19 -26.73 64.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.088 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.31 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.84 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.682 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -165.36 127.9 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' N ' HD13 ' A' ' 76' ' ' LEU . . . -69.16 126.56 30.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.09 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -73.05 132.73 43.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tt -102.87 147.56 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.4 p -98.03 145.87 30.52 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.84 146.71 18.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.94 -55.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -30.48 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.79 -23.39 42.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -79.25 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.5 -26.54 67.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 89' ' ' LEU . 1.2 m-20 -76.43 -41.9 45.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.812 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.65 40.05 13.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -82.3 -177.32 6.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -66.91 112.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 78.1 Cg_exo -50.51 -25.21 13.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.514 2.143 . . . . 0.0 112.482 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -21.07 41.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 90' ' ' TYR . 57.5 p -69.39 -53.95 16.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.442 ' CE3' ' N ' ' A' ' 95' ' ' ASP . 46.9 p-90 -92.92 -45.31 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 6.7 t70 -53.29 -26.72 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.288 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB1' HD11 ' A' ' 329' ' ' ILE . . . -80.56 -28.88 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.235 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.802 HG21 ' O ' ' A' ' 105' ' ' ALA . 11.3 p -114.57 63.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.34 104.66 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -94.44 93.1 7.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.61 -70.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.06 30.89 0.19 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -127.57 96.61 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -92.48 102.69 15.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.761 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -133.88 39.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.025 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.802 ' O ' HG21 ' A' ' 97' ' ' VAL . . . -172.42 93.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 t80 -98.95 141.73 23.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.71 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.3 Cg_endo -79.85 138.76 13.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.608 2.205 . . . . 0.0 112.205 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 107' ' ' PRO . 18.0 mm -143.6 39.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.245 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 173.26 99.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.976 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 317' ' ' ILE . 9.2 p -89.34 111.21 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -104.27 133.16 49.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.36 170.05 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.003 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.17 152.31 50.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.955 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 t -164.92 -176.06 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -107.53 138.18 44.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 244' ' ' VAL . 3.0 pt -130.17 140.22 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.088 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -152.76 165.66 34.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -80.32 168.8 18.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.89 36.9 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.68 -64.01 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -97.38 48.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.63 103.68 10.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.24 160.36 49.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.431 2.088 . . . . 0.0 112.313 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.19 110.85 4.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.09 124.66 11.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.439 2.093 . . . . 0.0 112.278 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.4 2.066 . . . . 0.0 112.238 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -101.04 -30.59 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 129' ' ' TRP . 1.5 m -126.62 169.11 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.519 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -72.58 -31.28 65.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -23.71 17.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.549 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.19 -16.33 40.69 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 147' ' ' LEU . 42.0 mt -65.55 -47.41 67.93 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 89.2 Cg_exo -46.38 -30.02 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.366 2.044 . . . . 0.0 112.629 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.89 60.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.11 -45.81 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.171 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 3.5 p30 -54.12 -28.69 41.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.208 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 15.8 tttt -55.79 -42.69 75.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -81.79 -33.31 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.79 -55.9 16.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -52.51 -25.01 9.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.54 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -112.2 -50.42 2.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.76 41.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.653 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -155.24 179.2 9.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -128.47 165.62 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -86.24 3.99 40.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.67 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER 170.8 151.19 0.05 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.859 0.362 . . . . 0.0 110.995 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 216' ' ' ALA . 6.4 tpt -117.77 144.75 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.09 145.86 40.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.0 170.79 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 12.5 mt -131.19 -46.5 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -98.5 39.72 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.732 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 93.87 8.68 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.55 112.78 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.153 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.07 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.464 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -111.94 -30.63 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.5 t -70.43 -27.09 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -70.22 -56.01 7.43 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.272 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 42.1 Cg_endo -67.13 -16.19 48.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.37 2.047 . . . . 0.0 112.446 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 255' ' ' SER . 1.7 tm? -78.18 -56.72 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.626 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.58 ' CG2' HD13 ' A' ' 195' ' ' LEU . 29.0 pt -65.09 -16.76 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 166' ' ' GLY . . . -84.61 -70.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.992 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.58 -80.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.2 -41.93 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.003 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.29 -35.49 65.68 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 162' ' ' ALA . . . -59.66 116.97 9.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.566 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.14 78.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.31 -31.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -116.55 36.57 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 177.63 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.23 -30.93 58.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.43 -52.65 49.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.71 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.705 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -60.4 -56.89 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.82 -30.66 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.05 -45.47 95.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 -46.89 39.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.968 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 189' ' ' LYS . 58.9 p -59.89 -29.04 68.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.4 -53.07 62.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.58 HD13 ' CG2' ' A' ' 161' ' ' ILE . 3.4 tp -59.83 -50.39 73.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.7 t -59.74 -37.8 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -27.68 56.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.45 -49.62 12.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 200' ' ' LYS . 2.3 pp -57.16 -40.16 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.495 ' N ' HD12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -72.08 -28.08 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -26.23 62.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -118.46 -67.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . 0.426 ' CD2' ' CB ' ' A' ' 207' ' ' ASP . 30.9 m170 -65.15 -28.78 69.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 mtm 69.28 -67.41 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.41 -48.42 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.23 -58.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . 0.426 ' CB ' ' CD2' ' A' ' 203' ' ' HIS . 6.4 t0 78.1 -55.18 0.5 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.107 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -79.82 147.86 31.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.873 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 t0 -144.0 -162.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.358 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 211' ' ' SER . 39.4 p90 -78.83 -46.02 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 110.392 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.7 p -81.08 -25.64 36.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.045 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.45 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 1.107 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.58 -30.36 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.625 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.6 tm-20 -70.41 -22.74 62.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.72 7.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.68 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -81.75 -41.99 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -75.98 -58.7 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -62.73 -32.94 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -23.47 16.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.632 0.253 . . . . 0.0 111.33 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.54 52.15 8.78 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.066 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.26 39.41 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.34 . . . . 0.0 111.121 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.4 HG23 ' HB1' ' A' ' 216' ' ' ALA . 20.8 p -149.58 -177.69 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.856 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -83.55 39.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.465 ' HG2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 173.66 128.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.925 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 116' ' ' ILE . 1.3 t -144.54 106.35 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.464 HD13 ' CD2' ' A' ' 156' ' ' PHE . 14.6 mt -78.99 141.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -86.81 112.48 21.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.08 -157.17 33.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo . . . . . 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 112.348 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.82 0.343 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.08 171.85 21.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 116' ' ' ILE . 19.5 t -113.29 136.36 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 111.112 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 115' ' ' LEU . 9.4 t -125.24 159.41 31.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.62 150.55 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.91 156.82 33.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.82 -168.33 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 t -123.99 177.48 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 253' ' ' GLN . 54.7 p90 -167.18 117.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt 64.17 16.24 9.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.62 33.04 28.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.667 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.409 ' O ' ' CE1' ' A' ' 250' ' ' PHE . 16.6 pt20 -156.19 90.63 2.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 111.003 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.52 161.08 47.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.788 2.326 . . . . 0.0 112.154 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.609 ' HB3' HD22 ' A' ' 160' ' ' LEU . 81.1 p -57.43 163.8 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -105.15 99.53 20.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 130.06 8.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.468 2.112 . . . . 0.0 112.249 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -111.87 139.75 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.11 150.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.72 160.39 28.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.621 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 m -129.85 144.96 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.861 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -88.0 126.29 35.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.978 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 28.3 m -91.71 125.88 36.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.62 140.12 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.58 168.12 34.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.404 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.1 tt -101.67 158.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.016 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -73.64 173.16 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -94.23 -27.4 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -30.95 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 p -76.75 122.36 86.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.18 -1.46 11.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.498 2.132 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -96.37 38.27 1.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -75.04 -31.05 61.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -60.33 -42.89 96.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.5 tp -75.59 -28.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.024 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 279' ' ' PHE . . . -76.8 -32.35 57.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.306 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -79.13 -30.76 43.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.54 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 279' ' ' PHE . 12.9 pt-20 -76.18 -48.72 19.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.7 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -70.25 -24.22 63.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.239 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 284' ' ' LEU . 6.5 tp -78.89 -29.9 44.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -105.56 -14.47 15.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.759 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 283' ' ' TYR . 14.7 m120 -111.06 27.42 9.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.685 0.278 . . . . 0.0 111.621 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 282' ' ' ASN . 6.7 m-85 -168.69 -52.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.185 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.41 HD13 HD12 ' A' ' 280' ' ' LEU . 2.7 tp -46.41 -66.51 0.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 290' ' ' LEU . 2.6 mt -95.72 63.25 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.0 m -154.78 166.33 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.75 -20.31 55.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.46 -29.57 52.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.181 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -111.46 -52.92 0.54 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.761 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 285' ' ' LEU . 1.3 tp -50.64 -27.3 6.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.91 -26.03 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.264 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.79 -57.94 3.53 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.381 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 297' ' ' LYS . 1.8 m -62.42 -28.78 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.634 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 297' ' ' LYS . 2.1 t-20 -22.2 -48.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -50.78 -27.77 7.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.785 ' O ' HD23 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -135.62 -13.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.962 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 298' ' ' PRO . 0.0 OUTLIER -45.52 -49.81 33.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 297' ' ' LYS . 59.5 Cg_endo -73.73 104.52 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.301 2.0 . . . . 0.0 112.556 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 296' ' ' ASP . 3.9 pp -177.94 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.655 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.633 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 177.82 72.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -179.31 93.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 308' ' ' GLU . 34.9 t -154.89 109.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.76 40.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 307' ' ' TYR . 3.2 mp -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -59.34 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 m -79.15 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.6 ' HB3' HD22 ' A' ' 304' ' ' LEU . 0.5 OUTLIER -80.29 -35.75 35.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -54.97 -25.27 28.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.234 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.47 -61.34 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.052 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.25 -31.16 14.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.422 ' CD2' HD23 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -71.92 -55.71 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 308' ' ' GLU . . . -77.38 -54.25 6.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt 54.1 30.06 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.06 110.42 18.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.68 -13.09 31.78 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.602 2.202 . . . . 0.0 112.615 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.95 4.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.719 0.295 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -58.51 -32.73 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.25 58.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.58 -26.47 61.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 317' ' ' ILE . 12.1 t -55.6 -29.44 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.9 mmm -59.4 -30.44 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.33 -52.59 13.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.6 -31.04 67.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.66 69.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -59.88 -31.13 69.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 36.35 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -172.57 171.42 44.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.07 147.18 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.452 HD11 ' HB1' ' A' ' 96' ' ' ALA . 27.6 pt -59.33 130.35 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -178.47 136.62 0.34 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -178.19 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.454 2.103 . . . . 0.0 112.272 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.687 ' C ' HD12 ' A' ' 333' ' ' ILE . 16.3 t-20 -127.31 36.5 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 332' ' ' ASN . 3.4 mp 64.13 127.76 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.46 -27.68 32.82 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.089 . . . . 0.0 112.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 333' ' ' ILE . 21.9 tt0 -58.28 -31.26 67.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.41 -28.47 68.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.9 m -58.65 -59.26 5.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.62 -27.46 66.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.5 OUTLIER -56.37 -24.32 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 343' ' ' VAL . 0.8 OUTLIER -57.31 -27.32 62.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -52.29 13.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.179 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.23 59.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.32 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 339' ' ' PHE . 27.4 m -56.29 -29.93 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.448 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.766 ' HG2' HD12 ' A' ' 348' ' ' ILE . 1.8 ttt85 -52.55 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 11.5 m -69.35 -27.66 65.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -60.5 -60.56 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.416 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.52 -57.02 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.087 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.766 HD12 ' HG2' ' A' ' 344' ' ' ARG . 27.1 mt -52.15 -58.79 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 345' ' ' THR . 0.1 OUTLIER -62.34 -31.06 71.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.75 0.31 . . . . 0.0 111.193 -179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -57.67 -30.02 65.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.17 -9.87 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.1 t -67.28 -22.82 65.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 110.46 -29.34 9.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.441 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 39.2 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -163.96 122.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.8 OUTLIER -104.77 171.06 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 361' ' ' LEU . 25.4 t -72.21 -31.71 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.21 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.53 -33.85 71.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.14 -53.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.572 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -57.13 -30.08 64.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 357' ' ' VAL . 21.1 mt -82.32 -56.63 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 366' ' ' THR . 10.7 mttm -64.07 -44.72 91.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 -35.36 80.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -79.78 -55.42 5.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -34.91 24.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 362' ' ' LYS . 12.8 t -80.48 -29.5 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.55 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.008 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 339' ' ' PHE . 33.7 mm -64.35 -47.24 90.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.8 m -66.72 -58.68 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.39 45.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 168.98 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 279' ' ' PHE . 67.4 mt -149.95 139.43 21.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 36' ' ' THR . 29.8 t -113.08 102.83 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 mp -97.51 129.95 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.774 ' CZ3' HD22 ' A' ' 43' ' ' LEU . 8.9 t90 -94.9 113.28 24.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -147.79 141.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -165.3 78.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.98 35.93 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.564 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.7 89.09 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.747 0.308 . . . . 0.0 110.991 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 mttp -152.92 81.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.51 78.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -80.94 -56.59 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -76.12 -32.26 59.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.83 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -64.11 -41.71 98.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.567 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.73 -31.53 59.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.68 -42.11 74.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.94 -33.31 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 19' ' ' GLY . 22.8 t -70.32 -35.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.44 -34.63 81.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.597 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -69.51 -28.38 66.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.983 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.3 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.778 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 6.9 m-85 -64.27 -56.39 14.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -58.36 -28.16 64.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.141 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 -26.98 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.644 ' O ' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -64.94 -57.3 9.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.828 ' O ' HG22 ' A' ' 31' ' ' THR . 5.9 m 156.45 36.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.731 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.48 52.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.705 0 C-N-CA 117.96 -2.067 . . . . 0.0 115.452 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 2.5 mm -138.36 95.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 118.168 0.984 . . . . 0.0 111.459 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.29 108.92 20.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.028 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.26 138.07 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.408 ' CG2' HG22 ' A' ' 8' ' ' VAL . 1.7 t -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 0.0 111.173 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.15 120.96 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -96.34 153.96 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.013 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.15 167.37 12.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.98 92.56 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.609 2.206 . . . . 0.0 112.35 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -177.43 -40.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.021 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -109.65 -29.09 8.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -57.42 -23.81 51.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.211 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.21 -28.74 55.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.09 -26.79 18.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.045 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 50' ' ' VAL . 36.8 mttm -69.49 -29.38 67.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.431 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.94 -60.77 7.83 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.143 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.0 Cg_endo -66.28 -15.83 49.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.553 2.169 . . . . 0.0 112.512 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.35 -55.22 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.789 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.3 p -73.92 -24.8 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.16 -31.28 65.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -65.1 -43.42 92.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.068 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.42 152.09 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.45 85.43 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.535 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.05 -35.94 16.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.38 -157.59 7.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.536 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.42 -175.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.585 2.19 . . . . 0.0 112.25 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 173.68 49.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -99.03 127.43 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 10' ' ' TRP . 32.6 pt -151.58 138.76 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' CD1' ' HB1' ' A' ' 264' ' ' ALA . 7.6 m-85 -116.12 148.97 39.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.445 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -165.78 173.7 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.41 -173.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.525 ' NE2' HG12 ' A' ' 97' ' ' VAL . 2.1 t-160 -76.82 -53.18 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.21 66.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -110.01 -23.17 11.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.45 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.725 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.72 -24.81 68.95 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.717 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -64.45 -53.1 53.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.962 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -59.49 -55.58 32.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -27.05 66.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -75.83 -26.85 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 -81.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.84 87.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.705 HD23 ' HB ' ' A' ' 104' ' ' ILE . 1.1 tp -117.52 141.51 48.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.91 119.86 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' A' ' 104' ' ' ILE . 9.8 pt-20 -61.22 159.34 12.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mt -126.24 148.94 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 m -120.41 92.66 47.71 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.48 114.41 3.26 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.954 2.436 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.27 -35.3 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -30.64 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB1' ' HZ2' ' A' ' 94' ' ' TRP . . . -53.46 -22.94 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.617 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -80.16 -57.77 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 111.217 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -24.61 58.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 18.1 p-10 -62.4 -17.72 59.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.339 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 66.71 71.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.353 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -105.36 155.92 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.443 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -83.95 134.38 44.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.78 -25.92 36.62 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.469 2.113 . . . . 0.0 112.296 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -55.69 -30.29 60.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 97' ' ' VAL . 5.1 m -75.72 -31.34 59.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.513 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 66.2 m95 -73.13 -48.02 39.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.39 -27.89 62.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 -30.02 57.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.208 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HD3' ' A' ' 107' ' ' PRO . 29.5 m -134.66 68.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.251 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -149.26 140.71 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.3 174.04 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.47 68.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.08 37.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -145.48 159.14 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.822 0.344 . . . . 0.0 110.837 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.1 mp -141.94 85.96 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -136.87 40.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.9 131.43 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.04 118.6 10.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.812 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.762 ' O ' HD13 ' A' ' 108' ' ' ILE . 94.1 Cg_endo -79.7 124.77 5.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.453 2.102 . . . . 0.0 112.463 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 107' ' ' PRO . 21.8 mm -141.2 39.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.07 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.773 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.52 125.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 HG12 ' A' ' 302' ' ' VAL . 3.9 m -106.32 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.45 136.49 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 176.44 8.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 mt -81.26 149.0 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.615 ' HB3' HG13 ' A' ' 244' ' ' VAL . 2.0 m -164.71 170.9 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 223' ' ' ALA . 12.1 tp -103.09 136.63 42.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 225' ' ' THR . 31.6 mm -111.64 125.85 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 51.1 p90 -128.18 152.4 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -105.04 176.98 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 30.83 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.41 -57.86 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 222' ' ' THR . 1.5 tt -140.28 82.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 ' N ' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -122.36 106.07 35.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 160.34 50.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.45 2.1 . . . . 0.0 112.346 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.9 149.43 98.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.28 119.11 6.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.555 2.17 . . . . 0.0 112.214 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.04 -71.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.353 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -177.15 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.68 -176.31 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.806 ' CZ3' HD13 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -65.5 -26.74 68.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 64.3 mm-40 -51.46 -24.07 4.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.383 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -15.81 33.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.592 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.806 HD13 ' CZ3' ' A' ' 129' ' ' TRP . 3.5 tt -52.44 -35.66 25.61 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.742 ' HD3' HG22 ' A' ' 132' ' ' ILE . 17.2 Cg_exo -67.93 -31.41 31.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.207 1.938 . . . . 0.0 112.104 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.51 63.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 146' ' ' ALA . 4.3 mp -77.68 -38.12 48.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.78 -36.51 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -28.14 67.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.74 -31.58 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.838 HD13 ' CB ' ' A' ' 145' ' ' SER . 11.9 tp -60.48 -55.94 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -30.36 67.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.08 76.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.038 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -139.39 -60.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.775 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.03 41.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -126.63 121.94 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.838 ' CB ' HD13 ' A' ' 139' ' ' LEU . 9.9 t -140.69 170.67 15.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.504 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.652 ' HB3' HD22 ' A' ' 135' ' ' LEU . . . -147.15 13.38 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.762 ' HB3' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER 170.67 115.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 111.717 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.412 ' N ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -121.35 148.8 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.129 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.99 132.96 21.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.019 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB1' ' A' ' 213' ' ' ALA . 2.3 m-80 -61.1 -176.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.787 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.789 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.1 OUTLIER -124.7 -47.43 1.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.482 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.91 39.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.82 157.85 33.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.74 149.93 21.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.563 2.175 . . . . 0.0 112.315 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 61.57 67.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.596 ' CE2' HG23 ' A' ' 157' ' ' THR . 20.3 p90 -120.31 -39.3 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.691 ' HB ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -63.6 -36.51 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.578 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 3.1 t-105 -67.95 -55.7 12.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.442 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -64.21 -11.72 29.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.276 1.984 . . . . 0.0 113.142 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.48 -56.79 2.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.643 0.259 . . . . 0.0 111.59 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 157' ' ' THR . 42.8 mt -65.81 -20.16 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.821 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -89.37 12.2 16.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -64.2 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.5 -51.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.059 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.75 -86.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -56.14 142.86 38.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -169.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.05 -38.37 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.3 61.05 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -122.96 168.71 11.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.37 -33.02 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.98 -32.38 36.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.46 74.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -60.45 -46.07 91.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.18 -35.2 31.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.03 -28.31 73.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.663 HD13 HG12 ' A' ' 357' ' ' VAL . 1.6 tt -82.53 -50.43 8.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 p -57.58 -28.93 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 2.1 m-85 -55.0 -60.63 3.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.51 -30.78 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.968 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.3 t -69.04 -54.03 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.3 -32.35 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.07 -55.98 27.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.708 HG12 HD21 ' A' ' 151' ' ' LEU . 6.2 mt -61.71 -33.71 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -33.29 71.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.968 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -106.51 19.34 20.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.28 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 -54.99 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.813 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.37 -46.15 3.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.833 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.8 ttm 58.34 44.31 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -176.79 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 65.76 77.09 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -143.96 30.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.789 HG21 ' HB2' ' A' ' 151' ' ' LEU . 3.2 t -81.8 148.08 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -124.01 -165.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 211' ' ' SER . 30.3 p90 -78.92 -44.26 23.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.083 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.448 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 14.2 t -73.18 -24.67 60.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.353 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -81.9 -50.48 16.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.082 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.46 ' N ' HG22 ' A' ' 212' ' ' ILE . . . -67.74 -30.34 69.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.467 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 210' ' ' TYR . 4.4 tt0 -75.15 -25.69 58.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -51.55 -25.58 7.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.533 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.726 ' HB1' ' SD ' ' A' ' 224' ' ' MET . . . -57.01 -57.47 12.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.763 0.315 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.696 ' CE1' HG21 ' A' ' 225' ' ' THR . 20.2 t80 -69.57 -40.27 76.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -59.43 -49.6 77.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -94.25 -1.49 53.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.642 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 217' ' ' PHE . . . -147.81 87.35 0.16 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.725 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.25 59.75 2.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.657 . . . . 0.0 110.461 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 145' ' ' SER . 0.3 OUTLIER -107.58 -175.07 2.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.125 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.632 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . . . -77.8 44.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.726 ' SD ' ' HB1' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -116.87 45.88 1.76 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.829 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.696 HG21 ' CE1' ' A' ' 217' ' ' PHE . 1.8 t -143.56 114.63 7.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.414 HD12 ' H ' ' A' ' 226' ' ' ILE . 3.7 mp -91.58 122.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -86.85 110.76 20.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.984 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 174.62 58.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -134.45 120.93 2.55 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.52 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 114' ' ' SER . 22.1 t -91.59 132.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 25.2 m -141.09 156.75 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.77 150.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.416 HD13 ' HD3' ' A' ' 248' ' ' PRO . 4.2 mm? -66.22 154.63 89.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.416 ' HD3' HD13 ' A' ' 247' ' ' LEU . 4.1 Cg_exo -79.78 -164.13 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.844 2.363 . . . . 0.0 112.135 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.854 HG22 ' HD3' ' A' ' 254' ' ' PRO . 21.8 p -97.29 177.95 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.509 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 79.8 m-85 -144.88 110.93 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.425 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 194' ' ' PHE . 0.0 OUTLIER 39.65 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.872 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 154.42 -59.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.803 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -150.87 166.06 15.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.854 ' HD3' HG22 ' A' ' 249' ' ' THR . 57.1 Cg_endo -70.96 173.83 11.45 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.682 2.255 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.66 179.46 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 125.85 66.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 -168.25 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.451 2.101 . . . . 0.0 112.333 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.19 119.62 13.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 328' ' ' GLU . 27.0 m -110.34 123.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.04 134.53 9.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 64' ' ' HIS . 14.4 m -97.39 144.87 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.773 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 6.3 tp -81.97 121.99 27.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.3 113.43 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 61' ' ' PHE . . . -116.75 145.82 43.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.023 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 176.94 -157.94 23.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.568 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.472 HD13 ' HB1' ' A' ' 276' ' ' ALA . 32.8 pt -137.95 155.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.802 0.334 . . . . 0.0 111.122 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.555 ' HB3' HD12 ' A' ' 76' ' ' LEU . 11.2 p30 -147.09 128.06 14.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.12 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -178.68 36.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.87 55.03 9.38 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.27 -45.56 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -151.88 80.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -30.24 71.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -69.56 -42.47 74.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 279' ' ' PHE . 6.2 tp -77.69 -31.24 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -73.61 -46.26 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -50.65 72.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.47 -40.66 92.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.414 ' CD2' ' HG ' ' A' ' 275' ' ' LEU . 1.1 m-85 -67.8 -53.87 23.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 280' ' ' LEU . 23.3 mt -57.43 -29.15 63.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -92.18 -25.04 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.86 27.33 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.018 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.738 ' C ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -112.82 -62.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.871 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 283' ' ' TYR . 3.8 mm? -139.07 57.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.3 mt -161.85 29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.759 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.1 t -154.76 177.35 11.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.87 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.4 -49.15 67.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -77.39 -28.08 52.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.759 ' H ' HG23 ' A' ' 286' ' ' THR . . . -66.49 -66.5 2.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.429 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.75 HD21 ' OH ' ' A' ' 307' ' ' TYR . 0.8 OUTLIER -59.05 -20.78 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.83 -31.4 27.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.29 6.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.407 ' CG2' ' HG ' ' A' ' 290' ' ' LEU . 11.2 m -64.31 -29.58 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -48.02 -28.6 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.39 -70.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -73.05 -50.01 25.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.789 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER 64.13 140.96 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.038 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.88 -2.23 10.78 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.689 2.26 . . . . 0.0 112.601 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 299' ' ' LEU . 2.8 mm? 61.78 46.51 6.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.96 83.87 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.514 ' CA ' HG22 ' A' ' 110' ' ' VAL . . . -166.98 133.59 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.222 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 110' ' ' VAL . 9.0 p -178.63 99.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.969 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.76 54.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 146.17 40.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -60.23 -37.37 80.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.1 m -79.54 -27.04 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.962 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.75 ' OH ' HD21 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -71.71 -40.93 69.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.76 -32.28 65.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.96 -37.64 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.649 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -74.34 -30.32 61.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.909 HD12 HG21 ' A' ' 302' ' ' VAL . 0.8 OUTLIER -45.49 -29.79 1.23 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.388 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.48 -29.49 50.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.215 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 30.93 4.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.97 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.4 172.83 8.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -88.04 -76.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.78 2.32 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -81.32 -58.83 2.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.406 HG22 HD21 ' A' ' 311' ' ' LEU . 2.0 mt -50.76 -28.14 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.409 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.15 75.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.56 -45.65 18.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -37.91 88.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -27.5 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.158 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -55.26 -46.86 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.27 -31.73 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.71 66.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.86 -32.19 67.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -111.15 36.36 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -135.04 -175.4 13.83 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 259' ' ' VAL . 6.0 mm-40 -120.42 -176.63 3.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.9 OUTLIER -118.98 116.01 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.436 ' CE ' ' CE1' ' A' ' 64' ' ' HIS . 7.2 ptp 43.84 52.94 9.67 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.516 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.7 97.66 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.553 2.169 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -134.5 -70.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.4 mt 63.72 139.11 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.73 -26.48 17.56 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.542 2.161 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.87 -27.23 63.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.4 tpt -57.57 -27.95 63.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.96 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.45 77.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.153 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.787 ' O ' HG12 ' A' ' 343' ' ' VAL . 4.3 t80 -59.97 -25.64 65.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.03 -38.7 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.049 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.549 ' O ' HG22 ' A' ' 345' ' ' THR . 0.1 OUTLIER -78.96 -44.27 22.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.73 96.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 339' ' ' PHE . 11.5 p -69.0 -30.37 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 341' ' ' TYR . 10.1 t -49.61 -27.58 4.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.364 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -75.42 -52.22 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.54 -55.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.987 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 344' ' ' ARG . 9.0 tp -53.48 -38.74 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -28.35 35.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -55.07 -39.05 68.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.261 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.23 -14.28 44.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.5 p -67.69 -56.32 9.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.768 0.318 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -134.1 -70.8 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -173.44 39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -88.46 99.07 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 358' ' ' ASP . 11.1 t -103.31 -167.05 1.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.663 HG12 HD13 ' A' ' 192' ' ' LEU . 16.7 m -56.38 -27.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.709 ' H ' HG23 ' A' ' 356' ' ' THR . 3.3 t70 -46.79 -56.12 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -80.34 -41.17 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.613 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 357' ' ' VAL . . . -54.95 -53.09 60.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.258 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 357' ' ' VAL . 4.0 mm? -64.67 -56.87 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.477 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -41.38 84.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.471 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 366' ' ' THR . 8.7 t0 -76.51 -47.71 21.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.716 0.293 . . . . 0.0 111.131 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -66.79 -47.4 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.613 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.2 pp0? -52.31 -37.62 56.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.285 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 363' ' ' ASP . 14.1 t -80.68 -29.5 36.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -73.81 -41.85 61.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.4 mt -59.34 -47.24 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.087 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 370' ' ' LYS . 1.3 t -159.9 -52.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 369' ' ' THR . 5.7 tttm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.861 0.362 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.89 -72.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 172.77 13.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -111.04 160.01 17.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 57' ' ' PRO . 31.8 t -118.62 102.91 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 37' ' ' VAL . 7.7 pt -105.03 114.95 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.189 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.915 ' CB ' HG22 ' A' ' 60' ' ' ILE . 47.1 t90 -94.94 111.9 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 tt -164.88 158.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.64 -171.28 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 51.53 0.78 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.394 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.11 -26.74 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.603 0.24 . . . . 0.0 111.135 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -43.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.279 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 42.19 2.91 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.851 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 40.7 p90 -81.12 -46.64 14.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 40.4 m-20 -76.62 -37.46 56.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -39.03 89.73 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.46 -28.95 52.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.288 . . . . 0.0 110.986 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.46 -49.2 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.133 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.02 -50.54 73.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 27' ' ' PHE . 11.9 p -58.55 -30.89 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.72 -34.03 64.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -77.14 -28.28 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -29.7 70.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 37.6 m-85 -74.39 -56.77 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.606 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -60.84 -27.42 68.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.269 0.557 . . . . 0.0 110.417 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.22 -29.21 1.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.863 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.737 ' O ' HG23 ' A' ' 31' ' ' THR . 4.8 m-20 -66.33 -57.37 7.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.77 37.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.722 0.639 . . . . 0.0 112.037 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 47.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.67 0 C-N-CA 118.131 -1.985 . . . . 0.0 115.358 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.606 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -140.36 95.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 118.077 0.938 . . . . 0.0 111.63 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.37 129.77 52.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.77 130.47 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.1 p -105.71 121.59 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 9' ' ' ILE . 19.8 t -94.34 118.2 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.08 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -109.76 159.92 16.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.53 166.43 23.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 122.02 9.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.25 -75.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 0.09 27.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.51 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -55.06 -30.54 59.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 111.06 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -33.5 76.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.93 -29.21 15.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 tptm -69.93 -25.46 63.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.436 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.48 -60.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.6 Cg_endo -63.85 -15.42 48.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.642 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -38.4 22.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.633 HG23 ' HA3' ' A' ' 54' ' ' GLY . 10.0 p -92.25 -18.31 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.267 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -37.12 65.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.31 -37.71 32.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -164.31 -71.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.633 ' HA3' HG23 ' A' ' 50' ' ' VAL . . . 65.94 -74.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.537 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -165.02 -57.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.95 -63.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.667 ' HB2' HG23 ' A' ' 8' ' ' VAL . 19.0 Cg_endo -60.2 159.15 27.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.602 2.201 . . . . 0.0 112.276 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.52 67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 266' ' ' ILE . 34.4 mt -107.0 113.68 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.915 HG22 ' CB ' ' A' ' 10' ' ' TRP . 42.9 pt -132.58 142.68 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.493 ' CE1' ' HB1' ' A' ' 264' ' ' ALA . 12.1 m-85 -108.64 123.58 49.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.45 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -163.18 174.01 12.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.721 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.52 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.7 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.409 ' HE1' HG12 ' A' ' 97' ' ' VAL . 49.0 t60 -77.24 -51.22 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.308 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -48.06 -28.14 2.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.624 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HG2' ' CE3' ' A' ' 62' ' ' TRP . 4.8 tpp180 -64.75 -36.54 84.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 263' ' ' SER . 34.0 m-85 -110.46 -59.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.32 -23.62 19.15 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.17 -50.41 2.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.41 -40.35 73.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.995 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.734 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -56.7 -26.64 57.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.31 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -54.84 -28.59 50.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -70.62 -26.76 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.91 64.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mt -149.81 40.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -133.53 146.05 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 131.49 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -58.02 160.94 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 80' ' ' THR . 32.9 mt -114.77 158.79 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -117.6 97.83 51.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.848 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.67 161.35 24.76 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 2.0 m-20 -97.79 -177.94 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -97.52 -51.4 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.13 -25.32 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.343 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 82' ' ' ASP . 34.2 m-85 -79.29 -59.04 2.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.22 -24.78 68.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.99 -38.17 90.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.96 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.63 39.57 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.562 HD22 HG21 ' A' ' 93' ' ' THR . 0.7 OUTLIER -123.78 153.35 41.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 93' ' ' THR . 3.1 m-85 -76.76 134.26 69.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.25 -22.89 27.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.414 2.076 . . . . 0.0 112.376 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -57.45 -40.71 79.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 90' ' ' TYR . 12.5 t -58.98 -29.7 67.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.819 ' CD1' HG23 ' A' ' 93' ' ' THR . 11.4 m0 -77.98 -56.67 4.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.91 -25.2 60.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.059 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.0 76.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.149 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.467 HG11 ' HG3' ' A' ' 107' ' ' PRO . 11.7 m -150.76 70.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.199 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 109.65 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -101.12 104.53 15.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 68.57 -67.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.006 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.01 33.01 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -136.23 140.37 43.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 tp -108.59 89.47 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.614 ' O ' HD22 ' A' ' 76' ' ' LEU . 34.9 pt -102.4 41.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.041 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.49 155.71 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.553 ' CD1' HD11 ' A' ' 108' ' ' ILE . 2.2 t80 -134.63 100.69 12.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.174 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.633 ' CB ' HG21 ' A' ' 261' ' ' VAL . 5.6 Cg_endo -85.41 142.32 8.28 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.074 2.516 . . . . 0.0 111.504 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 15.9 mt -155.88 39.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 160.6 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.267 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 110' ' ' VAL . 11.0 p -118.09 104.08 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.061 0.458 . . . . 0.0 110.841 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.783 ' HA ' HG21 ' A' ' 320' ' ' THR . 46.4 mp0 -158.49 132.23 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.775 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 113' ' ' LEU . . . -165.1 105.52 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.487 HD12 ' CG ' ' A' ' 323' ' ' ASN . 4.2 mt 158.2 106.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.305 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 m -164.98 123.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.876 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 224' ' ' MET . 4.8 tp -101.2 116.04 31.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.126 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.6 mt -74.71 133.16 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.553 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.851 ' HB3' HD22 ' A' ' 122' ' ' LEU . 50.5 p90 -152.87 124.14 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.674 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -150.81 -179.56 7.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt 59.53 24.07 12.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.075 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.43 27.83 4.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 39.73 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.841 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.851 HD22 ' HB3' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -157.01 114.65 1.97 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.422 ' HG3' HD12 ' A' ' 135' ' ' LEU . 56.5 Cg_endo -70.43 160.43 49.53 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.42 2.08 . . . . 0.0 112.224 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -64.95 154.04 87.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.09 108.98 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.62 2.214 . . . . 0.0 112.41 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.51 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.51 2.14 . . . . 0.0 112.344 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -101.34 14.77 30.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 130' ' ' GLU . 4.3 m -160.22 141.15 12.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.447 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.69 -29.15 64.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' HG22 ' A' ' 128' ' ' THR . 3.6 mt-10 -54.01 -23.71 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.89 -21.63 60.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 4.3 mt -73.38 -54.34 4.18 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.6 Cg_exo -52.92 -30.92 50.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.227 1.951 . . . . 0.0 112.332 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.07 -37.12 71.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.422 HD12 ' HG3' ' A' ' 123' ' ' PRO . 1.4 mt -65.15 -30.08 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -59.02 -34.9 72.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -59.27 -37.94 78.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.8 mp0 -81.76 -42.02 20.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.669 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -62.66 -50.98 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -25.95 64.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -56.84 -22.32 35.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.359 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -109.23 -53.51 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.941 0.401 . . . . 0.0 110.749 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.94 40.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.525 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 172.22 18.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 139' ' ' LEU . 5.6 m -122.68 177.53 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 136' ' ' ASP . . . -118.56 30.79 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.037 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 132' ' ' ILE . 1.3 pp 170.4 138.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.755 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.621 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -164.69 139.19 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.016 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -171.93 176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.56 155.31 12.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.661 ' CD1' HG21 ' A' ' 208' ' ' THR . 0.5 OUTLIER -128.49 -48.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -98.82 39.77 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.714 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.11 148.38 54.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.786 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HG2' ' CE2' ' A' ' 155' ' ' TYR . 98.8 Cg_endo -79.87 161.98 23.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.624 2.216 . . . . 0.0 112.503 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 154' ' ' PRO . 14.0 m-85 77.85 -2.13 2.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -121.04 -69.82 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.357 . . . . 0.0 110.836 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -29.59 60.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -64.31 -55.98 26.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 46.2 Cg_endo -68.82 -22.3 36.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.519 2.146 . . . . 0.0 112.673 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.65 -53.76 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.547 HD13 HD22 ' A' ' 192' ' ' LEU . 1.3 pp -83.61 0.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.329 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -92.53 -68.15 0.81 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 250' ' ' PHE . . . 63.64 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.73 -29.45 69.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 69.67 1.38 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.499 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 94.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -173.41 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.187 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.443 ' O ' HG12 ' A' ' 183' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 183' ' ' VAL . 14.1 p 43.55 38.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.952 0.406 . . . . 0.0 111.601 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -98.65 37.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -126.31 143.43 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.72 -28.43 67.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -58.87 -45.17 95.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.756 ' O ' HD23 ' A' ' 192' ' ' LEU . . . -75.95 -35.29 59.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -63.41 -49.42 73.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 193' ' ' THR . . . -67.27 -44.09 80.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.45 80.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 188' ' ' ALA . 1.9 mm? -64.22 -41.7 96.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HG21 ' A' ' 357' ' ' VAL . 7.6 t -77.46 -37.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.005 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -53.35 56.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.036 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -57.45 -53.07 62.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 192' ' ' LEU . 27.2 m -64.01 -28.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.18 -56.89 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.298 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 195' ' ' LEU . 3.5 pp -58.41 -37.35 75.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 195' ' ' LEU . 2.3 pp -74.67 -31.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 111.266 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -78.8 -26.12 44.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.204 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.39 23.1 14.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -76.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.936 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.03 -4.09 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.438 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.8 ptp 44.65 47.4 8.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.985 0.421 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -56.82 109.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.018 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.97 67.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -164.91 94.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.661 HG21 ' CD1' ' A' ' 151' ' ' LEU . 2.6 t -98.48 129.59 45.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.524 ' H ' HD12 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -113.8 -162.14 0.79 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 214' ' ' GLU . 2.3 t80 -79.13 -46.78 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 214' ' ' GLU . 1.7 t -63.86 -24.68 67.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 209' ' ' ASP . 23.1 mt -82.71 -57.28 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.539 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.97 68.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.012 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 210' ' ' TYR . 0.0 OUTLIER -51.25 -31.47 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 111.337 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.23 57.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.83 -52.92 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.833 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 226' ' ' ILE . 53.2 t80 -76.43 -58.67 3.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.793 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 214' ' ' GLU . 14.5 t-20 -47.48 -31.84 4.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.557 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -105.35 -23.7 12.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 52.87 43.42 60.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.25 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -110.48 39.26 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.585 0.231 . . . . 0.0 111.516 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.621 HG21 ' SD ' ' A' ' 148' ' ' MET . 17.6 p -131.59 -177.91 4.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.708 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -88.43 38.48 0.87 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.376 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.663 ' HG2' HD11 ' A' ' 115' ' ' LEU . 2.5 ttt 176.45 128.44 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.933 0.397 . . . . 0.0 111.513 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.71 105.04 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.484 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.404 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 2.4 tt -76.97 142.21 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.91 129.75 34.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -109.68 -144.48 10.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.396 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.456 2.104 . . . . 0.0 112.315 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.89 0.376 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.37 132.81 11.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.561 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.76 106.37 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.47 158.95 30.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.46 149.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 156.17 37.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.79 -158.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.925 2.417 . . . . 0.0 112.209 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.3 p -127.13 177.28 6.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 163' ' ' ALA . 49.9 p90 -167.26 118.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.77 12.21 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.85 16.03 60.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 46.0 mm-40 -152.91 92.75 3.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.643 0.258 . . . . 0.0 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 35.8 Cg_endo -65.22 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.484 2.123 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.4 m -49.7 175.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 111.208 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 2.5 mtpm? -86.28 134.59 38.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.3 Cg_exo -79.55 111.79 2.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.65 2.234 . . . . 0.0 112.213 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -132.33 103.35 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.641 HG23 HG13 ' A' ' 329' ' ' ILE . 30.2 m -101.51 153.06 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.4 ' C ' HG23 ' A' ' 110' ' ' VAL . . . -130.4 117.62 2.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.244 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.633 HG21 ' CB ' ' A' ' 107' ' ' PRO . 9.3 p -86.37 145.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.307 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.804 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.77 107.78 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.076 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 4.1 m -91.79 117.49 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.82 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -135.93 108.74 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -151.15 -143.41 3.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.567 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.668 HD13 ' H ' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -137.24 146.48 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 111.144 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -127.63 118.82 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.44 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 179.93 36.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 55.42 54.09 9.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 270' ' ' SER . 50.1 Cg_endo -69.07 -46.77 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.66 2.24 . . . . 0.0 112.299 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.8 65.06 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.81 -45.59 93.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.18 -33.39 72.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.957 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.82 -55.78 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.47 -52.58 63.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -29.43 68.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.85 -56.6 19.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.36 -29.7 62.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -33.53 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.084 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.31 -31.88 8.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.219 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -97.25 27.45 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 -43.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.98 42.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.1 38.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.0 p -136.03 153.75 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -38.14 65.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -57.26 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -63.1 -57.46 15.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.939 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 293' ' ' VAL . 2.8 tt -45.98 -40.71 10.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.332 . . . . 0.0 111.511 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 -57.91 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.411 . . . . 0.0 110.812 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 296' ' ' ASP . . . -49.06 -24.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.223 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 289' ' ' GLY . 34.4 m -80.86 -29.51 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.349 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -100.72 -85.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.389 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -120.39 14.61 12.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 292' ' ' ALA . 2.7 t0 59.95 27.97 17.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.75 160.26 2.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.17 155.46 6.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.909 HD22 ' N ' ' A' ' 300' ' ' GLY . 0.0 OUTLIER -164.46 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.66 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.909 ' N ' HD22 ' A' ' 299' ' ' LEU . . . 170.19 140.57 3.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.474 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 302' ' ' VAL . . . 172.88 156.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 301' ' ' ALA . 4.6 m -160.28 40.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -129.34 40.11 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.068 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 116.38 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -41.62 90.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 p -68.5 -31.52 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -74.71 -27.28 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.27 -36.45 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.0 -56.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.666 HD11 ' CB ' ' A' ' 317' ' ' ILE . 2.0 tt -55.58 -22.42 21.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.317 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -47.31 -29.17 2.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.541 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -29.6 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.96 109.83 2.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.927 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 319' ' ' ALA . 71.9 Cg_endo -76.89 -11.63 18.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.103 . . . . 0.0 112.736 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -66.04 -59.33 3.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.666 ' CB ' HD11 ' A' ' 311' ' ' LEU . 2.4 mp -80.13 -34.67 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.41 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.264 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 315' ' ' PRO . . . -56.78 -49.0 76.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.783 HG21 ' HA ' ' A' ' 111' ' ' GLU . 63.4 p -67.9 -26.51 66.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -26.9 28.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.239 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -66.57 -57.43 7.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.987 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.487 ' CG ' HD12 ' A' ' 113' ' ' LEU . 5.9 p-10 -76.47 -34.19 58.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.85 59.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.11 -30.87 66.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 -30.19 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.062 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -90.07 -148.01 18.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.64 -178.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.641 HG13 HG23 ' A' ' 259' ' ' VAL . 12.0 tt -104.55 114.96 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.51 147.09 0.77 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 -167.68 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.502 2.135 . . . . 0.0 112.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 30.29 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.95 90.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -51.94 -36.88 65.89 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.575 2.183 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.57 -36.74 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 19.8 mmt -61.81 -22.08 65.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 t -52.06 -27.31 13.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.0 -33.45 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.149 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -29.12 66.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 45.2 t90 -47.98 -28.83 2.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.92 -42.95 90.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.903 ' O ' HG22 ' A' ' 345' ' ' THR . . . -79.93 -30.45 39.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.471 HG11 ' HE1' ' A' ' 158' ' ' TRP . 43.5 t -53.9 -29.72 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.642 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -52.55 -46.73 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.186 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 342' ' ' ALA . 14.8 t -50.0 -30.57 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.079 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.18 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.754 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 348' ' ' ILE . 34.8 m -79.83 -49.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 347' ' ' VAL . 1.5 tt -49.99 -42.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.698 0.285 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.3 m120 -60.86 -33.23 72.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.17 65.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.39 -10.57 59.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.534 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 54.2 m -67.62 -29.05 68.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.035 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.01 -12.33 65.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -129.66 39.59 3.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.404 ' CG ' ' HB3' ' A' ' 349' ' ' ASN . 7.6 tp60 -123.73 127.1 47.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 18.2 p -110.07 141.26 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.824 HG21 ' HB ' ' A' ' 193' ' ' THR . 21.2 t -57.79 -27.91 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -37.75 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -80.24 -52.76 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -53.88 -33.21 55.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.107 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 361' ' ' LEU . 0.8 OUTLIER -82.24 -49.38 10.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -64.63 -55.48 19.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 364' ' ' ALA . 1.3 p-10 -59.64 -29.68 68.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.689 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.79 -55.49 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -30.74 60.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.0 p -80.06 -30.08 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.935 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -47.11 41.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.31 -35.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.3 p -99.0 30.7 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.717 0.294 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.32 51.97 3.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.674 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.5 ptmt -134.48 130.44 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 6' ' ' LYS . 9.4 mp -125.75 157.29 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 16.7 t -134.18 104.15 5.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.307 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.649 HG23 ' HE1' ' A' ' 61' ' ' PHE . 3.7 mp -99.88 124.18 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.346 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' ILE . 9.8 t90 -107.07 117.72 34.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.514 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -131.21 155.96 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.232 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -143.82 110.73 5.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.65 57.37 0.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -140.36 -50.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 tttt 59.4 31.53 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.66 36.52 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.525 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -60.13 -35.62 75.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.52 -51.15 38.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.13 54.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.97 -56.47 21.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.826 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.85 69.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -31.85 70.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.951 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -75.35 -38.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -25.32 75.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.54 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -57.26 -41.89 80.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -74.61 -47.67 30.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.609 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.5 m-85 -62.32 -56.24 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -51.85 -28.25 15.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.434 0.635 . . . . 0.0 110.683 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -25.69 49.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.61 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.643 ' O ' ' OG1' ' A' ' 31' ' ' THR . 14.5 t0 -51.58 -56.73 11.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.833 ' O ' HG22 ' A' ' 31' ' ' THR . 6.9 m 156.97 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.761 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.76 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.76 45.91 0.01 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 117.58 -2.248 . . . . 0.0 115.898 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.0 mm -131.45 95.79 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 118.425 1.113 . . . . 0.0 111.541 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -111.07 128.49 55.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.483 HG11 ' CE2' ' A' ' 283' ' ' TYR . 27.2 m -126.85 138.7 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.9 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.28 115.2 27.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 37' ' ' VAL . 14.7 p -86.3 116.27 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.808 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG3' ' CG1' ' A' ' 8' ' ' VAL . 6.0 mm-40 -104.27 143.32 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 111.277 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.59 ' O ' HD22 ' A' ' 43' ' ' LEU . 5.1 p80 -112.42 158.47 37.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.67 -83.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.358 2.039 . . . . 0.0 112.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 49.98 -92.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -120.34 -2.99 9.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 39' ' ' HIS . 7.2 mp -53.26 -25.79 15.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.687 0.28 . . . . 0.0 111.319 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -55.15 -38.84 68.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.36 -23.3 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.067 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -75.3 -29.53 60.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.164 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 64.5 t80 -55.74 -56.58 28.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.273 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.3 Cg_endo -64.01 -15.27 48.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.556 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.65 -55.3 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 46' ' ' LYS . 14.1 m -73.08 -28.87 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.04 -28.07 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -26.23 62.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.336 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.6 m -148.4 124.08 10.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.9 -54.25 2.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.343 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.98 -55.04 0.5 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.38 -107.01 0.35 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.575 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 87.3 Cg_exo -48.3 150.17 5.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.631 2.22 . . . . 0.0 112.259 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -153.89 38.53 0.46 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.551 HG22 ' HE1' ' A' ' 61' ' ' PHE . 13.1 mt -152.73 118.47 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 110.533 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 ' HB3' ' A' ' 10' ' ' TRP . 12.7 mt -151.15 142.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 111.694 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.779 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 2.1 m-85 -128.38 120.47 27.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.89 92.48 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.741 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . . . 42.59 -165.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.054 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -76.94 -29.53 55.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 p30 -47.78 -35.16 9.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.527 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -36.86 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.79 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 13.5 t80 -77.56 -64.03 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.2 -10.21 61.97 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.054 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.39 -61.11 1.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -96.57 -48.23 5.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.691 0.282 . . . . 0.0 111.088 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -57.01 -29.69 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.251 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -64.11 -31.62 72.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -26.8 25.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.77 70.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.59 39.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 265' ' ' GLY . 1.2 tt -148.79 118.48 7.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.41 156.09 28.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -93.4 156.85 16.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 HG22 ' CE ' ' A' ' 277' ' ' LYS . 2.9 pt -147.12 163.86 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -110.49 86.13 5.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.593 ' HD2' HD13 ' A' ' 103' ' ' LEU . 98.9 Cg_endo -79.8 -168.35 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.531 2.154 . . . . 0.0 112.362 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 86' ' ' GLN . 21.8 m-20 64.01 131.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -120.26 -100.89 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.71 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.4 -59.18 2.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 86' ' ' GLN . 50.9 p90 -80.91 -53.13 6.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 89' ' ' LEU . 2.5 mt-30 -52.76 -23.07 6.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.997 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 1.8 p-10 -45.5 -30.86 1.55 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -123.39 -65.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.821 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.581 ' C ' HD12 ' A' ' 89' ' ' LEU . 3.6 pp 42.69 -168.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.607 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.411 ' N ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -69.24 112.83 13.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.83 -26.12 29.66 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.384 2.056 . . . . 0.0 112.354 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.29 -31.9 70.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -75.35 -31.02 60.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 89' ' ' LEU . 2.4 m0 -70.17 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.81 -26.43 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.213 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.01 67.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.102 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 24.1 t -152.46 68.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.48 155.57 42.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.31 168.6 13.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -71.71 65.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.3 28.47 13.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 163.98 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.593 HD13 ' HD2' ' A' ' 81' ' ' PRO . 1.4 mt -145.33 75.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' A' ' 67' ' ' PHE . 2.3 pt -108.22 39.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -170.89 132.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 285' ' ' LEU . 29.5 t80 -155.14 102.19 2.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 5.3 Cg_exo -79.22 167.34 21.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.743 2.295 . . . . 0.0 111.925 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.99 39.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 262' ' ' LEU . . . -176.85 157.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 317' ' ' ILE . 30.9 m -132.27 106.16 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -126.94 159.65 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.25 159.43 20.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.642 ' C ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -79.72 161.43 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.496 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -165.15 -176.03 3.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 224' ' ' MET . 8.5 mp -103.09 108.68 19.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.864 HD11 ' CD1' ' A' ' 242' ' ' TYR . 9.1 tt -87.99 149.31 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.42 163.53 30.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -102.53 -178.04 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.7 81.25 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -163.06 -63.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.6 pt? -123.71 40.03 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.4 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 tt -144.65 115.82 5.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' HD23 ' A' ' 122' ' ' LEU . 40.6 Cg_endo -67.12 158.0 59.02 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.425 2.083 . . . . 0.0 112.197 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -65.02 111.25 5.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.51 154.76 24.29 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.51 2.14 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.54 -167.52 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.526 2.151 . . . . 0.0 112.238 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 p -76.99 140.52 40.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.01 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.837 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.1 m95 -71.71 -37.34 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.58 -23.82 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.643 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.04 -16.26 41.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.837 HD12 ' CE3' ' A' ' 129' ' ' TRP . 37.0 mt -65.61 -48.77 64.2 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 84.9 Cg_exo -46.4 -35.78 16.66 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.419 2.079 . . . . 0.0 112.465 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.07 93.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.51 -31.66 53.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.691 ' OD1' HG22 ' A' ' 132' ' ' ILE . 1.1 m-20 -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -71.83 -31.84 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.32 -45.27 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.44 -48.83 30.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -59.22 -25.64 64.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.021 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.76 33.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.387 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -109.03 -63.39 1.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.82 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.9 39.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.327 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -153.88 166.29 33.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 222' ' ' THR . 4.0 m -119.15 162.81 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.806 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -93.0 -2.15 56.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.597 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 147' ' ' LEU . 1.9 pt? 172.61 126.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.716 0.293 . . . . 0.0 110.477 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.23 120.74 8.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.587 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.38 123.85 48.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.077 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 156' ' ' PHE . 1.4 p-10 -85.04 154.25 22.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 151' ' ' LEU . 9.8 mt -128.37 -46.27 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.37 39.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 3.2 mt-10 -120.18 137.03 25.5 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 4.4 Cg_exo -79.63 179.24 6.49 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.726 2.284 . . . . 0.0 112.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' A' ' 258' ' ' PHE . 3.6 m-85 59.8 20.11 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CZ ' ' OD1' ' A' ' 150' ' ' ASN . 19.3 m-85 -120.84 -33.0 3.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.166 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -77.23 -24.28 51.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -69.42 -55.31 9.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 158' ' ' TRP . 21.6 Cg_exo -65.35 -32.84 49.79 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.48 2.12 . . . . 0.0 112.23 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.529 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.5 OUTLIER -70.1 -52.64 22.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.237 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.521 HD11 HD13 ' A' ' 195' ' ' LEU . 47.0 mt -77.06 -5.1 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.821 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -83.91 -63.96 1.25 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.34 -87.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ALA . 2.0 t0 -115.89 -39.57 3.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.67 -91.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.13 -47.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.516 ' OH ' HD21 ' A' ' 361' ' ' LEU . 0.3 OUTLIER 60.76 42.23 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.27 -24.68 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -144.23 65.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.64 -174.89 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.2 -30.0 51.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.13 93.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.181 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -67.04 -33.64 75.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.48 -46.32 80.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.77 -28.34 67.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -74.99 -31.82 61.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.89 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 p -75.25 -30.78 60.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CE1' ' HE3' ' A' ' 251' ' ' LYS . 5.8 m-85 -72.66 -41.98 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 161' ' ' ILE . 1.2 tt -60.54 -37.84 82.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 199' ' ' ILE . 31.4 m -76.05 -30.26 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.78 -41.33 68.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.23 -50.15 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 195' ' ' LEU . 17.1 tt -59.47 -30.85 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -62.23 -26.78 68.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -97.53 -23.73 15.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.071 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -88.88 -66.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -35.2 73.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 mtt -101.54 72.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -179.15 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.46 -45.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.07 95.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.9 t -63.36 137.56 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' HD12 ' A' ' 212' ' ' ILE . 2.8 t0 -86.78 -166.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.017 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 211' ' ' SER . 48.8 p90 -79.0 -40.36 31.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.172 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 0.3 OUTLIER -79.53 -24.67 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.356 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 209' ' ' ASP . 12.7 mt -81.56 -57.29 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.42 68.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.3 -42.62 20.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -57.18 -31.37 65.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.422 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.43 -52.23 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -68.65 -28.36 66.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.626 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -69.29 -50.85 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -107.05 -23.76 12.2 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 99.97 67.7 0.85 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.749 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.08 38.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 145' ' ' SER . 14.9 p -152.16 179.99 8.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -85.82 38.85 0.77 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.39 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.454 ' HG2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.63 159.19 0.24 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.024 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -144.52 105.14 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.827 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.4 mt -80.82 136.15 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -115.24 163.77 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -163.62 163.02 35.46 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--N 1.343 0.257 0 C-N-CA 122.576 2.184 . . . . 0.0 112.347 179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.864 ' CD1' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.809 0.337 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -145.1 144.22 12.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' A' ' 116' ' ' ILE . 23.6 m -93.4 136.47 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 61.6 m -141.01 150.13 42.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 323' ' ' ASN . 9.9 p -100.3 150.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.784 ' H ' HD22 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -126.25 97.45 34.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.54 51.89 4.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.924 2.416 . . . . 0.0 112.691 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.12 114.41 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -155.09 111.69 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.763 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HE3' ' CE1' ' A' ' 194' ' ' PHE . 13.7 mptt 58.11 19.97 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.261 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 116.06 -34.79 4.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.889 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -132.37 152.13 79.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.295 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HG3' ' CD ' ' A' ' 326' ' ' LYS . 71.8 Cg_endo -77.04 132.4 12.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.73 2.287 . . . . 0.0 112.485 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 159' ' ' PRO . 67.5 m -54.42 178.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.39 83.43 46.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.59 162.89 24.44 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.962 2.441 . . . . 0.0 112.151 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 5.1 m-85 -88.36 144.32 26.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 329' ' ' ILE . 35.8 m -99.83 154.51 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.08 110.51 1.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.442 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 109' ' ' ALA . 18.4 m -108.33 144.65 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 109' ' ' ALA . 9.8 mt -69.76 90.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.2 m -79.59 120.84 24.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.779 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -83.54 123.89 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.112 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.543 ' HA2' HD11 ' A' ' 76' ' ' LEU . . . -102.75 106.13 2.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 76' ' ' LEU . 14.7 tt -95.73 141.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 0.0 111.074 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -83.59 138.39 33.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.94 -30.84 44.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.6 52.53 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.8 p -115.86 149.24 42.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 125.64 12.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.599 2.199 . . . . 0.0 112.318 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.88 88.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -75.08 -33.89 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.52 -30.89 67.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.64 -32.96 60.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.78 69.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.518 ' CE ' HG22 ' A' ' 79' ' ' ILE . 32.2 mttt -65.23 -58.99 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.92 -32.09 70.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -51.35 69.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -31.28 64.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -71.79 -30.26 65.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.56 27.48 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -132.89 -69.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.33 -52.14 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 106' ' ' TYR . 16.8 mt -83.11 67.88 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.767 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.5 t -146.4 168.0 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.775 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.66 -45.66 66.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.47 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -71.87 -57.4 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.767 ' H ' HG23 ' A' ' 286' ' ' THR . . . -56.54 -57.19 20.66 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.803 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -56.1 -36.72 68.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 111.123 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -78.66 -27.7 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.07 -57.8 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.189 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.03 -29.9 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.371 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -64.72 -60.42 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -82.01 -47.44 12.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.398 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.52 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.259 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -159.93 89.77 1.86 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.011 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -173.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.188 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 300' ' ' GLY . 1.6 pp -178.84 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 164.34 121.89 0.58 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 110' ' ' VAL . . . 179.25 157.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 110' ' ' VAL . 11.8 p -178.28 56.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -97.33 40.34 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.26 167.74 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -113.33 -36.66 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.2 m -79.37 -52.46 8.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 311' ' ' LEU . 6.2 m-85 -67.48 -24.64 65.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -53.59 -29.9 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -69.17 -31.14 69.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -92.92 -38.16 11.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 307' ' ' TYR . 7.3 mp -58.97 -28.17 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.74 56.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -57.24 -29.51 63.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 0.8 OUTLIER -66.85 143.27 97.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.69 -37.27 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -59.02 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.637 ' CD1' HG21 ' A' ' 110' ' ' VAL . 8.9 tp -67.54 -29.93 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -67.39 -36.29 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.29 -33.79 43.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.2 m -76.85 -40.86 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.464 ' HA ' ' HB3' ' A' ' 324' ' ' ALA . 3.3 ptt? -58.17 -25.82 61.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.64 -57.62 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.677 ' HB2' HG21 ' A' ' 246' ' ' VAL . 2.2 t30 -78.47 -30.58 47.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 321' ' ' MET . . . -59.3 -42.21 90.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.27 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -29.05 64.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.402 ' CD ' ' HG3' ' A' ' 254' ' ' PRO . 6.0 mttp -97.44 -30.72 12.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.0 -165.02 30.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.57 165.78 30.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 110.915 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 329' ' ' ILE . 3.9 mp -83.21 130.77 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.82 101.76 10.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.82 -10.91 30.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.478 2.119 . . . . 0.0 112.541 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 65.87 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.878 0.371 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 336' ' ' MET . 8.3 tt -79.48 127.6 77.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.67 -34.59 54.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.344 2.029 . . . . 0.0 112.429 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -57.79 -30.4 65.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.416 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.7 p -54.73 -30.87 57.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.76 -30.95 45.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -77.93 -26.49 48.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.21 -43.68 78.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.98 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -28.94 43.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.39 -51.29 58.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.333 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 p -54.61 -29.89 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.349 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.493 ' HB3' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -75.17 -60.9 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 4.5 p -60.54 -29.94 69.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.6 -50.52 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 343' ' ' VAL . 37.4 t -79.54 -53.36 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.789 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 344' ' ' ARG . 69.3 mt -51.68 -39.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.901 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 350' ' ' ALA . 35.8 p30 -51.45 -25.8 7.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 111.41 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . 0.44 ' N ' ' OD1' ' A' ' 349' ' ' ASN . . . -62.14 -33.61 74.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.36 -11.57 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.484 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.5 p -67.67 -30.23 69.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.64 -14.24 64.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.73 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -130.38 39.86 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.17 132.87 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 68.5 p -115.7 142.22 47.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 31.0 m -58.62 -27.94 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.243 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.37 -38.24 65.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -51.08 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.76 -29.9 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.516 HD21 ' OH ' ' A' ' 167' ' ' TYR . 9.9 mt -82.18 -56.39 3.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.004 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -63.62 -53.18 55.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -55.93 -47.88 76.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.47 -53.21 55.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -56.97 -30.53 64.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 8.7 p -80.68 -40.24 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.3 mtp-105 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.5 mt -75.72 -47.21 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.247 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 92.8 m -103.65 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.956 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 17.7 tptm . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.877 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.856 0.36 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 p -103.02 178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -130.3 131.71 45.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 64.97 -75.3 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.31 43.71 97.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.559 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.82 139.74 40.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.851 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 57' ' ' PRO . 85.5 mt -138.21 154.77 49.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.491 HG22 ' HG2' ' A' ' 57' ' ' PRO . 5.4 m -125.61 102.82 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HA ' HG23 ' A' ' 59' ' ' ILE . 3.8 mp -96.43 118.36 42.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.212 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.436 ' CE2' HD13 ' A' ' 43' ' ' LEU . 93.8 m95 -94.98 112.05 23.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -145.24 145.56 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.068 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -163.75 112.67 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.66 -42.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.452 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -176.92 -48.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.761 0.315 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -153.17 -175.15 5.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' O ' HD23 ' A' ' 20' ' ' LEU . . . 124.97 -34.89 3.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.489 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 8.5 p90 -62.36 -34.65 77.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.414 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 21.4 t-20 -68.07 -36.89 80.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.57 -39.03 30.98 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 16' ' ' GLY . 4.5 mm? -68.28 -31.32 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.942 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.55 -40.35 94.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -60.44 -34.33 73.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.67 -31.0 40.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.13 -46.72 9.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.608 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -29.7 59.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.776 0.322 . . . . 0.0 111.087 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -37.74 37.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -67.26 -56.5 9.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.588 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.685 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -53.58 -27.7 27.95 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.312 0.577 . . . . 0.0 110.245 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -46.4 -32.49 3.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.809 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.746 ' O ' HG23 ' A' ' 31' ' ' THR . 24.7 t0 -62.97 -57.41 10.81 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.61 37.11 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.653 0.596 . . . . 0.0 112.248 176.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.87 43.37 0.02 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 117.909 -2.091 . . . . 0.0 115.537 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 27' ' ' PHE . 3.2 mp -140.38 95.33 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 118.039 0.919 . . . . 0.0 111.857 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -122.17 131.8 54.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -108.07 148.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.76 137.13 50.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.0 m -118.55 111.51 34.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.082 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -136.75 163.05 31.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -98.72 144.4 28.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.42 136.04 23.3 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.516 2.144 . . . . 0.0 112.326 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.46 -47.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.7 pttt -116.24 0.15 12.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.374 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD13 ' CE2' ' A' ' 10' ' ' TRP . 7.2 tp -56.6 -25.41 52.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.746 0.308 . . . . 0.0 111.147 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -55.73 -31.96 62.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.24 -29.6 13.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.835 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.522 ' O ' HG23 ' A' ' 50' ' ' VAL . 18.2 tttt -73.95 -24.55 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.059 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -49.15 -58.48 8.65 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.43 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 26.5 Cg_endo -61.96 -18.96 64.22 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.436 2.091 . . . . 0.0 112.455 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -89.75 -35.97 15.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.906 0.384 . . . . 0.0 110.829 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 46' ' ' LYS . 27.8 t -88.58 -17.83 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.39 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.27 -39.76 64.14 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.827 0.346 . . . . 0.0 111.271 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.695 ' O ' HG23 ' A' ' 53' ' ' THR . . . -80.55 -40.35 26.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -169.66 -74.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.808 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.08 -74.37 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -136.18 -71.83 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.376 . . . . 0.0 110.868 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.27 -91.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.644 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.3 Cg_endo -64.27 -177.74 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.26 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 167.09 106.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 9' ' ' ILE . 6.8 tt -146.94 117.31 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.81 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 43' ' ' LEU . 3.2 mp -121.19 142.74 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.408 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.656 ' HD1' HD13 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -96.05 117.13 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.386 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -143.12 173.23 11.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -57.26 -168.61 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 261' ' ' VAL . 0.4 OUTLIER -76.1 -56.4 4.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.04 -28.98 57.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.982 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -58.24 -41.77 84.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.887 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -111.88 -55.23 2.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.62 -29.07 74.33 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.25 -29.81 29.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.548 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.63 -45.93 8.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.939 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.788 ' HB3' HD12 ' A' ' 76' ' ' LEU . . . -61.5 -31.17 71.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.06 67.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 p -108.33 25.79 11.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.07 -75.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -176.77 83.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.808 0.337 . . . . 0.0 110.952 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -110.25 143.7 40.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.871 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.659 ' H ' HD23 ' A' ' 76' ' ' LEU . . . -62.49 83.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.11 96.65 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.856 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 80' ' ' THR . 40.2 mt -72.07 158.32 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.143 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 79' ' ' ILE . 43.6 p -101.2 157.96 32.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 98.1 Cg_endo -79.8 89.64 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.605 2.203 . . . . 0.0 112.397 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.12 -55.2 1.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.86 -25.29 64.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.32 -23.25 22.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.493 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -75.13 -59.18 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.924 0.392 . . . . 0.0 110.744 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -25.03 61.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -76.39 -39.86 52.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 61.02 37.3 18.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.69 -170.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -98.05 146.53 31.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.97 -32.4 8.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.541 2.161 . . . . 0.0 112.374 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.58 -31.73 72.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -31.3 62.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -86.54 -41.78 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -30.93 70.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.53 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 97' ' ' VAL . 22.8 m -122.06 60.49 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 93.04 3.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.958 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -101.93 113.66 27.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.4 -68.82 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.014 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.54 39.11 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.492 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.6 171.5 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.857 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.39 92.03 3.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.905 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.585 HG22 ' HB3' ' A' ' 76' ' ' LEU . 1.7 pp -112.97 46.87 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -171.51 124.76 0.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.087 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.741 ' HD2' HD11 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -123.96 100.99 36.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.997 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.84 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.0 Cg_endo -79.87 127.72 7.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.599 2.199 . . . . 0.0 112.135 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 285' ' ' LEU . 9.3 mm -138.8 39.27 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 111.252 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.939 ' CB ' HD23 ' A' ' 262' ' ' LEU . . . 176.02 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.779 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.97 105.72 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.918 0.39 . . . . 0.0 111.056 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 132.86 49.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.97 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.703 ' HB3' HG22 ' A' ' 320' ' ' THR . . . -152.48 174.32 14.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -99.92 160.73 14.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.65 ' OG ' ' HB1' ' A' ' 319' ' ' ALA . 4.2 m -164.07 -179.79 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -111.99 133.67 54.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.943 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.71 143.57 12.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.19 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' A' ' 245' ' ' THR . 46.7 p90 -139.1 179.36 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.919 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -139.41 177.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.77 34.93 4.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -131.11 -65.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 121' ' ' LEU . 1.3 pp -130.04 39.92 3.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.15 88.36 13.2 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.77 140.23 47.56 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.31 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -70.26 165.89 39.62 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.847 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.72 122.45 10.54 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.528 2.152 . . . . 0.0 112.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.64 -52.15 1.51 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.41 2.073 . . . . 0.0 112.361 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.43 -76.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.93 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.455 HG22 ' OG1' ' A' ' 249' ' ' THR . 17.6 p -116.42 -173.64 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.036 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.547 ' CE3' HG21 ' A' ' 132' ' ' ILE . 7.6 m95 -70.6 -31.23 68.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.415 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 2.4 tt0 -52.95 -24.17 8.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.313 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -89.05 -15.91 32.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.687 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.733 HG22 ' HD3' ' A' ' 133' ' ' PRO . 5.6 tp -52.75 -35.79 28.42 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.733 ' HD3' HG22 ' A' ' 132' ' ' ILE . 16.8 Cg_exo -68.2 -27.45 35.11 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.293 1.995 . . . . 0.0 112.2 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.05 -28.24 63.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.24 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.739 ' O ' HD23 ' A' ' 139' ' ' LEU . 0.1 OUTLIER -77.8 -31.86 52.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.806 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -71.08 -51.95 22.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -30.64 68.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.9 mt-10 -79.48 -43.28 23.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 135' ' ' LEU . 3.7 mm? -64.0 -49.93 70.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.93 -26.12 64.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.9 -23.12 29.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.383 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -110.63 -60.71 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.49 40.12 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.566 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.525 ' CB ' HD12 ' A' ' 139' ' ' LEU . 0.4 OUTLIER -150.65 -178.03 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.8 t -139.29 175.36 9.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.791 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -135.12 44.96 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.221 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.14 115.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 14.6 mmt -159.14 106.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.691 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 156' ' ' PHE . 1.6 t80 -168.97 177.03 5.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.013 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HA ' ' HB1' ' A' ' 213' ' ' ALA . 1.2 m120 -67.83 178.96 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.413 HD12 ' NE2' ' A' ' 152' ' ' GLN . 0.1 OUTLIER -135.04 -46.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.413 ' NE2' HD12 ' A' ' 151' ' ' LEU . 1.0 OUTLIER -97.62 40.06 1.18 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.858 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -93.76 149.07 36.48 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.959 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.8 155.88 23.85 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.666 2.244 . . . . 0.0 112.321 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 60.26 20.36 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.636 ' HZ ' HD13 ' A' ' 226' ' ' ILE . 0.4 OUTLIER -121.08 -56.35 1.93 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 0.0 110.927 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.455 ' O ' HD12 ' A' ' 161' ' ' ILE . 2.1 t -72.35 -32.03 66.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.172 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.546 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 66.1 t90 -64.36 -55.16 32.62 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.258 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -62.29 -28.66 79.12 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.264 1.976 . . . . 0.0 112.275 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.522 HD22 HD11 ' A' ' 195' ' ' LEU . 2.0 tp -68.7 -56.96 6.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.495 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.801 HD13 HD22 ' A' ' 192' ' ' LEU . 4.9 mt -78.23 -4.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.216 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -79.11 -50.45 11.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.874 0.369 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 254' ' ' PRO . . . -101.44 37.64 1.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 250' ' ' PHE . 0.4 OUTLIER -108.02 -31.21 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.847 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -166.3 -41.68 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.463 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . 171.01 164.77 27.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.506 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -176.18 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.329 . . . . 0.0 110.934 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.17 -50.87 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -152.75 165.38 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.916 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.88 135.3 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.427 ' CE2' ' HA2' ' A' ' 174' ' ' GLY . 0.1 OUTLIER -101.99 115.16 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.867 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -122.32 102.21 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.805 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 5.1 m120 60.04 31.14 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 171' ' ' TYR . . . 82.94 51.37 4.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.528 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -143.5 125.36 15.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -103.24 150.2 23.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.16 171.53 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.49 -66.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.32 32.98 4.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -128.36 98.85 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.2 t -92.69 150.28 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.107 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.3 42.63 1.4 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.23 -35.18 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 111.111 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -85.23 57.28 4.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -130.83 160.03 35.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.24 -31.48 72.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.068 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.79 -55.36 25.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.44 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 166' ' ' GLY . . . -60.26 -33.32 72.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 111.103 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.601 ' O ' HG23 ' A' ' 193' ' ' THR . 11.2 ttmt -74.26 -46.28 42.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.15 -30.48 68.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.642 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -74.02 -60.32 3.65 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.451 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.801 HD22 HD13 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -56.99 -31.57 65.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.818 0.342 . . . . 0.0 110.776 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 189' ' ' LYS . 40.3 p -72.9 -28.72 62.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -77.7 -50.44 12.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.416 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.654 HD12 HD11 ' A' ' 161' ' ' ILE . 8.4 mt -66.94 -28.84 68.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.663 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 192' ' ' LEU . 14.9 p -77.42 -46.59 27.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.492 ' N ' HG13 ' A' ' 196' ' ' VAL . 10.5 p30 -62.55 -27.19 69.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.712 0.291 . . . . 0.0 111.228 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.427 ' N ' ' OD1' ' A' ' 197' ' ' ASP . 0.2 OUTLIER -57.48 -30.69 65.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.144 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 5.7 mt -79.8 -55.2 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.326 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -21.02 64.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.404 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -93.82 15.54 16.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.327 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -120.15 -75.73 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -120.12 -4.93 10.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.49 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 24.1 ptm 45.53 30.56 0.78 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.907 0.384 . . . . 0.0 111.366 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 206' ' ' ALA . 0.9 OUTLIER -136.5 -43.84 0.61 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.985 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 205' ' ' ASN . . . 67.52 73.31 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.087 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -113.07 28.25 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.953 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.814 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.7 OUTLIER -106.18 119.65 39.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.899 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 -166.28 1.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.401 ' HA ' ' ND2' ' A' ' 150' ' ' ASN . 52.2 p90 -79.1 -40.81 30.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.284 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.6 m -79.94 -24.63 40.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.58 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 9.0 mt -81.82 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.814 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -55.71 -30.28 60.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.491 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -81.36 -30.48 33.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.925 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.36 -25.15 67.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.601 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.39 -56.92 10.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.612 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 218' ' ' ASN . 20.4 p90 -76.39 -34.6 58.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.824 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.451 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 1.8 m-20 -73.66 -8.31 55.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.305 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -23.65 58.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.001 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 221' ' ' GLU . . . -159.33 -85.42 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.385 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 220' ' ' GLY . 0.5 OUTLIER 171.78 101.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.766 0.317 . . . . 0.0 110.482 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 5.4 t -116.27 -177.36 3.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.791 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 39.56 0.43 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.831 -0.348 . . . . 0.0 110.98 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -162.47 99.68 1.04 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.914 0.388 . . . . 0.0 111.122 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 17.3 m -144.51 105.15 4.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.763 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.636 HD13 ' HZ ' ' A' ' 156' ' ' PHE . 4.0 mt -113.51 135.0 54.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -95.7 147.57 23.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -155.07 -157.05 8.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.507 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.34 76.83 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.551 2.167 . . . . 0.0 112.326 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.25 -52.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -156.54 79.49 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.096 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.5 -31.5 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.4 p -126.73 147.84 49.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -154.47 40.07 0.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 21.8 mt 69.11 -67.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 237' ' ' THR . 5.3 m-20 -160.27 170.42 21.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 236' ' ' ASP . 0.8 OUTLIER -157.89 168.19 27.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.28 114.69 4.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -138.01 31.22 2.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.879 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 20.4 t 68.79 -67.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.188 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -147.58 126.89 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -149.17 136.01 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.19 -173.7 13.07 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.467 HG21 ' CB ' ' A' ' 319' ' ' ALA . 11.4 p -132.04 136.48 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.416 HG23 ' CE1' ' A' ' 117' ' ' TYR . 0.9 OUTLIER -130.58 156.18 45.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 13.1 p -77.42 150.63 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.93 146.72 81.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HG2' ' CD1' ' A' ' 129' ' ' TRP . 95.6 Cg_endo -79.77 152.07 22.18 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.681 2.254 . . . . 0.0 112.435 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.79 HG22 ' HD3' ' A' ' 254' ' ' PRO . 45.6 p -63.82 177.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.404 ' CD1' ' OD1' ' A' ' 164' ' ' ASP . 4.5 t80 -159.88 111.89 2.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.739 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 7.2 mttm 59.38 21.24 9.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 136.51 -47.64 0.96 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.59 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -150.93 151.19 29.42 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.289 . . . . 0.0 110.952 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.79 ' HD3' HG22 ' A' ' 249' ' ' THR . 59.5 Cg_endo -72.21 -175.63 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.314 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -172.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -118.5 81.25 17.57 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -79.69 -168.3 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.631 2.221 . . . . 0.0 112.344 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -171.95 161.13 5.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 328' ' ' GLU . 27.6 m -75.8 146.01 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.208 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -111.53 74.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.524 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.449 ' CG2' ' CD2' ' A' ' 64' ' ' HIS . 13.3 m -95.83 135.13 30.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.657 0.265 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.939 HD23 ' CB ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -86.87 124.25 32.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 t -92.95 112.86 24.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.758 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -131.69 140.12 49.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 169.1 -173.26 43.55 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.618 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 276' ' ' ALA . 26.3 mm -88.53 159.74 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.783 0.325 . . . . 0.0 111.046 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.487 ' N ' HG22 ' A' ' 266' ' ' ILE . 6.4 m120 -98.12 108.02 20.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.994 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 75' ' ' LEU . . . 67.78 10.28 7.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.827 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . . . 45.41 30.3 0.7 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.814 0.34 . . . . 0.0 111.559 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER -64.2 -61.04 7.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.032 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 270' ' ' SER . 63.4 Cg_endo -73.63 97.85 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.504 2.136 . . . . 0.0 112.468 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.543 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 23.9 m-20 59.1 86.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.041 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.99 -30.94 61.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -76.43 -57.23 3.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.96 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 4.0 mp -61.62 -31.4 71.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 266' ' ' ILE . . . -59.22 -56.75 18.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.22 -43.94 80.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.79 -42.27 99.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.985 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -66.07 -31.3 72.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.997 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -81.24 -25.76 36.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -93.8 -32.24 14.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.204 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -110.15 27.53 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.219 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 27' ' ' PHE . 1.4 m-85 -177.31 48.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.03 0.443 . . . . 0.0 110.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 280' ' ' LEU . 1.1 mt -178.25 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 108' ' ' ILE . 4.1 mm? -107.44 65.12 0.64 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.832 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.1 t -150.99 171.85 16.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.739 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -52.37 -48.2 65.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -77.55 -35.02 53.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.096 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.832 ' H ' HG23 ' A' ' 286' ' ' THR . . . -55.34 -75.76 0.23 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.791 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.53 -21.92 29.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.676 0.274 . . . . 0.0 111.316 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.19 -29.12 5.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.359 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -76.91 -53.76 7.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.612 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 294' ' ' ASN . 12.3 p -72.41 -46.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.8 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.494 ' N ' HG13 ' A' ' 293' ' ' VAL . 46.6 p-10 -58.29 -21.22 48.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.326 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.76 -55.25 2.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 0.0 111.074 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -58.97 -64.09 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.022 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -126.62 87.66 55.98 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.485 ' C ' HD23 ' A' ' 299' ' ' LEU . 57.6 Cg_endo -71.09 163.71 38.28 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.539 2.159 . . . . 0.0 112.23 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.633 HD23 ' N ' ' A' ' 299' ' ' LEU . 1.3 pt? -175.72 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -160.32 -167.1 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.448 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.723 ' HB3' ' CG2' ' A' ' 317' ' ' ILE . . . -136.51 160.06 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.858 0.361 . . . . 0.0 111.156 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.557 ' CG2' HD23 ' A' ' 304' ' ' LEU . 27.5 m -79.95 -179.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.196 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -107.89 40.0 1.82 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.557 HD23 ' CG2' ' A' ' 302' ' ' VAL . 3.8 mm? -78.26 126.97 31.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.82 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.11 93.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.4 p -68.78 -52.42 30.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -65.68 -27.35 68.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -55.37 -28.13 51.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -58.87 -45.68 89.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -93.23 -31.95 14.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.819 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.726 ' O ' HD11 ' A' ' 317' ' ' ILE . 4.6 mp -59.88 -28.19 67.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.976 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.31 -26.51 29.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.327 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -58.73 -30.75 67.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -86.91 140.59 33.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.827 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 318' ' ' ALA . 95.8 Cg_endo -78.95 -17.94 11.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.589 2.193 . . . . 0.0 112.825 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.407 ' CG ' HD13 ' A' ' 317' ' ' ILE . 3.3 ptt180 -51.18 -54.56 24.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.283 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.726 HD11 ' O ' ' A' ' 311' ' ' LEU . 0.1 OUTLIER -80.46 -29.99 12.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.851 0.357 . . . . 0.0 111.094 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.53 ' HB3' ' HA ' ' A' ' 315' ' ' PRO . . . -60.79 -31.77 71.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.24 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.65 ' HB1' ' OG ' ' A' ' 114' ' ' SER . . . -79.13 -39.14 34.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.703 HG22 ' HB3' ' A' ' 112' ' ' ALA . 62.4 p -71.67 -43.39 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 20.4 ptm -59.43 -28.81 67.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -57.38 12.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -78.35 -31.13 48.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.933 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -71.67 -23.1 61.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.298 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -50.27 65.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.147 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -47.62 11.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 159.91 136.72 2.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.54 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 259' ' ' VAL . 0.4 OUTLIER -173.31 89.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.35 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 329' ' ' ILE . 1.0 OUTLIER -133.64 118.49 30.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.02 120.31 53.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.42 -168.23 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.397 2.065 . . . . 0.0 112.289 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -98.45 -65.07 0.98 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 333' ' ' ILE . 4.5 tp 34.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.955 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.1 -25.24 31.82 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.471 2.114 . . . . 0.0 112.392 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.24 -25.85 59.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.026 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -28.56 64.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.065 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 m -56.94 -47.6 80.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.993 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -33.88 63.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.041 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.836 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -61.4 -27.0 68.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.51 -32.48 65.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -78.94 -31.46 45.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -77.82 -40.71 39.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.4 t -59.4 -30.1 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.211 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.5 ' HB3' HD12 ' A' ' 348' ' ' ILE . 10.5 mmt180 -74.97 -60.64 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.827 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 50.3 m -58.8 -27.78 65.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.027 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.49 -52.28 11.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.406 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 343' ' ' VAL . 21.7 t -79.19 -54.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.691 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 344' ' ' ARG . 62.1 mt -49.43 -58.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.56 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -57.22 -50.66 72.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.002 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.78 59.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.192 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -81.31 -10.69 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.434 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 51.6 p -67.69 -30.22 69.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 112.54 -25.34 12.24 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 46.4 mmt-85 -112.83 39.85 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.61 145.67 26.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.4 t -124.15 148.95 46.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.89 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.01 -28.2 43.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.37 -30.4 60.25 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.113 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 -54.75 5.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -62.74 -30.06 71.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.138 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.19 -56.6 3.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -60.74 -52.27 65.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -58.65 -34.88 71.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -69.98 -33.91 72.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.163 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -31.58 69.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 27.0 m -80.7 -38.18 29.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.73 -43.43 59.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 364' ' ' ALA . 1.0 OUTLIER -59.47 -35.42 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.076 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 5.4 m -80.34 -54.37 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.974 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.885 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.8 0.333 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.3 p -80.47 84.67 6.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.024 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -117.57 164.89 14.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.64 172.28 8.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.52 86.26 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' C ' HD12 ' A' ' 7' ' ' LEU . 14.3 tttt -167.96 138.29 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 6' ' ' LYS . 4.9 mp -147.86 159.57 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.7 t -110.53 103.44 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.04 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.6 mp -100.04 119.53 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -103.29 126.37 50.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.4 HG12 ' N ' ' A' ' 12' ' ' ASN . 18.7 tt -172.11 158.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.203 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 39' ' ' HIS . 9.9 t30 -176.53 -169.88 0.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.877 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.92 -31.63 3.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.31 -51.42 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.831 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -178.28 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.79 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 54.16 24.26 28.07 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.699 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -80.97 -58.08 3.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.342 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -60.16 -40.9 91.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.033 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -59.26 -51.27 60.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.578 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -31.17 54.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.13 -38.0 66.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.087 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.46 -52.71 64.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.928 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.458 HG23 ' N ' ' A' ' 24' ' ' GLY . 28.1 m -61.68 -43.77 97.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.185 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.93 -36.34 92.97 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -59.45 -44.47 92.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.929 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -79.2 -30.06 43.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.966 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.877 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -60.66 -56.55 19.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.701 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -56.32 -27.89 57.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.536 0.684 . . . . 0.0 110.4 179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.52 -33.4 14.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.499 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' O ' ' HB ' ' A' ' 31' ' ' THR . 5.0 t70 -59.73 -57.4 13.07 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.65 36.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.872 176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' C ' HD12 ' A' ' 33' ' ' ILE . . . 156.61 44.9 0.02 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 117.958 -2.068 . . . . 0.0 115.47 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.877 HD13 ' O ' ' A' ' 27' ' ' PHE . 2.3 mp -139.69 95.57 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 117.998 0.899 . . . . 0.0 111.608 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.1 ttmm -126.4 114.8 18.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.835 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 9' ' ' ILE . 3.5 m -110.94 134.62 52.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 146.2 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 m -127.27 123.45 62.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.072 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -155.46 163.16 40.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.446 ' CG ' ' HB2' ' A' ' 12' ' ' ASN . 14.2 t-80 -152.8 79.42 5.82 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' O ' HD23 ' A' ' 43' ' ' LEU . 60.9 Cg_endo -72.79 -168.36 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.454 2.103 . . . . 0.0 112.268 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.69 -28.45 8.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -81.93 0.12 41.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 40' ' ' PRO . 2.9 pp -47.75 -28.77 2.66 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.779 0.323 . . . . 0.0 111.278 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -68.57 -37.0 79.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.26 -15.17 19.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.337 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.738 ' O ' HG12 ' A' ' 50' ' ' VAL . 25.5 mttm -71.58 -24.54 61.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.223 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.6 m-85 -51.22 -60.77 5.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.257 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.4 Cg_endo -69.61 -15.36 37.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.501 2.134 . . . . 0.0 112.658 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.52 -55.32 3.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.772 0.32 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.2 p -63.62 -26.22 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.036 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.14 69.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.183 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.3 -18.98 59.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.439 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 t -144.35 115.28 7.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.14 70.62 0.95 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.341 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -96.6 28.07 3.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.979 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.22 -93.47 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.489 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.33 128.35 17.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.541 2.161 . . . . 0.0 112.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.61 103.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.049 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' A' ' 9' ' ' ILE . 2.3 tt -133.04 145.66 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.647 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.0 tt -147.17 142.76 20.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.396 . . . . 0.0 111.399 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.569 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 64.5 m-85 -100.36 118.94 37.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.72 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' O ' ' N ' ' A' ' 263' ' ' SER . 2.2 m95 -138.73 173.7 11.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.743 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.18 -177.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.95 0.405 . . . . 0.0 111.336 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -76.92 -50.1 14.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -65.28 -25.96 67.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.72 -29.51 53.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 17.7 m-85 -115.72 -36.32 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.89 -26.1 39.73 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.715 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.9 -25.61 2.5 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.862 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -34.08 16.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.754 0.311 . . . . 0.0 111.119 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 76' ' ' LEU . . . -69.14 -55.66 9.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.172 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -66.18 -20.39 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.3 m -95.27 -26.77 15.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.51 -90.79 1.58 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.558 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.646 ' C ' HD22 ' A' ' 76' ' ' LEU . 0.5 OUTLIER 179.07 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.807 0.337 . . . . 0.0 110.886 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 71' ' ' ALA . 4.1 mm? -123.15 150.46 43.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.759 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.21 121.35 32.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.095 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.84 139.13 55.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.3 pt -115.76 147.82 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.2 p -104.73 145.73 31.27 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.918 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.85 162.12 23.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.646 2.231 . . . . 0.0 112.434 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.42 -47.11 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.813 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.78 -20.43 29.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.7 19.03 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.379 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -75.04 -59.16 2.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.39 . . . . 0.0 110.639 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -70.51 -24.82 62.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.753 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.695 ' OD1' HD21 ' A' ' 304' ' ' LEU . 9.8 t70 -72.12 -26.24 62.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 tttm 66.62 72.82 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -93.34 163.02 13.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' CE1' ' HG2' ' A' ' 305' ' ' LYS . 0.3 OUTLIER -64.14 139.16 97.62 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.78 -44.41 49.86 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.496 2.131 . . . . 0.0 112.321 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.08 -29.55 65.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.554 HG23 ' HG2' ' A' ' 107' ' ' PRO . 35.6 m -56.96 -30.22 63.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.949 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -92.58 -41.05 10.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.803 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.91 -30.43 69.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.48 -30.99 63.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.057 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 97' ' ' VAL . 21.6 t -87.72 54.68 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.041 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -138.34 96.36 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.11 120.22 23.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.803 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.6 -74.6 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -179.59 36.78 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.502 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 103' ' ' LEU . 21.3 mttp -145.62 -178.5 6.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 102' ' ' LYS . 5.9 mp -137.96 92.7 2.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.929 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 104' ' ' ILE . 3.5 mp -132.25 40.0 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.076 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.92 65.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -77.22 113.27 29.51 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.554 ' HG2' HG23 ' A' ' 93' ' ' THR . 98.2 Cg_endo -79.74 133.2 10.19 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.443 2.095 . . . . 0.0 112.436 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.4 pp -145.77 39.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.838 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -177.03 154.43 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.087 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 110' ' ' VAL . 5.2 m -126.69 106.15 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.067 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.14 135.37 54.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.79 176.58 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.61 164.64 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.5 m -165.05 -178.75 5.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.65 132.37 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 28.4 mm -104.27 138.92 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.128 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 243' ' ' GLY . 8.2 p90 -146.96 167.38 24.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.595 ' CB ' HD21 ' A' ' 121' ' ' LEU . 3.2 m120 -86.55 159.34 19.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.63 36.41 2.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.561 ' C ' HD23 ' A' ' 121' ' ' LEU . 8.0 p-10 -155.36 30.66 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.975 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.595 HD21 ' CB ' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -178.16 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.806 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tt -123.42 84.5 52.51 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.33 160.46 3.44 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.239 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.07 111.63 6.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.807 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.73 154.82 26.97 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.51 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.74 ' HG2' HG22 ' A' ' 128' ' ' THR . 83.5 Cg_endo -82.57 10.29 3.66 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.777 2.318 . . . . 0.0 112.893 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt 63.42 49.53 3.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.928 0.394 . . . . 0.0 111.196 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.74 HG22 ' HG2' ' A' ' 126' ' ' PRO . 12.6 t -160.14 142.63 13.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.948 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.936 ' CE3' HD12 ' A' ' 132' ' ' ILE . 2.8 m95 -57.98 -28.89 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.002 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' C ' ' HD2' ' A' ' 133' ' ' PRO . 1.4 tp10 -53.58 -23.8 11.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.632 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 126' ' ' PRO . 0.6 OUTLIER -73.31 -21.42 60.57 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.936 HD12 ' CE3' ' A' ' 129' ' ' TRP . 21.4 mt -73.33 -53.43 4.7 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 82.5 Cg_exo -46.79 -49.94 11.5 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.276 1.984 . . . . 0.0 112.536 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.81 -39.98 86.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 6.7 mt -59.11 -32.17 69.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -57.08 -34.36 68.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.961 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -31.17 57.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.7 mm-40 -78.3 -41.61 33.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.62 ' HG ' ' HB2' ' A' ' 146' ' ' ALA . 4.2 mm? -60.39 -55.84 28.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.822 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -61.31 -24.42 66.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.038 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -55.45 -23.23 24.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.476 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -110.61 -72.84 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.865 0.364 . . . . 0.0 110.921 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -176.72 39.72 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.441 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.71 178.95 9.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.6 138.65 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 223' ' ' ALA . . . -92.22 53.34 2.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.841 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.439 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER -176.68 115.48 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.048 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.42 ' HG2' ' HA ' ' A' ' 225' ' ' THR . 1.1 ppp? -87.7 -173.63 4.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.525 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' HB3' ' HB1' ' A' ' 213' ' ' ALA . 41.4 p90 -86.5 107.67 18.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.023 0.44 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.621 ' ND2' HG21 ' A' ' 226' ' ' ILE . 2.2 t30 177.54 79.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.598 ' CD1' HG21 ' A' ' 199' ' ' ILE . 0.6 OUTLIER -177.74 -32.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.68 43.57 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.075 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -143.8 144.23 26.18 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.817 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.67 90.8 1.23 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.535 2.157 . . . . 0.0 112.281 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.45 -31.59 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -117.64 -31.44 5.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.959 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -33.87 76.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.892 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.754 ' CE2' HG13 ' A' ' 343' ' ' VAL . 0.2 OUTLIER -63.5 -56.14 29.09 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 52.7 Cg_endo -68.72 -11.12 31.05 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.357 2.038 . . . . 0.0 112.44 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.77 -57.01 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.02 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -90.56 5.31 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.503 179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -94.38 -69.41 0.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.83 0.348 . . . . 0.0 110.905 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 57.87 -86.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.285 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -122.37 29.19 7.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.85 0.357 . . . . 0.0 110.977 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -114.41 -75.33 0.65 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.05 107.51 0.98 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.539 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 111.95 23.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.87 -67.87 0.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.108 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -139.72 165.65 26.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -131.74 119.53 21.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.866 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -79.41 128.59 33.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.43 113.73 19.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.954 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.64 30.07 18.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.77 74.15 0.76 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.18 129.59 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -59.34 162.57 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -143.06 160.37 40.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -142.77 -45.46 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.128 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.489 ' N ' HG23 ' A' ' 178' ' ' ILE . 61.1 mttt -62.36 -52.22 64.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.92 106.42 2.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.9 p -122.57 151.38 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.154 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -125.68 52.36 0.81 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.38 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 15.5 m -97.98 -19.42 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.733 0.301 . . . . 0.0 111.363 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.855 ' HA ' HD22 ' A' ' 361' ' ' LEU . 2.8 m-20 -83.26 56.49 3.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.1 129.3 50.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.67 -23.92 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.312 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -57.17 -49.63 70.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.647 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.65 -40.43 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.805 ' HG3' HD11 ' A' ' 361' ' ' LEU . 9.0 mmpt? -67.73 -30.91 70.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.051 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.89 -56.87 16.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.096 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.27 -26.02 74.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.609 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.561 ' O ' HD13 ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.78 -48.37 81.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 17.8 p -72.01 -31.03 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -70.21 -43.0 71.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.524 ' HB2' HG21 ' A' ' 161' ' ' ILE . 0.3 OUTLIER -65.34 -49.98 67.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 197' ' ' ASP . 28.3 m -58.73 -43.22 87.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 196' ' ' VAL . 1.7 m-20 -69.28 -30.87 69.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -48.23 82.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.949 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.598 HG21 ' CD1' ' A' ' 151' ' ' LEU . 11.9 pt -74.97 -33.16 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.193 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -29.93 66.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.997 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.14 -26.16 22.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.04 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -102.98 -69.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.117 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -60.24 -45.41 93.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.4 ttt 60.46 26.92 16.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.0 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.05 -45.27 0.64 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.6 29.02 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -166.75 76.64 0.19 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.831 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.6 p -55.23 148.11 15.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.975 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 1.6 t0 -111.11 -167.71 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.098 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -79.37 -41.81 26.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.454 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.5 m -78.8 -25.03 44.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.398 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 1.6 mp -82.07 -54.87 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.078 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 149' ' ' PHE . . . -60.51 -30.39 69.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.447 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -77.03 -23.38 52.11 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.103 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.69 -52.75 59.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.428 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.08 -55.48 7.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.086 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -55.38 -28.21 52.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -49.03 -30.86 6.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 -23.99 29.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.997 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 62.82 22.59 64.56 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.351 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -177.06 73.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.977 0.417 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.8 p -109.77 -177.08 3.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.997 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -79.63 39.1 0.4 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.991 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.439 ' CB ' ' HA ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 169.34 92.44 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 148' ' ' MET . 0.8 OUTLIER -136.49 105.09 5.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.816 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.621 HG21 ' ND2' ' A' ' 150' ' ' ASN . 2.4 tt -92.98 114.77 30.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.088 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -142.29 164.19 30.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.806 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -124.81 -159.87 10.54 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.41 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.3 62.32 2.69 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.542 2.161 . . . . 0.0 112.335 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -170.6 34.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.48 -35.05 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.029 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -76.99 69.59 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.8 t -166.88 -52.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.932 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.61 -58.23 3.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pt -75.32 129.83 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -119.34 112.17 19.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.07 31.24 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 17.6 m 59.56 -177.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -130.22 144.72 51.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.775 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.486 HG13 ' N ' ' A' ' 241' ' ' ASN . 12.2 p -160.78 -44.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.087 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.486 ' N ' HG13 ' A' ' 240' ' ' VAL . 14.9 m-80 -156.56 146.87 21.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -147.1 123.39 10.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 117' ' ' TYR . . . -95.79 83.5 0.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 244' ' ' VAL . 15.0 p -98.46 114.71 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 41.4 p -141.08 162.72 34.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.437 HG11 ' CD ' ' A' ' 322' ' ' GLU . 11.6 p -77.39 150.56 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.4 mp -59.92 158.67 23.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.43 -160.96 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.88 2.387 . . . . 0.0 112.263 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.09 177.61 7.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 129' ' ' TRP . 4.2 t80 -164.74 115.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.6 tttt 61.23 19.0 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.077 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.75 47.77 9.48 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -141.07 90.76 9.16 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 120.755 0.312 . . . . 0.0 110.959 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.21 130.29 10.08 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.604 2.203 . . . . 0.0 112.355 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 28.9 t -53.09 160.31 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.4 90.77 35.64 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.52 -159.93 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.054 2.502 . . . . 0.0 112.086 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -132.75 138.81 47.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 260' ' ' GLY . 22.2 t -100.17 155.17 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.031 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.421 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -132.86 136.08 8.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.612 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 28.7 m -109.77 144.59 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.838 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 2.3 mp -85.44 117.84 24.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' TRP . 92.4 p -87.65 114.73 24.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.569 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . . . -115.58 128.84 56.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -160.9 -179.28 35.55 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.573 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.666 ' CG2' ' HB2' ' A' ' 269' ' ' ALA . 1.8 mt -111.68 159.36 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 266' ' ' ILE . 5.7 p-10 -127.22 134.88 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . 58.68 30.64 20.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.057 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.666 ' HB2' ' CG2' ' A' ' 266' ' ' ILE . . . -97.72 34.97 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.435 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 1.4 m -55.76 -61.12 6.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.194 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 270' ' ' SER . 36.4 Cg_endo -65.36 -23.78 58.28 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.497 2.131 . . . . 0.0 112.542 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -117.09 38.06 3.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.004 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -30.76 60.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.074 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -77.67 -57.31 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.131 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.55 -30.03 68.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.067 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.414 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -70.2 -56.47 6.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.224 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -60.15 -40.43 89.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -63.65 -46.77 84.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -73.36 -29.61 62.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.078 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -53.99 51.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.36 -14.44 52.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.359 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -96.08 27.59 3.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.157 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.721 ' HB3' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -125.76 -57.05 1.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.771 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.721 HD12 ' HB3' ' A' ' 283' ' ' TYR . 4.9 mp -110.94 -78.17 0.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.657 ' O ' HD13 ' A' ' 290' ' ' LEU . 18.5 tp 62.5 -78.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.96 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.443 HG21 HD11 ' A' ' 304' ' ' LEU . 0.8 OUTLIER -158.11 137.65 11.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.302 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 291' ' ' GLU . 1.4 t70 70.84 -54.36 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.794 0.331 . . . . 0.0 111.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -62.79 -58.05 8.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 284' ' ' LEU . . . -120.75 -38.93 0.63 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.829 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 285' ' ' LEU . 1.0 OUTLIER -55.14 -58.85 5.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.893 0.378 . . . . 0.0 111.184 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.615 ' OE1' HD11 ' A' ' 311' ' ' LEU . 5.6 mm-40 -55.25 -35.87 65.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.116 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.82 -24.86 66.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.382 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 289' ' ' GLY . 23.5 t -71.68 -30.1 36.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.48 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -105.59 -49.63 3.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.186 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.09 -42.64 81.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -75.69 -51.31 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.926 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.42 138.19 32.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.791 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.479 ' C ' HD12 ' A' ' 299' ' ' LEU . 58.0 Cg_endo -71.09 122.44 8.76 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.413 2.075 . . . . 0.0 112.305 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 298' ' ' PRO . 4.1 mp -151.62 -47.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.015 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 178.1 -165.8 35.47 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.441 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.652 ' HB2' ' HB ' ' A' ' 317' ' ' ILE . . . -119.34 -176.62 3.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.797 0.332 . . . . 0.0 111.101 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.678 HG11 HD12 ' A' ' 304' ' ' LEU . 22.0 t -93.61 156.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.155 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.44 ' N ' HG12 ' A' ' 302' ' ' VAL . . . -100.45 40.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.695 HD21 ' OD1' ' A' ' 87' ' ' ASP . 0.3 OUTLIER -89.58 -175.77 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 14.3 mttt -102.8 -71.28 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 64.0 p -70.73 -47.06 61.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -58.77 -29.56 66.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -28.58 66.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 5.8 mt-10 -56.75 -61.73 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -60.71 -47.55 85.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.853 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.615 HD11 ' OE1' ' A' ' 291' ' ' GLU . 4.2 mm? -61.01 -23.3 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 309' ' ' GLU . . . -56.45 -21.63 26.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.443 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -90.18 46.6 1.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.821 0.343 . . . . 0.0 111.172 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.894 ' HB3' HG22 ' A' ' 317' ' ' ILE . 1.1 t0 -118.25 147.37 41.49 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -55.95 -48.65 18.71 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.592 2.195 . . . . 0.0 112.457 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -59.09 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.894 HG22 ' HB3' ' A' ' 314' ' ' ASP . 8.7 tp -62.28 -25.3 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.356 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -55.8 -39.94 72.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.218 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.12 -34.0 43.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.147 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -75.5 -29.12 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.949 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.5 ttt -57.15 -31.29 65.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.022 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.437 ' CD ' HG11 ' A' ' 246' ' ' VAL . 1.5 tt0 -67.02 -44.39 80.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -78.22 -30.81 49.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.01 -29.03 67.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.03 -30.71 66.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -141.43 31.12 1.71 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -110.63 -170.94 19.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.409 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.83 168.75 3.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 0.0 110.971 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mm -70.4 138.28 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 5.3 ttt -51.86 106.8 0.7 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -168.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.444 2.096 . . . . 0.0 112.339 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -177.18 79.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.811 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.465 HG23 ' O ' ' A' ' 333' ' ' ILE . 8.0 tt -124.97 123.24 25.5 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.063 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.97 -30.12 57.45 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.409 2.073 . . . . 0.0 112.224 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -58.91 -30.12 67.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.956 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 9.1 tpt -56.89 -28.27 61.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.054 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 38.3 m -59.24 -32.96 70.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.95 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.37 67.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.764 ' O ' HG23 ' A' ' 343' ' ' VAL . 37.8 m-85 -65.19 -28.02 69.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.59 -28.83 49.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.052 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.757 ' O ' HG23 ' A' ' 345' ' ' THR . 0.2 OUTLIER -62.39 -46.89 86.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.975 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -75.3 -27.93 59.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 339' ' ' PHE . 39.4 t -67.67 -42.1 86.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.676 ' O ' HG22 ' A' ' 348' ' ' ILE . 9.0 ptt180 -75.11 -47.19 29.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.734 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 341' ' ' TYR . 55.2 p -49.87 -27.47 5.2 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.4 -59.13 3.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.861 0.362 . . . . 0.0 111.136 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.44 -50.8 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.822 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 344' ' ' ARG . 7.4 tp -53.33 -40.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.738 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 345' ' ' THR . 5.4 t-20 -80.61 -41.67 23.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.984 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.18 87.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.04 -10.78 54.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 9.0 t -67.76 -57.02 7.04 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.727 0.299 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -132.43 -71.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.569 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -176.67 50.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.936 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.464 ' OE1' ' HB2' ' A' ' 360' ' ' ALA . 0.3 OUTLIER -80.03 132.52 36.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.2 p -93.29 153.96 18.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 30.9 m -62.02 -28.55 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.7 -37.75 79.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.2 -50.38 10.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.613 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB2' ' OE1' ' A' ' 355' ' ' GLN . . . -58.0 -25.19 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.152 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.855 HD22 ' HA ' ' A' ' 184' ' ' ASP . 17.8 mt -82.34 -56.47 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -70.43 -41.82 72.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.361 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.12 -46.96 78.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.061 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.677 ' O ' HG22 ' A' ' 368' ' ' ILE . . . -58.22 -57.09 14.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.643 ' O ' HG23 ' A' ' 369' ' ' THR . 1.0 OUTLIER -57.6 -30.54 65.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.169 -179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 93.5 m -77.65 -54.91 5.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.106 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -59.13 -47.05 86.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 364' ' ' ALA . 2.9 tt -56.36 -37.88 52.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.238 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 365' ' ' GLN . 77.3 p -78.21 -64.67 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.993 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.814 0.34 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.51 97.47 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -124.71 165.08 18.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.16 107.44 18.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.01 86.37 0.26 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.752 ' C ' HD22 ' A' ' 7' ' ' LEU . 2.9 pttm -153.63 137.36 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.818 0.342 . . . . 0.0 110.984 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.752 HD22 ' C ' ' A' ' 6' ' ' LYS . 3.9 mm? -133.92 131.5 39.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.806 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.804 HG23 ' HB2' ' A' ' 57' ' ' PRO . 38.3 t -104.21 104.12 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.067 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mt -93.06 114.96 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.585 ' NE1' HD22 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -101.9 115.74 31.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.759 HG21 ' HB2' ' A' ' 14' ' ' ASP . 29.9 mt -140.84 145.74 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.049 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.51 44.58 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.869 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.05 79.17 1.38 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.359 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.759 ' HB2' HG21 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -87.8 8.28 26.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.607 0.242 . . . . 0.0 111.328 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm 58.95 30.04 19.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.739 0.304 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.11 59.51 0.67 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.575 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -61.42 -54.46 43.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.847 0.356 . . . . 0.0 110.771 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.45 -30.41 57.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.807 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.25 -51.96 54.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.614 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.64 -26.35 50.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.727 0.299 . . . . 0.0 111.101 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.47 -46.3 20.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.387 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.02 -41.89 84.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.134 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 19' ' ' GLY . 35.2 t -59.45 -44.32 92.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.975 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.03 -25.51 57.57 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -43.76 89.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 111.029 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -74.39 -43.34 56.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.625 ' HB3' HG21 ' A' ' 33' ' ' ILE . 2.6 m-85 -63.9 -56.32 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.888 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.517 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 19.3 pt-20 -52.78 -28.05 20.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.487 0.66 . . . . 0.0 110.683 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.61 -25.55 49.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.473 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.645 ' O ' ' OG1' ' A' ' 31' ' ' THR . 4.4 t70 -51.53 -56.81 11.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.84 ' O ' HG22 ' A' ' 31' ' ' THR . 6.2 m 156.91 36.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.742 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.748 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.61 46.12 0.01 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.764 -2.16 . . . . 0.0 115.885 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.5 mm -131.37 95.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 118.535 1.167 . . . . 0.0 111.596 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -103.75 121.33 42.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.925 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.66 128.95 76.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.106 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.27 146.31 23.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.932 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.3 p -139.05 111.47 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.049 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.446 ' HB3' ' CH2' ' A' ' 10' ' ' TRP . 2.2 tt0 -142.8 163.14 33.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -104.9 150.3 38.53 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.095 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.13 -156.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.698 2.266 . . . . 0.0 112.361 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.78 -75.99 0.07 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -59.27 -30.04 68.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.585 HD22 ' NE1' ' A' ' 10' ' ' TRP . 28.9 tp -67.53 -24.01 65.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.099 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -52.93 -45.86 67.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 111.135 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -77.64 -28.26 51.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -24.57 53.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.013 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' HZ ' HD22 ' A' ' 75' ' ' LEU . 3.6 t80 -45.76 -55.43 12.66 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.66 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.6 Cg_endo -61.24 -21.39 71.57 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.271 1.981 . . . . 0.0 112.503 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -89.77 -55.23 3.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.003 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' A' ' 55' ' ' ASP . 33.8 t -65.78 -30.1 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.75 -26.8 37.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.86 -34.44 59.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 -25.82 8.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.4 -51.1 0.72 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.453 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' HB2' HG13 ' A' ' 50' ' ' VAL . 10.3 t70 75.46 -54.42 0.64 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 111.047 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.78 -94.99 0.45 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.804 ' HB2' HG23 ' A' ' 8' ' ' VAL . 56.7 Cg_endo -70.56 149.33 61.63 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.578 2.186 . . . . 0.0 112.218 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 p30 177.35 80.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 265' ' ' GLY . 28.2 mt -103.1 106.97 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 ' HB3' ' A' ' 10' ' ' TRP . 27.1 mt -112.65 137.45 45.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.289 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -86.68 128.56 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -157.62 173.25 17.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.848 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . -54.62 -177.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.29 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.691 ' HB3' HG13 ' A' ' 261' ' ' VAL . 13.8 p80 -77.2 -52.0 9.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -74.19 -29.64 61.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.147 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.603 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -56.14 -27.65 54.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.142 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -108.14 -30.31 8.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.935 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.2 57.22 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.88 -49.86 0.3 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.606 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.27 -50.15 75.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -74.51 -31.37 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' HG3' HD13 ' A' ' 104' ' ' ILE . 0.5 OUTLIER -73.41 -19.43 60.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.7 t -70.24 -26.7 63.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.57 50.02 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.607 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.668 HD22 ' HZ ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -179.36 39.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 110.891 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.641 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 1.4 tp -177.22 133.06 0.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB3' ' H ' ' A' ' 268' ' ' ALA . . . -110.71 160.49 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.14 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -85.7 134.8 33.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.492 HG22 ' N ' ' A' ' 80' ' ' THR . 4.6 mt -89.09 158.51 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.061 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.492 ' N ' HG22 ' A' ' 79' ' ' ILE . 74.9 p -88.94 146.31 36.38 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.92 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.606 2.204 . . . . 0.0 112.388 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -176.46 138.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.884 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -60.22 -48.02 83.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.64 -25.66 62.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.279 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 82' ' ' ASP . 6.2 m-85 -79.24 -59.24 2.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.691 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.2 -24.85 67.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.791 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.28 -31.57 68.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -94.24 -58.48 2.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.16 158.33 11.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 305' ' ' LYS . 4.7 m-85 -105.21 157.6 33.98 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.03 -26.27 24.97 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.627 2.218 . . . . 0.0 112.328 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -58.54 -35.72 72.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -30.13 16.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -75.74 -53.45 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -60.07 -31.35 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.28 -31.79 69.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.777 HG11 ' HD3' ' A' ' 107' ' ' PRO . 10.9 m -117.0 39.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -110.83 121.43 45.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.54 132.13 10.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.795 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.401 ' CB ' ' HD3' ' A' ' 102' ' ' LYS . 16.1 m-20 59.27 28.64 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.993 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.55 20.61 73.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.831 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.456 ' HG3' HD11 ' A' ' 104' ' ' ILE . 0.0 OUTLIER -145.73 166.84 24.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.894 0.378 . . . . 0.0 110.875 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.68 HD23 HG23 ' A' ' 97' ' ' VAL . 5.4 mp -118.74 91.98 3.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.591 ' O ' HD23 ' A' ' 76' ' ' LEU . 5.1 mt -101.37 40.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.87 164.76 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.243 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.68 119.03 7.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.797 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.777 ' HD3' HG11 ' A' ' 97' ' ' VAL . 94.6 Cg_endo -79.59 152.45 22.9 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.548 2.166 . . . . 0.0 112.336 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.551 HD11 ' HB3' ' A' ' 284' ' ' LEU . 7.4 tt -171.99 39.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.304 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -178.07 104.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 320' ' ' THR . 21.6 t -91.8 110.51 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.017 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.64 147.19 27.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.27 171.93 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.4 mp -94.06 159.51 15.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.7 m -164.93 145.57 7.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.411 ' C ' HD12 ' A' ' 115' ' ' LEU . 4.1 pp -93.47 150.02 20.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.658 HD11 ' HB2' ' A' ' 227' ' ' ASN . 4.5 mt -115.05 137.24 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -127.37 164.46 21.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -94.0 173.13 7.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -137.69 81.4 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.592 ' HB3' HD23 ' A' ' 121' ' ' LEU . 28.2 t0 -174.2 -54.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.831 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 120' ' ' ASP . 1.0 OUTLIER -134.51 62.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.845 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD11 ' CB ' ' A' ' 223' ' ' ALA . 0.7 OUTLIER -156.85 92.28 2.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.853 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.69 154.1 7.16 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.526 2.151 . . . . 0.0 112.298 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -65.2 111.27 5.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.99 149.77 37.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.452 2.102 . . . . 0.0 112.383 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.403 ' CG ' ' HB3' ' A' ' 131' ' ' GLU . 59.6 Cg_endo -72.3 -167.03 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.478 2.119 . . . . 0.0 112.229 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -95.71 -28.25 14.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 131' ' ' GLU . 15.4 t -75.78 140.23 42.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.41 ' HA ' HG12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -73.07 -35.73 66.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.2 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -23.97 4.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.837 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' HB2' HG23 ' A' ' 128' ' ' THR . 0.8 OUTLIER -87.21 -16.32 35.65 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.526 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.3 mm -61.3 -47.71 93.35 Favored Pre-proline 0 C--N 1.33 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 74.0 Cg_exo -47.92 -35.17 24.18 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.381 2.054 . . . . 0.0 112.482 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.205 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mp -60.63 -30.68 70.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -50.85 36.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.895 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -35.3 74.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.945 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -66.46 -45.61 79.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.957 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 145' ' ' SER . 10.1 mt -71.85 -43.94 64.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -27.15 67.99 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.982 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.45 -27.7 49.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.297 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -109.44 -55.97 2.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 40.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -148.93 177.49 9.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.868 0.366 . . . . 0.0 110.939 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.501 ' O ' HD13 ' A' ' 139' ' ' LEU . 0.5 OUTLIER -152.63 175.44 12.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.829 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -129.04 45.34 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.196 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 177.08 115.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.638 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.437 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 0.6 OUTLIER -154.62 106.53 2.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.056 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.506 ' CE1' ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -158.0 176.81 12.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.688 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -50.63 156.93 0.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD11 HD13 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -129.07 -49.03 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.687 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -97.11 39.78 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.68 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -154.91 166.01 16.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.836 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.74 106.4 1.97 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.694 2.263 . . . . 0.0 112.258 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -173.27 -40.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.605 ' O ' HD12 ' A' ' 160' ' ' LEU . 12.6 t80 -120.75 -41.73 2.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.416 ' HB ' HD11 ' A' ' 195' ' ' LEU . 2.5 p -68.55 -33.58 74.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.501 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 23.4 t90 -68.06 -55.79 12.47 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 38.2 Cg_endo -66.0 -14.08 42.8 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.301 2.001 . . . . 0.0 112.571 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.605 HD12 ' O ' ' A' ' 156' ' ' PHE . 0.5 OUTLIER -77.86 -55.62 5.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.833 0.349 . . . . 0.0 110.676 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.429 HG22 ' CZ ' ' A' ' 194' ' ' PHE . 3.1 pt -88.93 9.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.535 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 256' ' ' LYS . . . -109.29 -15.98 14.15 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.586 0.231 . . . . 0.0 111.422 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.66 -40.27 65.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.814 0.34 . . . . 0.0 111.256 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -88.92 -30.11 19.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 150.12 86.22 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.506 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -154.48 89.99 0.12 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.536 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.15 52.62 2.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.903 0.383 . . . . 0.0 110.858 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.58 -40.75 96.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.164 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.72 126.58 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.942 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.7 tptm -108.21 108.6 19.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.84 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 175' ' ' LYS . 2.4 t80 -97.35 110.68 23.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 102.23 4.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 58.93 31.24 21.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 97.95 74.3 1.16 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.52 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.4 ' O ' ' CD2' ' A' ' 171' ' ' TYR . 1.3 mtpt -158.26 166.72 31.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.333 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -175.54 113.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.637 ' OD1' HG11 ' A' ' 343' ' ' VAL . 10.6 t0 60.17 87.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.648 ' O ' HD13 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -155.31 -45.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.476 ' N ' HG23 ' A' ' 178' ' ' ILE . 8.3 tttt -120.57 -55.78 2.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.741 ' CA ' HD13 ' A' ' 333' ' ' ILE . 0.5 OUTLIER -77.15 141.95 39.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.017 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.909 HG22 ' HB3' ' A' ' 336' ' ' MET . 34.4 m -138.52 139.54 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.027 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -139.24 50.69 0.78 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.66 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.438 ' HB ' ' CE1' ' A' ' 339' ' ' PHE . 18.0 t -111.66 -30.71 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.401 ' OD2' ' CD2' ' A' ' 339' ' ' PHE . 22.1 p30 -94.17 50.13 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.863 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.34 162.79 30.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.99 -33.95 76.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.21 -28.3 49.53 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.496 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.14 -53.63 50.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.46 ' HB3' HD13 ' A' ' 361' ' ' LEU . 0.0 OUTLIER -53.75 -50.08 66.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.109 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.08 -31.33 68.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.431 ' HA2' ' CE2' ' A' ' 194' ' ' PHE . . . -60.76 -56.47 24.07 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.508 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.475 HD23 HG23 ' A' ' 196' ' ' VAL . 0.3 OUTLIER -63.95 -24.76 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.689 0.28 . . . . 0.0 111.065 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 63.0 m -56.48 -59.02 5.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.148 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.431 ' CE2' ' HA2' ' A' ' 191' ' ' GLY . 11.2 p90 -81.88 -23.04 36.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.267 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.416 HD11 ' HB ' ' A' ' 157' ' ' THR . 5.7 tp -52.92 -61.21 2.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.795 0.331 . . . . 0.0 111.165 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.475 HG23 HD23 ' A' ' 192' ' ' LEU . 30.5 t -59.74 -42.89 90.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.124 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -64.41 -30.3 71.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.89 -30.03 69.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.49 HD13 HD11 ' A' ' 151' ' ' LEU . 31.3 mt -77.2 -55.25 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.121 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -25.4 68.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.059 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -95.71 22.01 7.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.123 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -66.31 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -108.79 -29.25 8.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.8 mtp 62.87 31.39 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -176.71 114.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.95 88.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.146 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.98 -30.49 8.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 213' ' ' ALA . 2.7 p -81.6 147.94 29.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 0.9 OUTLIER -140.94 -161.33 1.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.284 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 211' ' ' SER . 47.0 p90 -78.73 -47.37 16.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.004 0.431 . . . . 0.0 110.45 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.464 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.3 m -81.09 -26.12 36.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.242 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 209' ' ' ASP . 22.9 mt -82.44 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.987 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 209' ' ' ASP . . . -58.13 -30.23 66.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.565 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.451 ' HA ' ' CD2' ' A' ' 217' ' ' PHE . 41.3 tt0 -72.45 -36.69 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.42 59.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.457 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -75.15 -56.97 4.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.49 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.506 ' CG ' ' CE1' ' A' ' 149' ' ' PHE . 1.1 p90 -75.14 -39.53 60.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -47.87 -35.94 11.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.119 0.485 . . . . 0.0 110.605 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.75 -23.56 12.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.498 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 68.31 52.59 26.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.368 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.21 38.61 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.128 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 21.4 p -154.52 -177.97 6.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -86.4 39.54 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.357 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.18 112.82 0.45 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.314 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 116' ' ' ILE . 26.4 m -144.66 105.12 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 149' ' ' PHE . 23.6 mt -88.3 144.88 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.658 ' HB2' HD11 ' A' ' 116' ' ' ILE . 2.0 t30 -120.16 164.3 16.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -130.74 178.61 17.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -66.01 66.05 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.826 2.35 . . . . 0.0 112.238 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.3 t-105 -112.97 -19.75 11.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.254 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 65.1 26.95 12.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.16 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 26.8 m95 55.13 -176.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.077 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.57 154.64 43.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.6 m120 61.2 168.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.0 pt -119.24 -41.45 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.0 100.87 0.34 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.823 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.1 t -123.03 138.61 54.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.59 -168.87 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.943 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.1 mttt 60.62 176.15 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 241' ' ' ASN . 11.3 p -60.0 158.25 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.084 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.482 ' N ' HG22 ' A' ' 240' ' ' VAL . 3.4 m-80 -104.18 166.42 10.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -115.22 170.78 8.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.62 151.28 17.62 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.571 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.785 HG21 ' HB3' ' A' ' 315' ' ' PRO . 15.8 m -105.0 136.39 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.804 0.335 . . . . 0.0 111.134 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 161.14 38.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.424 HG11 ' OE2' ' A' ' 322' ' ' GLU . 10.7 p -78.06 150.62 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.057 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.881 HD13 ' CB ' ' A' ' 255' ' ' SER . 1.3 mt -60.41 158.76 27.34 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.38 -173.98 2.09 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.904 2.402 . . . . 0.0 112.077 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 254' ' ' PRO . 43.7 p -116.8 150.15 38.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.05 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 250' ' ' PHE . 44.1 p90 -159.04 112.03 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.753 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 69.89 11.48 7.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.379 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.74 41.39 6.01 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.96 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -156.55 90.65 2.6 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.694 0.283 . . . . 0.0 111.024 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' A' ' 249' ' ' THR . 6.6 Cg_exo -73.74 85.07 1.36 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.852 2.368 . . . . 0.0 112.164 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.881 ' CB ' HD13 ' A' ' 247' ' ' LEU . 18.6 p 57.08 176.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . 13.2 tttm -92.1 142.09 25.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.835 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.2 Cg_exo -79.58 153.78 23.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.632 2.222 . . . . 0.0 111.967 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.429 ' CZ ' ' CE ' ' A' ' 330' ' ' MET . 11.8 t80 -153.62 107.34 3.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 17.0 t -75.94 99.91 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -102.36 63.28 0.47 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.555 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 64' ' ' HIS . 10.8 p -87.92 144.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.75 0.31 . . . . 0.0 110.888 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -111.72 128.91 56.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.949 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.2 m -93.27 131.44 38.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.94 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.22 149.87 21.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.428 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -79.95 111.13 3.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.613 ' O ' HG23 ' A' ' 266' ' ' ILE . 8.4 tp -135.16 104.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -96.86 116.38 29.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.575 ' H ' ' HB3' ' A' ' 77' ' ' ALA . . . -93.01 -23.49 18.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.251 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -54.39 -30.6 52.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.23 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -82.1 155.66 69.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.787 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.21 61.46 2.57 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.582 2.188 . . . . 0.0 112.393 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -165.17 31.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.944 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -75.07 -33.41 61.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.974 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.51 -40.03 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -57.96 10.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.908 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.17 -30.87 70.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -59.39 5.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -68.06 -39.11 83.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.48 -59.27 5.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 280' ' ' LEU . 2.3 tt -59.4 -31.3 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.975 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.05 -31.71 73.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -115.77 27.39 9.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -107.15 -64.54 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.795 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -100.08 -55.65 2.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.804 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 285' ' ' LEU . 3.8 mm? -74.98 64.34 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 289' ' ' GLY . 1.4 t -146.23 151.58 37.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.772 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -61.3 -31.43 71.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.957 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.65 -37.66 49.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.746 ' H ' HG23 ' A' ' 286' ' ' THR . . . -87.62 -56.55 2.1 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.913 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -43.74 65.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.739 0.304 . . . . 0.0 111.208 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -60.04 -31.52 70.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.837 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 296' ' ' ASP . . . -76.8 -34.78 57.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.814 HG13 ' HG3' ' A' ' 297' ' ' LYS . 21.8 t -69.55 -30.15 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.206 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -58.87 -28.31 66.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -113.68 -43.07 3.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.993 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.445 ' OD2' ' HB1' ' A' ' 292' ' ' ALA . 91.5 m-20 -60.12 -69.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.923 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.814 ' HG3' HG13 ' A' ' 293' ' ' VAL . 3.7 pttt -124.16 72.38 55.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.988 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.46 107.16 2.33 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.629 2.219 . . . . 0.0 112.326 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 300' ' ' GLY . 0.9 OUTLIER -135.1 -55.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.985 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.609 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 159.87 120.58 0.57 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -179.28 127.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 0.0 111.065 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 302' ' ' VAL . 10.9 p -178.34 112.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -108.87 39.96 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.645 HD13 ' CD2' ' A' ' 307' ' ' TYR . 6.9 mt -133.89 156.93 47.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.421 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -93.41 -55.24 3.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.96 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.8 t -66.04 -48.06 72.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.645 ' CD2' HD13 ' A' ' 304' ' ' LEU . 4.4 m-85 -59.47 -27.2 65.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.49 -28.73 60.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.058 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -58.81 -49.51 77.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.952 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.85 -42.04 50.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 307' ' ' TYR . 4.5 mm? -62.1 -20.85 64.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.454 ' HA ' HG22 ' A' ' 317' ' ' ILE . . . -52.0 -25.95 9.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.391 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.83 -27.56 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.093 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.707 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 3.7 m-20 -58.81 158.59 15.74 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.785 ' HB3' HG21 ' A' ' 244' ' ' VAL . 35.5 Cg_exo -61.26 -57.96 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.714 2.276 . . . . 0.0 112.665 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -58.92 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.409 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.454 HG22 ' HA ' ' A' ' 312' ' ' ALA . 3.0 mp -52.22 -25.27 6.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.625 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -58.59 -51.7 68.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.124 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.22 -28.9 42.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.887 HG21 HG11 ' A' ' 110' ' ' VAL . 24.5 m -58.37 -43.6 88.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.997 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -29.85 68.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.424 ' OE2' HG11 ' A' ' 246' ' ' VAL . 4.5 tt0 -77.6 -54.7 6.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -58.31 -30.21 66.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.22 -29.1 60.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -58.74 -30.69 67.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.884 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -145.53 41.83 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.983 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.65 164.06 41.02 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.473 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -135.03 158.24 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.821 0.343 . . . . 0.0 110.982 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 329' ' ' ILE . 4.7 tp -77.47 116.94 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.162 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.455 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 0.2 OUTLIER -55.22 -61.29 6.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 330' ' ' MET . 18.8 Cg_endo -59.1 -164.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.55 2.167 . . . . 0.0 112.416 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.625 ' O ' HG23 ' A' ' 333' ' ' ILE . 2.9 m120 70.0 69.14 0.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.741 HD13 ' CA ' ' A' ' 180' ' ' ASP . 0.8 OUTLIER -161.59 60.75 1.22 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.011 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.61 -45.56 0.24 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.589 2.193 . . . . 0.0 112.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -71.91 -34.92 69.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.127 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.909 ' HB3' HG22 ' A' ' 181' ' ' VAL . 23.9 mmt -57.14 -23.76 49.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.227 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . 0.403 ' O ' ' CE3' ' A' ' 340' ' ' TRP . 17.6 p -59.8 -24.92 64.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.75 -29.6 45.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.82 0.343 . . . . 0.0 111.302 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.793 ' HB3' HG21 ' A' ' 181' ' ' VAL . 23.2 t80 -73.75 -23.7 59.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.449 ' N ' HG11 ' A' ' 181' ' ' VAL . 0.0 OUTLIER -42.38 -29.37 0.26 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.833 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.2 -37.41 87.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.831 0.348 . . . . 0.0 111.19 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -74.91 -26.12 59.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.468 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.637 HG11 ' OD1' ' A' ' 177' ' ' ASP . 48.8 t -55.69 -29.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.35 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -70.59 -60.85 2.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 37.2 m -50.0 -29.75 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.84 -54.44 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.382 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 26.9 t -79.17 -58.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.029 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.5 tp -47.34 -31.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.719 0.295 . . . . 0.0 111.515 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.31 -55.8 30.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -54.41 -26.8 32.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.343 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.11 -10.74 59.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.569 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.9 m -104.39 -31.27 9.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.95 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 108.53 -24.48 22.1 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.466 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -97.52 39.93 1.18 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 0.0 110.613 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 356' ' ' THR . 0.8 OUTLIER -79.69 165.03 23.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 355' ' ' GLN . 0.9 OUTLIER -162.84 95.92 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.663 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.8 t -48.04 -27.82 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.398 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -66.17 -54.46 25.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -80.25 -25.94 39.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -77.79 -42.9 32.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.226 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 189' ' ' LYS . 1.5 tt -82.37 -54.82 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.458 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -55.87 20.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.524 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.96 -43.78 98.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.81 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.665 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -59.92 -47.03 87.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.505 ' O ' HD12 ' A' ' 368' ' ' ILE . 3.2 tt0 -58.84 -56.2 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 9.4 t -58.38 -29.5 66.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.043 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -57.26 -29.84 64.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.99 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 365' ' ' GLN . 7.4 mt -64.32 -36.82 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -65.1 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 40.7 mttp . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.826 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.869 0.366 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 t -137.78 162.59 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.13 170.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.96 -70.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.28 27.41 73.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.564 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -82.24 134.66 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 276' ' ' ALA . 6.4 mt -137.72 116.11 11.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.936 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.651 HG12 ' HB2' ' A' ' 57' ' ' PRO . 10.7 p -96.96 107.88 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.694 HD13 HD22 ' A' ' 20' ' ' LEU . 1.6 pp -98.67 114.94 37.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.056 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.656 ' HB2' HG23 ' A' ' 60' ' ' ILE . 67.2 m95 -96.75 112.1 23.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' HB ' ' CE2' ' A' ' 61' ' ' PHE . 16.9 tt -143.65 158.65 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -175.12 99.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.32 102.82 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HA ' ' CZ2' ' A' ' 232' ' ' TRP . 0.3 OUTLIER 69.54 44.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.057 0.456 . . . . 0.0 110.72 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.715 ' HE3' HG21 ' A' ' 237' ' ' THR . 0.1 OUTLIER 67.82 -166.12 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.877 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.24 12.72 8.05 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.725 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.617 ' CE2' HG13 ' A' ' 37' ' ' VAL . 0.3 OUTLIER -81.13 -59.53 2.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.806 0.336 . . . . 0.0 110.906 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.09 -28.86 65.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.81 -48.9 69.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.523 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mp -77.48 -31.28 53.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.747 0.308 . . . . 0.0 110.835 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.04 71.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.114 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.71 -55.91 27.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.31 -31.02 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.088 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.09 -28.07 56.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.497 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -60.91 -30.81 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 0.0 110.855 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -74.82 -33.07 62.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.572 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.7 m-85 -66.56 -56.31 11.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.776 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 11.7 pt-20 -58.32 -28.46 65.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.513 0.673 . . . . 0.0 110.557 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -78.07 -25.78 47.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.214 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 31' ' ' THR . 17.6 t0 -54.01 -56.54 16.94 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.69 37.44 0.0 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.594 177.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.857 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.91 43.52 0.02 OUTLIER Glycine 0 C--N 1.338 0.685 0 C-N-CA 117.857 -2.116 . . . . 0.0 115.84 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.857 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.1 mm -136.94 152.67 28.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 118.064 0.932 . . . . 0.0 111.287 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -142.22 129.2 20.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.85 105.81 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.92 113.84 27.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.809 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.617 HG13 ' CE2' ' A' ' 17' ' ' TYR . 10.8 p -100.35 140.89 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.55 160.28 40.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.29 147.38 36.19 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.94 125.7 11.22 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.519 2.146 . . . . 0.0 112.365 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -173.73 -68.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.867 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -92.05 0.05 57.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.391 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.639 HD12 ' CE3' ' A' ' 10' ' ' TRP . 0.5 OUTLIER -56.48 -28.44 59.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.794 0.331 . . . . 0.0 111.107 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -55.79 -43.47 76.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -98.39 -26.27 14.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -77.0 -24.57 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.141 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.567 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 68.8 t80 -52.87 -56.08 26.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.308 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.2 Cg_endo -63.71 -17.59 60.56 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.28 1.987 . . . . 0.0 112.448 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -89.67 -46.48 8.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.361 . . . . 0.0 110.876 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.8 t -90.45 9.88 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 47' ' ' PHE . . . -79.56 -47.5 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.96 -38.24 79.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.6 p -85.17 -38.45 18.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.52 43.9 2.46 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.528 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -62.06 -31.0 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.57 -79.58 0.82 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.577 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 8' ' ' VAL . 38.0 Cg_endo -66.21 130.22 23.55 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.585 2.19 . . . . 0.0 112.323 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -175.93 71.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.908 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.54 HG22 ' HE1' ' A' ' 61' ' ' PHE . 19.7 mt -123.2 111.44 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.656 HG23 ' HB2' ' A' ' 10' ' ' TRP . 2.0 mp -129.61 138.51 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.386 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 264' ' ' ALA . 0.0 OUTLIER -129.81 128.79 43.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -166.35 102.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.961 0.41 . . . . 0.0 111.988 -179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . . . 54.33 166.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.881 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' CD2' ' CG1' ' A' ' 97' ' ' VAL . 24.1 t-80 -77.22 -60.12 2.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.998 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -44.9 76.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.093 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -56.79 -23.0 40.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.025 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -99.68 -56.66 2.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.952 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -18.39 50.76 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.748 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.37 -38.78 4.67 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.654 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -97.96 -54.84 2.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.061 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.792 ' HB1' HD22 ' A' ' 76' ' ' LEU . . . -58.12 -30.79 66.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -70.5 -21.57 62.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.087 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.9 p -107.38 -26.31 11.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.918 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.25 -87.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.635 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.5 pp 177.41 46.43 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.784 0.326 . . . . 0.0 110.955 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.792 HD22 ' HB1' ' A' ' 71' ' ' ALA . 9.0 mp -80.05 137.66 36.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.59 121.74 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.046 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -58.89 159.89 6.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.005 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.8 pt -115.04 170.54 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.051 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 p -137.15 90.97 15.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.72 -176.14 3.09 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.585 2.19 . . . . 0.0 112.434 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.22 -176.17 3.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.85 83.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.05 -23.27 32.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.418 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -80.2 -59.26 2.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.998 0.427 . . . . 0.0 111.266 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -72.53 -24.73 61.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.816 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -76.33 -18.57 58.85 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.411 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -76.96 -67.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.89 151.01 22.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -97.63 156.35 36.2 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 94' ' ' TRP . 52.6 Cg_exo -52.82 -24.77 24.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.656 2.237 . . . . 0.0 112.489 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.87 -62.51 1.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.031 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -65.05 -25.93 68.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.042 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 98' ' ' ARG . 3.1 m0 -57.91 -49.75 75.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -46.38 -26.83 0.91 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.448 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 97' ' ' VAL . . . -54.65 -43.6 72.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.641 HG21 ' HD3' ' A' ' 107' ' ' PRO . 5.3 m -158.78 71.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.887 0.375 . . . . 0.0 111.511 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.759 ' CZ ' HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -145.21 109.14 4.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.804 179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.53 174.74 6.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.801 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -78.16 62.56 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.31 27.94 5.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.506 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -145.36 101.2 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.863 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.759 HD11 ' CZ ' ' A' ' 98' ' ' ARG . 9.5 tp -114.17 99.45 7.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.961 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.686 ' H ' HD13 ' A' ' 104' ' ' ILE . 0.2 OUTLIER -139.71 40.0 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.075 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.97 128.76 4.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -131.27 111.02 15.31 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.771 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.641 ' HD3' HG21 ' A' ' 97' ' ' VAL . 98.6 Cg_endo -79.6 139.23 14.13 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.44 2.093 . . . . 0.0 112.134 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 tt -166.51 39.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 111.278 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -176.18 109.31 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.042 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.681 ' HB ' HG22 ' A' ' 302' ' ' VAL . 12.5 p -89.29 124.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.16 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.15 132.99 46.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.917 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.18 176.52 12.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 tt -101.66 137.12 40.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 m -164.71 -176.06 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 ' OG1' ' A' ' 245' ' ' THR . 0.2 OUTLIER -96.2 152.53 18.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.768 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 243' ' ' GLY . 22.9 mm -100.8 147.72 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -120.0 126.56 51.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -80.0 155.4 27.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -75.73 -30.86 59.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.957 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -160.97 62.95 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 122' ' ' LEU . 20.9 tp -175.85 39.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.908 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -156.88 151.43 20.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.531 ' HG3' ' HB2' ' A' ' 223' ' ' ALA . 55.6 Cg_endo -70.15 160.39 49.76 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.609 2.206 . . . . 0.0 112.256 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -65.13 164.17 25.02 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.777 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.02 136.38 40.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.454 2.102 . . . . 0.0 112.223 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -74.4 -171.52 0.94 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.533 2.156 . . . . 0.0 112.311 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -109.58 -36.41 5.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.5 t -160.04 172.11 18.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.472 ' O ' HG22 ' A' ' 132' ' ' ILE . 0.2 OUTLIER -59.09 -24.71 63.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 0.4 OUTLIER -76.78 -25.3 53.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.61 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -89.37 -32.66 17.2 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.647 HG22 ' HD3' ' A' ' 133' ' ' PRO . 17.9 tt -56.43 -32.78 14.15 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.647 ' HD3' HG22 ' A' ' 132' ' ' ILE . 15.1 Cg_exo -69.49 -42.39 3.72 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.278 1.985 . . . . 0.0 112.198 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.03 64.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.248 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 123' ' ' PRO . 5.3 tp -58.89 -30.78 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.71 -47.74 84.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.97 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -58.53 -31.73 68.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -54.18 48.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 146' ' ' ALA . 5.6 mt -70.85 -40.56 72.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.948 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -27.6 65.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.09 -25.28 63.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.249 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -109.12 -75.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.856 0.36 . . . . 0.0 110.917 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -172.53 39.84 0.16 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.403 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.57 -174.89 4.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.783 0.325 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' HD13 ' A' ' 139' ' ' LEU . 37.7 m -150.19 162.05 41.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.723 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -111.77 33.49 4.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.521 ' C ' HD12 ' A' ' 147' ' ' LEU . 0.3 OUTLIER 178.93 125.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.623 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.638 ' HB3' ' HB1' ' A' ' 216' ' ' ALA . 1.8 mtt -170.09 106.18 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.67 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.64 177.35 3.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.76 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.449 ' N ' ' HB1' ' A' ' 213' ' ' ALA . 13.0 m-80 -45.55 167.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.425 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD23 HG12 ' A' ' 199' ' ' ILE . 0.5 OUTLIER -134.15 -45.55 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.674 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.455 ' OE1' ' HB1' ' A' ' 206' ' ' ALA . 78.9 mt-30 -95.52 39.54 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.682 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.98 170.73 5.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.76 166.17 21.73 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.59 2.194 . . . . 0.0 112.445 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.02 28.6 17.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.089 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -120.88 -59.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 1.026 HG23 HD13 ' A' ' 195' ' ' LEU . 62.2 m -73.11 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.512 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 0.9 OUTLIER -64.03 -55.42 32.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.191 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.5 Cg_endo -64.2 -27.17 64.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.288 1.992 . . . . 0.0 112.317 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.728 HD13 ' CD2' ' A' ' 195' ' ' LEU . 1.1 tt -71.94 -56.48 5.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.569 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 157' ' ' THR . 2.2 tt -76.01 -9.9 13.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.289 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -78.85 -23.54 44.91 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.72 0.295 . . . . 0.0 111.306 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.83 -78.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -122.26 39.97 3.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.066 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.34 -41.94 3.32 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.504 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 102.7 -48.46 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.496 ' CD2' ' CE2' ' A' ' 169' ' ' PHE . 0.3 OUTLIER 62.36 175.39 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.742 0.306 . . . . 0.0 110.985 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 339' ' ' PHE . . . -72.5 -29.17 63.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.254 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.496 ' CE2' ' CD2' ' A' ' 167' ' ' TYR . 13.7 p90 -113.78 117.46 31.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.958 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -96.04 138.03 34.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.36 110.69 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.729 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -137.2 178.61 6.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.774 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -67.57 72.19 0.14 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.777 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.7 25.5 4.24 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.538 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.01 154.59 22.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.785 0.326 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -148.94 127.5 12.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -71.65 122.86 21.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 179' ' ' LYS . 7.4 tp -162.23 -44.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.097 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.477 ' N ' HG23 ' A' ' 178' ' ' ILE . 3.9 pttm -132.1 37.86 3.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -138.87 141.35 38.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.824 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 18.9 t -140.67 148.28 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.251 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.79 39.92 1.41 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.41 -34.58 6.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.791 0.329 . . . . 0.0 111.094 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -104.99 30.69 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -103.66 175.24 5.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.14 -32.64 74.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.069 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.15 -50.51 66.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -71.34 -41.93 69.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.066 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.91 -31.89 70.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.83 -46.19 15.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.35 -43.04 63.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.407 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 361' ' ' LEU . 3.9 tp -60.58 -49.1 78.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.3 m -60.79 -34.55 74.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -63.3 -46.89 84.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 1.026 HD13 HG23 ' A' ' 157' ' ' THR . 3.3 mt -58.91 -47.35 85.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.979 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.4 t -64.23 -48.62 84.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.84 -35.42 78.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 tt -60.15 -41.21 92.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.649 HG12 HD23 ' A' ' 151' ' ' LEU . 21.6 mt -76.55 -30.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -31.65 72.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -100.06 18.34 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.188 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.1 -76.6 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.789 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -115.23 -13.42 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 ttt 70.02 -66.04 0.29 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.814 0.34 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -102.67 128.46 49.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.455 ' HB1' ' OE1' ' A' ' 152' ' ' GLN . . . -59.11 87.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.61 -29.47 8.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.018 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 t -78.14 108.83 11.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.924 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 211' ' ' SER . 2.8 p30 -94.12 -148.21 0.26 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.43 ' CD2' ' N ' ' A' ' 211' ' ' SER . 38.4 p90 -78.68 -51.72 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.86 0.362 . . . . 0.0 110.501 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' CD2' ' A' ' 210' ' ' TYR . 88.6 p -62.34 -25.25 67.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.036 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 24.1 mm -82.01 -58.78 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.593 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.449 ' HB1' ' N ' ' A' ' 150' ' ' ASN . . . -60.29 -30.53 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.676 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -66.44 -28.97 69.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.783 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -77.37 -25.06 50.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.336 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 148' ' ' MET . . . -52.45 -56.79 12.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.442 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 225' ' ' THR . 51.2 t80 -76.29 -36.74 58.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.736 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.76 -5.67 44.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -74.43 -24.04 59.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.647 0.26 . . . . 0.0 110.935 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 221' ' ' GLU . . . -172.01 -78.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.321 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.422 ' CB ' ' O ' ' A' ' 220' ' ' GLY . 0.9 OUTLIER 163.48 100.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 110.49 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 145' ' ' SER . 4.7 p -109.32 -177.41 3.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -79.88 38.96 0.41 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.789 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.3 OUTLIER -146.66 111.64 5.37 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.934 0.397 . . . . 0.0 111.143 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 217' ' ' PHE . 0.4 OUTLIER -144.56 104.71 4.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 37.0 mt -115.26 142.67 27.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -144.04 111.64 6.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.44 62.03 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.42 -44.73 1.0 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.56 2.173 . . . . 0.0 112.372 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 -148.97 -47.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -132.7 -53.27 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.43 ' CZ2' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -176.64 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.1 p 58.64 166.24 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 60.38 106.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.7 mt -145.92 145.04 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -160.17 -56.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.715 HG21 ' HE3' ' A' ' 15' ' ' LYS . 10.8 p 55.87 102.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.055 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 92.8 p -116.31 -55.02 2.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -164.49 -60.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.903 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 240' ' ' VAL . 12.2 p -72.51 125.78 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -99.7 -179.29 4.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -132.75 170.8 14.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 116' ' ' ILE . . . -124.26 165.88 17.05 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.71 136.43 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.473 ' OG1' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -123.48 149.67 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.931 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.441 HG13 ' ND2' ' A' ' 323' ' ' ASN . 21.5 t -91.35 150.57 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.585 ' H ' HD12 ' A' ' 247' ' ' LEU . 4.2 mp -60.05 158.77 24.29 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.818 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.2 166.04 23.09 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.875 2.383 . . . . 0.0 112.168 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 250' ' ' PHE . 0.2 OUTLIER -95.61 177.55 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.03 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.446 ' H ' HG22 ' A' ' 249' ' ' THR . 46.2 t80 -159.31 111.9 2.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.2 mttm 59.95 20.51 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.71 44.91 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.621 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -156.37 90.83 2.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.649 0.261 . . . . 0.0 110.864 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.21 159.39 22.64 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.587 2.191 . . . . 0.0 112.296 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.8 p -67.19 -175.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.484 ' CG ' ' HB1' ' A' ' 162' ' ' ALA . 20.0 mmtp -107.29 94.31 11.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.81 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.67 151.14 21.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.531 2.154 . . . . 0.0 112.461 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 331' ' ' PRO . 3.8 t80 -108.13 82.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.995 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.91 151.81 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.0 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -149.84 171.75 29.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.567 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 6.2 m -129.81 144.95 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.674 0.274 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.896 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 7.1 mp -78.3 105.25 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.348 . . . . 0.0 110.457 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.8 m -79.79 116.55 20.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.011 0.434 . . . . 0.0 111.288 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -101.57 155.3 18.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.597 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.449 ' N ' ' CZ ' ' A' ' 67' ' ' PHE . . . -146.17 172.13 26.87 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.939 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.724 HD11 ' CD ' ' A' ' 273' ' ' LYS . 11.3 tt -113.68 159.74 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.669 0.271 . . . . 0.0 110.777 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.557 ' O ' ' HB3' ' A' ' 268' ' ' ALA . 2.1 t-20 -116.47 108.01 15.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.388 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 267' ' ' ASN . . . 78.94 -53.71 0.45 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.415 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 268' ' ' ALA . . . 66.73 6.71 4.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.504 -178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.475 ' N ' ' HD2' ' A' ' 271' ' ' PRO . 3.3 t -67.45 -60.53 5.6 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.306 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 270' ' ' SER . 12.0 Cg_endo -55.88 -163.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.551 2.167 . . . . 0.0 112.442 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.26 55.42 1.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.052 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.724 ' CD ' HD11 ' A' ' 266' ' ' ILE . 0.7 OUTLIER -73.25 -29.66 62.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.817 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.24 73.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 8.3 tt -74.17 -48.78 26.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.735 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 7' ' ' LEU . . . -66.69 -32.08 73.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.03 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -78.86 -40.18 33.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.56 -36.59 76.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -60.38 -38.79 85.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.65 -27.66 67.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -100.61 -22.19 15.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.17 5.66 29.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.591 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -154.31 -48.23 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 110.991 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.766 HD21 ' NZ ' ' A' ' 297' ' ' LYS . 1.3 mt -89.31 53.42 2.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.998 0.428 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.37 36.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.774 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.6 p -154.71 174.9 14.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -21.03 52.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -73.56 -54.67 7.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.11 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -90.59 -45.75 4.21 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.773 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.577 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -54.27 -30.21 49.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.142 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -71.61 -38.09 70.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.5 67.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.991 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.942 HG13 ' CB ' ' A' ' 297' ' ' LYS . 85.9 t -58.12 -30.06 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.179 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.36 -13.23 60.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.518 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -114.31 -25.24 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -119.47 -81.65 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.693 0.282 . . . . 0.0 111.514 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.942 ' CB ' HG13 ' A' ' 293' ' ' VAL . 0.2 OUTLIER -49.53 164.93 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.354 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.39 147.16 69.61 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.548 2.166 . . . . 0.0 112.275 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.479 ' N ' HD22 ' A' ' 299' ' ' LEU . 3.4 mm? -79.13 -25.84 42.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.108 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -79.8 114.34 3.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 317' ' ' ILE . . . -169.89 137.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 111.076 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.681 HG22 ' HB ' ' A' ' 110' ' ' VAL . 28.5 m -155.82 108.34 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.164 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -146.08 39.94 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.1 mt -153.66 165.45 35.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -38.59 3.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.014 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 p -79.5 -47.82 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -60.65 -21.9 63.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.527 ' OE2' HD21 ' A' ' 311' ' ' LEU . 35.1 mm-40 -51.02 -28.21 9.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.273 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.19 -47.85 59.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.21 -54.15 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 317' ' ' ILE . 4.5 pp -62.51 -17.75 60.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.295 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 308' ' ' GLU . . . -53.71 -23.35 11.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.614 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.34 46.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.774 0.321 . . . . 0.0 111.301 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.615 ' HB3' HG22 ' A' ' 317' ' ' ILE . 0.4 OUTLIER -124.14 173.73 4.35 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.783 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -90.09 -51.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.839 2.359 . . . . 0.0 113.725 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmp_? -81.3 -59.44 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.635 ' CD1' HD13 ' A' ' 311' ' ' LEU . 16.7 tt -56.27 -31.58 32.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 111.611 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 314' ' ' ASP . . . -76.52 -33.08 58.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.803 0.335 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -36.47 75.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 44.9 p -76.76 -30.94 56.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -32.15 70.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.06 -52.7 32.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.441 ' ND2' HG13 ' A' ' 246' ' ' VAL . 16.0 m-20 -69.58 -30.45 68.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.25 71.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.32 -29.24 69.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -118.43 59.19 0.81 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 178.39 -154.19 14.22 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.92 166.23 22.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.82 0.343 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.5 101.46 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.176 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 53.66 87.62 0.14 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.42 ' HD2' ' CZ ' ' A' ' 258' ' ' PHE . 47.8 Cg_endo -68.77 161.47 45.32 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.492 2.128 . . . . 0.0 112.228 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -157.39 91.24 1.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 12.0 pt -152.59 132.15 7.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.021 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.03 -23.56 22.14 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.468 2.112 . . . . 0.0 112.411 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -55.94 -43.81 77.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 169' ' ' PHE . 1.6 mtp -69.17 -35.36 76.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 21.2 p -62.57 -35.55 79.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.7 -33.87 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.183 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.763 ' O ' HG23 ' A' ' 343' ' ' VAL . 2.5 m-85 -73.49 -27.28 61.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.029 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -42.74 81.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.982 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.99 -35.43 42.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -68.55 -53.51 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.763 HG23 ' O ' ' A' ' 339' ' ' PHE . 24.3 t -59.59 -30.13 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.068 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.878 ' HG3' HD12 ' A' ' 348' ' ' ILE . 4.2 tpt180 -58.89 -60.81 3.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 0.9 OUTLIER -67.45 -27.5 67.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.085 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.85 -59.72 4.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.651 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 350' ' ' ALA . 20.1 t -79.36 -59.1 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.878 HD12 ' HG3' ' A' ' 344' ' ' ARG . 21.9 mt -48.19 -58.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 345' ' ' THR . 15.2 t-20 -55.47 -36.21 66.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.721 0.296 . . . . 0.0 111.179 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 347' ' ' VAL . . . -56.02 -30.11 61.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.097 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.21 -10.15 55.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.553 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.6 p -67.58 -25.14 65.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.823 0.344 . . . . 0.0 111.096 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 111.95 -27.82 9.93 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.359 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.18 39.34 1.82 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.98 124.9 3.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.805 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 359' ' ' GLU . 8.2 t -115.56 177.92 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.966 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 192' ' ' LEU . 22.0 t -72.31 -35.15 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.78 -45.98 88.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.445 ' H ' HG23 ' A' ' 356' ' ' THR . 23.1 mt-10 -79.96 -43.4 22.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.766 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -59.99 -38.51 82.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.47 ' O ' HD13 ' A' ' 361' ' ' LEU . 0.3 OUTLIER -82.1 -48.82 10.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -62.81 -44.06 97.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.986 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -76.35 -26.52 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.985 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -51.81 -56.86 11.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.388 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.6 pt20 -56.55 -30.51 63.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 13.6 m -67.66 -43.2 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.407 ' HG3' HG13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -73.89 -29.82 62.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.995 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 365' ' ' GLN . 16.8 mt -75.06 -44.93 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.99 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 23.3 m -79.65 -67.94 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.971 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.83 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.09 40.03 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -119.71 153.08 36.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -133.86 -68.69 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.04 85.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.481 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -149.27 158.7 44.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.818 0.342 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.481 HD22 HD11 ' A' ' 59' ' ' ILE . 9.2 mt -136.58 155.35 50.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.947 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.772 HG23 ' HG2' ' A' ' 57' ' ' PRO . 28.3 t -123.91 102.97 12.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 28.2 mt -94.88 114.98 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -94.91 124.46 38.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pt -134.66 149.06 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.186 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -141.73 94.27 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 79.44 27.94 53.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.64 ' O ' HD22 ' A' ' 299' ' ' LEU . 1.3 m-20 -75.31 -29.98 60.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.706 0.288 . . . . 0.0 110.899 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' HD22 ' A' ' 299' ' ' LEU . 18.0 tttt 62.75 118.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.83 48.15 0.1 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.56 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -78.78 -34.72 45.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.36 -42.0 90.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.997 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.695 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -80.37 -33.75 30.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.6 HD22 HG11 ' A' ' 37' ' ' VAL . 1.2 tt -74.57 -31.56 62.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.825 0.345 . . . . 0.0 110.95 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.3 -36.12 77.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.271 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -76.96 -32.2 57.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.764 HG12 ' CE2' ' A' ' 27' ' ' PHE . 27.9 t -63.75 -43.16 97.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.104 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -58.42 -38.04 89.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -74.11 -26.74 60.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.879 0.371 . . . . 0.0 111.076 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -44.15 97.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.764 ' CE2' HG12 ' A' ' 23' ' ' VAL . 67.2 m-85 -62.24 -56.67 16.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.549 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -59.37 -27.42 65.95 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 110.131 179.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -27.3 1.05 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.829 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.519 ' O ' ' HB ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -69.28 -56.87 6.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.56 37.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.031 177.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.25 49.05 0.01 OUTLIER Glycine 0 C--N 1.338 0.664 0 C-N-CA 118.115 -1.993 . . . . 0.0 115.513 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER -139.56 95.42 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 118.103 0.951 . . . . 0.0 111.628 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -99.95 106.38 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.11 146.34 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 117.01 24.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.892 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 20' ' ' LEU . 5.8 m -116.63 118.26 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -143.9 162.8 35.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -87.16 154.67 54.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.51 130.01 20.1 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.595 2.197 . . . . 0.0 112.277 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.34 -60.73 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.803 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -79.41 -7.58 58.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.33 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' C ' HD12 ' A' ' 43' ' ' LEU . 4.6 pp -55.62 -24.93 36.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.793 0.33 . . . . 0.0 111.201 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' N ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.78 -34.39 62.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.067 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.3 -29.94 12.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.962 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.0 tttt -69.27 -31.18 69.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -56.36 -60.76 8.13 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.113 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.4 Cg_endo -63.77 -16.83 57.09 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.423 2.082 . . . . 0.0 112.513 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.86 -44.5 18.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.792 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 46' ' ' LYS . 31.1 m -90.21 -24.36 5.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.2 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.89 70.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.71 ' O ' HG23 ' A' ' 53' ' ' THR . . . -63.24 -30.78 71.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.059 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.84 128.79 0.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.64 72.78 0.35 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.24 -30.99 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -130.28 -168.81 12.36 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.539 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HG2' HG23 ' A' ' 8' ' ' VAL . 55.8 Cg_endo -70.23 -171.61 0.53 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.579 2.186 . . . . 0.0 112.314 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 175.09 103.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.481 HD11 HD22 ' A' ' 7' ' ' LEU . 32.2 mt -143.6 136.25 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.25 141.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 12.7 m-85 -108.79 144.67 36.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.862 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.606 ' N ' HD23 ' A' ' 262' ' ' LEU . 1.3 m95 -165.62 173.6 10.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.552 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.57 -174.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.344 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' HB2' HG23 ' A' ' 261' ' ' VAL . 57.1 t-80 -77.69 -45.01 26.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -54.3 -28.81 44.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.59 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HG3' ' CB ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -54.75 -24.17 21.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.217 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 4.3 m-85 -101.11 -28.5 12.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.965 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.74 -23.13 49.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.655 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -110.4 -50.17 0.67 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -75.3 -57.51 3.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.77 0.319 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -58.71 -30.6 67.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -71.37 -28.42 64.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.4 p -70.26 -26.74 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.951 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.34 77.68 1.07 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.519 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.797 ' O ' HD22 ' A' ' 76' ' ' LEU . 7.8 tp -167.48 39.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.797 HD22 ' O ' ' A' ' 75' ' ' LEU . 1.3 mm? -141.5 127.82 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.816 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.884 ' HB3' HG23 ' A' ' 266' ' ' ILE . . . -59.79 138.48 57.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.484 ' HG3' HG23 ' A' ' 104' ' ' ILE . 17.7 tt0 -89.04 157.96 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.7 mm -111.3 141.49 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.54 148.56 40.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.78 168.2 19.61 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.725 2.284 . . . . 0.0 112.372 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -175.95 153.01 1.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.39 -31.65 70.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.13 -23.28 64.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.282 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.596 ' CE2' HD22 ' A' ' 89' ' ' LEU . 1.4 t80 -79.3 -59.16 2.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.651 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.418 ' HB3' ' CZ2' ' A' ' 94' ' ' TRP . 8.3 pt20 -62.55 -24.73 67.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.66 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -68.19 -32.8 73.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 304' ' ' LEU . 8.9 mtmm -104.96 -63.32 1.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.07 113.53 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.825 ' O ' HG22 ' A' ' 93' ' ' THR . 15.3 m-85 -62.25 143.89 95.15 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.51 -24.94 30.4 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.544 2.163 . . . . 0.0 112.468 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -57.03 -34.72 68.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.076 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.825 HG22 ' O ' ' A' ' 90' ' ' TYR . 8.8 t -86.76 -28.23 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.982 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' A' ' 86' ' ' GLN . 4.4 m0 -59.74 -65.28 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -62.69 -29.25 70.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 330' ' ' MET . . . -59.63 -29.6 68.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.203 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.926 HG11 ' HD3' ' A' ' 107' ' ' PRO . 27.0 m -129.77 61.78 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.18 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.38 81.44 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -79.26 98.07 6.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.95 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 59.77 31.51 20.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.47 50.65 7.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.479 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -131.32 129.74 41.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.744 0.307 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.65 40.02 1.5 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.834 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.692 ' O ' HD12 ' A' ' 104' ' ' ILE . 2.0 pp -97.78 39.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 104' ' ' ILE . . . 178.22 101.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 6.7 p90 -118.73 129.14 25.56 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.926 ' HD3' HG11 ' A' ' 97' ' ' VAL . 98.0 Cg_endo -79.8 168.14 19.65 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.606 2.204 . . . . 0.0 112.283 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 0.6 OUTLIER -175.01 39.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.21 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.916 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 174.18 108.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.982 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.589 HG23 ' CG2' ' A' ' 259' ' ' VAL . 10.4 p -90.09 134.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.05 164.35 28.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -162.3 176.62 10.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.047 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.604 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.1 pp -146.11 157.54 43.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.64 -175.95 5.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 mt -92.62 146.15 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.524 HD12 ' HB ' ' A' ' 225' ' ' THR . 0.0 OUTLIER -73.77 155.94 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.05 0.452 . . . . 0.0 111.7 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -135.78 114.71 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.616 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -133.77 -177.49 4.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.35 76.27 1.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -156.05 -50.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 221' ' ' GLU . 0.6 OUTLIER -148.06 39.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.797 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.27 91.13 47.16 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.37 159.42 53.42 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.444 2.096 . . . . 0.0 112.27 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -102.2 95.77 6.2 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.38 159.48 52.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.443 2.095 . . . . 0.0 112.181 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.59 49.42 3.18 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.678 2.252 . . . . 0.0 112.702 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 14.8 mttp 55.47 32.9 19.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.848 0.356 . . . . 0.0 110.927 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.07 140.44 52.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -32.35 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.643 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.71 17.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.485 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.36 -17.09 58.52 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.674 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 12.9 mt -73.47 -53.0 4.77 Favored Pre-proline 0 CA--C 1.531 0.215 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.1 Cg_exo -52.15 -36.74 67.64 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.312 2.008 . . . . 0.0 112.428 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -32.87 56.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.273 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.62 ' O ' HD12 ' A' ' 139' ' ' LEU . 60.5 mt -77.02 -31.91 56.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -76.6 -31.07 57.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.969 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -71.75 -32.16 67.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.972 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.46 -40.69 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.799 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 6.7 mt -73.15 -53.24 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -57.77 -24.63 58.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.37 -26.13 60.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.391 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -109.76 -70.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.82 0.343 . . . . 0.0 110.986 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.62 39.85 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.476 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.89 -174.89 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.725 0.297 . . . . 0.0 110.787 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.474 ' C ' HD13 ' A' ' 139' ' ' LEU . 1.4 m -157.13 171.24 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.911 0.386 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.799 ' HB2' ' CD1' ' A' ' 139' ' ' LEU . . . -142.94 49.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 224' ' ' MET . 4.4 tt 170.62 120.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.548 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.03 106.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.906 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.6 OUTLIER -172.24 167.04 5.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 148.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.126 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.514 HD21 ' HB3' ' A' ' 203' ' ' HIS . 0.2 OUTLIER -178.64 -67.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.811 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -133.95 39.93 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 154' ' ' PRO . 6.8 pt-20 -87.65 173.41 6.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.452 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.501 ' HD2' ' HB2' ' A' ' 153' ' ' GLU . 88.7 Cg_endo -85.89 118.75 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.435 2.09 . . . . 0.0 112.617 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 61.52 80.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.219 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.614 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.1 p90 -121.13 -48.25 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.4 t -72.8 -35.27 67.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.349 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.657 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -49.27 -55.81 19.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.326 -179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.0 Cg_endo -78.7 -18.31 11.97 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.627 2.218 . . . . 0.0 112.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 156' ' ' PHE . 2.3 mm? -80.39 -56.7 4.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.174 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 167' ' ' TYR . 1.8 pt -80.6 1.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.862 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -88.13 -54.54 4.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 110.863 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 253' ' ' GLN . . . 62.67 -81.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.74 -56.8 2.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.937 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 100.67 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.579 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -170.95 87.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.82 ' CZ ' HG21 ' A' ' 343' ' ' VAL . 33.7 t80 -171.49 -50.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.801 0.334 . . . . 0.0 110.958 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -131.88 -46.03 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -152.27 160.01 43.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.22 138.0 36.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.846 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -117.48 110.71 18.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.939 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -137.18 178.43 7.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.729 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -70.34 66.42 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.15 -26.62 1.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.526 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -89.01 159.27 17.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.348 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -172.39 74.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 43.16 92.08 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.448 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.841 HD12 ' HB2' ' A' ' 179' ' ' LYS . 1.9 pp -142.9 -45.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.268 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.841 ' HB2' HD12 ' A' ' 178' ' ' ILE . 9.7 tptt -133.61 -44.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.029 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.39 95.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 179' ' ' LYS . 5.8 m -148.94 106.3 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 159.2 109.73 0.27 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.046 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 167' ' ' TYR . 17.2 m -74.56 42.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.808 0.337 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -110.93 -7.86 14.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.723 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.58 -173.49 0.33 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.63 63.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.177 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.79 -49.34 79.65 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.529 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.36 -45.18 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.836 0.35 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HG3' HD21 ' A' ' 361' ' ' LEU . 20.4 mtpt -60.2 -58.59 7.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.952 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -37.52 87.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.108 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.12 -53.34 18.85 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.598 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.743 ' O ' HG12 ' A' ' 196' ' ' VAL . 3.3 tt -60.05 -42.68 94.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.818 0.342 . . . . 0.0 111.033 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 89.9 m -59.46 -30.44 68.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.044 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.403 ' CZ ' ' CZ ' ' A' ' 250' ' ' PHE . 0.3 OUTLIER -76.15 -47.87 22.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.972 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -67.05 -50.02 63.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.767 HG11 HG21 ' A' ' 357' ' ' VAL . 12.0 p -56.49 -28.07 26.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.255 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.44 -54.6 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.976 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 202' ' ' LYS . 0.4 OUTLIER -59.0 -59.05 6.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.026 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 195' ' ' LEU . 0.7 OUTLIER -51.96 -25.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.37 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 196' ' ' VAL . 1.2 tptp -60.51 -59.97 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.517 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.18 20.99 18.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . 0.447 ' CE ' ' CD2' ' A' ' 203' ' ' HIS . 0.0 OUTLIER -120.28 -68.56 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.7 0.286 . . . . 0.0 111.414 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.514 ' HB3' HD21 ' A' ' 151' ' ' LEU . 27.4 m80 -81.16 -0.52 40.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.715 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -20.27 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.626 0.25 . . . . 0.0 111.288 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -142.52 37.93 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -162.28 84.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -83.72 57.71 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 208' ' ' THR . 11.5 t -57.4 108.88 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.538 ' H ' HD12 ' A' ' 212' ' ' ILE . 3.3 t0 -78.43 -156.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.721 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -78.38 -44.45 24.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.082 0.468 . . . . 0.0 110.157 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.1 p -73.93 -25.1 59.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.173 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.538 HD12 ' H ' ' A' ' 209' ' ' ASP . 13.3 mt -82.05 -53.94 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.107 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.44 -30.27 64.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.056 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.403 ' HA ' ' CE2' ' A' ' 217' ' ' PHE . 12.0 tm-20 -72.86 -42.62 63.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.423 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -78.16 -24.92 47.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.21 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.23 -56.66 11.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.681 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.94 ' CG ' HG23 ' A' ' 225' ' ' THR . 8.6 p90 -67.56 -30.93 70.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.749 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.463 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 0.1 OUTLIER -79.9 -11.9 59.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -74.45 -24.04 59.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.687 0.279 . . . . 0.0 111.001 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.65 -92.77 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.178 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 0.4 OUTLIER 165.54 91.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.607 0.241 . . . . 0.0 110.561 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.35 -177.89 3.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 38.59 0.66 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.52 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -154.11 101.87 2.43 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 120.558 -0.457 . . . . 0.0 112.044 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.94 HG23 ' CG ' ' A' ' 217' ' ' PHE . 0.7 OUTLIER -144.6 104.93 4.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.191 178.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.906 HD13 ' CD2' ' A' ' 149' ' ' PHE . 3.9 mp -106.26 119.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.229 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -139.18 162.89 33.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.14 -150.91 17.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.63 169.54 17.18 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.505 2.137 . . . . 0.0 112.318 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t90 61.71 37.02 16.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -141.61 -47.2 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.12 -51.39 69.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.923 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 4.7 t 60.26 -166.35 0.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.15 131.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 23.5 mm -76.93 -66.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.32 154.52 24.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.2 m -89.29 86.26 6.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.817 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 70.6 m -84.27 147.08 27.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.31 85.35 3.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.56 HG12 ' ND2' ' A' ' 241' ' ' ASN . 26.2 t -128.52 -69.32 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.049 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.56 ' ND2' HG12 ' A' ' 240' ' ' VAL . 16.4 p30 178.32 40.17 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.913 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -144.79 115.84 7.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -156.92 175.97 34.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.36 136.43 45.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 146.52 52.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.964 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.82 150.7 5.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.926 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mt -59.95 149.18 74.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.743 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.52 -174.61 2.35 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.813 2.342 . . . . 0.0 112.185 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 253' ' ' GLN . 0.2 OUTLIER -127.84 177.69 6.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.834 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.499 ' H ' HG22 ' A' ' 249' ' ' THR . 24.4 t80 -158.27 111.74 2.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.856 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 68.49 12.64 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.7 45.26 5.53 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.736 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.603 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 3.4 pt20 -156.35 90.49 2.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.674 0.273 . . . . 0.0 110.784 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.453 ' HB3' HG23 ' A' ' 249' ' ' THR . 91.9 Cg_endo -86.72 150.28 8.65 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.889 2.392 . . . . 0.0 112.618 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 69.5 m -55.24 150.5 10.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -109.41 89.5 7.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.805 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -79.76 125.3 6.03 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.578 2.185 . . . . 0.0 112.391 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -79.98 172.04 14.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.589 ' CG2' HG23 ' A' ' 110' ' ' VAL . 10.5 p -94.88 138.13 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -95.72 129.97 10.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.458 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 64' ' ' HIS . 30.8 m -122.22 144.78 30.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 111.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.916 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -92.57 115.67 28.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.461 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' TRP . 8.9 m -94.59 133.73 37.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.475 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . . . -101.67 126.07 48.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.603 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.774 ' HA3' HD11 ' A' ' 76' ' ' LEU . . . -114.91 159.04 13.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.743 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.884 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.5 tt -140.2 136.38 37.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.786 0.327 . . . . 0.0 110.888 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -51.37 125.56 14.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.722 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.46 -29.86 70.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.249 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -92.74 46.9 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.7 m -96.13 112.81 60.83 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.821 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.39 -26.98 12.74 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.448 2.099 . . . . 0.0 112.437 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 35.5 p30 -120.22 65.53 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.402 ' NZ ' ' HB1' ' A' ' 77' ' ' ALA . 7.2 tttp -75.04 -53.98 7.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -64.28 -32.17 73.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 279' ' ' PHE . 1.0 OUTLIER -73.0 -49.17 30.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.73 -42.96 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -59.86 -42.68 94.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -75.97 -30.51 58.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.994 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.513 ' CE1' HD23 ' A' ' 275' ' ' LEU . 1.8 m-85 -64.16 -59.2 4.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 281' ' ' GLU . 4.5 pp -58.86 -27.0 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.057 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.647 ' N ' HD12 ' A' ' 280' ' ' LEU . 1.1 mm-40 -74.33 -29.26 61.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -110.54 27.47 9.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.425 ' CD2' ' CE1' ' A' ' 27' ' ' PHE . 14.6 m-85 -148.2 -74.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.014 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 5.5 tp -70.83 -31.38 68.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.48 72.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.76 164.42 38.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.7 -27.86 63.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -77.54 -27.68 51.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.125 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -105.62 -54.46 0.73 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.711 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 tt -54.39 -30.71 53.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.744 0.307 . . . . 0.0 111.152 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -72.28 -40.71 67.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.928 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.65 81.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.08 -33.55 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -80.15 -55.06 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -59.72 -57.8 11.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.945 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -60.47 -34.4 73.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.96 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 299' ' ' LEU . 2.6 tptt -139.24 89.42 12.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.64 115.73 4.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.55 2.166 . . . . 0.0 112.296 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -126.34 -43.07 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.998 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.88 123.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.445 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' A' ' 310' ' ' GLU . . . -86.07 90.13 8.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.15 79.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.079 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.83 ' HB3' ' HB2' ' A' ' 306' ' ' SER . . . -139.08 78.17 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 304' ' ' LEU . 0.1 OUTLIER 40.59 -91.87 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.971 179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -78.37 -41.26 33.87 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.784 0.326 . . . . 0.0 111.203 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.83 ' HB2' ' HB3' ' A' ' 303' ' ' ALA . 1.8 m -53.28 -25.16 13.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.234 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.804 ' O ' HD13 ' A' ' 311' ' ' LEU . 87.8 t80 -56.1 -44.67 79.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -76.35 -31.81 58.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.915 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -66.86 -48.22 69.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.519 ' HB2' ' HB1' ' A' ' 301' ' ' ALA . 71.4 mm-40 -71.19 -35.9 71.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.959 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.804 HD13 ' O ' ' A' ' 307' ' ' TYR . 3.4 mp -56.03 -23.06 30.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -55.89 -39.1 71.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.24 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -176.8 74.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.16 139.16 19.85 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.34 -62.38 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.445 2.096 . . . . 0.0 112.352 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -60.78 -48.52 81.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.001 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.528 HG22 ' CE ' ' A' ' 321' ' ' MET . 42.2 mm -59.52 -29.91 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.21 -30.48 71.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -78.46 -56.26 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.1 t -58.38 -27.27 64.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.528 ' CE ' HG22 ' A' ' 317' ' ' ILE . 7.8 mtt -56.23 -29.14 60.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.47 -57.41 12.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.867 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -78.36 -31.85 48.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.92 71.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -59.68 -32.24 70.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -109.37 38.88 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -147.2 179.59 24.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.578 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.76 -177.2 3.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.978 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.0 OUTLIER -135.32 107.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 0.0 110.943 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.495 ' HB2' HD13 ' A' ' 329' ' ' ILE . 3.4 mmt 60.66 155.77 0.11 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.975 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -57.31 -161.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.646 2.231 . . . . 0.0 112.256 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -170.39 -42.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.939 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 333' ' ' ILE . 3.3 tt -123.77 122.97 26.34 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.101 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.51 -21.23 34.94 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.088 . . . . 0.0 112.443 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.35 -30.68 62.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.038 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -30.99 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 60.5 p -65.21 -41.74 94.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.42 -35.93 74.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.472 ' O ' HG23 ' A' ' 343' ' ' VAL . 0.4 OUTLIER -67.72 -27.52 66.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.428 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.43 -32.21 62.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.88 -31.42 45.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.017 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.589 ' HB1' ' NH1' ' A' ' 367' ' ' ARG . . . -76.71 -53.25 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.82 HG21 ' CZ ' ' A' ' 167' ' ' TYR . 21.9 t -58.05 -30.04 38.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.635 ' O ' HG22 ' A' ' 348' ' ' ILE . 16.9 mtp180 -59.71 -54.4 46.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.727 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 69.0 p -49.78 -27.66 5.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.59 ' HB1' ' HB1' ' A' ' 360' ' ' ALA . . . -75.66 -54.28 7.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.085 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.47 -59.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.932 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.4 tt -49.62 -39.63 14.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.917 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.64 -28.6 36.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.693 0.282 . . . . 0.0 110.943 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -59.61 -31.47 69.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -76.92 -10.2 59.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.517 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.0 p -67.57 -26.04 66.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.83 0.347 . . . . 0.0 111.122 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 109.56 -24.34 20.19 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.568 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 39.55 2.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 111.05 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -156.44 114.14 3.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.765 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.2 OUTLIER -105.18 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.767 HG21 HG11 ' A' ' 196' ' ' VAL . 21.6 t -72.28 -28.89 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.213 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -57.04 -37.48 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -80.22 -55.78 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.509 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.814 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -50.33 -36.49 32.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.505 HD21 ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -82.35 -42.52 18.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -65.53 -55.67 16.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.953 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.8 -27.17 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.814 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -53.36 -54.91 29.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.221 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.543 ' O ' HG23 ' A' ' 369' ' ' THR . 1.4 tt0 -58.86 -30.44 67.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 1.4 m -59.47 -57.66 12.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.589 ' NH1' ' HB1' ' A' ' 342' ' ' ALA . 24.1 ptt180 -58.37 -41.24 84.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.146 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 33.1 mm -71.96 -32.04 42.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.065 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 365' ' ' GLN . 17.4 p -108.52 35.45 3.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.89 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 p -151.43 169.09 22.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -131.17 150.05 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -108.97 154.42 22.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.8 72.19 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.66 141.58 13.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.713 HD22 ' CE1' ' A' ' 279' ' ' PHE . 2.7 mp -141.82 138.87 32.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.721 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 59' ' ' ILE . 44.9 t -115.22 113.53 43.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.094 0.474 . . . . 0.0 111.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' HG12 ' A' ' 37' ' ' VAL . 4.9 mt -99.15 133.89 40.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.814 ' HB2' HG23 ' A' ' 60' ' ' ILE . 5.1 m0 -94.71 111.95 23.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.8 tt -139.59 148.74 22.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.096 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -171.43 75.55 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.07 -112.34 1.4 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.42 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 178.38 58.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 0.0 110.849 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 296' ' ' ASP . 3.6 pttt -125.38 -97.63 0.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.006 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.81 80.76 0.28 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.596 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -61.94 -30.95 71.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -59.15 -28.38 66.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 293' ' ' VAL . . . -56.77 -51.59 55.97 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.637 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.73 -37.2 73.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 0.0 111.051 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.16 -30.32 43.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.141 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -64.25 -56.09 17.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.521 HG12 ' ND2' ' A' ' 282' ' ' ASN . 21.3 t -69.37 -43.97 80.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.57 -27.69 64.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.616 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -32.87 70.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.728 0.299 . . . . 0.0 111.021 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.59 -45.06 89.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.4 m-85 -63.9 -56.03 18.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.861 ' OE2' HG22 ' A' ' 35' ' ' VAL . 8.7 mt-10 -53.91 -28.4 36.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.437 0.637 . . . . 0.0 110.59 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -78.09 -25.78 47.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.486 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.516 ' O ' ' HB ' ' A' ' 31' ' ' THR . 4.4 t70 -52.65 -56.46 15.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 157.48 36.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.456 177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 157.26 44.39 0.02 OUTLIER Glycine 0 C--N 1.338 0.657 0 C-N-CA 117.883 -2.103 . . . . 0.0 115.75 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 32' ' ' GLY . 3.4 mm -133.94 149.28 30.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 118.21 1.005 . . . . 0.0 111.377 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.56 137.4 30.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.861 HG22 ' OE2' ' A' ' 28' ' ' GLU . 30.0 m -130.55 129.78 64.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.146 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.85 134.63 54.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 9' ' ' ILE . 31.2 m -127.91 120.17 53.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.151 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -139.11 163.02 33.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -80.11 152.91 74.43 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.86 179.07 5.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.551 2.167 . . . . 0.0 112.449 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 76.67 -0.28 3.04 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.65 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 -48.83 2.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.2 -12.73 57.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.412 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -26.37 8.43 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.279 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -79.63 -51.12 9.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.991 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -71.81 -24.55 61.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.672 ' CZ ' HD11 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -49.85 -60.46 5.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.316 -179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 36.1 Cg_endo -65.08 -15.35 49.96 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.432 2.088 . . . . 0.0 112.568 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.67 -40.95 12.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.811 0.339 . . . . 0.0 110.961 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.28 -29.85 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.64 -30.97 71.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.84 -27.77 66.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.157 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.1 m -100.26 -45.48 5.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.69 73.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.47 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -99.68 -28.86 12.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.718 0.294 . . . . 0.0 111.085 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -171.29 -64.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.63 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' HG21 ' A' ' 8' ' ' VAL . 5.8 Cg_endo -48.96 115.3 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.823 2.349 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -175.32 39.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.803 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -145.25 129.74 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.882 0.372 . . . . 0.0 110.516 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 10' ' ' TRP . 63.8 mt -141.5 142.72 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 111.736 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE2' ' HB1' ' A' ' 264' ' ' ALA . 51.0 m-85 -123.14 112.38 17.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.268 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.439 ' O ' ' N ' ' A' ' 263' ' ' SER . 0.1 OUTLIER -162.95 174.03 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.753 -179.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.88 -173.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.084 0.469 . . . . 0.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -76.86 -33.41 57.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -57.01 -29.28 63.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.117 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -56.98 14.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.074 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.523 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -66.34 -48.83 68.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.47 -17.87 54.39 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.719 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -90.77 -56.07 1.8 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.66 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -95.45 -54.45 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.771 0.32 . . . . 0.0 111.101 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.032 ' HB1' HD23 ' A' ' 76' ' ' LEU . . . -55.67 -27.81 52.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.363 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -68.25 -22.33 64.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.9 p -95.82 25.63 4.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.169 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.549 ' O ' HD12 ' A' ' 75' ' ' LEU . . . 91.27 77.49 1.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.578 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.549 HD12 ' O ' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -168.36 39.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.879 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.032 HD23 ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -158.3 136.55 10.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.922 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' N ' ' HB2' ' A' ' 268' ' ' ALA . . . -104.41 130.46 52.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' HG22 ' A' ' 104' ' ' ILE . 0.7 OUTLIER -68.4 138.76 55.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.438 HD11 ' HG ' ' A' ' 103' ' ' LEU . 18.2 pt -83.66 162.43 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -89.2 147.74 39.14 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.66 110.96 2.71 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.613 2.209 . . . . 0.0 112.44 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -176.77 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -21.83 47.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.178 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.779 ' HB1' ' CH2' ' A' ' 94' ' ' TRP . . . -54.8 -23.16 16.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.551 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -59.22 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.382 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -74.2 -24.64 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.765 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.714 ' OD2' HD12 ' A' ' 89' ' ' LEU . 13.7 p-10 -73.94 -20.58 60.32 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.35 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 53.15 48.57 21.92 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.89 0.376 . . . . 0.0 111.255 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.714 HD12 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -102.12 155.49 18.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -96.32 145.0 28.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.16 -26.66 43.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.509 2.14 . . . . 0.0 112.345 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -56.62 -30.57 63.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 82.7 p -90.7 -29.76 17.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.008 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.779 ' CH2' ' HB1' ' A' ' 84' ' ' ALA . 34.1 m0 -70.1 -47.57 61.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -59.51 -30.71 68.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.6 83.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.076 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 97' ' ' VAL . 18.9 t -95.15 43.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.012 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -99.37 89.44 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 120.15 35.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.4 p30 44.43 38.66 2.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.13 31.12 78.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.642 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -145.62 160.05 42.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -105.8 93.23 4.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.601 ' HB ' HD13 ' A' ' 76' ' ' LEU . 4.5 pt -114.43 39.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.477 ' O ' HG11 ' A' ' 97' ' ' VAL . . . -176.25 125.09 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -107.73 116.23 57.79 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.838 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.81 133.82 10.46 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.466 2.11 . . . . 0.0 112.419 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.54 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 7.3 pt -156.07 39.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.045 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 169.58 102.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.877 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.95 HG22 HG21 ' A' ' 320' ' ' THR . 14.6 p -101.86 116.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.326 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -116.98 132.58 56.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.67 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.48 176.56 8.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.188 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.83 171.37 7.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.478 ' HB3' ' HB2' ' A' ' 319' ' ' ALA . 0.2 OUTLIER -164.33 -177.41 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.904 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HG ' ' A' ' 247' ' ' LEU . 3.3 mt -109.6 149.88 29.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.2 pt -110.48 140.53 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.186 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.77 130.87 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -98.29 162.09 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.886 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.5 37.7 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -90.19 -35.13 15.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.995 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 121' ' ' LEU . 3.5 pp -157.73 39.98 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.94 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.533 ' CD2' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -137.55 131.07 17.14 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.23 157.78 41.66 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.257 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -65.08 110.77 4.64 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.6 140.29 86.01 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.477 2.118 . . . . 0.0 112.184 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.56 -73.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.549 2.166 . . . . 0.0 112.228 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.42 -39.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.456 HG23 ' HB2' ' A' ' 130' ' ' GLU . 14.0 t -70.94 152.23 43.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.968 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.691 ' CE3' HD11 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -60.14 -23.56 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 128' ' ' THR . 33.4 mt-10 -45.26 -23.47 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.596 ' O ' HD13 ' A' ' 135' ' ' LEU . 4.8 pt-20 -48.78 -31.0 6.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.691 HD11 ' CE3' ' A' ' 129' ' ' TRP . 0.0 OUTLIER -73.53 -62.58 1.14 Allowed Pre-proline 0 N--CA 1.468 0.47 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.324 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.443 ' HD3' HG13 ' A' ' 132' ' ' ILE . 82.9 Cg_exo -45.67 -34.42 11.48 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.232 1.955 . . . . 0.0 112.407 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.49 -40.53 61.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.163 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.596 HD13 ' O ' ' A' ' 131' ' ' GLU . 9.1 mp -77.79 -28.77 50.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.068 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.49 -43.42 75.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -68.73 -28.03 66.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.54 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 1.4 tt0 -81.83 -50.84 8.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 146' ' ' ALA . 19.5 mt -57.92 -55.83 29.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -58.72 -24.66 61.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.031 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -57.16 -25.51 59.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.405 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -111.21 -67.47 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.4 39.87 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -142.07 -177.87 5.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.916 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD13 ' A' ' 139' ' ' LEU . 48.3 t -150.37 157.54 43.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.013 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.797 ' CB ' ' HB3' ' A' ' 223' ' ' ALA . . . -107.6 42.2 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 224' ' ' MET . 0.6 OUTLIER 176.84 115.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.875 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.77 106.56 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.86 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.444 ' CZ ' HG13 ' A' ' 226' ' ' ILE . 2.3 t80 -156.36 176.74 12.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -64.72 -169.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.82 HD12 HG23 ' A' ' 208' ' ' THR . 11.5 mt -148.81 -46.01 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.35 44.2 1.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -108.25 166.78 10.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 150.97 22.38 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.949 2.433 . . . . 0.0 112.173 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 61.31 55.24 2.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.449 ' O ' HD13 ' A' ' 160' ' ' LEU . 77.8 t80 -120.93 -49.57 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.864 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 161' ' ' ILE . 63.6 m -73.42 -42.84 61.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.52 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 9.8 t90 -55.72 -53.88 57.86 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.429 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.53 -24.17 42.47 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.17 1.913 . . . . 0.0 112.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.563 HD23 ' HG ' ' A' ' 195' ' ' LEU . 5.0 mp -81.57 -56.77 3.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.861 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.867 HG22 ' O ' ' A' ' 157' ' ' THR . 3.3 tt -67.27 -21.81 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.254 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -64.54 -30.35 71.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.201 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 250' ' ' PHE . . . -67.32 -25.16 65.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.286 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.55 -41.35 18.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.097 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.98 -82.36 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.596 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -171.09 -38.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.551 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.595 ' OH ' HG11 ' A' ' 343' ' ' VAL . 38.8 t80 70.16 -65.69 0.31 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.26 -82.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.062 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -155.94 -174.82 5.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -130.29 115.94 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -79.39 142.46 35.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -136.96 128.32 28.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.29 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.83 52.07 0.25 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.486 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.23 159.74 3.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.913 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -97.74 130.25 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.655 ' O ' HD13 ' A' ' 178' ' ' ILE . 1.4 m-20 -74.9 -175.99 2.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.655 HD13 ' O ' ' A' ' 177' ' ' ASP . 23.6 mm -137.04 -48.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.69 -31.53 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.65 108.31 4.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.691 HG12 HG23 ' A' ' 183' ' ' VAL . 22.0 t -121.62 150.7 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.155 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -131.26 50.02 0.9 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.691 HG23 HG12 ' A' ' 181' ' ' VAL . 27.4 t -94.08 -31.23 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 111.08 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.583 ' OD1' ' HB3' ' A' ' 364' ' ' ALA . 26.6 m-20 -123.52 72.88 1.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -128.92 -176.67 3.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.07 78.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.61 -52.06 32.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.497 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.522 ' HA ' HD11 ' A' ' 161' ' ' ILE . . . -62.92 -30.8 71.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -61.05 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.987 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 194' ' ' PHE . . . -77.77 -43.77 29.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -54.27 -26.21 35.67 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.761 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.754 ' O ' HG23 ' A' ' 196' ' ' VAL . 6.4 tp -81.68 -58.17 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.769 0.319 . . . . 0.0 110.899 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.7 t -64.2 -28.87 70.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.024 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.597 ' CE1' ' HB1' ' A' ' 190' ' ' ALA . 2.6 m-85 -56.99 -63.57 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.13 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 160' ' ' LEU . 4.3 mm? -62.41 -46.63 87.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.19 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 192' ' ' LEU . 36.4 t -59.3 -46.96 92.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.319 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -75.02 -36.44 61.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.46 -58.89 6.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.063 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 28.8 pt -49.84 -27.21 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.429 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -77.59 -31.7 53.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.991 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -106.7 18.32 22.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.399 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -41.75 2.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.845 0.355 . . . . 0.0 110.768 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -114.56 -51.67 2.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 169.54 -75.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.7 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -156.39 153.03 28.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.746 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' A' ' 151' ' ' LEU . . . -65.13 77.74 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -164.95 31.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.82 HG23 HD12 ' A' ' 151' ' ' LEU . 17.3 p -61.98 139.98 58.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.74 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.528 ' H ' HD13 ' A' ' 212' ' ' ILE . 4.7 m-20 -108.76 -150.73 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.927 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -79.1 -53.0 7.43 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.105 0.479 . . . . 0.0 110.083 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 1.1 m -56.88 -24.42 51.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.397 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 212' ' ' ILE . 2.7 mp -81.94 -58.85 3.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.015 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.32 -30.42 70.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -22.6 38.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.443 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -47.75 -55.58 9.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.489 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -81.66 -54.94 4.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.931 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -47.38 -28.47 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.81 -41.35 23.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.876 0.369 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -106.78 -23.58 12.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.773 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 55.01 46.74 76.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.41 43.02 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.687 0.279 . . . . 0.0 111.23 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.77 -177.63 3.36 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.797 ' HB3' ' CB ' ' A' ' 146' ' ' ALA . . . -82.82 38.67 0.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.894 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.577 ' HE2' ' HA ' ' A' ' 224' ' ' MET . 0.0 OUTLIER -173.8 99.22 0.11 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.04 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.51 105.31 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.807 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.444 HG13 ' CZ ' ' A' ' 149' ' ' PHE . 23.7 mm -82.77 138.53 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -97.45 112.22 24.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 231' ' ' ALA . . . -111.84 159.83 13.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.461 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.47 -27.16 30.87 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.634 2.223 . . . . 0.0 112.323 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -137.31 37.32 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.962 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 228' ' ' GLY . . . -118.66 38.56 3.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.078 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -131.25 100.78 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.73 -41.22 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.931 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.7 m120 60.59 174.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 236' ' ' ASP . 1.0 OUTLIER -161.74 -44.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 235' ' ' ILE . 5.7 m-20 -95.12 -47.99 6.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 m 59.66 104.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 4.2 m -98.12 168.87 9.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -98.66 31.95 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.985 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 241' ' ' ASN . 27.7 t -102.65 158.45 4.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 240' ' ' VAL . 1.4 t-20 -84.79 132.93 34.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.974 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -101.23 170.44 8.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -151.7 150.76 22.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 315' ' ' PRO . 10.3 p -122.71 127.72 75.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.789 0.328 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 68.8 p -141.12 162.74 34.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.182 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 322' ' ' GLU . 15.8 m -86.6 150.9 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.045 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 247' ' ' LEU . 1.2 mp -59.76 151.68 61.86 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.78 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.71 -158.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.914 2.41 . . . . 0.0 112.343 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -77.94 177.82 7.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.437 ' CB ' ' HB1' ' A' ' 163' ' ' ALA . 0.1 OUTLIER -152.36 111.54 3.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.702 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? 60.1 17.71 7.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.241 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 120.66 -24.95 7.42 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.684 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.61 140.04 18.12 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.652 0.263 . . . . 0.0 110.941 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.31 169.04 21.97 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.595 2.197 . . . . 0.0 112.449 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.5 m -58.31 -175.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.005 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -144.15 73.72 16.13 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.49 174.13 12.25 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.966 2.444 . . . . 0.0 112.223 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -111.81 135.22 52.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' ILE . 21.5 t -77.97 154.77 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.154 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.413 ' N ' HG12 ' A' ' 259' ' ' VAL . . . -107.66 77.99 0.24 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.612 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 12.9 m -88.81 132.09 34.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.756 0.313 . . . . 0.0 111.039 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.923 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 4.9 tp -79.29 127.48 32.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.003 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' TRP . 0.8 OUTLIER -91.32 110.52 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.764 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' CE2' ' A' ' 61' ' ' PHE . . . -126.79 117.71 23.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -177.61 -169.99 39.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.618 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 276' ' ' ALA . 3.9 mp -100.82 159.22 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.486 ' N ' HG22 ' A' ' 266' ' ' ILE . 53.5 p30 -88.79 158.2 18.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.624 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -97.46 29.08 3.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.173 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -100.64 -30.7 11.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 t -118.2 146.66 39.85 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.874 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.61 74.86 2.65 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.488 2.125 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.51 ' O ' ' HB2' ' A' ' 276' ' ' ALA . 2.4 t30 -117.48 35.42 4.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -66.03 -48.97 69.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -71.57 -36.09 70.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.3 mt -76.35 -29.68 57.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.875 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -58.37 -40.82 83.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.081 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -74.23 -29.38 61.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -59.09 -35.19 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.713 ' CE1' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -57.79 -57.59 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 280' ' ' LEU . 3.7 mm? -60.38 -25.61 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.798 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.21 -14.06 62.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.263 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.521 ' ND2' HG12 ' A' ' 23' ' ' VAL . 27.7 t30 -88.95 27.93 1.26 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.348 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 70.92 35.46 1.69 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 110.725 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.75 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -101.24 28.3 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.795 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.565 ' HA ' HD22 ' A' ' 290' ' ' LEU . 5.9 tp -147.0 28.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.969 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.0 t -136.84 155.62 49.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -57.63 -20.99 36.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.305 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 292' ' ' ALA . 3.8 mt-10 -75.17 -38.13 61.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.418 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 286' ' ' THR . . . -119.64 -50.51 0.29 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.032 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 284' ' ' LEU . 25.1 tp -54.59 -55.14 32.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.809 0.338 . . . . 0.0 111.392 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -79.1 -32.93 44.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.734 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 288' ' ' GLU . . . -77.17 -58.59 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 19' ' ' GLY . 28.8 t -82.03 -60.62 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.412 ' OD1' HD23 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -56.27 -21.65 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.879 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.765 ' O ' HD21 ' A' ' 299' ' ' LEU . 0.0 OUTLIER -111.76 -20.04 12.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.605 0.24 . . . . 0.0 111.377 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 37.6 t70 54.68 90.14 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.81 0.338 . . . . 0.0 110.651 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt 64.65 165.9 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.716 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.6 144.63 79.37 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.504 2.136 . . . . 0.0 112.375 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 295' ' ' LYS . 2.5 pp -174.74 -51.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 299' ' ' LEU . . . -119.21 160.79 14.11 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.401 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.806 ' HB3' HD12 ' A' ' 317' ' ' ILE . . . -132.95 105.04 6.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.876 0.37 . . . . 0.0 111.391 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.549 HG21 ' N ' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -163.99 44.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.198 0.523 . . . . 0.0 110.645 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -149.77 88.63 1.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.668 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.411 HD23 ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER 77.17 115.29 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -55.28 -23.98 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.35 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.9 m -53.94 -52.41 60.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.854 0.359 . . . . 0.0 111.026 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.36 -30.4 37.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.624 ' HG3' ' HB1' ' A' ' 301' ' ' ALA . 8.3 tt0 -59.14 -27.74 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -56.98 -37.18 71.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.099 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -83.62 -44.61 14.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 301' ' ' ALA . 23.8 mt -62.53 -18.6 62.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.174 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -52.09 -25.87 9.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.756 0.312 . . . . 0.0 111.502 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -58.4 -27.57 64.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.116 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 146.57 95.51 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.995 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.803 ' HA ' HG11 ' A' ' 244' ' ' VAL . 49.1 Cg_exo -55.8 -51.42 9.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.592 2.195 . . . . 0.0 112.39 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 320' ' ' THR . 7.9 mtm180 -55.44 -56.26 22.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.806 HD12 ' HB3' ' A' ' 301' ' ' ALA . 3.9 mm -52.92 -55.34 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.303 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.48 -37.49 75.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.235 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 114' ' ' SER . . . -69.7 -56.56 6.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.132 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.95 HG21 HG22 ' A' ' 110' ' ' VAL . 32.9 p -62.97 -29.96 71.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.53 -52.25 66.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.638 ' HB3' HG21 ' A' ' 246' ' ' VAL . 0.9 OUTLIER -77.8 -45.63 23.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.032 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.13 -30.49 66.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.95 -31.14 67.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.71 -40.2 96.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.72 -58.87 1.89 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.04 177.46 54.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.425 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.424 ' HG2' HD13 ' A' ' 329' ' ' ILE . 1.1 tt0 -154.22 151.44 29.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.861 0.362 . . . . 0.0 110.892 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.782 HG22 ' HB ' ' A' ' 259' ' ' VAL . 0.2 OUTLIER -49.17 138.17 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.42 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -127.47 137.67 31.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.862 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 -168.37 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.578 2.185 . . . . 0.0 112.387 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -136.44 76.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.587 HD12 ' HB2' ' A' ' 335' ' ' GLN . 25.2 pt -86.2 148.6 47.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.08 -27.9 38.62 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.675 2.25 . . . . 0.0 112.323 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.587 ' HB2' HD12 ' A' ' 333' ' ' ILE . 10.4 mt-30 -58.96 -41.59 87.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -66.65 -31.72 72.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.57 -44.28 97.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.4 -32.56 72.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.167 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.775 ' O ' HG23 ' A' ' 343' ' ' VAL . 40.3 m-85 -71.05 -37.51 72.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.952 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -43.12 97.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -59.36 -52.09 67.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 346' ' ' ALA . . . -59.79 -46.91 87.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.111 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 339' ' ' PHE . 28.9 t -69.5 -29.97 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.131 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -59.42 -60.66 3.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.929 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 9.2 t -71.64 -41.18 69.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -46.37 -56.34 6.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.586 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.37 -55.76 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.813 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.8 mm -57.08 -58.75 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.728 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 345' ' ' THR . 1.0 OUTLIER -59.49 -27.91 66.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.671 0.272 . . . . 0.0 111.11 -179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -61.92 -57.07 13.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 355' ' ' GLN . . . -60.82 -10.57 5.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.004 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.5 m -110.04 26.63 10.45 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.614 0.245 . . . . 0.0 111.385 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 154.3 -71.53 0.27 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.005 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -87.76 51.63 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.464 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.519 ' HA ' ' HB1' ' A' ' 350' ' ' ALA . 0.0 OUTLIER -79.37 99.29 7.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.805 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 1.5 t -166.22 97.4 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.731 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 21.5 t -48.86 -27.77 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.324 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -57.49 -45.72 84.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.015 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -80.01 -43.91 21.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.82 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.685 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -56.35 -37.77 70.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.144 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.26 -53.06 6.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -58.83 -55.69 31.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.056 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -59.28 -44.11 92.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.055 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -58.48 -32.41 68.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.0 m -72.66 -31.26 64.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.84 -40.77 68.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.409 HD12 ' HE1' ' A' ' 339' ' ' PHE . 31.8 mm -71.22 -35.81 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 18.8 m 61.3 51.02 4.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.902 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 pttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.846 0.355 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.9 p -87.13 153.39 21.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.47 157.8 17.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.971 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -175.57 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.44 28.64 21.67 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.52 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.703 ' O ' HD22 ' A' ' 7' ' ' LEU . 12.8 mttm -114.92 130.27 56.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.0 110.833 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 ' O ' ' A' ' 6' ' ' LYS . 4.3 mm? -129.1 148.56 51.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 8' ' ' VAL . 30.8 m -126.48 102.92 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.617 HD13 HD21 ' A' ' 20' ' ' LEU . 3.9 mt -94.87 114.87 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.561 ' CH2' HD13 ' A' ' 43' ' ' LEU . 95.5 m95 -105.83 111.96 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.91 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 12' ' ' ASN . 4.7 mt -118.25 157.27 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' ILE . 1.7 t30 -170.31 40.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.91 25.7 3.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.603 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.92 31.81 11.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 110.785 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.5 -165.91 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.11 63.86 0.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.543 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -62.9 -29.59 70.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.357 . . . . 0.0 111.058 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -59.34 -47.18 86.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.68 -28.3 65.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.617 HD21 HD13 ' A' ' 9' ' ' ILE . 56.6 tp -64.76 -32.81 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.17 72.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.043 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.41 -31.41 65.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.45 -31.05 51.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.55 -35.18 29.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -59.73 -28.44 67.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.762 0.315 . . . . 0.0 110.968 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -68.02 -33.45 74.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.942 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' HB3' HG21 ' A' ' 33' ' ' ILE . 9.3 m-85 -78.08 -50.6 11.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.662 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.542 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -51.54 -27.93 12.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.464 0.65 . . . . 0.0 110.425 179.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -60.45 -26.4 66.72 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.301 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 31' ' ' THR . 7.4 m-20 -64.32 -57.19 10.09 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 30' ' ' ASP . 1.7 t 156.98 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.611 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.841 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.89 48.49 0.01 OUTLIER Glycine 0 C--N 1.338 0.682 0 C-N-CA 117.873 -2.108 . . . . 0.0 115.566 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.841 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.4 mm -139.27 95.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 118.071 0.935 . . . . 0.0 111.676 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.27 113.76 26.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.866 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.648 HG12 ' HB2' ' A' ' 7' ' ' LEU . 30.2 m -98.85 139.85 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.29 119.63 39.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.853 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.0 t -112.9 112.97 42.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -151.84 163.08 39.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.877 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -104.73 142.05 23.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.15 155.62 37.73 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.551 2.167 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -178.84 -51.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -111.57 -23.31 10.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' CH2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -79.77 -1.12 37.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.545 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -54.4 -30.36 51.91 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.041 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -90.4 -30.9 17.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.532 ' HG2' HG23 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -72.46 -24.53 61.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.117 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.462 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -52.8 -59.31 9.15 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.303 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.2 Cg_endo -63.1 -17.25 59.24 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.395 2.063 . . . . 0.0 112.482 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -89.69 -43.84 10.44 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG23 ' HG2' ' A' ' 46' ' ' LYS . 29.8 t -82.76 -30.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 -31.22 72.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.066 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.7 -29.51 61.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.8 m -71.06 -31.89 68.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.33 55.06 1.05 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HB2' HG12 ' A' ' 50' ' ' VAL . 13.5 t0 -59.41 -34.08 72.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 110.86 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.36 -93.92 0.3 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.569 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.519 ' HB2' HG22 ' A' ' 8' ' ' VAL . 60.8 Cg_endo -72.85 -173.42 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.581 2.187 . . . . 0.0 112.4 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.8 t0 178.97 60.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.773 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mm -99.01 121.07 49.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.583 HD11 ' CZ3' ' A' ' 62' ' ' TRP . 3.2 tt -146.68 141.62 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.078 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.5 136.87 52.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.583 ' CZ3' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -161.17 173.31 15.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -175.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -76.9 -53.26 8.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -58.39 -28.44 65.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.078 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HG3' ' CD1' ' A' ' 62' ' ' TRP . 13.0 mmt180 -57.54 -29.17 64.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HZ ' HG23 ' A' ' 60' ' ' ILE . 48.3 m-85 -107.52 -37.4 6.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.9 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.86 -23.47 51.05 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.653 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.39 -25.28 4.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.651 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.65 -59.38 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 111.074 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 76' ' ' LEU . . . -57.3 -29.76 64.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.26 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -67.53 -27.05 66.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.5 t -70.19 -26.73 64.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.088 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.31 75.28 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.487 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -172.84 39.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.379 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.682 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -165.36 127.9 2.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.856 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' N ' HD13 ' A' ' 76' ' ' LEU . . . -69.16 126.56 30.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.09 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HA ' HG22 ' A' ' 104' ' ' ILE . 0.4 OUTLIER -73.05 132.73 43.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 tt -102.87 147.56 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.171 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.4 p -98.03 145.87 30.52 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.84 146.71 18.75 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.94 -55.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -30.48 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.79 -23.39 42.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.319 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -79.25 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -66.5 -26.54 67.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.468 ' CB ' HD23 ' A' ' 89' ' ' LEU . 1.2 m-20 -76.43 -41.9 45.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.812 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.65 40.05 13.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.939 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' CB ' ' A' ' 87' ' ' ASP . 0.5 OUTLIER -82.3 -177.32 6.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.436 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -66.91 112.96 11.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.417 ' HA ' ' CE2' ' A' ' 94' ' ' TRP . 78.1 Cg_exo -50.51 -25.21 13.89 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.514 2.143 . . . . 0.0 112.482 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.91 -21.07 41.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 90' ' ' TYR . 57.5 p -69.39 -53.95 16.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.442 ' CE3' ' N ' ' A' ' 95' ' ' ASP . 46.9 p-90 -92.92 -45.31 8.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.196 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' CE3' ' A' ' 94' ' ' TRP . 6.7 t70 -53.29 -26.72 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.288 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB1' HD11 ' A' ' 329' ' ' ILE . . . -80.56 -28.88 37.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.235 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.802 HG21 ' O ' ' A' ' 105' ' ' ALA . 11.3 p -114.57 63.01 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.34 104.66 5.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -94.44 93.1 7.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.3 t30 67.61 -70.11 0.13 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.959 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.06 30.89 0.19 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -127.57 96.61 4.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -92.48 102.69 15.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.761 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -133.88 39.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.025 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.802 ' O ' HG21 ' A' ' 97' ' ' VAL . . . -172.42 93.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.96 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD2' ' HD2' ' A' ' 107' ' ' PRO . 1.4 t80 -98.95 141.73 23.4 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.71 ' O ' HD13 ' A' ' 108' ' ' ILE . 92.3 Cg_endo -79.85 138.76 13.42 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.608 2.205 . . . . 0.0 112.205 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.71 HD13 ' O ' ' A' ' 107' ' ' PRO . 18.0 mm -143.6 39.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.245 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 173.26 99.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.976 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 317' ' ' ILE . 9.2 p -89.34 111.21 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -104.27 133.16 49.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.36 170.05 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.003 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.6 mp -131.17 152.31 50.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.955 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.0 t -164.92 -176.06 4.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.617 HD13 ' N ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -107.53 138.18 44.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.724 HG22 HG22 ' A' ' 244' ' ' VAL . 3.0 pt -130.17 140.22 49.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.088 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -152.76 165.66 34.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -80.32 168.8 18.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -107.89 36.9 2.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -123.68 -64.01 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.451 ' H ' HD12 ' A' ' 121' ' ' LEU . 0.9 OUTLIER -97.38 48.37 1.04 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.5 tt -93.63 103.68 10.66 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.24 160.36 49.22 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.431 2.088 . . . . 0.0 112.313 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.19 110.85 4.79 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.09 124.66 11.59 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.439 2.093 . . . . 0.0 112.278 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.94 -168.82 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.4 2.066 . . . . 0.0 112.238 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -101.04 -30.59 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 129' ' ' TRP . 1.5 m -126.62 169.11 13.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -72.58 -31.28 65.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -23.71 17.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.549 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -85.19 -16.33 40.69 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.524 HG21 HD21 ' A' ' 147' ' ' LEU . 42.0 mt -65.55 -47.41 67.93 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 89.2 Cg_exo -46.38 -30.02 7.74 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.366 2.044 . . . . 0.0 112.629 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.89 60.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.197 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.11 -45.81 69.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.171 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 133' ' ' PRO . 3.5 p30 -54.12 -28.69 41.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.208 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 141' ' ' ALA . 15.8 tttt -55.79 -42.69 75.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.071 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -81.79 -33.31 30.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.79 -55.9 16.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -69.2 -24.45 64.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.998 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 137' ' ' LYS . . . -52.51 -25.01 9.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.54 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -112.2 -50.42 2.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.941 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.76 41.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.653 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.4 mttt -155.24 179.2 9.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.943 0.401 . . . . 0.0 110.99 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.8 p -128.47 165.62 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -86.24 3.99 40.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.67 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 146' ' ' ALA . 0.4 OUTLIER 170.8 151.19 0.05 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.859 0.362 . . . . 0.0 110.995 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 216' ' ' ALA . 6.4 tpt -117.77 144.75 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.09 145.86 40.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.0 170.79 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' LEU . 12.5 mt -131.19 -46.5 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.756 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -98.5 39.72 1.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.732 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -140.44 93.87 8.68 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.948 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.55 112.78 3.0 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.017 2.478 . . . . 0.0 112.153 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 176.07 -34.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.95 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.464 ' CD2' HD13 ' A' ' 226' ' ' ILE . 0.9 OUTLIER -111.94 -30.63 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.5 t -70.43 -27.09 64.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.483 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 1.0 OUTLIER -70.22 -56.01 7.43 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.272 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 42.1 Cg_endo -67.13 -16.19 48.32 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.37 2.047 . . . . 0.0 112.446 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' A' ' 255' ' ' SER . 1.7 tm? -78.18 -56.72 4.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.38 . . . . 0.0 110.626 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.58 ' CG2' HD13 ' A' ' 195' ' ' LEU . 29.0 pt -65.09 -16.76 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.053 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 166' ' ' GLY . . . -84.61 -70.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.992 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 62.58 -80.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.175 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -122.2 -41.93 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.003 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.29 -35.49 65.68 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.676 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 162' ' ' ALA . . . -59.66 116.97 9.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.566 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.14 78.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.781 0.324 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.62 -69.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.091 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CE1' HG12 ' A' ' 181' ' ' VAL . 6.7 m-85 -139.93 158.92 43.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.12 125.42 44.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.439 ' CE1' ' HG2' ' A' ' 330' ' ' MET . 9.3 p90 -107.85 116.39 31.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -137.05 130.14 30.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 64.18 -79.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.85 66.27 0.15 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -163.97 149.3 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.35 . . . . 0.0 110.912 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.43 ' CE2' HG13 ' A' ' 333' ' ' ILE . 96.2 m-85 -125.5 72.68 1.28 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -177.7 109.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 180' ' ' ASP . 4.0 tt -138.2 28.23 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.73 31.05 19.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.466 ' HB2' HG23 ' A' ' 178' ' ' ILE . 0.9 OUTLIER -132.15 143.46 50.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.462 HG12 ' CE1' ' A' ' 169' ' ' PHE . 18.9 m -148.35 129.76 5.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.17 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -95.43 39.92 2.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.416 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.31 -31.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -116.55 36.57 4.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 177.63 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.23 -30.93 58.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.43 -52.65 49.98 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.2 -32.71 70.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.705 ' O ' HG23 ' A' ' 193' ' ' THR . 0.0 OUTLIER -60.4 -56.89 15.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.939 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.82 -30.66 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.05 -45.47 95.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.586 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 -46.89 39.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.968 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 189' ' ' LYS . 58.9 p -59.89 -29.04 68.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.4 -53.07 62.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.96 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.58 HD13 ' CG2' ' A' ' 161' ' ' ILE . 3.4 tp -59.83 -50.39 73.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 28.7 t -59.74 -37.8 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -27.68 56.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.002 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.45 -49.62 12.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.495 HD12 ' N ' ' A' ' 200' ' ' LYS . 2.3 pp -57.16 -40.16 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.301 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.495 ' N ' HD12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -72.08 -28.08 63.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.032 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.3 -26.23 62.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.129 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 10.6 ttmm -118.46 -67.49 0.99 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . 0.426 ' CD2' ' CB ' ' A' ' 207' ' ' ASP . 30.9 m170 -65.15 -28.78 69.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 mtm 69.28 -67.41 0.22 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -103.41 -48.42 3.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.878 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.23 -58.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . 0.426 ' CB ' ' CD2' ' A' ' 203' ' ' HIS . 6.4 t0 78.1 -55.18 0.5 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.107 HG22 ' HB2' ' A' ' 213' ' ' ALA . 0.2 OUTLIER -79.82 147.86 31.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.873 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 213' ' ' ALA . 1.3 t0 -144.0 -162.71 1.52 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.358 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 211' ' ' SER . 39.4 p90 -78.83 -46.02 19.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.998 0.428 . . . . 0.0 110.392 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.45 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 4.7 p -81.08 -25.64 36.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.045 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.45 -58.93 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.016 0.436 . . . . 0.0 110.862 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 1.107 ' HB2' HG22 ' A' ' 208' ' ' THR . . . -58.58 -30.36 67.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.625 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 210' ' ' TYR . 6.6 tm-20 -70.41 -22.74 62.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.111 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -76.96 -53.72 7.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.721 0.296 . . . . 0.0 111.68 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.481 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -81.75 -41.99 20.42 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -75.98 -58.7 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -62.73 -32.94 74.15 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -23.47 16.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.632 0.253 . . . . 0.0 111.33 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.54 52.15 8.78 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.066 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.26 39.41 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.815 0.34 . . . . 0.0 111.121 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.4 HG23 ' HB1' ' A' ' 216' ' ' ALA . 20.8 p -149.58 -177.69 6.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.856 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -83.55 39.53 0.68 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.738 0.304 . . . . 0.0 110.993 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.465 ' HG2' HD21 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 173.66 128.78 0.03 OUTLIER 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.925 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 116' ' ' ILE . 1.3 t -144.54 106.35 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.464 HD13 ' CD2' ' A' ' 156' ' ' PHE . 14.6 mt -78.99 141.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -86.81 112.48 21.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.08 -157.17 33.04 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.474 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.32 -46.43 32.94 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.506 2.137 . . . . 0.0 112.348 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 14.3 t-105 -158.12 45.9 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.822 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -96.86 39.36 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 1.8 t-105 -172.72 175.55 3.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 17.4 p -123.0 -72.7 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.818 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 60.34 90.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 24.0 mt -123.84 -66.38 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -74.7 150.32 39.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 237' ' ' THR . 10.1 t -161.69 106.69 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.883 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.7 m -143.06 96.5 2.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.15 -69.37 0.15 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.974 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.8 m -92.32 134.83 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.069 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -176.37 -167.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.07 130.67 45.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -103.08 171.85 21.01 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.56 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.724 HG22 HG22 ' A' ' 116' ' ' ILE . 19.5 t -113.29 136.36 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.774 0.321 . . . . 0.0 111.112 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 115' ' ' LEU . 9.4 t -125.24 159.41 31.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.945 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.0 p -79.62 150.55 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -59.91 156.82 33.7 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.82 -168.33 0.62 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.714 2.276 . . . . 0.0 112.427 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 9.3 t -123.99 177.48 5.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 253' ' ' GLN . 54.7 p90 -167.18 117.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.753 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt 64.17 16.24 9.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 81.62 33.04 28.82 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.667 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.409 ' O ' ' CE1' ' A' ' 250' ' ' PHE . 16.6 pt20 -156.19 90.63 2.7 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.678 0.275 . . . . 0.0 111.003 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.52 161.08 47.31 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.788 2.326 . . . . 0.0 112.154 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.609 ' HB3' HD22 ' A' ' 160' ' ' LEU . 81.1 p -57.43 163.8 2.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -105.15 99.53 20.27 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.72 130.06 8.53 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.468 2.112 . . . . 0.0 112.249 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -111.87 139.75 47.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.11 150.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.919 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.72 160.39 28.77 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.621 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 9.1 m -129.85 144.96 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 0.0 110.861 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -88.0 126.29 35.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.978 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 67' ' ' PHE . 28.3 m -91.71 125.88 36.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.62 140.12 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 174.58 168.12 34.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.404 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 15.1 tt -101.67 158.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.885 0.374 . . . . 0.0 111.016 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -73.64 173.16 10.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -94.23 -27.4 16.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.213 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -57.47 -30.95 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.202 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 10.7 p -76.75 122.36 86.39 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -77.18 -1.46 11.63 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.498 2.132 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -96.37 38.27 1.21 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -75.04 -31.05 61.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -60.33 -42.89 96.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 7.5 tp -75.59 -28.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.024 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 279' ' ' PHE . . . -76.8 -32.35 57.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.306 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -79.13 -30.76 43.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.54 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 279' ' ' PHE . 12.9 pt-20 -76.18 -48.72 19.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.7 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -70.25 -24.22 63.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.705 0.288 . . . . 0.0 111.239 -179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.41 HD12 HD13 ' A' ' 284' ' ' LEU . 6.5 tp -78.89 -29.9 44.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.181 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -105.56 -14.47 15.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.759 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.406 ' O ' ' CD2' ' A' ' 283' ' ' TYR . 14.7 m120 -111.06 27.42 9.7 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.685 0.278 . . . . 0.0 111.621 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.406 ' CD2' ' O ' ' A' ' 282' ' ' ASN . 6.7 m-85 -168.69 -52.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.751 0.31 . . . . 0.0 111.185 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.41 HD13 HD12 ' A' ' 280' ' ' LEU . 2.7 tp -46.41 -66.51 0.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.306 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 290' ' ' LEU . 2.6 mt -95.72 63.25 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.896 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 3.0 m -154.78 166.33 33.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -59.75 -20.31 55.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.46 -29.57 52.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.181 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -111.46 -52.92 0.54 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.761 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 285' ' ' LEU . 1.3 tp -50.64 -27.3 6.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.956 0.408 . . . . 0.0 111.176 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -65.91 -26.03 67.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.264 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -77.79 -57.94 3.53 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.382 0.61 . . . . 0.0 109.381 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 297' ' ' LYS . 1.8 m -62.42 -28.78 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.634 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 297' ' ' LYS . 2.1 t-20 -22.2 -48.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER -50.78 -27.77 7.94 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.972 0.415 . . . . 0.0 110.827 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.785 ' O ' HD23 ' A' ' 299' ' ' LEU . 0.4 OUTLIER -135.62 -13.8 1.96 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.962 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 298' ' ' PRO . 0.0 OUTLIER -45.52 -49.81 33.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 297' ' ' LYS . 59.5 Cg_endo -73.73 104.52 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.301 2.0 . . . . 0.0 112.556 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.785 HD23 ' O ' ' A' ' 296' ' ' ASP . 3.9 pp -177.94 -38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.655 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.633 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 177.82 72.04 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 109' ' ' ALA . . . -179.31 93.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.807 0.337 . . . . 0.0 111.201 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 308' ' ' GLU . 34.9 t -154.89 109.96 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.992 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -100.76 40.68 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 307' ' ' TYR . 3.2 mp -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.52 -59.34 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.933 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 18.9 m -79.15 -30.65 43.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.983 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.6 ' HB3' HD22 ' A' ' 304' ' ' LEU . 0.5 OUTLIER -80.29 -35.75 35.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.612 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.7 OUTLIER -54.97 -25.27 28.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.234 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -55.47 -61.34 2.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.052 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -93.25 -31.16 14.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.422 ' CD2' HD23 ' A' ' 290' ' ' LEU . 1.0 OUTLIER -71.92 -55.71 7.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 308' ' ' GLU . . . -77.38 -54.25 6.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.275 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt 54.1 30.06 11.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -129.06 110.42 18.28 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.079 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.68 -13.09 31.78 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.602 2.202 . . . . 0.0 112.615 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -58.95 4.74 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.719 0.295 . . . . 0.0 111.268 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -58.51 -32.73 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.073 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -75.49 -26.25 58.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.58 -26.47 61.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.391 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 317' ' ' ILE . 12.1 t -55.6 -29.44 59.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.9 mmm -59.4 -30.44 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -73.33 -52.59 13.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.6 -31.04 67.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -30.66 69.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -59.88 -31.13 69.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 36.35 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.835 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -172.57 171.42 44.31 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -152.07 147.18 26.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.907 0.384 . . . . 0.0 110.855 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.452 HD11 ' HB1' ' A' ' 96' ' ' ALA . 27.6 pt -59.33 130.35 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.439 ' HG2' ' CE1' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -178.47 136.62 0.34 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.06 -178.19 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.454 2.103 . . . . 0.0 112.272 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.687 ' C ' HD12 ' A' ' 333' ' ' ILE . 16.3 t-20 -127.31 36.5 4.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 332' ' ' ASN . 3.4 mp 64.13 127.76 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.46 -27.68 32.82 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.433 2.089 . . . . 0.0 112.376 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.485 ' H ' HG22 ' A' ' 333' ' ' ILE . 21.9 tt0 -58.28 -31.26 67.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -60.41 -28.47 68.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.002 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 18.9 m -58.65 -59.26 5.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.62 -27.46 66.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.273 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.774 ' O ' HG22 ' A' ' 343' ' ' VAL . 0.5 OUTLIER -56.37 -24.32 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.204 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HA ' ' CG2' ' A' ' 343' ' ' VAL . 0.8 OUTLIER -57.31 -27.32 62.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.155 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -52.29 13.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.179 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.23 59.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.32 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 339' ' ' PHE . 27.4 m -56.29 -29.93 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.448 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.766 ' HG2' HD12 ' A' ' 348' ' ' ILE . 1.8 ttt85 -52.55 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 349' ' ' ASN . 11.5 m -69.35 -27.66 65.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -60.5 -60.56 3.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.416 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 23.9 t -79.52 -57.02 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.087 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.766 HD12 ' HG2' ' A' ' 344' ' ' ARG . 27.1 mt -52.15 -58.79 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 345' ' ' THR . 0.1 OUTLIER -62.34 -31.06 71.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.75 0.31 . . . . 0.0 111.193 -179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -57.67 -30.02 65.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 0.0 110.999 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.17 -9.87 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.558 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 3.1 t -67.28 -22.82 65.64 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.674 0.273 . . . . 0.0 111.177 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 110.46 -29.34 9.18 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.441 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.57 39.2 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -163.96 122.1 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.747 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 357' ' ' VAL . 0.8 OUTLIER -104.77 171.06 7.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.006 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.709 HG12 HD12 ' A' ' 361' ' ' LEU . 25.4 t -72.21 -31.71 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.21 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.53 -33.85 71.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -80.14 -53.25 6.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.568 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.572 ' HB1' ' HB1' ' A' ' 346' ' ' ALA . . . -57.13 -30.08 64.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.086 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.709 HD12 HG12 ' A' ' 357' ' ' VAL . 21.1 mt -82.32 -56.63 3.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.645 ' O ' HG22 ' A' ' 366' ' ' THR . 10.7 mttm -64.07 -44.72 91.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.376 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.39 -35.36 80.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.005 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -79.78 -55.42 5.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.427 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.25 -34.91 24.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.417 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 362' ' ' LYS . 12.8 t -80.48 -29.5 37.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -34.55 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.008 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.432 ' CD1' ' CZ ' ' A' ' 339' ' ' PHE . 33.7 mm -64.35 -47.24 90.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.135 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.8 m -66.72 -58.68 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 t -160.54 117.66 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.852 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.79 141.02 29.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 61.47 166.42 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.901 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.39 45.68 0.44 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.473 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 168.98 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 110.837 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.412 HD11 ' CE2' ' A' ' 279' ' ' PHE . 67.4 mt -149.95 139.43 21.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 36' ' ' THR . 29.8 t -113.08 102.83 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.04 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.4 mp -97.51 129.95 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.052 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.774 ' CZ3' HD22 ' A' ' 43' ' ' LEU . 8.9 t90 -94.9 113.28 24.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -147.79 141.02 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.062 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -165.3 78.93 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.98 35.93 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.564 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.7 89.09 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.747 0.308 . . . . 0.0 110.991 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 mttp -152.92 81.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.51 78.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.54 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -80.94 -56.59 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -76.12 -32.26 59.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.982 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.83 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -64.11 -41.71 98.35 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.567 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.73 -31.53 59.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.68 -42.11 74.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.94 -33.31 75.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 19' ' ' GLY . 22.8 t -70.32 -35.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.149 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.44 -34.63 81.82 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.597 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -69.51 -28.38 66.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.983 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -34.3 43.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.778 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 6.9 m-85 -64.27 -56.39 14.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -58.36 -28.16 64.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.519 0.676 . . . . 0.0 110.141 178.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.86 -26.98 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.646 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.644 ' O ' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -64.94 -57.3 9.11 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.828 ' O ' HG22 ' A' ' 31' ' ' THR . 5.9 m 156.45 36.71 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.731 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.91 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.48 52.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.705 0 C-N-CA 117.96 -2.067 . . . . 0.0 115.452 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.91 HD13 ' O ' ' A' ' 32' ' ' GLY . 2.5 mm -138.36 95.54 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 118.168 0.984 . . . . 0.0 111.459 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.29 108.92 20.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.028 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.26 138.07 23.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.408 ' CG2' HG22 ' A' ' 8' ' ' VAL . 1.7 t -136.77 139.1 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.948 0.404 . . . . 0.0 111.173 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.3 m -101.15 120.96 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.991 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -96.34 153.96 17.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.013 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.15 167.37 12.07 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.98 92.56 0.8 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.609 2.206 . . . . 0.0 112.35 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -177.43 -40.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.021 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -109.65 -29.09 8.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.046 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' CZ3' ' A' ' 10' ' ' TRP . 0.8 OUTLIER -57.42 -23.81 51.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.211 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.21 -28.74 55.19 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.12 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -92.09 -26.79 18.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.045 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.506 ' O ' HG12 ' A' ' 50' ' ' VAL . 36.8 mttm -69.49 -29.38 67.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.087 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.431 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.94 -60.77 7.83 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.143 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.0 Cg_endo -66.28 -15.83 49.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.553 2.169 . . . . 0.0 112.512 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -79.35 -55.22 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.789 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 46' ' ' LYS . 11.3 p -73.92 -24.8 19.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.16 -31.28 65.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.078 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 53' ' ' THR . . . -65.1 -43.42 92.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.068 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -170.42 152.09 3.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.838 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.45 85.43 0.84 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.535 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.05 -35.94 16.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.38 -157.59 7.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.536 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.42 -175.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.585 2.19 . . . . 0.0 112.25 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 p30 173.68 49.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mt -99.03 127.43 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.019 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 10' ' ' TRP . 32.6 pt -151.58 138.76 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.215 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' CD1' ' HB1' ' A' ' 264' ' ' ALA . 7.6 m-85 -116.12 148.97 39.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.445 ' CE3' ' HA ' ' A' ' 62' ' ' TRP . 0.5 OUTLIER -165.78 173.7 10.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.41 -173.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.233 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.525 ' NE2' HG12 ' A' ' 97' ' ' VAL . 2.1 t-160 -76.82 -53.18 8.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.93 -33.49 76.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -27.21 66.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.068 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -110.01 -23.17 11.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.45 -93.42 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.725 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.72 -24.81 68.95 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.717 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -64.45 -53.1 53.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.32 . . . . 0.0 110.962 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -59.49 -55.58 32.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -27.05 66.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -75.83 -26.85 57.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.97 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.53 -81.01 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.84 87.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.751 0.31 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.705 HD23 ' HB ' ' A' ' 104' ' ' ILE . 1.1 tp -117.52 141.51 48.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.91 119.86 32.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.134 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.744 ' HA ' HG22 ' A' ' 104' ' ' ILE . 9.8 pt-20 -61.22 159.34 12.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mt -126.24 148.94 30.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.088 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.9 m -120.41 92.66 47.71 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.48 114.41 3.26 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.954 2.436 . . . . 0.0 112.265 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.27 -35.3 18.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -30.64 67.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.947 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.513 ' HB1' ' HZ2' ' A' ' 94' ' ' TRP . . . -53.46 -22.94 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.617 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -80.16 -57.77 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.918 0.39 . . . . 0.0 111.217 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.97 -24.61 58.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.802 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 18.1 p-10 -62.4 -17.72 59.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.339 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 tttt 66.71 71.01 0.39 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.84 0.353 . . . . 0.0 110.932 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.443 HD23 ' N ' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -105.36 155.92 18.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.443 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -83.95 134.38 44.1 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.78 -25.92 36.62 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.469 2.113 . . . . 0.0 112.296 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -55.69 -30.29 60.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 97' ' ' VAL . 5.1 m -75.72 -31.34 59.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.513 ' HZ2' ' HB1' ' A' ' 84' ' ' ALA . 66.2 m95 -73.13 -48.02 39.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.39 -27.89 62.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.949 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.16 -30.02 57.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.208 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HD3' ' A' ' 107' ' ' PRO . 29.5 m -134.66 68.09 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.251 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -149.26 140.71 23.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -103.3 174.04 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -30.47 68.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.08 37.49 0.22 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' HD12 ' A' ' 103' ' ' LEU . 0.2 OUTLIER -145.48 159.14 43.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.822 0.344 . . . . 0.0 110.837 -180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.512 HD12 ' O ' ' A' ' 102' ' ' LYS . 2.1 mp -141.94 85.96 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.808 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.744 HG22 ' HA ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -136.87 40.28 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.9 131.43 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.061 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.04 118.6 10.23 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.812 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.762 ' O ' HD13 ' A' ' 108' ' ' ILE . 94.1 Cg_endo -79.7 124.77 5.83 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.453 2.102 . . . . 0.0 112.463 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.762 HD13 ' O ' ' A' ' 107' ' ' PRO . 21.8 mm -141.2 39.81 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.07 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.773 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 177.52 125.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.992 HG21 HG12 ' A' ' 302' ' ' VAL . 3.9 m -106.32 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.45 136.49 52.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.822 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 176.44 8.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.5 mt -81.26 149.0 29.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.615 ' HB3' HG13 ' A' ' 244' ' ' VAL . 2.0 m -164.71 170.9 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.426 HD21 ' O ' ' A' ' 223' ' ' ALA . 12.1 tp -103.09 136.63 42.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.474 ' HB ' HG23 ' A' ' 225' ' ' THR . 31.6 mm -111.64 125.85 68.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 223' ' ' ALA . 51.1 p90 -128.18 152.4 48.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.959 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -105.04 176.98 4.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.25 30.83 6.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -104.41 -57.86 1.97 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 222' ' ' THR . 1.5 tt -140.28 82.62 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.421 HD21 ' N ' ' A' ' 223' ' ' ALA . 0.2 OUTLIER -122.36 106.07 35.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.93 160.34 50.2 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.45 2.1 . . . . 0.0 112.346 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.9 149.43 98.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.28 119.11 6.04 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.555 2.17 . . . . 0.0 112.214 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.04 -71.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.331 2.021 . . . . 0.0 112.353 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -177.15 -75.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.68 -176.31 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.806 ' CZ3' HD13 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -65.5 -26.74 68.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.018 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.417 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 64.3 mm-40 -51.46 -24.07 4.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.383 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.89 -15.81 33.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.592 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.806 HD13 ' CZ3' ' A' ' 129' ' ' TRP . 3.5 tt -52.44 -35.66 25.61 Favored Pre-proline 0 CA--C 1.536 0.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.742 ' HD3' HG22 ' A' ' 132' ' ' ILE . 17.2 Cg_exo -67.93 -31.41 31.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.207 1.938 . . . . 0.0 112.104 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.51 63.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.075 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 146' ' ' ALA . 4.3 mp -77.68 -38.12 48.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.959 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.78 -36.51 74.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -28.14 67.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -66.74 -31.58 72.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.979 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.838 HD13 ' CB ' ' A' ' 145' ' ' SER . 11.9 tp -60.48 -55.94 27.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.52 -30.36 67.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.08 76.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.038 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -139.39 -60.33 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.775 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 160.03 41.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.498 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -126.63 121.94 33.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.169 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.838 ' CB ' HD13 ' A' ' 139' ' ' LEU . 9.9 t -140.69 170.67 15.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.504 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.652 ' HB3' HD22 ' A' ' 135' ' ' LEU . . . -147.15 13.38 1.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.762 ' HB3' HD11 ' A' ' 132' ' ' ILE . 0.2 OUTLIER 170.67 115.55 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.825 0.345 . . . . 0.0 111.717 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.412 ' N ' ' HB2' ' A' ' 224' ' ' MET . 0.0 OUTLIER -121.35 148.8 43.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.129 178.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.99 132.96 21.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 0.0 111.019 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.439 ' ND2' ' HB1' ' A' ' 213' ' ' ALA . 2.3 m-80 -61.1 -176.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.787 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.789 ' HB2' HG21 ' A' ' 208' ' ' THR . 0.1 OUTLIER -124.7 -47.43 1.83 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.482 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -100.91 39.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.587 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.82 157.85 33.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.881 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.74 149.93 21.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.563 2.175 . . . . 0.0 112.315 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 61.57 67.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.596 ' CE2' HG23 ' A' ' 157' ' ' THR . 20.3 p90 -120.31 -39.3 2.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.691 ' HB ' HD12 ' A' ' 161' ' ' ILE . 17.3 p -63.6 -36.51 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.12 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.578 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 3.1 t-105 -67.95 -55.7 12.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.442 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -64.21 -11.72 29.17 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.276 1.984 . . . . 0.0 113.142 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.48 -56.79 2.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.643 0.259 . . . . 0.0 111.59 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 157' ' ' THR . 42.8 mt -65.81 -20.16 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.821 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 158' ' ' TRP . . . -89.37 12.2 16.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 250' ' ' PHE . . . -64.2 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -122.5 -51.43 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.059 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -64.75 -86.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -56.14 142.86 38.38 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.463 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.77 -169.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 110.865 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -128.99 -45.66 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.08 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' HE1' HD12 ' A' ' 333' ' ' ILE . 23.8 m-85 -153.26 160.35 42.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -129.11 135.05 48.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.05 110.78 12.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -137.02 178.23 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -70.93 69.67 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 152.96 -30.92 0.81 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.522 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -91.72 139.13 30.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.914 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.741 ' CZ ' HG21 ' A' ' 178' ' ' ILE . 3.0 p90 -140.07 36.6 1.93 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 178' ' ' ILE . 0.7 OUTLIER 61.09 93.05 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.741 HG21 ' CZ ' ' A' ' 176' ' ' TYR . 2.4 pp -157.47 -45.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.721 ' N ' HD12 ' A' ' 178' ' ' ILE . 8.3 mtpp -139.01 31.82 2.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.04 121.57 39.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.2 t -126.68 151.4 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.193 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.89 40.0 2.7 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.529 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.05 -38.37 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.786 0.327 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -95.3 61.05 2.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -122.96 168.71 11.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.37 -33.02 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.097 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.98 -32.38 36.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.463 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.7 -33.46 74.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -60.45 -46.07 91.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -81.18 -35.2 31.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.03 -28.31 73.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.484 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.663 HD13 HG12 ' A' ' 357' ' ' VAL . 1.6 tt -82.53 -50.43 8.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.797 0.332 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.1 p -57.58 -28.93 64.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.428 ' CE2' ' HD3' ' A' ' 251' ' ' LYS . 2.1 m-85 -55.0 -60.63 3.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.201 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 192' ' ' LEU . 0.6 OUTLIER -58.51 -30.78 67.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.968 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 192' ' ' LEU . 21.3 t -69.04 -54.03 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -63.3 -32.35 73.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.07 -55.98 27.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.708 HG12 HD21 ' A' ' 151' ' ' LEU . 6.2 mt -61.71 -33.71 58.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -33.29 71.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.968 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -106.51 19.34 20.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.28 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.14 -54.99 2.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.787 0.327 . . . . 0.0 110.813 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.37 -46.15 3.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.833 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 2.8 ttm 58.34 44.31 18.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -176.79 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.049 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 65.76 77.09 0.3 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -143.96 30.7 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.789 HG21 ' HB2' ' A' ' 151' ' ' LEU . 3.2 t -81.8 148.08 29.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -124.01 -165.84 1.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' A' ' 211' ' ' SER . 30.3 p90 -78.92 -44.26 23.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.083 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.448 ' N ' ' CD1' ' A' ' 210' ' ' TYR . 14.2 t -73.18 -24.67 60.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.353 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 213' ' ' ALA . 0.4 OUTLIER -81.9 -50.48 16.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.082 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.46 ' N ' HG22 ' A' ' 212' ' ' ILE . . . -67.74 -30.34 69.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.467 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.4 ' CB ' ' O ' ' A' ' 210' ' ' TYR . 4.4 tt0 -75.15 -25.69 58.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -51.55 -25.58 7.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.533 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.726 ' HB1' ' SD ' ' A' ' 224' ' ' MET . . . -57.01 -57.47 12.4 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.763 0.315 . . . . 0.0 111.016 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.696 ' CE1' HG21 ' A' ' 225' ' ' THR . 20.2 t80 -69.57 -40.27 76.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -59.43 -49.6 77.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -94.25 -1.49 53.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.642 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 217' ' ' PHE . . . -147.81 87.35 0.16 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.725 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -78.25 59.75 2.35 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.479 0.657 . . . . 0.0 110.461 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 145' ' ' SER . 0.3 OUTLIER -107.58 -175.07 2.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.125 179.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.632 ' HB2' ' HB3' ' A' ' 117' ' ' TYR . . . -77.8 44.95 0.48 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.45 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.726 ' SD ' ' HB1' ' A' ' 216' ' ' ALA . 0.0 OUTLIER -116.87 45.88 1.76 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.829 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.696 HG21 ' CE1' ' A' ' 217' ' ' PHE . 1.8 t -143.56 114.63 7.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.075 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.414 HD12 ' H ' ' A' ' 226' ' ' ILE . 3.7 mp -91.58 122.29 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -86.85 110.76 20.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.984 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 174.62 58.92 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.5 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.72 -42.53 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.641 2.227 . . . . 0.0 112.284 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -44.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -142.33 -46.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -170.01 -47.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 69.6 m 61.41 -179.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -176.54 -47.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 235' ' ' ILE . 30.4 mt 59.44 41.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.05 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.5 t0 61.83 113.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.68 -46.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.974 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.44 163.84 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.44 155.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.0 t -117.47 111.34 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.3 77.55 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -149.11 168.16 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 117' ' ' TYR . . . -134.45 120.93 2.55 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.52 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.615 HG13 ' HB3' ' A' ' 114' ' ' SER . 22.1 t -91.59 132.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 111.068 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 25.2 m -141.09 156.75 45.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.77 150.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.025 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.416 HD13 ' HD3' ' A' ' 248' ' ' PRO . 4.2 mm? -66.22 154.63 89.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.416 ' HD3' HD13 ' A' ' 247' ' ' LEU . 4.1 Cg_exo -79.78 -164.13 0.26 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.844 2.363 . . . . 0.0 112.135 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.854 HG22 ' HD3' ' A' ' 254' ' ' PRO . 21.8 p -97.29 177.95 5.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.842 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.509 ' HB2' ' HB1' ' A' ' 163' ' ' ALA . 79.8 m-85 -144.88 110.93 5.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.425 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.428 ' HD3' ' CE2' ' A' ' 194' ' ' PHE . 0.0 OUTLIER 39.65 28.65 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.872 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 154.42 -59.28 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.803 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -150.87 166.06 15.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.854 ' HD3' HG22 ' A' ' 249' ' ' THR . 57.1 Cg_endo -70.96 173.83 11.45 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.682 2.255 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.66 179.46 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 125.85 66.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.74 -168.25 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.451 2.101 . . . . 0.0 112.333 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.19 119.62 13.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.805 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 328' ' ' GLU . 27.0 m -110.34 123.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.159 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -122.04 134.53 9.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.448 ' CG2' ' CE1' ' A' ' 64' ' ' HIS . 14.4 m -97.39 144.87 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.811 0.339 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.773 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 6.3 tp -81.97 121.99 27.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.942 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.3 113.43 24.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.915 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 61' ' ' PHE . . . -116.75 145.82 43.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.023 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 176.94 -157.94 23.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.568 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.472 HD13 ' HB1' ' A' ' 276' ' ' ALA . 32.8 pt -137.95 155.41 29.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.802 0.334 . . . . 0.0 111.122 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.555 ' HB3' HD12 ' A' ' 76' ' ' LEU . 11.2 p30 -147.09 128.06 14.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.959 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.12 -80.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -178.68 36.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.155 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 55.87 55.03 9.38 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.27 -45.56 1.8 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.504 2.136 . . . . 0.0 112.336 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -151.88 80.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.965 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -30.24 71.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.955 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -69.56 -42.47 74.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.99 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 279' ' ' PHE . 6.2 tp -77.69 -31.24 52.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.472 ' HB1' HD13 ' A' ' 266' ' ' ILE . . . -73.61 -46.26 48.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.31 -50.65 72.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -60.47 -40.66 92.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.414 ' CD2' ' HG ' ' A' ' 275' ' ' LEU . 1.1 m-85 -67.8 -53.87 23.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 280' ' ' LEU . 23.3 mt -57.43 -29.15 63.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.107 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -92.18 -25.04 18.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.139 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -99.86 27.33 5.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.018 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.738 ' C ' HD22 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -112.82 -62.25 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.871 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.738 HD22 ' C ' ' A' ' 283' ' ' TYR . 3.8 mm? -139.07 57.4 1.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.3 mt -161.85 29.77 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.759 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.1 t -154.76 177.35 11.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.87 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -53.4 -49.15 67.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -77.39 -28.08 52.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.759 ' H ' HG23 ' A' ' 286' ' ' THR . . . -66.49 -66.5 2.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.429 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.75 HD21 ' OH ' ' A' ' 307' ' ' TYR . 0.8 OUTLIER -59.05 -20.78 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.83 -31.4 27.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -70.87 -56.29 6.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.407 ' CG2' ' HG ' ' A' ' 290' ' ' LEU . 11.2 m -64.31 -29.58 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.114 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 25.9 m-20 -48.02 -28.6 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.244 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -93.39 -70.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -73.05 -50.01 25.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.789 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 293' ' ' VAL . 0.0 OUTLIER 64.13 140.96 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.038 179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.88 -2.23 10.78 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.689 2.26 . . . . 0.0 112.601 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 299' ' ' LEU . 2.8 mm? 61.78 46.51 6.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.829 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 159.96 83.87 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.393 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.514 ' CA ' HG22 ' A' ' 110' ' ' VAL . . . -166.98 133.59 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.826 0.346 . . . . 0.0 111.222 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 110' ' ' VAL . 9.0 p -178.63 99.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.969 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -148.76 54.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.129 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.96 146.17 40.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -60.23 -37.37 80.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.1 m -79.54 -27.04 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.962 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.75 ' OH ' HD21 ' A' ' 290' ' ' LEU . 0.3 OUTLIER -71.71 -40.93 69.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 -179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -56.76 -32.28 65.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.955 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.96 -37.64 39.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.649 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -74.34 -30.32 61.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.83 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.909 HD12 HG21 ' A' ' 302' ' ' VAL . 0.8 OUTLIER -45.49 -29.79 1.23 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.388 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -54.48 -29.49 50.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.215 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 30.93 4.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.97 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.4 172.83 8.49 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.891 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -88.04 -76.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.78 2.32 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -81.32 -58.83 2.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.811 0.338 . . . . 0.0 111.127 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.406 HG22 HD21 ' A' ' 311' ' ' LEU . 2.0 mt -50.76 -28.14 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.409 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -65.65 -33.15 75.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.56 -45.65 18.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.267 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -37.91 88.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.238 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -27.5 51.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.158 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -55.26 -46.86 76.1 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -78.27 -31.73 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.71 66.13 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -57.86 -32.19 67.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -111.15 36.36 3.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.922 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -135.04 -175.4 13.83 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 259' ' ' VAL . 6.0 mm-40 -120.42 -176.63 3.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 329' ' ' ILE . 0.9 OUTLIER -118.98 116.01 49.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.436 ' CE ' ' CE1' ' A' ' 64' ' ' HIS . 7.2 ptp 43.84 52.94 9.67 Favored Pre-proline 0 N--CA 1.463 0.197 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.516 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.7 97.66 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.553 2.169 . . . . 0.0 112.33 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -134.5 -70.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.489 HD12 ' HE1' ' A' ' 169' ' ' PHE . 8.4 mt 63.72 139.11 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.981 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.73 -26.48 17.56 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.542 2.161 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -57.87 -27.23 63.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.05 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.4 tpt -57.57 -27.95 63.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.12 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.12 -49.96 75.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.024 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.45 77.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.153 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.787 ' O ' HG12 ' A' ' 343' ' ' VAL . 4.3 t80 -59.97 -25.64 65.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.071 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.412 ' CE3' ' HD2' ' A' ' 344' ' ' ARG . 0.0 OUTLIER -55.03 -38.7 68.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.049 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.549 ' O ' HG22 ' A' ' 345' ' ' THR . 0.1 OUTLIER -78.96 -44.27 22.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.73 96.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.169 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 339' ' ' PHE . 11.5 p -69.0 -30.37 46.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.195 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.817 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -75.18 -60.03 2.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.841 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 341' ' ' TYR . 10.1 t -49.61 -27.58 4.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.364 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 350' ' ' ALA . . . -75.42 -52.22 11.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.54 -55.95 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.987 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.817 HG22 ' O ' ' A' ' 344' ' ' ARG . 9.0 tp -53.48 -38.74 33.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -28.35 35.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.747 0.308 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 346' ' ' ALA . . . -55.07 -39.05 68.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.261 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -86.23 -14.28 44.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 24.5 p -67.69 -56.32 9.77 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.768 0.318 . . . . 0.0 110.944 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -134.1 -70.8 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.473 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -173.44 39.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.86 0.362 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -88.46 99.07 11.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.743 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 358' ' ' ASP . 11.1 t -103.31 -167.05 1.33 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.663 HG12 HD13 ' A' ' 192' ' ' LEU . 16.7 m -56.38 -27.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.376 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.709 ' H ' HG23 ' A' ' 356' ' ' THR . 3.3 t70 -46.79 -56.12 6.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.506 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -80.34 -41.17 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.613 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 357' ' ' VAL . . . -54.95 -53.09 60.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.258 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.623 HD23 ' HB ' ' A' ' 357' ' ' VAL . 4.0 mm? -64.67 -56.87 11.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.477 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -41.38 84.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.471 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 366' ' ' THR . 8.7 t0 -76.51 -47.71 21.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.716 0.293 . . . . 0.0 111.131 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 360' ' ' ALA . . . -66.79 -47.4 72.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.576 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.613 ' HA ' HD12 ' A' ' 368' ' ' ILE . 4.2 pp0? -52.31 -37.62 56.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.697 0.285 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 363' ' ' ASP . 14.1 t -80.68 -29.5 36.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -73.81 -41.85 61.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 365' ' ' GLN . 5.4 mt -59.34 -47.24 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.087 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 370' ' ' LYS . 1.3 t -159.9 -52.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.422 ' H ' HG23 ' A' ' 369' ' ' THR . 5.7 tttm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.852 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 tptt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.859 0.361 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.5 p -105.54 110.91 23.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -89.7 118.82 29.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -158.88 88.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -133.89 -72.79 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 172.77 13.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mt -111.04 160.01 17.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 57' ' ' PRO . 31.8 t -118.62 102.91 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.065 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 37' ' ' VAL . 7.7 pt -105.03 114.95 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.189 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.915 ' CB ' HG22 ' A' ' 60' ' ' ILE . 47.1 t90 -94.94 111.9 23.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.0 tt -164.88 158.1 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.64 -171.28 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -137.84 51.53 0.78 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.394 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.11 -26.74 62.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.603 0.24 . . . . 0.0 111.135 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 -43.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.279 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 42.19 2.91 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.851 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 18' ' ' ASN . 40.7 p90 -81.12 -46.64 14.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.786 0.327 . . . . 0.0 110.797 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.439 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 40.4 m-20 -76.62 -37.46 56.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.936 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.35 -39.03 89.73 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.618 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.46 -28.95 52.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.288 . . . . 0.0 110.986 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.46 -49.2 51.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.133 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.02 -50.54 73.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.989 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 27' ' ' PHE . 11.9 p -58.55 -30.89 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.72 -34.03 64.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.551 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -77.14 -28.28 54.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -29.7 70.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' O ' HD12 ' A' ' 33' ' ' ILE . 37.6 m-85 -74.39 -56.77 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.598 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.606 ' HA ' ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -60.84 -27.42 68.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.269 0.557 . . . . 0.0 110.417 179.176 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.22 -29.21 1.5 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.863 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.737 ' O ' HG23 ' A' ' 31' ' ' THR . 4.8 m-20 -66.33 -57.37 7.61 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER 157.77 37.08 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.722 0.639 . . . . 0.0 112.037 177.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.89 47.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.67 0 C-N-CA 118.131 -1.985 . . . . 0.0 115.358 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.606 ' H ' ' HA ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -140.36 95.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 118.077 0.938 . . . . 0.0 111.63 179.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.37 129.77 52.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.77 130.47 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.1 p -105.71 121.59 44.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 9' ' ' ILE . 19.8 t -94.34 118.2 39.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.08 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -109.76 159.92 16.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -127.53 166.43 23.23 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 122.02 9.26 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.596 2.197 . . . . 0.0 112.302 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.25 -75.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.98 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 0.09 27.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.51 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -55.06 -30.54 59.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.822 0.344 . . . . 0.0 111.06 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -33.5 76.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.978 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -93.93 -29.21 15.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' HG12 ' A' ' 50' ' ' VAL . 18.9 tptm -69.93 -25.46 63.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.436 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -55.48 -60.84 7.3 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.166 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 32.6 Cg_endo -63.85 -15.42 48.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.521 2.147 . . . . 0.0 112.642 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.32 -38.4 22.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.803 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.633 HG23 ' HA3' ' A' ' 54' ' ' GLY . 10.0 p -92.25 -18.31 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.267 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.78 -37.12 65.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.802 0.334 . . . . 0.0 111.223 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.31 -37.71 32.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.972 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -164.31 -71.28 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.739 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.633 ' HA3' HG23 ' A' ' 50' ' ' VAL . . . 65.94 -74.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.537 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -165.02 -57.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.95 -63.74 0.22 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.667 ' HB2' HG23 ' A' ' 8' ' ' VAL . 19.0 Cg_endo -60.2 159.15 27.51 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.602 2.201 . . . . 0.0 112.276 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.52 67.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.934 0.397 . . . . 0.0 111.018 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.566 HG12 HG22 ' A' ' 266' ' ' ILE . 34.4 mt -107.0 113.68 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.915 HG22 ' CB ' ' A' ' 10' ' ' TRP . 42.9 pt -132.58 142.68 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.493 ' CE1' ' HB1' ' A' ' 264' ' ' ALA . 12.1 m-85 -108.64 123.58 49.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.45 ' CE3' ' HG2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -163.18 174.01 12.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.721 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.52 -169.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.966 0.412 . . . . 0.0 111.7 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.409 ' HE1' HG12 ' A' ' 97' ' ' VAL . 49.0 t60 -77.24 -51.22 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.308 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -48.06 -28.14 2.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.624 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' HG2' ' CE3' ' A' ' 62' ' ' TRP . 4.8 tpp180 -64.75 -36.54 84.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 0.0 111.042 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 263' ' ' SER . 34.0 m-85 -110.46 -59.75 1.9 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.959 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.32 -23.62 19.15 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.17 -50.41 2.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.597 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.41 -40.35 73.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 0.0 110.995 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.734 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -56.7 -26.64 57.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.31 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -54.84 -28.59 50.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -70.62 -26.76 63.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.91 64.59 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.4 mt -149.81 40.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.854 0.359 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.734 HD12 ' HB2' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -133.53 146.05 50.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.043 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 131.49 43.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -58.02 160.94 4.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 80' ' ' THR . 32.9 mt -114.77 158.79 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.2 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -117.6 97.83 51.14 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.848 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.67 161.35 24.76 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.424 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HB2' ' CD1' ' A' ' 85' ' ' PHE . 2.0 m-20 -97.79 -177.94 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -97.52 -51.4 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.13 -25.32 45.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.343 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 82' ' ' ASP . 34.2 m-85 -79.29 -59.04 2.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.627 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.22 -24.78 68.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -62.99 -38.17 90.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.96 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.63 39.57 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD22 HG21 ' A' ' 93' ' ' THR . 0.7 OUTLIER -123.78 153.35 41.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.898 ' O ' HG22 ' A' ' 93' ' ' THR . 3.1 m-85 -76.76 134.26 69.12 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.25 -22.89 27.8 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.414 2.076 . . . . 0.0 112.376 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -57.45 -40.71 79.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.898 HG22 ' O ' ' A' ' 90' ' ' TYR . 12.5 t -58.98 -29.7 67.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.819 ' CD1' HG23 ' A' ' 93' ' ' THR . 11.4 m0 -77.98 -56.67 4.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.873 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.91 -25.2 60.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.059 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.68 -39.0 76.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.149 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.467 HG11 ' HG3' ' A' ' 107' ' ' PRO . 11.7 m -150.76 70.51 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.199 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.72 109.65 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -101.12 104.53 15.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.972 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 68.57 -67.76 0.2 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.006 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -171.01 33.01 0.15 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.465 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -136.23 140.37 43.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 tp -108.59 89.47 3.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.878 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.614 ' O ' HD22 ' A' ' 76' ' ' LEU . 34.9 pt -102.4 41.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.041 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.49 155.71 2.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.553 ' CD1' HD11 ' A' ' 108' ' ' ILE . 2.2 t80 -134.63 100.69 12.22 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.174 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.633 ' CB ' HG21 ' A' ' 261' ' ' VAL . 5.6 Cg_endo -85.41 142.32 8.28 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.074 2.516 . . . . 0.0 111.504 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.646 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 15.9 mt -155.88 39.3 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.834 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.804 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . 160.6 93.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.267 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 110' ' ' VAL . 11.0 p -118.09 104.08 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.061 0.458 . . . . 0.0 110.841 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.783 ' HA ' HG21 ' A' ' 320' ' ' THR . 46.4 mp0 -158.49 132.23 7.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.775 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 113' ' ' LEU . . . -165.1 105.52 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.017 178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.487 HD12 ' CG ' ' A' ' 323' ' ' ASN . 4.2 mt 158.2 106.47 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.305 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.9 m -164.98 123.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.876 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 224' ' ' MET . 4.8 tp -101.2 116.04 31.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.126 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.6 mt -74.71 133.16 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.553 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.851 ' HB3' HD22 ' A' ' 122' ' ' LEU . 50.5 p90 -152.87 124.14 7.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.674 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -150.81 -179.56 7.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.068 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt 59.53 24.07 12.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.075 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.43 27.83 4.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.193 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 39.73 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.841 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.851 HD22 ' HB3' ' A' ' 117' ' ' TYR . 0.0 OUTLIER -157.01 114.65 1.97 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.422 ' HG3' HD12 ' A' ' 135' ' ' LEU . 56.5 Cg_endo -70.43 160.43 49.53 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.42 2.08 . . . . 0.0 112.224 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -64.95 154.04 87.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.09 108.98 0.63 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.62 2.214 . . . . 0.0 112.41 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.51 -168.33 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.51 2.14 . . . . 0.0 112.344 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -101.34 14.77 30.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 130' ' ' GLU . 4.3 m -160.22 141.15 12.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.447 ' CG ' HD12 ' A' ' 132' ' ' ILE . 0.0 OUTLIER -71.69 -29.15 64.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' HG22 ' A' ' 128' ' ' THR . 3.6 mt-10 -54.01 -23.71 14.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.564 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.89 -21.63 60.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.697 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 4.3 mt -73.38 -54.34 4.18 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.697 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 50.6 Cg_exo -52.92 -30.92 50.22 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.227 1.951 . . . . 0.0 112.332 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.07 -37.12 71.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.422 HD12 ' HG3' ' A' ' 123' ' ' PRO . 1.4 mt -65.15 -30.08 70.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.728 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 1.8 m-20 -59.02 -34.9 72.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -59.27 -37.94 78.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 3.8 mp0 -81.76 -42.02 20.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.953 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.669 ' CD1' ' HB2' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -62.66 -50.98 69.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -25.95 64.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -56.84 -22.32 35.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.359 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -109.23 -53.51 2.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.941 0.401 . . . . 0.0 110.749 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 159.94 40.28 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.525 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 172.22 18.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.5 ' O ' HD13 ' A' ' 139' ' ' LEU . 5.6 m -122.68 177.53 5.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.728 ' HB3' ' OD1' ' A' ' 136' ' ' ASP . . . -118.56 30.79 7.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.037 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 132' ' ' ILE . 1.3 pp 170.4 138.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.755 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.621 ' SD ' HG21 ' A' ' 222' ' ' THR . 0.0 OUTLIER -164.69 139.19 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.016 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -171.93 176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.56 155.31 12.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.661 ' CD1' HG21 ' A' ' 208' ' ' THR . 0.5 OUTLIER -128.49 -48.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.708 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -98.82 39.77 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.714 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.11 148.38 54.34 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.786 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HG2' ' CE2' ' A' ' 155' ' ' TYR . 98.8 Cg_endo -79.87 161.98 23.96 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.624 2.216 . . . . 0.0 112.503 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 154' ' ' PRO . 14.0 m-85 77.85 -2.13 2.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.758 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -121.04 -69.82 0.82 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.851 0.357 . . . . 0.0 110.836 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.22 -29.59 60.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.897 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -64.31 -55.98 26.76 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 46.2 Cg_endo -68.82 -22.3 36.91 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.519 2.146 . . . . 0.0 112.673 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -73.65 -53.76 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.547 HD13 HD22 ' A' ' 192' ' ' LEU . 1.3 pp -83.61 0.93 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.329 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -92.53 -68.15 0.81 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.872 0.368 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 250' ' ' PHE . . . 63.64 -79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.123 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.73 -29.45 69.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.866 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 81.46 69.67 1.38 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.499 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 94.29 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -173.41 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.28 -31.63 8.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.187 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.404 ' CD1' ' HG3' ' A' ' 336' ' ' MET . 0.2 OUTLIER -153.71 117.14 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.516 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.0 OUTLIER -102.97 134.81 45.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.891 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -106.97 120.23 41.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -127.68 127.93 44.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.41 32.87 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.32 30.3 77.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -126.94 125.72 42.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -82.64 157.92 23.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 25.1 t70 61.83 116.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.98 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.678 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -138.79 19.53 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.354 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.86 30.26 11.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.86 92.98 2.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.958 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 21.4 m -148.33 124.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.443 ' O ' HG12 ' A' ' 183' ' ' VAL . . . 173.65 48.72 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.489 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 183' ' ' VAL . 14.1 p 43.55 38.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.952 0.406 . . . . 0.0 111.601 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -98.65 37.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 19.7 m-20 -126.31 143.43 51.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.72 -28.43 67.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -58.87 -45.17 95.41 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.446 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.756 ' O ' HD23 ' A' ' 192' ' ' LEU . . . -75.95 -35.29 59.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.772 0.32 . . . . 0.0 111.089 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -63.41 -49.42 73.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 193' ' ' THR . . . -67.27 -44.09 80.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.195 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.35 -31.45 80.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 188' ' ' ALA . 1.9 mm? -64.22 -41.7 96.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.849 0.357 . . . . 0.0 110.925 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.824 ' HB ' HG21 ' A' ' 357' ' ' VAL . 7.6 t -77.46 -37.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.005 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.31 -53.35 56.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.036 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 199' ' ' ILE . 0.2 OUTLIER -57.45 -53.07 62.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 192' ' ' LEU . 27.2 m -64.01 -28.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.456 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.18 -56.89 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.298 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 195' ' ' LEU . 3.5 pp -58.41 -37.35 75.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.34 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 195' ' ' LEU . 2.3 pp -74.67 -31.47 26.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.779 0.323 . . . . 0.0 111.266 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -78.8 -26.12 44.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.204 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.39 23.1 14.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.14 -76.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.936 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -120.03 -4.09 10.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.438 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.8 ptp 44.65 47.4 8.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.985 0.421 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -56.82 109.74 0.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.018 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.02 -30.97 67.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -164.91 94.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.968 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.661 HG21 ' CD1' ' A' ' 151' ' ' LEU . 2.6 t -98.48 129.59 45.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.524 ' H ' HD12 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -113.8 -162.14 0.79 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.857 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 214' ' ' GLU . 2.3 t80 -79.13 -46.78 17.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.83 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.404 ' O ' ' CG ' ' A' ' 214' ' ' GLU . 1.7 t -63.86 -24.68 67.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.183 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 209' ' ' ASP . 23.1 mt -82.71 -57.28 4.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.539 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.97 -29.97 68.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.012 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 210' ' ' TYR . 0.0 OUTLIER -51.25 -31.47 20.99 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.851 0.358 . . . . 0.0 111.337 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.23 57.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.83 -52.92 6.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.833 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 226' ' ' ILE . 53.2 t80 -76.43 -58.67 3.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.793 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 214' ' ' GLU . 14.5 t-20 -47.48 -31.84 4.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.557 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 29.7 mmtt -105.35 -23.7 12.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.956 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 52.87 43.42 60.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.25 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -110.48 39.26 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.585 0.231 . . . . 0.0 111.516 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.621 HG21 ' SD ' ' A' ' 148' ' ' MET . 17.6 p -131.59 -177.91 4.63 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.708 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -88.43 38.48 0.87 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.376 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.663 ' HG2' HD11 ' A' ' 115' ' ' LEU . 2.5 ttt 176.45 128.44 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.933 0.397 . . . . 0.0 111.513 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.71 105.04 4.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.484 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.404 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 2.4 tt -76.97 142.21 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.205 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.91 129.75 34.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.879 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -109.68 -144.48 10.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.396 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -51.1 -179.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.456 2.104 . . . . 0.0 112.315 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -98.37 34.65 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -90.37 -30.71 17.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.109 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 59.96 173.01 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.7 t -89.9 -63.66 1.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.31 65.75 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.42 HG22 ' N ' ' A' ' 236' ' ' ASP . 27.5 mt 61.43 155.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 235' ' ' ILE . 5.7 m-20 -62.49 -48.38 79.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 p 56.8 174.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 23.3 t 62.12 150.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -72.85 -46.07 54.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 240' ' ' VAL . 9.1 p -163.01 106.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.098 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -167.65 40.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -139.75 115.96 10.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -101.37 132.81 11.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.561 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.76 106.37 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.853 0.359 . . . . 0.0 111.161 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.47 158.95 30.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.845 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.5 p -77.46 149.51 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.015 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.9 156.17 37.74 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.79 -158.44 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.925 2.417 . . . . 0.0 112.209 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.3 p -127.13 177.28 6.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 163' ' ' ALA . 49.9 p90 -167.26 118.49 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.735 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.77 12.21 8.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.85 16.03 60.37 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.873 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 254' ' ' PRO . 46.0 mm-40 -152.91 92.75 3.29 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.643 0.258 . . . . 0.0 110.84 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 253' ' ' GLN . 35.8 Cg_endo -65.22 -177.67 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.484 2.123 . . . . 0.0 112.217 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 9.4 m -49.7 175.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.933 0.397 . . . . 0.0 111.208 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 2.5 mtpm? -86.28 134.59 38.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 4.3 Cg_exo -79.55 111.79 2.86 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.65 2.234 . . . . 0.0 112.213 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -132.33 103.35 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.811 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.641 HG23 HG13 ' A' ' 329' ' ' ILE . 30.2 m -101.51 153.06 5.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.246 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.4 ' C ' HG23 ' A' ' 110' ' ' VAL . . . -130.4 117.62 2.31 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.244 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.633 HG21 ' CB ' ' A' ' 107' ' ' PRO . 9.3 p -86.37 145.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.307 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.804 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -78.77 107.78 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.076 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 4.1 m -91.79 117.49 29.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.82 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 61' ' ' PHE . . . -135.93 108.74 7.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -151.15 -143.41 3.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.567 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.668 HD13 ' H ' ' A' ' 266' ' ' ILE . 0.2 OUTLIER -137.24 146.48 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.749 0.309 . . . . 0.0 111.144 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -127.63 118.82 24.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.964 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -175.44 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.107 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . 179.93 36.89 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 271' ' ' PRO . 0.3 OUTLIER 55.42 54.09 9.31 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 270' ' ' SER . 50.1 Cg_endo -69.07 -46.77 1.36 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.66 2.24 . . . . 0.0 112.299 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -143.8 65.06 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -60.81 -45.59 93.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.18 -33.39 72.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.957 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.82 -55.78 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.47 -52.58 63.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -29.43 68.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.85 -56.6 19.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.919 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -73.36 -29.7 62.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.038 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.72 -33.53 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.084 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -105.31 -31.88 8.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.219 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -97.25 27.45 4.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.171 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.05 -43.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.853 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.98 42.12 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 6.3 tp -148.1 38.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.928 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.0 p -136.03 153.75 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.743 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -54.14 -38.14 65.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.0 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.65 -57.26 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.697 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -63.1 -57.46 15.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.939 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.603 ' O ' HG22 ' A' ' 293' ' ' VAL . 2.8 tt -45.98 -40.71 10.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.796 0.332 . . . . 0.0 111.511 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -79.39 -57.91 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.962 0.411 . . . . 0.0 110.812 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 296' ' ' ASP . . . -49.06 -24.31 1.53 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.223 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 289' ' ' GLY . 34.4 m -80.86 -29.51 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 111.349 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -100.72 -85.96 0.41 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.389 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -120.39 14.61 12.05 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 292' ' ' ALA . 2.7 t0 59.95 27.97 17.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.757 0.313 . . . . 0.0 110.98 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.75 160.26 2.48 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.935 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -51.17 155.46 6.42 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.397 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.909 HD22 ' N ' ' A' ' 300' ' ' GLY . 0.0 OUTLIER -164.46 -31.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.66 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.909 ' N ' HD22 ' A' ' 299' ' ' LEU . . . 170.19 140.57 3.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.474 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.572 ' O ' HG13 ' A' ' 302' ' ' VAL . . . 172.88 156.27 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 301' ' ' ALA . 4.6 m -160.28 40.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -129.34 40.11 3.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.068 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.94 116.38 4.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -41.62 90.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.5 p -68.5 -31.52 70.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -74.71 -27.28 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.27 -36.45 68.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -60.0 -56.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.748 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.666 HD11 ' CB ' ' A' ' 317' ' ' ILE . 2.0 tt -55.58 -22.42 21.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.317 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -47.31 -29.17 2.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.541 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -29.6 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -57.96 109.83 2.09 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.927 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 319' ' ' ALA . 71.9 Cg_endo -76.89 -11.63 18.1 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.454 2.103 . . . . 0.0 112.736 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -66.04 -59.33 3.91 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.799 0.333 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.666 ' CB ' HD11 ' A' ' 311' ' ' LEU . 2.4 mp -80.13 -34.67 15.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -62.79 -28.41 69.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.264 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 315' ' ' PRO . . . -56.78 -49.0 76.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.225 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.783 HG21 ' HA ' ' A' ' 111' ' ' GLU . 63.4 p -67.9 -26.51 66.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -26.9 28.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.239 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -66.57 -57.43 7.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.987 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.487 ' CG ' HD12 ' A' ' 113' ' ' LEU . 5.9 p-10 -76.47 -34.19 58.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.967 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.1 -28.85 59.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.11 -30.87 66.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.85 -30.19 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.062 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -90.07 -148.01 18.79 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.64 -178.09 1.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.641 HG13 HG23 ' A' ' 259' ' ' VAL . 12.0 tt -104.55 114.96 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.124 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.51 147.09 0.77 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.87 -167.68 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.502 2.135 . . . . 0.0 112.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 30.29 5.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 15.7 mm 57.95 90.34 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -51.94 -36.88 65.89 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.575 2.183 . . . . 0.0 112.445 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -62.57 -36.74 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.015 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.404 ' HG3' ' CD1' ' A' ' 169' ' ' PHE . 19.8 mmt -61.81 -22.08 65.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.6 t -52.06 -27.31 13.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.162 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.0 -33.45 73.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.149 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -29.12 66.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 45.2 t90 -47.98 -28.83 2.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.208 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.92 -42.95 90.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.903 ' O ' HG22 ' A' ' 345' ' ' THR . . . -79.93 -30.45 39.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.527 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.471 HG11 ' HE1' ' A' ' 158' ' ' TRP . 43.5 t -53.9 -29.72 18.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.642 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.48 ' O ' HG22 ' A' ' 348' ' ' ILE . 0.2 OUTLIER -52.55 -46.73 66.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.186 -179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 342' ' ' ALA . 14.8 t -50.0 -30.57 10.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.079 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -76.18 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.754 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 348' ' ' ILE . 34.8 m -79.83 -49.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 347' ' ' VAL . 1.5 tt -49.99 -42.52 19.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.698 0.285 . . . . 0.0 111.578 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 345' ' ' THR . 2.3 m120 -60.86 -33.23 72.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -57.27 -31.17 65.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.102 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -77.39 -10.57 59.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.534 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 54.2 m -67.62 -29.05 68.27 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.877 0.37 . . . . 0.0 111.035 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 97.01 -12.33 65.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.601 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -129.66 39.59 3.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.876 0.369 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.404 ' CG ' ' HB3' ' A' ' 349' ' ' ASN . 7.6 tp60 -123.73 127.1 47.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.786 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 18.2 p -110.07 141.26 43.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.875 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.824 HG21 ' HB ' ' A' ' 193' ' ' THR . 21.2 t -57.79 -27.91 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -63.19 -37.75 88.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -80.24 -52.76 7.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.528 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 364' ' ' ALA . . . -53.88 -33.21 55.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.107 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 361' ' ' LEU . 0.8 OUTLIER -82.24 -49.38 10.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -64.63 -55.48 19.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 364' ' ' ALA . 1.3 p-10 -59.64 -29.68 68.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.689 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 360' ' ' ALA . . . -64.79 -55.49 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.02 -30.74 60.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 60.0 p -80.06 -30.08 39.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.935 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.7 -47.11 41.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 42.7 mm -61.31 -35.02 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.09 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.3 p -99.0 30.7 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.821 0.343 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.11 93.1 4.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.16 119.29 38.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 63.78 -79.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.32 51.97 3.36 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.674 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.5 ptmt -134.48 130.44 36.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.824 0.345 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.674 HD12 ' C ' ' A' ' 6' ' ' LYS . 9.4 mp -125.75 157.29 37.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 16.7 t -134.18 104.15 5.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 120.999 0.428 . . . . 0.0 111.307 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.649 HG23 ' HE1' ' A' ' 61' ' ' PHE . 3.7 mp -99.88 124.18 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.346 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.674 ' HB3' HG23 ' A' ' 60' ' ' ILE . 9.8 t90 -107.07 117.72 34.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.514 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -131.21 155.96 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.232 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -143.82 110.73 5.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.65 57.37 0.83 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.506 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -140.36 -50.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.6 tttt 59.4 31.53 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.66 36.52 4.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.525 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -60.13 -35.62 75.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -69.52 -51.15 38.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.86 -46.13 54.37 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.97 -56.47 21.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 0.0 110.826 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.45 -28.85 69.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.154 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -31.85 70.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.951 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.3 t -75.35 -38.06 39.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.34 -25.32 75.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.54 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -57.26 -41.89 80.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -74.61 -47.67 30.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.009 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.609 ' HB3' HG21 ' A' ' 33' ' ' ILE . 1.5 m-85 -62.32 -56.24 20.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' ' HB ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -51.85 -28.25 15.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.434 0.635 . . . . 0.0 110.683 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -25.69 49.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.61 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.643 ' O ' ' OG1' ' A' ' 31' ' ' THR . 14.5 t0 -51.58 -56.73 11.84 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.833 ' O ' HG22 ' A' ' 31' ' ' THR . 6.9 m 156.97 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.761 176.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.76 ' O ' HD13 ' A' ' 33' ' ' ILE . . . 156.76 45.91 0.01 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 117.58 -2.248 . . . . 0.0 115.898 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 32' ' ' GLY . 4.0 mm -131.45 95.79 2.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 118.425 1.113 . . . . 0.0 111.541 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -111.07 128.49 55.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.483 HG11 ' CE2' ' A' ' 283' ' ' TYR . 27.2 m -126.85 138.7 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.9 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.28 115.2 27.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 37' ' ' VAL . 14.7 p -86.3 116.27 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.808 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HG3' ' CG1' ' A' ' 8' ' ' VAL . 6.0 mm-40 -104.27 143.32 33.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.979 0.418 . . . . 0.0 111.277 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.59 ' O ' HD22 ' A' ' 43' ' ' LEU . 5.1 p80 -112.42 158.47 37.17 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.564 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.67 -83.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.358 2.039 . . . . 0.0 112.405 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 49.98 -92.29 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -120.34 -2.99 9.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.534 0.207 . . . . 0.0 111.449 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 39' ' ' HIS . 7.2 mp -53.26 -25.79 15.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.687 0.28 . . . . 0.0 111.319 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -55.15 -38.84 68.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.87 0.367 . . . . 0.0 110.955 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.36 -23.3 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.067 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -75.3 -29.53 60.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.164 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.499 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 64.5 t80 -55.74 -56.58 28.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.273 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.3 Cg_endo -64.01 -15.27 48.25 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.556 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -83.65 -55.3 4.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.844 0.354 . . . . 0.0 110.936 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 46' ' ' LYS . 14.1 m -73.08 -28.87 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.227 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.04 -28.07 69.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.248 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.16 -26.23 62.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.336 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.6 m -148.4 124.08 10.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.914 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.9 -54.25 2.25 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.343 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.6 t70 77.98 -55.04 0.5 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.702 0.287 . . . . 0.0 111.046 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.38 -107.01 0.35 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.575 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' HB ' ' A' ' 8' ' ' VAL . 87.3 Cg_exo -48.3 150.17 5.69 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.631 2.22 . . . . 0.0 112.259 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -153.89 38.53 0.46 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.551 HG22 ' HE1' ' A' ' 61' ' ' PHE . 13.1 mt -152.73 118.47 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.795 0.331 . . . . 0.0 110.533 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.674 HG23 ' HB3' ' A' ' 10' ' ' TRP . 12.7 mt -151.15 142.86 16.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 111.694 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.779 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 2.1 m-85 -128.38 120.47 27.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.176 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.89 92.48 1.02 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.836 0.35 . . . . 0.0 111.741 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HB3' ' OD2' ' A' ' 65' ' ' ASP . . . 42.59 -165.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.054 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -76.94 -29.53 55.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.94 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 63' ' ' ALA . 2.2 p30 -47.78 -35.16 9.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.527 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.72 -36.86 84.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 0.0 110.77 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.79 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 13.5 t80 -77.56 -64.03 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.2 -10.21 61.97 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.054 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.39 -61.11 1.92 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.668 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -96.57 -48.23 5.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.691 0.282 . . . . 0.0 111.088 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 67' ' ' PHE . . . -57.01 -29.69 63.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.251 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -64.11 -31.62 72.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.836 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.7 -26.8 25.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.77 70.97 0.4 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.59 39.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.831 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.543 HD11 ' HA2' ' A' ' 265' ' ' GLY . 1.2 tt -148.79 118.48 7.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.622 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.41 156.09 28.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.038 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -93.4 156.85 16.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 HG22 ' CE ' ' A' ' 277' ' ' LYS . 2.9 pt -147.12 163.86 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.127 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 t -110.49 86.13 5.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.593 ' HD2' HD13 ' A' ' 103' ' ' LEU . 98.9 Cg_endo -79.8 -168.35 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.531 2.154 . . . . 0.0 112.362 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 86' ' ' GLN . 21.8 m-20 64.01 131.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -120.26 -100.89 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.71 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.4 -59.18 2.8 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 86' ' ' GLN . 50.9 p90 -80.91 -53.13 6.73 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' HD23 ' A' ' 89' ' ' LEU . 2.5 mt-30 -52.76 -23.07 6.08 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.997 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.557 ' HB3' ' O ' ' A' ' 83' ' ' LYS . 1.8 p-10 -45.5 -30.86 1.55 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.186 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -123.39 -65.56 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.821 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.581 ' C ' HD12 ' A' ' 89' ' ' LEU . 3.6 pp 42.69 -168.62 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.607 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.411 ' N ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -69.24 112.83 13.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.905 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.83 -26.12 29.66 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.384 2.056 . . . . 0.0 112.354 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.29 -31.9 70.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -75.35 -31.02 60.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.945 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.472 ' CD1' HD11 ' A' ' 89' ' ' LEU . 2.4 m0 -70.17 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -53.81 -26.43 24.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.213 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.01 67.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.102 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.424 ' CG1' ' HB3' ' A' ' 105' ' ' ALA . 24.1 t -152.46 68.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.107 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.48 155.57 42.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -126.31 168.6 13.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -71.71 65.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.855 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.3 28.47 13.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 163.98 32.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.593 HD13 ' HD2' ' A' ' 81' ' ' PRO . 1.4 mt -145.33 75.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.403 ' O ' ' CE1' ' A' ' 67' ' ' PHE . 2.3 pt -108.22 39.91 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -170.89 132.81 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.701 ' CE1' HD11 ' A' ' 285' ' ' LEU . 29.5 t80 -155.14 102.19 2.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 262' ' ' LEU . 5.3 Cg_exo -79.22 167.34 21.69 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.743 2.295 . . . . 0.0 111.925 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.99 39.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 0.0 111.325 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.73 ' HB2' HD12 ' A' ' 262' ' ' LEU . . . -176.85 157.99 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.142 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.637 HG21 ' CD1' ' A' ' 317' ' ' ILE . 30.9 m -132.27 106.16 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.095 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -126.94 159.65 33.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -164.25 159.43 20.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.956 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.642 ' C ' HD22 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -79.72 161.43 25.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.496 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -165.15 -176.03 3.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 224' ' ' MET . 8.5 mp -103.09 108.68 19.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.864 HD11 ' CD1' ' A' ' 242' ' ' TYR . 9.1 tt -87.99 149.31 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.123 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -137.42 163.53 30.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -102.53 -178.04 3.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.925 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.7 81.25 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -163.06 -63.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.6 pt? -123.71 40.03 3.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.4 HD23 ' HD2' ' A' ' 123' ' ' PRO . 2.0 tt -144.65 115.82 5.29 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' HD2' HD23 ' A' ' 122' ' ' LEU . 40.6 Cg_endo -67.12 158.0 59.02 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.425 2.083 . . . . 0.0 112.197 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -65.02 111.25 5.46 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.51 154.76 24.29 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.51 2.14 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.54 -167.52 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.526 2.151 . . . . 0.0 112.238 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.4 p -76.99 140.52 40.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.01 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.837 ' CE3' HD12 ' A' ' 132' ' ' ILE . 3.1 m95 -71.71 -37.34 70.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -53.58 -23.82 11.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.643 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -85.04 -16.26 41.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.837 HD12 ' CE3' ' A' ' 129' ' ' TRP . 37.0 mt -65.61 -48.77 64.2 Favored Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 84.9 Cg_exo -46.4 -35.78 16.66 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.419 2.079 . . . . 0.0 112.465 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.07 93.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.1 mt -77.51 -31.66 53.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.691 ' OD1' HG22 ' A' ' 132' ' ' ILE . 1.1 m-20 -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 22.8 mttp -71.83 -31.84 66.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -67.32 -45.27 76.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.44 -48.83 30.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -59.22 -25.64 64.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.021 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.76 33.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.387 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -109.03 -63.39 1.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.82 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.9 39.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.327 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -153.88 166.29 33.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.392 . . . . 0.0 110.929 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 222' ' ' THR . 4.0 m -119.15 162.81 18.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.888 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.806 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -93.0 -2.15 56.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.597 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.587 HD23 ' N ' ' A' ' 147' ' ' LEU . 1.9 pt? 172.61 126.78 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.716 0.293 . . . . 0.0 110.477 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.23 120.74 8.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.587 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.38 123.85 48.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.077 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.405 ' OD1' ' CZ ' ' A' ' 156' ' ' PHE . 1.4 p-10 -85.04 154.25 22.21 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.696 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 151' ' ' LEU . 9.8 mt -128.37 -46.27 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.822 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -102.37 39.75 1.46 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.81 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 3.2 mt-10 -120.18 137.03 25.5 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 4.4 Cg_exo -79.63 179.24 6.49 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.726 2.284 . . . . 0.0 112.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' A' ' 258' ' ' PHE . 3.6 m-85 59.8 20.11 8.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.22 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.405 ' CZ ' ' OD1' ' A' ' 150' ' ' ASN . 19.3 m-85 -120.84 -33.0 3.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.166 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -77.23 -24.28 51.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.421 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -69.42 -55.31 9.81 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.684 -0.235 . . . . 0.0 111.188 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 158' ' ' TRP . 21.6 Cg_exo -65.35 -32.84 49.79 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.48 2.12 . . . . 0.0 112.23 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.529 HD21 ' CZ ' ' A' ' 250' ' ' PHE . 0.5 OUTLIER -70.1 -52.64 22.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.237 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.521 HD11 HD13 ' A' ' 195' ' ' LEU . 47.0 mt -77.06 -5.1 7.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.821 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 158' ' ' TRP . . . -83.91 -63.96 1.25 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-O 120.743 0.306 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 51.34 -87.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.53 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 162' ' ' ALA . 2.0 t0 -115.89 -39.57 3.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.828 0.346 . . . . 0.0 110.862 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.67 -91.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.537 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.13 -47.83 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.516 ' OH ' HD21 ' A' ' 361' ' ' LEU . 0.3 OUTLIER 60.76 42.23 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 0.0 110.895 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -160.87 -63.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 176' ' ' TYR . 17.5 p90 -155.32 172.93 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.95 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.14 125.85 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.421 ' CZ ' ' HG3' ' A' ' 328' ' ' GLU . 45.9 p90 -133.53 123.64 25.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -137.06 102.13 4.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 t30 56.2 29.08 14.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.14 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -157.28 -85.8 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.56 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -173.25 174.49 3.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.424 ' HB3' ' CD2' ' A' ' 169' ' ' PHE . 15.2 p90 -59.75 134.06 56.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 164.69 23.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 179' ' ' LYS . 4.3 tt -119.93 -41.85 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.44 ' N ' HG23 ' A' ' 178' ' ' ILE . 0.0 OUTLIER -80.36 -37.43 32.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.944 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -94.94 97.62 10.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.0 151.42 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -112.0 39.87 2.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.387 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.4 t -67.27 -24.68 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.765 0.317 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -144.23 65.51 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -101.64 -174.89 2.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.91 -32.67 72.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.154 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.2 -30.0 51.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.53 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.13 93.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.38 . . . . 0.0 111.181 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -67.04 -33.64 75.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.48 -46.32 80.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.77 -28.34 67.31 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.418 HD22 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -74.99 -31.82 61.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.89 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 p -75.25 -30.78 60.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.972 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.416 ' CE1' ' HE3' ' A' ' 251' ' ' LYS . 5.8 m-85 -72.66 -41.98 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.521 HD13 HD11 ' A' ' 161' ' ' ILE . 1.2 tt -60.54 -37.84 82.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.891 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.423 ' HA ' HG22 ' A' ' 199' ' ' ILE . 31.4 m -76.05 -30.26 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.126 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -71.78 -41.33 68.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.23 -50.15 42.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 195' ' ' LEU . 17.1 tt -59.47 -30.85 45.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -62.23 -26.78 68.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.045 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -97.53 -23.73 15.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.071 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -88.88 -66.07 0.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.41 -35.2 73.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.043 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 mtt -101.54 72.81 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -179.15 -39.21 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.46 -45.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 2.8 t0 64.07 95.11 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.9 t -63.36 137.56 58.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' HD12 ' A' ' 212' ' ' ILE . 2.8 t0 -86.78 -166.08 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.997 0.427 . . . . 0.0 111.017 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 211' ' ' SER . 48.8 p90 -79.0 -40.36 31.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.172 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 215' ' ' ALA . 0.3 OUTLIER -79.53 -24.67 42.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.356 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.445 HD12 ' H ' ' A' ' 209' ' ' ASP . 12.7 mt -81.56 -57.29 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.562 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.83 -30.42 68.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.469 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -81.3 -42.62 20.33 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 211' ' ' SER . . . -57.18 -31.37 65.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.422 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 220' ' ' GLY . . . -81.43 -52.23 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.325 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -68.65 -28.36 66.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.626 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -69.29 -50.85 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -107.05 -23.76 12.2 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 216' ' ' ALA . . . 99.97 67.7 0.85 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.749 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.08 38.35 1.03 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.338 . . . . 0.0 111.431 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 145' ' ' SER . 14.9 p -152.16 179.99 8.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.806 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -85.82 38.85 0.77 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.39 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.454 ' HG2' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER 175.63 159.19 0.24 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.024 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -144.52 105.14 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.827 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.4 mt -80.82 136.15 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.435 ' HB3' ' CH2' ' A' ' 232' ' ' TRP . 60.7 m-20 -115.24 163.77 15.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -163.62 163.02 35.46 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.84 -28.28 25.04 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.576 2.184 . . . . 0.0 112.347 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -75.65 -34.85 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -106.88 62.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.435 ' CH2' ' HB3' ' A' ' 227' ' ' ASN . 0.0 OUTLIER -154.0 104.6 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.869 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 7.8 p -167.58 -56.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.911 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.36 -60.88 3.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.6 mt 64.16 136.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.007 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -126.87 160.81 29.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.7 p -68.38 169.48 10.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 54.0 p -145.13 162.74 36.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.873 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.65 ' HG3' HG23 ' A' ' 240' ' ' VAL . 0.6 OUTLIER -116.61 -40.94 3.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.96 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.65 HG23 ' HG3' ' A' ' 239' ' ' LYS . 21.6 t -98.1 148.75 5.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -80.26 140.15 36.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.864 ' CD1' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -137.84 166.6 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -145.1 144.22 12.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.468 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.753 HG12 ' HB ' ' A' ' 116' ' ' ILE . 23.6 m -93.4 136.47 25.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.783 0.325 . . . . 0.0 111.094 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 61.6 m -141.01 150.13 42.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.677 HG21 ' HB2' ' A' ' 323' ' ' ASN . 9.9 p -100.3 150.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.173 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.784 ' H ' HD22 ' A' ' 247' ' ' LEU . 0.0 OUTLIER -126.25 97.45 34.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.598 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.54 51.89 4.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.924 2.416 . . . . 0.0 112.691 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.12 114.41 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.734 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.529 ' CZ ' HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -155.09 111.69 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.763 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.416 ' HE3' ' CE1' ' A' ' 194' ' ' PHE . 13.7 mptt 58.11 19.97 6.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.261 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 116.06 -34.79 4.56 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.889 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -132.37 152.13 79.52 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.739 0.304 . . . . 0.0 111.295 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.402 ' HG3' ' CD ' ' A' ' 326' ' ' LYS . 71.8 Cg_endo -77.04 132.4 12.75 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.73 2.287 . . . . 0.0 112.485 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 159' ' ' PRO . 67.5 m -54.42 178.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.39 83.43 46.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.749 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.59 162.89 24.44 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.962 2.441 . . . . 0.0 112.151 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 155' ' ' TYR . 5.1 m-85 -88.36 144.32 26.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 329' ' ' ILE . 35.8 m -99.83 154.51 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.087 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.08 110.51 1.29 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.442 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 109' ' ' ALA . 18.4 m -108.33 144.65 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' A' ' 109' ' ' ALA . 9.8 mt -69.76 90.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.597 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.2 m -79.59 120.84 24.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.779 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -83.54 123.89 30.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.112 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.543 ' HA2' HD11 ' A' ' 76' ' ' LEU . . . -102.75 106.13 2.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.453 HG22 HD21 ' A' ' 76' ' ' LEU . 14.7 tt -95.73 141.78 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.762 0.315 . . . . 0.0 111.074 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -83.59 138.39 33.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.622 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -78.94 -30.84 44.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.6 52.53 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.8 p -115.86 149.24 42.88 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 125.64 12.33 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.599 2.199 . . . . 0.0 112.318 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.88 88.88 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -75.08 -33.89 61.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -70.52 -30.89 67.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 tp -75.64 -32.96 60.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.59 -30.78 69.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.518 ' CE ' HG22 ' A' ' 79' ' ' ILE . 32.2 mttt -65.23 -58.99 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.959 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.92 -32.09 70.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.96 -51.35 69.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -31.28 64.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -71.79 -30.26 65.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -106.56 27.48 8.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.951 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 35' ' ' VAL . 26.3 t80 -132.89 -69.11 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.98 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.33 -52.14 6.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.701 HD11 ' CE1' ' A' ' 106' ' ' TYR . 16.8 mt -83.11 67.88 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.767 HG23 ' H ' ' A' ' 289' ' ' GLY . 3.5 t -146.4 168.0 22.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.775 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -52.66 -45.66 66.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.47 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -71.87 -57.4 4.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.767 ' H ' HG23 ' A' ' 286' ' ' THR . . . -56.54 -57.19 20.66 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.803 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.432 ' O ' HD13 ' A' ' 290' ' ' LEU . 0.2 OUTLIER -56.1 -36.72 68.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.722 0.296 . . . . 0.0 111.123 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -78.66 -27.7 45.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.04 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.07 -57.8 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.189 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.3 t -54.03 -29.9 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.371 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -64.72 -60.42 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.364 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -82.01 -47.44 12.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.398 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -52.52 -67.07 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.259 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -159.93 89.77 1.86 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.011 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 -173.51 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.592 2.194 . . . . 0.0 112.188 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 300' ' ' GLY . 1.6 pp -178.84 -43.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.962 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 299' ' ' LEU . . . 164.34 121.89 0.58 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 110' ' ' VAL . . . 179.25 157.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 111.077 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.533 HG12 HG11 ' A' ' 110' ' ' VAL . 11.8 p -178.28 56.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -97.33 40.34 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 2.9 mt -145.26 167.74 22.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -113.33 -36.66 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.2 m -79.37 -52.46 8.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HD13 ' A' ' 311' ' ' LEU . 6.2 m-85 -67.48 -24.64 65.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -53.59 -29.9 39.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.101 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -69.17 -31.14 69.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -92.92 -38.16 11.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.948 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 307' ' ' TYR . 7.3 mp -58.97 -28.17 66.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.6 -26.74 56.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.214 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -57.24 -29.51 63.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 318' ' ' ALA . 0.8 OUTLIER -66.85 143.27 97.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.801 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.69 -37.27 1.77 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.493 2.129 . . . . 0.0 112.498 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.05 -59.02 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.637 ' CD1' HG21 ' A' ' 110' ' ' VAL . 8.9 tp -67.54 -29.93 47.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 314' ' ' ASP . . . -67.39 -36.29 81.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.152 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -79.29 -33.79 43.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.2 m -76.85 -40.86 46.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.464 ' HA ' ' HB3' ' A' ' 324' ' ' ALA . 3.3 ptt? -58.17 -25.82 61.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.64 -57.62 11.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.677 ' HB2' HG21 ' A' ' 246' ' ' VAL . 2.2 t30 -78.47 -30.58 47.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 321' ' ' MET . . . -59.3 -42.21 90.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.27 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -29.05 64.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.402 ' CD ' ' HG3' ' A' ' 254' ' ' PRO . 6.0 mttp -97.44 -30.72 12.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -80.0 -165.02 30.83 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.506 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.421 ' HG3' ' CZ ' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -160.57 165.78 30.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.773 0.321 . . . . 0.0 110.915 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 329' ' ' ILE . 3.9 mp -83.21 130.77 35.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.82 101.76 10.12 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.971 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -68.82 -10.91 30.45 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.478 2.119 . . . . 0.0 112.541 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 65.87 84.79 0.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.878 0.371 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 336' ' ' MET . 8.3 tt -79.48 127.6 77.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -51.67 -34.59 54.12 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.344 2.029 . . . . 0.0 112.429 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -57.79 -30.4 65.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.416 ' HB2' HG23 ' A' ' 333' ' ' ILE . 0.0 OUTLIER -59.27 -25.57 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.7 p -54.73 -30.87 57.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.76 -30.95 45.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -77.93 -26.49 48.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.046 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 41.3 m95 -56.21 -43.68 78.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.98 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 -28.94 43.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.39 -51.29 58.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.333 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 347' ' ' VAL . 12.8 p -54.61 -29.89 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.349 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.493 ' HB3' HD12 ' A' ' 348' ' ' ILE . 0.0 OUTLIER -75.17 -60.9 2.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.606 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 4.5 p -60.54 -29.94 69.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -75.6 -50.52 15.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.511 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 343' ' ' VAL . 37.4 t -79.54 -53.36 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.789 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.493 HD12 ' HB3' ' A' ' 344' ' ' ARG . 69.3 mt -51.68 -39.81 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.901 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 350' ' ' ALA . 35.8 p30 -51.45 -25.8 7.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 111.41 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . 0.44 ' N ' ' OD1' ' A' ' 349' ' ' ASN . . . -62.14 -33.61 74.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 0.0 111.038 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -78.36 -11.57 59.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.484 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.5 p -67.67 -30.23 69.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.819 0.342 . . . . 0.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 96.64 -14.24 64.39 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.73 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -130.38 39.86 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 110.97 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.17 132.87 11.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 68.5 p -115.7 142.22 47.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 31.0 m -58.62 -27.94 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.243 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.37 -38.24 65.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -51.08 9.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.76 -29.9 67.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.516 HD21 ' OH ' ' A' ' 167' ' ' TYR . 9.9 mt -82.18 -56.39 3.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.004 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -63.62 -53.18 55.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -55.93 -47.88 76.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.47 -53.21 55.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.161 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -56.97 -30.53 64.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 8.7 p -80.68 -40.24 25.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.043 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 5.3 mtp-105 -73.67 -37.42 65.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.5 mt -75.72 -47.21 34.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.247 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 92.8 m -103.65 -75.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.956 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 17.7 tptm . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.877 -179.936 . . . . . . . . 0 0 . 1 stop_ save_